Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,regulation of smoothened signaling pathway (GO:0008589),-0.5826860463916995,-2.036447590380012,0.0,0.11621991062835986,0.105,17/50,9.91%,GLI3;ZIC1;FGFR2;GPC3;SMO;DCDC2;GAS1;TULP3;IFT81;CREBBP;RORA;ARMC9;EVC;MEGF8;INTU;GLI1;PTCH1
prerank,retinoid metabolic process (GO:0001523),-0.5329231316408266,-2.010285813759161,0.0,0.09684992552363322,0.16,12/71,3.93%,GPC6;ALDH1A1;LRP1;ALDH1A2;SDC2;HSPG2;GPC3;RBP1;CYP26B1;APOE;ABCA4;RBP4
prerank,mesonephric tubule development (GO:0072164),-0.7759306307224998,-1.9978520317497444,0.0,0.0771571073338278,0.192,8/15,11.67%,FGFR2;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1;PKD1
prerank,cellular nitrogen compound biosynthetic process (GO:0044271),0.8138632555664109,1.9945504289578904,0.0,0.17841740463156738,0.136,7/26,5.93%,NOS1;ACER2;NOS3;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,ureteric bud development (GO:0001657),-0.739773102193483,-1.9761450277247312,0.0,0.07941693892937925,0.252,8/17,11.08%,FGFR2;GPC3;BMP7;SLIT2;BMP4;OSR1;SIX1;SALL1
prerank,establishment of endothelial barrier (GO:0061028),0.7749226236558393,1.9720819169421855,0.0,0.15966330244018104,0.224,12/29,9.21%,PECAM1;RAPGEF2;F11R;RAPGEF1;F2RL1;SOX18;MSN;RAPGEF6;PPP1R16B;ROBO4;TJP2;TJP1
prerank,skeletal system morphogenesis (GO:0048705),-0.5794509885668462,-1.9572406443077517,0.0,0.08813343222650623,0.332,14/42,8.10%,FGFR2;HOXC4;PDGFRA;TGFBR1;CYP26B1;HOXA3;HOXB3;FBN2;HOXB4;MEGF8;ANKRD11;SFRP4;SIX1;WWOX
prerank,B cell differentiation (GO:0030183),0.7063316398605289,1.9415653318534731,0.0,0.20511243297606324,0.374,8/46,6.32%,PTPRJ;PLCG2;VCAM1;KLF6;HDAC9;HHEX;TPD52;ADAM17
prerank,heterochromatin organization (GO:0070828),0.8623673323209541,1.9246895652495708,0.0,0.2250492262966361,0.485,2/14,0.09%,PRDM16;MECOM
prerank,embryonic skeletal system development (GO:0048706),-0.6067831523981194,-1.9241188917866858,0.0,0.12186948961723847,0.469,15/35,7.50%,COL1A1;HOXC4;PDGFRA;SULF1;SULF2;OSR1;WNT5A;HOXA3;HOXB3;RBP4;XYLT1;HOXB4;MEGF8;SIX1;WNT9A
prerank,regulation of glucose import (GO:0046324),-0.6148169754362662,-1.91888155007496,0.0,0.1117924854615652,0.49,13/30,8.12%,PRKAG2;PID1;IGF1;SORBS1;APPL2;RHOQ;GRB10;ENPP1;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,collagen fibril organization (GO:0030199),-0.480475032923268,-1.9088498793165256,0.0,0.11464609933860083,0.549,40/88,13.67%,COL1A2;COL3A1;ADAMTS2;COL4A5;COL1A1;COL4A6;COL5A1;COL12A1;COL22A1;TGFBR1;COL4A3;COL25A1;COL4A4;LOXL1;COL6A2;COL6A3;COL11A1;COL26A1;COL8A2;COL6A1;TLL1;COL13A1;COL27A1;COL23A1;LOXL3;P4HA1;COL15A1;ADAMTS3;SERPINH1;COL20A1;COL16A1;P3H1;COL9A2;PLOD2;P3H2;DPT;LUM;ADAMTS14;COL8A1;COL5A3
prerank,vasodilation (GO:0042311),0.8993450770570065,1.908101130035259,0.0,0.2518118369913712,0.576,5/13,2.63%,NOS1;NOS3;KLF2;F2RL1;ADRB2
prerank,mesoderm development (GO:0007498),0.8299820351905692,1.9052692132143205,0.0,0.2218390646602727,0.594,4/18,1.44%,BMX;TIE1;TBX1;TBXT
prerank,regulation of systemic arterial blood pressure by hormone (GO:0001990),0.8512918058811574,1.8937959487531422,0.004754358161648178,0.2327246503595201,0.666,3/14,1.04%,NOS3;EDN1;ACE
prerank,regulation of cell-cell adhesion (GO:0022407),0.7053206450848949,1.8915473203405062,0.0,0.21275768634687617,0.673,8/39,1.06%,PODXL;JAG1;PTPRG;PTPRR;EFNA5;CEACAM1;MAGI1;SMAD7
prerank,positive regulation of interleukin-10 production (GO:0032733),0.7391742943835574,1.8886773382937931,0.0014184397163120568,0.1985794724529377,0.689,5/30,5.43%,PLCG2;NOD2;F2RL1;LGALS9;CD34
prerank,regulation of vasculogenesis (GO:2001212),0.8470494876664115,1.8879888438288057,0.0,0.18166135744305043,0.697,9/14,5.43%,RAPGEF2;CEACAM1;ASB4;HEY1;EMP2;TMEM100;HEY2;RRAS;CD34
prerank,B cell receptor signaling pathway (GO:0050853),0.7348203212916923,1.8764048198682448,0.0014285714285714286,0.1996136872065986,0.762,4/32,5.48%,BMX;PLCG2;MEF2C;PLEKHA1
prerank,nitric oxide metabolic process (GO:0046209),0.8517279450586736,1.8763700964999033,0.0,0.18306369121051444,0.762,3/14,3.43%,NOS1;NOS3;GCH1
prerank,lymphocyte differentiation (GO:0030098),0.6508004697937941,1.8737601624744114,0.0,0.17638993412439047,0.781,11/68,6.32%,PTPRJ;PLCG2;JAG2;VCAM1;KLF6;DLL4;HDAC9;HHEX;TPD52;GATA3;ADAM17
prerank,ceramide biosynthetic process (GO:0046513),0.6973816126136548,1.8733820853808472,0.0,0.16552848497879993,0.784,12/40,9.87%,SGMS1;ST6GALNAC3;ST8SIA6;SGMS2;DEGS2;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5;B4GALT6
prerank,zinc ion homeostasis (GO:0055069),-0.6152652782834884,-1.8726934384373641,0.0032258064516129032,0.1643220403050977,0.721,13/28,6.94%,SLC39A14;SLC30A10;PRKN;SLC39A8;SLC39A13;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,regulation of endothelial cell proliferation (GO:0001936),0.6288394320150316,1.8686469830428845,0.0,0.1692937873492713,0.806,22/88,7.71%,VEGFC;PTPRM;CDH13;TEK;TIE1;PDGFB;BMPR2;FLT4;EGFL7;ACVRL1;EGR3;CAV1;PRKD1;CAV2;VEGFD;NRAS;VASH2;ANGPT1;PPP1R16B;AKT3;STAT1;ATP5F1A
prerank,peptide hormone secretion (GO:0030072),0.7523837148978352,1.8660075744888964,0.002967359050445104,0.16454190334807545,0.815,3/26,0.76%,LTBP4;EDN1;EXOC3L1
prerank,nitric oxide biosynthetic process (GO:0006809),0.8544207470713532,1.865682341414042,0.0,0.15545928271206422,0.817,3/13,3.43%,NOS1;NOS3;GCH1
prerank,positive regulation of tumor necrosis factor production (GO:0032760),0.6488242343572018,1.8627182212271718,0.0012004801920768306,0.15391880266984648,0.831,20/69,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,regulation of interleukin-10 production (GO:0032653),0.6792603677569964,1.86081198458438,0.0013175230566534915,0.15158009765498892,0.838,10/44,10.88%,PLCG2;NOD2;F2RL1;LGALS9;FCGR2B;CD34;CD47;HMGB1;TYROBP;VSIR
prerank,lung development (GO:0030324),-0.5851939751697919,-1.8596932104769708,0.003436426116838488,0.17597631467644154,0.791,13/33,11.67%,ERRFI1;GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6;PKD1
prerank,diterpenoid metabolic process (GO:0016101),-0.5122039030729391,-1.853934157354618,0.0,0.17230482204522746,0.811,13/55,9.63%,GPC6;ALDH1A1;LRP1;SDC2;HSPG2;GPC3;RBP1;APOE;ABCA4;RBP4;NAPEPLD;DHRS3;STRA6
prerank,positive regulation of calcium-mediated signaling (GO:0050850),0.8710634297363319,1.8531974119003156,0.0,0.16351549640381713,0.868,2/11,0.16%,PLCG2;CDH13
prerank,negative regulation of blood pressure (GO:0045776),0.876971095494154,1.852937127930633,0.0,0.15640486769650386,0.869,3/13,0.97%,NOS1;NOS3;BMPR2
prerank,positive regulation of endothelial cell proliferation (GO:0001938),0.6331530469460872,1.8494221308696277,0.0,0.158004462934309,0.88,17/75,6.91%,VEGFC;CDH13;TEK;GATA2;PDGFB;BMPR2;FLT4;EGFL7;JCAD;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B;ADAM17;AKT3
prerank,respiratory system development (GO:0060541),-0.5908267760022641,-1.8480947262520209,0.0,0.16956807793762785,0.832,11/32,9.63%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.6410907876833839,1.8469417437635205,0.0012106537530266344,0.1572611906436345,0.897,20/73,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;IL1A;HSPB1;OAS2;JAK2;HMGB1;DHX9;TYROBP;CYBA;CLU;DDT
prerank,cardiac ventricle development (GO:0003231),0.7839588148066311,1.845964024721877,0.0015015015015015015,0.1533274571052532,0.9,8/20,6.03%,GJA5;ENG;NOTCH1;DAND5;HEY1;DLL4;HEY2;GATA3
prerank,positive regulation of cell-matrix adhesion (GO:0001954),0.6909669299008526,1.8459398902825879,0.0,0.14723490823118662,0.9,8/42,4.97%,PTPRJ;CDH13;TEK;UTRN;EMP2;PPM1F;RRAS;MAP4K4
prerank,endothelial cell development (GO:0001885),0.738325976174033,1.8404559631791673,0.0,0.15416573818033596,0.92,8/25,5.54%,PECAM1;RAPGEF2;RAPGEF1;F2RL1;SOX18;MSN;PPP1R16B;ROBO4
prerank,activation of protein kinase A activity (GO:0034199),-0.7093048972606679,-1.8353370252980674,0.0,0.18177986021358852,0.869,10/16,14.78%,ADCY5;ADCY9;ADCY1;ADCY2;PRRC1;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A
prerank,aortic valve development (GO:0003176),0.7061261733791943,1.8346341532851507,0.001375515818431912,0.16493848033385428,0.931,15/34,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;BMPR2;NOTCH1;HEY1;DLL4;HEY2;EFNA1;TNFRSF1B;GATA3;SNAI2;ROCK1
prerank,blood vessel morphogenesis (GO:0048514),0.6533180876049551,1.8329802217786761,0.0,0.16357342413259363,0.932,13/54,3.58%,GJA5;SOX17;ENG;FLT1;RASIP1;FLT4;SMAD7;TBX1;EGFL7;CAV1;ID1;SOX18;HEY2
prerank,regulation of lymphocyte migration (GO:2000401),0.8833785863936746,1.8305438712979316,0.0,0.16356093970828836,0.938,3/10,4.24%,STK10;JAM2;MSN
prerank,regulation of calcium-mediated signaling (GO:0050848),0.7463526722156111,1.8295133029230688,0.0,0.160541872993291,0.939,6/25,10.16%,PLCG2;CDH13;GPR143;LRRK2;CMKLR1;CCL4
prerank,regulation of epidermal growth factor receptor signaling pathway (GO:0042058),0.6365085929099795,1.8260032311110523,0.002583979328165375,0.1643886167673917,0.945,14/65,7.33%,PTPRJ;CDH13;AFAP1L2;HIP1;CEACAM1;HIP1R;ITGA1;DAB2IP;CBL;SHKBP1;SH3KBP1;BCAR3;DUSP3;PTPN12
prerank,cellular response to vascular endothelial growth factor stimulus (GO:0035924),0.6928225551604323,1.824841333592089,0.00410958904109589,0.16197588598742968,0.949,11/34,7.60%,VEGFC;FLT1;FLT4;NOTCH1;EGR3;DAB2IP;PRKD1;DLL4;VEGFD;HSPB1;NUS1
prerank,energy reserve metabolic process (GO:0006112),-0.6629191850415397,-1.8236648671123132,0.0,0.19390738660195994,0.896,5/19,6.77%,PRKAG2;PID1;LEPR;PHKB;PYGM
prerank,negative regulation of T cell mediated immunity (GO:0002710),0.8507619594858681,1.8218013891048335,0.001652892561983471,0.16490093458372135,0.957,2/11,1.06%,CEACAM1;SMAD7
prerank,embryonic limb morphogenesis (GO:0030326),-0.5588794107380235,-1.8211936421761794,0.0034965034965034965,0.18640382332448607,0.899,14/34,11.56%,CACNA1C;AFF3;GLI3;OSR1;CYP26B1;CREBBP;FBXW4;NIPBL;MEGF8;INTU;PTCH1;SALL1;TBX2;HDAC1
prerank,ceramide metabolic process (GO:0006672),0.6630620412367921,1.8194744049338014,0.0025940337224383916,0.16550718801969094,0.965,12/49,9.27%,SGMS1;ACER2;ST6GALNAC3;SGMS2;DEGS2;PLPP1;CERS4;SPTLC2;SPTLC1;ASAH2;CERS6;CERS5
prerank,regulation of angiogenesis (GO:0045765),0.5648965227475238,1.8188165921910044,0.0,0.16190800193026975,0.965,40/192,7.36%,VEGFC;PTPRM;TEK;NOS3;GATA6;CLDN5;GATA2;FLT1;TIE1;CEACAM1;PIK3R6;FOXO4;ATP2B4;ECSCR;DAB2IP;PRKD1;TGFB2;RHOB;EMP2;CEMIP2;BTG1;HHEX;ANXA3;PDE3B;KLF4;VEGFD;PLXND1;RRAS;VASH2;PPP1R16B;CD34;TSPAN12;PGK1;WARS1;IL1A;NPR1;ZC3H12A;ADAM12;STAT1;HSPB1
prerank,positive regulation of vasculature development (GO:1904018),0.6118137376340357,1.8181385738310272,0.0,0.15864956718659257,0.965,20/94,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;VEGFD;RRAS;VASH2;CD34;IL1A;ZC3H12A;ADAM12;HSPB1
prerank,glutamine family amino acid catabolic process (GO:0009065),0.8449418177113545,1.8141269320176658,0.005042016806722689,0.16408811983084412,0.972,6/13,5.83%,NOS1;NOS3;GLS2;GLS;ARG1;GLUD1
prerank,heart morphogenesis (GO:0003007),0.6446220925207481,1.8134082050188722,0.0012987012987012987,0.1613973232686876,0.972,14/50,4.11%,SOX17;NOS3;ENG;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;INSR;HEY1;TGFB2;FKBP1A;HEY2;ACVR1
prerank,B cell activation (GO:0042113),0.630271421454398,1.8115325385842107,0.0012165450121654502,0.16154781028339033,0.975,11/68,6.32%,PTPRJ;PLCG2;VCAM1;CASP8;KLF6;HDAC9;HHEX;CTPS1;MEF2C;TPD52;ADAM17
prerank,blood vessel diameter maintenance (GO:0097746),0.7115622277062379,1.8076285183009304,0.0014367816091954023,0.16721563007941498,0.98,6/34,2.44%,NOS1;NOS3;EDN1;ACE;KLF2;F2RL1
prerank,regulation of plasminogen activation (GO:0010755),-0.7482203781548278,-1.8067576293240215,0.0024875621890547263,0.20544290451700697,0.931,5/12,11.24%,SERPINE2;THBS1;CLEC3B;RUNX1;SERPINE1
prerank,cellular zinc ion homeostasis (GO:0006882),-0.6030152062246064,-1.8016455406879512,0.003134796238244514,0.2046951661214201,0.942,12/26,6.94%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,membrane lipid biosynthetic process (GO:0046467),0.6345375714215334,1.80058624684456,0.0012987012987012987,0.18009872163751894,0.985,17/58,9.75%,SGMS1;ACER2;SGPP2;ST8SIA6;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;CERT1;ELOVL4;CERS6;CERS5;HACD4
prerank,positive regulation of cation transmembrane transport (GO:1904064),0.6686394564600042,1.7933022792905435,0.0013404825737265416,0.19415443761584525,0.988,6/41,5.31%,NOS1;KCNN4;KCNQ1;KCNN3;NOS1AP;STAC
prerank,negative regulation of catalytic activity (GO:0043086),0.7394396194299947,1.791876975344078,0.008968609865470852,0.19329338009701652,0.989,2/24,1.60%,NOS1;NOTCH1
prerank,positive regulation of vasculogenesis (GO:2001214),0.8529878194255949,1.7866881689617329,0.001718213058419244,0.20267793240494553,0.993,6/10,5.43%,RAPGEF2;CEACAM1;ASB4;TMEM100;RRAS;CD34
prerank,negative regulation of cell adhesion (GO:0007162),0.6273572061549545,1.7822272222860946,0.0025348542458808617,0.2108569327463978,0.994,19/72,10.05%,CDH13;PODXL;ACER2;JAG1;PLXNA4;RND1;ACVRL1;NOTCH1;DUSP1;PDE3B;PLXND1;ANGPT1;GCNT2;ARHGDIA;PTPRO;SNAI2;PTK2;ADAM10;SPINT2
prerank,positive regulation of nitrogen compound metabolic process (GO:0051173),0.7455757946778254,1.782019877150542,0.009375,0.2068240294549481,0.994,6/19,6.03%,PDGFB;KLF2;APP;SLCO1C1;KLF4;GATA3
prerank,interferon-gamma-mediated signaling pathway (GO:0060333),0.6545570787161572,1.7809166944792125,0.003952569169960474,0.20522746676370449,0.994,16/45,12.46%,IRF6;VCAM1;B2M;IRF2;IFNGR1;IRF9;CAMK2D;FCGR1A;STAT1;MT2A;OAS2;JAK2;TRIM25;GBP2;TRIM8;IRF5
prerank,leukocyte cell-cell adhesion (GO:0007159),0.7241870581428715,1.7782484485190153,0.004464285714285714,0.2074778152344363,0.995,6/24,9.75%,PECAM1;VCAM1;F11R;MSN;ROCK1;GFUS
prerank,negative regulation of cell-cell adhesion (GO:0022408),0.6566116888393504,1.7780412596193127,0.005376344086021506,0.20367803207302654,0.995,12/39,10.05%,PODXL;JAG1;NOTCH4;NOTCH1;APOA1;KLF4;PPM1F;ASS1;FXYD5;PTK2;MAD2L2;SPINT2
prerank,cellular response to sterol (GO:0036315),-0.7182049751649145,-1.7759864814531396,0.0,0.2590735507757188,0.98,9/13,17.12%,SMO;GRAMD1C;RORA;GPLD1;PTCH1;INSIG2;GRAMD1A;OSBPL7;GRAMD1B
prerank,sphingolipid biosynthetic process (GO:0030148),0.6063812708699243,1.7755443891212137,0.003708281829419036,0.20629512410524978,0.996,26/71,14.95%,SGMS1;ACER2;SGPP2;SGMS2;DEGS2;PRKD1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;CERT1;A4GALT;ELOVL4;CERS6;CERS5;HACD4;B4GALT6;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK
prerank,intestinal lipid absorption (GO:0098856),0.8360120797160124,1.7745936599095993,0.008347245409015025,0.20455587244468132,0.997,1/11,0.46%,LIMA1
prerank,regulation of cellular respiration (GO:0043457),0.770480809738078,1.7728920481439243,0.003115264797507788,0.2054178532127213,0.997,1/17,0.01%,PRDM16
prerank,positive regulation of angiogenesis (GO:0045766),0.5817583866613504,1.7712439837859368,0.0,0.20582651063896834,0.997,22/108,7.36%,VEGFC;TEK;NOS3;GATA6;GATA2;FLT1;TIE1;PIK3R6;PRKD1;RHOB;BTG1;ANXA3;KLF4;VEGFD;RRAS;VASH2;CD34;IL1A;JMJD8;ZC3H12A;ADAM12;HSPB1
prerank,regulation of hydrolase activity (GO:0051336),0.6189347247129016,1.771241128448309,0.002466091245376079,0.20201490859009857,0.997,16/71,5.38%,NOS1;FGD5;EFNA5;RASIP1;RABGAP1;PLXNA4;CHN2;DAB2IP;CAV1;PRKG1;CRK;APOA1;GPR137B;PLXND1;RAPGEF6;FGD6
prerank,positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),-0.7363742508393623,-1.7699686950780973,0.0048543689320388345,0.2620045353639341,0.983,4/11,9.13%,EGFR;DDX5;BMP4;MAP2K2
prerank,hemidesmosome assembly (GO:0031581),0.8282020784471564,1.7696092089147366,0.017699115044247787,0.20263646141729869,0.997,3/11,6.94%,LAMA3;DST;PLEC
prerank,clathrin coat assembly (GO:0048268),0.7939758521283968,1.768913431448878,0.0075528700906344415,0.20075578504099859,0.997,5/15,8.71%,HIP1;HIP1R;PIK3C2A;FCHO2;NSG2
prerank,regulation of T cell receptor signaling pathway (GO:0050856),0.6771848348722227,1.76867297514388,0.004149377593360996,0.19785622273985118,0.997,3/33,0.80%,PTPRJ;KCNN4;CEACAM1
prerank,peptidyl-tyrosine autophosphorylation (GO:0038083),0.7804284780762222,1.766579090435773,0.006299212598425197,0.1996359321808153,0.997,1/15,0.01%,BMX
prerank,positive regulation of interleukin-12 production (GO:0032735),0.6955597185875575,1.7663363203436089,0.004297994269340974,0.19681927677721536,0.997,9/31,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;LTB;HMGB1;LAPTM5;IRF5
prerank,T cell mediated immunity (GO:0002456),0.8078895890101259,1.7645750563569593,0.014492753623188406,0.1978135391502264,0.998,4/13,2.80%,JAG1;CRTAM;CADM1;EMP2
prerank,cellular response to zinc ion (GO:0071294),-0.6787385090161367,-1.763574245294337,0.005681818181818182,0.2666278449665622,0.987,9/15,7.34%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;P2RX4
prerank,cellular response to glucagon stimulus (GO:0071377),-0.6609419649264134,-1.7625914931213156,0.015060240963855422,0.2566984216497821,0.987,10/17,17.75%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,endocardial cushion development (GO:0003197),0.7422378447388851,1.7606911032830612,0.00741839762611276,0.20409315818556997,0.999,8/21,4.11%,NOS3;ENG;BMPR2;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,lamellipodium assembly (GO:0030032),0.7020013108553907,1.7593380876212825,0.007082152974504249,0.20394064222594754,1.0,10/26,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,morphogenesis of a polarized epithelium (GO:0001738),0.8057623345284454,1.7589351985110782,0.014754098360655738,0.20162067821370303,1.0,4/12,11.20%,LAMA3;LAMA5;ACTG1;ACTB
prerank,cellular response to drug (GO:0035690),0.7030600247289871,1.7589048992315497,0.009929078014184398,0.19853371356996322,1.0,5/25,5.32%,ACER2;KCNQ1;AIM2;PPM1F;MEF2C
prerank,regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),-0.6376588894927001,-1.7587554182847136,0.002857142857142857,0.2537908275653389,0.989,6/16,7.26%,IGF1;IGFBP5;IGFBP2;BMP5;IGFBP6;IGFBP3
prerank,regulation of cell junction assembly (GO:1901888),0.6968595515773149,1.7587535408617352,0.007518796992481203,0.19572888357746246,1.0,11/27,9.21%,RAPGEF2;CLDN5;F11R;OCLN;RAPGEF1;PDLIM5;MEF2C;MYO1C;SNAI2;ROCK1;TJP1
prerank,vascular endothelial growth factor signaling pathway (GO:0038084),0.7966055836028596,1.7548700955885543,0.004830917874396135,0.20224018309089598,1.0,5/14,8.12%,VEGFC;FLT4;VEGFD;NUS1;MYO1C
prerank,positive regulation of ion transmembrane transporter activity (GO:0032414),-0.5757374658647074,-1.754808964381497,0.005649717514124294,0.252862522943225,0.991,11/25,14.75%,ANK2;DMD;WNK1;ACTN2;WNK4;ATP1B3;SLC6A9;COX17;TRPC6;ATP1B1;ATP1B2
prerank,regulation of cardiac muscle cell proliferation (GO:0060043),-0.6238375530741589,-1.7537582419339768,0.0,0.24511101984606173,0.991,11/19,11.27%,TGFBR3;BMPR1A;FGFR2;TGFBR1;ZFPM2;RBPJ;RBP4;FGF2;RUNX1;GLI1;TBX2
prerank,macrophage activation (GO:0042116),0.687714296242105,1.7516453783917716,0.006963788300835654,0.2068625132397209,1.0,9/34,9.09%,PLCG2;CD93;DYSF;IFNGR1;APP;ITGAM;JAK2;NMI;FOXP1
prerank,response to glucagon (GO:0033762),-0.6349298576375071,-1.7484156466756366,0.006097560975609756,0.2489817885361563,0.994,11/19,17.75%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;CREB1;PRKAR2A;PRKAR2B;PRKAR1A;CYSLTR2
prerank,respiratory tube development (GO:0030323),-0.5738103705723621,-1.7475718408074503,0.006578947368421052,0.2414170643533334,0.994,11/28,9.63%,GLI2;FGFR2;PDPN;BMP4;FGF1;RBP4;LOXL3;NPHP3;FGF2;VEGFA;STRA6
prerank,substrate-dependent cell migration (GO:0006929),0.798554586265729,1.7465670027071436,0.0031496062992125984,0.2160448719853505,1.0,4/14,4.50%,VEGFC;CD2AP;NTN1;SHTN1
prerank,mesenchyme morphogenesis (GO:0072132),0.7686304314239879,1.7464110255263239,0.0030816640986132513,0.21320762318950146,1.0,8/17,5.38%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1;SMAD2
prerank,aortic valve morphogenesis (GO:0003180),0.6956140885171488,1.744082613758411,0.002894356005788712,0.2163745489123578,1.0,13/30,9.04%,ELN;JAG1;NOS3;TIE1;SMAD6;NOTCH1;HEY1;DLL4;HEY2;EFNA1;GATA3;SNAI2;ROCK1
prerank,regulation of nitric oxide biosynthetic process (GO:0045428),0.6619259686790667,1.7427190933664847,0.007989347536617843,0.21682512057738335,1.0,15/38,12.63%,EDN1;KLF2;ATP2B4;INSR;CAV1;NOS1AP;KLF4;CD34;ASS1;CD47;ZC3H12A;JAK2;RAC1;CLU;CX3CR1
prerank,regulation of cardiac conduction (GO:1903779),0.6212841577669976,1.7417766029243908,0.0037593984962406013,0.21605232592103862,1.0,11/54,3.81%,NOS1;ATP2A3;GJA5;NPR2;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,response to prostaglandin E (GO:0034695),-0.7470896559952815,-1.7413069945246307,0.014388489208633094,0.2476488465982088,0.994,1/10,0.09%,TGFBR3
prerank,negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.727775495625782,1.7401989801042477,0.007575757575757576,0.21716153281666026,1.0,6/22,11.23%,PTPRJ;CEACAM1;FCGR2B;DUSP3;PRNP;LAPTM5
prerank,response to lipid (GO:0033993),0.5764848643568702,1.7391953305156915,0.0011560693641618498,0.2164050783910373,1.0,21/105,10.93%,NOS1;ACER2;NOS3;GATA6;SMAD6;ALPL;FOXO1;LGALS9;GCH1;TIRAP;TRIM6;IFNAR1;PCK2;RXRG;ADAM17;HNRNPA0;PAQR8;JAK2;FOXP1;STRN3;TAB2
prerank,branching involved in blood vessel morphogenesis (GO:0001569),0.7778947698555418,1.7382013732010457,0.006389776357827476,0.21625000429548835,1.0,3/13,2.96%,NOTCH4;ENG;DLL4
prerank,response to molecule of bacterial origin (GO:0002237),0.6042876011763891,1.7378452768971557,0.0012391573729863693,0.21424494267286448,1.0,17/69,12.88%,NOS1;NOS3;SMAD6;LGALS9;GCH1;TIRAP;FCGR2B;TRIM6;IFNAR1;ADAM17;HNRNPA0;JAK2;ACOD1;FOXP1;TAB2;IRF5;RPS6KA3
prerank,positive regulation of sodium ion transport (GO:0010765),0.812154185293082,1.731604807245592,0.00641025641025641,0.22755065094834787,1.0,2/12,0.99%,NOS1;CNKSR3
prerank,negative regulation of T cell receptor signaling pathway (GO:0050860),0.7481972476409682,1.7303748196619742,0.007716049382716049,0.2281684116922929,1.0,5/17,11.23%,PTPRJ;CEACAM1;DUSP3;PRNP;LAPTM5
prerank,amide biosynthetic process (GO:0043604),0.6380307008992901,1.724555661978654,0.0026041666666666665,0.24101234851769984,1.0,13/47,9.27%,SGMS1;SGMS2;DEGS2;CERS4;PCSK5;SPTLC2;FURIN;SPTLC1;ARG1;ASAH2;ASS1;CERS6;CERS5
prerank,nitric oxide mediated signal transduction (GO:0007263),0.7561071816193722,1.721180369564306,0.015479876160990712,0.2471359831341945,1.0,2/16,0.41%,NOS1;NOS3
prerank,skeletal system development (GO:0001501),-0.40236789822041846,-1.7201519544775425,0.0,0.2946313091465385,0.998,38/148,10.82%,COL1A2;BMP6;IGF1;SOX5;COL1A1;GLI2;FGFR2;SULF1;TGFBR1;CDH11;BMP5;BMP7;NPR3;SULF2;MMP14;TLL1;WNT5A;COL13A1;TRIP11;GJA1;RBP4;SH3PXD2B;FBN1;ITGB8;TNFRSF11B;XYLT1;PRELP;EVC;ANKRD11;VCAN;IGF2;WWOX;P3H1;PKDCC;PTH1R;COL9A2;MMP16;HYAL1
prerank,positive regulation of nitric oxide biosynthetic process (GO:0045429),0.7014158171299867,1.7191898396268104,0.014598540145985401,0.2491285673818729,1.0,6/25,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,artery development (GO:0060840),0.7003070607128106,1.7181583028859349,0.01167883211678832,0.24863711488013326,1.0,6/23,1.57%,GJA5;ENG;BMPR2;SMAD7;TBX1;ACVRL1
prerank,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.7362969099160281,1.7178230498486808,0.020933977455716585,0.24636209397750172,1.0,2/17,1.54%,JAG1;BACH2
prerank,cellular glucan metabolic process (GO:0006073),-0.7503145353904784,-1.716623124636294,0.0,0.2949247214824845,0.998,3/11,6.77%,PRKAG2;PHKB;PYGM
prerank,regulation of tumor necrosis factor production (GO:0032680),0.5699129236085833,1.7165958540383606,0.0011376564277588168,0.24684453424878783,1.0,28/112,12.70%,PTPRJ;PLCG2;NOD2;ARHGEF2;IFNGR1;IFIH1;LGALS9;APP;TLR3;TIRAP;CD34;IL1A;NFKBIL1;CD47;ZC3H12A;HSPB1;OAS2;JAK2;CACTIN;FOXP1;HMGB1;DHX9;TYROBP;VSIR;CYBA;CLU;CX3CR1;DDT
prerank,eye development (GO:0001654),-0.4707501472443552,-1.7139598531775795,0.0,0.292034808762262,0.998,13/54,6.70%,CACNA1C;SMOC1;EFEMP1;COL5A1;LAMA1;PBX3;FBN2;RBP4;SH3PXD2B;FBN1;NIPBL;MEIS1;SHROOM2
prerank,lipoprotein localization (GO:0044872),-0.7048483685535095,-1.7133157020162415,0.007425742574257425,0.28383276560716386,0.999,5/11,13.81%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,positive regulation of lyase activity (GO:0051349),0.7752143728591192,1.7122466886244818,0.008237232289950576,0.25555669428109795,1.0,4/14,5.17%,NOS1;NOS3;ORAI1;AKAP5
prerank,positive regulation of interleukin-1 production (GO:0032732),0.6111187688421469,1.7114020000361947,0.002570694087403599,0.25494262865826767,1.0,15/51,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;TMED10;P2RX7;HSPB1;JAK2;EGR1;HMGB1;TYROBP;CASP1
prerank,positive regulation of cyclase activity (GO:0031281),0.7678188834455428,1.709528417316408,0.008012820512820512,0.25695275646129334,1.0,4/14,5.17%,NOS1;NOS3;ORAI1;AKAP5
prerank,regulation of epithelial cell migration (GO:0010632),0.6213080719977108,1.7092461332182292,0.006476683937823834,0.2548968176835415,1.0,19/51,10.49%,PLCG2;PTPRG;PTPRR;CEACAM1;BMPR2;RAB11A;MACF1;DAB2IP;TGFB2;EMP2;EVL;PPM1F;ADIPOR1;CLASP1;MCC;PTK2;RTN4;CLASP2;PLCG1
prerank,positive regulation of cell-substrate junction organization (GO:0150117),0.7169623542893069,1.709198691545541,0.005961251862891207,0.25215810161731605,1.0,8/24,10.68%,PTPRJ;TEK;PPM1F;IQSEC1;MAP4K4;DUSP3;ROCK1;RAC1
prerank,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),0.8236892832230484,1.7068488705658187,0.01584507042253521,0.2555964486047681,1.0,3/11,4.95%,NOS1;NOS1AP;CAMK2D
prerank,cellular response to interferon-gamma (GO:0071346),0.5721090245612455,1.7063278633839645,0.0023923444976076554,0.25394625099782775,1.0,25/88,12.46%,IRF6;VCAM1;GBP5;B2M;IRF2;IFNGR1;LGALS9;GBP4;IRF9;CAMK2D;GBP3;FCGR1A;CD47;STAT1;MT2A;OAS2;JAK2;ACOD1;GAPDH;TRIM25;CCL4;CASP1;GBP2;TRIM8;IRF5
prerank,regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.5742557460470608,1.7056070817122155,0.0023952095808383233,0.2530812098306472,1.0,11/86,4.92%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;FYN;ARHGEF2;APP;ACVR1;ANGPT1;EFNA1
prerank,regulation of interleukin-12 production (GO:0032655),0.6257143259118494,1.7055366517065713,0.00392156862745098,0.2506106152177643,1.0,12/47,12.46%,PLCG2;PLCB1;LGALS9;TLR3;TIRAP;CD47;CMKLR1;LTB;FOXP1;HMGB1;LAPTM5;IRF5
prerank,regulation of cardiac muscle contraction (GO:0055117),0.6561989426653148,1.704874999256182,0.010973936899862825,0.24971318932809125,1.0,5/34,3.81%,NOS1;GJA5;KCNQ1;SMAD7;SLC8A1
prerank,sphingolipid metabolic process (GO:0006665),0.5579788450040907,1.7048218816533751,0.00117096018735363,0.24715932572227053,1.0,29/108,15.26%,SGMS1;ACER2;SGPP2;ST6GALNAC3;SGMS2;DEGS2;ESYT2;PRKD1;PPT1;PLPP1;CERS4;SPTLC2;SPNS2;SPTLC1;ASAH2;GLTP;CERT1;ELOVL4;CERS6;CERS5;HACD4;ELOVL7;PRKD2;ALOXE3;PPM1L;ELOVL5;VAPA;AGK;TECR
prerank,dephosphorylation (GO:0016311),0.5402835860524207,1.7013220401135738,0.0,0.2537294861794094,1.0,25/147,9.03%,PTPRM;PTPRJ;PTPRB;SGPP2;PTPRG;PTPRR;ALPL;PTPN14;DUSP12;DUSP1;PLPP1;INPP5K;PPM1F;ACP6;PTPRE;CTTNBP2NL;DUSP16;THTPA;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C
prerank,cardiac atrium morphogenesis (GO:0003209),0.7557427240845768,1.7000788117124057,0.016025641025641024,0.25435349074057445,1.0,6/16,3.58%,ENG;BMPR2;NOTCH1;TGFB2;DLL4;HEY2
prerank,keratan sulfate catabolic process (GO:0042340),-0.7198725963756334,-1.6990277520290473,0.009900990099009901,0.31576102280877044,0.999,7/11,12.72%,OGN;FMOD;GNS;PRELP;HEXA;LUM;OMD
prerank,negative regulation of receptor binding (GO:1900121),0.8301501255581952,1.6988494894062336,0.015280135823429542,0.2550888913621551,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,positive regulation of focal adhesion assembly (GO:0051894),0.7385078993594814,1.6983299550254118,0.006069802731411229,0.2538741226486714,1.0,6/19,10.68%,PTPRJ;TEK;PPM1F;MAP4K4;ROCK1;RAC1
prerank,membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.620864272458282,-1.6981928972603055,0.0121580547112462,0.30883386857127043,0.999,5/17,6.67%,ATP1A2;ANK2;CACNA1C;CACNA2D1;CACNA1G
prerank,atrioventricular valve morphogenesis (GO:0003181),0.7262349954162002,1.6981240155791348,0.0109204368174727,0.2519030731641942,1.0,8/19,4.92%,SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;ACVR1;EFNA1
prerank,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),-0.6142023217400503,-1.6980963226371484,0.005633802816901409,0.300063857489986,0.999,4/16,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,glycosaminoglycan catabolic process (GO:0006027),-0.4780032240966768,-1.69744123978545,0.004524886877828055,0.29362130278036347,0.999,23/55,18.14%,GPC6;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;FMOD;GNS;BGN;FGF2;PRELP;HEXA;VCAN;HYAL1;LUM;CSPG4;OMD;HPSE2;GPC1;SDC1;SLC9A1;IDUA
prerank,defense response to fungus (GO:0050832),0.7360863317115668,1.6948999687692958,0.01098901098901099,0.25830175001087907,1.0,4/17,14.38%,PLCG2;GAPDH;CX3CR1;FAM3A
prerank,regulation of heart contraction (GO:0008016),0.5659078702511283,1.6931854064279748,0.007067137809187279,0.2602516799065409,1.0,15/90,4.95%,NOS1;ATP2A3;GJA5;KCNQ1;NPR2;SMAD7;ITPR3;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;TGFB2;SLC8A1;CAMK2D
prerank,regulation of glucose metabolic process (GO:0010906),-0.5425696675492738,-1.6920399998947626,0.0,0.3001809636090832,1.0,12/34,15.35%,OGT;PDK1;PRKN;RORA;IRS2;IRS1;GPLD1;ZNF692;FOXK2;PDK3;SLC45A3;PDK2
prerank,response to laminar fluid shear stress (GO:0034616),0.8144849627117421,1.691790810242958,0.010273972602739725,0.2610811172033091,1.0,6/10,8.27%,SMAD6;SMAD7;KLF2;KLF4;ASS1;NFE2L2
prerank,regulation of cell-matrix adhesion (GO:0001952),0.601439094500075,1.6910654198827018,0.005242463958060288,0.26048122290042475,1.0,16/64,9.21%,CDH13;ACER2;JAG1;EFNA5;UTRN;LIMCH1;MACF1;EMP2;ADAM15;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,glomerular visceral epithelial cell differentiation (GO:0072112),0.8080821901341092,1.6900252047369357,0.010169491525423728,0.2606651248727103,1.0,6/12,7.87%,PODXL;JAG1;MYO1E;IQGAP1;PROM1;PTPRO
prerank,regulation of natural killer cell mediated cytotoxicity (GO:0042269),0.6979248019054579,1.6861602758213365,0.009433962264150943,0.26859202450029857,1.0,4/23,2.70%,PIK3R6;CRTAM;LGALS9;CADM1
prerank,positive regulation of supramolecular fiber organization (GO:1902905),0.5681781888872206,1.6861178069495464,0.0035971223021582736,0.2661386636313381,1.0,18/86,11.83%,SYNPO;EDN1;FCHSD2;TRPV4;STMN2;OCLN;F2RL1;APP;FES;EVL;CDC42EP1;CLIP1;CLASP1;WDR1;NCKAP1;RAC1;NUMA1;CLU
prerank,positive regulation of nitric oxide metabolic process (GO:1904407),0.6845941608352818,1.6842863027119939,0.020437956204379562,0.2683019304497434,1.0,6/26,6.07%,EDN1;KLF2;INSR;NOS1AP;KLF4;ASS1
prerank,lipoprotein transport (GO:0042953),-0.7129266400634677,-1.6839671557456928,0.00966183574879227,0.3158878111403258,1.0,5/10,13.81%,LRP1;PRKCB;ZDHHC17;PPARG;UNC119B
prerank,branching involved in ureteric bud morphogenesis (GO:0001658),-0.6202740836214657,-1.6827247025651841,0.005434782608695652,0.31134702373597456,1.0,6/16,11.08%,FOXD1;BMP4;FGF1;FGF2;SIX1;SALL1
prerank,regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),-0.5661962414421522,-1.6817503170849324,0.014619883040935672,0.3061947645401019,1.0,7/20,10.07%,ATP1A2;ANK2;CACNA1C;DMD;CALM2;PRKACA;ATP2A2
prerank,Rap protein signal transduction (GO:0032486),0.8149002292042755,1.681694163781549,0.020618556701030927,0.2731411987398093,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,vasculogenesis (GO:0001570),0.6460222046510548,1.6814317041029125,0.011251758087201125,0.27139535893569355,1.0,8/32,3.58%,SOX17;ENG;RASIP1;EGFL7;NOTCH1;CAV1;SOX18;HEY2
prerank,sprouting angiogenesis (GO:0002040),0.6116413028250579,1.680755251790722,0.005115089514066497,0.270822569458666,1.0,10/51,4.45%,VEGFC;CDH13;TEK;ENG;FLT4;RECK;ACVRL1;EGR3;VEGFD;ANGPT1
prerank,axon extension (GO:0048675),-0.5745967579646017,-1.6800344064255126,0.006211180124223602,0.3037213664421138,1.0,10/23,11.04%,ALCAM;AUTS2;NRP2;SLIT2;SEMA5A;SEMA3A;USP9X;SPG11;PPP3CB;ULK2
prerank,"positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.7639828755499359,1.6793904255613041,0.011023622047244094,0.2697971151895493,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,"regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.7639828755499359,1.6793904255613041,0.011023622047244094,0.2697971151895493,1.0,3/15,2.60%,NANOS1;NANOS3;TNRC6C
prerank,peptidyl-tyrosine phosphorylation (GO:0018108),0.5767554009851562,1.6793778862833937,0.004962779156327543,0.2674749359007633,1.0,8/67,3.24%,BMX;TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES
prerank,second-messenger-mediated signaling (GO:0019932),0.5728224429171401,1.6784045694612872,0.0036144578313253013,0.26808449158375625,1.0,6/82,1.49%,NOS1;PLCG2;NOS3;EDN1;CCR1;MCTP1
prerank,cellular response to fluid shear stress (GO:0071498),0.7826467302953214,1.6766990430076916,0.016611295681063124,0.2704575743797878,1.0,5/12,8.27%,KLF2;KLF4;MEF2C;ASS1;NFE2L2
prerank,intestinal absorption (GO:0050892),0.7637157221488426,1.674504819490741,0.0224,0.27391646416192555,1.0,3/13,7.70%,KCNQ1;F11R;TJP2
prerank,negative regulation of cell growth (GO:0030308),0.5494246047988207,1.6740742873441172,0.0011376564277588168,0.27290955763342645,1.0,19/121,7.45%,SEMA3G;PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;SH3BP4;NPR1;HSPA1B
prerank,G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.7190868694761838,1.6730125503444866,0.01854714064914992,0.27301849699375014,1.0,4/18,6.12%,PLCB1;GNAQ;AGRN;CHRM3
prerank,lamellipodium organization (GO:0097581),0.6553358095090528,1.6727944203087262,0.01694915254237288,0.2713431362105087,1.0,10/29,10.68%,CDH13;SPATA13;S1PR1;ABLIM1;PARVB;WHAMM;PTPRO;CCDC88A;CYFIP1;RAC1
prerank,positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.6876735618062928,-1.6722744948458435,0.015151515151515152,0.31686460999366245,1.0,8/12,26.83%,STX4;ANO1;GPLD1;PPP3CB;C2CD2L;PLA2G6;CFTR;BAIAP3
prerank,neutrophil migration (GO:1990266),0.5808996194622197,1.6711851630156196,0.005154639175257732,0.2735325809455317,1.0,5/58,6.86%,PECAM1;EDN1;TGFB2;PIP5K1C;BSG
prerank,sphingosine metabolic process (GO:0006670),0.7359338477756713,1.671055579505452,0.015873015873015872,0.2716145735188466,1.0,6/17,5.93%,ACER2;SGPP2;PLPP1;SPTLC2;SPTLC1;ASAH2
prerank,regulation of Notch signaling pathway (GO:0008593),0.5724379907016247,1.6686389564812083,0.002466091245376079,0.27576895597617535,1.0,21/76,11.31%,JAG1;JAG2;NOTCH4;NOS3;GATA2;EGFL7;MFNG;NOTCH1;NOD2;HEY1;TGFB2;DLL4;TSPAN14;ARRDC1;POGLUT1;ARRB1;TM2D3;FBXW7;EPN2;MAML2;HIF1AN
prerank,endocardial cushion morphogenesis (GO:0003203),0.7226577150049823,1.6673540676017304,0.01669195751138088,0.2769377557686192,1.0,7/18,4.11%,NOS3;ENG;ACVRL1;NOTCH1;HEY1;TGFB2;ACVR1
prerank,embryonic digestive tract development (GO:0048566),-0.6126244391609706,-1.6637884112367078,0.014164305949008499,0.33277173219798833,1.0,10/18,11.08%,GLI3;GLI2;FGFR2;PDGFRA;RARB;NIPBL;RBPMS2;PKDCC;STRA6;SALL1
prerank,positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.6642984468656054,1.66287098667687,0.024853801169590642,0.2874790981536273,1.0,8/26,11.08%,TRPV4;STMN2;OCLN;FES;CLIP1;CLASP1;RAC1;NUMA1
prerank,membrane repolarization during action potential (GO:0086011),0.7662002055302795,1.6623421204190238,0.02037617554858934,0.28654916501433547,1.0,3/13,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,acetylcholine receptor signaling pathway (GO:0095500),0.7164910866241543,1.6608868001774664,0.01892744479495268,0.2884595637336964,1.0,5/20,7.75%,PLCB1;GNAQ;AGRN;CHRM3;LYPD1
prerank,negative regulation of cytokine production involved in immune response (GO:0002719),0.7510152099296485,1.6597737749551424,0.009787928221859706,0.2893342970261475,1.0,3/15,3.48%,SMAD7;TGFB2;APOA1
prerank,positive regulation of smooth muscle cell migration (GO:0014911),-0.6078075421484814,-1.6586107478448628,0.019444444444444445,0.34028108716536065,1.0,6/17,1.61%,DOCK5;IGF1;PDGFRB;IGFBP5;DOCK7;VTN
prerank,regulation of feeding behavior (GO:0060259),-0.6814725057278828,-1.6586081662697927,0.016706443914081145,0.3325474260934206,1.0,3/11,15.27%,LEPR;CFAP20;EIF2AK4
prerank,positive regulation of interleukin-1 beta production (GO:0032731),0.6092573103675237,1.6581926665851001,0.010652463382157125,0.29156283239254815,1.0,13/45,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;P2RX7;HSPB1;JAK2;EGR1;TYROBP;CASP1
prerank,regulation of biomineral tissue development (GO:0070167),0.6661826663635224,1.656906398123607,0.02,0.29353873962176974,1.0,8/26,9.04%,NOS3;SGMS2;S1PR1;NOTCH1;HEY1;HEY2;NBR1;ROCK1
prerank,positive regulation of peptidyl-lysine acetylation (GO:2000758),0.7026379804750684,1.6568907950598741,0.017830609212481426,0.2913289396324001,1.0,7/20,12.77%,NOS1;RPS6KA5;ARRB1;PRKAA1;BRCA1;DIP2B;GLYR1
prerank,negative regulation of vascular permeability (GO:0043116),0.7826350038308073,1.6566961774095585,0.015254237288135594,0.28957501115004647,1.0,4/12,4.45%,PTPRJ;CLDN5;CEACAM1;ANGPT1
prerank,plasma membrane tubulation (GO:0097320),0.7632155522140326,1.6563613237615307,0.028892455858747994,0.28837338033282295,1.0,6/13,8.40%,CAVIN2;PACSIN2;FNBP1L;PACSIN1;WHAMM;BIN3
prerank,positive regulation of positive chemotaxis (GO:0050927),0.7612056276878117,1.6549905777309553,0.00847457627118644,0.29001906478781236,1.0,4/15,3.84%,VEGFC;CDH13;F2RL1;VEGFD
prerank,diol metabolic process (GO:0034311),0.708304875432401,1.6543864929047989,0.015873015873015872,0.28937260542432997,1.0,6/19,5.93%,SGPP2;NOS3;DEGS2;PLPP1;GCH1;ASAH2
prerank,polyol metabolic process (GO:0019751),0.6044855501445762,1.6540451193599182,0.006622516556291391,0.28811697615407644,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,artery morphogenesis (GO:0048844),0.6664043645354671,1.6535066633772653,0.0113314447592068,0.2873754455738297,1.0,9/30,3.58%,GJA5;JAG1;ENG;BMPR2;SMAD7;TBX1;NOTCH1;TGFB2;HEY2
prerank,sphingoid biosynthetic process (GO:0046520),0.7954734593002658,1.6530378689844492,0.018151815181518153,0.2844657810519247,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,sphingosine biosynthetic process (GO:0046512),0.7954734593002658,1.6530378689844492,0.018151815181518153,0.2844657810519247,1.0,4/11,5.93%,ACER2;SPTLC2;SPTLC1;ASAH2
prerank,muscle cell differentiation (GO:0042692),0.6571127863971012,1.6524075179469349,0.011157601115760111,0.28401241322499865,1.0,8/32,5.52%,MRTFB;NEBL;GATA6;SYNE1;TBX1;HEY2;MEF2C;TMEM204
prerank,regulation of nitric-oxide synthase biosynthetic process (GO:0051769),0.7691696309275642,1.6523878591168004,0.02905982905982906,0.28204846807287187,1.0,4/13,8.51%,EDN1;NOD2;JAK2;NAMPT
prerank,endothelial cell migration (GO:0043542),0.6328907267096382,1.6516246961026166,0.006720430107526882,0.28190406826549824,1.0,10/37,7.31%,CDH13;NOS3;EGR3;EMP2;ID1;SOX18;PLXND1;PLEKHG5;MYH9;STAT1
prerank,positive regulation of purine nucleotide biosynthetic process (GO:1900373),0.7592793815712948,1.6501550903222133,0.026101141924959218,0.28379624760074446,1.0,2/13,0.41%,NOS1;NOS3
prerank,positive regulation of interleukin-6 production (GO:0032755),0.5718087618238797,1.6484802139259958,0.009913258983890954,0.28633093034168794,1.0,15/68,11.05%,PLCG2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;HMGB1;DHX9;TYROBP;CYBA
prerank,lipid oxidation (GO:0034440),0.7756600468614003,1.6480554997884083,0.02975206611570248,0.2855727165746721,1.0,3/12,8.17%,ADIPOR2;ADIPOR1;ACOX1
prerank,pulmonary valve morphogenesis (GO:0003184),0.725441325799288,1.6479601544592164,0.0265625,0.2838250408283227,1.0,8/17,3.58%,GJA5;JAG1;NOS3;SMAD6;NOTCH1;HEY1;TGFB2;HEY2
prerank,camera-type eye development (GO:0043010),-0.5575234400603105,-1.6459038316230308,0.014204545454545454,0.3615945774939026,1.0,8/25,9.63%,CACNA1C;EFEMP1;LAMA1;FBN2;FBN1;SHROOM2;VEGFA;STRA6
prerank,positive regulation of morphogenesis of an epithelium (GO:1905332),-0.5547878126094975,-1.6455180661496343,0.0125,0.35508130303392915,1.0,11/23,22.67%,SMO;BMP4;GJA1;FGF2;SIX1;VEGFA;MDK;PAX2;AGT;WNT5B;SIX4
prerank,regulation of interleukin-6 production (GO:0032675),0.5503539301104708,1.6433168459737137,0.004796163069544364,0.29400391201521386,1.0,20/96,11.05%,PLCG2;AFAP1L2;NOD2;ARHGEF2;F2RL1;IFIH1;LGALS9;APP;TLR3;TIRAP;HYAL2;IL1A;CD47;ZC3H12A;ARRB1;CD200;HMGB1;DHX9;TYROBP;CYBA
prerank,inositol phosphate metabolic process (GO:0043647),0.5988816039074449,1.642704527774602,0.007905138339920948,0.29362704628938996,1.0,9/46,4.18%,PLCG2;PLCB1;ITPKB;IP6K3;PLCB4;INPP5D;INPP1;IPPK;MINPP1
prerank,phosphatidylinositol metabolic process (GO:0046488),0.5435215142483604,1.6426492003318056,0.002317497103128621,0.291758448856601,1.0,23/109,11.65%,BMX;PLCG2;PIP5K1B;PLCB1;PITPNM3;PIK3R6;IP6K3;INPP5D;PIK3C2A;INPP5K;PLEKHA1;PIP5K1C;PGAP1;FIG4;LCLAT1;MTMR10;INPP5B;PIK3C3;ARF3;PLCG1;MTMR11;OCRL;INPP5F
prerank,regulation of microtubule depolymerization (GO:0031114),0.6511114317013251,1.6425806623975228,0.028985507246376812,0.2899553154663927,1.0,8/25,9.92%,TRPV4;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,regulation of cAMP-dependent protein kinase activity (GO:2000479),0.7534844260713871,1.6423292200940192,0.03225806451612903,0.2885453059551763,1.0,3/14,2.63%,RAPGEF2;ATP2B4;ADRB2
prerank,Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.5656631754210137,1.6422210019059407,0.00834326579261025,0.2868937460764105,1.0,27/70,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,diol biosynthetic process (GO:0034312),0.7493026135958387,1.6418532985132908,0.023923444976076555,0.2859263472768367,1.0,5/15,5.93%,ACER2;GCH1;SPTLC2;SPTLC1;ASAH2
prerank,positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),0.6273363512317837,1.6412113892222844,0.023121387283236993,0.285570537475157,1.0,9/33,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;ADAM17;FBXW7;CCDC88A
prerank,negative regulation of potassium ion transport (GO:0043267),0.7551838585770455,1.6411710784907079,0.01589825119236884,0.2837935491852262,1.0,4/13,10.96%,NOS1;CAV1;STK39;NEDD4L
prerank,endoderm development (GO:0007492),0.7442487200009259,1.6406250528021518,0.02264808362369338,0.28327402034889587,1.0,2/13,2.05%,SOX17;DUSP1
prerank,embryonic skeletal system morphogenesis (GO:0048704),-0.5259567025787094,-1.640198488456691,0.009345794392523364,0.36407329450033016,1.0,10/31,7.10%,FGFR2;HOXC4;PDGFRA;TGFBR1;OSR1;HOXA3;HOXB3;HOXB4;MEGF8;SIX1
prerank,bicellular tight junction assembly (GO:0070830),0.6020388971733625,1.6391993308814465,0.014322916666666666,0.28532450395426795,1.0,5/46,3.22%,PECAM1;CLDN5;F11R;OCLN;ESAM
prerank,platelet-derived growth factor receptor signaling pathway (GO:0048008),0.72541766088586,1.6339121283552367,0.01746031746031746,0.29692818861278436,1.0,4/16,2.53%,PTPRJ;PDGFD;PDGFB;PIK3C2A
prerank,endothelial cell differentiation (GO:0045446),0.7703407241660438,1.6337826501771129,0.03471074380165289,0.29540500317304214,1.0,5/12,3.25%,JAG1;TIE1;BMPR2;ACVRL1;SOX18
prerank,response to growth factor (GO:0070848),0.615146855291559,1.6328072536557467,0.012295081967213115,0.29604870911983727,1.0,7/41,4.11%,NOS1;GATA6;PDGFB;BMPR2;ACVRL1;KLF4;ACVR1
prerank,response to lipopolysaccharide (GO:0032496),0.5278439235250851,1.632793404871934,0.003409090909090909,0.29428545516904986,1.0,31/138,10.93%,NOS1;NOS3;SMAD6;NOD2;DAB2IP;LGALS9;VIM;GCH1;TIRAP;DEFA6;TRIM6;MEF2C;TNFRSF1B;IFNAR1;IL1A;PDCD4;ADAM17;NFKBIL1;IRGM;HNRNPA0;ZC3H12A;JAK2;NR1D1;ACOD1;CACTIN;FOXP1;STAP1;HMGB1;NFKBIB;CASP1;TAB2
prerank,lymphocyte migration (GO:0072676),0.6241715791822366,1.632590203210895,0.02,0.2930258069122617,1.0,5/32,10.16%,S1PR1;CRTAM;MSN;GATA3;CCL4
prerank,oogenesis (GO:0048477),0.735803551829597,1.631617608201331,0.030448717948717948,0.2937717695613747,1.0,2/15,0.40%,NANOS1;NANOS3
prerank,positive regulation of cell migration (GO:0030335),0.5051583622284863,1.6308707805981646,0.0,0.29377305891490685,1.0,49/253,9.54%,SEMA3G;PECAM1;PLCG2;CDH13;PODXL;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;BMPR2;CCR1;NOTCH1;RAB11A;MYLK;INSR;FAM107A;ARHGEF2;DAB2IP;CAV1;F2RL1;TGFB2;NEDD9;SEMA3F;ACTN4;TNFRSF18;MGAT5;PPM1F;ACVR1;SHTN1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;CLASP1;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RTN4;RIPOR1
prerank,negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.7475131359066018,1.630269255974574,0.02773246329526917,0.29349785938893264,1.0,5/13,10.63%,MMRN2;DAB2IP;HHEX;EPN2;PTPN1
prerank,smooth muscle cell differentiation (GO:0051145),0.760934690990913,1.6288965298441127,0.025974025974025976,0.29518016396055036,1.0,7/12,8.56%,MRTFB;GATA6;HEY1;HEY2;MEF2C;TMEM204;MRTFA
prerank,positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.6918579318810796,-1.6280577907346923,0.026829268292682926,0.39173777167527896,1.0,5/10,13.92%,IRS2;IRS1;GPLD1;PTH1R;SLC45A3
prerank,sphingolipid catabolic process (GO:0030149),0.7299695538288984,1.6270916486948361,0.02280130293159609,0.2982142024134122,1.0,4/15,5.93%,ACER2;PPT1;SMPDL3A;ASAH2
prerank,negative regulation of cell-substrate adhesion (GO:0010812),0.6294687224812175,1.626727566401657,0.023448275862068966,0.2974347507135829,1.0,8/39,4.97%,ACER2;JAG1;EFNA5;NOTCH1;ACTN4;ADAM15;GCNT2;MAP4K4
prerank,epithelial cell migration (GO:0010631),0.6197301111976089,1.6245404344346246,0.019498607242339833,0.3013492998211633,1.0,9/37,9.04%,NANOS1;CDH13;NOS3;PKN3;PLXND1;PKN1;PLEKHG5;STAT1;ROCK1
prerank,positive regulation of blood vessel endothelial cell migration (GO:0043536),0.5949716256497994,1.624050620932546,0.0160857908847185,0.3007692865911429,1.0,18/48,11.99%,NOS3;GATA2;PDGFB;JCAD;PRKD1;PIK3C2A;HDAC9;HDAC7;ANGPT1;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;MAP3K3;PRKD2
prerank,Fc receptor mediated stimulatory signaling pathway (GO:0002431),0.5580628439251732,1.62369818061215,0.011933174224343675,0.2998877867720782,1.0,27/73,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,cellular response to cAMP (GO:0071320),0.6335914275967327,1.623542243410853,0.015536723163841809,0.29858039503948214,1.0,4/30,3.52%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K
prerank,Fc-gamma receptor signaling pathway (GO:0038094),0.5598683419751913,1.6232515589310885,0.010804321728691477,0.29764556188453967,1.0,27/71,16.57%,PLCG2;FYN;ELMO1;CRK;FCGR2B;FCGR1A;MAPK1;CD247;MYO1C;ARPC5;NCKAP1;ACTG1;YES1;MYO10;PTK2;PLCG1;CYFIP1;RAC1;ACTB;WASF2;PIK3CB;DOCK1;PLPP4;ARPC3;ARPC2;NCK1;ELMO2
prerank,negative regulation of cartilage development (GO:0061037),-0.6361244492498654,-1.6227175727888465,0.015189873417721518,0.40056338584937773,1.0,4/13,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,regulation of membrane depolarization (GO:0003254),0.6992704836034773,1.621630482553919,0.03715170278637771,0.3001821563556974,1.0,6/18,10.96%,GJA5;SMAD7;CAMK2D;LRRK2;SCN1B;NEDD4L
prerank,hemopoiesis (GO:0030097),0.5470037469591178,1.621606353963519,0.009501187648456057,0.29854213579536004,1.0,17/87,7.98%,MECOM;JAG1;TEK;NOTCH4;FLT1;PDGFB;FLT4;KITLG;TAL1;SNRK;TGFB2;TIRAP;RRAS;CD34;ZBTB16;CEBPA;TPO
prerank,neurotransmitter uptake (GO:0001504),-0.6532638039906666,-1.619795361471066,0.01904761904761905,0.40111365154867934,1.0,4/12,10.51%,ATP1A2;SLC1A3;SNAP25;SLC29A1
prerank,regulation of cell migration involved in sprouting angiogenesis (GO:0090049),0.6257947495444884,1.619655259841202,0.01637107776261937,0.30190879006870597,1.0,10/32,4.05%,MMRN2;GATA2;NOTCH1;JCAD;PIK3C2A;DLL4;HDAC9;HDAC7;KLF4;CARD10
prerank,eye morphogenesis (GO:0048592),-0.6009856222070953,-1.6192873599404871,0.013550135501355014,0.39486284341429523,1.0,9/19,8.98%,EFEMP1;COL5A1;NKD1;MFAP5;FBN2;FBN1;NIPBL;SHROOM2;VEGFA
prerank,cellular response to calcium ion (GO:0071277),0.5641799454415154,1.6190726367781916,0.016270337922403004,0.301766648453796,1.0,13/67,8.29%,PLCG2;SYT15;ITPKB;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;MCOLN1;PRKAA1
prerank,positive regulation of interleukin-8 production (GO:0032757),0.5836753026726387,1.6184176173599438,0.018276762402088774,0.3017912630500315,1.0,10/49,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;HYAL2;HSPA1B;HMGB1
prerank,early endosome to Golgi transport (GO:0034498),-0.6792482901753698,-1.6183780555136749,0.021844660194174758,0.3902865748745643,1.0,8/11,16.07%,SURF4;TRAPPC10;LMAN1;EHD3;STX5;SNX1;SNX8;SNX2
prerank,ameboidal-type cell migration (GO:0001667),0.5793032228777378,1.6178006102080646,0.010723860589812333,0.3017589693684549,1.0,7/51,4.99%,SEMA3G;NANOS1;TBX1;SEMA3F;PKN3;SEMA7A;PKN1
prerank,positive regulation of ERBB signaling pathway (GO:1901186),0.6559050404467488,1.6169019615363913,0.02416918429003021,0.30240285800795486,1.0,8/25,10.33%,AFAP1L2;HIP1;HIP1R;CBL;SHKBP1;BCAR3;RTN4;CCDC88A
prerank,cGMP-mediated signaling (GO:0019934),-0.6427762927091745,-1.6138019639106023,0.024,0.3963354782419021,1.0,3/13,2.91%,IRAG1;PDE3A;APOE
prerank,2-oxoglutarate metabolic process (GO:0006103),-0.6515448412721178,-1.612477338309682,0.014598540145985401,0.3931927624545576,1.0,9/13,28.02%,IDH2;ADHFE1;L2HGDH;IDH1;GOT1;DLST;D2HGDH;PHYH;GOT2
prerank,regulation of macrophage cytokine production (GO:0010935),0.7402045592149535,1.6112788531589965,0.027868852459016394,0.31607817147107314,1.0,3/13,4.67%,PLCG2;TGFB2;SEMA7A
prerank,tight junction assembly (GO:0120192),0.5879187278161334,1.6112632874875243,0.02053915275994865,0.31436932809083606,1.0,6/49,3.70%,PECAM1;CLDN5;F11R;OCLN;ESAM;LSR
prerank,cytoplasmic microtubule organization (GO:0031122),0.5773286952743215,1.6111559199305618,0.013280212483399735,0.3129450583659692,1.0,17/54,11.08%,CCDC88C;TRPV4;PLK3;RAB11A;CLIP2;SLK;DST;CAMSAP2;CLIP1;CLASP1;KPNB1;HOOK1;PCM1;KATNAL2;CCDC88A;LIMK2;NUMA1
prerank,positive regulation of cytokine production involved in immune response (GO:0002720),0.6552980675356472,1.6102734416153823,0.020802377414561663,0.31371800440126946,1.0,5/25,5.08%,PLCG2;NOD2;B2M;F2RL1;TRIM6
prerank,regulation of sodium ion transmembrane transport (GO:1902305),0.6473382706983574,1.6101415251284037,0.025604551920341393,0.3122797749554174,1.0,8/27,13.00%,NOS1;UTRN;ATP2B4;CAMK2D;FXYD5;SCN1B;NEDD4L;YWHAH
prerank,positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.7647558303337884,1.6101290156471115,0.018363939899833055,0.31062265219229346,1.0,3/12,11.05%,PLCG2;ADGRB1;CYBA
prerank,epithelial tube morphogenesis (GO:0060562),0.6309313884785325,1.6087823829647518,0.02844950213371266,0.3126153522389583,1.0,8/32,6.03%,PODXL;SOX17;RASIP1;ACVRL1;RHOB;ACVR1;MEF2C;GATA3
prerank,positive regulation of protein-containing complex disassembly (GO:0043243),0.760157332650073,1.6087720411704076,0.028469750889679714,0.31097946566464435,1.0,6/12,7.07%,INSR;ADRB2;SMCR8;SETX;IRGM;FYCO1
prerank,regulation of acrosome reaction (GO:0060046),0.7761479417217522,1.6086619396849153,0.02459016393442623,0.3097095291677478,1.0,1/10,0.84%,PLCB1
prerank,retinoic acid metabolic process (GO:0042573),-0.6207331424989898,-1.608357719265045,0.02564102564102564,0.39881038422895365,1.0,2/14,2.57%,ALDH1A2;CYP26B1
prerank,positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.5278277022512279,1.6076309185613897,0.00683371298405467,0.3107845515067036,1.0,14/121,6.05%,PTPRJ;PECAM1;PLCG2;EFNA5;PDGFB;ACE;ARHGEF2;NEDD9;TNFRSF18;ACVR1;ANGPT1;EFNA1;FGFR3;FCGR1A
prerank,negative regulation of platelet activation (GO:0010544),0.6984038909428752,1.6074954200608136,0.025889967637540454,0.3094864731518124,1.0,5/16,3.41%,NOS3;CEACAM1;PDGFB;PRKG1;ADAMTS18
prerank,positive regulation of phospholipase C activity (GO:0010863),-0.48044418417349904,-1.6073063781650714,0.007874015748031496,0.3948536874339411,1.0,10/40,5.54%,ARHGAP6;EGFR;NTRK3;LPAR1;PDGFRB;PDGFRA;KIT;EDNRA;NTRK2;FGF2
prerank,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),-0.5497778075013474,-1.605015983479828,0.012539184952978056,0.3953515907164733,1.0,4/21,0.76%,ATP1A2;ANK2;CACNA1C;DMD
prerank,organonitrogen compound biosynthetic process (GO:1901566),0.5098593432358988,1.6049613668303524,0.0021810250817884407,0.31436352603466855,1.0,40/151,14.92%,SGMS1;ACER2;SGPP2;GCNT1;SGMS2;DEGS2;GSTA2;PRKD1;PLPP1;GCH1;APOA1;GPHN;CERS4;SLC44A1;PCSK5;SPTLC2;LCAT;SPNS2;FURIN;SPTLC1;ARG1;ASS1;ALAS1;CERT1;PCYT1A;ELOVL4;CERS6;CERS5;HACD4;CEPT1;LPCAT3;ELOVL7;ACHE;PRKD2;PPM1L;TYW1;ELOVL5;VAPA;STARD10;CSNK2B
prerank,regulation of hemopoiesis (GO:1903706),-0.6734618821393787,-1.6044779915925533,0.03051643192488263,0.3904888807534764,1.0,5/10,9.67%,PTN;PRKCB;CREBBP;RUNX1;IL17D
prerank,regulation of cellular component organization (GO:0051128),0.5115202827919605,1.6032314292113834,0.0022522522522522522,0.3172886293446506,1.0,28/135,11.63%,CDH13;LTBP4;RAPGEF2;HIP1;CEACAM1;HIP1R;RAPGEF1;FAM107A;DAB2IP;RASGRP2;PACSIN2;CISH;WFDC1;CAMK2D;STK38L;CAMSAP2;PACSIN1;IRGM;ROCK1;TJP1;SGK1;STON1;TAOK2;MAD2L2;ERMN;PTPN1;SPOCK1;SNCAIP
prerank,cardiac muscle tissue morphogenesis (GO:0055008),0.6437719837201967,1.602932419188541,0.01775147928994083,0.316395133348078,1.0,6/29,2.67%,ENG;S1PR1;SMAD7;MYBPC3;NOTCH1;FKBP1A
prerank,negative regulation of alcohol biosynthetic process (GO:1902931),-0.6377533823296221,-1.6014842535172642,0.022556390977443608,0.3931778671427225,1.0,7/13,16.36%,BMP5;DKK3;APOE;ERLIN1;REST;NFKB1;SCAP
prerank,positive regulation of histone methylation (GO:0031062),-0.5435808017071027,-1.6011012145370727,0.009146341463414634,0.3877063935253577,1.0,9/24,11.92%,AUTS2;OGT;SNW1;JARID2;MTF2;PAF1;WDR5;CTR9;TET1
prerank,regulation of axon extension (GO:0030516),0.6107269266034706,1.600561345075275,0.024324324324324326,0.3213072876066041,1.0,10/37,11.97%,SEMA3G;MACF1;NTN1;SHTN1;SEMA7A;ISLR2;NRCAM;RTN4;TRIM46;DIP2B
prerank,negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),0.5539853662071469,1.5996835443286344,0.015018773466833541,0.3219074920821,1.0,13/65,9.82%,PRDM16;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;WFIKKN1;SMAD2;ADAM17;UBA52;RPS27A;PMEPA1
prerank,negative regulation of axonogenesis (GO:0050771),0.6457317844777324,1.5989802648903793,0.015625,0.32203847533031693,1.0,9/27,18.15%,SEMA3G;ARHGDIA;RTN4;DCC;TRIM46;DIP2B;MAP2;GDI1;CDKL3
prerank,negative regulation of glucose transmembrane transport (GO:0010829),-0.6976616224343957,-1.598956118077935,0.02528735632183908,0.3873679480205907,1.0,5/10,4.91%,PID1;APPL2;PRKCB;GRB10;ENPP1
prerank,regulation of Rho protein signal transduction (GO:0035023),0.5493117264045018,1.5987897757656682,0.01824817518248175,0.32092912576103466,1.0,14/72,7.74%,EPS8L2;HEG1;ARHGEF3;RASIP1;ARHGEF28;F11R;ARHGEF2;F2RL1;APOA1;BCR;LPAR6;CUL3;ARHGDIA;ARRB1
prerank,sequestering of extracellular ligand from receptor (GO:0035581),-0.6285823075810393,-1.5977927382998105,0.02981029810298103,0.3846660348418497,1.0,6/13,4.80%,FSTL1;NBL1;LTBP1;GREM2;FBN2;FBN1
prerank,negative regulation of cell motility (GO:2000146),0.5253874632147955,1.597197861267821,0.0033975084937712344,0.3236362532448637,1.0,21/108,7.86%,PTPRJ;JAG1;ENG;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;RHOB;CRK;CLIC4;ADAM15;STK24;SPOCK3;GATA3;SRGAP1;DUSP3;PTPRU
prerank,pulmonary valve development (GO:0003177),0.6942006899749541,1.596562048471258,0.031818181818181815,0.3237464905860077,1.0,9/18,5.71%,JAG1;NOS3;SMAD6;BMPR2;NOTCH1;HEY1;TGFB2;HEY2;TNFRSF1B
prerank,cellular response to copper ion (GO:0071280),-0.6038471886043142,-1.5951365871695504,0.024930747922437674,0.3863082188068856,1.0,8/16,6.94%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,atrioventricular valve development (GO:0003171),0.7265796359899485,1.5937224631697389,0.03403565640194489,0.32955473967776194,1.0,5/14,4.11%,GJA5;BMPR2;NOTCH1;TGFB2;ACVR1
prerank,alcohol catabolic process (GO:0046164),-0.6945737307116795,-1.593452956640241,0.026829268292682926,0.38555350038923863,1.0,2/10,2.91%,CYP27A1;APOE
prerank,positive regulation of cell adhesion mediated by integrin (GO:0033630),0.6961764094756316,1.591688438048481,0.025954198473282442,0.33331314028507003,1.0,3/17,2.55%,PODXL;PIEZO1;TGFB2
prerank,positive regulation of leukocyte chemotaxis (GO:0002690),0.5742975573120094,1.5916074822446666,0.02059202059202059,0.3319758235864682,1.0,11/51,9.50%,VEGFC;CCR1;F2RL1;LGALS9;VEGFD;ANO6;ADAM17;MAPK1;CMKLR1;PTK2;HMGB1
prerank,metal ion transport (GO:0030001),0.5407327996333676,1.5914544061109879,0.010752688172043012,0.3308802051969951,1.0,17/86,11.28%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B2;CAV1;CACNA1A;SLC8A1;ATP2C1;NIPAL2;SLC30A1;NIPAL3;NDFIP2;NIPA2;GRIN3A;TRPM2
prerank,vascular endothelial growth factor receptor signaling pathway (GO:0048010),0.5546732870983638,1.5908137396628514,0.019417475728155338,0.33085846152118287,1.0,28/67,16.98%,VEGFC;FLT1;FYN;FLT4;ELMO1;DAB2IP;PRKD1;CRK;VEGFD;SHB;CLEC14A;HSPB1;NCKAP1;ROCK1;PTK2;CYFIP1;RAC1;CYBA;PRKD2;WASF2;PIK3CB;DOCK1;PGF;NCF2;PAK2;NCK1;ELMO2;MAPK14
prerank,calcium-mediated signaling using intracellular calcium source (GO:0035584),0.6775100952028242,1.5906440626777434,0.0343213728549142,0.32965587816813957,1.0,6/19,11.89%,PTPRJ;VCAM1;GPR143;PRNP;TRPM2;GRM5
prerank,negative regulation of developmental growth (GO:0048640),0.6318680685753221,1.589593633763624,0.024390243902439025,0.33078622079049236,1.0,8/30,11.97%,SEMA3G;FGFR3;SLC6A4;WWC2;RTN4;DCC;TRIM46;DIP2B
prerank,activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.5509474709153296,1.5880689207976548,0.013447432762836185,0.33327033834438397,1.0,17/73,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;CASP8;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,neurotransmitter biosynthetic process (GO:0042136),0.7247789169876888,1.587969215239357,0.0457516339869281,0.33196191749087844,1.0,3/14,7.72%,NOS1;ALDH9A1;SLC6A4
prerank,regulation of cell adhesion (GO:0030155),0.5126210110638938,1.585882982928459,0.005605381165919282,0.33602427270018326,1.0,22/129,9.41%,PTPRJ;CDH13;PODXL;NUAK1;EFNA5;PLXNA4;RND1;ACVRL1;DUSP1;FES;CYTH1;TNFRSF18;PDE3B;PLXND1;ANGPT1;EFNA1;ARHGDIA;PPP3CA;RSU1;ROCK1;PTK2;ADAM10
prerank,endoplasmic reticulum tubular network organization (GO:0071786),0.7183503522603188,1.585513493374861,0.05055292259083728,0.3354887157479997,1.0,7/15,12.56%,ATL2;ATL1;REEP2;RTN4;REEP1;REEP3;RTN3
prerank,negative regulation of developmental process (GO:0051093),0.5470660303299714,1.585085676023016,0.015228426395939087,0.33499646538040617,1.0,10/69,5.43%,NOTCH4;NOS3;TBX1;NOTCH1;ARHGEF15;HEY1;KLF7;HEY2;OMA1;FGFR3
prerank,response to muramyl dipeptide (GO:0032495),0.7436749248567931,1.5849207927067421,0.044142614601018676,0.3337425864912514,1.0,4/12,2.69%,NOD1;NOD2;ARHGEF2;VIM
prerank,positive chemotaxis (GO:0050918),0.6917761569954611,1.584131461646417,0.030627871362940276,0.3344236808298312,1.0,2/17,4.45%,PTPRJ;ANGPT1
prerank,regulation of cell migration (GO:0030334),0.47958320949290956,1.583031323787498,0.0,0.33562652474852617,1.0,70/382,9.54%,SEMA3G;PTPRJ;PECAM1;CDH13;PODXL;JAG1;SPATA13;EDN1;PDGFD;ENG;CLDN5;FLT1;CEACAM1;PDGFB;LDB2;DACH1;RECK;ACE;SMAD7;PLXNA4;CCR1;LIMCH1;MCTP1;ACVRL1;NOTCH1;MYLK;INSR;FAM107A;ADARB1;MACF1;CAV1;F2RL1;RHOB;NEDD9;SEMA3F;ACTN4;CLIC4;MGAT5;PPM1F;PLXND1;ADAM15;ACVR1;SLK;STK24;LEF1;GCNT2;SEMA7A;MAP4K4;TTBK2;ROBO4;SPAG9;SRGAP1;ADAM17;KIF2A;DUSP3;PPP3CA;PRR5L;PTPRU;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;ROCK1;TJP1;PTK2;SGK1;ADAM10;RIPOR1
prerank,positive regulation of ruffle assembly (GO:1900029),0.7238620567549934,1.5829268171079145,0.030508474576271188,0.33435898458982416,1.0,2/13,7.52%,EPS8L2;PLEKHM1
prerank,cellular modified amino acid catabolic process (GO:0042219),-0.6189238785044666,-1.5825694225026963,0.034482758620689655,0.4128786825015195,1.0,7/15,16.48%,GGACT;ALDH4A1;PRODH;GGT5;SARDH;ABHD12;GGT7
prerank,filopodium assembly (GO:0046847),0.7021164153821625,1.5816898043392917,0.0384,0.33625177918336185,1.0,4/16,5.38%,SPATA13;FGD5;DNM3;FGD6
prerank,negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.7665108525164523,1.5815274306919505,0.03741496598639456,0.33508135276640644,1.0,3/10,4.30%,CEACAM1;LGALS9;FCGR2B
prerank,positive regulation of protein phosphorylation (GO:0001934),0.47956292019664487,1.581300573349126,0.001017293997965412,0.33409751444292257,1.0,48/348,8.22%,VEGFC;NOS1;PTPRJ;PECAM1;PLCG2;TEK;PDGFD;ENG;RAPGEF2;EFNA5;PDGFB;BMPR2;FLT4;RPS6KA5;FAS;TBX1;LIMCH1;CCND2;ACVRL1;ATP2B4;INSR;CCND3;ARHGEF2;RBPMS;CAV1;PRKD1;TGFB2;APP;IQGAP1;VEGFD;KRAS;ACVR1;ANGPT1;EFNA1;TRIM6;CSNK1D;BRAT1;BCAR3;ADAM17;MAPK1;IRGM;LRRK2;PDE8A;MAPRE3;ARRB1;THPO;TOM1L1;JAK2
prerank,protein hydroxylation (GO:0018126),-0.6038238197431458,-1.580294773726607,0.03640776699029126,0.4138133181464329,1.0,10/15,18.58%,P3H3;EGLN3;VIPAS39;P3H1;PLOD2;P3H2;JMJD4;VPS33B;P3H4;PLOD3
prerank,macrophage activation involved in immune response (GO:0002281),0.7208177387217214,1.579214467763241,0.031496062992125984,0.33813600172194413,1.0,5/13,12.63%,PLCG2;DYSF;NMI;TYROBP;CX3CR1
prerank,calcium ion transmembrane import into cytosol (GO:0097553),0.5848033827416267,1.5788907572627318,0.02435723951285521,0.33738577091374544,1.0,9/41,11.28%,PLCG2;TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;HTR2A;TRPM2
prerank,somite development (GO:0061053),-0.6662359481996376,-1.5787866212252362,0.03740648379052369,0.41250840666685396,1.0,5/11,9.91%,SMO;MEOX2;LOXL3;MTHFD1;PTCH1
prerank,acylglycerol biosynthetic process (GO:0046463),-0.5417618733605373,-1.5780483630713722,0.022364217252396165,0.40906275161239264,1.0,7/23,9.81%,PLCE1;AGMO;LPGAT1;MOGAT3;PLA2G4A;GK;DGAT1
prerank,icosanoid secretion (GO:0032309),0.7371930109228385,1.577582407036698,0.04628099173553719,0.33935472570125824,1.0,2/12,1.04%,ABCC4;ACE
prerank,positive regulation of phagocytosis (GO:0050766),0.5739971554013313,1.57745099592509,0.02925531914893617,0.33821481106269397,1.0,11/47,12.10%,PTPRJ;GATA2;MERTK;F2RL1;APOA1;ANO6;FCGR2B;CD47;STAP1;CYBA;DOCK2
prerank,phosphatidylinositol biosynthetic process (GO:0006661),0.514185479078768,1.5758490122416502,0.007882882882882882,0.34097709351057254,1.0,16/119,7.29%,BMX;PLCG2;EFR3B;PIP5K1B;PITPNM3;PIK3R6;ITPKB;IP6K3;INPP5D;PIK3C2A;INPP5K;CISH;PLEKHA1;PIP5K1C;FIG4;SOCS6
prerank,establishment of endothelial intestinal barrier (GO:0090557),0.7443232459011848,1.573921210098387,0.03494176372712146,0.3446429532799776,1.0,5/11,9.21%,RAPGEF2;F11R;RAPGEF6;TJP2;TJP1
prerank,cardiac cell development (GO:0055006),0.7532132855155961,1.5727010034238094,0.0415944540727903,0.34642832347408514,1.0,4/11,4.18%,JAG1;NOTCH1;SLC8A1;ALPK3
prerank,leukocyte tethering or rolling (GO:0050901),0.6919846322247595,1.5726918630378879,0.049206349206349205,0.3449290022760563,1.0,3/17,1.64%,GCNT1;VCAM1;JAM2
prerank,regulation of toll-like receptor 2 signaling pathway (GO:0034135),0.7399115726425124,1.5721991743396984,0.033277870216306155,0.34461663173304236,1.0,5/11,11.05%,F2RL1;TIRAP;MFHAS1;ACOD1;CYBA
prerank,membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.6964499359876837,1.5714793082966654,0.04141104294478527,0.3450861046211096,1.0,2/15,2.15%,KCNQ1;ATP1A1
prerank,positive regulation of immune effector process (GO:0002699),0.6274713002653554,1.5713619273877695,0.041968162083936326,0.3438501829280409,1.0,2/27,2.67%,PTPRJ;LGALS9
prerank,positive regulation of cell motility (GO:2000147),0.4919299515517869,1.5712635261410957,0.0,0.3426205733913902,1.0,40/205,9.54%,SEMA3G;PECAM1;CDH13;PODXL;EDN1;PDGFD;FLT1;PDGFB;CCR1;NOTCH1;MYLK;INSR;FAM107A;CAV1;F2RL1;NEDD9;SEMA3F;ACTN4;MGAT5;PPM1F;SPOCK2;NTN1;ACVR1;LEF1;GCNT2;SEMA7A;MAP4K4;SPAG9;ADAM17;PPP3CA;NUMB;MYO1C;SEMA6D;APC;ACTG1;SNAI2;TJP1;PTK2;ADAM10;RIPOR1
prerank,purinergic nucleotide receptor signaling pathway (GO:0035590),0.6547812638040313,1.570826675064457,0.045317220543806644,0.3422142999592255,1.0,6/20,11.77%,ENTPD1;APP;ANO6;P2RX7;CASP1;SUGT1
prerank,UDP-N-acetylglucosamine biosynthetic process (GO:0006048),-0.6615131640427343,-1.5702376191852472,0.014457831325301205,0.4271222077803129,1.0,8/11,20.23%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,negative regulation of epithelial cell migration (GO:0010633),0.6151453720879763,1.5692138095322328,0.024390243902439025,0.3452225371952052,1.0,7/33,3.54%,PTPRM;PTPRG;PTPRR;ACVRL1;DAB2IP;DLL4;EVL
prerank,cardiac ventricle morphogenesis (GO:0003208),0.5878617419802735,1.568693949538948,0.015235457063711912,0.34502522677902314,1.0,12/41,6.03%,JAG1;ENG;SMAD7;MYBPC3;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4;HEY2;MEF2C;GATA3
prerank,aorta morphogenesis (GO:0035909),0.68083322689911,1.5671611639464669,0.04747320061255743,0.3476076615719616,1.0,8/17,3.58%,JAG1;ENG;TBX1;ACVRL1;MYLK;HEY1;DLL4;HEY2
prerank,positive regulation of histone acetylation (GO:0035066),0.6447314487095605,1.5670727656365302,0.044096728307254626,0.34631086277461054,1.0,2/23,1.03%,NOS1;RPS6KA5
prerank,cholesterol homeostasis (GO:0042632),0.5560862180178276,1.5670280954550455,0.015151515151515152,0.34493946014824245,1.0,10/64,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,vesicle transport along actin filament (GO:0030050),0.6834328602113298,1.566893767374331,0.031578947368421054,0.3439501490021891,1.0,5/19,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,regulation of ruffle assembly (GO:1900027),0.6392824862051307,1.5665905562111464,0.033950617283950615,0.3434144814708592,1.0,5/23,9.11%,EPS8L2;CAV1;EVL;PLEKHM1;STAP1
prerank,establishment of epithelial cell polarity (GO:0090162),0.6739902727003757,1.5652224969925441,0.04272151898734177,0.3454471832478245,1.0,6/19,6.73%,CYTH3;SIPA1L3;CYTH1;MSN;SYNE4;CLASP1
prerank,regulation of calcineurin-NFAT signaling cascade (GO:0070884),0.6093937459280631,1.5618972666929487,0.04178674351585014,0.35259478795352,1.0,4/26,2.89%,PLCG2;LMCD1;ATP2B4;HOMER2
prerank,antigen receptor-mediated signaling pathway (GO:0050851),0.49120373390214095,1.5618937605165342,0.00437636761487965,0.3511419736861649,1.0,42/163,18.86%,BMX;PTPRJ;PLCG2;FYN;INPP5D;PSMD13;MEF2C;PLEKHA1;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;CD38;PRKD2;PIK3CB;BTK;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;CD79A;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,negative regulation of cytoskeleton organization (GO:0051494),0.6241714587602405,1.5618521676330839,0.031203566121842496,0.349784551738178,1.0,8/29,9.21%,KANK4;LIMA1;HIP1R;FKBP4;KANK3;SHANK3;CLASP1;TJP1
prerank,response to cAMP (GO:0051591),0.5915327862839667,1.5616586161655344,0.028767123287671233,0.34887864938353685,1.0,6/37,8.30%,KCNQ1;RAPGEF2;RAPGEF1;INPP5K;STAT1;NDUFS4
prerank,sterol homeostasis (GO:0055092),0.5542288511737873,1.5614370542086822,0.016455696202531647,0.34805462065858495,1.0,10/65,5.21%,LIMA1;ACSM3;MALL;CYP39A1;CAV1;HNF4A;HDAC9;APOA1;EHD1;LCAT
prerank,positive regulation of immune response (GO:0050778),0.5459136783657605,1.560980309450121,0.018518518518518517,0.3477441589809554,1.0,14/64,11.05%,GBP5;NOD2;F2RL1;TGFB2;LGALS9;FCGR2B;KARS1;ITGAM;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;CYBA
prerank,protein autophosphorylation (GO:0046777),0.49276210741600374,1.559713043382586,0.002145922746781116,0.34970172476622496,1.0,34/157,12.17%,BMX;TEK;FLT1;STK10;FLT4;INSR;PRKD1;OXSR1;FES;SLK;STK24;CAMK2D;FGFR3;MEX3B;UHMK1;EEF2K;ALK;SIK2;LRRK2;LMTK2;JAK2;STK39;PASK;PIM3;CAD;PTK2;TAOK2;MAP3K11;MARK3;MINK1;MAP3K3;PRKD2;MARK2;VRK1
prerank,positive regulation of Notch signaling pathway (GO:0045747),0.5928693595234557,1.5596137420176637,0.027586206896551724,0.34853280805330356,1.0,10/39,6.28%,JAG1;JAG2;NOTCH4;NOS3;NOTCH1;NOD2;TGFB2;DLL4;TSPAN14;POGLUT1
prerank,plasma membrane bounded cell projection organization (GO:0120036),0.5068964448082602,1.558689806588028,0.008948545861297539,0.3494536766737538,1.0,22/124,10.68%,PTPRM;LIMA1;STMN2;RAPGEF2;FRYL;RAB11A;FRY;BTG2;APP;MAP4;BLOC1S6;TTC29;EHD1;FAM161A;PLEKHA1;UHMK1;FLRT3;RAB35;ROCK1;HMGB1;CYFIP1;RAC1
prerank,negative regulation of multicellular organismal process (GO:0051241),0.488520211268195,1.558557707271976,0.0010604453870625664,0.3483640374841497,1.0,38/199,10.04%,LAMA4;NOS3;PTPRG;PTPRR;SMAD6;BMPR2;RPS6KA5;SMAD7;NOVA2;NOTCH1;ATP2B4;PAEP;HEY1;KLF7;DAB2IP;IFNGR1;ID1;HDAC9;APOA1;EVL;HEY2;IL17RD;FCGR2B;EFNA1;MEF2C;GATA3;ADAM17;ADIPOR1;SLC6A4;PTPRO;WWC2;ABHD6;PROC;NR1D1;MCC;ROCK1;MAD2L2;ACOT13
prerank,vasoconstriction (GO:0042310),0.7472230857174019,1.5582467310707544,0.06341463414634146,0.34772734712432213,1.0,3/11,3.81%,EDN1;PIK3C2A;SLC8A1
prerank,apical junction assembly (GO:0043297),0.5651266525143448,1.5573428739653818,0.025806451612903226,0.3489864065657099,1.0,8/53,8.44%,PECAM1;CLDN5;F11R;OCLN;ESAM;WDR1;CTNNA1;APC
prerank,epidermis development (GO:0008544),0.549939462004565,1.5568890585287105,0.016581632653061226,0.34884112613701235,1.0,4/56,3.89%,LAMA3;GATA6;EMP1;ATP2C1
prerank,negative regulation of hydrolase activity (GO:0051346),0.562876994298231,1.5568093933194116,0.03598971722365039,0.34765132572570556,1.0,8/49,7.14%,NOS1;F11R;DAB2IP;ZCCHC9;LRCH1;SH3BP4;GPATCH2;LRRK2
prerank,positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.6097360366416288,-1.556636700063887,0.05080213903743316,0.4660833487306617,1.0,6/14,14.75%,ANK2;ACTN2;ATP1B3;LRRC38;ATP1B1;ATP1B2
prerank,myeloid cell activation involved in immune response (GO:0002275),0.6790247509456968,1.5554270387250706,0.03067484662576687,0.35009645140104684,1.0,6/18,12.10%,PLCG2;DYSF;KARS1;NMI;TYROBP;DOCK2
prerank,neuron projection regeneration (GO:0031102),-0.674560119345781,-1.5547783377543745,0.04819277108433735,0.4655207617387368,1.0,3/10,12.78%,PTN;GAP43;NREP
prerank,female gamete generation (GO:0007292),0.6112284954244992,1.5524561872801375,0.048104956268221574,0.3563913000896898,1.0,2/29,0.40%,NANOS1;NANOS3
prerank,positive regulation of cell junction assembly (GO:1901890),0.5582733417561843,1.552320477162396,0.008838383838383838,0.35534773459152835,1.0,9/56,10.68%,PTPRJ;TEK;CLDN5;CAV1;PPM1F;MAP4K4;IL1RAP;ROCK1;RAC1
prerank,cation transmembrane transport (GO:0098655),-0.4632197847332965,-1.550780558191508,0.02390438247011952,0.47223754657752653,1.0,8/44,7.04%,ATP1A2;TRPM3;SLC7A2;TRPM6;SFXN2;ABCC9;SLC25A20;SLC6A9
prerank,negative regulation of transforming growth factor beta production (GO:0071635),0.7459048015106498,1.5505437258156785,0.04,0.35854794325757106,1.0,5/10,12.58%,GATA6;FURIN;CDH3;TYROBP;TSKU
prerank,regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.7055639288835736,1.5489406959806116,0.048465266558966075,0.36152773810117544,1.0,2/12,2.62%,PTPRJ;CBL
prerank,positive regulation of cytoskeleton organization (GO:0051495),0.5327528443076682,1.5488342277985607,0.01608910891089109,0.36040627654116175,1.0,20/76,16.66%,TEK;SYNPO;EDN1;FCHSD2;F2RL1;FES;EVL;CDC42EP1;P2RX7;WDR1;NCKAP1;STAP1;PFDN2;NUMA1;SORBS3;NES;VIL1;TENM1;NCK1;PYCARD
prerank,regulation of T cell mediated cytotoxicity (GO:0001914),0.67109592046613,1.5483973887710945,0.05203252032520325,0.3601673182576899,1.0,2/16,3.80%,CEACAM1;STX7
prerank,homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),0.551040011844805,1.5475535904504871,0.021683673469387755,0.3612225030706511,1.0,13/59,11.00%,PTPRM;PECAM1;CDH13;CEACAM1;CADM1;AMIGO2;ROBO4;BSG;TENM3;NECTIN4;NECTIN1;KIRREL3;CDH2
prerank,purine ribonucleotide transport (GO:0015868),0.6733155489643775,1.5471463197911208,0.050955414012738856,0.3608589142241475,1.0,3/16,4.75%,LRRC8C;ABCC4;SLC17A9
prerank,negative regulation of chondrocyte differentiation (GO:0032331),-0.5900568451945845,-1.5471438004781768,0.03508771929824561,0.4779344817895018,1.0,4/14,7.50%,ADAMTS12;EFEMP1;TGFBR1;WNT9A
prerank,adenine nucleotide transport (GO:0051503),0.6663007074569298,1.546133650175646,0.05063291139240506,0.3621415597194197,1.0,3/17,4.75%,LRRC8C;ABCC4;SLC17A9
prerank,cardiac muscle cell membrane repolarization (GO:0099622),0.7437565459728182,1.5460790341017776,0.04194630872483222,0.36092035360589875,1.0,2/11,2.15%,KCNQ1;ATP1A1
prerank,regulation of blood vessel endothelial cell migration (GO:0043535),0.5504932166100095,1.5460320611009863,0.03205128205128205,0.35971214052801925,1.0,21/54,17.40%,NOS3;GATA2;PDGFB;ACVRL1;ATP2B4;PRKD1;ANGPT1;MEF2C;ADAM17;AKT3;HSPB1;NUS1;ATP5F1A;HMGB1;PLCG1;PRKD2;HIF1A;CSNK2B;TMSB4X;MAPK14;ETS1
prerank,cell differentiation in spinal cord (GO:0021515),0.748358428160451,1.5445915466543885,0.04638218923933209,0.36232112926851046,1.0,3/10,12.21%,SOX13;ZC4H2;SOX6
prerank,cyclic-nucleotide-mediated signaling (GO:0019935),-0.4694791606460509,-1.5439811715218994,0.025362318840579712,0.48271835176867084,1.0,9/35,5.64%,IRAG1;PDE7B;PDE3A;ADCY1;ADGRG6;APOE;NUDT4;KSR1;ADCY2
prerank,regulation of GTPase activity (GO:0043087),0.4808164561151721,1.5439364947165153,0.003303964757709251,0.36263352621742984,1.0,30/177,7.14%,FGD5;RAPGEF2;EFNA5;DOCK9;RASIP1;RABGAP1;F11R;PLXNA4;CHN2;RAPGEF1;DAB2IP;RASGRP2;CAV2;F2RL1;PRKG1;AGRN;CRK;GPR137B;PLXND1;TBC1D30;RAPGEF6;MAP4K4;FGD6;RAP1GDS1;BCAR3;LRCH1;SH3BP4;RGS7;RAB3GAP2;LRRK2
prerank,regulation of gene expression by genetic imprinting (GO:0006349),-0.6555501887594538,-1.5434160230036202,0.04878048780487805,0.47820619226549144,1.0,4/10,8.91%,MECP2;PCGF3;IGF2;DNMT3A
prerank,limb development (GO:0060173),-0.49842188655729225,-1.5430061818042993,0.010238907849829351,0.47317560323921376,1.0,8/28,11.08%,GLI3;SMOC1;KAT2B;MEGF8;RSPO2;INTU;PTCH1;SALL1
prerank,dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.5916534817367468,-1.5428766909501348,0.03937007874015748,0.46739522499457287,1.0,7/15,12.27%,UST;DSE;DCN;BGN;VCAN;B3GAT3;CSPG4
prerank,regulation of receptor binding (GO:1900120),0.7577841814394954,1.5401216550537171,0.05673758865248227,0.37111377906182114,1.0,3/10,4.08%,ATP2A3;B2M;ADAM15
prerank,determination of heart left/right asymmetry (GO:0061371),0.5788271371804401,1.5400003107241058,0.036734693877551024,0.3700283858598377,1.0,7/42,5.57%,SOX17;ENG;NOTCH1;DAND5;SOX18;MEF2C;BBS7
prerank,ketone body metabolic process (GO:1902224),-0.6595846484123244,-1.5390514538036386,0.05200945626477541,0.4744901351230923,1.0,6/10,11.90%,OXCT1;ACSS3;HMGCS2;BDH2;BDH1;HMGCL
prerank,negative regulation of protein depolymerization (GO:1901880),0.6187845757734599,1.538963429713271,0.05,0.37133758261428756,1.0,8/24,9.92%,LIMA1;STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,platelet degranulation (GO:0002576),0.5010282518332508,1.5378885265378477,0.009269988412514484,0.37285704402481396,1.0,14/118,4.78%,VEGFC;PECAM1;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;VEGFD;TIMP3;SELENOP;TAGLN2
prerank,positive regulation of protein depolymerization (GO:1901881),0.7341196164312745,1.5377848916730945,0.04807692307692308,0.37178461926660406,1.0,4/11,7.47%,TRPV4;STMN2;F2RL1;WDR1
prerank,regulation of cellular component biogenesis (GO:0044087),0.5735964310140234,1.5373324950516785,0.04016620498614958,0.3716375638237457,1.0,9/39,9.21%,RAPGEF2;TIE1;NOTCH1;RAPGEF1;DAB2IP;MSN;IRGM;ROCK1;TJP1
prerank,negative regulation of smooth muscle cell migration (GO:0014912),-0.5866318989291709,-1.5371598209663746,0.029490616621983913,0.47454011609731583,1.0,7/14,11.24%,LRP1;BMPR1A;IGFBP5;SLIT2;TPM1;IGFBP3;SERPINE1
prerank,regulation of ossification (GO:0030278),0.5824671138113018,1.5361323771056388,0.03856749311294766,0.37371810912289877,1.0,10/36,8.57%,SGMS2;SMAD6;S1PR1;BMPR2;NOTCH1;TGFB2;ACVR1;MEF2C;ZBTB16;NBR1
prerank,detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.5962859391422554,-1.5360141799344664,0.04,0.47197389955804564,1.0,4/15,2.70%,PIEZO2;ADGRV1;COL11A1;KIT
prerank,positive regulation of epithelial cell migration (GO:0010634),0.5160015823585018,1.5357928271648593,0.012895662368112544,0.3732529128266869,1.0,30/92,13.57%,PLCG2;TEK;EDN1;BMPR2;FLT4;RAB11A;PRKD1;TGFB2;RHOB;ANXA3;PPM1F;RRAS;ANGPT1;IQSEC1;MAP4K4;GPI;GATA3;CLASP1;ZC3H12A;FOXP1;RTN4;GFUS;CLASP2;PLCG1;RAC1;PRKD2;PIK3CB;DOCK1;ITGB1BP1;HIF1A
prerank,lymphocyte mediated immunity (GO:0002449),0.7216614342333648,1.535788478217147,0.05442176870748299,0.37191274877499186,1.0,1/12,0.26%,JAG1
prerank,positive regulation of leukocyte apoptotic process (GO:2000108),0.738076643065602,1.5354299789269927,0.05254237288135593,0.37149021208389726,1.0,3/11,5.32%,RAPGEF2;LGALS9;MEF2C
prerank,positive regulation of endothelial cell migration (GO:0010595),0.5216869325653398,1.533093023213725,0.017964071856287425,0.3763937227759184,1.0,29/84,13.57%,TEK;NOS3;EDN1;GATA2;PDGFB;BMPR2;FLT4;PRKD1;RHOB;ANXA3;RRAS;ANGPT1;GPI;GATA3;ADAM17;AKT3;ZC3H12A;HSPB1;NUS1;ATP5F1A;FOXP1;HMGB1;GFUS;PLCG1;RAC1;PRKD2;PIK3CB;ITGB1BP1;HIF1A
prerank,response to cholesterol (GO:0070723),-0.5606423849719664,-1.5320333691488859,0.03591160220994475,0.4790723414759768,1.0,9/17,17.12%,TGFBR1;SMO;GRAMD1C;GPLD1;PTCH1;GRAMD1A;OSBPL7;TGFBR2;GRAMD1B
prerank,regulation of DNA repair (GO:0006282),-0.4478959520331759,-1.5312026007374848,0.0041841004184100415,0.4761827374800391,1.0,8/44,8.59%,EYA2;EGFR;EYA1;TRIP12;EYA4;UBE2V2;UBE2N;USP1
prerank,regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.6674232083122698,1.5309978507861044,0.04888888888888889,0.3806322443411236,1.0,4/17,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,negative regulation of cell migration (GO:0030336),0.48953337587850876,1.530674681181809,0.0066518847006651885,0.38017958088580683,1.0,24/137,6.93%,PTPRJ;JAG1;PTPRG;ENG;PTPRR;CLDN5;DACH1;RECK;SMAD7;LIMCH1;MCTP1;ACVRL1;ADARB1;DAB2IP;RHOB;CLIC4;EVL;ADAM15;STK24;HYAL2;SRGAP1;ADIPOR1;CLASP1;DUSP3
prerank,positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6604459789552578,1.5304734236466195,0.05747126436781609,0.37941378489359245,1.0,6/17,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,negative regulation of microtubule depolymerization (GO:0007026),0.6273463855916112,1.5300343733746562,0.058383233532934134,0.37941280680153755,1.0,7/21,9.92%,STMN2;ARHGEF2;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,positive regulation of heart rate (GO:0010460),0.6756249060127149,1.5299140202036972,0.05076923076923077,0.3783909613632075,1.0,2/17,0.47%,KCNQ1;EDN1
prerank,bone development (GO:0060348),-0.4577841815285952,-1.5298427982282816,0.01056338028169014,0.4748446830432206,1.0,9/39,8.50%,RANBP3L;FGFR2;SULF1;SULF2;CYP26B1;GJA1;SH3PXD2B;SFRP4;P3H1
prerank,positive regulation of JNK cascade (GO:0046330),0.5331444731545705,1.5298089756722988,0.013959390862944163,0.3773691728384545,1.0,17/70,10.64%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,regulation of smooth muscle cell migration (GO:0014910),-0.5389797540635608,-1.5290914197796532,0.03170028818443804,0.4714400719923617,1.0,7/20,1.90%,IGF1;LRP1;BMPR1A;PDGFRB;IGFBP5;VTN;SLIT2
prerank,positive regulation of developmental growth (GO:0048639),0.5484565543927934,1.528792838905741,0.037283621837549935,0.37858403834012333,1.0,12/49,13.94%,PLCB1;INSR;MACF1;ITSN2;AGRN;NTN1;SHTN1;SEMA7A;ISLR2;NEDD4L;SMURF1;RASAL1
prerank,plasma membrane bounded cell projection assembly (GO:0120031),0.4707467577844389,1.5269821681681646,0.002074688796680498,0.38198038860214584,1.0,49/259,10.78%,CDH13;SPATA13;EXOC6;EHD4;FGD5;CD2AP;ABCC4;RAPGEF2;S1PR1;ABLIM1;EMP1;NOTCH1;RAB11A;MYLK;PARVB;EMP2;DNM3;INPP5K;ANO6;NTN1;TEKT5;EHD1;SHTN1;RAPGEF6;MAP4K4;FAM161A;TTBK2;FGD6;TTC36;FNBP1L;BBS7;SNX10;RAB23;P2RX7;FXYD5;WHAMM;TMEM216;PTPRO;IFT140;CFAP43;PCM1;CFAP52;CCDC88A;CDC14A;DYNLL1;CYFIP1;MINK1;RAC1;EXOC8
prerank,positive regulation of protein modification process (GO:0031401),0.47419349341038547,1.526545501707013,0.0032119914346895075,0.3817558009138508,1.0,30/203,7.97%,VEGFC;PECAM1;TEK;ENG;EFNA5;FLT4;ACE;FAS;TBX1;LIMCH1;CCND2;INSR;CCND3;APP;NOS1AP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;PPP1R16B;FAM161A;BRAT1;ADAM17;IRGM;RAB3GAP2;LRRK2;PDE8A;ARRB1;THPO
prerank,embryonic eye morphogenesis (GO:0048048),-0.6570881046094137,-1.5259409729681959,0.03201970443349754,0.4762965396163431,1.0,7/11,19.36%,EFEMP1;MFAP5;FBN2;FBN1;TBX2;RARG;MFAP2
prerank,negative regulation of biomineral tissue development (GO:0070168),0.6405160445964212,1.5253753306934388,0.04682779456193353,0.38360583852052943,1.0,5/21,3.58%,NOS3;CCR1;NOTCH1;HEY1;HEY2
prerank,glycerophospholipid biosynthetic process (GO:0046474),0.48081105406499786,1.5249504845430142,0.009761388286334056,0.38348206387728906,1.0,31/172,11.85%,BMX;PLCG2;PIP5K1B;PITPNM3;PIK3R6;INPP5D;PIK3C2A;APOA1;INPP5K;ACP6;SLC44A1;LPCAT4;LCAT;FAR1;PLEKHA1;PIP5K1C;CRLS1;FIG4;LCLAT1;PLD1;PLSCR1;PCYT1A;DGKH;PIK3C3;ARF3;CEPT1;LPCAT3;PTDSS1;OCRL;INPP5F;ACHE
prerank,peptidyl-tyrosine dephosphorylation (GO:0035335),0.5909761971749865,1.524533325029712,0.034482758620689655,0.38315360596712356,1.0,7/34,7.87%,PTPRJ;PTPRB;DUSP1;DUSP16;DUSP3;PTPN12;PTPRO
prerank,myoblast fusion (GO:0007520),0.7119565400604895,1.5239178671757339,0.05221518987341772,0.38355992564027136,1.0,2/12,1.64%,NOS1;JAM2
prerank,regulation of integrin activation (GO:0033623),0.6921263785558418,1.523600678781621,0.04866562009419152,0.38307775089613266,1.0,3/15,2.02%,RASIP1;PIEZO1;FBLIM1
prerank,melanocyte differentiation (GO:0030318),-0.6275065759894125,-1.523365580914661,0.04785894206549118,0.4793620848649967,1.0,5/11,6.86%,LRMDA;MITF;KIT;ENPP1;USP13
prerank,regulation of interleukin-1 production (GO:0032652),0.6911918379183399,1.5230335301894666,0.0576,0.3834022586811586,1.0,4/15,9.50%,CEACAM1;TMED10;FOXP1;HMGB1
prerank,cellular response to superoxide (GO:0071451),0.7388808045278874,1.5228849731854293,0.04991680532445923,0.38252870245323933,1.0,2/10,4.38%,NOS3;ATP7A
prerank,cellular response to cadmium ion (GO:0071276),-0.5154434150378222,-1.5227701710361794,0.03170028818443804,0.4755665308470818,1.0,9/24,6.94%,EGFR;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,pattern recognition receptor signaling pathway (GO:0002221),0.5453712044261536,1.522676648167213,0.022727272727272728,0.38174324338255633,1.0,10/56,10.93%,PLCG2;NOD1;NOD2;TLR3;IRAK2;HSP90B1;UBA52;RPS27A;HMGB1;TAB2
prerank,dermatan sulfate biosynthetic process (GO:0030208),-0.6277969295012275,-1.5225957106544747,0.05486284289276808,0.47061359833137273,1.0,5/12,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,Rac protein signal transduction (GO:0016601),0.6551024002028254,1.5225532177724816,0.06511627906976744,0.3807924110979406,1.0,6/18,13.75%,CDH13;ELMO1;NCKAP1;CYFIP1;RAC1;RHOH
prerank,microvillus organization (GO:0032528),0.6968828296159155,1.5223442072088407,0.04730831973898858,0.3800112464533969,1.0,5/13,10.64%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,amino sugar biosynthetic process (GO:0046349),-0.6205962610329233,-1.521880342457492,0.0275,0.4677851402791485,1.0,8/12,20.23%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,lung epithelium development (GO:0060428),-0.6575277033838705,-1.5214268245069025,0.05060240963855422,0.4638035322298435,1.0,5/10,16.11%,ERRFI1;BMP4;STRA6;PKD1;RCN3
prerank,nucleobase-containing compound biosynthetic process (GO:0034654),-0.5429531874871787,-1.5212987632544657,0.03823529411764706,0.4591537897736906,1.0,14/19,32.68%,ADK;AMPD3;GMPR;PNP;TERT;APRT;TYMS;CDA;POLD2;DCK;AMPD2;ADA;POLL;POLD3
prerank,bile acid and bile salt transport (GO:0015721),0.6258491285718626,1.5210628463981841,0.05997001499250375,0.38207986845450465,1.0,3/24,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,positive regulation of glucose transmembrane transport (GO:0010828),-0.4935437236383401,-1.521014091136298,0.05063291139240506,0.45515254129780497,1.0,10/26,8.12%,IGF1;SORBS1;RHOQ;IRS2;C2CD5;IRS1;PIK3R1;CLIP3;OSBPL8;PRKCI
prerank,negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.6852191379248093,1.519948789915301,0.06074766355140187,0.3838103043611234,1.0,5/14,4.05%,MMRN2;NOTCH1;DLL4;KLF4;CARD10
prerank,response to cadmium ion (GO:0046686),-0.5074426459939508,-1.519268835414124,0.03115264797507788,0.45567369260345114,1.0,9/26,6.94%,EGFR;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,regulation of histone acetylation (GO:0035065),0.5962911872954273,1.519097378568192,0.04850213980028531,0.3848186173098671,1.0,2/33,1.03%,NOS1;RPS6KA5
prerank,cellular response to peptide (GO:1901653),0.5412230922754148,1.5187274849599903,0.03870967741935484,0.38447755698929664,1.0,12/56,4.30%,FYN;VCAM1;NOD1;NOD2;ARHGEF2;ATP1A3;CAV1;CACNA1A;ADRB2;VIM;APP;FCGR2B
prerank,regulation of histone modification (GO:0031056),-0.585443867102376,-1.5185564398843174,0.057692307692307696,0.45306189096284294,1.0,7/13,21.31%,UBE2N;IGF2;FLCN;AKAP8L;NNMT;PARG;MTHFR
prerank,negative regulation of protein serine/threonine kinase activity (GO:0071901),0.527117689998339,1.5180097102182437,0.02912621359223301,0.3851056438929117,1.0,12/75,8.44%,PTPRJ;HEG1;RASIP1;DUSP1;DAB2IP;HHEX;INPP5K;SLC8A1;STK38;HYAL2;CEBPA;APC
prerank,regulation of potassium ion transmembrane transport (GO:1901379),0.5449381558431259,1.5175371189507125,0.030612244897959183,0.3852660815397635,1.0,7/54,4.87%,KCNN4;KCNQ1;CAV1;KCNN3;NOS1AP;DPP6;DPP10
prerank,positive regulation of MAPK cascade (GO:0043410),0.4690524266887006,1.517453962921999,0.0010427528675703858,0.38419568994359415,1.0,44/245,9.67%,PTPRJ;PLCG2;TEK;EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;FLT4;PIK3R6;TBX1;CCR1;NOTCH1;JCAD;NOD2;INSR;DAB2IP;ARL6IP5;CAV2;F2RL1;TGFB2;ADRB2;LGALS9;APP;IQGAP1;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;IAPP;BCAR3;MFHAS1;LRRK2;PDE8A;ARRB1;THPO;TPD52L1;ROCK1;HTR2A;TAOK2;HMGB1;FBXW7
prerank,UDP-N-acetylglucosamine metabolic process (GO:0006047),-0.6091592801835559,-1.5151479109115629,0.03826530612244898,0.45875261038294435,1.0,8/13,20.23%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;GNPNAT1
prerank,regulation of focal adhesion assembly (GO:0051893),0.5466950310417951,1.5141653208742092,0.026385224274406333,0.39180536265163046,1.0,17/54,10.68%,PTPRJ;TEK;EFNA5;LIMCH1;ACVRL1;FAM107A;MACF1;PPM1F;SLK;MAP4K4;CLASP1;DUSP3;ACTG1;ROCK1;PTK2;CLASP2;RAC1
prerank,negative regulation of protein polymerization (GO:0032272),0.6037318419191837,1.5139352754213742,0.04499274310595065,0.3911730271851748,1.0,4/27,2.97%,KANK4;STMN2;HIP1R;KANK3
prerank,positive regulation of mRNA catabolic process (GO:0061014),0.5675163329067688,1.5135803508896175,0.03713527851458886,0.3907949402583478,1.0,13/44,13.27%,NANOS1;NANOS3;TNRC6C;BTG2;ZC3H12A;PRR5L;POLR2G;ROCK1;ZFP36L2;CNOT1;GTPBP1;TOB1;METTL14
prerank,negative regulation of endothelial cell apoptotic process (GO:2000352),0.6276322892242562,1.5129140273956538,0.036231884057971016,0.3913542990309589,1.0,5/24,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,maintenance of blood-brain barrier (GO:0035633),0.5958623614304756,1.512911517427013,0.05128205128205128,0.3900951359219997,1.0,12/30,11.60%,PECAM1;CLDN5;F11R;OCLN;JAM2;ESAM;LSR;TJP2;ACTG1;TJP1;ACTB;SLC1A1
prerank,modified amino acid transport (GO:0072337),-0.5768657032972445,-1.512896961709112,0.05181347150259067,0.46077360921259375,1.0,4/15,6.15%,SLC6A13;SLC16A12;PDPN;SLC19A1
prerank,positive regulation of histone modification (GO:0031058),0.5924387415319393,1.5127311050843584,0.049723756906077346,0.38932323136125724,1.0,7/33,12.77%,NOS1;RPS6KA5;ING2;ARRB1;BRCA1;CHTOP;GLYR1
prerank,cellular response to catecholamine stimulus (GO:0071870),0.6085436029517928,1.511929538306917,0.0687593423019432,0.3902783251771922,1.0,4/23,7.14%,KCNQ1;ATP2B4;MAPK1;LRRK2
prerank,negative regulation of angiogenesis (GO:0016525),0.5091928652030097,1.5116573302515737,0.02822085889570552,0.3897083326622491,1.0,20/84,11.18%,PTPRM;TEK;CLDN5;KLF2;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1;EPN2;ADGRB1;ADAMTS1
prerank,regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.636922645687865,1.5110250735371415,0.047895500725689405,0.3901460205578024,1.0,4/21,3.68%,GJA5;KCNQ1;KCNE3;NOS1AP
prerank,modulation by symbiont of host process (GO:0044003),0.7340480494371321,1.5103530352700911,0.058919803600654665,0.39073218521883996,1.0,4/10,8.54%,B2M;PGK1;UBA52;RPS27A
prerank,release of sequestered calcium ion into cytosol (GO:0051209),0.6146271921463451,1.5102214326548633,0.041968162083936326,0.38980045314248574,1.0,2/26,1.09%,PLCG2;ITPR3
prerank,regulation of interleukin-1 beta production (GO:0032651),0.5277249391609875,1.509966283841837,0.026022304832713755,0.3892295667358509,1.0,16/66,10.37%,GBP5;NOD2;AIM2;CASP8;F2RL1;LGALS9;APP;APOA1;P2RX7;ZC3H12A;HSPB1;JAK2;FOXP1;EGR1;TYROBP;CASP1
prerank,regulation of DNA biosynthetic process (GO:2000278),0.6042374552801371,1.5089885341846987,0.0695266272189349,0.39055903960185245,1.0,9/27,13.96%,PDGFB;DACH1;BMPR2;ACVRL1;HMBOX1;TOM1L1;TNKS;PRKD2;ATM
prerank,regulation of MAPK cascade (GO:0043408),0.48330095325300165,1.5089601037709146,0.006550218340611353,0.3893919179559676,1.0,30/157,9.50%,PTPRJ;PLCG2;TEK;FLT1;CEACAM1;PDGFB;FLT4;FAS;TBX1;JCAD;INSR;DUSP1;DAB2IP;CAV1;CAV2;ADRB2;IQGAP1;RRAS;MAP4K4;FGFR3;IAPP;BCAR3;MAPK1;P2RX7;DUSP3;THPO;NBR1;ROCK1;TAOK2;HMGB1
prerank,ganglioside metabolic process (GO:0001573),0.6346869879276279,1.5089045619223769,0.06800618238021638,0.388323960577726,1.0,2/20,0.49%,ST6GALNAC3;ST8SIA6
prerank,negative regulation of sequestering of calcium ion (GO:0051283),0.618949326563121,1.507307952779633,0.052478134110787174,0.39140918171262495,1.0,2/24,1.09%,PLCG2;ITPR3
prerank,T-helper cell differentiation (GO:0042093),0.6743531866520938,1.5069531061740864,0.0594855305466238,0.39125143594707557,1.0,5/14,11.95%,ATP7A;LEF1;FOXP1;HMGB1;TMEM98
prerank,negative regulation of blood vessel morphogenesis (GO:2000181),0.514838774256533,1.5069164467753835,0.03549571603427173,0.39015311716435763,1.0,16/75,9.04%,PTPRM;TEK;CLDN5;FOXO4;ATP2B4;ECSCR;DAB2IP;TGFB2;HHEX;PDE3B;KLF4;PGK1;NPR1;STAT1;ISM1;ROCK1
prerank,positive regulation of SMAD protein signal transduction (GO:0060391),-0.5952510588804708,-1.505612207641271,0.047493403693931395,0.47874815246728764,1.0,5/13,2.18%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4
prerank,leukocyte adhesion to vascular endothelial cell (GO:0061756),0.6567799992654644,1.5040554424795922,0.06995230524642289,0.396523795966127,1.0,3/18,1.64%,GCNT1;VCAM1;JAM2
prerank,digestive tract development (GO:0048565),-0.4777317855965042,-1.5032148933198926,0.04950495049504951,0.4813737777888419,1.0,15/32,11.67%,GLI3;CLMP;GLI2;FGFR2;RARB;SMO;COBL;KIT;NIPBL;MEGF8;GLI1;PKDCC;STRA6;SALL1;PKD1
prerank,circulatory system development (GO:0072359),0.4937708133796638,1.5021934753718365,0.016147635524798153,0.40013222174024643,1.0,20/118,5.32%,HEG1;SOX17;TEK;NOTCH4;PDGFB;FLT4;TBX1;ACVRL1;NOTCH1;HEY1;CASP8;TGFB2;HDAC9;SOX18;HEY2;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,regulation of endothelial cell apoptotic process (GO:2000351),0.5673080488856321,1.5020168479200746,0.04483695652173913,0.39937437450574215,1.0,9/39,10.49%,TEK;GATA2;ECSCR;ANO6;ANGPT1;GATA3;PDCD4;NFE2L2;PLCG1
prerank,regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),0.49533591521263887,1.5009815770007895,0.01884570082449941,0.4008067384279622,1.0,13/95,6.32%,PRDM16;LTBP4;ENG;SMAD6;SMAD7;DAND5;CAV1;FKBP1A;IL17RD;ING2;WFIKKN1;SMAD2;ADAM17
prerank,regulation of striated muscle contraction (GO:0006942),0.6067140834836997,1.5004091691784602,0.049926578560939794,0.4011177321698888,1.0,4/27,1.45%,NOS1;GJA5;SMAD7;MYBPC3
prerank,regulation of Rac protein signal transduction (GO:0035020),-0.5682942836790643,-1.4994937955553778,0.046703296703296704,0.48893559876218834,1.0,8/16,22.50%,AUTS2;OGT;ARHGAP24;CADM4;GABARAP;ARF6;KBTBD7;RASGRF1
prerank,positive regulation of neuron migration (GO:2001224),0.7258376580482936,1.4994765812700328,0.09135399673735727,0.4024837082963047,1.0,4/11,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6279102473968224,1.4986944819967294,0.07407407407407407,0.40336218547783376,1.0,6/20,7.56%,PDGFB;CCNY;CCND2;CCND3;ADAM17;MAPRE3
prerank,regulated exocytosis (GO:0045055),0.47125835743652866,1.4983753526312382,0.00646551724137931,0.40298273313343924,1.0,20/173,6.37%,VEGFC;PECAM1;SYT15;ABCC4;PDGFB;VWF;TGFB2;APP;ACTN4;APOA1;VTI1B;SYT7;VEGFD;TIMP3;SELENOP;TAGLN2;TMED10;MYH9;PIP5K1C;CYB5R1
prerank,positive regulation of cardiac muscle cell proliferation (GO:0060045),-0.5893010982146449,-1.4977529582101463,0.0610079575596817,0.4899831432091652,1.0,8/13,11.27%,TGFBR3;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2;GLI1;TBX2
prerank,myotube differentiation (GO:0014902),0.6617595209893381,1.4970419833078432,0.056074766355140186,0.4052009731692825,1.0,5/17,7.18%,NOS1;JAM2;MEF2C;MYEF2;ADAM12
prerank,intracellular estrogen receptor signaling pathway (GO:0030520),-0.5658228131556508,-1.4966155876451912,0.056451612903225805,0.4887852726451639,1.0,8/16,19.35%,PPARGC1B;DDX5;DDX17;PADI2;SAFB;TADA3;AR;TRIP4
prerank,regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),0.6936960609877085,1.4955948595727844,0.07131537242472266,0.40776206769340867,1.0,5/12,9.50%,F2RL1;TIRAP;KLF4;FOXP1;HMGB1
prerank,inositol lipid-mediated signaling (GO:0048017),-0.41977692017340656,-1.4946150421796949,0.027906976744186046,0.49093417149744434,1.0,20/50,14.39%,IGF1;PLCE1;OGT;PDGFRB;PDGFRA;PLCL1;ADAP2;PITPNM2;NGF;IRS2;IRS1;PIK3R1;PLCB3;PI4KB;TNFAIP8L3;PI4KA;PLCD3;PIK3R2;PLCD1;GAB2
prerank,actin filament-based transport (GO:0099515),0.6372889724665474,1.4944836596956503,0.05718475073313783,0.4095156559593465,1.0,5/21,8.12%,MYO1D;MYO1E;ACTN4;FNBP1L;MYO1C
prerank,T cell proliferation (GO:0042098),0.7004464554199981,1.4943298335189255,0.054009819967266774,0.40870174134225723,1.0,4/13,4.64%,CRTAM;CADM1;MSN;CTPS1
prerank,regulation of cell aging (GO:0090342),0.7211801398862925,1.4943217427711384,0.0676818950930626,0.4075064865965217,1.0,2/11,4.15%,NUAK1;ING2
prerank,cell-substrate junction assembly (GO:0007044),0.5694658583889288,1.4942247339446335,0.04971590909090909,0.4065770233679971,1.0,6/33,9.44%,LAMA3;BCR;DST;PLEC;WHAMM;TAOK2
prerank,metal ion export (GO:0070839),0.5730523254986758,1.4941360851208232,0.05142083897158322,0.40564406227171,1.0,7/31,4.38%,KCNQ1;KCNE3;ATP2B4;ATP1A4;ATP1A1;ATP1A3;ATP7A
prerank,endodermal cell fate commitment (GO:0001711),0.7292632997722978,1.4932021301332528,0.0858085808580858,0.4069892861751864,1.0,2/10,6.27%,SOX17;RTF1
prerank,embryonic heart tube development (GO:0035050),0.6799313873632831,1.4928943313789174,0.05306799336650083,0.40654957872882247,1.0,3/14,4.11%,SOX17;SOX18;ACVR1
prerank,positive regulation of toll-like receptor signaling pathway (GO:0034123),0.5969790824325183,1.492878635482942,0.06723891273247497,0.40539005236243136,1.0,9/26,11.05%,CAV1;F2RL1;TLR3;TIRAP;MFHAS1;SLC15A4;RTN4;HMGB1;CYBA
prerank,phospholipid biosynthetic process (GO:0008654),0.5735510996769947,1.492072385169102,0.04126547455295736,0.40639519943857016,1.0,5/36,7.60%,SGMS1;SGMS2;FAR1;CRLS1;NUS1
prerank,regulation of cellular response to growth factor stimulus (GO:0090287),-0.5581000841405446,-1.4917117163522782,0.06182795698924731,0.4952886385467821,1.0,7/17,9.48%,FSTL1;SULF1;CASK;SLIT2;TWSG1;SFRP4;ZDHHC17
prerank,pyrimidine-containing compound catabolic process (GO:0072529),-0.5501092785172077,-1.4913522198455407,0.08157894736842106,0.49166237191785955,1.0,6/16,11.03%,DPYSL3;DPYD;TET2;NT5M;NT5E;UPB1
prerank,fat cell differentiation (GO:0045444),0.5367322833571405,1.4911584986387856,0.03254067584480601,0.40775505615548285,1.0,12/57,13.92%,PRDM16;SMAD6;NR4A2;FOXO1;KLF4;BBS7;CEBPA;PSMB8;NR4A1;ALOXE3;CTBP2;SDF4
prerank,microvillus assembly (GO:0030033),0.6709455347091933,1.4911231455259553,0.06050955414012739,0.40668759788219244,1.0,5/14,10.64%,RAPGEF2;RAPGEF6;MAP4K4;FXYD5;MINK1
prerank,chondroitin sulfate metabolic process (GO:0030204),-0.4690579727949486,-1.4905226037648196,0.029900332225913623,0.48971011865721287,1.0,10/30,12.27%,DSE;DCN;NDNF;CHST15;BGN;HEXA;VCAN;HYAL1;CHPF2;CSPG4
prerank,inositol phosphate dephosphorylation (GO:0046855),0.7081637437260466,1.4887562725580865,0.07601351351351351,0.4105334789965715,1.0,6/11,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,phosphorylated carbohydrate dephosphorylation (GO:0046838),0.7081637437260466,1.4887562725580865,0.07601351351351351,0.4105334789965715,1.0,6/11,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,embryonic heart tube morphogenesis (GO:0003143),0.5570116127872584,1.4887091624985436,0.04993252361673414,0.40949645675934637,1.0,7/43,5.57%,SOX17;ENG;NOTCH1;SOX18;ACVR1;MEF2C;BBS7
prerank,positive regulation of glycogen metabolic process (GO:0070875),-0.5935258338247604,-1.488609643295541,0.052486187845303865,0.4907550188420177,1.0,5/13,7.81%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,posttranscriptional regulation of gene expression (GO:0010608),0.5436115255069537,1.4876534299836197,0.05771812080536913,0.41121820997934966,1.0,5/45,4.59%,NANOS1;NANOS3;APP;PUM2;GCNT2
prerank,toll-like receptor signaling pathway (GO:0002224),0.5084400032020525,1.487452513629535,0.025059665871121718,0.4106005386153474,1.0,17/84,12.88%,PLCG2;CASP8;LGALS9;TLR3;TIRAP;IRAK2;UBE2D1;ITGAM;HSP90B1;UBA52;NMI;RPS27A;HMGB1;PIK3C3;TAB2;BTK;RPS6KA3
prerank,heart looping (GO:0001947),0.5667640827348389,1.486516272539873,0.05471956224350205,0.41186904798723234,1.0,6/39,5.57%,SOX17;ENG;NOTCH1;SOX18;MEF2C;BBS7
prerank,branching morphogenesis of an epithelial tube (GO:0048754),0.551795746742837,1.4856556128268381,0.0472972972972973,0.4128703972691835,1.0,5/39,2.96%,NOTCH4;ENG;TIE1;RASIP1;DLL4
prerank,intraciliary transport involved in cilium assembly (GO:0035735),-0.4568359198815606,-1.4848496287500732,0.02877697841726619,0.4977181032423872,1.0,18/37,22.14%,IFT80;TRIP11;IFT81;KIF3C;WDR35;DYNC2LI1;IFT43;DYNLRB1;DYNC2I2;KIF3A;TTC21B;WDR19;IFT27;IFT74;IFT20;IFT88;DYNC2H1;DYNC2I1
prerank,clathrin-dependent endocytosis (GO:0072583),0.602582331690316,1.4847734940097543,0.0771513353115727,0.41398989404357905,1.0,8/26,11.65%,FCHSD2;ITSN2;AP2B1;FCHO2;FNBP1L;PIP5K1C;AP2M1;INPP5F
prerank,regulation of protein metabolic process (GO:0051246),0.5481722057596196,1.484733700755502,0.0488771466314399,0.41290901481998493,1.0,7/44,5.65%,LTBP4;ACE;KLF2;FKBP1A;APP;KLF4;FURIN
prerank,positive regulation of integrin activation (GO:0033625),0.7221488749648257,1.4844935176693548,0.06271186440677966,0.41240124672254236,1.0,2/11,1.14%,RASIP1;PIEZO1
prerank,cellular response to dsRNA (GO:0071359),0.6614868124728494,1.4840523081500117,0.07530647985989491,0.41234181168356376,1.0,7/15,21.89%,CAV1;IFIH1;DHX9;NPM1;RIOK3;RALB;PQBP1
prerank,positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.5879472364799555,1.4835961860115698,0.0529500756429652,0.4124678026602066,1.0,6/29,10.12%,CRTAM;CADM1;STX7;ITGAM;STAP1;TYROBP
prerank,dermatan sulfate metabolic process (GO:0030205),-0.6056023549066011,-1.4834556094639837,0.061855670103092786,0.4974140434208229,1.0,5/13,7.61%,UST;DSE;DCN;BGN;VCAN
prerank,regulation of branching involved in ureteric bud morphogenesis (GO:0090189),-0.5702799454553122,-1.4829806069694753,0.06666666666666667,0.4942278355413808,1.0,7/15,22.67%,SMO;BMP4;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,sphingoid metabolic process (GO:0046519),0.6941615158717267,1.4827166727700916,0.06174957118353345,0.4136579357604975,1.0,4/12,5.93%,SGPP2;DEGS2;PLPP1;ASAH2
prerank,actin filament depolymerization (GO:0030042),-0.6218366687595996,-1.4822570398374357,0.05392156862745098,0.4921472988176842,1.0,3/11,1.41%,MICAL3;GSN;MICAL2
prerank,regulation of T cell cytokine production (GO:0002724),0.6563193449595818,1.4821596279002793,0.06935483870967742,0.4140060795702599,1.0,3/15,5.71%,SMAD7;B2M;TNFRSF1B
prerank,Rho protein signal transduction (GO:0007266),0.5302722646864912,1.4819190991730629,0.04177545691906005,0.4134571471599471,1.0,14/53,10.19%,EPS8L2;CDH13;ARHGEF3;RHOB;CDC42EP1;NTN1;SHTN1;PLEKHG5;ARHGDIA;ARHGAP5;ROCK1;RIPOR1;TAX1BP3;ARHGEF1
prerank,negative regulation of MAPK cascade (GO:0043409),0.49829002886176554,1.4817824013304777,0.029691211401425176,0.41266346242325874,1.0,13/87,6.93%,PTPRJ;PTPRR;CNKSR3;FOXO1;DUSP1;DAB2IP;CAV1;INPP5K;TIMP3;STK38;HYAL2;P2RX7;DUSP3
prerank,negative regulation of DNA-dependent DNA replication (GO:2000104),-0.6102398363719577,-1.4801766383471007,0.06483790523690773,0.49439705675185847,1.0,7/11,21.04%,FBH1;TIPIN;LIG3;DONSON;SMARCAL1;TIMELESS;ZRANB3
prerank,negative regulation of growth (GO:0045926),0.49066781755208655,1.4799833292337898,0.011507479861910242,0.4162464346375693,1.0,21/121,7.69%,PTPRJ;SOX17;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;NOTCH1;TGFB2;HNF4A;PPT1;BTG1;ADAM15;WFDC1;SERTAD2;HYAL2;FGFR3;SH3BP4;NPR1;HSPA1B;MT2A
prerank,regulation of cell growth (GO:0001558),0.4607137887535647,1.4793216725788954,0.006396588486140725,0.4168776202360353,1.0,37/204,10.41%,PTPRJ;SOX17;LTBP4;CEACAM1;MSX1;BMPR2;SMARCA2;APBB2;ACVRL1;FAM107A;RASGRP2;TGFB2;HNF4A;PPT1;BTG1;CISH;ADAM15;KIF26A;WFDC1;SERTAD2;CAMK2D;HYAL2;BRAT1;TAF9B;ADAM17;SH3BP4;SLC25A33;NPR1;HSPA1B;SGK1;SERTAD3;ADAM10;TAOK2;RTN4;MAD2L2;RPS6KA1;GNG4
prerank,regulation of cell-substrate adhesion (GO:0010810),0.5509837934192072,1.4777696032533596,0.05394736842105263,0.4199321489864886,1.0,14/42,12.49%,PDGFB;NOTCH1;EMP2;FBLN2;PPM1F;GCNT2;PTPRO;JAK2;RSU1;PTK2;MINK1;RAC1;SPOCK1;PIK3CB
prerank,negative regulation of cell adhesion mediated by integrin (GO:0033629),0.7136976301263136,1.4777012669405003,0.08231173380035026,0.4189817932846355,1.0,3/10,8.76%,ACER2;PDE3B;SNAI2
prerank,ruffle organization (GO:0031529),0.6456169250216894,1.4775758926491454,0.08490566037735849,0.4181949543522571,1.0,5/16,10.68%,LIMA1;INPP5K;PLEKHA1;CYFIP1;RAC1
prerank,cholesterol transport (GO:0030301),0.5436354347303364,1.4760747998071078,0.04825737265415549,0.42107958851718974,1.0,14/45,19.69%,LIMA1;CAV1;APOA1;LCAT;STX12;ABCG4;CLU;TSKU;VPS4A;LDLRAP1;ABCA7;SCARB1;SOAT1;RELCH
prerank,positive regulation of cell-substrate adhesion (GO:0010811),0.5142005007547249,1.4746900892991437,0.037267080745341616,0.42380486709215925,1.0,10/67,4.06%,CDH13;UTRN;PDGFB;EMP2;FBLN2;NEDD9;CRK;APOA1;PPM1F;LIMS2
prerank,regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.726882348139452,1.4734958467636157,0.09010600706713781,0.4257274857767043,1.0,2/10,1.14%,PODXL;PIEZO1
prerank,JNK cascade (GO:0007254),0.5487084011046423,1.4730927999438097,0.056375838926174496,0.42561770775661456,1.0,10/40,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;IRAK2;UBA52;RPS27A;MAP3K11;MINK1;TAB2
prerank,ganglioside biosynthetic process (GO:0001574),0.6592158170162251,1.4729380967213308,0.08401976935749589,0.42488110320400707,1.0,2/15,0.49%,ST6GALNAC3;ST8SIA6
prerank,striated muscle contraction (GO:0006941),0.5343604857851247,1.4723423701220415,0.04409857328145266,0.4254108568623513,1.0,5/53,5.31%,NOS1;KCNQ1;MYBPC3;SLC8A1;STAC
prerank,angiogenesis involved in wound healing (GO:0060055),0.6976530029839758,1.4699878468679504,0.05815831987075929,0.4307339291739187,1.0,4/11,6.22%,GATA2;ADIPOR2;CD34;MCAM
prerank,Notch signaling pathway (GO:0007219),0.5177030230145654,1.4699032856361791,0.03865979381443299,0.4297748273215981,1.0,14/59,9.41%,JAG1;JAG2;NOTCH4;SORBS2;NOTCH1;HEY1;DLL4;HEY2;PLXND1;ADAM17;STAT1;SNAI2;APH1A;ADAM10
prerank,negative regulation of MAP kinase activity (GO:0043407),0.5504789627646943,1.468879533719407,0.04456824512534819,0.4314609028508279,1.0,10/44,12.49%,PTPRJ;DUSP1;DAB2IP;INPP5K;STK38;HYAL2;PDCD4;AIDA;PTPN1;PIK3CB
prerank,synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.6002831144969352,-1.4673143419533152,0.05699481865284974,0.5312996673301382,1.0,6/12,13.27%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29
prerank,calcium-mediated signaling (GO:0019722),0.49243626875429186,1.4670313334088254,0.028503562945368172,0.43548985176556027,1.0,22/93,13.33%,PTPRJ;PLCG2;EDN1;VCAM1;CCR1;MCTP1;SLC8A1;GPR143;CHRM3;P2RX7;IRGM;LRRK2;PPP3CA;PRKAA1;PRNP;PLCG1;TPCN2;TRPM2;GRM5;BTK;CX3CR1;KSR2
prerank,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),0.4826308527739304,1.4660634873291205,0.02662037037037037,0.4368659722086655,1.0,16/104,8.54%,PRDM16;SMAD6;BMPR2;SMAD7;NOTCH1;DAND5;CAV1;FKBP1A;IL17RD;ACVR1;WFIKKN1;SMAD2;ADAM17;UBE2D1;UBA52;RPS27A
prerank,positive regulation of cell-cell adhesion (GO:0022409),0.5537344247971466,1.465457994181629,0.06149732620320856,0.43737163838840715,1.0,8/41,9.21%,PODXL;MAGI1;SMAD7;PIEZO1;GCNT2;CD47;PTPRU;TJP1
prerank,endochondral bone morphogenesis (GO:0060350),0.7048618420220887,1.4637185658953145,0.07588532883642496,0.4409533805966145,1.0,4/11,5.43%,TRPV4;BMPR2;MEF2C;FGFR3
prerank,regulation of membrane repolarization (GO:0060306),0.6682826205949619,1.4624501537162178,0.08265802269043761,0.443133369215055,1.0,2/13,2.28%,KCNQ1;CAV1
prerank,protein dephosphorylation (GO:0006470),0.46763495828125995,1.4622350637909471,0.012276785714285714,0.4424954381913589,1.0,31/135,14.97%,PTPRM;PTPRJ;PTPRB;PTPRG;PTPRR;PTPN14;DUSP12;DUSP1;PPM1F;PTPRE;CTTNBP2NL;DUSP16;DUSP3;PPP3CA;PTPN12;PTPRU;PTPRO;PP2D1;PPP2R5C;DUSP11;PPP2R2C;RPRD1B;PTPN1;PDP1;EYA3;DUSP22;PPM1D;PPM1L;PPP1R15B;PPP4R1;PPP2CB
prerank,pteridine-containing compound metabolic process (GO:0042558),0.6688849159668661,1.4608270775611765,0.07941653160453808,0.4451654731702985,1.0,2/13,3.43%,NOS3;GCH1
prerank,regulation of fatty acid oxidation (GO:0046320),-0.5412123781171346,-1.4606118057990518,0.07062146892655367,0.5487962461242264,1.0,3/16,3.93%,PRKAG2;APPL2;PPARA
prerank,regulation of microtubule polymerization or depolymerization (GO:0031110),0.5759125049490743,1.4601908081194823,0.07111756168359942,0.44567198556974985,1.0,7/28,9.92%,STMN2;FKBP4;CAMSAP2;PRUNE1;CLASP1;MAPRE3;CLASP2
prerank,cellular copper ion homeostasis (GO:0006878),0.662885193547984,1.460039283334865,0.09181969949916527,0.4448947880800741,1.0,6/14,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.5885470136802601,1.4597413257399807,0.08985507246376812,0.44459418695855374,1.0,3/24,4.95%,NOS1;FKBP1A;CAMK2D
prerank,regulation of JNK cascade (GO:0046328),0.48384589422296537,1.459232605125622,0.022458628841607566,0.4447743677029974,1.0,21/101,10.64%,MECOM;MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;F2RL1;APP;TIRAP;FCGR2B;MAP4K4;TRAF1;DUSP3;MFHAS1;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;AIDA;MINK1
prerank,negative regulation of supramolecular fiber organization (GO:1902904),0.5011772923238139,1.459060345178106,0.04369538077403246,0.4441237176142211,1.0,17/72,11.83%,KANK4;LIMA1;STMN2;HIP1R;ARHGEF2;KANK3;TTBK2;IAPP;SHANK3;CAMSAP2;CLASP1;PFDN6;VBP1;APC;CLASP2;PFDN2;CLU
prerank,modulation by symbiont of entry into host (GO:0052372),0.6499919204951723,1.4584931305501556,0.061068702290076333,0.4445294573758845,1.0,5/16,11.57%,TRIM14;CAV1;TRIM6;TRIM25;HS3ST5
prerank,actin filament organization (GO:0007015),0.47125109492387784,1.4584643347740402,0.014099783080260303,0.4434699826490612,1.0,32/151,13.75%,MYO1D;CD2AP;TRPV4;NEBL;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;RND1;ARHGEF2;PLS3;RHOB;EMP2;NEDD9;FLII;EVL;WHAMM;ARHGAP25;ENAH;MYO1C;BIN3;MAD2L2;GAS2L3;ERMN;RAC1;SHROOM1;TPM4;TMOD3;RND2;CAPG;RHOH
prerank,negative regulation of blood vessel endothelial cell migration (GO:0043537),0.5635838208709754,1.4582583075264341,0.07162921348314606,0.44289806568924933,1.0,8/33,5.32%,MMRN2;ACVRL1;NOTCH1;ATP2B4;DLL4;KLF4;CARD10;MEF2C
prerank,regulation of interleukin-8 production (GO:0032677),0.5053259667990453,1.4575252672585182,0.04868913857677903,0.4437950987728824,1.0,13/69,9.50%,AFAP1L2;NOD1;NOD2;F2RL1;LGALS9;TLR3;TIRAP;KLF4;HYAL2;HSPA1B;ARRB1;CACTIN;HMGB1
prerank,sulfur compound catabolic process (GO:0044273),-0.4480104956875402,-1.4574902525264497,0.039711191335740074,0.5543129026877629,1.0,13/38,12.72%,DCN;OGN;FMOD;GNS;BGN;PRELP;HEXA;VCAN;GGT5;HYAL1;LUM;CSPG4;OMD
prerank,regulation of protein neddylation (GO:2000434),0.7226864931539142,1.4574378253387763,0.07979626485568761,0.4428597087875972,1.0,1/10,0.18%,EPAS1
prerank,nucleobase-containing small molecule catabolic process (GO:0034656),0.6618010026268176,1.4572397946749331,0.08146964856230032,0.4422601067932044,1.0,1/14,0.10%,ENTPD1
prerank,aminoglycan catabolic process (GO:0006026),-0.47087620744387004,-1.4568223030227252,0.056666666666666664,0.5518171887030452,1.0,5/28,4.59%,GPC6;SDC2;HSPG2;GPC3;GNS
prerank,positive regulation of mRNA 3'-end processing (GO:0031442),-0.6284783323900458,-1.456272719040825,0.06718346253229975,0.5487633668010208,1.0,5/10,13.86%,CPEB1;NUDT21;NCBP1;PAF1;CPEB3
prerank,negative regulation of cellular process (GO:0048523),0.4371687347308342,1.4556008678387362,0.0,0.4455895232719679,1.0,93/521,12.26%,NOS1;PTPRJ;CDH13;PODXL;SOX17;NOTCH4;NOS3;IRF6;RAPGEF2;SMAD6;MSX1;BMPR2;SMARCA2;PLXNA4;TBX1;PTPN14;APBB2;FOXO4;RND1;ITGA1;ACVRL1;NOTCH1;JAM2;DYSF;DUSP1;ADARB1;DAB2IP;AQP11;PRKD1;TGFB2;RHOB;HNF4A;BTG2;DLL4;APP;PPT1;BTG1;PLPP1;PPP1R13B;APOA1;PDE3B;KLF4;DDX4;PLXND1;ADAM15;TMEM109;FCGR2B;WFDC1;ANGPT1;SERTAD2;HYAL2;CTTNBP2NL;CD34;TNFRSF1B;GMNC;GATA3;MYH9;WARS1;IL1A;PDCD4;SH3BP4;ARHGDIA;NPR1;IGFBP7;VAMP8;HSPA1B;PDE8A;CEBPA;PTPRU;PLSCR1;CD200;JAK2;APC;NMI;KLF11;PPP2R5C;SERTAD3;ADAM10;RTN4;LPCAT3;CHD5;GNG4;ADGRB1;ADAMTS1;NPM1;VPS35;E2F7;TMBIM6;NR4A1;CLU;TMEM98;COPS8;TOB1
prerank,alanine transport (GO:0032328),0.7106668711389371,1.4548233372040111,0.08305084745762711,0.44648091003858864,1.0,1/10,0.19%,SLC6A6
prerank,regulation of ATP biosynthetic process (GO:2001169),-0.5524971058059261,-1.4548212570842842,0.04736842105263158,0.5489238556622812,1.0,6/16,22.29%,PID1;PPARA;FLCN;SPHK2;ANTKMT;PARP1
prerank,positive regulation of protein tyrosine kinase activity (GO:0061098),0.547707026881973,1.45448872165495,0.0521978021978022,0.44622316086436453,1.0,13/41,11.89%,PDGFB;FYN;ACE;NEDD9;EFNA1;FCGR1A;ADAM17;DOCK3;STAP1;FBXW7;PRNP;PTPN1;GRM5
prerank,negative regulation of T cell differentiation (GO:0045581),-0.6172374343039154,-1.4542599622553882,0.07,0.5460201818123072,1.0,2/10,2.18%,GLI3;BMP4
prerank,endocrine system development (GO:0035270),-0.49531945018563217,-1.4540990464689891,0.06857142857142857,0.5420991461578287,1.0,11/21,20.44%,GLI2;WNT4;TGFBR1;DKK3;SIX1;STRA6;SALL1;MDK;FOXE1;NF1;SOX2
prerank,negative regulation of ossification (GO:0030279),0.602875815115721,1.453711469459097,0.07533234859675036,0.4472594818957228,1.0,4/23,5.32%,SMAD6;CCR1;NOTCH1;MEF2C
prerank,microglial cell activation (GO:0001774),0.6188095743118719,1.4532080593720744,0.0572289156626506,0.44750155397135927,1.0,7/21,12.63%,IFNGR1;APP;ITGAM;JAK2;TYROBP;CLU;CX3CR1
prerank,cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),0.5982453066542738,1.452792228572498,0.08272859216255443,0.44748006103375226,1.0,8/26,10.93%,NOD1;NOD2;CASP8;IFIH1;IRAK2;UBA52;RPS27A;TAB2
prerank,positive regulation of biomineral tissue development (GO:0070169),-0.43694113038443494,-1.4521137693597261,0.03488372093023256,0.5441997315172951,1.0,13/40,8.72%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT6;FBN2;KL;CEBPB;PKDCC
prerank,glycosaminoglycan biosynthetic process (GO:0006024),-0.3644632785514017,-1.4519737287269288,0.007874015748031496,0.540174456513507,1.0,28/95,12.72%,GPC6;UST;DSE;DCN;SDC2;OGN;HSPG2;GPC3;CEMIP;HS3ST3A1;FMOD;B3GNT2;CHST15;BGN;PXYLP1;XYLT1;PRELP;HEXA;ST3GAL4;B4GALT1;VCAN;B3GAT3;HS2ST1;HYAL1;CHPF2;LUM;CSPG4;OMD
prerank,regulation of apoptotic signaling pathway (GO:2001233),0.5618014160367787,1.4516549536747576,0.06232294617563739,0.44940230357201094,1.0,11/36,12.63%,SGMS1;FAS;NR4A2;DAB2IP;TRAF1;ASAH2;MADD;CRADD;TPD52L1;TMBIM6;CX3CR1
prerank,regulation of response to cytokine stimulus (GO:0060759),0.6142801116116509,1.4514884055214439,0.08660130718954248,0.44869696360518624,1.0,7/19,12.73%,LIFR;IFIH1;APOA1;KLF4;IRAK2;DHX9;CBFB
prerank,glycogen metabolic process (GO:0005977),-0.4804348137906761,-1.4514057832393812,0.07098765432098765,0.53752502517465,1.0,9/27,12.76%,PRKAG2;PHKB;PYGB;PYGM;PGM1;AGL;PHKA2;GYS1;GYG1
prerank,negative regulation of voltage-gated potassium channel activity (GO:1903817),0.7150708138026607,1.4508059693710096,0.10855263157894737,0.4493501592390025,1.0,2/10,2.28%,KCNE3;CAV1
prerank,inositol phosphate catabolic process (GO:0071545),0.6818169067310469,1.4505838749646234,0.08848080133555926,0.44883506612051643,1.0,6/12,17.34%,INPP1;INPP5K;INPP5B;OCRL;INPP5J;SYNJ1
prerank,positive regulation of glycogen biosynthetic process (GO:0045725),-0.5965359321491605,-1.450442635281997,0.07777777777777778,0.5363202420480674,1.0,5/12,7.81%,IGF1;SORBS1;IRS2;IRS1;IGF2
prerank,regulation of MAP kinase activity (GO:0043405),0.4842481132986421,1.450395553363927,0.031914893617021274,0.44828982815821,1.0,12/92,5.33%,PTPRJ;EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DUSP1;DAB2IP;INPP5K;STK38;HYAL2
prerank,negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.49542093376435214,1.4495099497647677,0.04656862745098039,0.44955394628131995,1.0,24/76,19.95%,AIM2;DAB2IP;KLF4;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;NFKBIB;NFKBIA;NWD1;HAVCR2;PTGIS;TMSB4X;PYCARD;PYDC1;ERBIN;FOXJ1
prerank,regulation of interleukin-2 production (GO:0032663),0.530336111863975,1.4487122604443086,0.07171853856562922,0.45058905039500885,1.0,13/43,18.77%,PLCG2;HOMER2;HDAC7;CD34;IL1A;PRNP;LAPTM5;PRKD2;NAV3;HAVCR2;PDE4D;SPTBN1;MALT1
prerank,regulation of non-canonical Wnt signaling pathway (GO:2000050),-0.5589207225591297,-1.4483394392948905,0.07591623036649214,0.5389542145832893,1.0,6/15,6.77%,GPC3;RSPO3;NPHP3;DACT1;SFRP4;DAAM2
prerank,potassium ion export across plasma membrane (GO:0097623),0.6597888785550492,1.448144275365059,0.09621451104100946,0.4510597532647786,1.0,2/13,1.44%,KCNQ1;KCNE3
prerank,response to zinc ion (GO:0010043),-0.4873910566793222,-1.4480993883415703,0.07210031347962383,0.535417380270812,1.0,9/25,7.34%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;P2RX4
prerank,cellular response to growth factor stimulus (GO:0071363),0.46421568877776265,1.4472698682926235,0.017660044150110375,0.4522579328509165,1.0,41/151,13.05%,NOS1;STMN2;RAPGEF2;FLT1;PDGFB;BMPR2;FLT4;SMAD7;TBX1;ACVRL1;NOTCH1;RAPGEF1;EGR3;DAB2IP;PRKD1;DLL4;IQGAP1;TMEM100;INPP5K;KLF4;ACVR1;EHD1;MEF2C;HYAL2;SETX;DUSP3;PTPN12;HSPB1;PDE8A;SYAP1;RAB35;SNAI2;ZFP36L2;PLCG1;NR4A1;VSTM2A;PRKD2;SOX6;RPS6KB1;DUSP22;ITGB1BP1
prerank,adherens junction organization (GO:0034332),0.5364614276572959,1.4472353030758882,0.05256064690026954,0.4512811437224587,1.0,21/48,20.22%,CDH13;SMAD7;CADM1;PIP5K1C;CTNNA1;CDH15;CDH3;NECTIN4;TJP1;NECTIN1;CDH12;CDH2;ACTB;CTNNB1;CDH22;PAK2;VCL;ANG;CDH18;CDH24;JUP
prerank,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.4733179885627653,1.4459339643081444,0.032073310423825885,0.4536849438205155,1.0,22/108,11.78%,ATP2A3;ACER2;HIP1;HIP1R;FAS;NOD1;ARL6IP5;CASP8;LGALS9;PPM1F;CASP2;TNFSF10;DAP;BBC3;CRADD;JAK2;GRAMD4;HMGB1;HSPE1;CASP1;LAPTM5;CASP8AP2
prerank,positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),0.6532264464471378,1.4459258632183152,0.08372827804107424,0.45260312042713835,1.0,2/14,4.67%,PLCG2;SEMA7A
prerank,cell-cell junction assembly (GO:0007043),0.5045623663540963,1.4452505568433307,0.06419753086419754,0.45345043850477273,1.0,19/63,15.69%,GJA5;TRPV4;CLDN5;SMAD7;GJB1;GJA4;PIP5K1C;WDR1;CTNNA1;ACTG1;TJP1;CDH12;CDH2;ACTB;CTNNB1;CD9;CDH22;PKN2;PAK2
prerank,cellular response to exogenous dsRNA (GO:0071360),0.6716262094664502,1.4444858853532405,0.10909090909090909,0.45446587996006715,1.0,3/12,9.64%,CAV1;IFIH1;DHX9
prerank,protein import into peroxisome membrane (GO:0045046),-0.491432878304865,-1.4444703076829286,0.04664723032069971,0.5430436816126321,1.0,15/22,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,protein localization to cell-cell junction (GO:0150105),0.6624640372724184,1.4435724909121463,0.07704654895666131,0.4559452258960512,1.0,8/15,15.69%,F11R;LSR;TJP2;ACTG1;TJP1;DSP;ACTB;PAK2
prerank,response to calcium ion (GO:0051592),0.47991886021051167,1.4428635415193978,0.03707995365005794,0.45678322854084824,1.0,16/102,8.29%,PLCG2;SYT15;ITPR3;ITPKB;CPNE8;RASGRP2;CAV1;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;CPNE2;PPP3CA;MCOLN1;PRKAA1
prerank,copper ion homeostasis (GO:0055070),0.6250901160207316,1.4426483071626492,0.10220125786163523,0.4562712453301831,1.0,6/17,9.97%,ATOX1;APP;ATP7A;SLC31A1;MT2A;PRNP
prerank,atrial septum development (GO:0003283),0.6686171714381589,1.4426268412008763,0.09546925566343042,0.4552280504509734,1.0,5/13,3.58%,GJA5;BMPR2;DAND5;TGFB2;HEY2
prerank,dicarboxylic acid transport (GO:0006835),-0.4581072610776091,-1.4424173525500545,0.040268456375838924,0.5458599070122947,1.0,8/28,6.15%,SLC1A3;SLC13A3;PDPN;SLC26A7;SLC25A13;GJA1;SLC22A6;SLC19A1
prerank,positive regulation of response to DNA damage stimulus (GO:2001022),-0.4107329198113233,-1.4423498204998677,0.03319502074688797,0.5417921028999809,1.0,14/53,13.29%,EYA2;EGFR;EYA1;DDX5;PLA2R1;FXR2;EYA4;FBH1;UBE2N;SPRED1;BCLAF1;ATR;SPRED2;HMGA2
prerank,cell-cell junction organization (GO:0045216),0.4866729534599674,1.4418353768520755,0.03485576923076923,0.4563729146784324,1.0,18/79,9.28%,CDH13;TRPV4;CLDN5;OCLN;F2RL1;TGFB2;CADM1;LIMS2;GJA4;CTNNA1;TJP2;CDH15;CDH3;NECTIN4;TJP1;DSP;NECTIN1;CDH12
prerank,ceramide catabolic process (GO:0046514),0.6582616747962349,1.4415271406397971,0.07967479674796749,0.45616631289106724,1.0,2/14,5.93%,ACER2;ASAH2
prerank,Notch signaling involved in heart development (GO:0061314),0.6930709075926037,1.441205072210139,0.08644067796610169,0.455941341942714,1.0,5/11,3.58%,JAG1;NOTCH1;HEY1;DLL4;HEY2
prerank,regulation of calcium ion transport (GO:0051924),0.5168389504010393,1.441124827841141,0.06176084099868594,0.4550488597482958,1.0,10/54,8.24%,NOS1;CCR1;MYLK;HOMER2;INPP5K;ORAI1;EPB41;STIM2;CASQ1;CRACR2A
prerank,negative regulation of ion transport (GO:0043271),0.5966463024542266,1.4409680906674367,0.08357771260997067,0.45442308089599165,1.0,4/24,9.06%,NOS1;INPP5K;PXK;HTR1B
prerank,Ras protein signal transduction (GO:0007265),0.4644842956701354,1.4408195563627406,0.018038331454340473,0.4537209946842945,1.0,31/137,10.68%,EPS8L2;CDH13;ARHGEF3;RAPGEF2;ELMO1;RAPGEF1;RASGRP2;PRKD1;RHOB;KRAS;NRAS;CDC42EP1;NTN1;RRAS;SHTN1;RAPGEF6;PLEKHG5;ARHGDIA;SHOC2;ARHGAP5;PLD1;KPNB1;NCKAP1;ROCK1;JUN;RIPOR1;TAX1BP3;RRAS2;ARHGEF1;CYFIP1;RAC1
prerank,positive regulation of hormone secretion (GO:0046887),0.6267353048668536,1.4403277577061377,0.08487654320987655,0.45395208447925395,1.0,3/17,8.94%,EDN1;VAMP8;VAMP7
prerank,phasic smooth muscle contraction (GO:0014821),0.7121305268697905,1.4402569634086713,0.09640522875816994,0.45307749534320435,1.0,1/10,0.47%,EDN1
prerank,vesicle cytoskeletal trafficking (GO:0099518),0.5442436818997787,1.4400556173530303,0.051075268817204304,0.4525123351265229,1.0,7/39,9.56%,MYO1D;MYO1E;TANC2;ACTN4;FNBP1L;MYO1C;PPFIA2
prerank,neural crest cell migration (GO:0001755),0.5423490014979038,1.4396106000812632,0.06896551724137931,0.45255902126043296,1.0,4/36,4.67%,SEMA3G;TBX1;SEMA3F;SEMA7A
prerank,response to exogenous dsRNA (GO:0043330),0.6267898924843689,1.4394386043820806,0.11538461538461539,0.4519953483019776,1.0,4/18,9.64%,CAV1;IFIH1;TLR3;DHX9
prerank,negative regulation of DNA metabolic process (GO:0051053),0.5941573740714445,1.4392876693529297,0.0841799709724238,0.45135141041838506,1.0,3/24,1.57%,DACH1;BMPR2;ACVRL1
prerank,cellular response to interferon-beta (GO:0035458),0.6523624528644147,1.4392315661061337,0.10638297872340426,0.45045054245990324,1.0,5/14,8.74%,AIM2;TRIM6;IRGM;STAT1;ACOD1
prerank,positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),0.5767213897960011,1.4378878310778247,0.0641399416909621,0.45299584939945875,1.0,6/27,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,cardiac conduction system development (GO:0003161),0.5805057838836536,1.4369299786293486,0.07555555555555556,0.4544591606214694,1.0,5/24,3.58%,GJA5;GATA6;MSX1;HEY1;HEY2
prerank,negative regulation of ERBB signaling pathway (GO:1901185),0.5397272012830354,1.4364521607300615,0.07152875175315568,0.4546743408907202,1.0,8/39,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;PTPN12;RNF115
prerank,positive regulation of T cell receptor signaling pathway (GO:0050862),0.6398083965045847,1.4361287588643992,0.09206349206349207,0.45449754853205443,1.0,1/14,0.26%,KCNN4
prerank,cAMP biosynthetic process (GO:0006171),-0.6245993698099992,-1.4360733754446786,0.0906801007556675,0.5576153231388594,1.0,5/10,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,chordate embryonic development (GO:0043009),-0.3929303129059904,-1.4351493270524964,0.01556420233463035,0.5565816219957781,1.0,18/55,9.91%,ALDH1A2;COL1A1;FGFR2;SULF1;TGFBR1;ARNT2;BMP5;BMP7;SULF2;WNT5A;RBP4;ZNF568;XYLT1;DACT1;IGF2;FLCN;VEGFA;PTCH1
prerank,negative regulation of axon extension (GO:0030517),0.5605054369147803,1.434679919386929,0.07439198855507868,0.45735576925893884,1.0,8/30,11.97%,SEMA3G;SEMA3F;SEMA7A;SEMA6D;RTN4;SEMA4G;TRIM46;DIP2B
prerank,negative regulation of stress-activated MAPK cascade (GO:0032873),0.5433095482156615,1.434652851073186,0.0821529745042493,0.4563533156292065,1.0,4/36,2.44%,MECOM;FOXO1;DUSP1;F2RL1
prerank,regulation of platelet aggregation (GO:0090330),0.6195683720887728,1.4346060615638405,0.10130718954248366,0.4554484636448939,1.0,4/17,3.41%,CEACAM1;F11R;PRKG1;ADAMTS18
prerank,sterol transport (GO:0015918),0.612002760701043,1.4337525389438563,0.10014947683109118,0.4566610544980817,1.0,3/19,5.21%,CAV1;APOA1;LCAT
prerank,negative regulation of stem cell differentiation (GO:2000737),0.6663860634350233,1.4336758720304936,0.10085470085470086,0.455868411468149,1.0,2/12,1.60%,JAG1;NOTCH1
prerank,regulation of B cell activation (GO:0050864),0.5857546250286494,1.433595249905884,0.09585121602288985,0.4550424324974473,1.0,8/25,21.03%,NOD2;SH3KBP1;FCGR2B;ZFP36L2;LAPTM5;BANK1;FOXJ1;ZFP36L1
prerank,regulation of endothelial cell migration (GO:0010594),0.48723820314463984,1.4321685978533552,0.031578947368421054,0.4579525968648246,1.0,23/85,10.68%,PTPRM;TEK;EDN1;CEACAM1;BMPR2;FLT4;ACVRL1;DAB2IP;PRKD1;RHOB;EMP2;DLL4;ANXA3;RRAS;ANGPT1;GPI;GATA3;ZC3H12A;FOXP1;PTK2;GFUS;ADGRB1;RAC1
prerank,positive regulation of cold-induced thermogenesis (GO:0120162),0.48286819147030224,1.4318531127772223,0.04240282685512368,0.45785663055440834,1.0,13/90,8.44%,PRDM16;EPAS1;ADIPOR2;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,phosphorylation (GO:0016310),0.43333289778242823,1.4310708093796234,0.0020304568527918783,0.4588872161492698,1.0,75/384,12.62%,BMX;NUAK1;CDK19;ERG;MAP4K2;STK10;PDGFB;FYN;BMPR2;RPS6KA5;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;CDC42BPA;APP;MAP3K6;PKN3;CDC42BPG;BCR;ACVR1;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;MEX3B;PGK1;MAPK1;PXK;MAST1;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;GNPTAB;JAK2;PRKAA1;STK39;PASK;PIM3;DGKH;NEK7;ROCK1;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;MINK1;LIMK2;NEK11;PRKD2;MARK2;MATK;VRK1;COPS8;PIK3CB;TTBK1;BTK
prerank,positive regulation of lipid biosynthetic process (GO:0046889),-0.4660925526313137,-1.431017813651228,0.06756756756756757,0.5663650568388526,1.0,12/29,15.80%,ZBTB20;SORBS1;LPGAT1;APOE;PPARA;GPLD1;SLC27A1;SREBF1;CREB1;SLC45A3;MFSD2A;NR1H3
prerank,positive regulation of protein serine/threonine kinase activity (GO:0071902),0.4727223371773689,1.4309011770362126,0.04711425206124853,0.4583273283763514,1.0,19/101,8.72%,EDN1;PDGFD;RAPGEF2;FLT1;PDGFB;PIK3R6;CCNY;CCND2;NOD2;ATP2B4;CCND3;DAB2IP;ADRB2;ADAM17;IRGM;LRRK2;MAPRE3;SYAP1;TPD52L1
prerank,cardiocyte differentiation (GO:0035051),0.7004440856395601,1.430474538798408,0.10580204778156997,0.45856451187324065,1.0,2/10,2.55%,GATA6;TGFB2
prerank,positive regulation of lipid kinase activity (GO:0090218),0.565537346466035,1.4301618090427217,0.059248554913294796,0.45839285721870043,1.0,6/29,5.43%,TEK;FLT1;PDGFB;NOD2;PRKD1;FGFR3
prerank,tetrahydrobiopterin metabolic process (GO:0046146),0.6816318009732494,1.4301374991945082,0.09225700164744646,0.4574559885032853,1.0,2/11,3.43%,NOS3;GCH1
prerank,regulation of sodium ion transport (GO:0002028),0.5595652555822677,1.4287769632092746,0.0890125173852573,0.46011107260354744,1.0,7/34,8.96%,NOS1;CNKSR3;ATP2B4;ATP1A1;P2RX7;NKAIN3;SCN1B
prerank,positive regulation of metabolic process (GO:0009893),0.47513713061188856,1.4287593149721076,0.04050925925925926,0.45911798098792306,1.0,15/103,8.44%,PRDM16;EPAS1;ADIPOR2;FASN;INSR;CAV1;ADRB2;YBX2;OMA1;ADIPOR1;KDM3A;CMKLR1;GADD45G;JAK2;APC
prerank,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.5578375964375167,1.428642244720881,0.09261939218523878,0.45842507979869357,1.0,6/30,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;BCL2L1
prerank,nucleoside phosphate catabolic process (GO:1901292),0.6566849254506708,1.4280330653840452,0.09208400646203554,0.45916575125036896,1.0,2/13,5.80%,ENTPD1;SMPDL3A
prerank,regulation of hematopoietic progenitor cell differentiation (GO:1901532),0.49292056393745753,1.4275575593335599,0.07317073170731707,0.45930523662586265,1.0,27/73,18.86%,GATA2;LMO2;KITLG;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,cellular response to increased oxygen levels (GO:0036295),0.6822649243992667,1.4274721259608254,0.0912106135986733,0.4585312945257779,1.0,3/11,2.28%,FAS;FOXO1;CAV1
prerank,nucleotide-sugar biosynthetic process (GO:0009226),-0.5051464581643142,-1.426953687217614,0.08010335917312661,0.5754646483840606,1.0,10/19,20.23%,RENBP;GFPT1;GFPT2;NAGK;PGM3;AMDHD2;UAP1L1;PMM1;NANS;GNPNAT1
prerank,regulation of dendritic cell apoptotic process (GO:2000668),0.6772781826632265,1.4266308746446892,0.10499139414802065,0.45979271554811807,1.0,2/10,2.67%,RAPGEF2;LGALS9
prerank,regulation of chromatin binding (GO:0035561),0.6806325551757435,1.4265184140786562,0.10152284263959391,0.45910819212681714,1.0,4/10,16.04%,HMBOX1;BTAF1;DTX3L;KDM4D
prerank,establishment of protein localization to extracellular region (GO:0035592),-0.42819024300533975,-1.426111608903935,0.04,0.5740870359779453,1.0,19/39,26.58%,STEAP3;ABCA1;TANGO2;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;AFM;MON1A;PDIA4;PREB;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3
prerank,positive regulation of gene silencing by miRNA (GO:2000637),-0.4682837672314905,-1.4256037615303456,0.055384615384615386,0.5714579262277302,1.0,7/27,9.13%,EGFR;DDX5;BMP4;LIMD1;EIF4E2;PUM1;MAP2K2
prerank,endoderm formation (GO:0001706),0.5440962047900729,1.4254500421401441,0.08555399719495091,0.4610512493111641,1.0,3/35,2.05%,LAMA3;SOX17;DUSP1
prerank,regulation of epithelial cell differentiation (GO:0030856),0.6160221146456711,1.4253440429355495,0.10252365930599369,0.46032250617058207,1.0,7/17,10.59%,CEACAM1;KLF7;CAV1;MAFF;GATA3;DSPP;APOLD1
prerank,nucleoside diphosphate metabolic process (GO:0009132),0.639889972438762,1.4252912675755225,0.09719934102141681,0.4594572032166632,1.0,2/15,7.42%,ENTPD1;CMPK1
prerank,ceramide transport (GO:0035627),0.656361382149216,1.4228168819683613,0.0919931856899489,0.46499017920057156,1.0,4/12,8.07%,PLTP;ABCB4;GLTP;CERT1
prerank,regulation of cellular senescence (GO:2000772),0.5536888191284179,1.4222185383093586,0.08450704225352113,0.4655363816185082,1.0,6/28,11.13%,NUAK1;B2M;ING2;AKT3;RBL1;MAP3K3
prerank,heart trabecula morphogenesis (GO:0061384),0.6290163863674835,1.421310825705416,0.07726597325408618,0.4668889936739036,1.0,8/18,2.96%,TEK;ENG;S1PR1;NOTCH1;HEY1;TGFB2;FKBP1A;DLL4
prerank,renal absorption (GO:0070293),0.6756613221656598,1.4209970881623606,0.09672131147540984,0.46669864224476726,1.0,5/10,9.30%,KCNQ1;HNF1A;KLHL3;HYAL2;SGK1
prerank,response to peptide hormone (GO:0043434),-0.4173956998576491,-1.419802401980375,0.06299212598425197,0.5869822893587904,1.0,9/43,8.37%,TGFBR3;OGT;ROCK2;IGFBP5;GNAI1;ANXA1;IRS1;SRC;SLC27A1
prerank,cellular response to osmotic stress (GO:0071470),0.587568771604402,1.4197094380861397,0.10151515151515152,0.4691619415178966,1.0,4/21,2.77%,TRPV4;MYLK;ARHGEF2;OXSR1
prerank,ventricular septum development (GO:0003281),0.5402411964187371,1.4193448439649063,0.06292749658002736,0.4690923042668787,1.0,10/37,6.03%,GJA5;BMPR2;SMAD7;NOTCH1;DAND5;HEY1;TGFB2;HEY2;ACVR1;GATA3
prerank,neural crest cell development (GO:0014032),0.518872003950357,1.418375198804008,0.06182795698924731,0.47073801496536305,1.0,10/44,13.01%,SEMA3G;TBX1;SEMA3F;SEMA7A;SEMA6D;SNAI2;CDH2;SEMA4G;SOX10;CYP26C1
prerank,protein phosphorylation (GO:0006468),0.42815214295246157,1.4183608128933487,0.0010111223458038423,0.4697583762854457,1.0,96/478,12.94%,BMX;NUAK1;CDK19;TEK;ERG;FLT1;MAP4K2;STK10;PDGFB;FYN;BMPR2;FLT4;RPS6KA5;SMAD7;CDK17;MERTK;ACVRL1;IP6K3;MAP4K3;INSR;SBK1;DAB2IP;CDK14;SNRK;PRKD1;PRKG1;TGFB2;MAST4;OXSR1;CDC42BPA;APP;MAP3K6;FES;PKN3;TLR3;CDC42BPG;BCR;ACVR1;SLK;STK24;CCNE1;CAMK2D;MAP4K4;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;SMAD2;FGFR3;MEX3B;MAPK1;PXK;UHMK1;MAST1;EEF2K;ALK;AKT3;SIK2;LRRK2;LMTK2;TLK1;JAK2;PRKAA1;STK39;PASK;PIM3;CAD;NEK7;ROCK1;CSNK1G3;PTK2;SGK1;ADAM10;TAOK2;MAP3K11;MARK3;PRKCG;RPS6KA1;MINK1;LIMK2;TNKS;MAP3K3;NEK11;GTF2H3;PRKD2;MARK2;MATK;VRK1;COPS8;TTBK1;BTK;STK33;RPS6KA3;RPS6KB1
prerank,negative regulation of ATP metabolic process (GO:1903579),-0.5342741081216245,-1.4175235040002756,0.09164420485175202,0.5902931747484913,1.0,5/17,11.43%,PID1;NUPR1;PPARA;FLCN;HDAC4
prerank,cellular response to lectin (GO:1990858),0.46615926685358816,1.4171845021152563,0.04423748544819558,0.4711415993776116,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.46615926685358816,1.4171845021152563,0.04423748544819558,0.4711415993776116,1.0,29/104,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,regulation of neural precursor cell proliferation (GO:2000177),0.599996249592463,1.4170949591985416,0.10698365527488855,0.4703709915640721,1.0,6/22,7.18%,GATA2;RASSF10;DLL4;TAFA1;LRRK2;SLC16A2
prerank,cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),0.4523962070206107,1.4155670653633554,0.02631578947368421,0.4735872820191692,1.0,29/159,11.00%,PTPRM;PECAM1;CDH13;CLDN5;CEACAM1;VCAM1;CRTAM;MPZ;TGFB2;CADM1;ATP2C1;ACVR1;AMIGO2;ROBO4;MILR1;BSG;ITGAM;FLRT3;TENM3;LRRC4C;CDH15;CDH3;NECTIN4;NECTIN1;CDH12;FAT4;TENM4;KIRREL3;CDH2
prerank,negative regulation of interleukin-2 production (GO:0032703),0.5970673841288466,1.4152861020993563,0.09937888198757763,0.4733194605510026,1.0,7/18,14.84%,HOMER2;HDAC7;CD34;PRNP;LAPTM5;NAV3;HAVCR2
prerank,fatty-acyl-CoA metabolic process (GO:0035337),0.5930574420640107,1.4149378119781773,0.09936908517350158,0.4733024436101238,1.0,4/20,5.27%,FASN;FAR2;PPT1;FAR1
prerank,phosphatidylcholine catabolic process (GO:0034638),-0.6095166972939189,-1.414274078868564,0.09047619047619047,0.5971540188983082,1.0,7/10,35.76%,PLA2G4A;PLA2G15;PLA2G6;ENPP2;PLA2G7;LIPC;PLA2G5
prerank,regulation of protein tyrosine kinase activity (GO:0061097),0.5379270634443875,1.4141010187004364,0.0850480109739369,0.4747459648182321,1.0,11/38,11.89%,PDGFB;ACE;CAV1;APP;NEDD9;EFNA1;HYAL2;FCGR1A;PRNP;PTPN1;GRM5
prerank,negative regulation of endothelial cell proliferation (GO:0001937),0.5352003620883029,1.4140678486552989,0.07534246575342465,0.47382800170052664,1.0,8/35,7.71%,PTPRM;FLT1;CAV1;CAV2;DLL4;MEF2C;STAT1;ATP5F1A
prerank,negative regulation of homotypic cell-cell adhesion (GO:0034111),0.6781646320003238,1.4139352363065292,0.1164021164021164,0.47325182359611734,1.0,3/10,3.41%,CEACAM1;PRKG1;ADAMTS18
prerank,innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.4652059256309324,1.413469152074683,0.04906542056074766,0.47356375598949335,1.0,29/105,18.86%,PLCG2;FYN;RPS6KA5;ICAM2;KRAS;NRAS;PSMD13;PSMD4;PSMA5;PSMB10;TYROBP;TAB2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,endothelial cell proliferation (GO:0001935),0.6142912553435568,1.4130157693384782,0.11684370257966616,0.47370613176559995,1.0,4/17,5.43%,TEK;BMPR2;ACVRL1;CD34
prerank,regulation of keratinocyte proliferation (GO:0010837),-0.4809607283364471,-1.412870978317359,0.07734806629834254,0.597528949928091,1.0,5/22,3.90%,NOTCH2;FGFR2;CASK;PTPRK;STXBP4
prerank,positive regulation of stress-activated MAPK cascade (GO:0032874),0.47192752001946536,1.4126416244985722,0.03500583430571762,0.4736587650068604,1.0,20/93,10.64%,MAP4K2;PLCB1;FLT4;NOD2;DAB2IP;ARL6IP5;F2RL1;TGFB2;APP;TIRAP;FCGR2B;TRAF1;MFHAS1;ZC3H12A;GADD45G;TPD52L1;TAOK2;HMGB1;MAP3K11;MINK1
prerank,regulation of coagulation (GO:0050818),0.6756037306890323,1.4111339811126726,0.11599297012302284,0.4768054987197144,1.0,4/11,11.57%,CAV1;F2RL1;PROC;HS3ST5
prerank,miRNA mediated inhibition of translation (GO:0035278),0.6692617379742057,1.410734149807743,0.10286677908937605,0.4759360298691078,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,"negative regulation of translation, ncRNA-mediated (GO:0040033)",0.6692617379742057,1.410734149807743,0.10286677908937605,0.4759360298691078,1.0,2/11,2.60%,NOTCH4;TNRC6C
prerank,glycolipid metabolic process (GO:0006664),0.5083280131196579,1.4102091122076703,0.08005427408412483,0.47633543839768516,1.0,6/47,7.84%,ST6GALNAC3;ST8SIA6;ST3GAL6;ESYT2;PGAP1;GLTP
prerank,regulation of bicellular tight junction assembly (GO:2000810),0.6080563067329303,1.4100608590451915,0.10110584518167456,0.4757699308200371,1.0,7/19,9.21%,CLDN5;F11R;OCLN;MYO1C;SNAI2;ROCK1;TJP1
prerank,positive regulation of filopodium assembly (GO:0051491),-0.4738731536037588,-1.409903305879847,0.06622516556291391,0.6038836723117477,1.0,7/24,8.25%,DPYSL3;DOCK11;RHOQ;ARAP1;RIPOR2;PIK3R1;BCAS3
prerank,positive regulation of epithelial cell proliferation (GO:0050679),0.4602721520749171,1.4096756940820783,0.040840140023337225,0.4757755480226741,1.0,15/113,5.23%,VEGFC;CDH13;TEK;PDGFB;BMPR2;FLT4;TBX1;EGFL7;NOD2;EGR3;PRKD1;VEGFD;NRAS;VASH2;PPP1R16B
prerank,positive regulation of cell projection organization (GO:0031346),-0.3532167151819068,-1.4091903957670118,0.013986013986013986,0.6020537263140197,1.0,24/115,5.85%,ROBO1;PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;PLXNA2;CUX1;PTK7;SLIT2;WNT5A;GRIP1;NDNF;APOE;MAGI2;DLG4;OBSL1;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1;NGF
prerank,calcium ion homeostasis (GO:0055074),0.46938606979801734,1.4091386941722477,0.05363528009535161,0.4761707179582909,1.0,12/95,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1
prerank,energy derivation by oxidation of organic compounds (GO:0015980),-0.47069128441473707,-1.4088387373606017,0.07317073170731707,0.5990957804376801,1.0,11/24,22.83%,PID1;LEPR;SLC25A13;COQ10A;COX10;GFPT1;GFPT2;ACADVL;LYRM7;CYCS;MTLN
prerank,glycosphingolipid biosynthetic process (GO:0006688),0.6125638861168805,1.4085811319342423,0.11967213114754098,0.4767001197529016,1.0,4/16,9.87%,ST6GALNAC3;ST8SIA6;A4GALT;B4GALT6
prerank,regulation of phospholipase activity (GO:0010517),-0.6079061621999368,-1.4082083338708828,0.10049019607843138,0.5971889175298452,1.0,2/10,1.03%,LRP1;FGFR2
prerank,negative regulation of axon extension involved in axon guidance (GO:0048843),0.5922632814202234,1.407896908171001,0.1021671826625387,0.4775673405655074,1.0,3/20,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,regulation of ion transport (GO:0043269),0.4795423319738073,1.4075983749918273,0.04860267314702309,0.4774359989698166,1.0,8/76,7.62%,NOS1;SYT15;B2M;ATP1A1;SYT7;PXK;P2RX7;NKAIN3
prerank,positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770),0.6889511994525006,1.4073526134330403,0.11524822695035461,0.4771826334053342,1.0,3/10,8.51%,NOD2;JAK2;NAMPT
prerank,dendrite morphogenesis (GO:0048813),-0.42861425587877444,-1.4073035900164426,0.06367041198501873,0.596162087013447,1.0,8/35,6.55%,PTN;SDC2;FARP1;DCDC2;PHACTR1;DOCK10;DLG4;CTNND2
prerank,positive regulation of stem cell differentiation (GO:2000738),-0.530222799019264,-1.4059473662814728,0.08174386920980926,0.5967098779432126,1.0,4/16,5.50%,PTN;SOX5;NUDT21;HOXB4
prerank,positive regulation of potassium ion transport (GO:0043268),0.5331373603279106,1.404277272161496,0.0912751677852349,0.4844431395998159,1.0,4/38,3.68%,KCNN4;KCNQ1;KCNN3;NOS1AP
prerank,small GTPase mediated signal transduction (GO:0007264),0.46249602092621417,1.4038449682872034,0.04976851851851852,0.48462958548642493,1.0,29/103,14.49%,CCDC88C;RAPGEF2;ARHGAP31;RASGRP2;RAPGEF5;ABR;PRKD1;NUCB2;KRAS;NRAS;NTN1;BCR;RRAS;SHTN1;RAPGEF6;SHOC2;TIAM2;PLD1;JUN;SIAH2;RHEBL1;RRAS2;CCDC88A;RAC1;RGS19;KSR2;RRAD;SOS1;RHEB
prerank,negative regulation of smoothened signaling pathway (GO:0045879),-0.48909800455285934,-1.4030405390244067,0.09538461538461539,0.6018254372038568,1.0,6/23,9.91%,GLI3;GPC3;TULP3;ENPP1;MEGF8;PTCH1
prerank,atrial septum morphogenesis (GO:0060413),0.6761193678528672,1.4025960731489786,0.12647554806070826,0.4870492058182672,1.0,4/10,4.11%,BMPR2;TGFB2;HEY2;ACVR1
prerank,activation of phospholipase C activity (GO:0007202),-0.4470713902219005,-1.4025023422429075,0.05844155844155844,0.5995872752263449,1.0,5/29,5.53%,ARHGAP6;EGFR;LPAR1;EDNRA;NTRK2
prerank,phagosome-lysosome fusion (GO:0090385),0.6749317996251244,1.402183332811748,0.11438474870017332,0.48727286609986337,1.0,3/10,4.75%,SYT7;RAB39A;RAB34
prerank,regulation of transferase activity (GO:0051338),0.6114121016636977,1.4021274008294011,0.11023622047244094,0.48644487113775386,1.0,5/17,8.03%,LDB2;EMP2;HMBOX1;JMJD8;NLRC5
prerank,nerve growth factor signaling pathway (GO:0038180),0.6794476469831684,1.4020080078966795,0.12227805695142378,0.48574951040823616,1.0,2/10,1.83%,RAPGEF2;RAPGEF1
prerank,negative regulation of epithelial cell differentiation (GO:0030857),0.6312651556992728,1.4016597864650027,0.1076158940397351,0.485751214269477,1.0,2/14,2.28%,NOTCH4;CAV1
prerank,regulation of phosphatidylinositol 3-kinase activity (GO:0043551),0.5349787308373606,1.4013491806768583,0.07818930041152264,0.4856200628903837,1.0,7/34,5.43%,TEK;FLT1;PDGFB;NOD2;DAB2IP;PRKD1;FGFR3
prerank,positive regulation of cell cycle phase transition (GO:1901989),0.6294841007882266,1.4012955961541202,0.12480499219968799,0.4847714618000129,1.0,2/15,6.09%,PLCG2;CUL3
prerank,regulation of small molecule metabolic process (GO:0062012),-0.4581611108842114,-1.4005275113006919,0.09294871794871795,0.6021627648356127,1.0,12/28,21.90%,PDK1;APOE;PPARA;PRKN;RORA;EPHX2;FOXK2;PDK3;PDK2;PANK2;ACADVL;NR1H4
prerank,regulation of vesicle-mediated transport (GO:0060627),0.4731520753537099,1.4003260185092772,0.06264775413711583,0.48647892739675175,1.0,29/91,19.49%,CDH13;HIP1;HIP1R;RAB11A;FES;PACSIN2;SYT7;PACSIN1;MAPK1;LRRK2;PLD1;STON1;PTPN1;INPP5F;CHMP3;NSF;ZFYVE16;RNF139;CPLX1;STXBP5L;RIT2;OPHN1;STXBP5;RUFY1;SCARB1;SYT1;HAP1;RAB5C;MAP2K1
prerank,negative regulation of activated T cell proliferation (GO:0046007),0.6772365136305161,1.3996694247108528,0.11148648648648649,0.48718003492543654,1.0,3/10,9.97%,CRTAM;LGALS9;PRNP
prerank,secretion (GO:0046903),0.6432853800079201,1.3996222435215047,0.10586319218241043,0.4863394879090594,1.0,3/14,6.82%,FBLN5;TPD52;NPR1
prerank,negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.5785179826933385,1.3986666291614793,0.11958146487294469,0.487887912864765,1.0,5/21,3.85%,CNKSR3;SMAD7;CAV1;INPP5K;PPM1F
prerank,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),0.6118422181966797,1.3982619608632099,0.11930926216640503,0.48804082645716346,1.0,4/16,5.23%,GATA2;JCAD;DLL4;PPP1R16B
prerank,mitochondrion morphogenesis (GO:0070584),-0.5971644945960188,-1.3978061871530554,0.09798994974874371,0.6072948404303874,1.0,2/11,3.15%,PID1;WASF1
prerank,calcium-ion regulated exocytosis (GO:0017156),0.5533436613127801,1.3971643699123364,0.0988538681948424,0.49010371061261765,1.0,8/27,18.29%,SYT15;DOC2B;SYT7;VAMP7;RIMS3;SDF4;SYT1;SYT2
prerank,response to estrogen (GO:0043627),0.5409971943179402,1.39650081907369,0.10903873744619799,0.49096566069329234,1.0,13/31,19.36%,CAV1;PELP1;GATA3;TRIM24;NCOA4;ARID5A;TRIM25;SFR1;BRCA1;ESR1;RARA;CD24;WBP2
prerank,negative regulation of epithelial to mesenchymal transition (GO:0010719),0.5573433311704787,1.3962791614133274,0.10460251046025104,0.4905996852198081,1.0,7/29,9.89%,SMAD7;DAB2IP;IL17RD;EFNA1;GATA3;ADIPOR1;MAD2L2
prerank,innate immune response (GO:0045087),0.4344658399080627,1.3951719935357416,0.021367521367521368,0.4926893572494716,1.0,53/217,20.92%,PLCG2;FYN;TRIM14;NOD2;B2M;IFIH1;APP;FES;GCH1;TLR3;DEFA6;ADAM15;TRIM11;TRIM6;MFHAS1;IRGM;SERINC3;NLRC5;YES1;ADAR;PTK2;HMGB1;TRIM25;TYROBP;TRIM17;CYBA;SERINC5;CFB;CHGA;TRIM8;IRF5;BTK;CX3CR1;AKAP1;CR2;RNASE6;NCF2;SLPI;SRPK1;SLA;PYDC1;CXCL10;IFITM3;RELA;MALT1;ANG;AGER;CAPZA2;SETD2;DHX58;ANKRD17;MID2;RPL39
prerank,regulation of calcium ion transmembrane transport (GO:1903169),0.5727360884364333,1.3949737209425046,0.09896602658788774,0.49228543506953004,1.0,7/23,9.97%,NOS1;FYN;DIAPH1;NOS1AP;CAMK2D;CASQ1;PRNP
prerank,retina homeostasis (GO:0001895),0.5838558723730684,1.394880482368464,0.10298507462686567,0.49155982535667236,1.0,6/23,11.20%,B2M;HSPB1;CDH3;ACTG1;POTEF;ACTB
prerank,phagolysosome assembly (GO:0001845),0.6441147999782739,1.3948728955802618,0.12141652613827993,0.49062197165960664,1.0,3/12,4.75%,SYT7;RAB39A;RAB34
prerank,phospholipid translocation (GO:0045332),0.5555210485550706,1.3944322436284893,0.0891089108910891,0.4909360815834187,1.0,10/28,15.39%,ATP10A;PLSCR4;ANO6;ABCB4;P2RX7;PLSCR1;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,protein O-linked mannosylation (GO:0035269),-0.5059932489211901,-1.3943097448261377,0.09863013698630137,0.6150685270200884,1.0,4/18,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,vasculature development (GO:0001944),0.6323517786251638,1.3940545006418557,0.12636505460218408,0.4909176631174131,1.0,5/16,3.25%,NOTCH4;BMPR2;FLT4;ACVRL1;SOX18
prerank,regulation of cytokine production involved in immune response (GO:0002718),0.5948142079240143,1.3937618663989306,0.11607142857142858,0.4907567600785044,1.0,7/22,12.62%,NOD2;F2RL1;APOA1;TRIM6;TNFRSF1B;LAPTM5;BTK
prerank,regulation of synapse maturation (GO:0090128),0.6861961103897383,1.393215016658453,0.10238907849829351,0.49129799704174315,1.0,2/10,2.21%,ARHGEF15;DAB2IP
prerank,positive regulation of telomerase activity (GO:0051973),0.5390075420079302,1.393162175868373,0.09631728045325778,0.49049008293080426,1.0,18/33,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;CTNNB1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),0.6001151405232326,1.3928833487207,0.1029641185647426,0.4903171685181639,1.0,6/18,6.91%,GATA2;JCAD;PIK3C2A;HDAC9;HDAC7;AKT3
prerank,positive regulation of alpha-beta T cell differentiation (GO:0046638),-0.5574388055810973,-1.3928515537480441,0.10941475826972011,0.615758913155857,1.0,6/13,19.56%,GLI3;RUNX1;NCKAP1L;PNP;TGFBR2;ZBTB7B
prerank,muscle organ development (GO:0007517),-0.39314989071061723,-1.3927523912296742,0.021367521367521368,0.6120530458952466,1.0,16/54,9.80%,LAMA2;IGF1;DMD;CHD2;COL6A3;LARGE1;VAMP5;MRAS;ITGA11;FHL1;SGCD;SPEG;EVC;POU6F1;SMTN;SGCE
prerank,histone H3-K4 trimethylation (GO:0080182),-0.5877287152573114,-1.392443966883406,0.12213740458015267,0.6091605447211467,1.0,5/11,11.20%,OGT;SETD1A;SETD1B;TET2;CTR9
prerank,regulation of receptor-mediated endocytosis (GO:0048259),0.5328344063901326,1.392442790301835,0.1,0.49064000432399174,1.0,10/35,14.09%,HIP1;HIP1R;B2M;CBL;PPT1;HNRNPK;RAC1;CLU;PIK3CB;LDLRAP1
prerank,enzyme linked receptor protein signaling pathway (GO:0007167),0.4501896165447626,1.392168566366539,0.02654867256637168,0.4903792326986253,1.0,25/138,9.21%,TEK;PTPRG;FLT1;TIE1;NPR2;FYN;BMPR2;FLT4;MPZL1;MERTK;LIFR;RAPGEF1;INSR;TRIO;NEDD9;FES;FGFR3;NPR1;ALK;LMTK2;PTPRU;JAK2;YES1;STAP1;PTK2
prerank,neural tube development (GO:0021915),-0.5307782699078284,-1.3910271958488472,0.10804020100502512,0.6100595798915132,1.0,4/15,11.67%,ALDH1A2;DACT1;PTCH1;PKD1
prerank,regulation of hormone secretion (GO:0046883),0.642866714695562,1.391024667022785,0.11410459587955626,0.4925422560292304,1.0,2/15,4.32%,EDN1;SCG5
prerank,defense response to tumor cell (GO:0002357),-0.5990778204374632,-1.390689074146097,0.11137440758293839,0.6074377017192653,1.0,2/10,0.65%,RBMS3;DAPK1
prerank,positive regulation of small molecule metabolic process (GO:0062013),-0.5208353199831002,-1.3906382471491983,0.1008174386920981,0.6036437164507843,1.0,7/15,17.71%,PPARA;IRS2;IRS1;GPLD1;PPARG;SLC45A3;ADM
prerank,positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.5922669654485913,-1.3905375109271547,0.09476309226932668,0.6001901634613617,1.0,4/11,4.29%,NKD1;DAB2;RSPO3;PLEKHA4
prerank,regulation of carbohydrate biosynthetic process (GO:0043255),-0.6096514669439317,-1.390425000915083,0.11893203883495146,0.5967065793567543,1.0,3/10,15.35%,OGT;ZNF692;PDK2
prerank,regulation of cell-substrate junction assembly (GO:0090109),0.5898062073131437,1.3898502242013895,0.1171875,0.4947653076588998,1.0,9/21,9.21%,EFNA5;LIMCH1;MACF1;SLK;CLASP1;DUSP3;ACTG1;ROCK1;PTK2
prerank,negative regulation of endothelial cell migration (GO:0010596),0.5331944351687601,1.3888283051722257,0.08891928864569083,0.4965762644794305,1.0,7/36,5.32%,PTPRM;ACVRL1;NOTCH1;ATP2B4;DAB2IP;DLL4;MEF2C
prerank,positive regulation of alpha-beta T cell activation (GO:0046635),-0.5304473433251412,-1.3880219795611366,0.09333333333333334,0.6007331171577612,1.0,3/15,13.04%,GLI3;CD55;PNP
prerank,positive regulation of ATP metabolic process (GO:1903580),-0.4383370291292798,-1.3878611009647905,0.08417508417508418,0.5974604902459804,1.0,6/32,3.93%,PID1;IGF1;ZBTB20;NUPR1;PRKAA2;PPARA
prerank,mesenchymal cell development (GO:0014031),0.6115939483472139,1.3877581861756603,0.12191358024691358,0.49856900710794,1.0,9/18,21.33%,NOTCH1;HEY2;SNAI2;CDH2;CYP26C1;TBX20;TCOF1;SOX11;NOLC1
prerank,morphogenesis of an epithelium (GO:0002009),0.5604429422084605,1.3862773190369437,0.08836524300441827,0.5016455308231539,1.0,5/25,12.09%,LAMA3;LAMA5;ACTG1;ACTB;SOX10
prerank,positive regulation of cell death (GO:0010942),0.4942215325998509,1.385870865674216,0.07989690721649484,0.5017834440596891,1.0,17/59,14.96%,SLC6A6;ACER2;FYN;FCGR2B;ZC3H12A;ITGAM;LRRK2;CIDEB;GRIN2B;APC;EGR1;PRNP;TYROBP;CLU;BNIP3;SARM1;EIF2S1
prerank,blood circulation (GO:0008015),0.5096876797206408,1.3858588939937944,0.1102257636122178,0.50085679581541,1.0,12/49,13.10%,ELN;NOS3;ACE;ACVRL1;DLL4;TBC1D8;NPR1;STAT1;ROCK1;MYOF;ITGB1BP1;SGCZ
prerank,endoplasmic reticulum mannose trimming (GO:1904380),0.6028766310126551,1.3854793739999123,0.11093990755007704,0.5009995478691678,1.0,9/18,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,organic hydroxy compound transport (GO:0015850),0.529467570993169,1.3853737933313484,0.0925414364640884,0.5003573650325871,1.0,3/36,2.99%,ABCC4;CEACAM1;SLCO1C1
prerank,regulation of tissue remodeling (GO:0034103),0.5899704401330413,1.3852523330974285,0.11514195583596215,0.49978879238586593,1.0,3/18,3.73%,CEACAM1;FLT4;SYT7
prerank,regulation of sequestering of triglyceride (GO:0010889),-0.5290341177728968,-1.3847230245561841,0.10649350649350649,0.6042830040640189,1.0,7/15,23.75%,PPARA;OSBPL8;PPARG;OSBPL11;LPL;PLIN3;FITM2
prerank,regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5654557669997551,1.384606555337976,0.10579710144927536,0.5005989798189105,1.0,9/24,14.00%,MMRN2;DAB2IP;HHEX;TMEM204;EPN2;PTPN1;PRKD2;HIF1A;ITGA5
prerank,regulation of phagocytosis (GO:0050764),0.5002717302606369,1.3843547495888815,0.08695652173913043,0.5003597914044592,1.0,16/53,17.96%,GATA2;MERTK;DYSF;APOA1;SYT7;FCGR2B;CD47;PLSCR1;CYBA;DOCK2;TUB;ABCA7;RACK1;PYCARD;SCARB1;RAB27A
prerank,positive regulation of bone mineralization (GO:0030501),-0.42374782717561144,-1.3838241724544142,0.08208955223880597,0.6035795638052662,1.0,10/35,5.87%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;FBN2;KL
prerank,histone modification (GO:0016570),-0.34813286054031845,-1.3832816780410886,0.015503875968992248,0.6015874972633729,1.0,26/109,14.56%,EYA2;EYA1;PRDM5;TBL1XR1;CREBBP;BAZ1B;EYA4;NSD3;NSD1;UBE2N;EHMT1;USP3;PHF20;RBM14;HDAC4;HDAC1;USP22;TAF6L;HDAC6;PADI2;ATXN7L3;MSL3;KDM4A;SIRT2;SIN3B;MTA2
prerank,positive regulation of RNA metabolic process (GO:0051254),-0.4057253810560527,-1.3832122571676155,0.04938271604938271,0.5981344449501586,1.0,14/45,17.82%,EGFR;DDX5;BMP4;PIK3R1;LIN28B;MAP2K2;BUD23;NFKB1;RBM20;HNRNPLL;SUPV3L1;NMD3;ZPR1;U2AF2
prerank,renal water homeostasis (GO:0003091),-0.4762187030782917,-1.382703789693898,0.06984126984126984,0.5961231025644897,1.0,10/23,15.56%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7;PRKACA;PRKAR2A;PRKAR2B;PRKAR1A;WFS1
prerank,epithelial cell differentiation (GO:0030855),0.47181156335224195,1.3823770088358522,0.05476190476190476,0.5047866004623307,1.0,12/88,6.23%,JAG1;IRF6;GATA6;TBX1;RHCG;GSTA2;DEUP1;TST;TAGLN2;GATA3;PGK1;PCK2
prerank,regulation of oxidoreductase activity (GO:0051341),0.638696490588426,1.3819843535969674,0.14049586776859505,0.5049222478424239,1.0,3/13,6.37%,NOD2;ATP7A;SIRT4
prerank,cAMP metabolic process (GO:0046058),-0.5533258268114449,-1.381772654000758,0.09414758269720101,0.595462690581577,1.0,5/13,6.64%,ADCY5;ADCY9;ADCY1;ADCY2;ADCY7
prerank,negative regulation of dephosphorylation (GO:0035305),0.5873726213485437,1.3815535419546567,0.11912225705329153,0.5051374170005068,1.0,6/18,12.11%,INPP5K;ZCCHC9;PPP1R16B;GPATCH2;MFHAS1;ARPP19
prerank,negative regulation of cell activation (GO:0050866),0.627382893522747,1.3814631402281854,0.11398963730569948,0.5044255328625039,1.0,4/14,8.68%,NOS3;PDGFB;CD200;NR1D1
prerank,neuron development (GO:0048666),0.44276465826716066,1.3812810057156044,0.039779005524861875,0.5039858850059347,1.0,23/141,9.87%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;TGFB2;FRY;BTG2;APP;MAP4;PPT1;BLOC1S6;EHD1;ATP7A;MEF2C;UHMK1;ALK;FLRT3;TENM3;RAB35;ROCK1;HMGB1;B4GALT6
prerank,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),0.6138415768251895,1.381176203828023,0.11811023622047244,0.5033470284742866,1.0,1/16,0.65%,CLDN5
prerank,regulation of trophoblast cell migration (GO:1901163),-0.5292741220178969,-1.3810865048271854,0.11704834605597965,0.5939584227715636,1.0,4/14,9.46%,GJA1;SYDE1;VEGFA;ACVR1B
prerank,chondrocyte differentiation (GO:0002062),-0.4393433628870653,-1.3802970569777828,0.07931034482758621,0.5928955261067735,1.0,10/32,7.53%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;RUNX2;RUNX1;CCN3;GPLD1
prerank,"phagocytosis, engulfment (GO:0006911)",0.536309654199546,1.3796552373610795,0.09379310344827586,0.5065744757414153,1.0,13/36,13.75%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;XKR6;VAMP7;ADGRB1;RAC1;DOCK1;RHOH
prerank,negative regulation of Ras protein signal transduction (GO:0046580),0.538283586851758,1.379447316072884,0.10957004160887657,0.5062446609959309,1.0,5/35,6.09%,HEG1;RASIP1;DAB2IP;TGFB2;CUL3
prerank,glutamate receptor signaling pathway (GO:0007215),0.5209550870496006,1.3792185010543108,0.12181303116147309,0.5059047667299436,1.0,13/37,19.59%,PLCB1;GNAQ;HOMER2;APP;GRIN2B;GRIN2C;GRIK2;GRIN3A;GRM5;GRIK1;GRIN2A;GRM7;GRID2
prerank,chondroitin sulfate catabolic process (GO:0030207),-0.5461713038933712,-1.3784307356100345,0.116751269035533,0.595315738638304,1.0,6/13,12.27%,DCN;BGN;HEXA;VCAN;HYAL1;CSPG4
prerank,positive regulation of protein localization to cell periphery (GO:1904377),-0.38490039857943625,-1.3782620791720193,0.058333333333333334,0.5921885830760142,1.0,13/52,9.12%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;EPB41L2;GNAI1;STX4;GPSM2;PIK3R1;CLIP3;PRKCI;STX3
prerank,phospholipid dephosphorylation (GO:0046839),0.5264859714433391,1.3781495072757666,0.0941336971350614,0.5078211773945397,1.0,13/37,17.34%,SGPP2;PLPP1;INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;PLPP6;PLPP4;INPP5J;PLPPR1;SYNJ1
prerank,regulation of transport (GO:0051049),0.5263738132370785,1.3780210113964348,0.10803324099722991,0.5072336978580213,1.0,8/36,11.20%,RAB11A;ARL6IP5;ICA1;FES;EPB41;LRRK2;ACTG1;ACTB
prerank,positive regulation of smoothened signaling pathway (GO:0045880),-0.4868472202220436,-1.3774561142317947,0.08333333333333333,0.5910864895796187,1.0,9/21,20.35%,SMO;DCDC2;ARMC9;EVC;GLI1;KIF7;GAS8;ULK3;STK36
prerank,regulation of smooth muscle cell proliferation (GO:0048660),0.5136254751041911,1.3771755925608997,0.10133333333333333,0.5086440057598481,1.0,4/46,0.88%,ELN;CDH13;EDN1;PDGFB
prerank,regulation of SMAD protein signal transduction (GO:0060390),-0.48427277302861604,-1.377035075787014,0.115625,0.5890344505487356,1.0,9/21,14.03%,BMP6;BMPR1A;TGFBR1;DAB2;BMP4;CCN3;SLC2A10;SH2B1;NUP93
prerank,cellular response to mechanical stimulus (GO:0071260),0.5047140093804958,1.3769794954148997,0.09768637532133675,0.5082049343704538,1.0,12/46,14.04%,F11R;PIEZO1;FAS;CASP8;TLR3;CASP2;CRADD;CASP1;TMEM150C;CASP8AP2;HABP4;BNIP3
prerank,calcium ion transport (GO:0006816),0.45171877276559713,1.3769485032388042,0.05963302752293578,0.5073586256371238,1.0,20/113,8.35%,ATP2A3;KCNN4;TRPV4;FYN;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;FKBP1A;SLC8A1;ATP2C1;ANO6;ORAI1;STIM2;P2RX7;CRACR2B;MCOLN1;CRACR2A;MCUR1
prerank,regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5714017549025012,1.3768787748119957,0.12427745664739884,0.50659742162553,1.0,6/23,8.22%,IFNGR1;ARG1;IRGM;STAT1;NLRC5;JAK2
prerank,epidermal cell differentiation (GO:0009913),0.5240529549018961,1.3768479725385747,0.11756756756756757,0.5057515879829354,1.0,4/41,4.02%,JAG1;GATA6;CLIC4;BCR
prerank,stress-activated MAPK cascade (GO:0051403),0.48346359810265394,1.3758523471806636,0.08248730964467005,0.5075824401140635,1.0,13/61,10.93%,MAP4K2;NOD1;NOD2;MAP4K3;LGALS9;IRAK2;MAPK1;UBA52;RPS27A;TAOK2;MAP3K11;MINK1;TAB2
prerank,positive regulation of JUN kinase activity (GO:0043507),0.5645492845993811,1.3753898546882013,0.11711711711711711,0.5079314001681922,1.0,2/23,2.21%,EDN1;DAB2IP
prerank,mesoderm formation (GO:0001707),0.6119835407742089,1.3748951434842553,0.14215686274509803,0.5083068348732251,1.0,6/17,17.39%,BMPR2;TBXT;SMAD2;TBX20;ITGA3;ITGA8
prerank,positive regulation of mononuclear cell migration (GO:0071677),0.5358399728122514,1.3747490667858306,0.10784313725490197,0.50777426433432,1.0,4/29,3.92%,CCR1;JAM2;LGALS9;ANO6
prerank,regulation of programmed cell death (GO:0043067),0.4351680591063965,1.3745713291262216,0.040268456375838924,0.5073284155458566,1.0,36/161,15.09%,MECOM;ACER2;HIP1;FAS;ACTN4;PPP1R13B;GLS2;SLK;CASP2;OMA1;AMIGO2;TNFRSF25;APEX1;TOX3;TRIM24;MADD;ALK;FANK1;CRADD;LRRK2;STAT1;CIDEB;DCPS;JAK2;SGK1;RTN4;CASP1;CLU;NF2;BNIP3L;ATM;BNIP3;ANP32B;PSMC5;TM7SF3;DFFA
prerank,regulation of macrophage derived foam cell differentiation (GO:0010743),-0.4447810295203294,-1.374205260268679,0.0744336569579288,0.5946754351439784,1.0,10/27,20.59%,ABCA1;ITGAV;PPARA;PPARG;NFKB1;AGTR1;NR1H3;MAPK9;LPL;AGT
prerank,regulation of secretion (GO:0051046),0.6487658612735698,1.374034392823832,0.14091680814940577,0.5078740028082235,1.0,3/13,9.30%,KCNQ1;OAS2;SGK1
prerank,regulation of protein phosphorylation (GO:0001932),0.4218561174292783,1.3737926707184605,0.013569937369519834,0.5076554753880469,1.0,43/256,10.83%,VEGFC;PECAM1;TEK;CCDC88C;ENG;EFNA5;FYN;FLT4;FAS;TBX1;LIMCH1;CCND2;OCLN;INSR;CCND3;DAB2IP;APP;INPP5K;VEGFD;KRAS;ANGPT1;WWTR1;EFNA1;CSNK1D;BRAT1;WARS1;ADAM17;IRGM;ZC3H12A;LRRK2;HSPB1;PDE8A;PRR5L;ARRB1;THPO;NDUFS4;PPP2R5C;CACTIN;PTK2;PRNP;CCDC88A;RAC1;LIMK2
prerank,positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.4343602686368576,1.3736495654234786,0.05200433369447454,0.5071169360066812,1.0,32/149,12.80%,TRIM14;RPS6KA5;NOD1;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;TIRAP;TRIM6;TRAF1;IRAK2;ALK;IL1RAP;HSPA1B;UBA52;RPS27A;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;NPM1;CLU;PRKD2;TRIM8;BTK;CX3CR1;RTKN2
prerank,positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),-0.4638822660166298,-1.373068156034772,0.08307692307692308,0.5916138927575547,1.0,9/23,13.87%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),-0.4638822660166298,-1.373068156034772,0.08307692307692308,0.5916138927575547,1.0,9/23,13.87%,DAB2;ZEB2;THBS1;SNW1;CREBBP;FLCN;SDCBP;SLC2A10;CITED2
prerank,negative regulation of Notch signaling pathway (GO:0045746),0.5369771243660826,1.3729983794335066,0.11356932153392331,0.5078886814359265,1.0,8/28,11.31%,GATA2;EGFL7;HEY1;DLL4;ARRDC1;ARRB1;FBXW7;HIF1AN
prerank,IRE1-mediated unfolded protein response (GO:0036498),-0.3881947640603409,-1.3719008503863535,0.03571428571428571,0.5918747991414858,1.0,17/52,19.93%,SHC1;LMNA;DNAJC3;SSR1;ARFGAP1;SEC31A;TSPYL2;SRPRB;EXTL2;VAPB;GFPT1;FKBP14;WFS1;TLN1;PDIA6;ADD1;ACADVL
prerank,negative regulation of JNK cascade (GO:0046329),0.5298063587972227,1.371891106623492,0.10014727540500737,0.5098394236547452,1.0,5/31,10.36%,MECOM;F2RL1;PDCD4;DUSP3;AIDA
prerank,protein localization to microtubule organizing center (GO:1905508),0.6109214942196288,1.371804500097674,0.13689482470784642,0.5091430613202658,1.0,6/15,14.33%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83
prerank,activation of adenylate cyclase activity (GO:0007190),-0.43818673035101896,-1.3716536743995114,0.07116104868913857,0.589238248587791,1.0,8/35,9.89%,LGR4;ADCY5;ADCY9;ADCY1;EDNRA;ADCY2;ADCY7;RAF1
prerank,mesonephros development (GO:0001823),-0.5800538002281782,-1.37125144288373,0.12686567164179105,0.5871786642862489,1.0,4/11,2.43%,BMP7;BMP4;OSR1;FGF1
prerank,regulation of trans-synaptic signaling (GO:0099177),0.5287722989058763,1.3711255643006277,0.09550561797752809,0.5099561523334348,1.0,16/33,21.52%,ABR;CACNA1A;BCR;GRID1;BTBD9;PXK;LRRC4C;GRIK5;GRIK2;CX3CR1;PSMC5;GRIK1;LRP8;GRID2;BDNF;NLGN1
prerank,regulation of metal ion transport (GO:0010959),-0.5153847160008878,-1.3699018973755466,0.10498687664041995,0.5881293342528405,1.0,4/16,6.07%,ANK2;BCL2;SLC30A10;CACNA2D1
prerank,positive regulation of heart contraction (GO:0045823),0.5891017523571282,1.3697515093080224,0.12575757575757576,0.5128483014444283,1.0,3/19,2.55%,KCNQ1;EDN1;TGFB2
prerank,establishment of spindle localization (GO:0051293),0.6133995340363083,1.3680070251746221,0.13145539906103287,0.5167329573479307,1.0,6/14,18.50%,MAP4;CLASP1;KPNB1;CLASP2;CFL1;ZBED3
prerank,negative regulation of signal transduction in absence of ligand (GO:1901099),-0.4806798681022431,-1.3678764446788034,0.10149253731343283,0.5881211727422627,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.4806798681022431,-1.3678764446788034,0.10149253731343283,0.5881211727422627,1.0,4/21,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,protein localization to cell junction (GO:1902414),0.5801881062541492,1.3676104290743603,0.12102874432677761,0.5169307594276151,1.0,5/22,9.23%,HEG1;TJP2;TJP1;DSP;NECTIN1
prerank,negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.6483030052520632,1.3674067116196051,0.132996632996633,0.5165821378874368,1.0,3/10,3.85%,NOTCH4;NOTCH1;PPM1F
prerank,positive regulation of oxidoreductase activity (GO:0051353),0.5838358814917811,1.3663518667222851,0.12364760432766615,0.518491310022204,1.0,5/18,11.93%,EDN1;NOD2;ATP7A;RFK;PDP1
prerank,negative regulation of macrophage derived foam cell differentiation (GO:0010745),-0.5617444237331705,-1.3660088492584959,0.1446700507614213,0.5904313912696013,1.0,5/12,15.80%,ABCA1;ITGAV;PPARA;PPARG;NR1H3
prerank,nuclear migration (GO:0007097),-0.5443451308263242,-1.3654054154527522,0.12878787878787878,0.5892306897462011,1.0,4/13,8.55%,DOCK7;SYNE2;CLMN;SYNE3
prerank,protein import (GO:0017038),-0.35238156924504244,-1.3652085564158747,0.047619047619047616,0.5866247620077377,1.0,33/84,24.75%,APPL2;APOE;ABCD3;HSPA4;NUP107;HEATR3;CSE1L;PPP1R10;ATAD1;NUP155;PEX2;TNPO3;PXMP4;RANBP6;IPO5;FAM53C;PXMP2;NUP93;TNPO2;GDAP1;RANBP17;TSC2;PHB2;TOMM22;PEX11B;SEC13;SYK;PEX13;IPO7;POM121;PEX3;IPO8;PEX16
prerank,sulfate transport (GO:0008272),-0.5186353712194844,-1.3651142980934818,0.1345646437994723,0.583726081013337,1.0,3/14,2.86%,SLC13A4;SLC26A7;SLC26A2
prerank,positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),0.5803783235552628,1.3650658034670757,0.14790996784565916,0.5210185066484913,1.0,2/17,2.70%,CRTAM;CADM1
prerank,carnitine shuttle (GO:0006853),-0.5685369109107747,-1.3649314360273497,0.1172069825436409,0.5811571395840026,1.0,6/11,20.15%,PRKAG2;PRKAA2;SLC25A20;PRKAB2;CPT2;ACACA
prerank,protein localization to cell periphery (GO:1990778),0.43743030581745135,1.3647417096720147,0.052808988764044947,0.5209682527949372,1.0,27/133,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;PDZD11
prerank,outflow tract septum morphogenesis (GO:0003148),0.5536064565099525,1.3643944073658825,0.12023460410557185,0.5209827688118898,1.0,7/24,4.11%,ENG;GATA6;SMAD6;BMPR2;TBX1;TGFB2;ACVR1
prerank,positive regulation of cell adhesion (GO:0045785),0.47116609052955594,1.363930372761751,0.07237635705669482,0.521416339629736,1.0,12/74,8.73%,PTPRJ;PDGFB;MAGI1;SMAD7;TGFB2;FBLN2;TNFRSF18;PPM1F;CD47;PPP3CA;JAK2;RSU1
prerank,regulation of stress-activated protein kinase signaling cascade (GO:0070302),0.6551292385270877,1.3631355960393632,0.15213675213675212,0.5226511449929536,1.0,3/10,8.57%,FAS;MAPK1;NBR1
prerank,positive regulation of DNA metabolic process (GO:0051054),-0.37360088634449146,-1.3629848826571116,0.04,0.5841039836271292,1.0,10/61,6.61%,EYA2;EGFR;EYA1;PDGFRB;EYA4;FGF2;UBE2N;USP9X;MECP2;RAD50
prerank,regulation of reactive oxygen species biosynthetic process (GO:1903426),0.5454753905271361,1.3629795637016489,0.12280701754385964,0.5221432606594781,1.0,4/26,11.05%,PLCG2;SLC25A33;ADGRB1;CYBA
prerank,regulation of multicellular organismal development (GO:2000026),0.5453962931526308,1.362838435456302,0.11834319526627218,0.5216157822058339,1.0,6/25,11.00%,SOX17;SPAAR;INSR;GATA3;OAS2;BAG6
prerank,embryonic organ morphogenesis (GO:0048562),-0.4118624525029377,-1.36280727251167,0.08185053380782918,0.5816019297608257,1.0,15/42,7.10%,EFEMP1;FGFR2;HOXC4;PDGFRA;MFAP5;HOXA3;HOXB3;FBN2;RBP4;FBN1;NIPBL;HOXB4;RBPMS2;MEGF8;SIX1
prerank,T cell receptor signaling pathway (GO:0050852),0.4353586199850769,1.3625370734125335,0.05239687848383501,0.5214636359629982,1.0,36/138,18.86%,PTPRJ;PLCG2;FYN;INPP5D;PSMD13;GATA3;CD247;PSMD4;ZC3H12A;EIF2B2;PSMA5;PSMB10;PLCG1;TAB2;PSMB8;PSMD14;PRKD2;PIK3CB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PDE4D;PAK2;PSMC6;NCK1;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6
prerank,regulation of stress-activated MAPK cascade (GO:0032872),0.5027089850055199,1.3623165841147988,0.11409395973154363,0.5211735439105403,1.0,12/47,9.44%,FAS;NOD2;FOXO1;DAB2IP;ARL6IP5;F2RL1;TGFB2;LGALS9;MAP4K4;MAPK1;NBR1;TAOK2
prerank,positive regulation of fatty acid oxidation (GO:0046321),-0.5571489772460045,-1.3623158937869329,0.1306532663316583,0.5799765061330678,1.0,5/12,22.83%,PPARA;IRS2;IRS1;TWIST1;MTLN
prerank,pyroptosis (GO:0070269),0.6129880229132515,1.3616143348255836,0.13776337115072934,0.5221091008866392,1.0,4/15,10.37%,AIM2;CASP8;DHX9;CASP1
prerank,positive regulation of natural killer cell mediated immunity (GO:0002717),0.5878005343887664,1.3611592879118801,0.1454248366013072,0.5224044906633595,1.0,2/16,2.70%,CRTAM;CADM1
prerank,glucose import (GO:0046323),0.6182019284479064,1.361090728542625,0.14480408858603067,0.5216586246144402,1.0,2/13,2.68%,SLC2A1;HNF1A
prerank,cGMP biosynthetic process (GO:0006182),0.6713316383104079,1.3610289630238677,0.12897822445561138,0.5209030117573866,1.0,3/10,11.52%,NPR2;NPR1;NPPC
prerank,calcium ion import into cytosol (GO:1902656),0.6106541172114252,1.3606391633852084,0.1500815660685155,0.5210124015044519,1.0,3/15,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,autophagy of nucleus (GO:0044804),-0.515795532834014,-1.359996407376875,0.13609467455621302,0.5840152995768759,1.0,7/16,21.51%,ATG3;ATG5;ATG2A;ULK2;ATG7;WIPI2;WDR45
prerank,calcium ion import across plasma membrane (GO:0098703),0.6191554486153829,1.3598451771463076,0.1490066225165563,0.5222440755626937,1.0,3/14,3.81%,TRPV4;ATP2B4;SLC8A1
prerank,regulation of actin filament polymerization (GO:0030833),0.4685455827194395,1.3586214471364035,0.09523809523809523,0.5247132257652678,1.0,7/69,3.93%,KANK4;FCHSD2;HIP1R;KANK3;ESAM;EVL;CDC42EP1
prerank,cellular metal ion homeostasis (GO:0006875),0.44790527927920676,1.3579878408061494,0.0660486674391657,0.5255245574716668,1.0,14/102,5.71%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;ATP1A4;ATP1A1;ATP1A3;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2
prerank,transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),0.41003607113839563,1.3579750845101466,0.007106598984771574,0.5246464457588836,1.0,60/390,9.21%,VEGFC;PTPRJ;TEK;PTPRG;PDGFD;RAPGEF2;KALRN;FLT1;EFNA5;TIE1;PLCB1;PDGFB;ARHGEF28;FYN;FLT4;MPZL1;ELMO1;MERTK;FOXO4;ESRP2;IRS4;RAPGEF1;FOXO1;INSR;PRKD1;CAV2;PIK3C2A;CBL;ADRB2;NEDD9;FES;CRK;AP2B1;VEGFD;SHB;ANGPT1;EFNA1;FGFR3;BCAR3;MAPK1;SETX;SHOC2;ALK;LMTK2;FRS3;NUS1;FLRT3;JAK2;GRIN2B;ARPC5;POLR2G;NCKAP1;APC;NAMPT;ACTG1;APH1A;YES1;ROCK1;STAP1;PTK2
prerank,"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.5710350108355048,1.3576299556112204,0.12686567164179105,0.5246036317042541,1.0,7/24,10.93%,NOD1;NOD2;CASP8;IRAK2;UBA52;RPS27A;TAB2
prerank,long-chain fatty acid transport (GO:0015909),-0.4337424712842577,-1.3573260472476774,0.09477124183006536,0.5890106628477298,1.0,9/30,11.57%,PRKAG2;ACSL1;APOE;PRKAA2;ABCD3;SLC25A20;SLC27A1;PPARG;PRKAB2
prerank,cellular calcium ion homeostasis (GO:0006874),0.43456584826765493,1.3570908936580859,0.05955056179775281,0.5252071774557938,1.0,17/133,7.19%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;CAV2;MCUB;SLC8A1;ATP2C1;SMDT1;CAMK2D;ATP13A3;STIM2;HCRTR1;SLC30A1
prerank,phosphate-containing compound metabolic process (GO:0006796),0.4219310917685445,1.3569898102965718,0.04219409282700422,0.524600169017373,1.0,27/198,7.29%,PLCG2;PTPRB;PLCB1;ALPL;ITPKB;IP6K3;PLCB4;DUSP12;INPP5D;INPP1;PLPP1;INPP5K;IPPK;MINPP1;ACP6;PGM2L1;LPCAT4;GPI;LCAT;GPD2;PGK1;DUSP16;THTPA;ALK;DUSP3;LRRK2;PPP3CA
prerank,spinal cord development (GO:0021510),-0.5573896382545483,-1.3568317492822797,0.1261904761904762,0.5872908494278912,1.0,6/12,19.93%,GLI2;VIT;LOXL3;PKD1;ZPR1;NF1
prerank,negative regulation of Rho protein signal transduction (GO:0035024),0.5899022378713406,1.3566817576588255,0.1406003159557662,0.5245073145458793,1.0,3/18,6.09%,HEG1;RASIP1;CUL3
prerank,positive regulation of neuron projection development (GO:0010976),-0.3479141185300603,-1.3565312456049536,0.033707865168539325,0.5851147896374667,1.0,19/85,5.83%,PTN;DPYSL3;NTRK3;ROR1;CAMK1D;EPHA3;BMP5;BMP7;PTK7;COBL;WNT5A;NDNF;APOE;MAGI2;CBFA2T2;ROR2;NTRK2;PLXNB2;CAMK1
prerank,cardiac muscle tissue development (GO:0048738),0.49342718156839277,1.356313277121347,0.09855453350854139,0.5246279218609401,1.0,7/50,3.58%,GJA5;GATA6;MSX1;BMPR2;NOTCH1;HEY1;HEY2
prerank,embryonic axis specification (GO:0000578),0.6150240487197824,1.355927392845581,0.14992025518341306,0.5247757963251941,1.0,4/15,10.07%,SMAD6;TBXT;SMAD2;TASOR
prerank,positive regulation of glucose import (GO:0046326),-0.4685539219636292,-1.3558071536920144,0.12037037037037036,0.5843513019365825,1.0,8/21,8.12%,IGF1;SORBS1;RHOQ;IRS2;IRS1;PIK3R1;OSBPL8;PRKCI
prerank,cell surface receptor signaling pathway involved in heart development (GO:0061311),0.5888942759444734,1.3557245955178958,0.12480499219968799,0.5244551563045233,1.0,6/17,4.11%,JAG1;NOTCH1;HEY1;DLL4;HEY2;ACVR1
prerank,female gonad development (GO:0008585),-0.4852343984419307,-1.355424205394902,0.09467455621301775,0.5825872478740696,1.0,5/19,8.98%,NR2F2;KIT;NUP107;CEBPB;VEGFA
prerank,negative regulation of protein binding (GO:0032091),0.4666268735000959,1.3552752866583921,0.08787128712871287,0.5247459168957769,1.0,19/71,15.64%,ATP2A3;PDGFB;B2M;CAV1;ADRB2;ADAM15;TTBK2;LRRK2;CTNNBIP1;ROCK1;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;NES;MAP2;RACK1;SLPI
prerank,membrane depolarization during action potential (GO:0086010),-0.4421299234523272,-1.3549256290025704,0.10631229235880399,0.5812237197129835,1.0,5/26,6.67%,ATP1A2;CACNA1C;SCN7A;SCN2A;CACNA1G
prerank,cellular response to alcohol (GO:0097306),-0.4033573131652614,-1.3543360585132533,0.07037037037037037,0.5798444571681768,1.0,14/42,17.12%,ADCY5;SMO;ADCY1;GNAI1;CDH1;GRAMD1C;ADCY2;ADCY7;GPLD1;PTCH1;GRAMD1A;OSBPL7;LARP1;GRAMD1B
prerank,male gonad development (GO:0008584),0.5289675957018833,1.3542065465692699,0.11294765840220386,0.5268015515939902,1.0,7/34,8.81%,GATA6;KITLG;TGFB2;ING2;GATA3;COL9A3;NCOA4
prerank,negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),0.654295930463049,1.3539781974848948,0.13559322033898305,0.5265409634952217,1.0,1/10,0.07%,PTPRJ
prerank,monocyte chemotaxis (GO:0002548),0.5207223527505437,1.3534845172280503,0.1138328530259366,0.5270291228529034,1.0,4/32,10.16%,FLT1;PDGFB;PTPRO;CCL4
prerank,calcium import into the mitochondrion (GO:0036444),0.6643373590550222,1.353351713787632,0.15358931552587646,0.52648991103556,1.0,3/10,8.35%,MCUB;SMDT1;MCUR1
prerank,regulation of intracellular pH (GO:0051453),-0.43210923602828494,-1.3520687233468511,0.059800664451827246,0.5835773380384446,1.0,17/34,22.64%,SLC4A10;SLC9A2;CA2;SLC9A9;SLC4A2;ATP5F1B;VPS33A;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;TMEM165;SLC4A8;CFTR
prerank,negative regulation of protein kinase activity (GO:0006469),0.4571994123920084,1.3520175627435176,0.07600950118764846,0.5292843390713003,1.0,27/88,17.56%,PTPRB;CEACAM1;GNAQ;ADARB1;DAB2IP;CAV1;INPP5K;SLC8A1;PPM1F;WWTR1;HYAL2;WARS1;SMCR8;DUSP3;HSPB1;PTPRO;ADAR;PTPN1;NPM1;ITGB1BP1;LRP5;SH3BP5L;DUSP26;PAK2;PYCARD;TRIB3;PYDC1
prerank,COPII-coated vesicle cargo loading (GO:0090110),-0.5336139321612048,-1.3519852812841004,0.11796246648793565,0.5809968335238197,1.0,9/14,21.12%,SEC24D;SEC31A;SEC24C;SAR1A;SCAP;SEC23B;TBC1D20;SEC23A;SEC13
prerank,positive regulation of cell cycle G1/S phase transition (GO:1902808),0.5235733078224636,1.351649206637302,0.125,0.5293848371239326,1.0,4/33,1.96%,PLCG2;PLCB1;CCND2;CCND3
prerank,histone H3-K4 methylation (GO:0051568),-0.44661257720745157,-1.3508344498470948,0.12457912457912458,0.5815375678803484,1.0,10/26,16.37%,OGT;KMT2C;ASH2L;SETD1A;SETD1B;TET2;WDR5;CTR9;DPY30;SETD4
prerank,transforming growth factor beta receptor signaling pathway (GO:0007179),0.45173603463448736,1.350100967907839,0.07460890493381468,0.5327306539361963,1.0,21/87,9.21%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2
prerank,positive regulation of lipid metabolic process (GO:0045834),-0.4598344895769968,-1.3497281824297132,0.10059171597633136,0.5818501400646076,1.0,6/22,12.51%,ZBTB20;SORBS1;APOE;PPARA;PPARG;CREB1
prerank,interleukin-1-mediated signaling pathway (GO:0070498),0.4511401628406331,1.3487242464691802,0.07380952380952381,0.5356383177580655,1.0,33/94,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;PSMD13;IRAK2;IL1A;PSMD4;IL1RAP;UBA52;RPS27A;EGR1;PSMA5;RBX1;PSMB10;NFKBIA;TAB2;PSMB8;MAP3K3;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,negative regulation of cell projection organization (GO:0031345),0.4926810589208825,1.3486421183795438,0.09486166007905138,0.5349873182505483,1.0,12/48,13.00%,TRPV4;STMN2;RAPGEF2;FYN;FKBP4;PTPRO;GRIN2B;PRNP;SPOCK1;DCC;TSKU;YWHAH
prerank,regulation of histone methylation (GO:0031060),-0.539442699737448,-1.3485712247845976,0.13624678663239073,0.5821403284608593,1.0,8/13,21.31%,JARID2;NSD1;PAF1;CTR9;TET1;PIH1D1;NNMT;MTHFR
prerank,negative regulation of macromolecule biosynthetic process (GO:0010558),0.6296311235618,1.3484739394770293,0.15816326530612246,0.5345758253224918,1.0,1/12,0.47%,EDN1
prerank,cellular response to interleukin-1 (GO:0071347),0.4328343096627212,1.347629447739568,0.05393258426966292,0.5359359351675731,1.0,46/143,18.86%,PLCB1;RPS6KA5;NOD1;NOD2;DAB2IP;PSMD13;HYAL2;IRAK2;GBP3;IL1A;PSMD4;CD47;ZC3H12A;IL1RAP;UBA52;RPS27A;NR1D1;ACOD1;CACTIN;EGR1;PSMA5;RBX1;PSMB10;CCL4;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PYCARD;PSMA4;PSMD5;PSMD9;RELA;PSMB6
prerank,nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.5506142963688853,1.3472468844222416,0.12682215743440234,0.5361071306252284,1.0,8/28,10.93%,NOD1;NOD2;CASP8;IRAK2;IRGM;UBA52;RPS27A;TAB2
prerank,positive regulation of phosphorylation (GO:0042327),0.4149568484900172,1.347243632285881,0.030303030303030304,0.5352184789444995,1.0,33/240,8.29%,VEGFC;PECAM1;TEK;ENG;FLT1;EFNA5;TIE1;FLT4;FAS;TBX1;MERTK;LIMCH1;CCND2;INSR;CCND3;APP;VEGFD;KRAS;ANGPT1;EFNA1;CSNK1D;BRAT1;FGFR3;ADAM17;P2RX7;ALK;IRGM;LRRK2;LMTK2;PDE8A;ARRB1;THPO;PRKAA1
prerank,nucleoside phosphate biosynthetic process (GO:1901293),-0.51844056464453,-1.3471236214977838,0.12971698113207547,0.583645459599871,1.0,7/14,19.85%,NMNAT2;ME1;AK5;PNP;CMPK2;AK1;NME2
prerank,negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),0.49739378958941893,1.3468386511924086,0.11428571428571428,0.5354256602919107,1.0,8/43,9.62%,PTPRJ;ITGA1;DAB2IP;CBL;SH3KBP1;DUSP3;GPRC5A;RNF115
prerank,heart process (GO:0003015),0.6151695290995123,1.3456057475886936,0.16071428571428573,0.5377941172171329,1.0,2/14,1.04%,FYN;ACE
prerank,regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.45530683820891643,1.344819782417308,0.08643457382953182,0.5390067267461547,1.0,32/86,20.43%,EPAS1;KLF2;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;GCN1;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,negative regulation of actin filament polymerization (GO:0030837),0.5631297330114381,1.3440406269809035,0.1452599388379205,0.5401834913348853,1.0,3/22,2.97%,KANK4;HIP1R;KANK3
prerank,regulation of calcium ion import (GO:0090279),0.5617895423791096,1.3439568293209696,0.14992503748125938,0.5395764806117419,1.0,7/21,16.05%,PDGFB;FYN;SLC30A1;PRNP;PLPP4;CTNNB1;PSEN2
prerank,vascular process in circulatory system (GO:0003018),0.615741988113424,1.3435718348849641,0.1490066225165563,0.5388353011643757,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,regulation of tube diameter (GO:0035296),0.615741988113424,1.3435718348849641,0.1490066225165563,0.5388353011643757,1.0,5/13,13.05%,NOS3;ACE;NPR1;ROCK1;ITGB1BP1
prerank,positive regulation of potassium ion transmembrane transport (GO:1901381),0.4979922796523537,1.3433072759328604,0.10921052631578948,0.5386845982836994,1.0,5/44,3.92%,KCNN4;KCNQ1;KCNN3;NOS1AP;ANO6
prerank,negative regulation of heart contraction (GO:0045822),-0.5640527729106748,-1.3427150630957156,0.1409921671018277,0.5942387006734291,1.0,1/11,0.03%,ATP1A2
prerank,regulation of cell population proliferation (GO:0042127),0.4011499580843425,1.342517534363165,0.0010030090270812437,0.5399718993376385,1.0,86/691,9.41%,VEGFC;PTPRJ;ELN;CDH13;ACER2;NUAK1;JAG1;JAG2;NOS3;EDN1;PDGFD;ENG;IRF6;RAPGEF2;CLDN5;FLT1;SMAD6;PDGFB;BMPR2;FLT4;SMARCA2;KITLG;TBX1;PTPN14;FOXO4;CCND2;ITGA1;LIFR;ACVRL1;NOTCH1;INSR;ARHGEF2;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;EMP2;BTG2;DLL4;APP;FES;BTG1;HHEX;PLPP1;KLF4;VEGFD;KRAS;IER5;WWTR1;LEF1;GCNT2;SERTAD1;TBC1D8;FGFR3;GATA3;CUL3;BCL6B;WARS1;IL1A;ADAM17;SH3BP4;SLC25A33;CD47;ALK;GNAI2;IGFBP7;STAT1;HSPA1B;CNOT6L;CEBPA;PTPRU;THPO;CD200;JAK2;APC;NMI;NAMPT;TSPO;KLF11;PPP2R5C;JUN;TJP1;PTK2;SGK1;ADAM10
prerank,negative regulation of DNA-binding transcription factor activity (GO:0043433),0.4353011199532209,1.341416015015508,0.05782312925170068,0.5421957196823742,1.0,39/136,20.17%,FZD6;SMAD7;TBXT;AIM2;DAB2IP;ID1;KLF4;NFKBIE;DAP;IRAK2;COMMD7;NFKBIL1;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CTNNBIP1;CACTIN;MAD2L2;PRNP;NFKBIA;NWD1;KEAP1;HAVCR2;PTGIS;TMSB4X;ESR1;PYCARD;MEN1;PYDC1;TBX6;ID3;TAF3;ERBIN;FOXJ1;EGLN1;SIGIRR
prerank,negative regulation of cellular biosynthetic process (GO:0031327),0.4951723126570391,1.3411895330480839,0.11984536082474227,0.5419309402712849,1.0,10/47,11.66%,RAPGEF2;CEACAM1;FYN;ATP2B4;CAV1;CD34;ZC3H12A;SNAI2;FBXW7;BRCA1
prerank,cellular component maintenance (GO:0043954),0.6305773925808095,1.34088396696539,0.17235772357723578,0.5418373587230695,1.0,4/12,14.23%,FYN;INSR;PRNP;ITGA3
prerank,neuron projection extension (GO:1990138),-0.4293374754615187,-1.3396741137477168,0.1095890410958904,0.6008161090584488,1.0,11/32,12.07%,ALCAM;AUTS2;NRP2;SEMA5A;SEMA3A;USP9X;SPG11;FLRT1;PPP3CB;ULK2;LLPH
prerank,regulation of hematopoietic stem cell differentiation (GO:1902036),0.4620586840786761,1.3395159055174126,0.11814859926918392,0.5447010849961462,1.0,25/70,18.86%,GATA2;LMO2;TAL1;PSMD13;LMO1;GATA3;PSMD4;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,cytoskeleton-dependent intracellular transport (GO:0030705),0.5568595364289189,1.3391345291563184,0.12166172106824925,0.5448093472285327,1.0,12/23,25.15%,CCDC88C;TUBB;HOOK1;MYO10;CCDC88A;TUBA1A;KIF1A;HOOK2;DYNC1I2;TUBA1B;KIF5A;MAP6
prerank,regulation of axon extension involved in axon guidance (GO:0048841),0.5481885649091728,1.3388581780069637,0.14548238897396631,0.5446407847091861,1.0,3/24,4.67%,SEMA3G;SEMA3F;SEMA7A
prerank,myoblast differentiation (GO:0045445),0.6097311008654633,1.338756788681855,0.1504,0.5439765805017599,1.0,3/14,4.60%,EPAS1;JAG1;MBNL1
prerank,axon guidance (GO:0007411),0.41316664571702544,1.338617073999316,0.04670912951167728,0.543485122046418,1.0,35/201,11.35%,SEMA3G;LAMA3;PTPRM;EFNA5;FYN;RPS6KA5;PLXNA4;NTN4;NOTCH1;KLF7;SEMA3F;SH3KBP1;EVL;PLXND1;LAMA5;NTN1;TMEFF1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;MAPK1;BSG;PTPRO;ENAH;SEMA6D;SCN1B;PTK2;PLCG1;CYFIP1;RAC1;RANBP9;DCC;SEMA4G
prerank,negative regulation of cardiac muscle hypertrophy (GO:0010614),0.6554842205842718,1.3382652178040506,0.1485148514851485,0.5435717213070274,1.0,3/11,1.88%,NOTCH1;ATP2B4;FOXO1
prerank,cellular response to type I interferon (GO:0071357),0.4992150740121249,1.3381894793744045,0.12129380053908356,0.5420235083099757,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,type I interferon signaling pathway (GO:0060337),0.4992150740121249,1.3381894793744045,0.12129380053908356,0.5420235083099757,1.0,11/41,12.46%,IRF6;IRF2;IRF9;IFNAR1;STAT1;OAS2;ADAR;EGR1;PSMB8;GBP2;IRF5
prerank,homeostasis of number of cells (GO:0048872),0.6160321769506215,1.3368100166472545,0.15798319327731092,0.5449821165698195,1.0,4/12,12.63%,NOS3;NOTCH1;LPCAT3;CX3CR1
prerank,negative regulation of potassium ion transmembrane transport (GO:1901380),0.6394726222779624,1.3365348044925789,0.13278688524590163,0.544813543509607,1.0,4/11,10.96%,KCNE3;CAV1;STK39;NEDD4L
prerank,positive regulation of protein ubiquitination (GO:0031398),0.4518533160195259,1.336438538714574,0.08,0.5441630117567737,1.0,27/80,21.60%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;RBX1;LAPTM5;BRCA1;FBXO4;PIN1;SPRTN;BMI1;TRIB3;GSK3A;XIAP;CRY1;MALT1;ARRDC4;DCUN1D2;UBB
prerank,regulation of leukocyte activation (GO:0002694),0.6016191083007797,1.3362698353059896,0.16271186440677965,0.5437854317653082,1.0,4/14,8.02%,GPR137B;MFHAS1;PLSCR1;CD200
prerank,T cell differentiation (GO:0030217),0.5006468475001887,1.336104099852832,0.12568306010928962,0.5433863867042465,1.0,5/40,6.32%,SOX13;JAG2;DLL4;GATA3;ADAM17
prerank,aminoglycan biosynthetic process (GO:0006023),-0.3801088011954548,-1.3359286469192164,0.06306306306306306,0.6094222508741984,1.0,12/49,10.39%,GPC6;B3GALT1;SDC2;HSPG2;GPC3;HS3ST3A1;B3GNT2;PXYLP1;XYLT1;HEXA;B3GAT3;HS2ST1
prerank,regulation of cell communication by electrical coupling (GO:0010649),0.6023286879190833,1.3349806429374318,0.160828025477707,0.5454995090099232,1.0,7/13,19.12%,CAV1;SLC8A1;CAMK2D;CALM3;PDE4D;ANK3;IRX3
prerank,beta-catenin-TCF complex assembly (GO:1904837),-0.42180219751633546,-1.3341669479197007,0.08917197452229299,0.6118517552219005,1.0,11/29,14.08%,TCF7L2;CREBBP;PYGO1;BCL9;ASH2L;TLE1;PYGO2;TLE2;HDAC1;AXIN2;TERT
prerank,response to copper ion (GO:0046688),-0.47160396375485936,-1.3340436632034234,0.14080459770114942,0.609298321312376,1.0,8/20,6.94%,MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G
prerank,peptide cross-linking (GO:0018149),-0.44651753367154207,-1.3338299472290067,0.09763313609467456,0.6070348456978876,1.0,4/25,6.16%,COL3A1;NDNF;THBS1;ANXA1
prerank,positive regulation of protein autophosphorylation (GO:0031954),0.5480561169434256,1.3337487876220253,0.15174506828528073,0.5480094586544307,1.0,6/22,12.45%,PDGFD;PDGFB;ACE;TOM1L1;TAOK2;CALM3
prerank,heart development (GO:0007507),0.4242037105500681,1.3325884987318328,0.06896551724137931,0.5503728246246972,1.0,22/150,5.32%,HEG1;SOX17;TEK;PDGFB;BMPR2;TBX1;TBXT;MYBPC3;ACVRL1;NOTCH1;DAND5;INSR;CASP8;TGFB2;FKBP1A;HDAC9;SOX18;ACVR1;ALPK3;PDLIM5;PCSK5;MEF2C
prerank,regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.5024699945553089,1.3325349130062978,0.14104372355430184,0.549660127324275,1.0,7/38,7.97%,NOS3;FAS;ARHGEF2;CASP8;TNFSF10;MADD;BCL2L1
prerank,purine-containing compound salvage (GO:0043101),-0.5486860365876547,-1.3318110340324145,0.16195372750642673,0.6106967050231126,1.0,8/12,30.33%,ADK;AMPD3;GMPR;PNP;APRT;DCK;AMPD2;ADA
prerank,regulation of neutrophil chemotaxis (GO:0090022),-0.4636125439856528,-1.3316703381015702,0.1144578313253012,0.6081391299677545,1.0,13/23,25.46%,CAMK1D;SLIT2;DPP4;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,extracellular matrix assembly (GO:0085029),0.55668557693622,1.3314221484620554,0.14714714714714713,0.5518736163251714,1.0,3/23,4.38%,FBLN5;NTN4;ATP7A
prerank,hematopoietic stem cell proliferation (GO:0071425),0.6316173631880136,1.3310103198018715,0.16351118760757316,0.5520847103364066,1.0,2/11,5.43%,MECOM;CD34
prerank,regulation of peptidyl-serine phosphorylation (GO:0033135),0.4467808269247251,1.3308610162128263,0.09123222748815166,0.5516673582063635,1.0,12/93,6.97%,NOS1;CNKSR3;SMAD7;ATP2B4;CAV1;PRKD1;APP;INPP5K;PPM1F;TRIM6;BCAR3;IRGM
prerank,regulation of pseudopodium assembly (GO:0031272),0.6462370992252151,1.3306423577947488,0.17850953206239167,0.5505061357026355,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,positive regulation of pseudopodium assembly (GO:0031274),0.6462370992252151,1.3306423577947488,0.17850953206239167,0.5505061357026355,1.0,3/10,8.44%,F2RL1;CDC42EP1;APC
prerank,protein localization to plasma membrane (GO:0072659),0.42631543396276445,1.330565180398583,0.06447963800904978,0.5498111098165211,1.0,26/129,10.33%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;ZDHHC22;PACS1;EMP2;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;RAB40B;CLASP2;NKD2;CCDC88A
prerank,neuron projection development (GO:0031175),0.4248385993056001,1.3304570550777415,0.058695652173913045,0.5492869567540374,1.0,31/168,10.64%,PTPRM;STMN2;RAPGEF2;FRYL;RAB11A;DAB2IP;FRY;BTG2;TRIO;APP;MAP4;BLOC1S6;EHD1;ATP7A;VASH2;SHTN1;MAP4K4;SHANK3;CAMSAP2;PACSIN1;UHMK1;LRRK2;FLRT3;NCKAP1;RAB35;ROCK1;SGK1;TAOK2;HMGB1;NEFH;MINK1
prerank,regulation of cellular pH (GO:0030641),-0.4294674228097752,-1.3304547413247088,0.09880239520958084,0.6090070198329695,1.0,16/29,22.43%,SLC4A10;SLC9A2;CA2;LACC1;SLC9A9;ATP6AP1;SLC4A2;ATP5F1B;SLC4A3;SLC9A1;SLC26A6;SLC9B1;SLC9A6;CLN3;TM9SF4;SLC4A8
prerank,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),0.5096965434480573,1.3304010134473232,0.12049861495844875,0.5485817202306794,1.0,10/35,21.52%,CDH13;ATP2C1;CDH12;PCDHB16;PCDHB14;CDH22;PCDHB9;CDH18;CDH24;NLGN1
prerank,regulation of delayed rectifier potassium channel activity (GO:1902259),0.5888397470230236,1.3297791507072652,0.16998468606431852,0.5494587854062585,1.0,2/17,3.68%,KCNE3;NOS1AP
prerank,regulation of histone H3-K4 methylation (GO:0051569),-0.4978669983205506,-1.3296242277813384,0.12849162011173185,0.6087748761994488,1.0,7/16,18.34%,AUTS2;SNW1;WDR5;CTR9;PIH1D1;BCOR;DNMT3B
prerank,positive regulation of protein exit from endoplasmic reticulum (GO:0070863),-0.5177273954227887,-1.3289864451133453,0.11989100817438691,0.6078901522584776,1.0,7/13,21.11%,SEC16B;BCAP31;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,positive regulation of sodium ion transmembrane transport (GO:1902307),0.6210665912001139,1.3288749738491892,0.15960912052117263,0.5511029149613579,1.0,1/12,0.06%,NOS1
prerank,plasma membrane invagination (GO:0099024),0.5278616366654234,1.3277974127722685,0.15983026874115983,0.5532606434307578,1.0,8/29,8.94%,ELMO1;GULP1;FCGR2B;FCGR1A;MYH9;ITGAM;ARHGAP25;VAMP7
prerank,regulation of protein exit from endoplasmic reticulum (GO:0070861),-0.5149761857603778,-1.3275186019328586,0.14209115281501342,0.6096567040789079,1.0,7/13,21.11%,GCC2;SEC16B;SAR1A;CD81;SEC16A;SAR1B;TM9SF4
prerank,actin filament polymerization (GO:0030041),-0.42156292431272674,-1.327371729125354,0.09836065573770492,0.6072670516239754,1.0,7/29,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;WASHC3;PREX1
prerank,negative regulation of phagocytosis (GO:0050765),0.5783167009136494,1.327334234239667,0.16923076923076924,0.5536952477917629,1.0,5/17,9.50%,DYSF;FCGR2B;CD47;PLSCR1;HMGB1
prerank,negative regulation of DNA binding (GO:0043392),0.5342594598368554,1.3264179568695906,0.142433234421365,0.5553109287180394,1.0,10/28,13.35%,HEY1;HEY2;SUMO3;LEF1;JAK2;JUN;MAD2L2;NFKBIA;TNKS;HABP4
prerank,regulation of melanin biosynthetic process (GO:0048021),0.649768170782008,1.326378561272751,0.16501650165016502,0.554549388543368,1.0,3/10,8.23%,RAPGEF2;ATP7A;CDH3
prerank,regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),0.43594295696505747,1.3262892549071028,0.0912280701754386,0.5539332328468762,1.0,18/100,9.21%,TEK;PDGFD;PIP5K1B;FLT1;CEACAM1;PDGFB;FBXL2;INSR;DAB2IP;F2RL1;TGFB2;CBL;PPP1R16B;PIP5K1C;MAPK1;JAK2;PPP2R5C;PTK2
prerank,regulation of dendrite development (GO:0050773),-0.4055132457102275,-1.32591720192279,0.08494208494208494,0.6086659115732482,1.0,7/37,2.62%,PTN;CAMK1D;SDC2;BMP5;BMP7;MARK1;COBL
prerank,synaptic membrane adhesion (GO:0099560),-0.5235055620729173,-1.3257612128217786,0.13972602739726028,0.6063117756894032,1.0,8/14,19.26%,GPC6;PTPRF;LRRC4;SLITRK1;PTPRS;NTNG1;PTPRD;GPC4
prerank,cell migration involved in sprouting angiogenesis (GO:0002042),-0.488507427811004,-1.3255786963317764,0.15895953757225434,0.6041125170964975,1.0,7/17,12.59%,ROBO1;SLIT2;EFNB2;FGF2;GPLD1;VEGFA;EPHB4
prerank,regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.45632401799365996,1.325576116896553,0.09225092250922509,0.5551079293183162,1.0,31/74,20.43%,EPAS1;NOTCH1;PSMD13;ELOC;PSMD4;UBA52;NFE2L2;RPS27A;PSMA5;RBX1;PSMB10;CUL2;PSMB8;HIF1AN;PSMD14;PSMA7;PSMC3;HIF1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;PSMB2
prerank,positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.45526274803539746,1.325214051408228,0.10336538461538461,0.5551931854131259,1.0,16/76,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;CUL3;UBE2D1;ZC3H12A;LRRK2;UBE3A;NDFIP2;NSMCE3;FBXW7;LAPTM5;BRCA1;FBXO4
prerank,negative regulation of chemokine production (GO:0032682),0.6013789877488962,1.3244582718250353,0.1824,0.556390471219528,1.0,3/14,3.83%,F2RL1;LGALS9;KLF4
prerank,cytosolic calcium ion transport (GO:0060401),0.5367656701998481,1.324319015909225,0.14327485380116958,0.5559330378662137,1.0,5/28,4.82%,ATP2A3;ITPR3;MCUB;SLC8A1;SMDT1
prerank,positive regulation of DNA repair (GO:0045739),-0.3927709828400945,-1.3241566449203601,0.1015625,0.6056304452367579,1.0,8/46,8.57%,EYA2;EGFR;EYA1;EYA4;UBE2N;SLF1;FMN2;XRCC1
prerank,I-kappaB phosphorylation (GO:0007252),0.6500878788429095,1.3233824069352034,0.18055555555555555,0.5575543894736481,1.0,2/10,3.64%,DAB2IP;TLR3
prerank,positive regulation of GTPase activity (GO:0043547),0.4087439934886482,1.3233002492701496,0.061027837259100645,0.5569221674875391,1.0,42/188,13.86%,RAPGEF2;DOCK9;RABGAP1;SIPA1L2;F11R;ARHGEF15;RAPGEF1;RASGRP2;ABR;CAV2;F2RL1;AGRN;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;RAPGEF6;MAP4K4;TBC1D8;RAP1GDS1;BCAR3;TIAM2;RGS7;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;RSU1;TBC1D1;RAP1GAP2;TAX1BP3;CCL4;RALGAPB;ARHGAP27;USP6NL;PIN1;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,positive regulation of MAP kinase activity (GO:0043406),0.4561710690413351,1.322753966584664,0.11330049261083744,0.5575124096395271,1.0,7/66,2.21%,EDN1;PDGFD;FLT1;PDGFB;PIK3R6;NOD2;DAB2IP
prerank,negative regulation of transport (GO:0051051),0.47888112728446064,1.3226130672534075,0.12179487179487179,0.5571026330283276,1.0,10/51,9.11%,MCTP1;DYSF;PRKD1;ARL6IP5;PPM1F;FCGR2B;CTTNBP2NL;PXK;PLSCR1;NDFIP2
prerank,regulation of T-helper 17 cell differentiation (GO:2000319),0.6365689729893016,1.3219425757066323,0.1986062717770035,0.558123259256625,1.0,2/10,7.01%,SMAD7;ZC3H12A
prerank,regulation of vasoconstriction (GO:0019229),0.5311945987448056,1.3218765672352257,0.1568627450980392,0.5574646236038647,1.0,4/27,6.12%,BMPR2;ACE;CAV1;CHRM3
prerank,regulation of cell adhesion mediated by integrin (GO:0033628),0.5039690920595379,1.321671432073979,0.13464235624123422,0.5571356055502906,1.0,6/33,9.21%,ACER2;TGFB2;PDE3B;EFNA1;SNAI2;PTK2
prerank,T cell activation (GO:0042110),0.4595550162621032,1.3198519927961156,0.125,0.5613146220657258,1.0,10/69,7.29%,JAG2;CRTAM;CASP8;F2RL1;FKBP1A;DLL4;MSN;CTPS1;GATA3;PPP3CA
prerank,cellular protein modification process (GO:0006464),0.3925252627250589,1.3192793431240422,0.0,0.5620530322403323,1.0,199/982,15.76%,BMX;PTPRM;PTPRJ;LMO7;PTPRB;EPAS1;NUAK1;CDK19;PTPRG;ST8SIA6;ERG;PTPRR;MAP4K2;STK10;PDGFB;ASB4;FYN;BMPR2;RPS6KA5;CDK17;PTPN14;MERTK;ACVRL1;IP6K3;ST3GAL6;FBXL2;RAB11A;MAP4K3;INSR;DUSP12;DUSP1;ST6GALNAC2;CDK14;SNRK;PRKD1;PRKG1;TGFB2;OXSR1;GOLM1;CDC42BPA;APP;TULP4;KLHL2;MAP3K6;PKN3;FBXO7;UBA7;APOA1;SERP2;COPS4;CDC42BPG;PPM1F;CISH;PSMD13;BCR;ACVR1;STK24;FBXL14;FBXL5;KLHL3;MANBA;GCNT2;CCNE1;PTPRE;CAMK2D;MAP4K4;PKN1;STK38;STK38L;TMEM132A;CSNK1D;NLK;ELOC;CTTNBP2NL;RHBDD1;MEX3B;GAN;CUL3;CHRM3;DUSP16;PGAP1;SIRT4;MAPK1;PGGT1B;CD247;PXK;PSMD4;MAST1;KLHL20;ZBTB16;AKT3;SIK2;LRRK2;PRKCSH;FBXL18;IGFBP7;LMTK2;SOCS6;PPP3CA;PTPN12;HSP90B1;NUS1;PTPRU;PTPRO;ASB5;TLK1;B3GNT3;UBA52;JAK2;FEM1C;PRKAA1;PROC;STK39;PASK;PIM3;PP2D1;NEK7;YES1;PPP2R5C;ROCK1;FBXL16;CSNK1G3;IGFBP4;DSP;SGK1;ADAM10;TAOK2;PSMA5;PIK3C3;MAP3K11;FBXW7;RBX1;PSMB10;CUL2;MARK3;DUSP11;PRKCG;APLP2;PTPN1;MINK1;LIMK2;FBXW2;LIPT1;TNKS;CDH2;MGAT1;PSMB8;PSMD14;NEK11;HS3ST5;PDP1;PRKD2;MARK2;MATK;VRK1;FBXO4;CP;COPS8;SETD3;METAP2;TTBK1;BTK;B3GALNT2;DCAF17;PSMA7;PSMC3;PPM1D;KEAP1;NAGPA;DCAF10;PPM1L;HIF1A;PSMA8;ST3GAL1;PSMC1;LTK;ATM;FBXO2;PSMB5;UBE2E1;ACVR2A;MAP3K20;PSMC5;PRKG2;MSRA;UBE2D3;PPP4R1;PPP2CB;EVPL;ACVR2B;ABCA7;PSMB9;MPI;DUSP26;ST3GAL2;PKN2;PAK2;KLHL25;ENGASE
prerank,poly-N-acetyllactosamine biosynthetic process (GO:0030311),-0.5328798974569158,-1.3190070265614584,0.1513647642679901,0.6188358059412804,1.0,2/12,3.22%,B3GALT1;B3GNT2
prerank,negative regulation of locomotion (GO:0040013),0.6179125977835928,1.3187256633044335,0.1819620253164557,0.5627722801871109,1.0,8/12,17.42%,CRK;SPOCK3;GATA3;DUSP3;SPINT2;PIN1;FRMD5;PTPN2
prerank,negative regulation of calcium ion transport (GO:0051926),0.6010275946152707,1.3174686082833547,0.17103235747303544,0.5652633852884366,1.0,3/15,7.19%,NOS1;INPP5K;SLC30A1
prerank,negative regulation of cell-matrix adhesion (GO:0001953),0.507299964920248,1.3173764001929247,0.15451895043731778,0.5646244643889926,1.0,6/32,4.97%,ACER2;JAG1;ACVRL1;FAM107A;ADAM15;MAP4K4
prerank,regulation of superoxide anion generation (GO:0032928),0.5939662170017619,1.3162003734877896,0.17333333333333334,0.5670501180348293,1.0,4/14,10.12%,F2RL1;ITGAM;AATF;TYROBP
prerank,oligodendrocyte differentiation (GO:0048709),0.5599595070791786,1.3161973084629413,0.15233785822021115,0.566205541909249,1.0,4/19,12.21%,SOX13;EIF2B2;SOX10;SOX6
prerank,regulation of Wnt signaling pathway (GO:0030111),-0.33043919727084253,-1.315982675181768,0.046357615894039736,0.6252911662178318,1.0,24/108,8.83%,TRABD2B;WLS;LRP1;FGFR2;SULF1;GPC3;PTK7;RNF43;NKD1;SULF2;RSPO3;DCDC2;APCDD1;PRKN;GRB10;DACT1;RUNX1;CTNND2;SFRP4;DAAM2;RSPO2;FZD7;WWOX;TLE1
prerank,regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.430924888201184,-1.315343800277127,0.13975155279503104,0.6244377135089962,1.0,4/26,5.10%,EYA2;EYA1;BCL2;EYA4
prerank,cGMP metabolic process (GO:0046068),0.6238783706972585,1.3143545773812846,0.1895424836601307,0.5704092853098148,1.0,3/12,11.52%,NPR2;NPR1;NPPC
prerank,gene silencing by miRNA (GO:0035195),0.5140666352867955,1.313560984071441,0.1476121562952243,0.5717131459177526,1.0,9/32,14.77%,NOTCH4;TNRC6C;PUM2;ZC3H7A;ADAR;CNOT1;AGO4;RAN;EIF6
prerank,pancreas development (GO:0031016),-0.5386607056707308,-1.31342725729934,0.15288220551378445,0.6275223717033291,1.0,7/12,31.47%,TCF7L2;NPHP3;MET;NKX6-1;PROX1;FOXF1;CCDC39
prerank,positive regulation of protein polymerization (GO:0032273),0.4617881828528158,1.3126809460277484,0.10872313527180784,0.5732368434041613,1.0,15/65,16.66%,FCHSD2;OCLN;FES;EVL;CDC42EP1;CLIP1;CLASP1;NCKAP1;RAC1;NUMA1;TTBK1;NAV3;TENM1;NCK1;PYCARD
prerank,semaphorin-plexin signaling pathway (GO:0071526),0.49881809644771025,1.3121225961593546,0.14657534246575343,0.5739519751572549,1.0,9/35,11.35%,SEMA3G;PLXNA4;SEMA3F;PLXND1;SEMA7A;ARHGDIA;SEMA6D;RAC1;SEMA4G
prerank,regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),0.46242957544015517,1.3120911139968423,0.14285714285714285,0.5731595385943816,1.0,8/56,4.11%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.5103346307059409,-1.3115740899802526,0.15608465608465608,0.6301082096511914,1.0,5/14,9.67%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.5455778025838659,1.3115267745277148,0.1558641975308642,0.5738332502050393,1.0,4/23,5.38%,LTBP4;ENG;SMAD7;SMAD2
prerank,cellular biogenic amine metabolic process (GO:0006576),0.6114789655868538,1.311369221609391,0.17766497461928935,0.5734276678996129,1.0,4/12,11.17%,AMD1;ATP7A;MAOA;SMS
prerank,cardiac epithelial to mesenchymal transition (GO:0060317),0.5580355852800039,1.310948271239031,0.1554160125588697,0.5737318516128808,1.0,8/20,8.76%,ENG;ACVRL1;NOTCH1;HEY1;TGFB2;HEY2;PDCD4;SNAI2
prerank,negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.42701421703283404,1.3106259013896586,0.09851088201603665,0.5737620852542348,1.0,17/116,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,positive regulation of cytokine production involved in inflammatory response (GO:1900017),0.5713382581545513,1.3103829300993524,0.17041800643086816,0.5735436906873796,1.0,2/15,1.72%,GBP5;NOD2
prerank,peptidyl-tyrosine modification (GO:0018212),0.46202828422615266,1.310084587661535,0.11883691529709228,0.5734658215919154,1.0,9/56,5.43%,TEK;FLT1;PDGFB;FYN;FLT4;INSR;FES;TTL;FGFR3
prerank,outer dynein arm assembly (GO:0036158),-0.5104946614652912,-1.3100448253250285,0.14594594594594595,0.6322320093771433,1.0,11/14,41.47%,DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;ODAD3;ODAD4;DNAH17;DNAAF4;CCDC63;DNAH8
prerank,positive regulation of establishment of protein localization (GO:1904951),0.5609106787214072,1.3096103864333102,0.15359477124183007,0.5739333475116268,1.0,11/18,25.82%,CCT8;CEP135;DKC1;CCT2;CCT4;CCT6A;CEP120;TCP1;CCT3;WRAP53;PTP4A3
prerank,protein targeting to ER (GO:0045047),0.4361439323172482,1.3093609846814418,0.10684273709483794,0.5737411621470707,1.0,51/99,28.18%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SGTB;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;ZFAND2A;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;SGTA;RPL3;SPCS2;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;CHMP4A;CHMP4B;RPS13;RPL11;RPL14
prerank,neuron remodeling (GO:0016322),0.6353903042271172,1.3089137037352387,0.17957166392092258,0.5741455070656126,1.0,2/10,2.98%,RND1;APP
prerank,regulation of autophagosome maturation (GO:1901096),0.6106403303967546,1.3087949620024792,0.1625207296849088,0.5736410820892205,1.0,6/13,17.71%,ADRB2;SMCR8;IRGM;FYCO1;RUBCN;UBQLN4
prerank,positive regulation of DNA biosynthetic process (GO:2000573),0.46037676611600603,1.307906244089787,0.13793103448275862,0.5751805432348633,1.0,19/60,15.37%,PDGFB;HMBOX1;KLF4;MAPK1;NVL;CCT8;NEK7;DKC1;PTGES3;TNKS;POLG2;CCT2;PRKD2;FBXO4;CCT4;ATM;CTNNB1;CCT6A;RFC2
prerank,regulation of osteoblast differentiation (GO:0045667),-0.33783908252538647,-1.307869952051996,0.03428571428571429,0.6364754264876572,1.0,22/82,11.10%,RANBP3L;BMP6;IGF1;BMPR1A;SMOC1;FGFR2;WNT4;BMP7;DDX5;BMP4;TMEM64;LIMD1;FBN2;RUNX2;NOCT;IL6R;ATP6AP1;PRKACA;PTCH1;PPARG;REST;IFITM1
prerank,SNARE complex assembly (GO:0035493),0.6227215125624603,1.3077576049478934,0.18461538461538463,0.5747386928091098,1.0,2/10,7.40%,STXBP6;VAMP8
prerank,regulation of macrophage migration (GO:1905521),0.6375933550339058,1.3076802405520724,0.18030050083472454,0.5740554985573896,1.0,7/10,24.93%,MTUS1;CD200;CX3CR1;CD200R1;P2RY12;EMILIN1;CSF1
prerank,response to interleukin-4 (GO:0070670),0.62660475277342,1.3071720271479017,0.1760797342192691,0.5746288423445726,1.0,2/10,6.03%,LEF1;GATA3
prerank,primary alcohol metabolic process (GO:0034308),-0.43869813594304463,-1.3064446216984724,0.13504823151125403,0.6379295534931119,1.0,5/25,9.47%,IGF1;RBP4;NAPEPLD;NAAA;DHRS3
prerank,actin polymerization or depolymerization (GO:0008154),-0.3710596994177945,-1.3063706382723403,0.0761904761904762,0.6353312636312829,1.0,11/50,8.28%,ARHGAP6;MICAL3;GAS7;GSN;MICAL2;COBL;WASF1;SVIL;WASHC3;PREX1;VILL
prerank,positive regulation of intracellular signal transduction (GO:1902533),0.392325636163861,1.3062530208430865,0.011066398390342052,0.576295875633328,1.0,75/509,11.23%,PTPRJ;PLCG2;CDH13;TEK;PDGFD;ENG;RAPGEF2;HIP1;FLT1;PDGFB;FYN;TRIM14;FLT4;VWF;KITLG;TBX1;NOD1;JCAD;NOD2;INSR;DAB2IP;CAV1;PRKD1;CASP8;CAV2;F2RL1;TGFB2;CBL;ADRB2;LGALS9;FKBP1A;APP;IQGAP1;ACTN4;TLR3;NOS1AP;TIRAP;ATP2C1;PUM2;ANGPT1;GCNT2;TRIM6;TNFSF10;PLEKHG5;FGFR3;IAPP;BCAR3;GATA3;SMCR8;PDCD4;JMJD8;BBC3;MFHAS1;WDR59;BCL2L1;THPO;JAK2;NMI;GAPDH;ROCK1;NDFIP2;PTK2;RTN4;HMGB1;TRIM25;RRAGD;CCL4;RPL37;LURAP1;CHD5;CASP1;RAC1;TAB2;MAP3K3;LAPTM5
prerank,regulation of cell-cell adhesion mediated by cadherin (GO:2000047),0.5522648375489567,1.305430897070337,0.17619783616692428,0.5777001545350922,1.0,6/19,9.89%,NOTCH4;NOTCH1;PPM1F;PTPRU;TJP1;MAD2L2
prerank,positive regulation of transforming growth factor beta production (GO:0071636),0.6168490087105001,1.3050475442519704,0.20903010033444816,0.5779104893468001,1.0,4/11,8.02%,GATA6;LGALS9;CD34;CD200
prerank,regulation of cytoplasmic translation (GO:2000765),-0.5141817015971293,-1.3050250761910562,0.13636363636363635,0.6367607701643555,1.0,5/14,13.86%,CPEB1;UNK;YBX3;CPEB2;CPEB3
prerank,cellular response to low-density lipoprotein particle stimulus (GO:0071404),0.6017576420841677,1.3046881968042514,0.17398373983739837,0.5780433680319627,1.0,1/13,0.16%,CDH13
prerank,poly-N-acetyllactosamine metabolic process (GO:0030309),-0.5128843776980114,-1.3043351518821533,0.16414141414141414,0.6361187325718771,1.0,2/13,3.22%,B3GALT1;B3GNT2
prerank,regulation of intracellular signal transduction (GO:1902531),0.39140677876890595,1.3042534222800273,0.016210739614994935,0.5784444185639708,1.0,63/420,10.68%,PLCG2;RASGRF2;SGMS1;NUAK1;ARHGEF3;TEK;PIP5K1B;ARHGAP31;KALRN;CEACAM1;VWF;PLK3;CHN2;FBXL2;CASTOR1;ARHGEF2;DAB2IP;ABR;F2RL1;RHOB;TRIO;BOP1;CRK;PPP1R13B;RBBP8;ARAP3;BCR;ING2;RRAS;ARHGAP8;MAP4K4;TRIM6;AKAP5;PPP1R16B;PLEKHG5;TRAF1;TAF9B;GPR143;SRGAP1;PIP5K1C;MAPK1;PAK1IP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;LRRK2;ARHGAP25;CMKLR1;HSPB1;PRKAA1;WWC2;INPP5B;SLC15A4;PPP2R5C;SGK1;TAOK2;ARHGEF1;DIPK2A;BRIP1;MINK1;NFKBIA;RAC1
prerank,regulation of insulin receptor signaling pathway (GO:0046626),-0.3883627477862398,-1.303628433122486,0.11494252873563218,0.6355493359459302,1.0,11/43,9.76%,PID1;OGT;SORBS1;PRKCB;NUCKS1;GRB10;ENPP1;IRS1;PIP4K2A;IGF2;PRKCZ
prerank,cartilage development (GO:0051216),-0.3778045253223964,-1.3033147627751063,0.08641975308641975,0.6337491764480089,1.0,17/49,13.29%,SOX5;SULF1;SULF2;BMP4;OSR1;SLC39A14;TRIP11;RUNX2;ITGB8;FGF2;RUNX1;CCN3;GPLD1;HYAL1;PKD1;NFIB;HMGA2
prerank,negative regulation of response to cytokine stimulus (GO:0060761),0.6342770779129301,1.3029536563742992,0.18537414965986396,0.581047114594599,1.0,2/10,3.83%,APOA1;KLF4
prerank,regulation of establishment of endothelial barrier (GO:1903140),0.5652714667109817,1.3028329856869516,0.14645669291338584,0.5804980578981158,1.0,4/17,9.04%,CLDN5;F11R;PROC;ROCK1
prerank,carbohydrate derivative catabolic process (GO:1901136),0.5632695770890591,1.302797757484738,0.17993630573248406,0.5797493148011273,1.0,8/18,19.34%,AOAH;MANBA;BPGM;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,positive regulation of phospholipase activity (GO:0010518),-0.4537136158392468,-1.302739267781245,0.13354037267080746,0.6329412815165099,1.0,6/22,5.54%,NTRK3;PDGFRB;FGFR2;PDGFRA;KIT;FGF2
prerank,low-density lipoprotein receptor particle metabolic process (GO:0032799),0.6395695422833565,1.30222765558515,0.19322033898305085,0.5795474636963698,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,low-density lipoprotein particle receptor catabolic process (GO:0032802),0.6395695422833565,1.30222765558515,0.19322033898305085,0.5795474636963698,1.0,3/10,13.89%,AP2B1;AP2M1;VLDLR
prerank,regulation of systemic arterial blood pressure (GO:0003073),0.5774238502978757,1.3019326573658667,0.18856259659969088,0.5795274302300004,1.0,2/16,1.04%,BMPR2;ACE
prerank,negative regulation of chemotaxis (GO:0050922),0.5073477720956974,1.3015815183613868,0.15796897038081806,0.5796827401315896,1.0,6/31,8.34%,SEMA3G;NOTCH1;SEMA3F;SEMA7A;DUSP3;SEMA6D
prerank,response to alcohol (GO:0097305),-0.4229363504382631,-1.3014090080072502,0.1320754716981132,0.6342428456086134,1.0,3/27,1.90%,TGFBR3;TGFBR1;SLIT2
prerank,cellular response to epidermal growth factor stimulus (GO:0071364),0.5298839030265444,1.3012589316306022,0.164804469273743,0.5797763413994322,1.0,12/26,15.85%,DAB2IP;IQGAP1;INPP5K;DUSP3;PTPN12;PDE8A;SYAP1;SNAI2;ZFP36L2;PLCG1;DUSP22;VIL1
prerank,ventricular cardiac muscle tissue morphogenesis (GO:0055010),0.5154250534541243,1.3012406068625535,0.15021459227467812,0.5789870248997314,1.0,7/31,2.96%,ENG;SMAD7;MYBPC3;NOTCH1;TGFB2;FKBP1A;DLL4
prerank,glucosamine-containing compound metabolic process (GO:1901071),-0.5200203010820847,-1.3010701074037245,0.15594059405940594,0.6326278347937987,1.0,6/13,16.04%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;PGM3
prerank,presynapse organization (GO:0099172),-0.5553149388193749,-1.3005672925037388,0.17772511848341233,0.6315148639493348,1.0,2/10,4.01%,WNT5A;NLGN2
prerank,peptidyl-threonine phosphorylation (GO:0018107),0.45773118525595696,1.3003407188463567,0.14540816326530612,0.5805445087756175,1.0,18/59,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;MARK2;TTBK1
prerank,regulation of platelet activation (GO:0010543),0.5398452009842349,1.2994294968928353,0.16113744075829384,0.5822674540510995,1.0,2/21,0.88%,NOS3;PDGFB
prerank,regulation of cytokine production (GO:0001817),0.4182451989321251,1.2992975198116634,0.08286038592508513,0.58183762707892,1.0,19/126,10.87%,AFAP1L2;RPS6KA5;CRTAM;CASP8;IFIH1;LGALS9;CADM1;HDAC9;FCGR2B;TNFRSF1B;GATA3;BCL6B;IL1A;CD47;SNAI2;GAPDH;FOXP1;LURAP1;POLA1
prerank,regulation of amyloid fibril formation (GO:1905906),0.5752945605016333,1.2990825435454834,0.1723027375201288,0.5816190162006185,1.0,6/15,11.83%,APP;IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,negative regulation of lipid metabolic process (GO:0045833),0.5359270087932935,1.298684269679342,0.16380655226209048,0.5819332038887608,1.0,4/22,8.29%,CEACAM1;PDE3B;ALK;PRKAA1
prerank,regulation of generation of precursor metabolites and energy (GO:0043467),0.480009543425684,1.2986628840387953,0.1327319587628866,0.5811504493648664,1.0,11/48,15.93%,PRDM16;JMJD8;NUP54;NUP35;RANBP2;NUP153;NUP160;HIF1A;NUP42;EIF6;NUP205
prerank,nucleus organization (GO:0006997),0.4762541260946461,1.2980662844918305,0.1287001287001287,0.5819878605075068,1.0,25/47,27.34%,SYNE1;IRAG2;SUN3;CHMP1B;NUP54;NUP35;NUMA1;REEP3;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;NUP205;RPS19;SUN1;CHMP1A;LEMD3;ATXN7;SEH1L;CTDNEP1;TPR;VPS4B;CHMP4A;CHMP4B
prerank,SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.43627601537955124,1.2972922660623167,0.12363636363636364,0.5832289627285941,1.0,39/87,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.498827159207786,1.2961019427009968,0.14738292011019283,0.5857649879703173,1.0,8/32,9.92%,STMN2;ARHGEF2;FKBP4;TTBK2;CAMSAP2;CLASP1;APC;CLASP2
prerank,Golgi ribbon formation (GO:0090161),-0.5124405921648836,-1.2959830669228136,0.1791044776119403,0.643095764961168,1.0,6/13,17.88%,TRIP11;GOLGA2;GCC2;OPTN;STX16;FHDC1
prerank,positive regulation of ossification (GO:0045778),-0.39278514715708973,-1.295924720464976,0.1411764705882353,0.640556454899186,1.0,10/39,3.64%,PTN;BMP6;BMPR1A;WNT4;ADGRV1;BMP7;BMP4;OSR1;WNT5A;FBN2
prerank,regulation of extracellular matrix disassembly (GO:0010715),-0.5002470702285307,-1.295686575365643,0.1466992665036675,0.638621925225815,1.0,4/15,5.79%,LRP1;PDPN;DPP4;FAP
prerank,cellular response to fatty acid (GO:0071398),-0.540849268340871,-1.2956195046429846,0.17048346055979643,0.6362111961783101,1.0,7/12,25.28%,PID1;IRS1;PDK3;LPL;NR1H4;DGAT2;PDK4
prerank,negative regulation of protein kinase B signaling (GO:0051898),0.48623045267399095,1.295332787961694,0.14814814814814814,0.5869182505726337,1.0,4/38,5.48%,PTPRJ;INPP5K;HYAL2;PLEKHA1
prerank,positive regulation of cell cycle (GO:0045787),0.4603494393839081,1.2953150881485438,0.14360313315926893,0.5861440177923186,1.0,11/62,7.56%,PDGFB;CCNY;CCND2;CCND3;TAL1;TGFB2;APP;TTL;ADAM17;DUSP3;MAPRE3
prerank,cellular amino acid catabolic process (GO:0009063),0.43567398666228657,1.295215534224063,0.12753277711561384,0.5855695645749356,1.0,8/87,7.36%,NOS1;NOS3;BCAT2;GLS2;GLS;ARG1;GLUD1;HGD
prerank,chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.41530578782497496,-1.2948513582890542,0.13522012578616352,0.6356770983092874,1.0,9/27,12.27%,DCN;CHST15;BGN;PXYLP1;XYLT1;VCAN;B3GAT3;CHPF2;CSPG4
prerank,regulation of viral entry into host cell (GO:0046596),0.5105107024646011,1.2946748054410864,0.15236686390532544,0.5862006317947265,1.0,7/30,11.57%,TRIM14;LY6E;LGALS9;TRIM11;TRIM6;TRIM25;HS3ST5
prerank,positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.4092864517103143,1.2930696032354683,0.07888888888888888,0.5896855136240065,1.0,25/151,10.16%,TEK;PDGFD;RAPGEF2;PDGFB;FLT4;CCR1;NOTCH1;NOD2;F2RL1;LGALS9;APP;TIRAP;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4
prerank,positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),-0.5321939252186183,-1.292890318792956,0.16080402010050251,0.6389573784845747,1.0,6/12,22.67%,SMO;SIX1;VEGFA;PAX2;AGT;SIX4
prerank,negative regulation of inflammatory response (GO:0050728),0.4050231036941371,1.292789842630705,0.07905982905982906,0.589620361137789,1.0,29/182,11.41%,PLCG2;TEK;FYN;AOAH;ADRB2;APOA1;GPR39;KLF4;HRH2;IAPP;FURIN;TNFRSF1B;GATA3;FCGR1A;MYH9;ADAM17;CD247;MFHAS1;MC4R;CD200;PROC;NR1D1;ACOD1;YES1;LPCAT3;ADCY4;PLCG1;GLP1R;VPS35
prerank,anion transport (GO:0006820),-0.40197076665150644,-1.2926274239622018,0.12371134020618557,0.6371290285743604,1.0,9/33,8.43%,SLC13A4;SLC13A3;SLC26A7;SLCO2B1;SLC17A5;SLC22A6;SLC19A1;LRRC8D;SLC4A2
prerank,regulation of ERBB signaling pathway (GO:1901184),0.5849145365951193,1.2922395917532887,0.18284789644012944,0.5902715557548406,1.0,2/15,0.80%,CDH13;CEACAM1
prerank,vesicle organization (GO:0016050),0.47289310805793455,1.2921815258878644,0.1553784860557769,0.5895787553247368,1.0,16/46,20.35%,ALS2CL;CAV1;CAV2;CD34;FNBP1L;SNX10;HOOK1;EXOC8;SNX11;CHMP2B;ZFYVE16;SRGN;PHETA1;HOOK2;SORT1;EPS15
prerank,regulation of inflammatory response to antigenic stimulus (GO:0002861),0.42243117041513395,1.2920943933202218,0.0956221198156682,0.5890071584830948,1.0,17/117,11.03%,PLCG2;FYN;ADRB2;GPR39;HRH2;KARS1;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;YES1;ADCY4;PLCG1;GLP1R
prerank,odontogenesis (GO:0042476),-0.408076164904996,-1.292084197307859,0.10424710424710425,0.6360896706911606,1.0,7/35,2.71%,COL1A2;GLI2;FGFR2;EDA;BMP4;OSR1;WNT6
prerank,positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.5733114928691966,1.2920285274603556,0.2025518341307815,0.588374776805824,1.0,11/15,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;TCP1;CCT3;RUVBL1;RUVBL2
prerank,negative regulation of transcription regulatory region DNA binding (GO:2000678),0.6047626067453022,1.291547567307957,0.18151815181518152,0.5888414308616334,1.0,6/13,18.99%,HEY1;HEY2;MAD2L2;TMSB4X;SIN3A;SOX11
prerank,actomyosin structure organization (GO:0031032),0.4378518077962038,1.2913966081259776,0.1273176761433869,0.5884429167890551,1.0,16/75,9.21%,EPB41L4A;FRMD3;F11R;ZYX;CDC42BPA;FLII;CDC42BPG;EPB41;CSRP2;MYH9;CUL3;WDR1;ARRB1;CASQ1;ROCK1;TJP1
prerank,cellular response to estrogen stimulus (GO:0071391),0.5756742288142375,1.2911858149128341,0.20729684908789386,0.5881768183247343,1.0,7/14,19.36%,PELP1;TRIM24;NCOA4;ARID5A;SFR1;RARA;WBP2
prerank,regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),-0.4780551612408259,-1.2910460366703087,0.16224188790560473,0.6364423677267326,1.0,3/18,2.18%,EGFR;DDX5;BMP4
prerank,positive regulation of reactive oxygen species metabolic process (GO:2000379),0.4671287795830859,1.2906079178518992,0.16216216216216217,0.5888405998729912,1.0,9/47,11.05%,PLCG2;PDGFB;F2RL1;ZC3H12A;ITGAM;ACOD1;TYROBP;ADGRB1;CYBA
prerank,positive regulation of DNA-binding transcription factor activity (GO:0051091),0.39804238931484476,1.290506755159953,0.058394160583941604,0.588286055279308,1.0,42/234,12.80%,PLCG2;EDN1;TRIM14;RPS6KA5;NOD1;NEUROG2;NOD2;ARHGEF2;AIM2;CAV1;PRKD1;LGALS9;APP;ANXA3;TIRAP;TRIM6;TRAF1;IRAK2;ALK;FANK1;IL1RAP;MBTPS2;HSPA1B;CD200;UBA52;RPS27A;TCF3;DHX9;TRIM25;NFKBIB;RHEBL1;NFKBIA;TAB2;CRTC1;NPM1;CLU;PRKD2;ARID5B;TRIM8;BTK;CX3CR1;RTKN2
prerank,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.5027414092050797,1.2903746192296803,0.16170212765957448,0.5878230337721948,1.0,8/28,19.18%,ATP2A3;DAB2IP;BBC3;BAG6;TRIB3;SELENOK;DNAJC10;ERN1
prerank,defense response to bacterium (GO:0042742),0.4269891482955819,1.2903608180126114,0.1061130334486736,0.5870411679509487,1.0,29/105,21.23%,NOD1;NOD2;GBP4;ANXA3;TLR3;TIRAP;DEFA6;ADAM17;IRGM;GALP;OAS2;ADGRB1;GBP2;CHGA;RPL30;RNASE6;LYST;HMGB2;SLPI;DROSHA;STAB2;PYCARD;GBP7;EPX;ANG;ANKRD17;RPL39;STAB1;RPS19
prerank,pigment granule transport (GO:0051904),0.5496132403438906,1.2901304968699188,0.1858267716535433,0.5860089859148422,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,melanosome transport (GO:0032402),0.5496132403438906,1.2901304968699188,0.1858267716535433,0.5860089859148422,1.0,4/18,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,dendritic cell chemotaxis (GO:0002407),0.5767890393663452,1.2898754428213366,0.18790849673202614,0.5859180027412918,1.0,4/14,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,anion transmembrane transport (GO:0098656),-0.34739248615927637,-1.289638272061374,0.05851063829787234,0.6383945517655975,1.0,14/67,8.37%,SLC1A3;SLC6A13;SLC16A12;SLC7A2;SLC13A4;SLC13A3;SLC25A13;SLC25A4;SFXN2;SLC39A8;SLC19A1;SLC6A9;LRRC8D;SLC27A1
prerank,regulation of lipoprotein lipase activity (GO:0051004),0.5745114467611929,1.2884392094485968,0.18615384615384614,0.5890513951419603,1.0,4/17,5.65%,HDAC9;APOA1;PCSK5;FURIN
prerank,embryonic cranial skeleton morphogenesis (GO:0048701),-0.49682095596945874,-1.288263965720604,0.14690721649484537,0.6401231130165868,1.0,6/15,8.15%,FGFR2;PDGFRA;TGFBR1;NIPBL;SIX1;MTHFD1
prerank,oligosaccharide metabolic process (GO:0009311),0.470746688837818,1.2881212445423575,0.1608108108108108,0.5891001014983132,1.0,5/46,5.90%,ST6GALNAC3;ST8SIA6;ST3GAL6;MANBA;ST6GAL2
prerank,regulation of JUN kinase activity (GO:0043506),0.491026788884128,1.2878959282560396,0.17630057803468208,0.5888980252195579,1.0,5/33,10.36%,EDN1;DAB2IP;PDCD4;MAP3K11;AIDA
prerank,catecholamine biosynthetic process (GO:0042423),0.622700929412294,1.2876387868167936,0.1964573268921095,0.5888021876675933,1.0,3/11,6.03%,TGFB2;GCH1;GATA3
prerank,microtubule polymerization or depolymerization (GO:0031109),0.5231471377260827,1.2875432429867337,0.18518518518518517,0.5882372393750683,1.0,5/24,13.37%,TRPV4;STMN2;KIF2A;PIN1;KIF24
prerank,positive regulation of cellular response to insulin stimulus (GO:1900078),-0.5110595848052659,-1.2873611758319208,0.18961038961038962,0.6401077134104323,1.0,7/13,19.56%,SORBS1;IRS1;IGF2;PRKCZ;ECHDC3;SNX5;ZBTB7B
prerank,protein catabolic process (GO:0030163),0.4546007521522344,1.2863441663985622,0.13814955640050697,0.5905943927797285,1.0,18/59,19.79%,CEACAM1;DENND3;DAB2IP;PPT1;MANBA;TRIM24;SOCS6;NR1D1;SIAH2;BAG6;PSMA8;FBXO2;OGA;FBXO6;LAMP2;NGLY1;NEU4;RNF5
prerank,protein mannosylation (GO:0035268),-0.4399432109286961,-1.2857339858629313,0.13569321533923304,0.6425700841849922,1.0,4/22,3.45%,TMTC4;TMTC1;LARGE1;CRPPA
prerank,cardiac right ventricle morphogenesis (GO:0003215),0.6103866305737833,1.285533779194919,0.2054794520547945,0.5920006148322622,1.0,4/11,6.03%,JAG1;TGFB2;HEY2;GATA3
prerank,regulation of monooxygenase activity (GO:0032768),0.5299269194025037,1.2849665124859697,0.17541229385307347,0.5927253324941227,1.0,4/23,6.22%,NOS3;CAV1;NOS1AP;IL1A
prerank,positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),0.4951802621609884,1.2848184844469968,0.16101694915254236,0.5923542357742859,1.0,9/33,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,triglyceride biosynthetic process (GO:0019432),-0.4667649194380862,-1.2844773164127563,0.1501416430594901,0.6436413610479408,1.0,5/18,9.81%,AGMO;LPGAT1;MOGAT3;GK;DGAT1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.5234224022767177,1.2844187148000816,0.1961367013372957,0.5926806608183972,1.0,7/24,13.57%,KLF2;NOTCH1;MBTPS2;NFE2L2;CHD6;GCN1;HIF1A
prerank,negative regulation of toll-like receptor signaling pathway (GO:0034122),0.496060889999154,1.2842596309862742,0.15804195804195803,0.5923340482893573,1.0,9/34,9.05%,DAB2IP;F2RL1;TLR3;NFKBIL1;MFHAS1;GRAMD4;NR1D1;ACOD1;CACTIN
prerank,synaptic vesicle membrane organization (GO:0048499),-0.4719347568923654,-1.2828625915654772,0.16666666666666666,0.6460777501863405,1.0,10/17,27.89%,STX4;SNAP23;SNAP25;STX3;SNAP47;SNAP29;TOR1A;STX2;STX1A;SYNGR1
prerank,regulation of steroid metabolic process (GO:0019218),-0.43606670570424433,-1.2821262781315974,0.15030674846625766,0.6459428842304794,1.0,10/23,28.73%,APOE;RORA;EPHX2;STUB1;PANK2;ACADVL;NR1H4;STAR;ABCG1;ARV1
prerank,negative regulation of leukocyte apoptotic process (GO:2000107),0.6078613825700474,1.281977963367477,0.20938023450586266,0.5977571764368546,1.0,2/11,1.72%,MERTK;NOD2
prerank,carbohydrate derivative biosynthetic process (GO:1901137),0.5218980008871775,1.2818620131677574,0.1951219512195122,0.5972370422391179,1.0,2/26,0.49%,GCNT1;ST8SIA6
prerank,regulation of chemokine production (GO:0032642),0.4942552988891373,1.2813928167736595,0.16828929068150209,0.5977594862901892,1.0,13/36,20.88%,F2RL1;LGALS9;APP;TLR3;ADAM17;SNAI2;FOXP1;EGR1;HIF1A;PYCARD;AGER;SIGIRR;EIF2AK2
prerank,regulation of lamellipodium morphogenesis (GO:2000392),-0.523437858551407,-1.2811995057192833,0.19796954314720813,0.6461268134133391,1.0,5/11,18.19%,PDPN;RREB1;SRC;ARPIN;ENPP2
prerank,regulation of mitochondrial fusion (GO:0010635),-0.5480458706767244,-1.28052286938952,0.18615751789976134,0.645565761442117,1.0,2/11,4.31%,PID1;PRKN
prerank,calcium ion transport into cytosol (GO:0060402),0.5386136418359208,1.2791360213499376,0.19718309859154928,0.6029615093593815,1.0,7/21,11.28%,TRPV4;ITPR3;ATP2B4;SLC8A1;GRIN2B;GRIN2C;TRPM2
prerank,negative regulation of GTPase activity (GO:0034260),0.5241121683708169,1.278379406757761,0.2074074074074074,0.6042792394750784,1.0,5/22,7.14%,F11R;DAB2IP;LRCH1;SH3BP4;LRRK2
prerank,regulation of small GTPase mediated signal transduction (GO:0051056),0.40580960108147013,1.2776941054820614,0.08879023307436182,0.6053406670541915,1.0,20/140,7.24%,RASGRF2;ARHGEF3;CD2AP;ARHGAP31;KALRN;CHN2;ARHGEF2;ABR;RHOB;TRIO;ARAP3;BCR;ARHGAP8;PLEKHG5;SRGAP1;ARHGDIA;TIAM2;MCF2L;ARHGAP5;ARHGAP25
prerank,positive regulation of calcium ion transport (GO:0051928),0.48410893189361576,1.2775630894418752,0.17056396148555708,0.6048765880408913,1.0,9/36,10.16%,PDGFB;CCR1;MYLK;CAV1;ORAI1;STIM2;P2RX7;CRACR2A;CCL4
prerank,ethanol metabolic process (GO:0006067),-0.5242799346922871,-1.2774682788565728,0.18205128205128204,0.6521076397139502,1.0,1/12,0.24%,ALDH1A1
prerank,calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),0.5951585473983224,1.277381745523079,0.19966442953020133,0.6045649993114286,1.0,3/12,3.73%,UNC13B;DOC2B;SYT7
prerank,negative regulation of cell population proliferation (GO:0008285),0.38551079531466625,1.2770385339617585,0.03842264914054601,0.6046638233185954,1.0,44/351,9.03%,PTPRJ;CDH13;NOS3;IRF6;GATA6;RAPGEF2;GATA2;SMAD6;BMPR2;SMARCA2;PTPN14;FOXO4;ITGA1;ACVRL1;NOTCH1;B2M;ADARB1;DAB2IP;AQP11;TGFB2;HNF4A;BTG2;DLL4;APP;BTG1;PLPP1;KLF4;GATA3;WARS1;IL1A;SH3BP4;SLC16A2;IGFBP7;HSPA1B;CEBPA;PTPRU;CD200;JAK2;APC;NMI;MCC;KLF11;CTNNBIP1;PPP2R5C
prerank,negative regulation of oxidative stress-induced cell death (GO:1903202),0.5177998368208144,1.2767829030038602,0.18154761904761904,0.6045707782657482,1.0,6/26,8.27%,FYN;FBXO7;LRRK2;HSPB1;PDE8A;NFE2L2
prerank,regulation of interleukin-13 production (GO:0032656),0.5947435959240155,1.2763984291186636,0.20504201680672268,0.6048226794572348,1.0,3/13,6.03%,LGALS9;LEF1;GATA3
prerank,positive regulation of ion transport (GO:0043270),0.46520005442808504,1.2761312083432579,0.163659793814433,0.604783881254803,1.0,12/48,10.16%,CNKSR3;CCR1;MYLK;ANO6;ORAI1;STIM2;P2RX7;VAMP8;CRACR2A;VAMP7;SCN1B;CCL4
prerank,positive regulation of immune system process (GO:0002684),0.5753905559097735,1.2760532278787646,0.2078740157480315,0.604218693977283,1.0,3/16,3.46%,TGFB2;LGALS9;TNFRSF18
prerank,regulation of microtubule polymerization (GO:0031113),0.48103381072727025,1.275995645214552,0.16955941255006676,0.6035833765745828,1.0,12/40,15.30%,STMN2;OCLN;FES;CAMSAP2;PRUNE1;CLIP1;CLASP1;MAPRE3;RAC1;NUMA1;NAV3;MAP2
prerank,iron ion transmembrane transport (GO:0034755),-0.5448364065097216,-1.2752112499743904,0.18160377358490565,0.6566765438521751,1.0,3/10,4.83%,SLC39A14;SCARA5;SLC39A8
prerank,hematopoietic progenitor cell differentiation (GO:0002244),0.5052330186512859,1.2750397020389501,0.18032786885245902,0.6054537176675046,1.0,3/30,1.04%,FLT1;FLT4;ACE
prerank,plasma membrane repair (GO:0001778),0.58376208697519,1.274343274773571,0.1951219512195122,0.6065345180692367,1.0,4/13,10.34%,DYSF;SYT7;MYH9;MYOF
prerank,embryonic hemopoiesis (GO:0035162),0.6000293297273509,1.2742603509987909,0.20135363790186125,0.6059686619697275,1.0,3/12,7.98%,KITLG;TAL1;TPO
prerank,peptidyl-threonine modification (GO:0018210),0.4393271052899305,1.2732080226945646,0.1484771573604061,0.6079346115193596,1.0,19/66,12.61%,SBK1;PRKD1;OXSR1;CDC42BPA;CDC42BPG;ACVR1;CAMK2D;NLK;MAPK1;LRRK2;LMTK2;STK39;CAD;ROCK1;TNKS;PRKD2;GALNT4;MARK2;TTBK1
prerank,regulation of neuron death (GO:1901214),0.4293762443017173,1.2731485692841786,0.14199759326113118,0.6072864955102872,1.0,30/82,21.60%,FYN;SNCG;FCGR2B;LANCL1;MEF2C;CD34;TNFRSF1B;ITGAM;LRRK2;CD200;GRIN2B;EGR1;PRNP;RRAS2;TYROBP;DCC;VPS35;CLU;CHGA;TRIM2;SARM1;EIF2S1;DAXX;GRID2;NENF;GSK3B;CD200R1;SORL1;AKT1S1;UBB
prerank,regulation of cellular carbohydrate metabolic process (GO:0010675),-0.4868091408208601,-1.2727798715757215,0.16971279373368145,0.661119448805956,1.0,6/16,15.35%,PDK1;PRKN;RORA;FOXK2;PDK3;PDK2
prerank,regulation of steroid biosynthetic process (GO:0050810),-0.5323200293847294,-1.2704772135170546,0.19602977667493796,0.6658920383250484,1.0,2/11,1.60%,WNT4;BMP5
prerank,urogenital system development (GO:0001655),-0.5362329507859497,-1.269765129508282,0.1994949494949495,0.6656207449028295,1.0,5/11,20.48%,OSR1;ANXA1;EPHB2;EPHB3;PAX2
prerank,rRNA metabolic process (GO:0016072),0.4040653663416138,1.2690615597471926,0.09641255605381166,0.6175605437039168,1.0,68/160,26.74%,BOP1;PELP1;RPL27;DHX37;RPL7;TRIR;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;RPL21;DKC1;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;RPL30;XRN1;RPL27A;NOL8;RPL23A;RPS15;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,positive regulation of cytokine production (GO:0001819),0.3874789084158941,1.268974108088099,0.05894519131334023,0.6169844513217351,1.0,41/292,11.99%,PLCG2;AFAP1L2;PLCB1;FLT4;NOD1;CRTAM;GBP5;NOD2;PAEP;ARHGEF2;F2RL1;IFIH1;LRRFIP1;LGALS9;CADM1;APP;TLR3;TIRAP;TRIM6;HYAL2;DDX41;CD34;TMED10;GATA3;IL1A;ADAM17;HSPA1B;CD200;POLR3B;GAPDH;LTB;FOXP1;EGR1;HMGB1;DHX9;TYROBP;LURAP1;CYBA;LAPTM5;BRCA1;PRKD2
prerank,lipid modification (GO:0030258),0.48041820571244903,1.2688266810333448,0.16968011126564672,0.6165676900011466,1.0,9/37,15.81%,SGPP2;PLPP1;MBOAT2;DGKH;LPCAT3;PLPP6;PLPP4;DGKI;PLPPR1
prerank,negative regulation of ERK1 and ERK2 cascade (GO:0070373),0.4644248788134042,1.2685220154417647,0.15435356200527706,0.6165954525630781,1.0,13/46,18.13%,PTPRR;CNKSR3;DAB2IP;TIMP3;DUSP3;PTPN1;RANBP9;ITGB1BP1;PIN1;DUSP26;PTPN2;SEMA6A;SMAD4
prerank,regulation of ERK1 and ERK2 cascade (GO:0070372),0.3909927936617248,1.2679910277061521,0.07379679144385026,0.6172807361182928,1.0,34/214,10.95%,TEK;PDGFD;RAPGEF2;PTPRR;CEACAM1;PDGFB;CNKSR3;FLT4;CCR1;NOTCH1;NOD2;DAB2IP;F2RL1;LGALS9;APP;TIRAP;TIMP3;RRAS;ANGPT1;GCNT2;ARHGAP8;SEMA7A;FGFR3;DUSP3;MFHAS1;PDE8A;ARRB1;THPO;HTR2A;HMGB1;FBXW7;CCL4;PTPN1;RANBP9
prerank,O-glycan processing (GO:0016266),0.4564946600116402,1.2677448048954068,0.14640522875816994,0.6171556282595276,1.0,11/54,13.79%,GCNT1;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;B3GNT3;C1GALT1C1;XXYLT1;GALNT4;ST3GAL1
prerank,positive regulation of protein kinase B signaling (GO:0051897),0.4017297713838292,1.2674261583610793,0.09836065573770492,0.6172237511454973,1.0,17/150,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;ANGPT1;GCNT2;FGFR3;IAPP;GATA3;MFHAS1;THPO;PTK2;RTN4
prerank,autophagy of peroxisome (GO:0030242),0.5776145586178938,1.2671240249136941,0.20100502512562815,0.6172611372600326,1.0,4/12,13.96%,TRAPPC8;NBR1;PIK3C3;ATM
prerank,positive regulation of myeloid cell differentiation (GO:0045639),0.49550812026032276,1.2670556286387298,0.18828451882845187,0.6166416205960921,1.0,12/33,18.10%,TAL1;FES;STAT1;HSPA1B;THPO;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,negative regulation of hormone secretion (GO:0046888),-0.5393896985147917,-1.2670271695874677,0.20286396181384247,0.671665408497803,1.0,2/10,8.74%,GJA1;RAB11FIP1
prerank,negative regulation of TORC1 signaling (GO:1904262),0.5763951030569325,1.26686811024017,0.20707070707070707,0.6163377827405547,1.0,2/13,1.77%,SPAAR;CASTOR1
prerank,positive regulation of programmed cell death (GO:0043068),0.3873353966851466,1.2667801904053186,0.06444906444906445,0.6157674085331718,1.0,40/272,9.55%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;TRIO;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;LRRK2;GADD45G;UBA52;APC;RPS27A;KLF11;APH1A;JUN;HMGB1;MAP3K11
prerank,glycoprotein biosynthetic process (GO:0009101),0.4385736525111991,1.2657293835429557,0.13933415536374846,0.6178207520461725,1.0,11/79,8.01%,GCNT1;ST8SIA6;BMPR2;ST3GAL6;ST6GALNAC2;SERP2;ATP7A;GCNT2;CHST11;NUS1;B3GNT3
prerank,regulation of cell differentiation (GO:0045595),0.4008395940870786,1.265687869415598,0.1067853170189099,0.6171601744297596,1.0,28/148,13.00%,SLC6A6;LTBP4;NOTCH4;SMAD7;CASZ1;TBX1;HEY1;EMP2;FES;HEY2;KLF4;SPOCK2;MBOAT2;GATA3;BCL6B;CLASP1;ALK;APC;NR1D1;SNAI2;ROCK1;PTK2;CLASP2;RPS6KA1;MCRIP1;CBFB;RPS6KA3;YWHAH
prerank,regulation of response to interferon-gamma (GO:0060330),0.5817365439333322,1.2654291325946179,0.20766773162939298,0.6171037556769655,1.0,3/14,8.22%,IFNGR1;STAT1;JAK2
prerank,regulation of nitric-oxide synthase activity (GO:0050999),0.48637361374174953,1.2652500905404962,0.17597765363128492,0.616824988326313,1.0,7/36,7.60%,NOS3;ATP2B4;CAV1;GCH1;NOS1AP;IL1A;NUS1
prerank,ear morphogenesis (GO:0042471),-0.45332808653661827,-1.2652268474124129,0.16326530612244897,0.6749623449471749,1.0,5/20,7.10%,ZIC1;FGFR2;OSR1;NIPBL;SIX1
prerank,DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.3760281168665322,-1.2651221813041889,0.1274131274131274,0.6727705952433481,1.0,19/40,27.18%,NUCKS1;BOD1L1;FBH1;TIPIN;ATR;THOC1;RTEL1;DONSON;SMARCAL1;RFWD3;ATRX;TIMELESS;ZRANB3;MMS22L;EME2;SETMAR;RAD51;POLE;CENPX
prerank,negative regulation of signaling receptor activity (GO:2000272),-0.43106599993514244,-1.2650902088916507,0.15286624203821655,0.6703303723571286,1.0,8/25,12.33%,ERRFI1;CBLB;PPARA;SNX6;SLC6A9;TSG101;PPARG;CNRIP1
prerank,positive regulation of establishment of protein localization to telomere (GO:1904851),0.6157755620980025,1.2649150451398667,0.23498233215547704,0.6169413936225839,1.0,8/10,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,cyclooxygenase pathway (GO:0019371),-0.5282696209678595,-1.2647040539437473,0.1918158567774936,0.6690128719012065,1.0,3/10,6.50%,PTGDS;PTGES;PTGS1
prerank,sulfation (GO:0051923),-0.5270221787481342,-1.2646320286815762,0.17480719794344474,0.666652757163789,1.0,1/11,0.05%,UST
prerank,positive regulation of T-helper 1 type immune response (GO:0002827),-0.5135229685588557,-1.2644857041868598,0.19437939110070257,0.6645761787989549,1.0,1/12,1.29%,IL1R1
prerank,regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.43987628063399475,1.2638429809460838,0.17103620474406991,0.6191453717719805,1.0,16/67,13.12%,PODXL;RABGAP1;CAV1;PPP1R16B;TBC1D8;PLD1;IFT140;TBC1D5;TBC1D1;MYO10;RAC1;TRPM2;ATP8B1;FXR1;USP6NL;TBC1D10A
prerank,positive regulation of signaling receptor activity (GO:2000273),0.4890516237066449,1.2637525915614927,0.17304964539007092,0.6186237420659552,1.0,6/36,9.67%,EDN1;ADRB2;SHANK3;ADAM17;JAK2;FBXW7
prerank,unsaturated fatty acid metabolic process (GO:0033559),-0.3722025859314128,-1.2634525255127622,0.10144927536231885,0.6652574228823916,1.0,15/41,23.06%,ACSL1;PTGS1;PLA2G4A;SCP2;DEGS1;FADS3;SCD;GSTM2;FADS2;ELOVL1;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,regulation of cellular component movement (GO:0051270),-0.35867744279111624,-1.2633927216827285,0.11952191235059761,0.6629666506347989,1.0,14/49,12.81%,TGFBR3;EGFR;ROCK2;TGFBR1;PDPN;ARHGAP18;ARAP1;YTHDF1;MEMO1;VEGFA;RAF1;ERBB2;HDAC6;HBEGF
prerank,regulation of T cell differentiation in thymus (GO:0033081),-0.5041294727345054,-1.2632690686791441,0.209366391184573,0.6608945308139288,1.0,2/13,2.18%,GLI2;BMP4
prerank,regulation of potassium ion transmembrane transporter activity (GO:1901016),-0.4192699324702892,-1.2623814667207907,0.15901060070671377,0.6611191138299922,1.0,4/26,4.62%,ANK2;ACTN2;ATP1B3;FHL1
prerank,regulation of glycogen biosynthetic process (GO:0005979),-0.43577547927732674,-1.262059444936648,0.1550632911392405,0.6595765831998606,1.0,7/24,8.49%,IGF1;SORBS1;ENPP1;IRS2;IRS1;IGF2;PPP1R3B
prerank,cellular response to nerve growth factor stimulus (GO:1990090),0.5292852500181655,1.261915896586372,0.20060331825037708,0.6227464724805797,1.0,4/22,4.34%,STMN2;RAPGEF2;RAPGEF1;EHD1
prerank,positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),0.5466553422796709,1.2618452488887204,0.21752738654147105,0.6221509078777927,1.0,4/17,9.44%,NOD2;ARL6IP5;TGFB2;TAOK2
prerank,positive regulation of interleukin-2 production (GO:0032743),0.5186362876818751,1.26159693228242,0.19909502262443438,0.6219723006717153,1.0,1/25,0.08%,PLCG2
prerank,protein destabilization (GO:0031648),0.4976681154740919,1.261489283541069,0.19400855920114124,0.6214614601641539,1.0,6/32,9.97%,SOX17;CCDC88C;CUL3;IRGM;NR1D1;PRNP
prerank,histone H4-K16 acetylation (GO:0043984),-0.45911647249406395,-1.2614825504026699,0.18475073313782991,0.65892131682726,1.0,6/19,13.65%,OGT;KANSL2;PHF20;WDR5;MEAF6;MSL3
prerank,keratinocyte differentiation (GO:0030216),0.5138607206111179,1.2612570795820173,0.18914956011730205,0.6212802892773117,1.0,3/29,4.02%,JAG1;CLIC4;BCR
prerank,protein O-linked glycosylation (GO:0006493),0.4158352092999179,1.260959817098696,0.14521841794569068,0.6212947828703309,1.0,17/96,12.68%,EOGT;GCNT1;ST8SIA6;GALNT18;POMGNT1;ST6GALNAC2;GALNT5;GALNT15;GALNT7;POGLUT1;B3GNT3;DPM1;TET3;C1GALT1C1;XXYLT1;GALNT4;B3GALNT2
prerank,basement membrane organization (GO:0071711),-0.5024721742105785,-1.2606296014607425,0.20105820105820105,0.6594060881631603,1.0,3/14,2.97%,FLRT2;NID1;NID2
prerank,regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5065809738278482,1.2605258186496309,0.19313304721030042,0.6217030364564926,1.0,3/27,4.95%,NOS1;FKBP1A;CAMK2D
prerank,positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.436064526963323,1.2604248635480946,0.16502463054187191,0.6212029450369814,1.0,8/73,6.97%,NOS1;ATP2B4;CAV1;PRKD1;APP;TRIM6;BCAR3;IRGM
prerank,intraciliary retrograde transport (GO:0035721),-0.5152289196806629,-1.2604209361028842,0.1969309462915601,0.6577064303634672,1.0,8/12,22.14%,WDR35;DYNC2LI1;IFT43;DYNC2I2;TTC21B;WDR19;DYNC2H1;DYNC2I1
prerank,positive regulation of cardiac muscle tissue growth (GO:0055023),-0.47121692422667394,-1.260353601376792,0.16759776536312848,0.6555260795451062,1.0,7/16,5.54%,TGFBR3;IGF1;BMPR1A;FGFR2;ZFPM2;RBPJ;FGF2
prerank,mesenchyme development (GO:0060485),-0.48406903107128474,-1.2603103813415526,0.14430379746835442,0.6532773110438143,1.0,4/15,2.18%,FGFR2;TGFBR1;BMP7;BMP4
prerank,positive regulation of nucleic acid-templated transcription (GO:1903508),0.3776837093776839,1.2598674660582232,0.03229061553985873,0.6219952839185099,1.0,80/476,14.61%,PRDM16;NOS1;MECOM;SOX17;NOTCH4;AFAP1L2;IRF6;GATA6;PLCB1;PDGFB;KLF2;SMARCA2;CASZ1;TBX1;ACVRL1;NOTCH1;FOXO1;HEY1;TAL1;HNF1A;HNF4A;KLF6;SOX18;HHEX;FLI1;INPP5K;HEY2;KLF4;ACVR1;ING2;LEF1;KARS1;FOXF2;MEF2C;SMAD2;ZBTB48;GATA3;RYBP;ZBTB16;FANK1;KDM3A;STAT1;MAPRE3;EBF3;DNAJC2;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;SEC14L2;MAD2L2;RPS6KA1;SFR1;DEAF1;RAI1;NPM1;BRCA1;CD38;ILF2;DTX3L;SOX10;HINFP;MED30;SETD3;ELF2;YWHAH;PHIP;HIF1A;NFATC1;LRP5;SMARCC1;CTNNB1;MED17;MLLT3;MED4;HMGB2;PSMC5
prerank,positive regulation of protein binding (GO:0032092),0.4441304149666896,1.2597108498735676,0.1581569115815691,0.6216061445193459,1.0,15/56,14.97%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;EPB41;LRRK2;NVL;MARK3;DTX3L;PIN1;RAN;PPP2CB
prerank,regulation of establishment of protein localization to telomere (GO:0070203),0.6024166522551195,1.2594416372261306,0.24083769633507854,0.6215567715937005,1.0,8/11,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,regulation of Ras protein signal transduction (GO:0046578),0.4247549061779827,1.2589028460780063,0.1609870740305523,0.622250069389921,1.0,12/85,6.72%,EPS8L2;ARHGEF28;DENND3;NOTCH1;RAPGEF1;ARHGEF2;DAB2IP;TGFB2;BCR;ARHGDIA;MADD;SHOC2
prerank,positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5230084903642985,1.2579909449165705,0.2005856515373353,0.6240107971220603,1.0,4/21,11.99%,KCNN4;FOXP1;STAP1;PRKD2
prerank,negative regulation of protein localization to cell periphery (GO:1904376),-0.4564179524270584,-1.2579168152373261,0.16310160427807488,0.6582228620659979,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,negative regulation of small GTPase mediated signal transduction (GO:0051058),0.5344642467810474,1.2573178043104707,0.19407407407407407,0.6250611711382777,1.0,4/21,7.24%,CD2AP;DAB2IP;TGFB2;ARHGAP25
prerank,positive regulation of telomere maintenance via telomerase (GO:0032212),0.4889877589634301,1.256794893591461,0.1844380403458213,0.6257808303858434,1.0,11/32,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,inositol phosphate biosynthetic process (GO:0032958),0.604316638880616,1.256532399321455,0.21465076660988075,0.6256982128507971,1.0,3/11,3.53%,ITPKB;IP6K3;IPPK
prerank,negative regulation of fatty acid biosynthetic process (GO:0045717),0.5937404793590935,1.2564528426365502,0.22585924713584288,0.625121768939091,1.0,4/12,17.27%,CEACAM1;BRCA1;ERLIN2;TRIB3
prerank,regulation of calcium ion-dependent exocytosis (GO:0017158),0.4922883049944012,1.255771349957858,0.18129496402877698,0.6261897769653415,1.0,3/31,3.73%,SYT15;DOC2B;SYT7
prerank,regulation of mitotic cell cycle (GO:0007346),0.39741722836178967,1.2554316983720721,0.10303687635574837,0.6263079111232739,1.0,41/171,16.08%,AFAP1L2;TAL1;TTC28;CAV2;BTG2;APP;IQGAP1;BTG1;RPRM;TTL;PSMD13;ASAH2;CDC25C;UBE2D1;PSMD4;DUSP3;PIM3;NEK7;PSMA5;PSMB10;PSMB8;ANGEL2;PSMD14;NEK11;RPS6KB1;PSMA7;PSMC3;PIN1;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;BTG3;PSMB9;PKN2;ANAPC7;PSMC6;MEIS2
prerank,N-terminal protein amino acid acetylation (GO:0006474),-0.47736422457021466,-1.254853943096739,0.21052631578947367,0.6649548663559667,1.0,7/16,25.40%,CREBBP;KAT2B;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,cellular response to transforming growth factor beta stimulus (GO:0071560),0.40936410120452255,1.2545187393674604,0.12075029308323564,0.6281246806957121,1.0,24/112,9.31%,ENG;CLDN5;SMAD6;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;ACVR1;GCNT2;NLK;MEF2C;HYAL2;SMAD2;FURIN;UBA52;RPS27A;JUN;PTK2;ZFP36L2
prerank,barbed-end actin filament capping (GO:0051016),-0.44679433922313394,-1.2544073468238521,0.18181818181818182,0.661491909178238,1.0,5/18,9.42%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,actin filament capping (GO:0051693),-0.44679433922313394,-1.2544073468238521,0.18181818181818182,0.661491909178238,1.0,5/18,9.42%,ADD3;GSN;SVIL;VILL;CAPZB
prerank,regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5389336870927265,1.2536980360857348,0.2218700475435816,0.6294644785011825,1.0,12/18,26.25%,CCT8;DKC1;CCT2;NHP2;CCT4;CCT6A;SHQ1;EXOSC10;TCP1;CCT3;RUVBL1;RUVBL2
prerank,dendritic spine morphogenesis (GO:0060997),-0.4675289698038631,-1.253663615711534,0.18716577540106952,0.6614712048601482,1.0,6/15,19.33%,DOCK10;DLG4;CTNND2;EPHB2;EPHB3;PAK3
prerank,cellular response to molecule of bacterial origin (GO:0071219),0.4175525199687284,1.2535312415126707,0.15494636471990464,0.6290998707420012,1.0,20/95,10.37%,NOD2;DAB2IP;VIM;TIRAP;DEFA6;FCGR2B;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,cellular response to cytokine stimulus (GO:0071345),0.38022202320212395,1.2530358542306197,0.046464646464646465,0.6296416637124931,1.0,65/416,9.64%,PTPRJ;S1PR1;NPR2;FYN;VCAM1;PTPN14;CCR1;LIFR;GBP5;ST3GAL6;RAPGEF1;FOXO1;ARHGEF2;DUSP1;AIM2;MMP1;INPP5D;DAB2IP;IFNGR1;CBL;LGALS9;VIM;OXSR1;CSF2RB;GBP4;CRK;INPP5K;LAMA5;MAOA;LEF1;TRIM6;HYAL2;LRCH1;TNFRSF1B;IFNAR1;IRAK2;ASAH2;GBP3;GATA3;IL1A;CD47;IRGM;ZC3H12A;ITGAM;IL1RAP;SOCS6;STAT1;PTPN12;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;JAK2;NFE2L2;STK39;RPS27A;NR1D1;ACOD1;GAPDH;CACTIN;ZFP36L2;EGR1;DHX9
prerank,regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),-0.4651529141507168,-1.2519488492759059,0.16045845272206305,0.6639989681166029,1.0,5/17,12.36%,BMP6;SASH1;CD55;PRKCA;CD180
prerank,histone H4-K5 acetylation (GO:0043981),-0.48550415960955573,-1.2514265150081185,0.20485175202156333,0.6609291273172476,1.0,5/15,11.08%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,histone H4-K8 acetylation (GO:0043982),-0.48550415960955573,-1.2514265150081185,0.20485175202156333,0.6609291273172476,1.0,5/15,11.08%,OGT;KANSL2;PHF20;WDR5;MEAF6
prerank,regulation of lymphocyte activation (GO:0051249),0.5864259164755914,1.2511313216856215,0.2233502538071066,0.6341505462755258,1.0,1/12,1.39%,CRTAM
prerank,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),0.42095486053511944,1.250493095544033,0.14199759326113118,0.6350809998195076,1.0,33/88,19.04%,FBXL2;PSMD13;FBXL14;FBXL5;PSMD4;FBXL18;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;CUL2;PSMB8;PSMD14;FBXO4;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;FBXL13;PSMC6;AMN1;PSMA4;FBXO6;PSMD5;PSMD9;FBXL6;PSMB6;FBXL15
prerank,regulation of cell cycle G1/S phase transition (GO:1902806),0.48951033050453613,1.2500612020255435,0.16804407713498623,0.6355041598240451,1.0,2/33,1.78%,PLCG2;ATP2B4
prerank,development of primary male sexual characteristics (GO:0046546),0.4847715145790739,1.2500182591945503,0.1978319783197832,0.6348301606856287,1.0,6/34,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,negative regulation of phosphorylation (GO:0042326),-0.32204383013583504,-1.2495619575970347,0.09289617486338798,0.6641322226240609,1.0,15/85,7.26%,PID1;PTPN13;NTRK3;PLPP3;FBLN1;BMP7;NUPR1;SLIT2;BMP4;PPARA;PRKN;NIBAN1;IRS2;XDH;IGFBP3
prerank,negative regulation of response to stimulus (GO:0048585),0.4289931605492001,1.249447253932559,0.15849056603773584,0.6355626461037166,1.0,16/60,11.83%,MCTP1;KLF7;AQP11;APOA1;KLF4;ACVR1;FCGR2B;KIF26A;CD34;AKT3;RBL1;PIM3;LPCAT3;PTPN1;MAP3K3;CLU
prerank,cytokine-mediated signaling pathway (GO:0019221),0.3757316692031635,1.249400370497373,0.03006012024048096,0.6348864628084877,1.0,91/532,13.97%,PTPRJ;IRF6;ADIPOR2;S1PR1;CEACAM1;PLCB1;PDGFB;FYN;VCAM1;RPS6KA5;NOD1;CCR1;LIFR;NOD2;B2M;RAPGEF1;FOXO1;GSTA2;AIM2;MMP1;INPP5D;IRF2;IFNGR1;CBL;VIM;CSF2RB;CRK;ACTN4;TNFRSF18;CISH;PSMD13;LAMA5;MSN;MAOA;IRF9;CAMK2D;TNFRSF25;TRAF1;TNFRSF1B;IFNAR1;IRAK2;COMMD7;GATA3;FCGR1A;IL1A;PDCD4;ADAM17;ADIPOR1;PSMD4;ITGAM;IL1RAP;SOCS6;STAT1;IL20RB;HSP90B1;MT2A;CEBPA;BCL2L1;UBA52;OAS2;JAK2;RPS27A;PITPNA;LTB;ADAR;EGR1;PSMA5;RBX1;BOLA2;PSMB10;TRIM25;CCL4;CASP1;NFKBIA;TAB2;PSMB8;MAP3K3;GBP2;PSMD14;TRIM8;TALDO1;IRF5;PIK3CB;PSMA7;PSMC3;HIF1A;NDN;PSMA8;PSMC1;SOS1;CFL1
prerank,membrane repolarization (GO:0086009),0.5537452677934649,1.2491078752355949,0.20763358778625954,0.634930289134532,1.0,3/15,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,integrin-mediated signaling pathway (GO:0007229),0.4316169385567313,1.2487496116507193,0.16770186335403728,0.6351089189673943,1.0,13/73,6.80%,LAMA3;CEACAM1;ZYX;PRKD1;NEDD9;APOA1;LAMA5;ADAM15;DST;SEMA7A;MYH9;CUL3;CD47
prerank,"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",0.49255397103640924,1.2484190040828869,0.1894150417827298,0.6352102877938783,1.0,13/31,22.44%,LSM1;EXOSC3;DCPS;DCP1B;POLR2G;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2;DIS3L2;EXOSC1
prerank,"maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",0.5760281415829114,1.2481142439277344,0.23953098827470687,0.6352698997952739,1.0,7/14,22.66%,BOP1;RPL7;RPL35;RPL7L1;FTSJ3;URB1;RPF2
prerank,phosphate ion transmembrane transport (GO:0035435),0.5765953385482575,1.247571814678746,0.2197452229299363,0.6359235360233663,1.0,5/12,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4404383911958756,1.2473474903646333,0.16688227684346701,0.6357437393980118,1.0,14/57,13.12%,FYN;NOD1;AIM2;ARL6IP5;CASP8;PPM1F;TNFSF10;CIDEB;GRIN2B;GRAMD4;HMGB1;CASP1;TTBK1;TBC1D10A
prerank,positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.526452164838795,-1.246988318369012,0.19148936170212766,0.669466644279534,1.0,9/12,41.86%,GOLGA2;CDC14B;FZR1;BTRC;GORASP1;PLK1;CDC20;UBE2C;RAB1A
prerank,protein targeting to peroxisome (GO:0006625),-0.3988964347972372,-1.2469161483623241,0.15673981191222572,0.6674242202087004,1.0,18/29,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;HACL1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;ZFAND6;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,sodium ion transport (GO:0006814),-0.3228679647252231,-1.2463299173723625,0.07602339181286549,0.666973153772754,1.0,14/85,7.04%,ATP1A2;SLC24A3;NALCN;SLC6A13;SLC12A2;SCN7A;SLC6A12;SLC8A3;ATP1B3;SLC9B2;SCN2A;SLC6A1;SLC5A5;SLC6A9
prerank,regulation of toll-like receptor 4 signaling pathway (GO:0034143),0.5138191396065186,1.2461705026240275,0.21846153846153846,0.6382083691982718,1.0,6/22,8.74%,DAB2IP;F2RL1;TIRAP;MFHAS1;NR1D1;ACOD1
prerank,regulation of cardiac muscle hypertrophy (GO:0010611),0.5152423960411789,1.2459069187657714,0.20710059171597633,0.6381676180590051,1.0,4/22,4.95%,EDN1;LMCD1;NOTCH1;CAMK2D
prerank,regulation of granulocyte chemotaxis (GO:0071622),-0.43980930297760934,-1.2450951032595432,0.17365269461077845,0.6682912957810343,1.0,3/19,3.41%,CAMK1D;IL34;THBS1
prerank,positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),0.4287745510462095,1.244702661624332,0.15451174289245984,0.6408294281041242,1.0,8/72,2.62%,TEK;PDGFD;FLT1;PDGFB;INSR;F2RL1;TGFB2;CBL
prerank,T cell homeostasis (GO:0043029),0.5977556171732292,1.244441054754561,0.25084175084175087,0.6408404808990086,1.0,1/10,1.17%,FAS
prerank,regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.5827062892568315,1.2443915363573426,0.22532894736842105,0.6401794237218462,1.0,7/12,25.95%,CAV1;CAMK2D;CALM3;PDE4D;IRX3;SRI;CALM1
prerank,toll-like receptor 4 signaling pathway (GO:0034142),0.5320433147408956,1.2443898327543885,0.20333839150227617,0.6393954532633516,1.0,4/19,8.46%,LGALS9;TIRAP;ITGAM;NMI
prerank,regulation of vascular endothelial cell proliferation (GO:1905562),0.5236757815510494,1.2442038070253212,0.2149390243902439,0.6391258715967532,1.0,7/18,13.22%,FLT1;MEF2C;ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,regulation of oxidative stress-induced cell death (GO:1903201),0.5829461920748547,1.2439396935848643,0.2144082332761578,0.6390482683521961,1.0,2/11,4.89%,FYN;LANCL1
prerank,regulation of gluconeogenesis (GO:0006111),-0.40688170063094553,-1.2429149636104952,0.184375,0.6723889570793342,1.0,7/27,16.52%,OGT;C1QTNF3;ZNF692;PDK2;SIK1;CLK2;NNMT
prerank,positive regulation of protein kinase activity (GO:0045860),0.3970317674399629,1.2423148289474373,0.14301430143014301,0.6427515788459172,1.0,31/148,12.61%,RAPGEF2;PDGFB;ACE;INSR;DAB2IP;TGFB2;ADRB2;EMP2;IQGAP1;NEDD9;EFNA1;MAP4K4;FCGR1A;IRGM;MAPRE3;TOM1L1;SYAP1;PTK2;TAOK2;EGR1;PRNP;CCDC88A;PTPN1;MINK1;TAB2;MMD;CLU;GRM5;MARK2;CALM3;TTBK1
prerank,plasma membrane organization (GO:0007009),0.43908836892776065,1.2422057340094192,0.17434620174346202,0.6422545724097805,1.0,14/61,8.40%,CAVIN2;DYSF;PLSCR4;PACSIN2;SYT7;ANO6;FNBP1L;MYH9;PACSIN1;P2RX7;WHAMM;PLSCR1;A4GALT;BIN3
prerank,positive regulation of dendrite morphogenesis (GO:0050775),-0.45159752158422883,-1.2421156639493198,0.18333333333333332,0.6723415018782394,1.0,7/19,20.45%,CUX1;OBSL1;DBN1;PTPRD;FBXW8;SS18L2;CUX2
prerank,negative regulation of protein autophosphorylation (GO:0031953),0.6008484725650942,1.2420627778058373,0.2443280977312391,0.6418738924589379,1.0,2/10,2.28%,ENG;CAV1
prerank,negative regulation of epithelial cell proliferation (GO:0050680),0.43729117457532357,1.241711349497257,0.16793893129770993,0.641978755897496,1.0,14/66,9.67%,PTPRM;CEACAM1;B2M;DAB2IP;AQP11;CAV1;CAV2;TGFB2;GATA3;STAT1;ATP5F1A;SNAI2;MCC;FBXW7
prerank,regulation of cellular amino acid metabolic process (GO:0006521),0.4482928759017948,1.2416288299357516,0.17287234042553193,0.6414486989374895,1.0,23/53,22.45%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PPM1K;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,regulation of cell motility (GO:2000145),0.39979313459527543,1.2404040627935717,0.12840909090909092,0.6441498253632103,1.0,26/121,11.65%,SPATA13;CEACAM1;LDB2;PLXNA4;MACF1;RHOB;FES;CRK;DIAPH1;SPOCK2;PLXND1;NTN1;SLK;PKN1;TTBK2;ROBO4;SPOCK3;GATA3;KIF2A;ROCK1;SGK1;SPINT2;MINK1;RAC1;CAVIN1;INPP5F
prerank,tRNA metabolic process (GO:0006399),0.5434028812778835,1.2402508252796065,0.23482428115015974,0.6438093407103247,1.0,4/17,10.20%,DTD2;KARS1;TRPT1;FARS2
prerank,low-density lipoprotein particle remodeling (GO:0034374),-0.5146560122804444,-1.2399535323680488,0.23342175066312998,0.6764370277736936,1.0,6/11,35.76%,AGTR1;AGT;PLA2G7;ABCG1;LIPC;PLA2G5
prerank,calcium ion import (GO:0070509),0.5057748351177815,1.2394992468286037,0.19525801952580196,0.6449829037895015,1.0,6/28,8.35%,TRPV4;CACNA1A;MCUB;SLC8A1;SMDT1;MCUR1
prerank,positive regulation of Wnt signaling pathway (GO:0030177),-0.2925350790461363,-1.2394587713130112,0.04950495049504951,0.6756521852101791,1.0,43/152,17.21%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;SULF1;GPC3;PTK7;SULF2;RSPO3;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;RSPO2;PPM1A;PSMB3;SALL1;NFKB1;CSNK1G2;AXIN2;DDX3X;TERT;PPM1B;PSMA3;PSMB4;PSMC4;USP8;ZRANB1;PSMB7;GID8;AMER1;PSMD12;USP34
prerank,regulation of ion transmembrane transport (GO:0034765),0.47943263746605924,1.239424627768876,0.2017167381974249,0.6444173698511282,1.0,4/33,6.78%,KCNQ1;ANO6;CHRM3;P2RX7
prerank,fructose 6-phosphate metabolic process (GO:0006002),-0.5354540825208487,-1.2387516290651488,0.24213075060532688,0.6755644668940344,1.0,5/10,21.92%,PFKP;HK2;GFPT1;GFPT2;PFKL
prerank,nucleobase-containing compound catabolic process (GO:0034655),0.47007908862697684,1.2386823851149065,0.19583333333333333,0.645689219698766,1.0,7/37,13.99%,ENTPD1;DFFB;ADPRM;RNASEH2B;XRN2;RNASE6;NUDT9
prerank,negative regulation of epithelial cell apoptotic process (GO:1904036),0.48250835142228543,1.2385168771424706,0.19972451790633608,0.6453374882828739,1.0,5/33,8.27%,TEK;GATA2;ANGPT1;GATA3;NFE2L2
prerank,regulation of immune response (GO:0050776),0.3974380521175867,1.2374347485588402,0.13747228381374724,0.6475184959578665,1.0,19/135,10.12%,VCAM1;CLEC2D;CRTAM;B2M;ICAM2;CASP8;TGFB2;FKBP1A;SPPL2A;TIRAP;FCGR2B;CD34;FCGR1A;OSCAR;CD247;PLSCR1;CD200;FOXP1;TYROBP
prerank,cellular response to steroid hormone stimulus (GO:0071383),-0.4631343387386681,-1.237103306074247,0.19137466307277629,0.6781891411929994,1.0,9/17,17.12%,ATP1A2;TFPI;BMP7;BMP4;SRC;URI1;UBE2L3;GPER1;AR
prerank,positive regulation of response to stimulus (GO:0048584),0.463637485191842,1.2369197808611672,0.2101740294511379,0.6480629718552514,1.0,12/40,18.44%,B2M;IFIH1;TGFB2;IER5;FCGR2B;GATA3;DHX9;FXR1;NSMCE4A;RSAD2;EEF1E1;CDKN2AIP
prerank,stress-activated protein kinase signaling cascade (GO:0031098),0.49754022700571027,1.236817814843524,0.2052401746724891,0.6475301107523879,1.0,7/27,15.08%,CCDC88C;MAPK1;UBA52;RPS27A;TAOK2;MAP3K20;KAT7
prerank,bicarbonate transport (GO:0015701),-0.42255525076597894,-1.2367320605751526,0.16878980891719744,0.6769286280991023,1.0,10/25,22.64%,SLC4A10;SLC26A7;CA2;SLC39A8;SLC4A2;SLC4A3;SLC26A6;CYB5RL;SLC4A8;CFTR
prerank,positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.502834305234025,1.2363312045632286,0.21621621621621623,0.6480988801199724,1.0,10/25,19.44%,HRK;TNFSF10;BBC3;CIDEB;BNIP3;PYCARD;PLAUR;BMF;BID;PPIF
prerank,muscle cell development (GO:0055001),0.48684908901398816,1.2360750072489213,0.21843971631205675,0.6480046737887185,1.0,6/30,4.18%,ENG;NEBL;DYSF;HEY2;SLC8A1;ALPK3
prerank,cellular response to amyloid-beta (GO:1904646),0.4721411017708292,1.2360480240001461,0.19863013698630136,0.6473022090971625,1.0,7/35,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,regulation of mRNA polyadenylation (GO:1900363),-0.4533686038020652,-1.236030066444887,0.19667590027700832,0.6767527135924638,1.0,5/17,13.86%,CPEB1;NUDT21;NCBP1;CTR9;CPEB3
prerank,negative chemotaxis (GO:0050919),0.48550796141009067,1.236014406885452,0.211864406779661,0.6466062910127974,1.0,5/33,4.67%,SEMA3G;SEMA3F;APOA1;NTN1;SEMA7A
prerank,regulation of potassium ion transport (GO:0043266),0.4951884964158196,1.235924053479286,0.20251396648044692,0.6460759371145441,1.0,3/31,4.87%,NOS1;DPP6;DPP10
prerank,regulation of embryonic development (GO:0045995),0.47090076645831186,1.2358982086050199,0.18723404255319148,0.6453795129325605,1.0,7/34,11.00%,SOX17;PLCB1;INSR;POGLUT1;CLASP1;CLASP2;BAG6
prerank,positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),-0.43146440624206595,-1.23563767261009,0.18862275449101795,0.6755932304773575,1.0,6/21,7.62%,IGF1;BMPR1A;IGFBP5;GJA1;FGF2;MMP2
prerank,regulation of telomerase activity (GO:0051972),0.45496810961072426,1.2355483656925372,0.18614130434782608,0.6455458827931875,1.0,21/45,26.87%,HMBOX1;KLF4;MAPK1;NVL;NEK7;DKC1;PTGES3;TNKS;CCT2;CCT4;ERCC4;ATM;CTNNB1;MEN1;MAPKAPK5;PARM1;TCP1;GREM1;WRAP53;MAP3K4;HSP90AA1
prerank,peptidyl-serine dephosphorylation (GO:0070262),0.5648124049501722,1.2353407585336575,0.214170692431562,0.6453574111633341,1.0,7/14,16.50%,DUSP1;PPM1F;PPP3CA;PPP2R2C;PPP1R15B;PPP2CB;NCK1
prerank,negative regulation of focal adhesion assembly (GO:0051895),-0.4663856150392423,-1.235101033365589,0.19834710743801653,0.6727195826871564,1.0,6/16,8.25%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,negative regulation of cell-substrate junction organization (GO:0150118),-0.4663856150392423,-1.235101033365589,0.19834710743801653,0.6727195826871564,1.0,6/16,8.25%,ARHGAP6;PHLDB2;APOD;THBS1;SRC;BCAS3
prerank,"nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.44496848711351145,-1.2347637487106131,0.19718309859154928,0.6692650548800683,1.0,13/21,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,"nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.44496848711351145,-1.2347637487106131,0.19718309859154928,0.6692650548800683,1.0,13/21,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,neuron projection organization (GO:0106027),0.5508602390732779,1.234433133952013,0.22839506172839505,0.6470506591200087,1.0,4/15,9.97%,INSR;ATP1A3;APP;PRNP
prerank,regulation of stem cell differentiation (GO:2000736),0.41521044215749797,1.2342779398423203,0.17253521126760563,0.6467136118544351,1.0,29/89,18.86%,JAG1;GATA2;LMO2;NOTCH1;TAL1;PSMD13;LMO1;GATA3;PSMD4;ZFP36L2;TCF3;PSMA5;PSMB10;PSMB8;PSMD14;CBFB;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;NELFB;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,N-acetylglucosamine metabolic process (GO:0006044),-0.4762813444281131,-1.234086007568032,0.20865139949109415,0.6691658616575465,1.0,6/15,17.32%,LARGE1;MGAT3;RENBP;EXTL2;NAGK;AMDHD2
prerank,regulation of fibrinolysis (GO:0051917),-0.4930251130327028,-1.2339404140745651,0.1994949494949495,0.6673756331781647,1.0,4/13,17.39%,THBS1;FAP;SERPINE1;THBD
prerank,metanephric mesenchyme development (GO:0072075),-0.5278471157108868,-1.233517584731575,0.2136150234741784,0.6665497661201919,1.0,6/10,22.67%,WNT4;OSR1;SIX1;BASP1;PAX2;SIX4
prerank,protein targeting to lysosome (GO:0006622),0.5198364363914592,1.233497045186945,0.21343283582089553,0.6480842021793639,1.0,10/20,20.71%,GNPTAB;NCOA4;LAPTM5;CLU;VPS4A;NAGPA;AP3M1;ZFYVE16;LAMP2;SORL1
prerank,positive regulation of apoptotic process (GO:0043065),0.3755554701027397,1.2332459112787881,0.08978328173374613,0.6480031717314698,1.0,45/293,10.19%,RASGRF2;ARHGEF3;KALRN;UNC13B;HIP1R;FAS;TNFAIP8;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;TGFB2;RHOB;TRIO;BTG1;PNMA1;ANO6;ING3;HRK;CASP2;OMA1;TNFSF10;PLEKHG5;IAPP;STPG1;RYBP;TIAM2;MCF2L;FANK1;CRADD;ZC3H12A;GADD45G;UBA52;APC;RPS27A;TPD52L1;KLF11;APH1A;JUN;HMGB1;MAP3K11;PRNP;ARHGEF1
prerank,negative regulation of DNA biosynthetic process (GO:2000279),0.48717433467031424,1.2331210410149802,0.21763869132290184,0.6475808141766679,1.0,3/30,1.57%,DACH1;BMPR2;ACVRL1
prerank,negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.556102029025523,1.233005513406237,0.23734177215189872,0.6471198209011803,1.0,3/15,11.98%,SMAD7;MAD2L2;DTX3L
prerank,epithelial cell-cell adhesion (GO:0090136),-0.5080378266069365,-1.2330042010047615,0.22139303482587064,0.6659160336706333,1.0,4/11,7.09%,ITGB5;KIT;CCN3;PLEKHA7
prerank,regulation of endocytosis (GO:0030100),0.4383193911816094,1.2325848950913425,0.18393782383419688,0.6475164950311519,1.0,17/61,17.14%,CDH13;HIP1;HIP1R;MCTP1;PRKD1;PACSIN2;PACSIN1;ROCK1;STON1;PTPN1;NEDD4L;RUBCN;ABCA7;ZFYVE16;RIT2;OPHN1;RUFY1
prerank,negative regulation of wound healing (GO:0061045),-0.4023917704923833,-1.2324911022784293,0.16825396825396827,0.6652738108884306,1.0,8/28,5.54%,PHLDB2;TFPI;CASK;VTN;SLC12A2;APOE;SERPINE2;FGF2
prerank,positive regulation of vascular permeability (GO:0043117),0.5721261026453218,1.2323339669595477,0.2271186440677966,0.647497630454266,1.0,5/12,9.21%,TRPV4;OCLN;ANGPT1;TJP2;TJP1
prerank,positive regulation of hydrolase activity (GO:0051345),0.3901739813627074,1.2319758737298092,0.1436651583710407,0.6477935829976249,1.0,22/137,13.11%,RAPGEF2;DOCK9;F11R;RAPGEF1;RASGRP2;CAV2;F2RL1;AGRN;APOA1;TBC1D30;RAPGEF6;MAP4K4;RAP1GDS1;BCAR3;RGS7;CD200;RSU1;CCL4;ARHGAP27;CALM3;USP6NL;PIN1
prerank,ephrin receptor signaling pathway (GO:0048013),0.4132738184564351,1.231833948822597,0.17422434367541767,0.6474456894660815,1.0,18/82,11.20%,KALRN;EFNA5;ARHGEF28;FYN;CRK;AP2B1;EFNA1;GRIN2B;ARPC5;ACTG1;APH1A;YES1;ROCK1;PTK2;AP2M1;ANKS1B;RAC1;ACTB
prerank,muscle contraction (GO:0006936),0.39237793792910125,1.2315794797103108,0.15056179775280898,0.6474102584648675,1.0,18/126,12.98%,NOS1;UTRN;MYBPC3;ITGA1;DYSF;MYLK;VIM;SLC8A1;MYL6;MYL12B;ROCK1;CLCN1;MYOF;TPCN2;TPM4;SORBS3;GAMT;TMOD3
prerank,pinocytosis (GO:0006907),0.600917266803209,1.2311450122480132,0.2521440823327616,0.6478137985640334,1.0,6/10,21.45%,PPT1;RAB34;DOCK2;PYCARD;MAPKAPK2;CARMIL1
prerank,cellular response to organonitrogen compound (GO:0071417),0.41163197307666594,1.2306661866062436,0.1664670658682635,0.6483033499361883,1.0,30/99,21.41%,KCNQ1;RAPGEF2;SPAAR;RAPGEF1;DIAPH1;INPP5K;MEF2C;SH3BP4;P2RX7;HSP90B1;CTNNA1;HTR1B;EGR1;RRAGD;ACTB;TRPM2;BRCA1;CTNNB1;GLRA2;P2RY1;CIB2;GABRB1;GOLPH3;RELA;RRAGA;RRAGC;JUP;LAMTOR3;ZFP36L1;GABRB3
prerank,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.48226242166771915,1.2301747702757329,0.21659634317862167,0.6488869385355062,1.0,5/30,5.38%,LTBP4;ENG;SMAD7;FKBP1A;SMAD2
prerank,negative regulation of sodium ion transmembrane transporter activity (GO:2000650),-0.538703213860474,-1.2297856929760913,0.22058823529411764,0.6711888507473868,1.0,2/10,2.27%,ATP1A2;OSR1
prerank,positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.44839875388773054,1.2296925741458598,0.20844327176781002,0.6494406363689567,1.0,10/50,12.80%,NOD1;NOD2;LGALS9;APP;ACTN4;TLR3;PDCD4;NMI;LAPTM5;RTKN2
prerank,regulation of cellular amine metabolic process (GO:0033238),0.4456896478168387,1.2295789474803904,0.1827956989247312,0.6490125394540104,1.0,22/50,22.45%,AZIN1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NQO1
prerank,supramolecular fiber organization (GO:0097435),0.3754200037453551,1.228696621102857,0.07581967213114754,0.6506935390007133,1.0,54/333,10.33%,LAMA3;MYO1D;FBLN5;CD2AP;CCDC88C;TRPV4;STMN2;HIP1;MYO1E;SHROOM4;HIP1R;ELMO1;PLK3;RND1;B2M;ARHGEF2;TGFB2;RHOB;FKBP1A;VIM;EMP2;APP;FLII;APOA1;EVL;CLIP2;SLK;DST;TSPAN14;ATP7A;IAPP;FURIN;CAMSAP2;COL5A2;CLIP1;KIF2A;PLEC;WHAMM;ARHGAP25;HOOK1;UBA52;MYO1C;BIN3;RPS27A;COL9A3;APH1A;PCM1;DSP;ADAM10;SIAH2;KATNAL2;MAD2L2;ERMN;CCDC88A
prerank,regulation of cellular amide metabolic process (GO:0034248),0.4771584424894789,1.2285963768918826,0.21739130434782608,0.6501820797299807,1.0,9/32,15.72%,NANOS3;APP;TMED10;ROCK1;CYFIP1;GRM5;METTL18;EIF2A;TCOF1
prerank,regulation of postsynaptic membrane potential (GO:0060078),0.4715756024630602,1.2282400937087101,0.19888734353268428,0.6504134850129719,1.0,13/34,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GABRA4;GABRA2;GABRE;GRIN2A;GABRG3;GSK3A;GRID2;GSK3B;INSYN2A
prerank,neutrophil mediated immunity (GO:0002446),0.36898659647749255,1.2280225627250139,0.05172413793103448,0.6502544527152521,1.0,62/432,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;ACE;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;ADAM17;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;KMT2E;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,regulation of response to endoplasmic reticulum stress (GO:1905897),0.5595852399387861,1.22752195735893,0.237012987012987,0.6509773509169804,1.0,5/13,11.83%,AQP11;FCGR2B;MBTPS2;LPCAT3;CLU
prerank,negative regulation of cell death (GO:0060548),0.41196979354757207,1.2268884795931718,0.176196032672112,0.6519791132977212,1.0,20/88,14.80%,MECOM;FYN;PRKD1;TMEM109;AMIGO2;CD34;TNFRSF1B;LRRK2;HSPA1B;PDE8A;DCPS;CD200;VPS35;CLU;CHGA;BNIP3L;BNIP3;RAD18;PSMC5;TM7SF3
prerank,positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),-0.5300657895033649,-1.2268103459123052,0.24146981627296588,0.6778805240259012,1.0,3/10,4.72%,VTN;PRKCB;GRB10
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),0.4275189500602116,1.226739072306978,0.17314930991217065,0.6516221921280607,1.0,28/70,20.52%,B2M;MFSD6;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;LNPEP
prerank,regulation of neurotransmitter transport (GO:0051588),0.5610826378866939,1.2266238814554473,0.2145214521452145,0.6511931854092318,1.0,4/16,16.46%,MCTP1;MEF2C;SNCAIP;CPLX1
prerank,cardiac muscle cell action potential (GO:0086001),-0.39773588933066384,-1.2266130706367468,0.17164179104477612,0.6762999057403848,1.0,7/30,6.67%,ATP1A2;ANK2;CACNA1C;DMD;CACNA2D1;KCND3;CACNA1G
prerank,natural killer cell mediated cytotoxicity (GO:0042267),0.5347781920921553,1.2263344440472683,0.23624595469255663,0.6512185933153425,1.0,5/16,16.27%,TUBB;TUBB4B;VAMP7;LYST;PLEKHM2
prerank,regulation of cellular protein metabolic process (GO:0032268),0.45478442180744666,1.22614963819804,0.20822281167108753,0.6510104547732167,1.0,11/47,15.72%,NANOS3;EDN1;APP;KLF4;CYFIP1;NFKBIA;VPS35;GRM5;METTL18;EIF2A;TCOF1
prerank,chondroitin sulfate proteoglycan metabolic process (GO:0050654),-0.52597143483954,-1.2255885985162172,0.2525,0.6772145403238384,1.0,4/10,10.38%,DSE;PXYLP1;XYLT1;B3GAT3
prerank,determination of bilateral symmetry (GO:0009855),0.49830353771439084,1.2255310446092882,0.23654390934844194,0.6519770896428594,1.0,3/24,5.57%,TBX1;NOTCH1;BBS7
prerank,cellular response to estradiol stimulus (GO:0071392),-0.4479907357251618,-1.224612165937834,0.18204488778054864,0.6778253120942483,1.0,3/18,9.66%,EGFR;LCOR;CCDC62
prerank,regulation of epidermal cell differentiation (GO:0045604),-0.4261056768860978,-1.2245752343778704,0.21364985163204747,0.6758144483583621,1.0,6/21,6.74%,ERRFI1;ROCK2;BMP4;MAFG;RUNX1;SFRP4
prerank,peroxisomal membrane transport (GO:0015919),-0.3944705264689028,-1.2245532806544774,0.16666666666666666,0.6737392828584339,1.0,16/27,35.37%,ABCD3;ATAD1;PEX2;PXMP4;PXMP2;GDAP1;PEX7;PEX11B;PEX13;PEX3;PEX16;PEX12;RAB8B;SLC25A17;ACBD5;ALDH3A2
prerank,regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.41616462613187977,1.2245119691158468,0.17830423940149626,0.6540196100769545,1.0,12/78,8.44%,PDGFB;CCNY;CCND2;CCND3;HHEX;CCNE1;SERTAD1;CDC25C;ADAM17;MAPRE3;CEBPA;APC
prerank,cotranslational protein targeting to membrane (GO:0006613),0.4104327817841921,1.2235544734752675,0.18523002421307505,0.6558376007895471,1.0,41/91,25.82%,RPS21;RPL27;SRP14;RPL7;UBA52;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;RPL30;RPS5;RPL27A;SRP9;RPL23A;RPS15;SRPRA;RPL19;RPS18;RPL32;RPL37A;RPL18A;SEC62;SRP19;RPL18;RPL39;RPS19;RPL31;RPS8;SEC63;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,regulation of filopodium assembly (GO:0051489),-0.36696356943767483,-1.2234260763863443,0.15151515151515152,0.6749271460689331,1.0,11/38,13.25%,DPYSL3;DOCK11;RHOQ;FXR2;ARAP1;RIPOR2;PIK3R1;BCAS3;CAPZB;GAP43;PALM
prerank,protein localization to centrosome (GO:0071539),0.5331451336420621,1.223244345439288,0.2158154859967051,0.6559649582214863,1.0,8/17,20.15%,CSNK1D;SNX10;NEDD1;PCM1;CCDC14;CEP83;NUDCD3;CEP192
prerank,cellular response to inorganic substance (GO:0071241),0.5152904324000182,1.2232232166838617,0.2420091324200913,0.6552906000791113,1.0,4/21,9.77%,FOXO1;ADCY10;NSMCE3;SPIDR
prerank,manganese ion transport (GO:0006828),-0.47129026796022633,-1.223116646163665,0.20689655172413793,0.6736617240512691,1.0,6/14,9.43%,SLC39A14;SLC30A10;TRPC3;SLC39A8;TRPC6;TRPC4
prerank,muscle tissue morphogenesis (GO:0060415),0.5444135346045799,1.2229019485043269,0.24401913875598086,0.655441597730497,1.0,4/16,3.58%,TBX1;NOTCH1;MYLK;HEY2
prerank,positive regulation of nuclear division (GO:0051785),0.49768615921088516,1.2224418514417617,0.2411242603550296,0.6559565415805858,1.0,4/25,6.22%,EDN1;PDGFB;INSR;IL1A
prerank,positive regulation of calcium ion transmembrane transport (GO:1904427),-0.4013959370677188,-1.222111213726935,0.20588235294117646,0.674274069819851,1.0,2/25,1.58%,ANK2;CEMIP
prerank,positive regulation of lipid transport (GO:0032370),-0.5053470538160875,-1.2218613561326648,0.2694300518134715,0.6729059731098622,1.0,3/12,10.58%,LRP1;APOE;SPP1
prerank,positive regulation of erythrocyte differentiation (GO:0045648),0.5042234641851199,1.2218335775935785,0.22351233671988388,0.6568678931933203,1.0,10/25,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,positive regulation of transmembrane transport (GO:0034764),0.555418198396227,1.2217934070416967,0.23973727422003285,0.656231588075526,1.0,4/13,6.78%,AZIN1;ACSL5;ANO6;P2RX7
prerank,cellular divalent inorganic cation homeostasis (GO:0072503),0.40307796174732563,1.221538207632448,0.17099056603773585,0.6561418827053541,1.0,14/107,7.78%,ATP2A3;EDN1;TRPV4;CCR1;ATP2B4;ATP2B2;CAV1;SLC8A1;ATP2C1;ATP13A3;STIM2;SLC30A1;MT2A;SLC39A6
prerank,positive regulation of protein sumoylation (GO:0033235),-0.5316526723173776,-1.220868240776739,0.2481012658227848,0.6736625791406875,1.0,4/10,22.91%,PIAS3;HDAC4;GNL3;PIAS4
prerank,carboxylic acid transmembrane transport (GO:1905039),-0.3691759721079215,-1.2204561338973305,0.16532258064516128,0.6727256358075016,1.0,7/40,10.92%,SLC7A11;SLC13A3;SLC38A11;SLC19A1;SLC38A10;SLC27A1;SLC38A5
prerank,positive regulation of activated T cell proliferation (GO:0042104),-0.45084232427821225,-1.2202078768090494,0.20221606648199447,0.6713510117769533,1.0,3/18,7.81%,IGF1;IGFBP2;IGF2
prerank,interleukin-15-mediated signaling pathway (GO:0035723),0.5616552946285233,1.2200725696997048,0.2436548223350254,0.6586594370027757,1.0,1/13,0.84%,PLCB1
prerank,cellular response to interleukin-15 (GO:0071350),0.5616552946285233,1.2200725696997048,0.2436548223350254,0.6586594370027757,1.0,1/13,0.84%,PLCB1
prerank,response to estradiol (GO:0032355),-0.38940391686079723,-1.2196114467923111,0.18211920529801323,0.6710316268423159,1.0,8/31,17.03%,EGFR;LCOR;ANXA1;CCDC62;GGT5;GGT7;SOCS2;GPER1
prerank,T cell migration (GO:0072678),0.5458071687850077,1.2195637749406296,0.26143790849673204,0.6593336401164265,1.0,2/13,4.24%,S1PR1;MSN
prerank,negative regulation of protein modification process (GO:0031400),-0.3147725852224593,-1.2195577372097677,0.08333333333333333,0.6690890597823881,1.0,15/79,8.57%,PID1;PTPN13;NTRK3;DMD;PLPP3;FBLN1;SNTA1;SLIT2;PRKAA2;PRKN;NIBAN1;XDH;IGFBP3;P3H1;XRCC1
prerank,regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),0.4778801554676129,1.2194207944774695,0.22033898305084745,0.658964861903239,1.0,7/32,12.11%,CDK17;CDK14;CCNE1;KLF11;POLA1;E2F7;HINFP
prerank,external encapsulating structure organization (GO:0045229),0.3798909104864512,1.2193348991278836,0.13225806451612904,0.6584504559075949,1.0,27/205,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",0.47216967071130245,1.219020675159017,0.2157676348547718,0.6585247246748158,1.0,10/36,14.82%,FZD6;PLCB1;TNRC6C;LEF1;NLK;PPP3CA;AGO4;NFATC1;CTNNB1;FZD3
prerank,cellular response to tumor necrosis factor (GO:0071356),0.38389500296414714,1.2184843012715354,0.14426229508196722,0.6593064833891681,1.0,55/175,21.03%,ARHGEF2;AIM2;DAB2IP;ACTN4;TNFRSF18;INPP5K;PSMD13;TNFRSF25;HYAL2;TRAF1;TNFRSF1B;COMMD7;GBP3;GATA3;ADAM17;PSMD4;ZC3H12A;STAT1;JAK2;NFE2L2;NR1D1;ACOD1;LTB;CACTIN;ZFP36L2;PSMA5;DHX9;PSMB10;CCL4;NFKBIA;PSMB8;GBP2;PSMD14;BRCA1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;ERBIN;TNFRSF11A;PSMB2;BAG4;ZFP36L1
prerank,positive regulation of endopeptidase activity (GO:0010950),0.4957880495579866,1.2183378830006437,0.23076923076923078,0.6589796360189007,1.0,11/26,21.58%,FYN;AIM2;EFNA1;GRIN2B;APH1A;VSIR;TTBK1;PYCARD;AGER;APH1B;EPHA4
prerank,intracellular lipid transport (GO:0032365),-0.4273872710524716,-1.2179302865064356,0.20114942528735633,0.6717857580966137,1.0,4/21,6.25%,PRKAG2;PRKAA2;ABCD3;SLC25A20
prerank,regulation of AMPA receptor activity (GO:2000311),0.49709131295720044,1.2178124747094887,0.2311178247734139,0.6596098613111245,1.0,6/25,10.64%,ADRB2;SHISA8;MEF2C;SHANK3;SHISA6;MINK1
prerank,positive regulation of striated muscle cell differentiation (GO:0051155),0.49648565064201194,1.2173472714810316,0.21005917159763313,0.6600551792604088,1.0,3/23,5.32%,EDN1;PIEZO1;MEF2C
prerank,positive regulation of locomotion (GO:0040017),0.4856921215114845,1.217121044160409,0.22647058823529412,0.659909577106307,1.0,5/27,4.01%,PDGFB;F2RL1;PPM1F;SPOCK2;NTN1
prerank,positive regulation of osteoblast differentiation (GO:0045669),-0.3581114211233645,-1.2164073679131462,0.14859437751004015,0.6739831017155262,1.0,9/43,5.47%,BMP6;IGF1;BMPR1A;WNT4;BMP7;BMP4;FBN2;RUNX2;IL6R
prerank,positive regulation of receptor-mediated endocytosis (GO:0048260),0.4571362875251098,1.2163061529901489,0.22703412073490814,0.6612894831884825,1.0,10/40,11.83%,HIP1;B2M;INSR;CBL;PPT1;ANGPT1;ARRB1;TBC1D5;HNRNPK;CLU
prerank,wound healing (GO:0042060),-0.33130272900727376,-1.216114747466221,0.10900473933649289,0.672783159018635,1.0,17/62,11.80%,COL3A1;IGF1;PDGFRA;TGFBR1;FGF1;WNT5A;TPM1;AHNAK2;FGF2;SMAD3;FZD7;CFLAR;PRCP;RAF1;ERBB2;SYTL4;DCBLD2
prerank,glucose transmembrane transport (GO:1904659),0.5308854371778156,1.215935291029163,0.23244929797191888,0.6615051109957873,1.0,3/18,8.42%,SLC2A1;HNF1A;SLC2A9
prerank,positive regulation of T cell differentiation (GO:0045582),-0.37090720215995576,-1.2158607407484243,0.1649122807017544,0.6714631992496296,1.0,8/36,13.04%,GLI3;GLI2;ZMIZ1;BCL6;DUSP10;NCKAP1L;MDK;PNP
prerank,positive regulation of epithelial to mesenchymal transition (GO:0010718),0.457462334793224,1.2158240356612948,0.2082758620689655,0.6610809606526146,1.0,7/40,5.38%,JAG1;NOTCH1;TGFB2;WWTR1;LEF1;GCNT2;SMAD2
prerank,cell communication by electrical coupling involved in cardiac conduction (GO:0086064),0.5285264666505998,1.2152830288492034,0.2542901716068643,0.661863071798451,1.0,4/17,3.81%,GJA5;ATP1A1;ATP1A3;SLC8A1
prerank,cytoplasmic translation (GO:0002181),0.4060629832275482,1.2148899892339344,0.20024125452352232,0.6622379312897156,1.0,44/91,28.18%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPS25;EIF3I;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;RPL22L1;EIF3M;ZC3H15;RPL18;RPL39;RPS19;RPL31;RPS8;RPL3;RPL28;RPS16;RPLP1;RPL26;RPL9;RPS17;EIF4A1;RPS13;RPL11;RPL14
prerank,positive regulation of innate immune response (GO:0045089),0.4817770441579806,1.21430983941544,0.2372159090909091,0.6630954930972457,1.0,8/30,9.64%,GBP5;TRIM6;PLSCR1;NLRC5;NMI;POLR3B;SLC15A4;DHX9
prerank,Golgi to plasma membrane transport (GO:0006893),0.4415107794219675,1.2142861707383719,0.2306684141546527,0.6624305292400712,1.0,18/47,22.78%,EXOC6;MACF1;STXBP6;RAB34;GOPC;EXOC8;NSF;ANK3;SPTBN1;GOLPH3L;EXOC4;GOLPH3;EXOC2;STEAP2;RAB31;EXOC5;EXOC6B;OSBPL5
prerank,negative regulation of viral process (GO:0048525),0.4269424599851171,1.2137783664065722,0.1984732824427481,0.6630203175079538,1.0,18/57,21.70%,TRIM14;IFIH1;TRIM11;TRIM6;STAT1;PLSCR1;OAS2;TRIM8;CHMP3;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;MID2;EIF2AK2;BANF1;HEXIM1
prerank,neural crest cell differentiation (GO:0014033),0.5327651277829444,1.2137288020297146,0.23919753086419754,0.662426095209809,1.0,7/18,21.33%,MEF2C;SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,regulation of stress fiber assembly (GO:0051492),-0.32323186091700584,-1.2132274989276095,0.1443850267379679,0.6771670021330007,1.0,15/74,7.14%,ARHGAP6;PHLDB2;LPAR1;ROCK2;ARHGAP28;ASAP3;TGFBR1;CCN2;ARHGEF10L;PPM1E;TPM1;ARAP1;ALMS1;PIK3R1;TMEFF2
prerank,preassembly of GPI anchor in ER membrane (GO:0016254),-0.45020460597849926,-1.2129110221812698,0.1989247311827957,0.6760301427553594,1.0,10/16,26.51%,PIGA;PIGB;PIGN;PIGH;DPM2;PIGG;PIGP;PIGZ;PIGL;PIGW
prerank,positive regulation of protein secretion (GO:0050714),0.4180223274251682,1.2129071449837088,0.20248447204968945,0.6638482119739324,1.0,9/69,6.22%,MYRIP;CD2AP;UNC13B;DOC2B;F2RL1;TGFB2;TMED10;GLUD1;IL1A
prerank,regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.43622563534896275,1.2127738568773914,0.2212041884816754,0.6634772780631618,1.0,16/54,17.56%,CASP8;F2RL1;SPATA2;SPPL2A;APOA1;TRAF1;ADAM17;MADD;HSPA1B;CASP1;LAPTM5;RACK1;TRAIP;PYCARD;PTPN2;PYDC1
prerank,glycoprotein metabolic process (GO:0009100),0.43575607889346896,1.2126141754713533,0.2099737532808399,0.6632009727966157,1.0,14/53,19.34%,GCNT1;ST6GALNAC3;ST8SIA6;MANBA;PRKCSH;HIF1A;FBXO2;ST3GAL2;ENGASE;OGA;FBXO6;GOLPH3;NGLY1;NEU4
prerank,positive regulation of actin nucleation (GO:0051127),0.5570909564653735,1.2123056240456391,0.23089700996677742,0.663390381934314,1.0,5/11,12.12%,FCHSD2;WHAMM;NCKAP1;CYFIP1;WASF2
prerank,protein localization to endoplasmic reticulum (GO:0070972),-0.447611500507809,-1.2122199943523437,0.2185792349726776,0.67601248015496,1.0,5/16,15.19%,ANK2;BCAP29;SEC16B;BCAP31;SEC16A
prerank,negative regulation of protein localization to plasma membrane (GO:1903077),-0.43754683518089404,-1.2114848939756846,0.2131578947368421,0.6761587791361133,1.0,3/20,2.40%,PID1;DAB2;RHOQ
prerank,monocarboxylic acid metabolic process (GO:0032787),-0.29523545235569865,-1.2114219193720484,0.09090909090909091,0.6743205236247278,1.0,33/117,19.82%,IGF1;ALDH1A2;PCCA;ABAT;CYP26B1;PPARA;CPT1C;ME1;GNPAT;ACOT11;ALDH4A1;AASDH;MCCC2;NAAA;SCP2;GGT5;PPARG;CKB;LDHB;ECHDC3;THEM4;GBA2;AMACR;PDHA1;PDHX;HLCS;ACOT6;DLAT;HACL1;ACSF2;LPL;PANK2;ALOX12
prerank,regulation of protein binding (GO:0043393),0.39329003459943623,1.210236869987912,0.17307692307692307,0.6683300555938063,1.0,27/114,15.64%,RAPGEF2;CLDN5;PDGFB;HIP1R;B2M;CAV1;FKBP1A;APP;CRK;EPB41;LRRK2;NVL;CTNNBIP1;ROCK1;MARK3;ACTB;TMBIM6;DTX3L;MARK2;TTBK1;ITGB1BP1;PIN1;LDLRAP1;RAN;NES;RACK1;SLPI
prerank,dendritic cell migration (GO:0036336),0.5291941544626336,1.2100649119012148,0.24528301886792453,0.6680729331923649,1.0,4/16,14.74%,CCR1;HMGB1;TRPM2;CXCR4
prerank,regulation of cell communication (GO:0010646),0.4658151097607462,1.2100249010399198,0.2018842530282638,0.6674293394452726,1.0,7/35,7.22%,GJA5;KAZALD1;CRK;SLC8A1;SCG5;CAMK2D;IGFBP7
prerank,rRNA processing (GO:0006364),0.38224143996760446,1.2100062995377527,0.1453551912568306,0.6667287312351067,1.0,73/172,26.85%,BOP1;PELP1;RPL27;DHX37;RPL7;EXOSC3;NVL;UBA52;RPS14;MRPL1;MRM2;RPL35;WDR46;RPL21;DKC1;RRP15;RPL37;RPS28;RPL34;RPS9;XRN2;EXOSC8;RPLP2;RPS25;NHP2;RPL30;RPL27A;NOL8;RIOK3;SART1;RPL23A;RPS15;EIF6;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1;ERI1
prerank,protein polyglutamylation (GO:0018095),0.5841968620513557,1.209092749883898,0.25573192239858905,0.66842536803887,1.0,4/11,12.76%,TTLL7;TTLL1;TTLL5;TTLL11
prerank,regulation of urine volume (GO:0035809),0.5825067759872302,1.2090020329025908,0.2571912013536379,0.6679685493617299,1.0,3/10,6.82%,INPP5K;HYAL2;NPR1
prerank,positive regulation of Rho protein signal transduction (GO:0035025),0.47703624643679476,1.208910872714739,0.27753934191702434,0.6674836163428894,1.0,6/30,7.74%,ARHGEF3;F11R;F2RL1;APOA1;LPAR6;ARRB1
prerank,regulation of phospholipase C activity (GO:1900274),-0.4655670943160615,-1.2085693828552353,0.25068870523415976,0.6809771294903605,1.0,5/15,5.54%,NTRK3;PDGFRB;PDGFRA;KIT;FGF2
prerank,positive regulation of defense response (GO:0031349),0.40583820222010686,1.2085564530944681,0.20677570093457945,0.6677225716682605,1.0,18/89,13.70%,GBP5;APP;TLR3;MEF2C;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3
prerank,establishment of melanosome localization (GO:0032401),0.5091513113849799,1.2080287166278978,0.2588597842835131,0.6683980127417047,1.0,4/19,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,regulation of multicellular organism growth (GO:0040014),-0.46187231158287606,-1.207938049885641,0.22311827956989247,0.6807273897029068,1.0,5/15,15.02%,IGF1;MBD5;GHR;PTCH1;MFSD2A
prerank,mRNA metabolic process (GO:0016071),-0.30909931371009836,-1.2078015617685098,0.13793103448275862,0.6791694986227751,1.0,34/90,24.13%,SON;DDX5;SRSF5;SCAF11;NUDT21;HNRNPA2B1;NCBP1;PRPF8;SRSF1;PRKACA;SSB;CNOT10;PRPF3;AKAP8L;SNRPF;YTHDF2;PCF11;U2AF2;SNRPD3;AGO3;ZFP36;LSM11;SLBP;LSM6;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2;DCP2;LSM10;U2AF1
prerank,negative regulation of blood coagulation (GO:0030195),0.4603270051341053,1.2075149516633312,0.2374821173104435,0.669080897647618,1.0,3/38,0.88%,NOS3;EDN1;PDGFB
prerank,peptidyl-lysine trimethylation (GO:0018023),-0.4027925847171658,-1.2074912353659832,0.19242902208201892,0.6781339547140489,1.0,11/26,22.21%,OGT;KMT5C;SETD1A;SETD1B;TET2;CTR9;KMT5B;SUV39H1;SETD4;ANTKMT;KMT2D
prerank,regulation of microtubule cytoskeleton organization (GO:0070507),0.44825172750106934,1.2068447127994586,0.2347949080622348,0.6700901548249759,1.0,9/37,12.15%,STMN2;EFNA5;FAM107A;CLASP1;MAPRE3;PRKAA1;ROCK1;CLASP2;MARK2
prerank,positive regulation of osteoclast differentiation (GO:0045672),0.5500224807032215,1.2066209727777484,0.25333333333333335,0.6699598051800606,1.0,2/14,10.12%,CCR1;TYROBP
prerank,extracellular structure organization (GO:0043062),0.37618718957182534,1.2062433345613877,0.147470398277718,0.6702314523801896,1.0,27/204,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;ATP7A;FURIN;COL5A2;CD47;BSG;ITGAM;ADAM12
prerank,midbody abscission (GO:0061952),0.5290988236674702,1.2059958528413979,0.24307692307692308,0.6701879346996543,1.0,11/17,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,non-canonical Wnt signaling pathway (GO:0035567),0.39185572415500464,1.2057814747878113,0.17825112107623317,0.6700490235947515,1.0,35/124,18.86%,CCDC88C;FZD6;PLCB1;TNRC6C;AP2B1;PSMD13;LEF1;NLK;PSMD4;PPP3CA;PSMA5;AP2M1;PSMB10;AGO4;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;FZD9;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of leukocyte chemotaxis (GO:0002688),-0.42972911843646866,-1.2056219484710704,0.21022727272727273,0.6815533304935227,1.0,4/18,5.47%,PTN;CAMK1D;SLIT2;IL6R
prerank,smoothened signaling pathway (GO:0007224),-0.3826583577334031,-1.205455680351686,0.1925925925925926,0.6799781694130873,1.0,9/32,15.05%,GLI3;GLI2;CC2D2A;SMO;GLI1;PTCH1;TMEM231;TCTN2;IFT27
prerank,regulation of ceramide biosynthetic process (GO:2000303),-0.4652889390295357,-1.2044037654887525,0.22955145118733508,0.6809835382791817,1.0,8/15,27.40%,SIRT3;SPHK1;PLA2G6;PRKCD;ORMDL2;SPHK2;SMPD3;TNFRSF1A
prerank,hepaticobiliary system development (GO:0061008),-0.42515103776549895,-1.2039709293854435,0.2,0.6801798754796974,1.0,4/20,5.01%,TGFBR3;WNT4;COBL;NIPBL
prerank,negative regulation of intracellular protein transport (GO:0090317),0.5124967613011128,1.203738413761392,0.2563338301043219,0.6749147637878804,1.0,10/22,20.67%,INPP5K;UFM1;RAB23;LRRK2;RANGAP1;ITGB1BP1;CABP1;GDI1;BARD1;BAG4
prerank,positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.469912847886914,1.2034313503952068,0.23994452149791956,0.6750114062820489,1.0,10/36,14.74%,EDN1;TRIM6;ADAM17;IRGM;HSPA1B;NLRC5;CASP1;LAPTM5;HIF1A;CXCR4
prerank,translation (GO:0006412),0.3775431520283092,1.2030641633718588,0.13976164680390032,0.6752428549071666,1.0,90/208,28.18%,RPS21;GARS1;RPL27;VARS1;KARS1;RPL7;FARSB;WARS1;MRPL18;EEF2K;MRPL41;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;FARS2;RPS28;RPL34;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;RPS9;RPLP2;EEF2;GTPBP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS34;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;GATB;EEFSEC;RPL37A;RPL18A;RPL22L1;EEF1D;MRPS18B;COPS5;RARS1;EEF1E1;ZC3H15;EEF1G;DARS1;MRPL11;RSL24D1;RPL18;MRPS28;RPL39;RPS19;RPL31;RPS8;TSFM;EIF4G1;MRPL34;WARS2;EIF4EBP2;RPL3;PPA2;RPL28;MRPS24;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;DARS2;APEH;RPS13;MRPL13;RPL11;RPL14
prerank,phosphate ion transport (GO:0006817),0.5348923148404918,1.2029072192483226,0.2632398753894081,0.6749310026525002,1.0,5/16,16.56%,SLC25A30;XPR1;SLC37A2;SLC37A3;SLC25A10
prerank,transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),0.3886462913307607,1.202737409304235,0.1733181299885975,0.6746761484397099,1.0,24/128,9.21%,ENG;CLDN5;SMAD6;BMPR2;SMAD7;F11R;ACVRL1;ZYX;TGFB2;CBL;FKBP1A;ID1;APOA1;TMEM100;ACVR1;GCNT2;NLK;SMAD2;FURIN;PDCD4;UBA52;RPS27A;JUN;PTK2
prerank,Golgi to endosome transport (GO:0006895),0.5282348106828011,1.2023416925855972,0.26025236593059936,0.6749678760103273,1.0,6/16,20.35%,DOP1B;KLHL20;KIF16B;MON2;SORT1;EPS15
prerank,cellular response to chemokine (GO:1990869),0.43698984479054875,1.2020848440040264,0.23753280839895013,0.6749449318391906,1.0,7/46,10.16%,CCR1;DUSP1;OXSR1;LRCH1;ZC3H12A;STK39;CCL4
prerank,RNA destabilization (GO:0050779),-0.43235520197823296,-1.201419865587447,0.23497267759562843,0.6858309608744672,1.0,7/18,16.77%,ROCK2;YTHDF1;FTO;PUM1;LIN28B;YTHDF2;GIGYF2
prerank,interleukin-27-mediated signaling pathway (GO:0070106),0.5482374300524924,1.2005596830366678,0.2736156351791531,0.6783837067352396,1.0,7/13,27.40%,STAT1;OAS2;JAK2;IL27RA;OASL;CANX;JAK1
prerank,regulation of protein localization to plasma membrane (GO:1903076),-0.31762880281466,-1.1991244208193115,0.12560386473429952,0.690327578795953,1.0,10/78,3.14%,PID1;EGFR;LRP1;EPHA3;SORBS1;PTPN9;DAB2;MMP14;RHOQ;STX4
prerank,substrate adhesion-dependent cell spreading (GO:0034446),0.447103751510744,1.1990989453152057,0.22894736842105262,0.6816105160055188,1.0,6/46,4.92%,TEK;NTN4;PARVB;ATRNL1;LAMA5;EFNA1
prerank,protein localization to nucleus (GO:0034504),-0.3073258582942169,-1.1983413561193654,0.12781954887218044,0.6906811496329562,1.0,42/102,24.39%,COL1A1;APPL2;BMP7;BMP4;LMNA;TOR1AIP1;NUP107;SIX1;TOR1B;INTS13;HEATR3;BANP;CSE1L;PPP1R10;NUP155;PAF1;TNPO3;RANBP6;IPO5;FAM53C;BCL3;MDM2;NUP93;TNPO2;HNRNPU;RANBP17;TOPORS;TSC2;PHB2;MORC3;SUPT7L;PML;RRS1;CHCHD10;SEC13;SYK;IPO7;SIX4;POM121;TOR1A;TBRG1;IPO8
prerank,protein secretion (GO:0009306),-0.329222703827917,-1.198152077418303,0.1735159817351598,0.6892082825075548,1.0,22/56,26.68%,WLS;STEAP3;ABCA1;TANGO2;ANXA1;COPG1;MTTP;PPY;TVP23B;SVBP;RCN3;RAB3D;MON1A;PDIA4;PREB;PORCN;TMEM167A;LTBP2;RAB3C;RAB15;NECAB3;ADCYAP1
prerank,protein K63-linked ubiquitination (GO:0070534),-0.35226069500589824,-1.1979181589016168,0.1695501730103806,0.6879629187913109,1.0,10/41,13.72%,UBE2E2;PRKN;UBE2V2;TRAF3IP2;UBE2N;RNF135;RNF4;RNF152;BFAR;ARIH2
prerank,response to peptide (GO:1901652),0.4619021600469863,1.1977041740494527,0.25587828492392806,0.6847951875221088,1.0,11/33,20.02%,FYN;NOD2;CACNA1A;STAT1;EIF2B2;PRNP;IRF5;KAT7;ERBIN;AGER;STAT5A
prerank,positive regulation of myeloid leukocyte mediated immunity (GO:0002888),0.5653247359924056,1.1973550785768114,0.272108843537415,0.6850228206837933,1.0,4/11,10.12%,F2RL1;ITGAM;STAP1;TYROBP
prerank,positive regulation of mitotic nuclear division (GO:0045840),0.4638057540549044,1.1971679056843685,0.25383542538354253,0.684801726294082,1.0,5/34,6.22%,EDN1;PDGFB;INSR;CUL3;IL1A
prerank,regulation of establishment of cell polarity (GO:2000114),-0.4390667094290703,-1.195739583794025,0.2334293948126801,0.6921970544144295,1.0,4/16,8.25%,ROCK2;GSN;RIPOR2;BCAS3
prerank,cellular protein-containing complex assembly (GO:0034622),0.3807783301297925,1.195686622165249,0.17067833698030635,0.6882693103688621,1.0,41/159,20.35%,HIP1;HIP1R;STXBP6;PIK3C2A;ADRB2;FKBP1A;PSMD13;FCHO2;ANGPT1;OMA1;DNAAF3;SMAD2;PSMD4;PFDN6;VBP1;VAMP8;IMMP2L;TTC12;CASQ1;NSG2;RTN4;DHX9;AP2M1;PTGES3;CYBA;CCT2;CLU;NUP153;CHMP3;CSNK2B;SAMM50;NUP205;NCK1;SMAD4;SRP19;SHQ1;PSMG2;NSG1;HOPX;DNAJC28;EPS15
prerank,regulation of sprouting angiogenesis (GO:1903670),0.45644275735139894,1.1956639406242677,0.23397913561847988,0.6875957354072734,1.0,10/33,14.00%,CEACAM1;KLF2;CEMIP2;KLF4;PPP1R16B;JMJD8;TJP1;EPN2;PIK3CB;ITGA5
prerank,negative regulation of translational initiation (GO:0045947),-0.4873846387906788,-1.19476613734932,0.2670157068062827,0.692990523295025,1.0,5/13,17.14%,PAIP2;EIF2AK4;EIF3E;LARP1;EIF4EBP1
prerank,negative regulation of cellular response to insulin stimulus (GO:1900077),-0.39447176409987905,-1.1942847605390168,0.21019108280254778,0.6924129574857292,1.0,8/28,9.76%,PID1;APPL2;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,regulation of actomyosin structure organization (GO:0110020),-0.46746715499889196,-1.1940125553076526,0.2614213197969543,0.6911893352463281,1.0,3/13,4.84%,ROCK2;ASAP3;ALMS1
prerank,positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.48262885156340957,1.1936509595024167,0.24519940915805022,0.692385547749419,1.0,11/28,16.16%,ECSCR;DAB2IP;PTK2;FBXW7;LAPTM5;CLU;SMURF1;PSMC3;PSMC5;PSMC6;RNF139
prerank,positive regulation of lymphocyte migration (GO:2000403),0.5640701759126475,1.1933717105885575,0.271523178807947,0.6924095496934775,1.0,2/12,2.98%,JAM2;APP
prerank,positive regulation of transcription by RNA polymerase II (GO:0045944),0.35701003883154103,1.1931842375166524,0.03406813627254509,0.6921631706194952,1.0,128/834,13.29%,NOS1;LMO7;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;TGFB2;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;PELP1;HEY2;TLR3;KLF4;PLXND1;IER5;ACVR1;WWTR1;LEF1;BCLAF3;MAFF;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;ZC3H12A;PPP3CA;STAT1;GAL;AATF;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;NR1D1;JUN;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;RPS6KA1;RPRD1B;NFKBIA;TET3;TNKS;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;HELZ2;PRKD2;HINFP;MED30;GCN1;IRF5;SETD3;CTBP2;GLYR1;RPS6KA3;PSMC3;ITGB1BP1;PIN1;POU3F2;APLN;PHIP
prerank,response to leucine (GO:0043201),-0.5091164105050288,-1.1931615912612301,0.25970873786407767,0.6897177103565522,1.0,3/10,10.41%,KLHL22;SESN1;SESN2
prerank,cellular response to leucine (GO:0071233),-0.5091164105050288,-1.1931615912612301,0.25970873786407767,0.6897177103565522,1.0,3/10,10.41%,KLHL22;SESN1;SESN2
prerank,rRNA catabolic process (GO:0016075),0.5311916764442691,1.1929877521780061,0.26031746031746034,0.6919663198425692,1.0,7/16,21.35%,TRIR;EXOSC3;EXOSC8;PELO;XRN1;EXOSC9;EXOSC10
prerank,negative regulation of T cell proliferation (GO:0042130),0.4747487016507555,1.1929405196612395,0.25894134477825465,0.6913576536583941,1.0,4/28,9.97%,CRTAM;LGALS9;ARG1;PRNP
prerank,tumor necrosis factor-mediated signaling pathway (GO:0033209),0.39156571974544185,1.1923230821215727,0.20091848450057406,0.6923985627283047,1.0,37/114,20.67%,AIM2;ACTN4;TNFRSF18;PSMD13;TNFRSF25;TRAF1;TNFRSF1B;COMMD7;ADAM17;PSMD4;STAT1;JAK2;LTB;PSMA5;PSMB10;NFKBIA;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;TMSB4X;PYCARD;PSMA4;PYDC1;PSMD5;PSMD9;RELA;PSMB6;TNFRSF11A;PSMB2;BAG4
prerank,negative regulation of calcium ion transmembrane transport (GO:1903170),-0.5120558017031733,-1.1918255194075331,0.2426470588235294,0.6918441412760674,1.0,1/10,0.03%,ATP1A2
prerank,negative regulation of lipid storage (GO:0010888),-0.427947545562464,-1.1911327770148332,0.21902017291066284,0.6918761138483775,1.0,6/19,15.80%,ABCA1;ITGAV;PPARA;OSBPL8;PPARG;NR1H3
prerank,cell morphogenesis involved in differentiation (GO:0000904),0.4125788543813197,1.1907719215608035,0.22627737226277372,0.6960182518998146,1.0,8/70,5.32%,TEK;NTN4;PARVB;ATRNL1;SIPA1L3;LAMA5;EFNA1;MEF2C
prerank,regulation of mitotic nuclear division (GO:0007088),0.4250963234158535,1.1907097008898222,0.23574144486692014,0.6954516576000163,1.0,8/55,7.99%,EDN1;PDGFB;INSR;DUSP1;CAV2;CDC25C;IL1A;TOM1L1
prerank,negative regulation of protein secretion (GO:0050709),-0.3518475141331535,-1.1906338848652818,0.1773049645390071,0.6913771463058278,1.0,15/38,22.91%,APOE;PRKN;CCN3;IRS1;RAB11FIP1;REST;ADRA2A;DRD2;SERGEF;KCNB1;NR1H3;RHBDF1;CYP51A1;ERP29;INHBB
prerank,regulation of cellular catabolic process (GO:0031329),0.41688627825983493,1.1903231213607781,0.21525215252152521,0.6957906211264424,1.0,18/62,17.76%,ACER2;FBXL2;DRAM1;GPR137B;SMCR8;DEPP1;LRRK2;HSPB1;ROCK1;RRAGD;TPCN2;DRAM2;KEAP1;ATM;RMC1;LONP2;TRIB3;TYSND1
prerank,protein N-linked glycosylation (GO:0006487),-0.3177066989784313,-1.190217932764396,0.15346534653465346,0.6907091153323066,1.0,23/66,19.04%,MGAT4C;MGAT4A;ST6GAL1;TUSC3;MGAT3;MAN1C1;STT3A;SLC39A8;B4GALT1;LMAN1;UGGT2;MPDU1;GFPT1;GFPT2;DPM2;PGM3;ALG8;OST4;MAGT1;PMM1;ALG9;STT3B;ALG13
prerank,negative regulation of interferon-gamma production (GO:0032689),0.49064128068249224,1.1900420985293232,0.2591508052708638,0.6958248487581928,1.0,8/23,16.90%,LGALS9;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;RARA
prerank,apoptotic process (GO:0006915),0.3703928012659686,1.1900283103761435,0.17230443974630022,0.6951230186469183,1.0,37/203,11.32%,HIP1;EFNA5;ELMO1;FAS;TBX1;PLK3;PAEP;FOXO1;CASP8;RHOB;APP;ADAM15;CASP2;TNFRSF25;BRAT1;DDX41;IAPP;DAP;IL1A;PDCD4;BBC3;ZBTB16;CIDEB;PLSCR1;BCL2L1;JAK2;RFK;NCKAP1;MAL;GAPDH;TAOK2;RTN4;PRUNE2;CASP1;NFKBIA;BAG6;DCC
prerank,negative regulation of cellular protein metabolic process (GO:0032269),0.4034645612750494,1.1897008847315755,0.2222222222222222,0.6952831168182131,1.0,5/88,2.84%,NANOS1;NANOS3;EDN1;DAB2IP;BTG2
prerank,"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.43963223433526366,-1.189192842356524,0.23684210526315788,0.6919111027605811,1.0,5/16,12.36%,SNW1;RBMX;NCBP1;DAZAP1;TRA2A
prerank,positive regulation of insulin receptor signaling pathway (GO:0046628),-0.485855069701915,-1.1888769947342275,0.26342710997442453,0.6908953566653984,1.0,6/12,19.56%,SORBS1;IRS1;IGF2;PRKCZ;SNX5;ZBTB7B
prerank,positive regulation of superoxide anion generation (GO:0032930),0.5434818307962559,1.1886071844357367,0.27871621621621623,0.697660150611886,1.0,3/13,10.12%,F2RL1;ITGAM;TYROBP
prerank,positive regulation of myeloid leukocyte differentiation (GO:0002763),0.4602629336034778,1.1885090160308622,0.26495726495726496,0.6971891489094829,1.0,5/33,9.01%,CCR1;CASP8;FES;LEF1;CTNNBIP1
prerank,protein modification process (GO:0036211),0.4095955935736595,1.188483289868912,0.22787878787878788,0.6965286682936189,1.0,17/76,14.78%,ST3GAL6;FBXL2;DUSP12;UBA7;MANBA;STK38;CHRM3;UBA52;YES1;CSNK1G3;FBXW2;LIPT1;NAGPA;ST3GAL1;FBXO2;MSRA;UBE2D3
prerank,regulation of keratinocyte differentiation (GO:0045616),-0.4022168656369682,-1.1883683050792142,0.25609756097560976,0.690542674288687,1.0,9/24,21.25%,ERRFI1;ROCK2;RUNX1;SRSF6;HOXA7;CTSL;ZFP36;NME2;ETV4
prerank,regulation of establishment of protein localization (GO:0070201),0.5364079616581485,1.1882401023591984,0.2653061224489796,0.6964780446393273,1.0,8/13,32.00%,CEP135;SPIDR;CEP120;DNAJA1;PTP4A3;SCFD1;GAPVD1;CEP295
prerank,protein stabilization (GO:0050821),0.3748749694435266,1.188146752229524,0.1737704918032787,0.6960001271464555,1.0,30/168,13.44%,SOX17;HIP1;MSX1;SMAD7;HIP1R;GNAQ;TMEM88;SAXO1;APOA1;EFNA1;NLK;TAF9B;IRGM;HSPA1B;DNLZ;CCT8;STX12;GAPDH;RTN4;FBXW7;TYROBP;PTGES3;GET1;BAG6;CCT2;SUGT1;CLU;CCT4;PIN1;HYPK
prerank,negative regulation of protein metabolic process (GO:0051248),0.4344076549854723,1.1880492207869653,0.2393617021276596,0.6955414576263846,1.0,13/48,13.11%,EDN1;AZIN1;IAPP;PFDN6;VBP1;ROCK1;MAD2L2;PRNP;PRKCG;ADGRB1;PFDN2;CLU;PIN1
prerank,response to amyloid-beta (GO:1904645),0.4420548692280337,1.1876440881838661,0.22386058981233245,0.6958874591203005,1.0,7/44,4.30%,FYN;VCAM1;ATP1A3;CACNA1A;ADRB2;APP;FCGR2B
prerank,myelination in peripheral nervous system (GO:0022011),-0.46765128676214923,-1.1871645640512167,0.2416452442159383,0.6922233771597374,1.0,6/13,19.93%,ADGRG6;DICER1;PARD3;LGI4;SIRT2;NF1
prerank,neutrophil degranulation (GO:0043312),0.3568610828597577,1.1866311655752335,0.11370558375634518,0.6978245190293145,1.0,59/425,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,regulation of cell cycle (GO:0051726),0.3649046467088159,1.1862979219206564,0.16149068322981366,0.6979481673677701,1.0,32/271,9.52%,MECOM;NANOS3;AFAP1L2;IRF6;GATA6;APBB2;FOXO4;NOTCH1;DUSP1;ADARB1;DAB2IP;TTC28;TGFB2;RHOB;IQGAP1;BOP1;RPRM;PPP1R13B;GMNC;ASAH2;GATA3;PDCD4;MADD;UHMK1;WHAMM;GADD45G;APC;PIM3;NEK7;JUN;ADAM10;MLF1
prerank,regulation of osteoblast proliferation (GO:0033688),-0.44200217333891995,-1.185978726825853,0.23391812865497075,0.693660688805933,1.0,6/17,20.45%,FGFR2;NPR3;PLXNB1;ATRAID;CCN1;MN1
prerank,regulation of activin receptor signaling pathway (GO:0032925),0.5237529096205426,1.1853073718955849,0.26810477657935283,0.7000018181367392,1.0,6/15,15.16%,SMAD7;FKBP1A;ACVR1;ACVR2A;CSNK2B;ACVR2B
prerank,base conversion or substitution editing (GO:0016553),0.5583239977009021,1.1843553567752927,0.2918825561312608,0.7018921490590528,1.0,2/11,8.99%,ADARB1;ADAR
prerank,cellular response to thyroid hormone stimulus (GO:0097067),0.5553452335753177,1.1841095067980993,0.28338762214983715,0.7018437732020736,1.0,2/12,5.91%,LMO2;BRD8
prerank,neutrophil activation involved in immune response (GO:0002283),0.35588560749905374,1.1836854858888965,0.1105476673427992,0.7022768102509094,1.0,59/428,12.10%,PTPRJ;PECAM1;PTPRB;CEACAM1;STK10;IRAG2;ADGRE5;CD93;B2M;STOM;IQGAP1;DIAPH1;ANXA3;NRAS;ANO6;PSMD13;TSPAN14;MANBA;SRP14;ENPP4;TUBB;ACTR1B;GPI;PPIE;TNFRSF1B;ARG1;MAPK1;OSCAR;TUBB4B;CD47;ITGAM;PLD1;VAMP8;HSPA1B;KPNB1;CCT8;CRACR2A;ARPC5;SLC15A4;VAMP7;ROCK1;DSP;DSN1;HMOX2;ADAM10;NFASC;HMGB1;PSMA5;TYROBP;DYNLL1;CYFIP1;RAC1;CYBA;EEF2;TRPM2;CCT2;PSMD14;ILF2;DOCK2
prerank,regulation of cell-cell adhesion involved in gastrulation (GO:0070587),0.5639620287003841,1.1834209133097706,0.2957983193277311,0.7015759907263847,1.0,2/10,3.83%,APOA1;KLF4
prerank,negative regulation of heterotypic cell-cell adhesion (GO:0034115),0.5639620287003841,1.1834209133097706,0.2957983193277311,0.7015759907263847,1.0,2/10,3.83%,APOA1;KLF4
prerank,high-density lipoprotein particle remodeling (GO:0034375),0.5385231072957912,1.183354617975636,0.2922824302134647,0.7010101351395722,1.0,3/15,5.63%,APOA1;LCAT;PLTP
prerank,activation of GTPase activity (GO:0090630),0.396044582783299,1.1827683876308122,0.21311475409836064,0.7018568458013998,1.0,25/89,13.86%,RABGAP1;SIPA1L2;ARHGEF15;ABR;SIPA1L3;RALGAPA1;BCR;TBC1D30;SGSM1;TBC1D8;TIAM2;RANGAP1;ARHGAP25;TBC1D12;TBC1D5;TBC1D1;RAP1GAP2;TAX1BP3;RALGAPB;USP6NL;TBC1D10A;TBC1D4;TBC1D9;RALGAPA2;ARHGEF10
prerank,positive regulation of chemokine production (GO:0032722),0.43693522292728476,1.182393315046505,0.24338624338624337,0.7021212990543559,1.0,8/44,9.50%,F2RL1;LGALS9;APP;TLR3;TIRAP;ADAM17;EGR1;HMGB1
prerank,negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),0.5724712889566825,1.1818084218429294,0.2917369308600337,0.7023208576477235,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,negative regulation of cell morphogenesis involved in differentiation (GO:0010771),0.5724712889566825,1.1818084218429294,0.2917369308600337,0.7023208576477235,1.0,4/12,14.51%,EFNA5;ACTN4;ITGB1BP1;SPRY4
prerank,regulation of actin cytoskeleton reorganization (GO:2000249),0.45172270613770604,1.1816733127213714,0.27097661623108665,0.7019556964762105,1.0,8/35,11.28%,TEK;F11R;ESAM;FES;ARHGDIA;STAP1;TJP1;TRPM2
prerank,regulation of epithelial cell proliferation (GO:0050678),0.3985258704580417,1.1814569995975073,0.24029126213592233,0.7018339166061213,1.0,11/85,4.45%,SGPP2;TIE1;TBX1;ACVRL1;NOD2;B2M;DAB2IP;AQP11;PRKD1;TGFB2;ANGPT1
prerank,positive regulation of dendrite development (GO:1900006),-0.5080564420344756,-1.1809594122648492,0.2753623188405797,0.7060359570672861,1.0,4/10,2.62%,PTN;BMP5;BMP7;COBL
prerank,negative regulation of canonical Wnt signaling pathway (GO:0090090),0.3739432714965118,1.1809183675493142,0.19052744886975242,0.7026312850737342,1.0,38/161,16.04%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;PSMC6;LZTS2
prerank,regulation of chondrocyte differentiation (GO:0032330),-0.3954232121923917,-1.1808731362175455,0.20481927710843373,0.7043611489629272,1.0,4/24,1.40%,SOX5;ADAMTS12;EFEMP1;TGFBR1
prerank,regulation of actin filament depolymerization (GO:0030834),0.5675479566684202,1.1808040020704393,0.2816666666666667,0.7022322005301754,1.0,3/12,7.47%,LIMA1;F2RL1;WDR1
prerank,dopamine metabolic process (GO:0042417),0.5156634203862618,1.1806839928056028,0.2792511700468019,0.7018076541481806,1.0,4/18,4.43%,TGFB2;GCH1;ATP7A;MAOA
prerank,"antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",0.41268318171195423,1.18003050912459,0.22715736040609136,0.7028504896384897,1.0,25/67,18.86%,B2M;PSMD13;FCGR1A;PSMD4;VAMP8;PSMA5;PSMB10;TAP1;PSMB8;CYBA;PSMD14;PSMA7;PSMC3;TAPBP;PSMA8;PSMC1;PSMB5;PSMC5;NCF2;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,peptide metabolic process (GO:0006518),-0.3096368730927908,-1.1799425881896761,0.17277486910994763,0.7050754619381261,1.0,20/75,14.82%,AEBP1;CPQ;DMD;BACE2;ANPEP;GSTT1;MGAT3;CPE;BACE1;HM13;CARNMT1;CPXM2;GSTZ1;CPXM1;ENPEP;ETHE1;SPCS3;CLN5;GSTA3;GSTM1
prerank,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5176472999425706,1.179932388105831,0.2670807453416149,0.7024062432915232,1.0,7/18,20.34%,HIP1R;TMEM14A;FZD9;GSK3A;BID;GSK3B;ACAA2
prerank,phosphatidylcholine biosynthetic process (GO:0006656),0.4588199473869745,1.1796125413103786,0.2732474964234621,0.7025719955743696,1.0,9/32,14.92%,APOA1;SLC44A1;LCAT;PCYT1A;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B
prerank,response to endoplasmic reticulum stress (GO:0034976),0.3869923863532196,1.1795582108758844,0.22451317296678122,0.7020106158628395,1.0,25/107,20.25%,RASGRF2;ATP2A3;DAB2IP;RHBDD1;RNF185;UFM1;BBC3;MBTPS2;HSP90B1;JUN;BAG6;TMX1;PPP1R15B;EIF2S1;RNF139;UBXN6;NCK1;SEL1L;TRIB3;CCDC47;SELENOK;DNAJC10;ERN1;RNF5;GSK3B
prerank,protein-containing complex subunit organization (GO:0043933),0.3849819672846544,1.1795101965529415,0.21232876712328766,0.7014409793320534,1.0,21/109,15.93%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;CARD10;TRAF1;CD247;IL1RAP;APC;NUP54;NUP35;RANBP9;TAPBP;CAPG;PPIH;KPNA3;CLDN14;VIL1;NUP205
prerank,positive regulation of protein localization to plasma membrane (GO:1903078),-0.33371082010981723,-1.1790079078900617,0.18548387096774194,0.7060253142183276,1.0,11/52,9.70%,EGFR;LRP1;EPHA3;SORBS1;PTPN9;STX4;PIK3R1;CLIP3;PRKCI;STX3;CNST
prerank,positive regulation of glucose metabolic process (GO:0010907),-0.45177527588080973,-1.1788679168629062,0.26541554959785524,0.7045075856398447,1.0,5/14,16.52%,IRS2;IRS1;GPLD1;SLC45A3;NNMT
prerank,defense response to Gram-positive bacterium (GO:0050830),0.44483796270700426,1.1788608193391712,0.2554347826086957,0.7024715017817332,1.0,13/40,20.92%,GBP4;TIRAP;DEFA6;ADAM17;GBP2;CHGA;RNASE6;HMGB2;DROSHA;STAB2;GBP7;ANG;RPL39
prerank,regulation of protein localization to Cajal body (GO:1904869),0.5631774040228502,1.1784362161288946,0.3025210084033613,0.702164974923045,1.0,7/11,23.98%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,positive regulation of protein localization to Cajal body (GO:1904871),0.5631774040228502,1.1784362161288946,0.3025210084033613,0.702164974923045,1.0,7/11,23.98%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3
prerank,negative regulation of myeloid leukocyte differentiation (GO:0002762),0.46933848008230705,1.1783832885134269,0.27412587412587414,0.701600647120752,1.0,3/26,3.64%,CEACAM1;GPR137B;TLR3
prerank,Fc-epsilon receptor signaling pathway (GO:0038095),0.38186842017579886,1.1782437290608305,0.21142857142857144,0.7012716571908016,1.0,36/109,20.61%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3;PSMB2;TAB1
prerank,negative regulation of viral transcription (GO:0032897),0.5392340165431828,1.1774552318322296,0.2897822445561139,0.7026661721788575,1.0,2/13,4.67%,TRIM14;TRIM11
prerank,epithelial cell morphogenesis (GO:0003382),0.5113089179510045,1.1771308027897065,0.288,0.7027896218240779,1.0,2/17,3.32%,CCDC88C;SIPA1L3
prerank,regulation of release of sequestered calcium ion into cytosol (GO:0051279),0.42933094431053553,1.1771129415611388,0.2631578947368421,0.7021117915152952,1.0,4/48,4.95%,NOS1;FKBP1A;DIAPH1;CAMK2D
prerank,antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.4566810529442118,1.1769148923538306,0.2571428571428571,0.7019297765199886,1.0,10/32,21.23%,DEFA6;GALP;GAPDH;RPL30;RNASE6;FAM3A;CXCL10;ANG;RPL39;RPS19
prerank,BMP signaling pathway (GO:0030509),0.41664798247784157,1.17687512517246,0.23018867924528302,0.7013039122971038,1.0,10/62,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,regulation of protein kinase B signaling (GO:0051896),0.36781854110780243,1.1768186164506222,0.18622174381054898,0.7007527694328419,1.0,22/193,9.49%,PTPRJ;TEK;ENG;HIP1;PDGFB;FYN;KITLG;INSR;INPP5K;RRAS;ANGPT1;GCNT2;HYAL2;FGFR3;PLEKHA1;IAPP;GATA3;MFHAS1;THPO;PPP2R5C;PTK2;RTN4
prerank,negative regulation of cytokine production (GO:0001818),0.3748377187069729,1.1768113346593738,0.17869034406215317,0.7000632453519584,1.0,30/163,11.23%,CEACAM1;RPS6KA5;F2RL1;IFIH1;LGALS9;HOMER2;HDAC9;HDAC7;UBA7;APOA1;KLF4;FCGR2B;LEF1;CD34;RNF125;PDCD4;ZC3H12A;CMKLR1;ARRB1;CD200;NLRC5;ACOD1;CACTIN;HMGB1;PRNP;TRIM25;TYROBP;RAC1;VSIR;LAPTM5
prerank,regulation of DNA metabolic process (GO:0051052),-0.3391462618617207,-1.176252787114695,0.20363636363636364,0.7100263856926861,1.0,13/44,14.43%,NUCKS1;UBE2V2;UBE2N;USP1;KPNA1;YLPM1;HELB;THOC1;WDR70;SUB1;MPHOSPH8;MPV17;XRCC5
prerank,arachidonate transport (GO:1903963),0.5644059232709526,1.1761093201660116,0.30642504118616143,0.7006199685782447,1.0,1/10,1.04%,ACE
prerank,arachidonic acid secretion (GO:0050482),0.5644059232709526,1.1761093201660116,0.30642504118616143,0.7006199685782447,1.0,1/10,1.04%,ACE
prerank,L-alpha-amino acid transmembrane transport (GO:1902475),-0.38296972309098615,-1.1758964640205989,0.21864951768488747,0.7091235432488298,1.0,8/27,14.19%,SLC1A3;SLC7A2;SLC47A1;SLC25A13;SLC6A9;SLC38A5;SLC1A4;SLC25A12
prerank,positive regulation of secretion by cell (GO:1903532),0.40614427774548845,1.175806898314335,0.22932330827067668,0.7007331616367266,1.0,20/70,19.57%,EDN1;CD2AP;CADPS2;UNC13B;TGFB2;TMED10;IL1A;CLASP1;CLASP2;CADPS;ACHE;RAB27B;STXBP5;GOLPH3L;RAB27A;GOLPH3;PPID;SOX11;MYO18A;ANG
prerank,positive regulation of neutrophil migration (GO:1902624),-0.4316563580603596,-1.175708673751618,0.273224043715847,0.7077545168870397,1.0,11/18,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,cortical actin cytoskeleton organization (GO:0030866),-0.41180499092598305,-1.175392999422008,0.23795180722891565,0.7067183684666397,1.0,3/20,2.40%,FMNL2;ROCK2;RHOQ
prerank,positive regulation of lymphocyte activation (GO:0051251),0.4688501571676427,1.175382851908068,0.2471590909090909,0.7011919269379382,1.0,4/28,10.12%,NOD2;SH3KBP1;CD47;TYROBP
prerank,cAMP-mediated signaling (GO:0019933),-0.3945555182516567,-1.1747877862444231,0.238562091503268,0.7065699404404435,1.0,6/24,5.64%,PDE7B;PDE3A;ADCY1;ADGRG6;KSR1;ADCY2
prerank,positive regulation of actin cytoskeleton reorganization (GO:2000251),0.5180409448119775,1.1744870848030815,0.3035143769968051,0.7028989384891573,1.0,3/17,9.11%,TEK;FES;STAP1
prerank,ventricular cardiac muscle cell action potential (GO:0086005),0.5247330622546621,1.1742717416485258,0.27769110764430577,0.7027465441372996,1.0,2/17,1.44%,KCNQ1;KCNE3
prerank,regulation of ERAD pathway (GO:1904292),0.557670482566478,1.1739405551847943,0.2857142857142857,0.7029638354939397,1.0,3/11,11.00%,AQP11;RNF185;BAG6
prerank,positive regulation of granulocyte chemotaxis (GO:0071624),-0.4294682900187571,-1.173511170760852,0.24649859943977592,0.7083332059745853,1.0,11/19,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,response to tumor necrosis factor (GO:0034612),0.38863266668558416,1.1725722558983391,0.22823529411764706,0.7060004909556439,1.0,21/91,11.66%,MAP4K3;ARHGEF2;DAB2IP;CASP8;GCH1;INPP5K;HYAL2;GBP3;GATA3;ZC3H12A;JAK2;NFE2L2;NR1D1;ACOD1;CACTIN;ZFP36L2;ADAM10;DHX9;CCL4;GBP2;BRCA1
prerank,cellular response to metal ion (GO:0071248),0.37863524138015825,1.1725424866502174,0.22310305775764439,0.7053662052218768,1.0,19/123,9.97%,PLCG2;SYT15;ITPKB;B2M;CPNE8;RASGRP2;IQGAP1;CLIC4;SYT7;CAMK2D;MEF2C;MAPK1;CPNE2;LRRK2;MCOLN1;MT2A;PRKAA1;JUN;PRNP
prerank,oligosaccharide biosynthetic process (GO:0009312),-0.4136918974912058,-1.172320907026165,0.24932975871313673,0.7099854553742581,1.0,6/20,12.62%,B3GALT1;ST6GALNAC6;ST3GAL4;B4GALT1;MPDU1;ST6GALNAC5
prerank,positive regulation of canonical Wnt signaling pathway (GO:0090263),-0.28516385287539125,-1.1723174718016092,0.11382113821138211,0.7080975881896927,1.0,21/129,7.93%,RNF220;LGR4;WLS;EGFR;COL1A1;FGFR2;TBL1XR1;GPC3;PTK7;ZEB2;WNK1;LRRK1;PSME4;PLEKHA4;SEMA5A;DACT1;SFRP4;DAAM2;PSMF1;LYPD6;PPM1A
prerank,regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),0.5317010843825615,1.1722990618293658,0.2778649921507064,0.7053183222494823,1.0,6/15,12.26%,TNRC6C;BTG2;TENT4A;POLR2G;CNOT1;TOB1
prerank,chromatin disassembly (GO:0031498),-0.45847057996087026,-1.1722977045762644,0.26356589147286824,0.7043598076895572,1.0,3/14,10.19%,SET;SMARCB1;SMARCD1
prerank,nucleosome disassembly (GO:0006337),-0.45847057996087026,-1.1722977045762644,0.26356589147286824,0.7043598076895572,1.0,3/14,10.19%,SET;SMARCB1;SMARCD1
prerank,positive regulation of neutrophil chemotaxis (GO:0090023),-0.43986244681760356,-1.1721699748751324,0.260989010989011,0.7027775752644299,1.0,11/17,25.46%,CAMK1D;RIPOR2;NCKAP1L;MDK;DAPK2;CD74;DNM1L;MCU;C1QBP;CCL19;MOSPD2
prerank,maturation of LSU-rRNA (GO:0000470),0.4719890254844728,1.1719513814110232,0.2897058823529412,0.7055198819865841,1.0,12/26,22.66%,BOP1;RPL7;MRPL1;RPL35;RRP15;NHP2;EIF6;RPL7L1;LAS1L;FTSJ3;URB1;RPF2
prerank,positive regulation of fibroblast proliferation (GO:0048146),-0.38633877962829694,-1.1718661891647066,0.20504731861198738,0.7018357016765397,1.0,5/27,3.24%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6
prerank,proteoglycan metabolic process (GO:0006029),-0.38879927889986043,-1.1718644213915645,0.21405750798722045,0.6999841178057301,1.0,5/26,5.21%,IGF1;ADAMTS12;SULF1;SULF2;XYLT1
prerank,negative regulation of T-helper cell differentiation (GO:0045623),0.5643993476292171,1.1715978901244362,0.2991596638655462,0.7057690171893902,1.0,2/11,7.01%,SMAD7;ZC3H12A
prerank,negative regulation of protein processing (GO:0010955),-0.4730615199708245,-1.1715514511835978,0.26730310262529833,0.6990315864641126,1.0,5/12,13.59%,GAS1;SERPINE2;THBS1;SERPINE1;SNX12
prerank,positive regulation of microtubule polymerization (GO:0031116),0.469730073935123,1.1713735348632859,0.2565597667638484,0.705666821207448,1.0,8/28,14.42%,OCLN;FES;CLIP1;CLASP1;HSPA1B;RAC1;NUMA1;NAV3
prerank,"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",0.41343820727299624,1.1712768619505558,0.24567901234567902,0.7052388052363755,1.0,9/72,11.55%,ACER2;PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7
prerank,positive regulation of dendrite extension (GO:1903861),0.5099767061166409,1.1708918297305877,0.2936378466557912,0.705578057014193,1.0,6/17,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,negative regulation of cell junction assembly (GO:1901889),-0.38688697224277047,-1.170756743664607,0.2367601246105919,0.699633667253724,1.0,7/25,8.25%,ARHGAP6;PHLDB2;ROCK2;APOD;THBS1;SRC;BCAS3
prerank,protein localization to membrane (GO:0072657),0.36625529490222053,1.1707555485823848,0.20364415862808147,0.7052180965324609,1.0,31/187,10.72%,EHD4;EFR3B;RAPGEF2;F11R;RAB11A;TMEM88;CAV1;ZDHHC22;PACS1;EMP2;AGRN;INPP5K;FCHO2;TSPAN14;EHD1;DPP6;RAB34;DPP10;RAPGEF6;SHANK3;TSPAN32;PACSIN1;MRAP2;BSG;ROCK1;NUP54;RAB40B;CLASP2;NKD2;TM9SF1;PDZD11
prerank,response to interferon-beta (GO:0035456),0.48883136532424687,1.170367008857365,0.28484848484848485,0.7055536418968389,1.0,6/22,8.74%,AIM2;TRIM6;IRGM;STAT1;PLSCR1;ACOD1
prerank,arachidonic acid metabolic process (GO:0019369),-0.355774234876185,-1.1703083064738482,0.175,0.6990937747416945,1.0,11/35,23.06%,PTGDS;PTGES;PTGS1;PLA2G4A;EPHX2;CYP2A6;ALOX12;PLA2G4C;FAAH;GPX4;GPX1
prerank,regulation of dendrite extension (GO:1903859),0.5036895907397119,1.170095858567719,0.2917341977309562,0.7055739429976122,1.0,6/18,18.29%,ITSN2;NEDD4L;SMURF1;RASAL1;SYT1;SYT2
prerank,positive regulation of axon extension (GO:0045773),0.48668592516887765,1.1700844875612009,0.27956989247311825,0.7048967536417151,1.0,5/22,7.01%,MACF1;NTN1;SHTN1;SEMA7A;ISLR2
prerank,"G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4255077920991872,1.1699868141836949,0.2588699080157687,0.7044892887822342,1.0,10/53,16.45%,CCR1;HRH2;CHRM3;HTR5A;MTNR1B;HTR1B;HTR2A;HTR1F;HRH3;HTR4
prerank,negative regulation of amyloid fibril formation (GO:1905907),0.5404610622604439,1.1698386482558754,0.28187919463087246,0.7042060660691174,1.0,5/12,11.83%,IAPP;PFDN6;VBP1;PFDN2;CLU
prerank,peptidyl-proline hydroxylation (GO:0019511),-0.5049992990801848,-1.169770698222885,0.29024390243902437,0.6987291119008172,1.0,7/11,27.19%,P4HA1;EGLN3;P4HTM;P3H2;P4HB;P4HA3;OGFOD1
prerank,cellular response to interleukin-12 (GO:0071349),0.4346073030299142,1.169203065016517,0.26506024096385544,0.7052403543040087,1.0,12/48,15.69%,PLCB1;GSTA2;MSN;PDCD4;CD47;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,central nervous system neuron development (GO:0021954),0.5284703492793468,1.1689938850680632,0.2822458270106222,0.7050841694612668,1.0,3/15,9.87%,RAPGEF2;ATP7A;B4GALT6
prerank,"positive regulation of transcription, DNA-templated (GO:0045893)",0.3474829641747906,1.1689210900204086,0.035,0.704568192463455,1.0,156/1082,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;JAG1;NOTCH4;EDN1;AFAP1L2;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;PLCB1;PDGFB;LDB2;BMPR2;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;ACVRL1;NOTCH1;NOD2;FOXO1;ELK3;NR1I3;HEY1;ARHGEF2;TAL1;KLF7;DAB2IP;IRF2;PRKD1;ZNF296;F2RL1;HNF1A;HNF4A;AGRN;KLF6;APP;ZGLP1;SOX18;HHEX;FLI1;PELP1;INPP5K;HEY2;TLR3;KLF4;IER5;ACVR1;ING2;WWTR1;SERTAD2;LEF1;BCLAF3;SERTAD1;MAFF;KARS1;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;ZBTB48;FOSL2;BRD8;APEX1;GATA3;TOX3;RXRG;CHCHD2;SETX;RYBP;ZBTB16;FANK1;ZC3H12A;KDM3A;PPP3CA;STAT1;GAL;AATF;MAPRE3;EBF3;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;DNAJC2;UBA52;NFE2L2;NAMPT;RPS27A;MRTFA;KMT2E;NR1D1;KMT2B;JUN;SERTAD3;TCF3;EGR1;HMGB1;DHX9;SS18;PLAG1;SEC14L2;MAD2L2;ASF1A;RPS6KA1;SFR1;RPRD1B;NFKBIA;TET3;TNKS;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;PCBP1;EAF2;E2F7;BRCA1;NR4A1;CD38;ILF2;HELZ2;DTX3L;PRKD2;SOX10;HINFP;MED30;IRF5;SETD3;ELF2;CTBP2;GLYR1;RPS6KA3;YWHAH;PSMC3;ITGB1BP1;PIN1;POU3F2
prerank,cellular response to interleukin-4 (GO:0071353),0.5620384023280233,1.1687727835726878,0.28859060402684567,0.704274932870996,1.0,2/10,6.03%,LEF1;GATA3
prerank,connective tissue development (GO:0061448),-0.36359107800421625,-1.1684298800800559,0.24503311258278146,0.7007812796459256,1.0,7/35,5.81%,SOX5;SULF1;SULF2;TRIP11;SH3PXD2B;ITGB8;SLC39A13
prerank,RNA transport (GO:0050658),-0.3155063689717448,-1.1682201142402417,0.1702127659574468,0.6995792953657106,1.0,32/71,26.04%,SIDT1;SRSF5;HNRNPA2B1;NCBP1;CKAP5;SRRM1;ATXN2;SRSF1;NUP155;SRSF6;THOC1;SIDT2;RTRAF;TGFBR2;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;SRSF3;KIF5C;SLBP;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,B cell homeostasis (GO:0001782),-0.4989870482910734,-1.1677701832395313,0.28780487804878047,0.6990828870894336,1.0,3/10,12.11%,DOCK11;DOCK10;NCKAP1L
prerank,antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.4749548104225813,1.1677182892839335,0.28466076696165193,0.7064113949131884,1.0,6/24,13.20%,ACE;B2M;MFSD6;TAP1;SEC24B;TAPBP
prerank,excitatory postsynaptic potential (GO:0060079),0.49855526664303423,1.1676046195358096,0.27136431784107945,0.7060092798094211,1.0,8/19,20.25%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B
prerank,negative regulation of myeloid cell differentiation (GO:0045638),-0.4114430068008922,-1.1672893651782767,0.25386996904024767,0.6987395948024487,1.0,9/20,20.52%,LDB1;MEIS1;PAF1;HOXA5;CTR9;MAFB;HOXB8;ZFP36;CIB1
prerank,microtubule anchoring (GO:0034453),0.524982072256808,1.166610193706559,0.2636986301369863,0.7079981264484629,1.0,4/12,9.92%,SAXO1;CLASP1;PCM1;CLASP2
prerank,positive regulation of sodium ion transmembrane transporter activity (GO:2000651),-0.4676781375397672,-1.166299157913643,0.26216216216216215,0.699749470945442,1.0,3/14,3.67%,DMD;WNK1;WNK4
prerank,amide transport (GO:0042886),0.4661529203251411,1.1662928281813036,0.2691751085383502,0.7081653372087655,1.0,6/26,9.87%,AQP11;SLC25A32;PLTP;GLTP;CERT1;TAP1
prerank,negative regulation of viral release from host cell (GO:1902187),0.5271127039532516,1.1660927026694623,0.28503937007874014,0.7080203757777855,1.0,4/13,20.82%,TRIM11;TRIM8;CHMP3;MID2
prerank,cochlea morphogenesis (GO:0090103),0.5595845525820616,1.165779143691537,0.29931972789115646,0.7081992546726662,1.0,1/10,1.26%,TBX1
prerank,xenobiotic transport (GO:0042908),-0.44171587288510816,-1.1648306317109687,0.2845953002610966,0.7021719445747454,1.0,3/16,7.11%,SLC47A1;GJA1;SLC22A4
prerank,regulation of innate immune response (GO:0045088),0.4152779838814189,1.1646281150823607,0.26540880503144654,0.7106344171204119,1.0,12/57,10.63%,GBP5;CASP8;TIRAP;FCGR2B;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;CACTIN;DHX9;PTPN1
prerank,proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.48013973322327597,1.164247591997958,0.28313253012048195,0.7109213362658015,1.0,12/22,20.43%,NFE2L2;PSMA5;PSMB10;ENC1;PSMB8;PSMA7;PSMA8;PSMB5;PSMB9;PSMA4;PSMB6;PSMB2
prerank,anterograde trans-synaptic signaling (GO:0098916),0.3596183789817111,1.1635519440175686,0.17653167185877466,0.7120905885401381,1.0,71/224,22.10%,UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SNCG;HRH2;AKAP5;GABRQ;CHRM3;HCRTR1;MAPK1;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK2;MINK1;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;NPTX2;PCDHB14;GRIK1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;APBA2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP;GABRB3;NLGN1;KCNIP2;PDYN
prerank,"protein alpha-1,2-demannosylation (GO:0036508)",0.489198316689093,1.1635317208402711,0.2844311377245509,0.7114376049807208,1.0,9/22,21.60%,RNF103;RNF185;UBA52;RPS27A;UGGT1;RNF139;SEL1L;RNF5;UBB
prerank,carbohydrate transport (GO:0008643),0.5541331847893877,1.1634811549725248,0.30472854640980734,0.7108835909610975,1.0,1/11,2.23%,AQP11
prerank,membrane protein intracellular domain proteolysis (GO:0031293),0.4826016280997049,1.1634694237359036,0.3013698630136986,0.7102002141809824,1.0,10/20,20.99%,SPPL2A;RHBDD1;ADAM17;MBTPS2;APH1A;ADAM10;PSEN2;RELA;APH1B;SPPL2B
prerank,regulation of nervous system process (GO:0031644),0.49386559227576526,1.16305990426527,0.2917316692667707,0.7106224437649924,1.0,2/18,2.98%,NOS3;APP
prerank,cardiac muscle cell development (GO:0055013),0.49159905637794654,1.1626616309075724,0.2859399684044234,0.7110090604146456,1.0,5/20,4.46%,SORBS2;HEY2;SLC8A1;ALPK3;PDLIM5
prerank,inner ear morphogenesis (GO:0042472),-0.39473986934295435,-1.1626204337710557,0.24375,0.7064193732248861,1.0,4/22,7.10%,ZIC1;FGFR2;TBX18;SIX1
prerank,actin cytoskeleton reorganization (GO:0031532),0.41142453144741503,1.1622269948429207,0.2619647355163728,0.711449528392064,1.0,11/63,7.08%,TRPV4;S1PR1;PLEK2;THSD7A;PARVB;CDC42BPA;NEDD9;CDC42BPG;ATP2C1;MYH9;WHAMM
prerank,regulation of cysteine-type endopeptidase activity (GO:2000116),0.4894875346884281,1.1620119983641077,0.3010279001468429,0.7113406064172424,1.0,7/21,16.66%,FYN;AIM2;GRIN2B;DELE1;TTBK1;PSMB9;PYCARD
prerank,negative regulation of cellular response to growth factor stimulus (GO:0090288),0.39816696681499353,1.161551199862807,0.25609756097560976,0.7119116846652079,1.0,9/79,3.31%,MMRN2;SMAD6;BMPR2;SMAD7;NOTCH1;ATP2B4;DAND5;DAB2IP;HHEX
prerank,negative regulation of leukocyte migration (GO:0002686),-0.4948304390129382,-1.161538520497749,0.2652582159624413,0.7076128725213248,1.0,4/10,15.59%,BMP5;SLIT2;HOXA7;CD300A
prerank,organophosphate catabolic process (GO:0046434),-0.46611393108294985,-1.1610484890324135,0.2975609756097561,0.7072670162229191,1.0,8/11,47.54%,ABHD12;ENPP2;ANGPTL3;PLBD2;PLBD1;NUDT15;PDXP;PON1
prerank,regulation of postsynapse organization (GO:0099175),0.4583288589483862,1.1607229511097816,0.27705627705627706,0.713376585679529,1.0,9/28,15.66%,TANC2;FCGR2B;PDLIM5;SHANK3;LRRK2;PPFIA2;VPS35;CFL1;KIF1A
prerank,signal transduction in response to DNA damage (GO:0042770),0.4243784872521694,1.1603096725409623,0.28063241106719367,0.7137843436866755,1.0,15/49,19.44%,ACER2;MAD2L2;BRIP1;E2F7;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;MAPK14;TIPRL;ATRIP;BID;HUS1
prerank,negative regulation of cellular macromolecule biosynthetic process (GO:2000113),0.34784740299722267,1.1601727847907914,0.12209889001009082,0.7134482962096966,1.0,65/497,12.28%,PRDM16;NANOS1;MECOM;SOX13;NANOS3;GATA6;PLCB1;PDGFB;DACH1;BMPR2;RPS6KA5;SMARCA2;ACVRL1;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;BTG2;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;GMNC;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;PASK;GATAD2A;NR1D1;GAPDH;FOXP1;MBD1;JUN;ARID5A;ZBTB14;CNOT1;ENC1;CDAN1;DEAF1;SAMD1;DMAP1;BRCA1;CD38;ARID5B;HINFP;TOB1;SUV39H2
prerank,positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.374598344098595,-1.1599127168470116,0.23843416370106763,0.7086968593578207,1.0,7/29,6.78%,IGF1;NOTCH2;ITGAV;SHC1;NGF;IRS2;SRC
prerank,positive regulation of organelle organization (GO:0010638),0.46024193235928124,1.1597155916730266,0.28085106382978725,0.7139726533099615,1.0,10/32,12.53%,DOC2B;ADRB2;SMCR8;P2RX7;IRGM;FYCO1;RAB3GAP2;PFDN2;TMED9;SORBS3
prerank,maintenance of gastrointestinal epithelium (GO:0030277),0.5489970410354358,1.1591219214951234,0.30132450331125826,0.7148233833576882,1.0,1/12,1.72%,NOD2
prerank,activation of NF-kappaB-inducing kinase activity (GO:0007250),0.5259380659280971,1.1584152037174675,0.3085808580858086,0.7160487931010179,1.0,4/14,12.25%,TLR3;TIRAP;CARD10;COPS8
prerank,positive regulation of phosphate metabolic process (GO:0045937),-0.3881542430009849,-1.1584146966202904,0.2326283987915408,0.7112210014261087,1.0,7/25,12.11%,EGFR;THBS1;SRC;FZD7;SDCBP;PTH1R;NCKAP1L
prerank,exonucleolytic catabolism of deadenylated mRNA (GO:0043928),0.46543542246190645,1.158092340353734,0.27323943661971833,0.7162177355860175,1.0,10/29,18.99%,LSM1;EXOSC3;DCPS;DCP1B;EXOSC8;EDC3;NT5C3B;DDX6;EXOSC9;LSM2
prerank,mononuclear cell differentiation (GO:1903131),-0.39413863887105316,-1.1579621957266073,0.24025974025974026,0.7106547644291874,1.0,8/24,16.50%,AXL;BMP4;IL31RA;MT1G;VEGFA;PPARG;RELB;FLT3
prerank,central nervous system myelination (GO:0022010),0.5638889253031318,1.157893954725375,0.31788079470198677,0.7160736754564575,1.0,4/11,12.09%,B4GALT6;TENM4;CLU;SOX10
prerank,nucleotide-sugar metabolic process (GO:0009225),-0.46678238343690726,-1.1576963807352927,0.2849604221635884,0.7096206302600849,1.0,7/12,28.08%,GMDS;EXTL2;GFPT1;GFPT2;PARG;CSGALNACT1;GALT
prerank,regulation of developmental growth (GO:0048638),0.45610171977786346,1.157422452804569,0.2727272727272727,0.7166744791277492,1.0,6/29,7.89%,PLCB1;SPAAR;INSR;APP;FGFR3;NRCAM
prerank,regulation of adenylate cyclase activity (GO:0045761),-0.3963305252135181,-1.1573748175606586,0.2469879518072289,0.7087824839956458,1.0,9/22,19.93%,CACNA1C;ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB;CAP2;NF1
prerank,positive regulation of protein transport (GO:0051222),0.40235954129630175,1.1558206886534397,0.25667090216010163,0.7202849034676438,1.0,21/67,19.57%,CD2AP;UNC13B;PLK3;TGFB2;ATP2C1;TMED10;IL1A;PRR5L;PCM1;VPS28;RIPOR1;ACHE;ICE1;PDCD10;RACK1;TENM1;GOLPH3L;GOLPH3;PPID;MYO18A;ANG
prerank,polyamine metabolic process (GO:0006595),0.530090087642803,1.1557166285692388,0.30293159609120524,0.7198794822556982,1.0,3/13,11.17%,AMD1;PAOX;SMS
prerank,positive regulation of lymphocyte chemotaxis (GO:0140131),0.5264268088753657,1.1555173144496302,0.3034257748776509,0.7196775915171019,1.0,5/14,10.16%,OXSR1;ADAM17;STK39;ADAM10;CCL4
prerank,peptidyl-glutamic acid modification (GO:0018200),0.4780359677948368,1.1551686796845724,0.3023255813953488,0.7199027204233336,1.0,7/24,16.38%,TTLL8;TTLL7;TTLL1;TTLL10;TTLL5;TTLL11;VKORC1
prerank,regulation of insulin secretion (GO:0050796),0.3851434591387384,1.1549980294395605,0.2532239155920281,0.7196376549034706,1.0,13/101,8.68%,MYRIP;EFNA5;ITPR3;SLC2A1;DOC2B;CACNA1A;HNF4A;SYT7;RAPGEF4;GLUD1;SIRT4;MTNR1B;NR1D1
prerank,protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.5141085080477588,-1.1546748258102002,0.321256038647343,0.7148793066900361,1.0,3/10,9.21%,EMC2;EMC7;EMC1
prerank,regulation of viral transcription (GO:0046782),0.4338931899300422,1.1544414092640358,0.27385892116182575,0.720450315892035,1.0,14/39,23.64%,TRIM14;TRIM11;POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;IFITM3;MID2;HEXIM1;POLR2C;POLR2B;POLR2J
prerank,regulation of response to biotic stimulus (GO:0002831),0.46240355502827024,1.1543976412628603,0.28550295857988167,0.7198769175477611,1.0,4/28,4.30%,GATA6;CASP8;TIRAP;FCGR2B
prerank,response to thyroid hormone (GO:0097066),0.5388267808761246,1.154058802142087,0.3106312292358804,0.7200883172232695,1.0,2/13,5.91%,LMO2;BRD8
prerank,positive regulation of developmental process (GO:0051094),-0.27819193482725196,-1.1537785801666196,0.13131313131313133,0.7155919786132989,1.0,29/164,9.46%,PHLDB2;PTN;BMPR1A;SOX5;DCN;FOXD1;CCN2;BMP5;BMP7;BMP4;COBL;WNT5A;GRIP1;APOE;GJA1;ADGRL1;DLG4;LMNA;RREB1;PRKN;DDHD1;CAMK1;DAG1;SRC;KMT5C;SYDE1;CEBPB;VEGFA;ACVR1B
prerank,positive regulation of mRNA processing (GO:0050685),-0.4010493004548037,-1.153431806176739,0.26791277258566976,0.7147548776808423,1.0,6/21,12.36%,SNW1;RBMX;NCBP1;DAZAP1;PAF1;TRA2A
prerank,protein homooligomerization (GO:0051260),0.3763767871085208,1.1527754229288607,0.23875432525951557,0.7228302405536533,1.0,18/114,11.88%,EHD4;GBP5;B2M;AQP11;ATL2;GLS;EHD1;SSBP1;ATL1;ELAVL1;ALDH9A1;MCOLN1;MLKL;ACOT13;ACACB;TRPM2;TRMT61B;SLC1A2
prerank,extrinsic apoptotic signaling pathway (GO:0097191),0.4046043065107607,1.1526852091072763,0.2618757612667479,0.7224079774972211,1.0,23/70,20.25%,FAS;DAB2IP;CASP8;TGFB2;TLR3;CASP2;FGFR3;TNFRSF1B;P2RX7;CRADD;BCL2L1;JAK2;DELE1;DCC;CASP8AP2;DAXX;SIVA1;GSK3A;DDX47;BID;MCL1;SORT1;GSK3B
prerank,positive regulation of BMP signaling pathway (GO:0030513),0.46233273541333325,1.151720122871485,0.29213483146067415,0.724348342621357,1.0,12/25,19.04%,ENG;BMPR2;ACVRL1;NOTCH1;SMAD2;NUMA1;TBX20;ACVR2A;ACVR2B;SMAD4;SOX11;FBXL15
prerank,acyl-CoA biosynthetic process (GO:0071616),0.49948022288275107,1.151689065957263,0.3074433656957929,0.723719580092017,1.0,2/16,3.24%,FASN;PPT1
prerank,cellular response to organic cyclic compound (GO:0071407),0.3659971466818907,1.151668441898392,0.22982062780269058,0.7230755295490385,1.0,25/141,11.66%,KCNQ1;RAPGEF2;PDGFB;RAPGEF1;ATP1A1;ATP1A3;ARL6IP5;FES;DIAPH1;INPP5K;MSN;MEF2C;ABCB4;P2RX7;ZC3H12A;LRRK2;HSP90B1;CTNNA1;NCOA4;EGR1;SPIDR;ACTB;TRPM2;SLC1A1;BRCA1
prerank,negative regulation of smooth muscle cell proliferation (GO:0048662),-0.35755891232913695,-1.1516020436852625,0.2721311475409836,0.7182487326758163,1.0,12/33,20.80%,IGFBP5;OGN;APOD;TPM1;IGFBP3;EFEMP2;PPARG;CDKN1A;GPER1;NDRG4;TGFB3;TNFAIP3
prerank,glycerophospholipid metabolic process (GO:0006650),0.3989290278438566,1.1515615677270814,0.26506024096385544,0.7226585233800294,1.0,20/75,17.34%,PLCB1;IP6K3;GPCPD1;APOA1;ACP6;LCAT;FAR1;PNPLA6;CRLS1;ABHD6;GDPD1;DGKH;ENPP6;PLCG1;SERINC5;PIGF;AGK;PIGQ;PIGC;SYNJ1
prerank,adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.5174562127314157,1.151508171194336,0.3135464231354642,0.7220980477359041,1.0,2/17,2.63%,RAPGEF2;ADRB2
prerank,ncRNA processing (GO:0034470),0.3608724297242337,1.1514547248903326,0.19719827586206898,0.721549282052731,1.0,79/200,26.74%,BOP1;PELP1;RPL27;DHX37;KARS1;SMAD2;RPL7;INTS11;TRPT1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;ADAR;WDR46;RPL21;DKC1;RPL37;FARS2;RPS28;RPL34;AGO4;RPS9;XRN2;EXOSC8;RPLP2;INTS12;RPS25;RPL30;RPL27A;NOL8;INTS5;RPL23A;RPS15;RPL19;RPL32;UTP18;DROSHA;RPL37A;RPL18A;NOB1;EXOSC9;TUT7;POP1;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;EXOSC1;FBL;WDR43;INTS6;HELQ;RPL3;UTP20;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;UTP15;RPS17;ESF1
prerank,regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.49934319759659224,1.1512704138410494,0.30914826498422715,0.7213397965126676,1.0,5/17,12.41%,FCHSD2;NCKAP1;CYFIP1;WASF2;CTNNA2
prerank,negative regulation of neurogenesis (GO:0050768),0.4453971440283157,1.1506725634798218,0.29346314325452016,0.7222554733930905,1.0,6/34,9.49%,RAPGEF2;NOTCH1;B2M;ARHGDIA;PCM1;RTN4
prerank,protein modification by small protein conjugation (GO:0032446),0.3502794030280185,1.1504389851217471,0.1592292089249493,0.7222637014087367,1.0,73/361,16.41%,LMO7;EPAS1;TRIM14;RNF103;FBXL2;TRIM69;IFIH1;CBL;HERC2;KLHL2;FBXO7;UBA7;FBXL5;KLHL3;SUMO2;SUMO3;TRIM11;TRIM6;RNF38;ELOC;ARIH1;GAN;CUL3;ARRDC1;RTF1;UBE2D1;TRIM24;UFM1;KLHL20;RANGAP1;ARRB1;WWP1;ASB5;UBA52;NFE2L2;RPS27A;NUP54;FBXW7;RBX1;ZNRF3;CUL2;TRIM47;ENC1;TRIM17;NUP35;RANBP2;NEDD4L;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;NUP153;UBE2J2;RNF103-CHMP3;KEAP1;NUP160;HIF1A;FBXO2;UBE2E1;NUP42;RAD18;CDC27;UBE2D3;RACK1;TRAIP;KLHL25;KLHL24;NUP205;ANAPC7;RNF139;KLHL9
prerank,positive regulation of tissue remodeling (GO:0034105),-0.4847679751825914,-1.149928825532278,0.29504504504504503,0.7212904241397866,1.0,1/10,0.80%,ROCK2
prerank,interstrand cross-link repair (GO:0036297),-0.3222273624497276,-1.1498653159853678,0.21052631578947367,0.7197129975448401,1.0,36/53,39.67%,NUCKS1;FAN1;USP1;ATR;FAAP100;MSH6;POLN;DCLRE1B;RFWD3;RPA3;FANCB;RNF168;RPA1;FANCI;FANCD2;FANCG;MCM8;RPA2;EXO5;RAD51;RAD51AP2;CENPX;XRCC3;FANCM;SLX4;DCLRE1C;FANCC;RAD51AP1;DCLRE1A;ERCC6L2;UBC;FAAP24;XPA;ERCC1;MCM9;FANCF
prerank,regulation of T cell mediated immunity (GO:0002709),0.5638405234928474,1.1497282994084552,0.3252032520325203,0.7235342647154188,1.0,3/10,19.95%,TNFRSF1B;HMGB1;AGER
prerank,positive regulation of transcription of Notch receptor target (GO:0007221),0.49422989526698524,1.1496433523711465,0.32428355957767724,0.7230714594441658,1.0,4/17,7.31%,NOTCH4;NOTCH1;PLXND1;STAT1
prerank,regulation of blood coagulation (GO:0030193),0.45440560025334414,1.1496024141865409,0.2821637426900585,0.7224902693902729,1.0,6/27,8.44%,EDN1;CAV1;F2RL1;ENPP4;CD34;PROC
prerank,negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5271967835565561,1.1495337720915633,0.31085526315789475,0.722015878633065,1.0,5/14,17.56%,F2RL1;APOA1;TRAIP;PTPN2;PYDC1
prerank,activation of protein kinase B activity (GO:0032148),-0.37163551176477577,-1.1495016414445756,0.24702380952380953,0.7188763826770324,1.0,9/29,11.93%,IGF1;NTRK3;FGF1;WNT5A;OSBPL8;MAPKAP1;PPIA;TXN;ADRA2A
prerank,MAPK cascade (GO:0000165),0.3492284045076165,1.1491737941275455,0.18087318087318088,0.7223094076193528,1.0,58/295,15.02%,RASGRF2;TEK;RAPGEF2;PDGFB;FYN;KITLG;DAB2IP;LGALS9;CSF2RB;APOA1;KRAS;NRAS;PSMD13;IL17RD;ANGPT1;MAP4K4;KARS1;MEF2C;FGFR3;SHANK3;CUL3;MAPK1;PSMD4;SETX;SHOC2;LRRK2;FRS3;BCL2L1;UBA52;JAK2;GRIN2B;RPS27A;PTK2;ZFP36L2;TAOK2;PSMA5;RBX1;PSMB10;MARK3;MINK1;RANBP9;PSMB8;MAP3K3;PSMD14;PIK3CB;PSMA7;PSMC3;SPTAN1;PSMA8;PSMC1;RASAL1;SOS1;PSMB5;MAP3K20;GFRA3;PSMC5;PRKG2;FGF20
prerank,negative regulation of apoptotic signaling pathway (GO:2001234),-0.3013625788021356,-1.1491695456696984,0.20245398773006135,0.7180702794962128,1.0,20/77,14.56%,IGF1;TGFBR1;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV;PRKN;NDUFS3;SRC;CFLAR;NDUFA13;BIRC6;URI1;DDX3X;QARS1;MPV17L;FXN;PIH1D1
prerank,neuromuscular synaptic transmission (GO:0007274),0.49401984103508334,1.1488805998392928,0.3069466882067851,0.7223645322528852,1.0,1/18,0.53%,FCHSD2
prerank,presynapse assembly (GO:0099054),-0.4202575862958368,-1.1487538520688652,0.2725,0.7174881618409326,1.0,7/16,31.52%,WNT5A;NLGN2;PTPRD;PCLO;NLGN3;LRP4;BSN
prerank,negative regulation of cytokine production involved in inflammatory response (GO:1900016),-0.43863743486972184,-1.148687446170542,0.2958904109589041,0.7158831613175708,1.0,4/16,6.64%,APPL2;APOD;PPARA;ADCY7
prerank,"synaptic transmission, GABAergic (GO:0051932)",0.550817509619165,1.1486185092824148,0.3190394511149228,0.7224128455480036,1.0,7/10,30.69%,GABRA4;GABRA2;GABRE;GABRG3;GABRA3;GABRB2;GABRA5
prerank,chemical synaptic transmission (GO:0007268),0.3523327471166709,1.1483496594378908,0.19979402677651906,0.7224524522861128,1.0,80/284,20.82%,FCHSD2;UNC13B;APBA1;MPZ;PTCHD1;CACNA1A;NRGN;SYN3;SNCG;HRH2;AKAP5;GABRQ;GRID1;CHRM3;HCRTR1;MAPK1;SHISA6;HTR5A;GRIA1;MTNR1B;GRIN2B;HTR1B;GRIN2C;HTR2A;ASIC2;SLC6A2;RPS6KA1;GABRA4;GRIK5;GRIK2;MINK1;PDZD11;NPY5R;HTR1F;SLC1A1;GABRA2;SLC1A2;GRM5;KCNC4;KCNA1;GABRE;RPS6KA3;PCDHB16;SYPL1;STXBP3;NPTX2;PCDHB14;ERC2;GRIK1;SLC32A1;CACNA1E;HRH3;GLRA2;PCDHB9;HTR4;CPLX1;SNPH;SST;RIT2;GRIN2A;GABRG3;NPTX1;KCNQ3;GRM7;GABRB1;EXOC4;SYT1;PENK;HAP1;SLC1A6;HTR6;NSG1;APBA2;GRID2;GIPC1;UTS2;HCRTR2;KCNK3;NRXN1;MYCBPAP
prerank,response to axon injury (GO:0048678),-0.42656420380971716,-1.1481818523014502,0.2556818181818182,0.7155757937116166,1.0,5/18,12.78%,DPYSL3;APOD;P2RX4;GAP43;NREP
prerank,negative regulation of actin filament bundle assembly (GO:0032232),-0.3806967411771958,-1.1481622690188216,0.24198250728862974,0.7138646593804465,1.0,7/27,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PRKN;PIK3R1;TMEFF2
prerank,phosphatidylinositol dephosphorylation (GO:0046856),0.47833895801934595,1.1481403167210424,0.3088235294117647,0.7223399240064893,1.0,8/23,17.34%,INPP5K;MTMR10;INPP5B;MTMR11;OCRL;INPP5F;INPP5J;SYNJ1
prerank,positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),0.39000414958412805,1.1479431878593647,0.2640382317801673,0.7221502161802291,1.0,22/78,17.93%,SMAD7;PLK3;CAV1;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;NFE2L2;RBX1;NKD2;RNF144B;CLU;KEAP1;RACK1;UBQLN2;CBFA2T3;TRIB3;SOCS5;GSK3A
prerank,anaphase-promoting complex-dependent catabolic process (GO:0031145),0.3879531244896484,1.1471857884704357,0.2750301568154403,0.7235559236311806,1.0,27/84,19.11%,PSMD13;CUL3;UBE2D1;PSMD4;PTTG1;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,regulation of dendritic spine morphogenesis (GO:0061001),0.446423988813026,1.1470187842279698,0.28291316526610644,0.7233272826025537,1.0,11/31,21.58%,TANC2;PDLIM5;EFNA1;SHANK3;LRRK2;PPFIA2;CFL1;KIF1A;LRP8;NLGN1;EPHA4
prerank,replicative senescence (GO:0090399),-0.47315917625702736,-1.146999367019662,0.31151832460732987,0.7154912566422462,1.0,6/12,20.95%,PLA2R1;SERPINE1;ATR;TERT;WNT16;ROMO1
prerank,regulation of leukocyte cell-cell adhesion (GO:1903037),-0.45754954585863933,-1.1464704272775483,0.279126213592233,0.7151823695460059,1.0,4/12,17.94%,WNK1;PPARA;MDK;SKAP1
prerank,purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5153760072914877,1.1461708447808132,0.3082077051926298,0.7248959742528039,1.0,6/13,15.84%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,axonogenesis (GO:0007409),0.35297972167222974,1.1460362914848419,0.1997907949790795,0.7245713179247187,1.0,39/237,11.35%,SEMA3G;LAMA3;EFNA5;FYN;RPS6KA5;NTN4;NOTCH1;KLF7;APP;SEMA3F;SH3KBP1;EVL;LAMA5;SHTN1;SEMA7A;DAB1;EFNA1;ROBO4;SHANK3;ATL1;MAPK1;BSG;LMTK2;PTPRO;ENAH;NRCAM;SEMA6D;SCN1B;PTK2;TAOK2;B4GALT6;PLCG1;NEFH;ADGRB1;CYFIP1;RANBP9;ACTB;DCC;SEMA4G
prerank,negative regulation of peptidase activity (GO:0010466),-0.33086029577584486,-1.1460245674391834,0.22026431718061673,0.7147359552432778,1.0,11/47,13.45%,LRP1;SERPING1;VTN;SERPINE2;TIMP2;SERPINH1;SERPIND1;SERPINE1;SERPINA2;SERPINF1;ECM1
prerank,myeloid cell differentiation (GO:0030099),0.4238676821315037,1.1458104678602987,0.2787958115183246,0.724500229035762,1.0,9/47,8.61%,TAL1;SNRK;TIRAP;ZBTB16;MFHAS1;CEBPA;JAK2;RPS14;KMT2E
prerank,heart contraction (GO:0060047),0.4314843001860094,1.1455344460649626,0.28835978835978837,0.7245356823456613,1.0,4/41,3.81%,KCNQ1;ACE;MYBPC3;SLC8A1
prerank,calcium ion transmembrane transport (GO:0070588),0.38502694979964225,1.1453675682540454,0.26627218934911245,0.7243024484052,1.0,18/86,11.28%,ATP2A3;TRPV4;ATP2B4;CACNA1A;FKBP1A;MCUB;SLC8A1;ATP2C1;ANO6;ORAI1;SMDT1;P2RX7;MCOLN1;MCUR1;GRIN2B;GRIN2C;TRPM2;TRPC7
prerank,N-terminal protein amino acid modification (GO:0031365),-0.4547280474124278,-1.1452940892312529,0.30077120822622105,0.7150744998740427,1.0,7/14,25.40%,METAP1D;METAP1;NAA60;NAA40;NAA50;NAA10;NAA15
prerank,positive regulation of mitotic cell cycle (GO:0045931),0.4634848459783474,1.145188683468838,0.30735930735930733,0.7241265489671673,1.0,8/26,16.08%,TAL1;APP;TTL;CUL3;DUSP3;RPS6KB1;PKN2;MEIS2
prerank,"retrograde transport, endosome to Golgi (GO:0042147)",-0.2911722117273169,-1.145162964280762,0.18181818181818182,0.7137581557294974,1.0,22/80,16.07%,DENND2A;SGSM2;VPS54;SNX6;VPS26B;GCC2;SNX32;SURF4;TMEM87A;TRAPPC10;LMAN1;EHD3;RHOBTB3;STX5;SNX1;STX16;TBC1D17;SNX12;CLN5;SNX8;GGA1;SNX2
prerank,regulation of protein autophosphorylation (GO:0031952),0.4302398756701382,1.1451054001143013,0.28169014084507044,0.7236544370660534,1.0,6/36,9.44%,PDGFD;ENG;PDGFB;TOM1L1;PPP2R5C;TAOK2
prerank,positive regulation of interferon-gamma production (GO:0032729),0.413164642541743,1.144912381268948,0.2696929238985314,0.7234879899412768,1.0,4/48,3.64%,CRTAM;F2RL1;LGALS9;TLR3
prerank,positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),0.3848250087792012,1.14447322743927,0.26666666666666666,0.7238797860010777,1.0,14/80,10.68%,EPS8L2;OCLN;SAXO1;F2RL1;AGRN;CDC42EP1;FNBP1L;P2RX7;PLEKHM1;NCKAP1;APC;CCDC88A;CYFIP1;RAC1
prerank,negative regulation of stress fiber assembly (GO:0051497),-0.3863147836393159,-1.1444022942284937,0.2677595628415301,0.7142377889244326,1.0,6/24,7.14%,ARHGAP6;PHLDB2;ARHGAP28;ARAP1;PIK3R1;TMEFF2
prerank,AMP metabolic process (GO:0046033),-0.45868793505075994,-1.1443801308605346,0.3112244897959184,0.7125750773399904,1.0,8/13,33.10%,AMPD3;XDH;NT5E;NUDT2;NT5C1A;AMPD2;AK3;AK9
prerank,neutrophil chemotaxis (GO:0030593),0.4059780172987106,1.1442185954576694,0.28777923784494086,0.723844761751943,1.0,5/53,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,chromatin organization (GO:0006325),0.37169966841716734,1.144207945801082,0.2545045045045045,0.7232038269028961,1.0,15/132,14.54%,PRDM16;MECOM;SMARCA2;NPM3;HDAC11;CHRAC1;TCF7L1;HP1BP3;CDAN1;NPM1;SMARCAD1;SUV39H2;GATAD1;SMARCC1;HMGB2
prerank,embryo development ending in birth or egg hatching (GO:0009792),0.5205509977915348,1.1439974299997968,0.3217665615141956,0.723122346137405,1.0,5/15,16.03%,STOX2;TGFB2;CELF4;BRCA1;RICTOR
prerank,negative regulation of cellular protein catabolic process (GO:1903363),0.5568874685041052,1.143797486577937,0.3263327948303716,0.7229769517699501,1.0,3/10,5.65%,DAB2IP;EFNA1;FURIN
prerank,positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),0.41994572595886215,1.14338074508159,0.2874331550802139,0.7234050537424862,1.0,6/45,4.11%,ENG;BMPR2;ACVRL1;RBPMS;TGFB2;ACVR1
prerank,Fc receptor signaling pathway (GO:0038093),0.37006708913575126,1.1429878473259367,0.24715261958997722,0.7237975672100798,1.0,34/110,19.26%,PLCG2;PSMD13;MAPK1;PSMD4;PPP3CA;JUN;PSMA5;PSMB10;PLCG1;RAC1;TAB2;PSMB8;PSMD14;PIK3CB;BTK;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;SOS1;PSMB5;PSMC5;PSMB9;PAK2;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;GRAP2;PSMB6;NFATC3
prerank,positive regulation of T cell mediated immunity (GO:0002711),0.47092126833481973,1.1420403667719543,0.31715210355987056,0.7256465388346528,1.0,2/22,3.80%,B2M;STX7
prerank,negative regulation of receptor signaling pathway via STAT (GO:1904893),0.5366915404954583,1.1417614269137757,0.3287904599659284,0.7257086633063856,1.0,3/11,12.68%,CAV1;ADIPOR1;NF2
prerank,cellular response to chemical stress (GO:0062197),0.3831915655626126,1.141343578700637,0.2618483412322275,0.7261279652829047,1.0,22/96,14.96%,TRPV4;FAS;FOXO1;CAV1;PRKD1;CHCHD2;SETX;ZC3H12A;LRRK2;HSPA1B;PRR5L;NFE2L2;PRKAA1;BRF2;CYBA;RBM11;KEAP1;ATM;PYROXD1;MSRA;NCF2;EIF2S1
prerank,proteasome assembly (GO:0043248),0.5416512628034834,1.141220429052431,0.335042735042735,0.7257791639538396,1.0,6/11,21.80%,PSMD13;PSMD4;PSMD5;PSMD9;PSMG2;POMP
prerank,negative regulation of cold-induced thermogenesis (GO:0120163),0.4229440892385542,1.1404003315856477,0.276,0.7273143265517162,1.0,8/46,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,positive regulation of triglyceride biosynthetic process (GO:0010867),-0.48062475767872037,-1.1403455779203258,0.305,0.7226587567845636,1.0,5/11,15.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,epithelial to mesenchymal transition (GO:0001837),0.42262127825998946,1.1401800597808993,0.29465449804432853,0.7272316006734464,1.0,11/47,10.07%,NOTCH4;ENG;NOTCH1;HEY1;TGFB2;HEY2;LEF1;FOXF2;SNAI2;ROCK1;TASOR
prerank,defense response to symbiont (GO:0140546),0.3806048372578199,1.1401487621323332,0.2793764988009592,0.7266323493173167,1.0,29/92,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,response to organic cyclic compound (GO:0014070),0.41344939941694125,1.14009508020358,0.2822164948453608,0.726083674822285,1.0,12/52,16.29%,ALPL;ARL6IP5;TLR3;ABCB4;LRRK2;PAQR8;STRN3;TRPM2;SLC1A1;CTNNB1;CDKN2D;ESR1
prerank,carbohydrate biosynthetic process (GO:0016051),0.4806965415502574,1.1400273369696774,0.3126984126984127,0.7255938309939621,1.0,2/21,1.70%,ST8SIA6;ST3GAL6
prerank,endoplasmic reticulum membrane organization (GO:0090158),0.5478245322766053,1.139523125182149,0.3281786941580756,0.7262900633882691,1.0,4/11,10.10%,ATL2;ATL1;RTN4;LPCAT3
prerank,negative regulation of cell differentiation (GO:0045596),0.35418879334628817,1.1394608546683516,0.2508038585209003,0.7257962752282867,1.0,22/181,6.87%,JAG1;NOTCH4;GATA2;SMAD6;SMAD7;TBX1;NOTCH1;FOXO1;HEY1;DAB2IP;CAV1;TRIO;HDAC7;IL17RD;WWTR1;EFNA1;COL5A2;GATA3;EID2B;PDCD4;ADIPOR1;ZBTB16
prerank,positive regulation of proteasomal protein catabolic process (GO:1901800),0.38630327299524403,1.1393824087761308,0.26523297491039427,0.7253508247511051,1.0,26/85,17.93%,SMAD7;ECSCR;DAB2IP;SUMO2;CSNK1D;BBS7;RNF185;ARIH1;LRRK2;HSPA1B;CEBPA;FBXW7;RBX1;NKD2;RNF144B;BAG6;CLU;PSMC3;KEAP1;PSMC5;RACK1;CBFA2T3;PSMC6;TRIB3;SOCS5;GSK3A
prerank,regulation of fatty acid beta-oxidation (GO:0031998),-0.4459180144733447,-1.1392085865101906,0.28763440860215056,0.7240426110861046,1.0,6/14,22.83%,PPARA;IRS2;IRS1;MFSD2A;TWIST1;MTLN
prerank,cell-matrix adhesion (GO:0007160),-0.2922097299884544,-1.138982928631113,0.16766467065868262,0.7230101808564283,1.0,22/95,10.18%,ITGBL1;COL3A1;ADAMTS12;SORBS1;VTN;ITGB5;PTPRK;ITGA10;COL13A1;NID2;ITGAV;ACTN2;ITGA11;CD63;ITGB8;ADAM9;SRC;ADAMTS9;MSLN;THBS3;SGCE;ECM2
prerank,regulation of intracellular protein transport (GO:0033157),0.45276789713806653,1.1389104329884079,0.297029702970297,0.7258892631824947,1.0,11/32,16.40%,PTPN14;PLK3;UHMK1;PRR5L;PCM1;RIPOR1;PTPN1;ICE1;LCP1;PDCD10;TENM1
prerank,ether lipid biosynthetic process (GO:0008611),-0.4918706332544718,-1.1378767450211758,0.31516587677725116,0.7244882949063115,1.0,7/10,21.08%,GNPAT;LPCAT2;PLA2G4A;PEDS1;CHPT1;PEX7;PLA2G4C
prerank,negative regulation of G0 to G1 transition (GO:0070317),0.43066265865279074,1.137861354913899,0.28910614525139666,0.7280058030694623,1.0,7/36,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.4547790672515759,-1.137533067907614,0.2887700534759358,0.7237502696356802,1.0,6/12,17.97%,APOBEC1;TET1;RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,regulation of exocytosis (GO:0017157),0.4186863898860094,1.13719327753304,0.28021248339973437,0.729123284395703,1.0,14/46,18.42%,CADPS2;STXBP6;CLASP1;CLASP2;CADPS;CHMP3;NSF;CPLX1;RAB27B;STXBP5L;STXBP5;RAB27A;SYT1;HAP1
prerank,negative regulation of defense response to virus (GO:0050687),-0.48390219072168605,-1.1371591662306142,0.3242009132420091,0.72307096178231,1.0,6/10,39.32%,PPM1B;C1QBP;TRAF3IP1;TSPAN6;RNF26;PCBP2
prerank,detection of visible light (GO:0009584),0.5001050446820341,1.136927822839386,0.3285939968404423,0.7291267645638463,1.0,1/16,1.71%,GNAQ
prerank,regulation of protein ubiquitination (GO:0031396),0.37656997619521093,1.1368033599677927,0.2679814385150812,0.7287765882687867,1.0,22/108,12.21%,SMAD7;FAM107A;CAV1;FKBP1A;ANGPT1;FOXF2;CUL3;UBE2D1;LRRK2;HSPA1B;ARRB1;UBE3A;NDFIP2;VPS28;NSMCE3;FBXW7;PRKCG;ADGRB1;LAPTM5;NXN;BRCA1;FBXO4
prerank,neutral amino acid transport (GO:0015804),0.45067466675175694,1.1367944565445318,0.28798842257597684,0.7281319948265514,1.0,1/28,0.19%,SLC6A6
prerank,limb morphogenesis (GO:0035108),-0.40512425995005563,-1.1367495338678337,0.2861111111111111,0.7225876552397138,1.0,6/20,9.91%,GLI3;CYP26B1;FBXW4;NIPBL;MEGF8;PTCH1
prerank,maintenance of protein localization in endoplasmic reticulum (GO:0035437),-0.46768424846830214,-1.1365617304873519,0.31891891891891894,0.7213922797738349,1.0,6/12,26.76%,INSIG2;RER1;KDELR1;ANKRD13C;KDELR3;GPAA1
prerank,"positive regulation of DNA-templated transcription, elongation (GO:0032786)",-0.3986355715973951,-1.1362715085795727,0.27044025157232704,0.7204332467034998,1.0,6/22,12.75%,SCAF8;CCNK;CDK12;ELL;THOC1;HMGN1
prerank,monocyte differentiation (GO:0030224),-0.4883790528759127,-1.1362281306935964,0.3059125964010283,0.7188543295630612,1.0,5/10,10.78%,BMP4;IL31RA;MT1G;VEGFA;PPARG
prerank,protein-DNA complex disassembly (GO:0032986),-0.4293383673692466,-1.1358413150936622,0.29041095890410956,0.7182285897100853,1.0,3/16,10.19%,SET;SMARCB1;SMARCD1
prerank,cellular response to amino acid stimulus (GO:0071230),0.44135059411768396,1.135519126734282,0.3090128755364807,0.7308726226108663,1.0,5/33,10.04%,FYN;SPAAR;CASTOR1;SH3BP4;RRAGD
prerank,cell part morphogenesis (GO:0032990),-0.46340787243946036,-1.1352545947904809,0.2963917525773196,0.7182272533129425,1.0,2/13,3.15%,PID1;WASF1
prerank,mature B cell differentiation involved in immune response (GO:0002313),-0.47352882043136246,-1.134645209150725,0.3107769423558897,0.718296071471189,1.0,3/12,2.65%,NOTCH2;DOCK11;DOCK10
prerank,Wnt signaling pathway (GO:0016055),0.37924369193915963,1.1345517155147502,0.27432590855803046,0.7327819441041699,1.0,18/92,14.82%,PLCG2;CCDC88C;FZD6;NR4A2;LEF1;LRRK2;UBA52;APC;RPS27A;CSNK1G3;TCF7L1;RBX1;NXN;VPS35;LRP5;CTNNB1;FZD9;FZD3
prerank,determination of left/right symmetry (GO:0007368),0.43144995147268184,1.1340146089587615,0.3081081081081081,0.7335172449607213,1.0,4/36,5.57%,TBX1;NOTCH1;DAND5;BBS7
prerank,liver development (GO:0001889),-0.36218538155821006,-1.133808236986907,0.26366559485530544,0.718994431950868,1.0,7/32,10.95%,TGFBR3;WNT4;COBL;NPHP3;ANXA1;CEBPB;MET
prerank,"regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.29836616351027995,-1.1337597780583861,0.21951219512195122,0.7174349680690328,1.0,31/84,23.61%,CELF2;SON;DDX5;NOVA1;SNW1;FXR2;RBMX;DDX17;NCBP1;JMJD6;DAZAP1;PUF60;SRSF6;REST;TRA2A;RBM39;HNRNPL;PCBP4;HNRNPU;MAGOH;U2AF2;NCL;SRSF3;SF1;RBFOX3;SRPK2;ZC3H10;KHDRBS1;CELF1;C1QBP;CELF5
prerank,negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.3674463513066074,-1.1331882250308536,0.24271844660194175,0.7173478486006034,1.0,8/26,23.50%,ATP1A2;CALM2;ADRA2A;DRD2;GSTM2;GSTO1;CBARP;CASQ2
prerank,peptidyl-serine phosphorylation (GO:0018105),0.3640001184265142,1.1328036094829526,0.2399103139013453,0.7360584223905221,1.0,42/153,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;NLK;TTBK2;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,spliceosomal complex assembly (GO:0000245),-0.32582994319304104,-1.1323623973113133,0.23247232472324722,0.7180682151757432,1.0,9/46,10.83%,CELF2;SRSF5;SCAF11;NCBP1;SRSF1;SMN1;PUF60;SRSF6;DDX1
prerank,tRNA wobble base modification (GO:0002097),0.5187300365725268,1.1320178396913394,0.30845771144278605,0.737470759584636,1.0,6/14,20.60%,ADAT2;ELP4;ALKBH8;ELP3;DPH3;KTI12
prerank,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),0.532822221442407,1.1317804628150214,0.32463295269168024,0.7374243240193862,1.0,5/13,12.26%,TNRC6C;BTG2;POLR2G;CNOT1;TOB1
prerank,positive regulation of macrophage derived foam cell differentiation (GO:0010744),-0.43626670836379483,-1.1312848196727736,0.3168044077134986,0.7193869317890083,1.0,9/15,35.76%,NFKB1;AGTR1;MAPK9;LPL;AGT;MSR1;IL18;CD36;PLA2G5
prerank,negative regulation of nervous system development (GO:0051961),0.4986949356703159,1.130894137148507,0.322061191626409,0.7391003116058636,1.0,3/17,9.16%,NOTCH1;B2M;PCM1
prerank,positive regulation of cilium assembly (GO:0045724),0.48176587461327036,1.1306711350649523,0.3390894819466248,0.7390341193504306,1.0,8/18,25.80%,SAXO1;CEP135;CCDC88A;CEP120;HAP1;MARK4;WRAP73;KCTD17
prerank,regulation of cytoskeleton organization (GO:0051493),0.37213141860117344,1.1304919720252966,0.2734741784037559,0.7388001613331007,1.0,25/108,13.75%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK;DIAPH1;CLIC4;MAPK1;CLASP1;P2RX7;PRKAA1;ROCK1;TJP1;PTK2;TAOK2;CCDC88A;RAC1;PFDN2;MARK2;SORBS3;RND2;RHOH
prerank,negative regulation of metabolic process (GO:0009892),0.40708089948330306,1.1303230340506758,0.2966321243523316,0.7386069558177532,1.0,8/54,10.04%,LAMA4;NOVA2;NOTCH1;ID1;ADAM17;ABHD6;NR1D1;ACOT13
prerank,translational elongation (GO:0006414),0.373888994078834,1.1300285457675538,0.28205128205128205,0.7387126338649175,1.0,48/101,28.55%,MRPL4;MRPL18;EEF2K;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;GTPBP1;MRPL36;MRPL47;MRPL52;EEF2;GTPBP2;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;RACK1;EEFSEC;MRPL54;EEF1D;MRPS18B;EEF1G;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;EEF1A1;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,lipopolysaccharide-mediated signaling pathway (GO:0031663),-0.4003274987754186,-1.1298208360970863,0.29120879120879123,0.7219247006094122,1.0,10/20,40.21%,LBP;PTPN22;TICAM1;HCK;IL18;CCL2;MTDH;CD14;CCL5;BCL10
prerank,protein polymerization (GO:0051258),-0.3155261148608951,-1.129043239549235,0.1956521739130435,0.722422519178871,1.0,11/55,7.16%,ARHGAP6;GAS7;GSN;COBL;WASF1;PRKN;WASHC3;RNF135;HDGFL3;CKAP5;PREX1
prerank,cellular response to BMP stimulus (GO:0071773),0.39313269917589155,1.1289863250295518,0.277363184079602,0.7408291230414078,1.0,10/66,6.31%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;TGFB2;TMEM100;ACVR1;SMAD2;PDCD4
prerank,regulation of DNA recombination at telomere (GO:0072695),0.4860945607131769,1.1288837915844154,0.3168469860896445,0.7397582322686188,1.0,10/19,25.77%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,negative regulation of DNA recombination at telomere (GO:0048239),0.4860945607131769,1.1288837915844154,0.3168469860896445,0.7397582322686188,1.0,10/19,25.77%,POLR2G;POLR2D;POLR2I;DAXX;TERF2IP;POLR2C;TERF2;POLR2B;POLR2J;TINF2
prerank,negative regulation of secretion by cell (GO:1903531),0.43412426548277333,1.1287869541473656,0.2864864864864865,0.7393341833126622,1.0,11/38,20.15%,NOTCH1;STXBP6;TNFRSF1B;SLC30A1;VAMP8;HTR1B;CHGA;HRH3;RSAD2;GRM7;DPH3
prerank,central nervous system neuron differentiation (GO:0021953),0.4367510083765659,1.128782762501589,0.31643835616438354,0.7386784307669997,1.0,10/33,19.59%,NR4A2;ATP7A;CHD5;ZC4H2;SPOCK1;CTNNB1;MAP2;OPHN1;SIN3A;GRID2
prerank,protein K48-linked deubiquitination (GO:0071108),-0.3903118620117999,-1.1287477648877438,0.27988338192419826,0.7215763717224086,1.0,9/23,24.72%,USP33;USP20;USP50;OTUD7B;USP8;USP34;VCPIP1;TNFAIP3;BAP1
prerank,positive regulation of peptide hormone secretion (GO:0090277),0.42462252366823716,1.1287024236615888,0.31039136302294196,0.7382187706286679,1.0,3/39,5.83%,MYRIP;DOC2B;GLUD1
prerank,cellular response to retinoic acid (GO:0071300),-0.32741825600380586,-1.128654002162106,0.2426470588235294,0.7201955491535674,1.0,8/42,9.45%,EPHA3;PTK7;WNT6;WNT5A;SNW1;WNT9A;FZD7;NDUFA13
prerank,regulation of anatomical structure morphogenesis (GO:0022603),0.3655228522330817,1.1285460581991846,0.25836216839677045,0.7379856146763026,1.0,31/118,15.69%,EFNA5;CEACAM1;FLT4;TBX1;TANC2;EMP2;PLXND1;VASH2;PDLIM5;MEF2C;SHANK3;TSPAN12;WARS1;POGLUT1;CLASP1;LRRK2;LZTS1;LRRC4C;PPFIA2;CLASP2;NEDD4L;CDH2;INF2;MARK2;PHIP;ADGRA2;CFL1;CTNNB1;SARM1;KIF1A;PAK2
prerank,negative regulation of glycolytic process (GO:0045820),-0.47717555493620195,-1.1282697919422204,0.3412322274881517,0.7180440241430296,1.0,4/10,18.49%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,negative regulation of purine nucleotide metabolic process (GO:1900543),-0.47717555493620195,-1.1282697919422204,0.3412322274881517,0.7180440241430296,1.0,4/10,18.49%,NUPR1;PPARA;HDAC4;PFKFB1
prerank,linoleic acid metabolic process (GO:0043651),-0.40997465054718935,-1.1281318818509845,0.2991913746630728,0.7168215169551454,1.0,5/17,19.82%,ACSL1;GSTM2;FADS2;ELOVL1;ALOX12
prerank,kidney development (GO:0001822),-0.3042945722567272,-1.1279429189159955,0.22477064220183487,0.7157538917711881,1.0,19/65,11.67%,GLI2;SULF1;WNT4;TGFBR1;BMP7;SULF2;BMP4;OSR1;GREB1L;PYGO1;NPHP3;NIPBL;KANK2;SIX1;VEGFA;PYGO2;STRA6;SALL1;PKD1
prerank,myofibril assembly (GO:0030239),-0.3283577498125977,-1.1275999777927586,0.25177304964539005,0.7150942736309672,1.0,8/42,10.21%,PDGFRB;PDGFRA;TPM1;ACTN2;OBSL1;TMOD2;CFLAR;PGM5
prerank,interleukin-12-mediated signaling pathway (GO:0035722),0.42172663697743573,1.1273668261844734,0.30675675675675673,0.7404094997310139,1.0,11/46,15.69%,PLCB1;GSTA2;MSN;PDCD4;JAK2;PITPNA;BOLA2;TALDO1;CFL1;LCP1;PAK2
prerank,positive regulation of lymphocyte differentiation (GO:0045621),-0.39773848254515165,-1.1270097393647682,0.27146814404432135,0.7150322876210051,1.0,5/19,12.66%,AXL;MMP14;ZMIZ1;NCKAP1L;MDK
prerank,regulation of translation (GO:0006417),0.35785935022505994,1.1268876177601004,0.250814332247557,0.7410404703731577,1.0,41/173,16.16%,NANOS1;NANOS3;VIM;BTG2;APP;MTG2;YBX2;PLD1;ELAVL1;HSPB1;PASK;GAPDH;ETF1;EIF3B;EIF2B2;DHX9;EIF1;CNOT1;ENC1;RPS6KA1;CYFIP1;METTL5;NPM1;EEF2;GRM5;TOB1;RPS6KA3;RPS6KB1;FXR1;METTL14;METTL18;EIF6;EIF2A;YBX1;DDX6;RACK1;MTIF2;EIF3H;TCOF1;KLHL25;RNF139
prerank,mitochondrial calcium ion homeostasis (GO:0051560),0.4813401790298498,1.1262166215689828,0.32432432432432434,0.7421867081755589,1.0,4/21,8.35%,MCUB;SMDT1;RAP1GDS1;MCUR1
prerank,positive regulation of cellular process (GO:0048522),0.3378460943512234,1.1260287140596912,0.18036072144288579,0.7420224697288251,1.0,83/565,14.01%,VEGFC;PTPRJ;SLC6A6;ACER2;EDN1;PDGFD;CLDN5;GATA2;FLT1;PDGFB;FLT4;FASN;KITLG;TBX1;MERTK;CCND2;LIFR;NOTCH1;INSR;TAL1;AQP11;CAV1;TGFB2;EMP2;ACTN4;TNFRSF18;APOA1;VEGFD;KRAS;IER5;FCGR2B;WWTR1;LEF1;GCNT2;SERTAD1;BRAT1;TBC1D8;FGFR3;TNFRSF1B;TAF9B;CUL3;ADAM17;SLC25A33;P2RX7;CD47;GNAI2;ZC3H12A;PPP3CA;CIDEB;CNOT6L;THPO;CDH3;PRKAA1;APC;NAMPT;TJP1;PTK2;ADAM10;ACACB;RPS6KA1;RPRD1B;RAC1;TENM4;RPS9;CYBA;NUMA1;NPM1;PRKD2;DOCK2;MATK;CHTOP;RTKN2;PRC1;RPS6KA3;ITGB1BP1;MCTS1;FXR1;POU3F2;PHIP;PGF;LRP5;ATM;NSMCE4A
prerank,regulation of viral release from host cell (GO:1902186),0.4681474609803144,1.1260216452994065,0.33035714285714285,0.7413774761947259,1.0,6/21,15.24%,TRIM11;TRIM25;TRIM8;VPS4A;CHMP3;CHMP2B
prerank,negative regulation of defense response (GO:0031348),0.3872284437459012,1.1259849902613,0.2820823244552058,0.7408051389750031,1.0,13/77,11.41%,TEK;AOAH;APOA1;KLF4;GATA3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35
prerank,negative regulation of nuclear division (GO:0051784),-0.4722606342027796,-1.1255879191778453,0.3099273607748184,0.7171998741580509,1.0,2/11,2.18%,BMP7;BMP4
prerank,receptor-mediated endocytosis (GO:0006898),0.36771364483790797,1.1255802380690263,0.2675438596491228,0.7412122899076642,1.0,17/132,7.44%,FCHSD2;HIP1R;INSR;CAV1;CAV2;ADRB2;PPT1;DNM3;APOA1;AP2B1;FCHO2;FCGR2B;FNBP1L;FCGR1A;PIP5K1C;ITGAM;HSP90B1
prerank,negative regulation of intracellular signal transduction (GO:1902532),0.3520865193630671,1.1254817155085461,0.2607758620689655,0.7408064619679176,1.0,53/190,20.24%,PTPRJ;CD2AP;ATP2B4;DUSP1;DAB2IP;CAV1;CASP8;HDAC7;INPP5K;PDE3B;HYAL2;PLEKHA1;SH3BP4;ADIPOR1;P2RX7;DUSP3;ZC3H12A;ARHGAP25;STAT1;BCL2L1;PRKAA1;WWC2;NMI;NR1D1;PPP2R5C;CACTIN;MARK3;PIK3IP1;PIK3CB;RTKN2;RIOK3;RHOH;CARD19;EPM2A;PHLDA3;ABCA7;RACK1;PDE4D;TMSB4X;ESR1;PYCARD;MAPK14;TRIB3;PLAUR;GSK3A;RELA;BANK1;MAPKAPK5;PPIF;MCL1;SHANK2;NPRL3;RNF34
prerank,regulation of apoptotic process (GO:0042981),0.3363518618056031,1.1254319575540517,0.14829659318637275,0.7402578270384638,1.0,117/676,14.24%,RASGRF2;ACER2;ARHGEF3;TEK;GATA6;HIP1;KALRN;UNC13B;SMAD6;FLT4;HIP1R;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;ARHGEF2;DAB2IP;ABR;ARL6IP5;CASP8;RHOB;CBL;TRIO;PPT1;ACTN4;PPP1R13B;PNMA1;ANO6;GLS2;SLK;ING3;HRK;ANGPT1;CASP2;LEF1;OMA1;LANCL1;MAP4K4;TNFSF10;TNFRSF25;PLEKHG5;MEF2C;IAPP;RHBDD1;SPTLC1;TAF9B;STPG1;APEX1;TOX3;TRIM24;UFM1;ARHGDIA;MADD;SETX;RYBP;TIAM2;MCF2L;KLHL20;ALK;FANK1;CRADD;STAT1;HSPB1;HSP90B1;HSPA1B;AATF;CIDEB;GADD45G;BCL2L1;UBA52;JAK2;PRKAA1;PROC;APC;PIM3;RPS27A;KLF11;APH1A;JUN;TJP1;PTK2;SGK1;ADAM10;RTN4;HMGB1;MAP3K11;BABAM2;SIAH2;ARHGEF1;CASP1;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;CLU;TMEM14A;IRF5;NF2;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;ITGB3BP;NOL3;LTK;SOS1;ATM;CFL1;BNIP3;ANP32B;CTNNB1
prerank,purine-containing compound biosynthetic process (GO:0072522),-0.37559002574343675,-1.1253594686319741,0.27439024390243905,0.7162846379502253,1.0,13/25,30.82%,ADK;AMPD3;PRPSAP2;MTHFD1;GMPR;PNP;APRT;PPAT;DCK;PRPSAP1;AMPD2;ADA;SHMT2
prerank,chondroitin sulfate biosynthetic process (GO:0030206),-0.3901686669897794,-1.1251146351901502,0.290519877675841,0.7152996741588515,1.0,6/21,12.27%,DCN;CHST15;BGN;VCAN;CHPF2;CSPG4
prerank,negative regulation of fatty acid metabolic process (GO:0045922),0.4904456960895994,1.1250050301579337,0.3235747303543914,0.7407320206785605,1.0,5/16,17.27%,CEACAM1;SIRT4;BRCA1;ERLIN2;TRIB3
prerank,response to interferon-gamma (GO:0034341),0.39210763995046094,1.12481596940584,0.3048469387755102,0.74056649282348,1.0,12/67,11.38%,GBP5;LGALS9;GBP4;GCH1;GBP3;CD47;STAT1;ACOD1;GAPDH;CCL4;CASP1;GBP2
prerank,regulation of viral life cycle (GO:1903900),0.4813231888981273,1.1247745839379302,0.32326283987915405,0.7400357380969544,1.0,5/21,12.82%,TRIM14;TRIM6;TRIM25;HS3ST5;VPS4A
prerank,respiratory electron transport chain (GO:0022904),0.5132513298695227,1.1247061387072936,0.33447098976109213,0.7395320107278446,1.0,5/14,11.70%,GPD2;ETFDH;ETFB;ETFA;UQCRFS1
prerank,positive regulation of cellular senescence (GO:2000774),0.5333970797330828,1.124561485379274,0.32081911262798635,0.7392547505603205,1.0,1/10,1.74%,B2M
prerank,ventricular septum morphogenesis (GO:0060412),0.4474956104383205,1.124023942357508,0.3195435092724679,0.7400500806612816,1.0,7/27,4.11%,BMPR2;SMAD7;NOTCH1;HEY1;TGFB2;HEY2;ACVR1
prerank,neutrophil activation (GO:0042119),0.5226532309788678,1.1236374859829033,0.3474714518760196,0.7404044187848442,1.0,3/12,10.12%,F2RL1;KMT2E;TYROBP
prerank,positive regulation of neural precursor cell proliferation (GO:2000179),0.47974588476595104,1.1236235777678925,0.3323170731707317,0.7397865219913979,1.0,7/21,15.15%,RASSF10;DLL4;CX3CR1;CTNNB1;FZD9;FZD3;NES
prerank,cellular response to lipopolysaccharide (GO:0071222),0.37033904902333104,1.1234708086037564,0.2860548271752086,0.7395377780096228,1.0,18/101,10.37%,NOD2;DAB2IP;VIM;DEFA6;MEF2C;TNFRSF1B;IL1A;PDCD4;NFKBIL1;IRGM;ZC3H12A;NR1D1;ACOD1;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,positive regulation of RNA splicing (GO:0033120),-0.3658319488484618,-1.1234420516256876,0.265625,0.7182776143202734,1.0,11/29,19.19%,SNW1;RBMX;NCBP1;PIK3R1;DAZAP1;TRA2A;RBM20;HNRNPLL;ZPR1;U2AF2;NCL
prerank,negative regulation of immune response (GO:0050777),0.3557874914274194,1.122775101340203,0.25410733844468786,0.7407362603235371,1.0,20/154,11.03%,PLCG2;FYN;ADRB2;GPR39;FCGR2B;HRH2;IAPP;FURIN;FCGR1A;MYH9;ADAM17;CD247;MC4R;NMI;ACOD1;YES1;CACTIN;ADCY4;PLCG1;GLP1R
prerank,action potential (GO:0001508),0.4210738161229171,1.1226984504196726,0.3,0.7402672067097062,1.0,4/44,4.16%,KCNQ1;KCNE3;GNAQ;SCN11A
prerank,ribosome biogenesis (GO:0042254),0.3524062684393071,1.1226420326144622,0.2513842746400886,0.739748069569684,1.0,77/187,26.74%,BOP1;PELP1;RPL27;DHX37;RPL7;PAK1IP1;EXOSC3;NVL;UBA52;RPS14;MRM2;RPL35;WDR46;XPO1;RPL21;DKC1;RPL37;RPS28;RPL34;MRPL36;RPS9;XRN2;EXOSC8;RPLP2;NPM1;RPS25;RPL30;RPL27A;NOL8;RAN;RPL23A;RPS15;EIF6;EIF2A;RPL19;RPL32;UTP18;RPL37A;RPL18A;NOB1;EXOSC9;LAS1L;DDX47;DCAF13;RRP9;WDR18;PWP2;C1D;RPL18;RPL39;IMP4;RPS19;NOLC1;EXOSC10;RPL31;NOP53;LSG1;EXOSC1;FBL;RPF2;WDR43;HELQ;RPL3;UTP20;GLUL;MRTO4;MDN1;RPL28;RPS16;RPLP1;RPL26;RPL9;DDX27;NIP7;UTP15;RPS17;ESF1
prerank,positive regulation of autophagy (GO:0010508),0.37783874248992,1.122400885444152,0.2750301568154403,0.7397224360689761,1.0,19/81,14.75%,TRIM14;PLK3;FOXO1;PRKD1;PIK3C2A;FBXO7;TRIM6;SH3BP4;IRGM;ZC3H12A;LRRK2;PRKAA1;ROCK1;HMGB1;TRIM8;PIK3CB;BNIP3L;BNIP3;EPM2A
prerank,ATP transport (GO:0015867),0.5439772121170059,1.1223407183106808,0.3576388888888889,0.7392153902816049,1.0,3/10,11.16%,SLC17A9;CD47;ABCC6
prerank,positive regulation of protein-containing complex assembly (GO:0031334),0.3706034441786451,1.1222631898843844,0.28782707622298065,0.7387742643229563,1.0,25/113,16.29%,UNC13B;RASIP1;PIEZO1;GBP5;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;RBX1;SPIDR;GTF2H3;CLU;TTBK1;PSMC3;CAPG;ERCC4;ATM;ICE1;PSMC5;LCP1;RACK1;PSMC6;ESR1
prerank,regulation of wound healing (GO:0061041),0.4211729739866221,1.1215266323974662,0.308,0.7399733337892661,1.0,7/42,9.21%,OCLN;MYLK;CAV1;F2RL1;CRK;ACTG1;PTK2
prerank,acute-phase response (GO:0006953),-0.4596848416097866,-1.1213608048493726,0.29441624365482233,0.7225674610958402,1.0,3/12,8.52%,LBP;IL6R;CEBPB
prerank,regulation of heart rate by cardiac conduction (GO:0086091),0.4283594411776859,1.121297367585906,0.306282722513089,0.7398871242118382,1.0,6/38,9.23%,KCNQ1;KCNE3;CAV1;CAMK2D;SCN1B;DSP
prerank,regulation of keratinocyte migration (GO:0051547),0.516913224351329,1.121297013694306,0.3434991974317817,0.7392395577009194,1.0,2/12,4.97%,IQSEC1;MAP4K4
prerank,regulation of muscle contraction (GO:0006937),-0.3785734209417831,-1.121230255401562,0.2899022801302932,0.7213399709111654,1.0,3/26,3.47%,ATP1A2;PLCE1;TPM1
prerank,embryonic digit morphogenesis (GO:0042733),-0.4037979932126983,-1.120918859500954,0.29022988505747127,0.7206215558511454,1.0,7/18,11.56%,GLI3;OSR1;CREBBP;INTU;SALL1;TBX2;HDAC1
prerank,negative regulation of oxidoreductase activity (GO:0051354),-0.49408140411906765,-1.1207922684671972,0.3364485981308411,0.719369464552347,1.0,4/10,29.25%,PRKN;HDAC6;AOC3;ETFBKMT
prerank,negative regulation of Wnt signaling pathway (GO:0030178),0.35069709900470414,1.120653684508053,0.26394849785407726,0.7402717359339216,1.0,46/186,16.04%,DKK2;SOX17;SOX13;CCDC88C;FZD6;TMEM88;DAB2IP;CAV1;PSMD13;WWTR1;NLK;CUL3;PSMD4;SHISA6;PTPRU;PTPRO;APC;SNAI2;MCC;CTNNBIP1;IGFBP4;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;TAX1BP3;NKD2;PSMB8;NXN;PSMD14;HMGXB4;TSKU;PSMA7;PSMC3;NFATC1;PSMA8;PSMC1;PSMB5;MLLT3;PSMC5;PSMB9;RACK1;PSMC6;LZTS2
prerank,apoptotic cell clearance (GO:0043277),-0.35819773270365163,-1.1202226626231087,0.3006993006993007,0.7193463937343837,1.0,6/30,8.62%,LRP1;THBS1;ITGAV;ANXA1;RHOBTB2;TXNDC5
prerank,adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.31607094946093645,-1.1201118877213054,0.2376237623762376,0.7180256785316689,1.0,9/57,8.24%,LPAR1;ADCY5;ADCY9;ADCY1;GNAI1;AKAP12;ADCY2;ADCY7;FLNA
prerank,melanosome localization (GO:0032400),0.4637515371178625,1.1194182754858029,0.3098159509202454,0.7427983210053644,1.0,4/21,6.03%,RAB11A;BLOC1S6;BBS7;GPR143
prerank,regulation of protein localization (GO:0032880),0.3964833771431031,1.1192769678188952,0.3016905071521456,0.7425256279649532,1.0,14/58,16.27%,TRIM14;FKBP1A;PPM1F;TRIM6;FBXW7;TRIM25;TRIM17;MMD;TRIM46;VPS4A;MAP2;RACK1;DNAJB6;PLEKHM2
prerank,cellular response to heat (GO:0034605),0.42880161479445283,1.119155255105328,0.3314917127071823,0.7421852386551575,1.0,6/35,10.09%,TRPV4;HSBP1L1;IER5;IL1A;HSPA1B;POLR2D
prerank,histone deacetylation (GO:0016575),-0.33298745572432864,-1.1189198161222822,0.2209737827715356,0.7196354785477522,1.0,11/43,14.56%,PRDM5;TBL1XR1;RBM14;REST;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.4875544341716231,1.11873847656011,0.3058252427184466,0.7427070298999995,1.0,8/16,25.05%,CAV1;ADIPOR1;INPP5F;NF2;PTPN2;LEPROT;PARP14;PPP2R1A
prerank,phosphatidylinositol phosphate biosynthetic process (GO:0046854),0.429394307116205,1.1182694347892863,0.3081155433287483,0.743292429768226,1.0,7/39,9.53%,EFR3B;ITPKB;IP6K3;PIK3C2A;CISH;SOCS6;PIK3C3
prerank,regulation of macrophage chemotaxis (GO:0010758),0.4707355574136754,1.1175903534268539,0.34171597633136097,0.7444048704743529,1.0,6/21,12.70%,MTUS1;MAPK1;CMKLR1;STAP1;PTK2;DDT
prerank,negative regulation of endocytosis (GO:0045806),0.4532118821415706,1.1174989010131875,0.33183183183183185,0.744024328186592,1.0,6/24,15.39%,MCTP1;CAV1;PRKD1;RAC1;RUBCN;ABCA7
prerank,positive regulation of brown fat cell differentiation (GO:0090336),0.5083931486742495,1.117463246565924,0.34686971235194586,0.7434769610174345,1.0,1/13,0.24%,SOX13
prerank,carbohydrate homeostasis (GO:0033500),0.3906387752914248,1.1172433424061778,0.30875,0.7434219995874958,1.0,10/67,8.29%,ADIPOR2;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1
prerank,regulation of cell development (GO:0060284),0.42686874754466003,1.1170654147648529,0.3138075313807531,0.7432280969707452,1.0,11/36,14.54%,FOXO1;HEY1;HDAC9;HEY2;PRUNE1;CX3CR1;ADGRA2;HES3;CTNNB1;RHEB;HMGB2
prerank,regulation of myotube differentiation (GO:0010830),0.45791431615319866,1.1167609152054858,0.30454545454545456,0.743367753301387,1.0,3/24,3.10%,PIEZO1;NOTCH1;HDAC9
prerank,pre-replicative complex assembly (GO:0036388),0.38939119618455215,1.116652982944542,0.31352718078381797,0.7429792170843099,1.0,22/64,18.86%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;PSMB10;PSMB8;PSMD14;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6
prerank,smooth muscle tissue development (GO:0048745),0.5472166771843082,1.1165674417283995,0.3674496644295302,0.7425623897928308,1.0,2/10,1.89%,ENG;MYLK
prerank,positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.3828352387228758,1.1165344097359933,0.3002450980392157,0.7420024665437341,1.0,23/76,17.93%,SMAD7;SUMO2;CSNK1D;BBS7;ARIH1;LRRK2;HSPA1B;CEBPA;PTK2;FBXW7;RBX1;NKD2;RNF144B;LAPTM5;CLU;SMURF1;KEAP1;RACK1;CBFA2T3;RNF139;TRIB3;SOCS5;GSK3A
prerank,regulation of cyclin-dependent protein kinase activity (GO:1904029),0.4042212314831083,1.1161864727649775,0.32591623036649214,0.742251345153157,1.0,14/50,24.60%,CCND2;CCND3;CCNE1;SERTAD1;CDC25C;ACTB;TTBK1;CDKN2D;BLM;MNAT1;CAMK2N1;CDKN1B;CCND1;CCNH
prerank,synaptonemal complex assembly (GO:0007130),0.5010350828931818,1.1160501605262239,0.3465346534653465,0.7413212374278616,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,synaptonemal complex organization (GO:0070193),0.5010350828931818,1.1160501605262239,0.3465346534653465,0.7413212374278616,1.0,3/15,11.00%,SYCP2;RAD21;BAG6
prerank,protein complex oligomerization (GO:0051259),0.37866914109326055,1.1160473864263651,0.3094384707287933,0.7406856630344018,1.0,9/85,9.09%,LRRC8C;EHD4;AQP11;ATL2;EHD1;ATL1;ZC3H12A;ELAVL1;KCNC1
prerank,positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.4286187423666135,1.1157183802773627,0.3089887640449438,0.7408606000353117,1.0,11/35,14.60%,HMBOX1;MAPK1;CCT8;NEK7;TNKS;CCT2;FBXO4;CCT4;ATM;CTNNB1;CCT6A
prerank,phospholipid catabolic process (GO:0009395),0.4552716885556515,1.115542270798898,0.3367496339677892,0.7406574843350119,1.0,5/24,9.85%,GPCPD1;SMPDL3A;PNPLA6;GDPD1;ENPP6
prerank,peptide biosynthetic process (GO:0043043),0.35673592271597027,1.1154202917634657,0.2778402699662542,0.7403300712057677,1.0,64/153,28.18%,RPS21;RPL27;PCSK5;RPL7;FURIN;FARSB;WARS1;MRPL18;MRPL41;RPS14;RPS27A;RPL35;RPL21;RPL37;RPS28;RPL34;MRPL36;MRPL52;RPS9;RPLP2;MRPL23;RPS25;RPL30;RPS5;RPL27A;MRPL24;MRPL32;MRPS12;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;MRPS18B;COPS5;DARS1;MRPL11;RSL24D1;RPL18;RPL39;RPS19;RPL31;RPS8;EIF4G1;MRPL34;EIF4EBP2;RPL3;RPL28;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;MRPS18C;MRPL27;RPS17;EEF1A1;RPS13;MRPL13;RPL11;RPL14
prerank,negative regulation of histone methylation (GO:0031061),-0.4838049034084726,-1.1153716426687665,0.3542168674698795,0.7281113543772993,1.0,5/10,18.34%,JARID2;MTF2;WDR5;BCOR;DNMT3B
prerank,regulation of sister chromatid cohesion (GO:0007063),0.518249125469878,1.1153318008896178,0.3349282296650718,0.739917000891088,1.0,4/12,14.24%,RAD21;FEN1;BUB1;CTNNB1
prerank,adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.36700810979932413,1.1151810226088814,0.2855504587155963,0.7396429949935327,1.0,9/110,5.49%,ADGRL4;RAPGEF2;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;IAPP
prerank,positive regulation of actin filament bundle assembly (GO:0032233),0.4058341812135164,1.114691148565952,0.29815303430079154,0.7402579989081236,1.0,13/51,13.86%,SYNPO;LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,negative regulation of cellular amide metabolic process (GO:0034249),0.375919201444265,1.1146042506354463,0.30528846153846156,0.7398642942520277,1.0,20/84,16.16%,NANOS1;NANOS3;BTG2;RTN1;GAPDH;ROCK1;RTN4;PRNP;CNOT1;ENC1;CLU;TOB1;RTN3;FXR1;PIN1;YBX1;ABCA7;DDX6;RACK1;RNF139
prerank,positive regulation of pattern recognition receptor signaling pathway (GO:0062208),0.5098669226791066,1.114264430447148,0.3365539452495974,0.7400788105606783,1.0,6/14,24.23%,TLR3;PUM2;ZDHHC5;DHX58;ANKRD17;OASL
prerank,negative regulation of histone modification (GO:0031057),-0.4341463031603806,-1.1141909510263297,0.344559585492228,0.7298640122087258,1.0,6/14,21.82%,SET;JARID2;TAF7;TWIST1;NOC2L;SPHK2
prerank,membrane organization (GO:0061024),0.3464482704400979,1.1141394817576407,0.2608236536430834,0.739757908833331,1.0,49/227,15.38%,HIP1;HIP1R;DYSF;PIK3C2A;CBL;ADRB2;TTPA;PPT1;DNM3;PACSIN2;SH3KBP1;VTI1B;AP2B1;ATP2C1;FCHO2;FNBP1L;PIP5K1C;TMEM43;VAMP8;SUN3;ARRB1;GLTP;CERT1;UBA52;A4GALT;ARPC5;ACTG1;RPS27A;VAMP7;CHMP1B;AP2M1;LPCAT3;EPN2;CCDC88A;MYOF;REEP1;ACTB;OCRL;REEP3;VPS4A;CHMP3;SGCZ;ARPC3;CEP55;LDLRAP1;VAPA;CHMP2B;ARPC2;CHMP7
prerank,positive regulation of transport (GO:0051050),0.3765026394971803,1.113993364528502,0.3106682297772567,0.7395216003735503,1.0,15/85,12.10%,GATA2;HIP1R;DOC2B;MERTK;APOA1;INPP5K;FCGR2B;CD47;CDH3;SGK1;NEDD4L;CYBA;NUMA1;ACTB;DOCK2
prerank,regulation of interferon-gamma production (GO:0032649),0.38069432784677826,1.1139002512164842,0.29963459196102316,0.7391082269179831,1.0,14/71,16.90%,CRTAM;F2RL1;LGALS9;TLR3;CD47;ZC3H12A;HMGB1;PRNP;VSIR;LAPTM5;HAVCR2;PDE4D;PYCARD;RARA
prerank,defense response to protozoan (GO:0042832),0.530196944794039,1.1135354051563036,0.35737704918032787,0.7394826741344949,1.0,4/12,16.68%,GBP4;GBP2;LYST;GBP7
prerank,regulation of microtubule nucleation (GO:0010968),-0.4818926549334245,-1.113335566326154,0.3226600985221675,0.7306299042380031,1.0,3/10,6.83%,EML2;MECP2;CKAP5
prerank,mesenchymal to epithelial transition (GO:0060231),-0.4608836561212166,-1.1121736320864701,0.3026634382566586,0.7323250023535266,1.0,5/10,20.48%,BMP4;FZD7;SALL1;BASP1;PAX2
prerank,cell junction organization (GO:0034330),0.38481366479162443,1.1118761708493605,0.3213399503722084,0.7431318934879778,1.0,16/71,13.11%,APBB2;OCLN;FBLIM1;TGFB2;AGRN;APP;PPFIBP1;SNCG;LIMS2;TJP2;ACTG1;TJP1;PPFIA2;ACTB;GRM5;PIN1
prerank,granulocyte differentiation (GO:0030851),0.483121059469971,1.111732327624519,0.3684210526315789,0.7428857448509418,1.0,5/18,16.90%,TAL1;LEF1;CEBPA;CBFA2T3;RARA
prerank,regulation of axonogenesis (GO:0050770),-0.3085258583485872,-1.1112732226450528,0.26732673267326734,0.7331054057501335,1.0,13/51,11.76%,ROBO1;PLXNA2;SLIT2;SIPA1L1;NTRK2;PLXNB2;NGF;BRSK1;KIF13B;CHN1;PLXNB1;ARHGAP35;SLITRK1
prerank,response to fatty acid (GO:0070542),-0.4153141595307178,-1.1110818910516886,0.3074792243767313,0.7320191077387461,1.0,7/17,21.90%,PID1;IRS1;FOXO3;PDK3;SCD;LPL;NR1H4
prerank,regulation of glycolytic process (GO:0006110),-0.29587597488246264,-1.1109117791641436,0.23880597014925373,0.7308555887405227,1.0,9/68,7.46%,PRKAG2;IGF1;ZBTB20;OGT;NUPR1;PRKAA2;PPARA;NUP107;PFKFB4
prerank,protein homotetramerization (GO:0051289),0.3997289417350364,1.1102062474426255,0.3261744966442953,0.746246324432862,1.0,9/49,11.28%,GBP5;B2M;GLS;SSBP1;ALDH9A1;MCOLN1;ACOT13;ACACB;TRPM2
prerank,glycogen catabolic process (GO:0005980),-0.42697658324851373,-1.109792622720413,0.31630170316301703,0.7324684399877947,1.0,5/15,11.23%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,regulation of cardiac muscle cell action potential (GO:0098901),0.44387987058932427,1.1096922590315224,0.32724719101123595,0.7469435817818088,1.0,4/25,4.95%,GJA5;CAV1;NOS1AP;CAMK2D
prerank,glycerolipid catabolic process (GO:0046503),0.4761919978923367,1.1095609718515342,0.32,0.7466603705682849,1.0,5/19,9.85%,GPCPD1;PNPLA6;ABHD6;GDPD1;ENPP6
prerank,lipid translocation (GO:0034204),0.46462307400225267,1.1093395692789025,0.3496296296296296,0.746578149793227,1.0,6/21,15.39%,ATP10A;ABCB4;ATP11C;ATP8B1;ABCC1;ABCA7
prerank,positive regulation of keratinocyte migration (GO:0051549),0.5340884599837039,1.1093059663755105,0.35451505016722407,0.74602144435453,1.0,2/10,4.97%,IQSEC1;MAP4K4
prerank,actin filament bundle organization (GO:0061572),0.43240842419005576,1.109116620743834,0.33472803347280333,0.7458763311718436,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,establishment of mitotic spindle orientation (GO:0000132),-0.3787109792021008,-1.1086167288266753,0.32407407407407407,0.7341768220363885,1.0,7/23,18.11%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1;FBXW11;ZW10
prerank,sensory perception of sound (GO:0007605),0.37481443646987855,1.1084924702486025,0.3097238895558223,0.7468327527535258,1.0,6/88,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,mammary gland development (GO:0030879),0.4591401875428882,1.1084270446149302,0.3526717557251908,0.7463630092765163,1.0,2/21,2.28%,NOTCH4;CAV1
prerank,cellular macromolecule biosynthetic process (GO:0034645),0.3341179452229331,1.108413588616527,0.24895833333333334,0.7457672359342684,1.0,99/306,24.07%,GCNT1;NR4A2;EXT1;RBBP8;RPS21;RPL27;RPL7;FARSB;WARS1;MRPL18;ORC3;ALAS1;EEF2K;MRPL41;POLR2G;RPS14;RPS27A;RPL35;FEN1;MLF1;RPL21;NFKBIB;POLR2D;RPL37;RPS28;RPL34;TUFM;GTPBP1;MRPL36;BRIP1;MRPL52;RPS9;POLA1;RPLP2;EEF2;GTPBP2;BRCA1;MRPL23;RPS25;ORC5;RPL30;RPS5;RPL27A;RAD1;MRPL24;ATM;MRPL32;MRPS12;TAF1B;RPL23A;RPS15;RPL19;KAT7;RPS18;RFC2;RPL32;RAD9B;ST3GAL2;POLR2I;EEFSEC;PWP1;RPL37A;RPL18A;EEF1D;MMS19;MRPS18B;COPS5;HOXD3;ATRIP;GOLPH3;MEF2A;PTMA;BARD1;EEF1G;HUS1;DARS1;RRAGC;MRPL11;RSL24D1;BLM;RPL18;RPL39;RPS19;RPL31;RPS8;RMI1;POLR2C;PAX8;ORC4;KIN;TSFM;EIF4G1;POLR2B;POLR2J;MRPL34;RNASEH2A;EIF4EBP2;WRN;RPL3
prerank,hexose transmembrane transport (GO:0008645),0.46894816795567484,1.1075266195345075,0.33435114503816793,0.747402857762867,1.0,3/21,8.42%,SLC2A1;SLC5A10;SLC2A9
prerank,regulation of neurotransmitter secretion (GO:0046928),0.4441331011936921,1.107454827560332,0.33237410071942447,0.7469697522656653,1.0,7/32,16.46%,MCTP1;MEF2C;LRRK2;SLC30A1;SNCAIP;RIMS3;CPLX1
prerank,positive regulation of binding (GO:0051099),0.3736362294380015,1.107359728022855,0.30342384887839435,0.7465920812264941,1.0,23/84,17.31%,RAPGEF2;CLDN5;HIP1R;B2M;CAV1;FKBP1A;APP;HMBOX1;EPB41;LRRK2;NVL;HMGB1;DHX9;MARK3;DTX3L;PIN1;RAN;HMGB2;KDM4D;RARA;MEN1;TRIB3;PLAUR
prerank,positive regulation of chemotaxis (GO:0050921),0.406577068764463,1.1067471423846653,0.33986013986013985,0.7475336709907086,1.0,7/43,7.36%,CDH13;PDGFB;PRKD1;F2RL1;PPM1F;ADAM17;HSPB1
prerank,"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",0.5187754544436723,1.1067167409130394,0.3633276740237691,0.74698208533169,1.0,4/11,12.73%,LGALS9;HMGB1;VSIR;CBFB
prerank,cellular response to organic substance (GO:0071310),0.36460685606831494,1.1064750601286355,0.29330254041570436,0.7469523629285675,1.0,14/116,7.95%,NOS1;PDGFB;BMPR2;PTPN14;ACVRL1;ARL6IP5;INPP5K;KLF4;ACVR1;LEF1;ASAH2;LRRK2;PTPN12;DCPS
prerank,positive regulation of endothelial cell apoptotic process (GO:2000353),0.49572359912964464,1.1062528609879627,0.34219269102990035,0.7468962822497686,1.0,4/14,10.49%,ECSCR;ANO6;PDCD4;PLCG1
prerank,protein polyubiquitination (GO:0000209),0.335630950376731,1.105783656796171,0.2579650565262076,0.7474412168945557,1.0,85/297,21.24%,LMO7;TRIM14;ZNRF1;TRIM69;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM6;TRAF1;RNF125;ARIH1;CUL3;UBE2Q1;UBE2D1;PSMD4;KLHL20;FBXL18;WWP1;UBE4A;UBA52;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF115;FBXW7;RBX1;PSMB10;SIAH2;RNF144B;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;BRCA1;DTX3L;FBXO4;SMURF1;UBE2T;CBFB;UBE2J2;PSMA7;PSMC3;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;FBXL13;ANAPC7;PSMC6;PSMA4;FBXO6;UNKL;ANAPC13;RUSC1;FBXO10;MKRN1;PSMD5;PSMD9;PSMB6;FBXL15;ANAPC4;RNF166;BARD1;RNF5;RNF34;PSMB2;LNPEP;WWP2;WSB1;TMEM129
prerank,fatty acid transmembrane transport (GO:1902001),-0.3980499822510153,-1.105116245285312,0.32865168539325845,0.7426531605901547,1.0,6/19,11.57%,PRKAG2;PRKAA2;ABCD3;SLC25A20;SLC27A1;PRKAB2
prerank,regulation of protein localization to cell periphery (GO:1904375),0.46920566786190615,1.1043759736405758,0.36628849270664504,0.7504898096371017,1.0,7/18,17.72%,VTI1B;STX7;VAMP8;ACTB;VPS4A;LDLRAP1;SPTBN1
prerank,ion transport (GO:0006811),-0.2731272229773833,-1.1041068628949935,0.23333333333333334,0.7439074021381726,1.0,15/111,6.82%,SLC24A3;TRPM3;SLC1A3;PIEZO2;SLC12A2;SLC26A7;WNK1;SLC26A2;SLC8A3;WNK4;ANO1;SLC9A2;SLC17A5;SLC9A9;SLC5A5
prerank,negative regulation of nucleic acid-templated transcription (GO:1903507),0.3326541195621051,1.104048621161837,0.24233128834355827,0.7507045198610549,1.0,43/417,9.19%,PRDM16;MECOM;SOX13;GATA6;PLCB1;PDGFB;DACH1;RPS6KA5;SMARCA2;NOTCH1;FOXO1;ELK3;HEY1;DAB2IP;HNF4A;ID1;HDAC9;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;SMAD2;BTAF1;DAP;COMMD7;GATA3;EID2B;PDCD4;ZBTB16;PHC3;TMPRSS6;CEBPA;WWP1;ZHX3;GATAD2A;NR1D1;FOXP1;MBD1;JUN
prerank,defense response to virus (GO:0051607),0.36558725104749795,1.103506505139065,0.32269503546099293,0.7515259229542443,1.0,31/100,21.89%,IFI44L;IRF2;F2RL1;IFIH1;TLR3;SERINC3;STAT1;PLSCR1;BCL2L1;NLRC5;OAS2;ACOD1;MLKL;RNASE1;SERINC5;AKAP1;BNIP3L;RNASE6;BNIP3;LYST;PYCARD;RSAD2;CXCL10;IFITM3;RELA;G3BP1;SETD2;EIF2AK2;AGBL4;NT5C3A;PQBP1
prerank,sulfur amino acid catabolic process (GO:0000098),0.5406762612315387,1.1033795302415885,0.3648424543946932,0.7512236318661082,1.0,1/10,2.88%,TST
prerank,MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.4404408077279312,1.1031351744732885,0.3393103448275862,0.7512702118242939,1.0,6/27,12.62%,TIRAP;IRAK2;UBA52;RPS27A;TAB2;BTK
prerank,import into nucleus (GO:0051170),-0.2892533832954177,-1.1030638743510153,0.2694300518134715,0.7453100566943268,1.0,29/73,26.04%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;GEMIN5;NUP155;TNPO3;SMN1;RANBP6;IPO5;FAM53C;SNRPF;NUP93;TNPO2;RANBP17;HTATIP2;SNUPN;TSC2;PHB2;SNRPD3;SEC13;SYK;IPO7;GEMIN7;POM121;IPO8;SNRPD1;NUP188
prerank,chemokine-mediated signaling pathway (GO:0070098),0.404045487360058,1.10265234700818,0.34718498659517427,0.7518824408964988,1.0,5/42,10.16%,CCR1;OXSR1;THPO;STK39;CCL4
prerank,positive regulation of glial cell differentiation (GO:0045687),-0.41540351914389867,-1.1024750762344837,0.36857142857142855,0.7453690553002889,1.0,4/17,4.43%,PTN;IL34;SERPINE2;DICER1
prerank,negative regulation of B cell proliferation (GO:0030889),0.5194508132576074,1.10214775071126,0.34838709677419355,0.7525520349723374,1.0,3/11,13.96%,FCGR2B;TYROBP;ATM
prerank,mammary gland epithelium development (GO:0061180),0.5083885336035548,1.1020514035338644,0.3700159489633174,0.7521687300960361,1.0,2/14,8.22%,IRF6;JAK2
prerank,regulation of tau-protein kinase activity (GO:1902947),0.5347117344565079,1.1019320291748473,0.38524590163934425,0.7518274582507167,1.0,5/10,29.42%,EGR1;CLU;SORL1;HSP90AA1;HSP90AB1
prerank,sulfur compound biosynthetic process (GO:0044272),-0.26925792242467894,-1.1015568837480183,0.22535211267605634,0.7463756066021618,1.0,29/104,17.79%,UST;DSE;DCN;OGN;FMOD;SLC26A2;B3GNT2;GSTT1;CHST15;BGN;PRELP;GCLC;ST3GAL4;B4GALT1;VCAN;GSTZ1;GGT5;CHPF2;LUM;CSPG4;OMD;GSTA3;GSTM1;B4GALT2;GSTM2;GGT7;GGTA1;PAPSS2;AKR1A1
prerank,regulation of regulated secretory pathway (GO:1903305),0.4326597117020053,1.1015534775485951,0.3296398891966759,0.752174676643004,1.0,8/34,20.25%,SYT15;SYT7;LRRK2;RIMS3;RAB27A;SYT1;SYT2;GSK3B
prerank,regulation of cell size (GO:0008361),0.45796170844888473,1.10131067091011,0.34859675036927623,0.7521881846676104,1.0,4/23,10.68%,EDN1;MSN;RAP1GAP2;RAC1
prerank,hematopoietic stem cell differentiation (GO:0060218),0.5370783968869978,1.1010351996962988,0.3655737704918033,0.7522446465424943,1.0,1/10,1.04%,ACE
prerank,positive regulation of axonogenesis (GO:0050772),0.40981387656210466,1.1007338541157774,0.3390501319261214,0.7524028933359286,1.0,9/43,7.01%,PLXNA4;MACF1;PLXND1;NTN1;SHTN1;SEMA7A;ARHGDIA;TIAM2;ISLR2
prerank,regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.33980717370963465,1.1005889065372083,0.29411764705882354,0.7521469706369541,1.0,36/208,14.85%,PLCG2;TRIM14;NOD1;NOD2;DAB2IP;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;TRAF1;JMJD8;ZC3H12A;STAT1;HSPB1;NR1D1;GAPDH;CACTIN;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3;TRIM8;DDX21;RIOK3;RHOH;TMED4;CARD19;VAPA
prerank,response to X-ray (GO:0010165),-0.44639674388484374,-1.1005460089756827,0.3434343434343434,0.7477165305591628,1.0,5/14,17.74%,NUCKS1;NIPBL;ANXA1;XRCC5;IKBIP
prerank,positive regulation of lipid localization (GO:1905954),-0.4682381374265863,-1.100411494421759,0.36387434554973824,0.7464697706550464,1.0,3/11,11.39%,LRP1;IKBKE;NFKB1
prerank,adrenergic receptor signaling pathway (GO:0071875),0.476635393702023,1.0997807148292194,0.35355029585798814,0.7536087701340652,1.0,2/20,2.63%,RAPGEF2;ADRB2
prerank,glucan catabolic process (GO:0009251),-0.4301370415841978,-1.0997288650336392,0.3137755102040816,0.7467314321424077,1.0,5/15,11.23%,PHKB;PYGB;PYGM;AGL;PHKA2
prerank,negative regulation of mRNA catabolic process (GO:1902373),-0.3513414106852286,-1.0993240029452451,0.26813880126182965,0.746337427135288,1.0,10/29,21.22%,TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;DHX34;E2F1
prerank,natural killer cell mediated immunity (GO:0002228),0.4921398255054538,1.0991704171715777,0.3622704507512521,0.7545365033391169,1.0,4/15,16.27%,TUBB;TUBB4B;LYST;PLEKHM2
prerank,stabilization of membrane potential (GO:0030322),0.4857079979383496,1.0988338841962988,0.3438538205980066,0.7547703730916682,1.0,2/16,5.81%,KCNN4;KCNK12
prerank,regulation of mitochondrial depolarization (GO:0051900),-0.471927248321187,-1.0987515487459298,0.3486238532110092,0.7464201236867918,1.0,3/10,6.78%,DCN;BCL2;SRC
prerank,regulation of establishment or maintenance of cell polarity (GO:0032878),0.4777314372082485,1.0982477808559468,0.3447251114413076,0.7556671021048342,1.0,3/18,9.04%,TEK;SHTN1;ROCK1
prerank,regulation of actin filament-based process (GO:0032970),0.38371677729614917,1.098182090877801,0.3304130162703379,0.7552026032051075,1.0,8/70,3.27%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;CRK
prerank,receptor clustering (GO:0043113),-0.359478048072596,-1.0981172978382867,0.2925170068027211,0.7466741040871077,1.0,5/27,8.24%,PTN;MAGI2;DLG4;DNAJA3;FLNA
prerank,mitochondrion transport along microtubule (GO:0047497),0.5074722084123877,1.0976600676167507,0.36454849498327757,0.7559057970727644,1.0,6/13,21.60%,UXT;RHOT2;HIF1A;SYBU;LRPPRC;UBB
prerank,positive regulation of protein processing (GO:0010954),-0.39424988493581736,-1.0974602172702697,0.3224043715846995,0.7468250678062395,1.0,3/19,3.88%,GSN;CCBE1;CLEC3B
prerank,positive regulation of ERAD pathway (GO:1904294),0.5052346918508536,1.0973782287732552,0.34318555008210183,0.7560365589553255,1.0,5/13,15.56%,CAV1;RNF185;NFE2L2;BAG6;UBQLN2
prerank,negative regulation of anoikis (GO:2000811),0.4971043242699215,1.0972631695756743,0.37181663837011886,0.755705784660025,1.0,5/14,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.3894654642041913,-1.0970805058750992,0.30409356725146197,0.746421969078181,1.0,6/21,14.40%,SLC30A10;PPARA;PRKN;TRAP1;HDAC6;SIRT2
prerank,positive regulation of signal transduction (GO:0009967),0.3392211575432014,1.0968739009101336,0.29375,0.7560444201560879,1.0,33/238,9.66%,JAG1;TEK;JAG2;NOTCH4;NOS3;KLF2;FAS;VWF;NOTCH1;JCAD;NOD2;MACF1;DAB2IP;CAV2;TGFB2;EMP2;DLL4;HHEX;MGAT5;LIMS2;TSPAN14;RAB34;SHANK3;GATA3;POGLUT1;CRADD;LRRK2;MYO1C;JAK2;CDH3;TPD52L1;GKAP1;TM2D3
prerank,embryonic organ development (GO:0048568),0.3866955529559772,1.0966168460172758,0.33550065019505854,0.7560579360763169,1.0,10/61,6.03%,SOX17;KITLG;HEY1;TAL1;TGFB2;SOX18;TEAD4;HEY2;PCSK5;GATA3
prerank,regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.40068130783054406,-1.096335533912298,0.3342618384401114,0.7470032725241069,1.0,6/19,6.40%,ROBO1;DCN;CCBE1;CD63;ADAMTS3;XDH
prerank,ubiquitin-dependent ERAD pathway (GO:0030433),0.38304734166021204,1.0958846502195556,0.337888198757764,0.7573294285309412,1.0,20/69,19.79%,RNF103;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;PSMC6;SEL1L;ERLIN2;FBXO6;DNAJC10;RNF5
prerank,glucose homeostasis (GO:0042593),0.37229737718876854,1.095604022397669,0.3369304556354916,0.75740100785527,1.0,12/83,8.68%,ADIPOR2;FOXO1;INSR;KLF7;HNF1A;HNF4A;INPP5K;ADIPOR1;MTNR1B;CEBPA;PRKAA1;NR1D1
prerank,negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.2929535769750045,-1.0955826785801548,0.28888888888888886,0.7476368497629187,1.0,11/74,3.47%,EYA2;IGF1;EYA1;TGFBR1;BMP5;BMP4;BCL2;SH3RF1;TCF7L2;THBS1;ITGAV
prerank,cellular response to fibroblast growth factor stimulus (GO:0044344),0.3623539401577964,1.095528752492994,0.3056558363417569,0.7569780864412736,1.0,21/87,15.83%,TBX1;ESRP2;EGR3;CBL;DLL4;HYAL2;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;ZFP36L2;POLR2D;TIAL1;NR4A1;ITGB1BP1;FGF20;KIF16B;POLR2I
prerank,glutamate metabolic process (GO:0006536),0.46621637743016814,1.0952461142750014,0.36261980830670926,0.7570839326473401,1.0,4/19,5.83%,DGLUCY;GLS2;GLS;GLUD1
prerank,regulation of glucose transmembrane transport (GO:0010827),0.4702236969468328,1.0948984621334925,0.358814352574103,0.7573956761078966,1.0,3/18,3.52%,SLC2A1;OCLN;INPP5K
prerank,leukotriene biosynthetic process (GO:0019370),-0.4347141200698486,-1.0948846494702509,0.3674540682414698,0.7480332389681501,1.0,9/14,36.57%,PLA2G4A;GGT5;GGT7;GGTA1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,negative regulation of transcription by RNA polymerase II (GO:0000122),0.3284178079999492,1.0947915985259222,0.2359437751004016,0.7570418786797999,1.0,66/572,9.89%,PRDM16;SOX13;NOTCH4;KLF8;EDN1;GATA6;PDGFB;LDB2;DACH1;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;HEY2;HMBOX1;KLF4;MAFK;EFNA1;MEF2C;SMAD2;TAF9B;PHF6;GATA3;BCL6B;RTF1;UBE2D1;ZBTB16;GTF2IRD1;STAT1;PURA;TMPRSS6;UBA52;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;JUN;TCF3;HMGB1;ARID5A;MAD2L2
prerank,protein maturation by iron-sulfur cluster transfer (GO:0097428),0.5072320981083537,1.0935696722178148,0.3516666666666667,0.7595440422481907,1.0,6/13,17.37%,YAE1;BOLA2;ISCA2;GLRX5;GLRX3;MMS19
prerank,3'-UTR-mediated mRNA stabilization (GO:0070935),0.504026627061857,1.0933995227925335,0.36984126984126986,0.7593830275494935,1.0,6/14,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;ANGEL2;MAPK14
prerank,response to chemokine (GO:1990868),0.5113184140832989,1.0933403369095762,0.3756260434056761,0.7589166645834952,1.0,5/13,8.47%,DUSP1;OXSR1;LRCH1;ZC3H12A;STK39
prerank,V(D)J recombination (GO:0033151),0.5139492243382112,1.093195891525475,0.37964458804523427,0.7586819464025443,1.0,5/11,22.13%,TCF3;HMGB1;LIG1;HMGB2;XRCC4
prerank,regulation of BMP signaling pathway (GO:0030510),0.3787785085499053,1.0929495526052306,0.31585365853658537,0.7587320523354566,1.0,7/73,1.86%,ENG;SMAD6;BMPR2;SMAD7;ACVRL1;NOTCH1;DAND5
prerank,maintenance of protein localization in organelle (GO:0072595),-0.3883726815380497,-1.0927886631786168,0.33053221288515405,0.7522878496251664,1.0,8/19,20.61%,HK2;BCL3;HNRNPU;TOPORS;MORC3;SUPT7L;PML;CHCHD10
prerank,sensory perception of light stimulus (GO:0050953),-0.28005704864228365,-1.0927234900275535,0.2430939226519337,0.7509030441866857,1.0,14/87,10.39%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;WHRN;OAT
prerank,negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.3815843322966464,-1.0926954876933879,0.33432835820895523,0.7494255274356957,1.0,7/23,18.49%,NUPR1;PPARA;C1QTNF3;HDAC4;SIK1;CLK2;PFKFB1
prerank,regulation of G0 to G1 transition (GO:0070316),0.4106074193127288,1.0922460401006195,0.3333333333333333,0.7599081737033936,1.0,7/38,11.66%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;UXT;BRCA1
prerank,hydrogen peroxide catabolic process (GO:0042744),-0.45228974339618655,-1.0921868166026507,0.35058823529411764,0.7493597560499698,1.0,3/11,23.06%,CAT;PRDX3;GPX1
prerank,negative regulation of cyclase activity (GO:0031280),-0.41248247807090843,-1.0921339160838162,0.33509234828496043,0.7479595684236011,1.0,6/14,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,regulation of microtubule-based process (GO:0032886),0.41003435727588733,1.0918707329870978,0.33613445378151263,0.7602453050144294,1.0,10/36,12.15%,EFNA5;FAM107A;MACF1;DIAPH1;CLASP1;PRKAA1;APC;ROCK1;CLASP2;MARK2
prerank,reticulophagy (GO:0061709),-0.4500646470350802,-1.0917363355282936,0.34408602150537637,0.7475755890413608,1.0,4/12,11.04%,TEX264;UBA5;ATG2A;ULK2
prerank,aspartate family amino acid metabolic process (GO:0009066),-0.4033848428001446,-1.0916679220741383,0.3370473537604457,0.7462326617532369,1.0,10/18,21.46%,SLC25A13;MTHFD1;NAALAD2;ASPG;SLC25A12;GOT1;ADI1;ASNS;MTHFR;ASPA
prerank,"chemical synaptic transmission, postsynaptic (GO:0099565)",0.4431929809068438,1.0915521461756714,0.354978354978355,0.7604408390992767,1.0,9/25,20.37%,MEF2C;LRRK2;GRIN2B;GRIN2C;GRIN2A;GSK3A;GRID2;GSK3B;INSYN2A
prerank,positive regulation of cellular catabolic process (GO:0031331),0.35574074111392007,1.091182832810305,0.3262092238470191,0.7607596814929604,1.0,31/132,14.04%,TRIM14;FOXO1;INSR;PRKD1;PIK3C2A;APP;APOA1;MSN;TRIM6;FURIN;TNFRSF1B;SH3BP4;P2RX7;IRGM;ZC3H12A;LRRK2;PRR5L;PRKAA1;ROCK1;PFKFB3;HMGB1;CNOT1;GTPBP1;PTPN1;LAPTM5;VPS35;DTX3L;TRIM8;PIK3CB;HIF1A;BNIP3
prerank,muscle tissue development (GO:0060537),0.5024979715984913,1.0911575208692228,0.38870967741935486,0.7602149721152808,1.0,3/13,6.28%,ENG;CSRP2;POGLUT1
prerank,positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),0.49721096479770294,1.0904563972982306,0.3760262725779967,0.7613670141794852,1.0,1/12,1.84%,PAEP
prerank,"phototransduction, visible light (GO:0007603)",0.4960106042345168,1.090403994281318,0.37628865979381443,0.7608786033284177,1.0,1/14,1.71%,GNAQ
prerank,sensory perception of mechanical stimulus (GO:0050954),0.370647823149541,1.0903787985164952,0.3236363636363636,0.7603269067981949,1.0,6/85,2.89%,EPS8L2;KCNQ1;TBX1;ATP2B2;USP53;HOMER2
prerank,positive regulation of long-term synaptic potentiation (GO:1900273),0.49781617481409046,1.0899253835089115,0.3696,0.760895727093037,1.0,3/13,5.58%,APP;AKAP5;SHANK3
prerank,positive regulation of monocyte chemotaxis (GO:0090026),0.47302505493229097,1.0898051921936969,0.35857805255023184,0.760598343234865,1.0,3/17,9.50%,CCR1;ANO6;HMGB1
prerank,iron ion transport (GO:0006826),-0.31487050248056453,-1.0895461763799321,0.33064516129032256,0.7508693188948998,1.0,8/47,8.33%,STEAP3;SLC39A14;SCARA5;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,multivesicular body organization (GO:0036257),0.428423252987863,1.089486305129997,0.35804195804195804,0.7607702005511221,1.0,12/31,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;RAB27A;MVB12A;STAM2;CHMP1A
prerank,positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),0.4443557835463545,1.0892735481025646,0.37553956834532376,0.760661733819431,1.0,7/26,11.18%,PLCB1;CCND2;CCND3;ADAM17;MTBP;KMT2E;ADAMTS1
prerank,post-translational protein modification (GO:0043687),0.3300861892435145,1.089106919801731,0.27040816326530615,0.7604708051610661,1.0,80/332,19.04%,LMO7;EPAS1;ASB4;RAB11A;GOLM1;APP;TULP4;KLHL2;FBXO7;APOA1;COPS4;CISH;PSMD13;FBXL14;FBXL5;KLHL3;TMEM132A;ELOC;RHBDD1;GAN;CUL3;PSMD4;KLHL20;ZBTB16;PRKCSH;FBXL18;IGFBP7;SOCS6;HSP90B1;ASB5;FEM1C;PROC;FBXL16;IGFBP4;ADAM10;PSMA5;FBXW7;RBX1;PSMB10;CUL2;APLP2;FBXW2;CDH2;PSMB8;PSMD14;FBXO4;CP;COPS8;DCAF17;PSMA7;PSMC3;KEAP1;DCAF10;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;PSMC5;PSMB9;KLHL25;FBXL13;PSMC6;CST3;KLHL9;PSMA4;FBXO6;MEN1;CALU;SOCS5;COPS5;FBXO10;PENK;PSMD5;PSMD9;FEM1A;TIMP1;DCAF13;PSMB6;FBXL15
prerank,actin filament bundle assembly (GO:0051017),0.4248365488196311,1.0889914197338582,0.35195530726256985,0.7601559201307424,1.0,4/33,3.05%,LIMA1;FAM107A;PLS3;NEDD9
prerank,regulation of neuron migration (GO:2001222),0.4480150911383659,1.088676665693442,0.3545197740112994,0.7603161438452983,1.0,4/26,4.50%,RAPGEF2;ARHGEF2;DAB2IP;SHTN1
prerank,sodium ion import across plasma membrane (GO:0098719),-0.40376148642014864,-1.0884463788138696,0.32941176470588235,0.7525834602072717,1.0,4/17,6.64%,SLC12A2;SLC9A2;SLC6A1;SLC9A9
prerank,toll-like receptor 3 signaling pathway (GO:0034138),0.5313391286911864,1.0883510931236828,0.35858585858585856,0.7605601793824714,1.0,2/11,3.64%,CASP8;TLR3
prerank,endothelial tube morphogenesis (GO:0061154),0.5410829084493233,1.0883227232099,0.4125874125874126,0.7600233358297342,1.0,5/10,14.92%,ACVRL1;RHOB;PRKD2;CTNNB1;CSNK2B
prerank,cellular senescence (GO:0090398),-0.3503192858452312,-1.0876966209150942,0.30513595166163143,0.7531794903441582,1.0,11/27,27.53%,SMC6;TBX2;HMGA2;ECRG4;CDKN1A;PRKCD;PML;ULK3;SRF;OPA1;NSMCE2
prerank,cellular biogenic amine biosynthetic process (GO:0042401),-0.4086007947075838,-1.087478075258539,0.3515625,0.75222546542569,1.0,2/15,5.69%,MOXD1;SMOX
prerank,protein tetramerization (GO:0051262),0.3745094229583543,1.0870805736608105,0.3422391857506361,0.7625904935091276,1.0,12/67,11.28%,GBP5;B2M;GLS;SSBP1;FARSB;ALDH9A1;MCOLN1;GRIN2B;KCNC1;ACOT13;ACACB;TRPM2
prerank,positive regulation of T cell chemotaxis (GO:0010820),0.5295072482017987,1.0870588958621397,0.40237691001697795,0.7620325254516828,1.0,4/10,9.41%,OXSR1;ADAM17;STK39;ADAM10
prerank,dorsal/ventral pattern formation (GO:0009953),-0.3852529499912334,-1.0869414884917317,0.3151515151515151,0.7522418533074309,1.0,3/20,1.27%,BMPR1A;GLI2;NBL1
prerank,inorganic cation transmembrane transport (GO:0098662),0.33335704982962133,1.0863783551321198,0.3169456066945607,0.763150638311777,1.0,33/268,9.99%,ATP2A3;SLC6A6;KCNN4;KCNQ1;TRPV4;RHCG;ATP2B4;KCNH8;ATP1A4;ATP1A1;ATP1A3;CACNA1A;FKBP1A;KCNN3;KCNG3;SLC8A1;ATP2C1;ANO6;SCN11A;ORAI1;KCNK12;P2RX7;SLC30A1;MCOLN1;SLC6A4;SLC39A6;SCN1B;KCNC1;KCNH7;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,negative regulation of autophagy (GO:0010507),-0.30000066461102753,-1.086367537664869,0.26229508196721313,0.7522128992000786,1.0,15/54,14.48%,LEPR;NUPR1;BCL2;SNRNP70;KLHL22;GOLGA2;PTPN22;TAB3;DAPL1;MET;FOXK2;ATG7;KDM4A;SIRT2;TSC1
prerank,positive regulation of protein localization to cell surface (GO:2000010),-0.42199748448329655,-1.0862510598126212,0.3531073446327684,0.7509739296099456,1.0,4/13,9.12%,STX4;MAP1A;RIC3;STX3
prerank,positive regulation of multicellular organismal process (GO:0051240),0.33186877614436183,1.0861549712735805,0.2924819773429454,0.7630816924505784,1.0,36/308,10.24%,PRDM16;EPAS1;ADIPOR2;PLCB1;PDGFB;BMPR2;CRTAM;CAV1;F2RL1;TGFB2;ADRB2;CADM1;INPP5K;ACVR1;WWTR1;LEF1;GCNT2;YBX2;OMA1;SMAD2;IL1A;ADIPOR1;NPR1;ZBTB16;KDM3A;CMKLR1;VAMP8;GADD45G;JAK2;APC;GAPDH;VAMP7;ROCK1;RTN4;MAD2L2;LURAP1
prerank,regulation of dopamine secretion (GO:0014059),0.4478567365486897,1.0861352789856,0.34045584045584043,0.7625311703765147,1.0,2/25,3.73%,SYT15;SYT7
prerank,regulation of protein modification by small protein conjugation or removal (GO:1903320),0.46973151229498683,1.0859586696927106,0.38496932515337423,0.7623646227490819,1.0,3/20,9.48%,EPAS1;HSPA1B;EGR1
prerank,protein ubiquitination (GO:0016567),0.3258923755341653,1.0857562235798468,0.2752016129032258,0.7622737635007201,1.0,99/471,16.16%,LMO7;EPAS1;ASB4;TRIM14;RNF103;FBXL2;ZNRF1;TRIM69;CBL;HERC2;KLHL2;FBXO7;PSMD13;FBXL14;FBXL5;KLHL3;TRIM11;TRIM6;RNF38;ELOC;RNF125;RNF185;ARIH1;GAN;CUL3;UBE2Q1;ARRDC1;RTF1;UBE2D1;TRIM24;PSMD4;KLHL20;FBXL18;ARRB1;WWP1;ASB5;UBE4A;UBA52;NFE2L2;RPS27A;UBE3A;HERC6;FBXL16;PSMA5;RNF141;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;CUL2;TRIM25;TRIM47;ENC1;RNF144B;TRIM17;FBXW2;TNKS;NEDD4L;PSMB8;PSMD14;OBI1;BRCA1;DTX3L;FBXO4;SMURF1;KCTD10;UBE2T;CBFB;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;RAD18;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;IRF2BP1;PSMB9;RACK1;TRAIP;KLHL25;FBXL13;KLHL24;ANAPC7;PSMC6;RNF139
prerank,regulation of kinase activity (GO:0043549),0.3681273177370973,1.0855925098744537,0.3459715639810427,0.7620866190591683,1.0,13/89,8.03%,TEK;FLT1;TIE1;LDB2;FLT4;MERTK;INSR;EMP2;FGFR3;ALK;LMTK2;RBL1;NLRC5
prerank,hexose biosynthetic process (GO:0019319),-0.32430885296610723,-1.0855636225317393,0.29844961240310075,0.751408382702781,1.0,15/42,21.23%,SLC39A14;SLC25A13;CHST15;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;AKR1B1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of cardiac muscle cell contraction (GO:0086004),0.4334091055764927,1.0854211374285117,0.3372093023255814,0.7619022026484824,1.0,3/27,4.95%,GJA5;CAV1;CAMK2D
prerank,negative regulation of androgen receptor signaling pathway (GO:0060766),-0.4418917285426793,-1.0853288900652007,0.37017994858611825,0.7505595309100296,1.0,3/12,11.56%,DAB2;HEYL;HDAC1
prerank,amyloid fibril formation (GO:1990000),0.39243013057739173,1.0849108568372212,0.34155844155844156,0.7625716246459027,1.0,13/51,11.63%,B2M;FKBP1A;APP;APOA1;TSPAN14;IAPP;FURIN;UBA52;RPS27A;APH1A;ADAM10;SIAH2;SNCAIP
prerank,visual perception (GO:0007601),-0.28181813596559147,-1.0845820609194097,0.24861878453038674,0.7512137136568084,1.0,13/84,10.39%,COL1A1;EFEMP1;SLC4A10;ADGRV1;EML2;COL11A1;EYA4;RP2;OPA3;IMPG2;DHRS3;ZIC2;OAT
prerank,negative regulation of response to external stimulus (GO:0032102),0.36142558856140644,1.0845820340354548,0.3314543404735062,0.7628188018976176,1.0,18/105,12.41%,TEK;AOAH;CRK;APOA1;KLF4;GATA3;NFKBIL1;DUSP3;MFHAS1;PROC;NMI;NR1D1;ACOD1;CACTIN;LPCAT3;VPS35;INPP5F;CTNNA2
prerank,protein glycosylation (GO:0006486),0.35255483453270214,1.0834044306361235,0.34375,0.7651374823931184,1.0,26/125,16.63%,EOGT;ST8SIA6;GALNT18;ST3GAL6;POMGNT1;ST6GALNAC2;AQP11;SERP2;MGAT5;GCNT2;GALNT7;POGLUT1;NUS1;B3GNT3;DPM1;TET3;C1GALT1C1;MGAT1;B3GALNT2;KRTCAP2;ST3GAL1;ALG11;MPI;ST3GAL2;OGA;DDOST
prerank,regulation of protein localization to membrane (GO:1905475),-0.3500155649956333,-1.0831404121650765,0.3333333333333333,0.7537321095243575,1.0,5/28,4.31%,GPC6;GSN;GPC3;MMP14;PRKN
prerank,nuclear-transcribed mRNA catabolic process (GO:0000956),0.3422443166827542,1.082802102169751,0.3491891891891892,0.7660731128015381,1.0,70/168,25.82%,RPS21;RPL27;RPL7;LSM1;ZC3H12A;CNOT6L;MTPAP;DCPS;UBA52;DCP1B;POLR2G;RPS14;RPS27A;RPL35;ETF1;RPL21;POLR2D;RPL37;CNOT1;RPS28;RPL34;RPS9;XRN2;EXOSC8;PELO;RPLP2;RPS25;HELZ2;RPL30;RPS5;XRN1;RPL27A;ATM;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CNOT2;TENT2;EXOSC9;TUT7;DXO;NBDY;CTIF;SMG7;RPL18;RPL39;ZFP36L1;RPS19;EXOSC10;CSDE1;SMG9;RPL31;RPS8;DIS3L2;SMG8;EIF4G1;PATL2;RPL3;MRTO4;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,response to cytokine (GO:0034097),-0.2593464727363603,-1.0825469765834266,0.22916666666666666,0.7538502596561225,1.0,19/141,7.03%,PID1;PTPN13;AFF3;COL3A1;DPYSL3;ALDH1A2;IL1R1;PTPN9;BCL2;IKBKE;PTPN4;TIMP2;IL6R;ANXA1;SMAD3;ADAM9;SRC;TBK1;CXCL16
prerank,negative regulation of small molecule metabolic process (GO:0062014),-0.3896062651153531,-1.0820437943047398,0.3732193732193732,0.7537932570158737,1.0,4/20,16.15%,WNT4;C1QTNF3;SIK1;CLK2
prerank,response to retinoic acid (GO:0032526),0.3786247353318935,1.081948160136173,0.3582474226804124,0.7676790456804609,1.0,5/59,6.67%,ACER2;GATA6;TBX1;RXRG;SETX
prerank,regulation of integrin-mediated signaling pathway (GO:2001044),0.4888313355162601,1.0819452295148109,0.3681592039800995,0.767078477935916,1.0,3/14,4.06%,PRKD1;EMP2;LIMS2
prerank,positive regulation of smooth muscle cell proliferation (GO:0048661),0.4080724124920829,1.0816507893638818,0.3622994652406417,0.7671801854426537,1.0,7/43,9.19%,CDH13;EDN1;PDGFB;STAT1;HTR1B;FOXP1;JUN
prerank,negative regulation of myoblast differentiation (GO:0045662),0.49865882919913374,1.0815782899199888,0.38587848932676516,0.7667499227766648,1.0,2/13,6.06%,NOTCH1;EID2B
prerank,amino acid import (GO:0043090),0.44946794313999267,1.0815271089318967,0.3472222222222222,0.7662584411660333,1.0,5/21,7.82%,SLC6A6;SFXN1;SH3BP4;SLC16A2;SLC7A1
prerank,granulocyte chemotaxis (GO:0071621),0.38131438564921744,1.081498611085167,0.36129032258064514,0.7657139189066148,1.0,5/55,10.16%,EDN1;TGFB2;PIP5K1C;BSG;CCL4
prerank,positive regulation of macromolecule metabolic process (GO:0010604),0.3292635758163429,1.0814744576410242,0.3120494335736354,0.7651678509930063,1.0,59/348,12.61%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;KLF2;OCLN;NOTCH1;INSR;HEY1;IFNGR1;TNRC6C;LGALS9;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;WARS1;IL1A;MAPK1;P2RX7;ZC3H12A;HSPA1B;ARRB1;PLSCR1;TBC1D5;CDH3;NFE2L2;PRKAA1;ACTG1;ROCK1;STAP1;EGR1;TASOR;TYROBP;AGO4;PTPN1;VSIR;LAPTM5;NWD1;VPS35;INPP5F;BRCA1;VSTM2A;CLU;DTX3L;HINFP;PIK3CB;TTBK1
prerank,response to iron ion (GO:0010039),-0.44367626646189123,-1.081231474934684,0.3511450381679389,0.754581013736752,1.0,3/12,5.52%,BMP6;BCL2;ACO1
prerank,cellular response to hypoxia (GO:0071456),0.35208763751595906,1.0811296135371746,0.3356009070294785,0.765459139096265,1.0,38/126,20.43%,EPAS1;GATA6;PLK3;PSMD13;ELOC;PGK1;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;HP1BP3;CUL2;PSMB8;HIF1AN;PSMD14;SUV39H2;PSMA7;PSMC3;BNIP3L;HIF1A;PSMA8;PSMC1;BNIP3;PSMB5;PSMC5;PSMB9;PSMC6;PTGIS;PSMA4;PSMD5;PSMD9;EPO;PSMB6;EGLN1;ACAA2;PSMB2
prerank,regulation of protein targeting to membrane (GO:0090313),0.4332257842165486,1.0808554652878157,0.36086956521739133,0.7655191716032864,1.0,8/28,17.88%,FYN;INPP5K;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3;GDI1
prerank,protein import into nucleus (GO:0006606),-0.28598075792995,-1.0805257696825015,0.3147208121827411,0.7549905980645016,1.0,22/66,24.39%,APPL2;CBLB;NUP107;HEATR3;CSE1L;KPNA1;PPP1R10;NUP155;TNPO3;RANBP6;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,neurotrophin signaling pathway (GO:0038179),0.4505497343576021,1.0803598965678094,0.3755656108597285,0.7661580433862403,1.0,2/21,1.83%,RAPGEF2;RAPGEF1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.5140237088728924,1.0802118683492166,0.3647260273972603,0.7659237903310115,1.0,2/11,2.67%,FAS;LGALS9
prerank,pyrimidine nucleoside catabolic process (GO:0046135),-0.46543719259953764,-1.0800799832190997,0.37163814180929094,0.7546750700628303,1.0,4/10,11.03%,DPYD;NT5M;NT5E;UPB1
prerank,electron transport chain (GO:0022900),0.48576848687398544,1.0795231089680501,0.3923444976076555,0.7670066433237092,1.0,5/15,14.33%,ETFDH;ETFB;ETFA;UQCRFS1;CYB561
prerank,positive regulation of Ras protein signal transduction (GO:0046579),0.3834311237457846,1.0788053694250546,0.35875,0.7682339784640988,1.0,11/61,8.22%,ARHGEF3;F11R;NOTCH1;RAPGEF1;F2RL1;APOA1;MAP4K4;LPAR6;SHOC2;ARRB1;JAK2
prerank,positive regulation of ceramide biosynthetic process (GO:2000304),-0.4603113875889554,-1.078756587941743,0.3783132530120482,0.7554121244547813,1.0,6/10,27.40%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.4603113875889554,-1.078756587941743,0.3783132530120482,0.7554121244547813,1.0,6/10,27.40%,SIRT3;PLA2G6;PRKCD;SPHK2;SMPD3;TNFRSF1A
prerank,neuron projection morphogenesis (GO:0048812),-0.26095088080491213,-1.078625960689524,0.2727272727272727,0.7543228367669701,1.0,28/137,12.11%,ALCAM;GAS7;SDC2;FGFR2;DOCK7;NBL1;DCLK1;BMP7;FARP1;DCDC2;DOCK10;S100A6;DLG4;DICER1;PARD3;EPB41L3;NGF;MAP1A;CTNND2;BRSK1;FLRT1;NRK;ZDHHC17;DTNBP1;PLXNB1;DBN1;SLITRK1;NCKAP1L
prerank,peptidyl-serine modification (GO:0018209),0.3402925903019452,1.077383590151899,0.3384446878422782,0.771238605895802,1.0,43/166,16.98%,PDGFB;RPS6KA5;SBK1;PRKD1;MAST4;PKN3;CAMK2D;PKN1;STK38;STK38L;CSNK1D;TTBK2;POGLUT1;MAPK1;UHMK1;MAST1;AKT3;LRRK2;LMTK2;TLK1;STK39;ROCK1;CSNK1G3;SGK1;MARK3;PRKCG;RPS6KA1;TNKS;PRKD2;GALNT4;MARK2;VRK1;TTBK1;RPS6KA3;RPS6KB1;ATM;PRKX;PKN2;PAK2;RICTOR;CSNK1G1;STK32B;MAPK14
prerank,regulation of inflammatory response (GO:0050727),0.3418651308186029,1.0773276534146015,0.33297872340425533,0.7707745775751855,1.0,29/190,11.41%,TEK;NOD2;AOAH;SPATA2;APP;APOA1;TLR3;KLF4;SEMA7A;HYAL2;TNFRSF1B;GATA3;BCL6B;PDCD4;CD47;MFHAS1;CEBPA;CD200;JAK2;PROC;NMI;NR1D1;ACOD1;FOXP1;DHX9;LPCAT3;CASP1;NFKBIA;VPS35
prerank,negative regulation of protein localization to membrane (GO:1905476),-0.365353013540904,-1.0773005995335085,0.32967032967032966,0.7565663529926601,1.0,3/24,2.40%,PID1;DAB2;RHOQ
prerank,skeletal muscle tissue development (GO:0007519),0.417967801361826,1.0772245653059431,0.3721590909090909,0.7704419805739321,1.0,4/32,7.82%,CAV1;CAV2;MEF2C;MYL6
prerank,"synaptic transmission, glutamatergic (GO:0035249)",0.4554180430972022,1.077146703400098,0.38636363636363635,0.7700645149823786,1.0,4/18,10.51%,UNC13B;GRID1;GRIK5;GRIK2
prerank,tyrosine metabolic process (GO:0006570),0.5173362262506481,1.0767729481016495,0.4052718286655684,0.7703711573296129,1.0,2/11,9.85%,HGD;TYR
prerank,protein deacetylation (GO:0006476),-0.3213029978146833,-1.0766624786183905,0.3241106719367589,0.7568410974859558,1.0,12/41,14.56%,PRDM5;TBL1XR1;SIRT3;FLNA;RBM14;HDAC4;HDAC1;HDAC6;MSL3;SIRT2;SIN3B;MTA2
prerank,negative regulation of macromolecule metabolic process (GO:0010605),0.34068947630440977,1.0763559752076641,0.3412526997840173,0.7707981718132008,1.0,30/182,10.53%,ENG;CLDN5;GATA2;PDGFB;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;DLL4;APP;HEY2;KLF4;TRIM6;MEF2C;CD34;SMCR8;ANKRD13A;ZC3H12A;RBL1;PRKAA1;FOXP1;NDFIP2;ADAM10;FBXW7;TCEAL1;AGO4
prerank,positive regulation of cartilage development (GO:0061036),0.46431656511376007,1.0758778808370952,0.37422360248447206,0.7714501445907166,1.0,3/17,6.87%,BMPR2;ACVRL1;ZBTB16
prerank,endoplasmic reticulum organization (GO:0007029),0.37761442760532415,1.0758742671417194,0.345873786407767,0.7708555593741562,1.0,16/72,12.91%,ATL2;CAV2;APP;DOP1B;SHTN1;ATL1;LRRK2;REEP2;RTN4;PRNP;LPCAT3;GET1;REEP1;REEP3;RTN3;UBE2J2
prerank,positive regulation of muscle cell differentiation (GO:0051149),0.44559587478806795,1.0756016156262298,0.35745937961595275,0.770942487473724,1.0,10/24,18.66%,MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,membrane protein ectodomain proteolysis (GO:0006509),-0.3625779675342602,-1.075443774303107,0.3395061728395062,0.7586780858774941,1.0,7/21,6.35%,BACE2;RBMX;BACE1;HM13;ADAM19;DAG1;ADAM9
prerank,positive regulation of cell population proliferation (GO:0008284),0.3249041451923664,1.0753676151552913,0.3037716615698267,0.770965871651098,1.0,45/423,9.64%,VEGFC;CDH13;ACER2;EDN1;PDGFD;CLDN5;FLT1;PDGFB;FLT4;KITLG;TBX1;CCND2;LIFR;NOTCH1;NOD2;INSR;AQP11;TGFB2;EMP2;RASSF10;DLL4;VEGFD;KRAS;WWTR1;LEF1;GCNT2;SERTAD1;MEF2C;TBC1D8;FGFR3;CUL3;ADAM17;SLC25A33;CD47;GNAI2;STAT1;CNOT6L;THPO;NDUFS4;NAMPT;FOXP1;TJP1;PTK2;ADAM10;DHX9
prerank,dendrite self-avoidance (GO:0070593),0.47137821241217404,1.0753042967126736,0.38354037267080743,0.7705235346585775,1.0,9/16,27.55%,ROBO4;BSG;MYPN;NPTN;DSCAM;CNTN4;CNTN6;IGSF9;CNTN2
prerank,synaptic vesicle exocytosis (GO:0016079),0.4087210815396503,1.0751757968117104,0.37012113055181695,0.7702013840027289,1.0,11/40,18.29%,UNC13B;DOC2B;BLOC1S6;SYT7;PIP5K1C;STX19;RIMS3;CPLX1;SNPH;SYT1;SYT2
prerank,nuclear transport (GO:0051169),0.4620123759691236,1.0748402638267374,0.4075286415711948,0.7704245593149259,1.0,6/16,23.16%,XPO1;NPM1;RSRC1;NUP205;BANF1;NXT2
prerank,cardiac muscle cell contraction (GO:0086003),-0.38850759186712636,-1.0744939666108226,0.3652173913043478,0.7599408370296541,1.0,4/19,6.67%,CACNA1C;GSN;CACNA2D1;CACNA1G
prerank,signal transduction by p53 class mediator (GO:0072331),0.42392119940991624,1.0741586832139887,0.371900826446281,0.7715765782028015,1.0,2/30,3.46%,ACER2;PPP1R13B
prerank,response to hydrogen peroxide (GO:0042542),0.39622364884765887,1.0740969238488718,0.36473755047106327,0.7711414596864857,1.0,8/45,11.28%,FYN;RHOB;STK24;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,regulation of vasculature development (GO:1901342),0.4337844841902775,1.0739992028283034,0.38316400580551524,0.7707961639878262,1.0,10/26,22.01%,EMP2;PLXND1;VASH2;TSPAN12;WARS1;ADGRA2;CTNNB1;ETS1;EGLN1;EPHA2
prerank,positive regulation of T cell activation (GO:0050870),0.3758750169249331,1.0734816295793386,0.37579617834394907,0.771524261968429,1.0,6/62,7.82%,VCAM1;NOD2;LGALS9;GATA3;CD47;SLC7A1
prerank,positive regulation of interferon-alpha production (GO:0032727),0.45724380538775894,1.0734287706662453,0.37384615384615383,0.7710642051525135,1.0,5/19,12.46%,IFIH1;TLR3;STAT1;DHX9;IRF5
prerank,post-Golgi vesicle-mediated transport (GO:0006892),0.36066764253707684,1.0733041297744532,0.3624401913875598,0.7707913962936883,1.0,31/88,24.46%,EXOC6;STXBP6;APP;AP1S2;DOP1B;BLOC1S6;GOPC;KLHL20;VAMP8;ARRB1;VAMP7;EXOC8;AP1B1;CLVS1;KIF16B;MON2;EXOC4;SORCS1;SORT1;EXOC2;STEAP2;EPS15;SORL1;SCAMP1;EXOC5;EXOC6B;OSBPL5;SCAMP3;FTH1;FTL;MYO5A
prerank,negative regulation of establishment of protein localization (GO:1904950),0.5215522390244278,1.0733031158749213,0.3886861313868613,0.7701957793886978,1.0,4/10,20.91%,PPM1F;NDFIP2;DNAJA1;WWP2
prerank,inner dynein arm assembly (GO:0036159),-0.46947618335131086,-1.0731509071055525,0.36486486486486486,0.7622677834335666,1.0,8/10,47.06%,DNAAF5;CCDC39;CFAP100;CCDC40;DNAAF4;DNAH1;DNAAF1;DNAI3
prerank,regulation of actin filament-based movement (GO:1903115),-0.45589923600436133,-1.0729044633020062,0.3883495145631068,0.7613730857466114,1.0,2/10,1.63%,ANK2;PDPN
prerank,negative regulation of interleukin-1 production (GO:0032692),0.4447615080891388,1.0728088684188632,0.3614088820826952,0.7708969381945421,1.0,6/23,18.48%,CEACAM1;APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,prostanoid metabolic process (GO:0006692),-0.4307368350652119,-1.0726468041607558,0.3822784810126582,0.7606048369795083,1.0,4/13,14.82%,PTGES;PTGS1;HPGD;GSTM1
prerank,RNA modification (GO:0009451),0.3777240514104393,1.0721139498210834,0.36139896373056996,0.7720178954344004,1.0,13/54,21.08%,ADAT2;ADARB1;TRDMT1;TRMT61A;MRM2;ADAR;TRUB1;RBM15;NSUN5;FTSJ3;NSUN4;TRMT1;NSUN6
prerank,negative regulation of gene expression (GO:0010629),0.32867047951719347,1.0719758672701456,0.33815925542916236,0.7717805011510899,1.0,49/302,13.22%,NANOS1;NANOS3;ENG;CLDN5;GATA2;PDGFB;RPS6KA5;CCR1;OCLN;ACVRL1;NOTCH1;ATP2B4;TGFB2;TNRC6C;LGALS9;BTG2;DLL4;APP;HDAC9;HEY2;KLF4;FCGR2B;TRIM6;MEF2C;CD34;SMCR8;ZC3H12A;HSPA1B;RBL1;PRKAA1;GAPDH;FOXP1;NDFIP2;ZFP36L2;ADAM10;FBXW7;TCEAL1;TASOR;CNOT1;ENC1;AGO4;PTBP3;TMBIM6;HINFP;TOB1;TTBK1;PPM1D;FXR1;APLN
prerank,cellular response to unfolded protein (GO:0034620),0.43671344666780554,1.0717945899820018,0.3991228070175439,0.7716250119373381,1.0,8/26,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,polyol biosynthetic process (GO:0046173),0.4783178658595951,1.0717257445993922,0.38057324840764334,0.7712002692855597,1.0,3/16,3.53%,ITPKB;IP6K3;IPPK
prerank,inorganic anion transport (GO:0015698),-0.30776695536839715,-1.0715294906376664,0.30603448275862066,0.7621673797898723,1.0,8/53,6.82%,SLC13A4;SLC4A10;SLC26A7;ANO1;CLCN2;ENPP1;ENPP3;SLC5A5
prerank,fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.5186414335926002,1.0714235034689277,0.38605442176870747,0.771371116037666,1.0,3/10,6.58%,ETFDH;ETFB;ETFA
prerank,presynaptic endocytosis (GO:0140238),0.4403385475734312,1.071387513297322,0.37295690936106984,0.7708580536037068,1.0,9/24,18.29%,SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,methylguanosine-cap decapping (GO:0110156),0.5272738791493156,1.071353945339031,0.3955479452054795,0.7703520351226365,1.0,4/10,15.18%,LSM1;DCPS;DCP1B;EDC3
prerank,N-acetylneuraminate metabolic process (GO:0006054),-0.4550840496448211,-1.0705805467495415,0.3840749414519906,0.7634600490956567,1.0,4/10,17.32%,ST6GAL1;RENBP;NAGK;AMDHD2
prerank,"Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",0.3621062622828041,1.0703952640340426,0.3773809523809524,0.7721530830828673,1.0,25/85,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of phosphoprotein phosphatase activity (GO:0043666),0.4130217115348434,1.0702030090874033,0.3702664796633941,0.7720526530077623,1.0,9/35,17.21%,NUAK1;ITGA1;FKBP1A;HSP90B1;CALM3;PPP1R15B;CSNK2B;BOD1;TIPRL
prerank,amino acid import across plasma membrane (GO:0089718),-0.3608285223898518,-1.070098188119686,0.33636363636363636,0.7633335013557145,1.0,7/24,7.11%,SLC1A3;SLC6A13;SLC7A2;SLC47A1;SLC1A5;SLC6A9;SLC22A4
prerank,positive regulation of CREB transcription factor activity (GO:0032793),0.457216727030787,1.0697905558052658,0.38485804416403785,0.7724943359029606,1.0,5/18,11.99%,RPS6KA5;PRKD1;CD200;CRTC1;PRKD2
prerank,negative regulation of adenylate cyclase activity (GO:0007194),-0.4175879193571179,-1.0697270701722297,0.376,0.7628602108507745,1.0,6/13,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,regulation of myeloid cell differentiation (GO:0045637),-0.2962092720583688,-1.0692932375755069,0.33658536585365856,0.762568588642764,1.0,19/62,15.77%,PRKCB;THBS1;CREBBP;TNRC6A;KAT2B;KMT2C;MEIS1;RUNX1;ASH2L;SETD1A;PAF1;MYL9;HOXA5;WDR5;CTR9;HDAC1;DPY30;TNRC6B;MAFB
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.42867804655319075,1.0692464703401898,0.3776435045317221,0.7732571481555313,1.0,6/24,15.59%,ING2;TAF9B;BCL2L1;SNAI2;CLU;CDKN2D
prerank,zinc ion transport (GO:0006829),-0.38188983017971073,-1.0691984784054684,0.35327635327635326,0.7613600747554001,1.0,5/21,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.3818917968332298,-1.068698235342871,0.34195402298850575,0.761262807662121,1.0,5/20,9.67%,SULF1;SULF2;THBS1;FGF2;CREB3L1
prerank,retinol metabolic process (GO:0042572),-0.4217773943556835,-1.0684536912075044,0.3829268292682927,0.7604488527244583,1.0,2/14,9.47%,RBP4;DHRS3
prerank,RNA processing (GO:0006396),-0.244888504411754,-1.068418646612124,0.2631578947368421,0.7590822041832631,1.0,56/176,23.42%,CELF2;RBMS1;SON;NOVA1;SNRNP40;SRSF5;HNRNPH1;SCAF11;DDX17;DICER1;APOBEC1;NUDT21;HNRNPA2B1;NCBP1;LIN28B;PRPF8;SRRM1;FUS;SRSF1;PRKACA;CDK12;PRPF3;PABPN1;THOC1;TARDBP;AKAP8L;SNRPF;TENT4B;RBM39;WBP4;SNRPA1;TUT1;HNRNPL;SCNM1;RNASEL;HNRNPU;MAGOH;PPP2CA;BCAS2;U2AF2;SNRPD3;TUT4;MAGOHB;RNGTT;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;SF3A2;NCBP2;DHX15;TCERG1;CELF1;SRSF2
prerank,NIK/NF-kappaB signaling (GO:0038061),0.3700904903734344,1.068410339050037,0.3584905660377358,0.7747031767394377,1.0,24/72,18.86%,TLR3;TIRAP;PSMD13;CARD10;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;COPS8;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;RELA;MALT1;PSMB6
prerank,regulation of peptide hormone secretion (GO:0090276),0.3770464684295164,1.0683242422320633,0.3567774936061381,0.7743171275231846,1.0,8/67,8.47%,ITPR3;SLC2A1;CACNA1A;HNF4A;SYT7;RAPGEF4;MTNR1B;PASK
prerank,regulation of hydrogen peroxide-induced cell death (GO:1903205),0.5156372638899935,1.0683043931888658,0.40034071550255534,0.7737816313701907,1.0,3/10,8.27%,LRRK2;PDE8A;NFE2L2
prerank,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4212284224555507,1.0681948359990525,0.3869565217391304,0.7734768912534943,1.0,5/31,7.71%,HIP1R;CASP8;PPP1R13B;BBC3;NMT1
prerank,regulation of mast cell degranulation (GO:0043304),0.48176843393823976,1.0679850399703843,0.38388625592417064,0.7733814193323941,1.0,2/14,3.24%,LGALS9;FES
prerank,cellular response to acid chemical (GO:0071229),0.4255454116094653,1.0678208792667325,0.38814814814814813,0.7731976728320538,1.0,8/27,20.76%,SPAAR;KLF2;SH3BP4;RRAGD;GLRA2;RRAGA;RRAGC;LAMTOR3
prerank,positive regulation of interleukin-13 production (GO:0032736),0.5272955800302862,1.0676253237431288,0.3911504424778761,0.7731149607934619,1.0,2/10,6.03%,LGALS9;GATA3
prerank,adipose tissue development (GO:0060612),0.5006207025076769,1.0675527012961434,0.374113475177305,0.7726931726532701,1.0,4/11,13.91%,SPTLC2;NAMPT;ARID5B;LRP5
prerank,cell junction assembly (GO:0034329),0.35391389182843164,1.0673661182075833,0.36554132712456344,0.7725583506352982,1.0,29/100,20.66%,TRPV4;CLDN5;FBLIM1;DNM3;SPOCK2;PLXND1;LIMS2;SHANK3;GJA4;NRCAM;FLRT3;ACTG1;TJP1;CDH12;KIRREL3;CDH2;ACTB;ACHE;PCDHB16;PCDHB14;CDH22;PCDHB9;OPHN1;DSCAM;SHANK2;CDH18;CDH24;BDNF;NRXN1
prerank,renal filtration (GO:0097205),0.514173660317709,1.067323088881482,0.4075907590759076,0.7720796365167839,1.0,6/10,18.30%,MYO1E;CD34;MCAM;ITGA3;XPNPEP3;TBC1D8B
prerank,extracellular matrix organization (GO:0030198),0.325717218057926,1.0672159729013166,0.34024896265560167,0.7717708655756881,1.0,30/276,7.18%,LAMA4;LAMA3;PECAM1;ELN;FBLN5;PDGFB;VCAM1;RECK;F11R;VWF;ITGA1;JAM2;MMP1;ICAM2;TGFB2;AGRN;APP;ADAMTS18;SPOCK2;LAMA5;ADAM15;DST;ATP7A;FURIN;COL5A2;CD47;BSG;PLEC;ITGAM;ADAM12
prerank,positive regulation of protein import into nucleus (GO:0042307),-0.3549483288638485,-1.0669420609336553,0.3591331269349845,0.7616875569922168,1.0,10/28,18.45%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,coenzyme A metabolic process (GO:0015936),0.48338978418866674,1.066681789255197,0.40310077519379844,0.7725094994676067,1.0,6/14,22.62%,SLC25A16;PANK3;PPCS;CROT;ACAT1;ACLY
prerank,positive regulation of endocytosis (GO:0045807),0.39037019094627284,1.066166260908625,0.38263229308005425,0.773217692562402,1.0,11/45,11.83%,HIP1;B2M;F2RL1;CBL;PPT1;ANO6;STAP1;VPS28;HNRNPK;NEDD4L;CLU
prerank,GTP metabolic process (GO:0046039),0.469930149288717,1.066074977864368,0.38943894389438943,0.7728679028291674,1.0,6/15,15.84%,RAB23;LRRK2;GTPBP1;MFN1;RAN;EFL1
prerank,nucleoside catabolic process (GO:0009164),-0.44661463476115226,-1.0660531929385162,0.38213399503722084,0.7626552012907104,1.0,4/11,11.03%,DPYD;NT5M;NT5E;UPB1
prerank,negative regulation of T cell activation (GO:0050868),0.4013135716209979,1.0649321477282907,0.37397260273972605,0.7751269331172982,1.0,6/35,14.84%,CEACAM1;FCGR2B;ARG1;DUSP3;LAPTM5;HAVCR2
prerank,eye photoreceptor cell differentiation (GO:0001754),-0.43277509968964184,-1.064893041096646,0.36982968369829683,0.7644231545346826,1.0,3/12,8.98%,SDK2;NKD1;VEGFA
prerank,odontogenesis of dentin-containing tooth (GO:0042475),0.4677331928955095,1.063535749783759,0.4015748031496063,0.778034494688051,1.0,2/15,1.26%,MSX1;TBX1
prerank,regulation of transcription by RNA polymerase II (GO:0006357),0.3152329341338134,1.0625809555096664,0.203,0.7798808367128462,1.0,227/1668,13.15%,PRDM16;NOS1;LMO7;MECOM;CDH13;EPAS1;SOX17;SOX13;JAG1;NOTCH4;KLF8;EDN1;ERG;ENG;MRTFB;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;LDB2;DACH1;BMPR2;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;LMO2;TBX1;NR4A2;FOXO4;TBXT;NEUROG2;PLK3;BACH2;ACVRL1;NOTCH1;FOXQ1;NOD2;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;NR1I3;KLF12;HEY1;ARHGEF2;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CAV1;PRKD1;ZNF296;F2RL1;ZNF235;LRRFIP1;TNRC6C;SAP30;HNF1A;HNF4A;KLF3;AGRN;ID1;KLF6;ARID3B;DLL4;APP;HDAC9;ZGLP1;SOX18;CRK;HHEX;TEAD4;FLI1;PELP1;RBBP8;HEY2;TLR3;HMBOX1;MED26;KLF4;IER5;ACVR1;SIM2;WWTR1;LEF1;BCLAF3;MAFK;IRF9;ZBTB46;EFNA1;CAMK2D;PKN1;SP4;MAFF;ELOC;FOXF2;MEF2C;HYAL2;LMO1;SMAD2;BBS7;ZBTB48;TAF9B;FOSL2;BRD8;APEX1;PHF6;GATA3;BCL6B;RTF1;TOX3;RXRG;RAD21;UBE2D1;CHCHD2;SRCAP;SETX;ZBTB16;GTF2IRD1;MRGBP;ZC3H12A;KDM3A;PPP3CA;LCORL;STAT1;GAL;ELP4;TOX4;AATF;PURA;EBF3;ELP2;TMPRSS6;RBL1;ARRB1;CEBPA;PLSCR1;NLRC5;UBA52;ZHX3;NFE2L2;WWC2;RPS14;GATAD2A;NAMPT;RPS27A;MRTFA;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;JUN;TCF7L1;TCF3;ELOA;EGR1;HMGB1;ZNF182;DHX9;SS18;ARID5A;PLAG1;MAD2L2;ZBTB14;CNOT1;CHD5;ZXDB;RPS6KA1;HNRNPK;AGO4;RPRD1B;BRIP1;NFKBIA;TET3;ZBTB34;TNKS;NEDD4L;DEAF1;RAI1;CRTC1;MAML2;NPM1;PHOX2A;HDX;PCBP1;EAF2;DMAP1;E2F7;GTF2H3;BRCA1;TIAL1;NR4A1;HELZ2;PRKD2;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;GLYR1;RPS6KA3;TGIF1;ASCL4;PSMC3;DUSP22;PPM1D;ITGB1BP1;PIN1;POU3F2
prerank,replication fork processing (GO:0031297),-0.32564293731436766,-1.0624640322832708,0.34,0.7699403050685086,1.0,15/38,27.18%,NUCKS1;BOD1L1;FBH1;ATR;THOC1;RTEL1;SMARCAL1;RFWD3;ATRX;ZRANB3;MMS22L;EME2;SETMAR;RAD51;CENPX
prerank,aspartate family amino acid catabolic process (GO:0009068),-0.3806091988938857,-1.0624321132638492,0.39436619718309857,0.7685557141234642,1.0,6/19,22.35%,DDO;ALDH7A1;GOT1;DLST;ASPA;HYKK
prerank,cell-cell junction maintenance (GO:0045217),0.4965931486688944,1.0617598339739165,0.39864864864864863,0.7813347174354286,1.0,2/11,9.21%,F2RL1;TJP1
prerank,negative regulation of viral genome replication (GO:0045071),0.40019315424927854,1.0611505358118185,0.39752407152682256,0.7822480404502755,1.0,16/40,24.96%,IFIH1;INPP5K;TRIM6;PLSCR1;OAS2;TASOR;SLPI;RSAD2;SRPK1;IFITM3;ZC3HAV1;EIF2AK2;BANF1;SETDB1;OASL;BST2
prerank,cellular response to ketone (GO:1901655),-0.3269850625463956,-1.0609960750509153,0.3389261744966443,0.771134911750847,1.0,6/35,6.78%,ROCK2;ADCY5;ADCY1;GNAI1;ADCY2;SRC
prerank,positive regulation of cell differentiation (GO:0045597),0.32944187902150257,1.0609276136667207,0.35257082896117525,0.7822030330281394,1.0,40/237,11.44%,SLC6A6;RAPGEF2;CEACAM1;PLCB1;ASB4;BMPR2;KITLG;ACVRL1;ARHGEF2;PRKD1;TGFB2;FES;BTG1;TMEM100;BLOC1S6;ACVR1;RRAS;WWTR1;LEF1;GCNT2;MEF2C;SMAD2;CD34;SPAG9;ZBTB16;ZC3H12A;CMKLR1;CTNNA1;NRCAM;ZHX3;CDH15;SYAP1;CTNNBIP1;TCF3;RPS6KA1;ZC4H2;CDH2;MMD;HIF1AN;PCP4
prerank,epithelium development (GO:0060429),0.34752618468566704,1.06040989327943,0.37282229965156793,0.7828029888156193,1.0,13/107,8.76%,SOX17;GATA6;TBX1;RHCG;GSTA2;TST;SOX18;TAGLN2;CD34;PGK1;STAT1;JAK2;SNAI2
prerank,positive regulation of interferon-beta production (GO:0032728),0.4079507054031467,1.0603898171736736,0.3744740532959327,0.7822672364986852,1.0,7/33,13.70%,IFIH1;TLR3;OAS2;POLR3B;DHX9;IRF5;RIOK3
prerank,response to ethanol (GO:0045471),0.48000517584396324,1.0603446730766872,0.3953488372093023,0.7817920150385592,1.0,6/14,22.31%,GRIN2B;GRIN3A;SDF4;GLRA2;GRIN2A;SOD1
prerank,negative regulation of lyase activity (GO:0051350),-0.3885163086699819,-1.0596114242116748,0.39106145251396646,0.7736126257456228,1.0,6/16,16.12%,ADGRV1;GRM3;GABBR2;PALM;DRD2;EDNRB
prerank,negative regulation of insulin receptor signaling pathway (GO:0046627),-0.349281868869274,-1.0589725516005017,0.3549382716049383,0.7739077990145855,1.0,7/27,9.76%,PID1;PRKCB;GRB10;ENPP1;IRS1;PIP4K2A;PRKCZ
prerank,synaptic vesicle recycling (GO:0036465),0.4162694006715836,1.0585684332386975,0.37716763005780346,0.7855346495487727,1.0,10/31,18.29%,SNCG;SYT7;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,regulation of gastrulation (GO:0010470),-0.4136877152191283,-1.058071662620425,0.35135135135135137,0.7750515794668442,1.0,3/14,6.11%,PHLDB2;OSR1;DAG1
prerank,regulation of neurogenesis (GO:0050767),0.38048244871568637,1.0579672858183096,0.38482384823848237,0.7864865428841421,1.0,13/55,16.11%,NOTCH1;B2M;HEY1;RASSF10;HEY2;PRUNE1;NUMB;PCM1;CX3CR1;HES3;CTNNB1;HMGB2;SPEN
prerank,regulation of cation channel activity (GO:2001257),0.35595574357376564,1.0579043310639125,0.3814553990610329,0.7860443569776409,1.0,10/89,8.37%,NOS1;FKBP1A;APP;SHISA8;CAMK2D;STAC;MEF2C;SHISA6;GRIA1;GRIN2B
prerank,protein oxidation (GO:0018158),-0.44033370037952835,-1.0576373533299401,0.35645933014354064,0.7748595934083178,1.0,5/11,16.39%,LOXL1;LOXL3;SUMF1;PRDX3;CHCHD4
prerank,regulation of cellular localization (GO:0060341),0.3833166531512819,1.0575816220299137,0.3861788617886179,0.7862806961291211,1.0,12/46,16.31%,EFNA5;FES;TTL;PPM1F;CAMK2D;LRRK2;NR1D1;NUMA1;TRIM46;LRP5;MAP2;GOSR1
prerank,lipoprotein biosynthetic process (GO:0042158),-0.4543851495139252,-1.0574353035891726,0.3906633906633907,0.7739856463561886,1.0,5/11,23.45%,APOE;ATG7;WIPI2;WDR45;PORCN
prerank,relaxation of muscle (GO:0090075),-0.4167437852334481,-1.0569322657176616,0.39267015706806285,0.7738399902926966,1.0,2/13,0.82%,ATP1A2;GSN
prerank,regulation of neuroinflammatory response (GO:0150077),-0.37232154213719276,-1.0568886593123017,0.37057220708446864,0.7724924171990647,1.0,2/19,1.83%,IGF1;NUPR1
prerank,regulation of substrate adhesion-dependent cell spreading (GO:1900024),0.3870124761731513,1.056769262038045,0.3893229166666667,0.7877653512563887,1.0,11/47,14.51%,EFNA5;NEDD9;CRK;ACTN4;APOA1;LIMS2;PTK2;RAC1;DOCK1;ITGB1BP1;SPRY4
prerank,regulation of toll-like receptor signaling pathway (GO:0034121),-0.34217929648592094,-1.0565200350856012,0.3684210526315789,0.7721238118540391,1.0,2/26,1.32%,LGR4;APPL2
prerank,response to acidic pH (GO:0010447),-0.43015957328614485,-1.0561774525036305,0.38578680203045684,0.7716445540031653,1.0,4/13,29.94%,GPR4;SLC9A1;LGMN;IMPACT
prerank,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),0.40205130195837735,1.0561333964952517,0.39436619718309857,0.7887790165406403,1.0,9/37,10.75%,VCAM1;CRTAM;CADM1;AMIGO2;TENM3;NECTIN4;NECTIN1;FAT4;TENM4
prerank,cognition (GO:0050890),0.38935658516541255,1.0560613118417521,0.38227146814404434,0.7883585245427217,1.0,5/42,3.47%,SHROOM4;PTCHD1;FAM107A;APP;DOP1B
prerank,cellular component assembly (GO:0022607),0.3251774431018305,1.0556903146891903,0.3707983193277311,0.7887088591668957,1.0,44/253,16.23%,LIMA1;CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;FAM107A;FBLIM1;PLS3;PARVB;NEDD9;CFAP206;STX7;CARD10;LIMS2;SYCP2;TRAF1;RAD21;CD247;IL1RAP;NCKAP1;APC;ACTG1;RTN4;CDAN1;NEFH;CYFIP1;RAC1;RANBP9;BAG6;ACTB;SHROOM1;RTN3;TAPBP;CAPG;RHOH;PPIH;LCP1;KPNA3;CLDN14;PDCD10;VIL1;ANK3
prerank,transcription preinitiation complex assembly (GO:0070897),-0.4174885248850431,-1.0555088831506316,0.3728813559322034,0.7720165469249509,1.0,8/12,30.04%,TAF1;DR1;GTF2B;TAF7;GTF2A2;BDP1;TBP;POLR1E
prerank,modulation of chemical synaptic transmission (GO:0050804),0.3476764190019188,1.0554544595361472,0.38602520045819017,0.7886769013930579,1.0,33/107,20.14%,MCTP1;ABR;CACNA1A;SYN3;APP;BCR;MEF2C;GRID1;BTBD9;PXK;LRRK2;LRRC4C;GRIK5;GRIK2;CDH2;SNCAIP;GRM5;CX3CR1;RIMS3;NPTX2;PSMC5;DGKI;GRIK1;NMU;CPLX1;OPHN1;LRP8;NPTX1;GRM7;SYT1;GRID2;AGER;BDNF
prerank,macrophage differentiation (GO:0030225),-0.4196673444401771,-1.0553045441341824,0.3979848866498741,0.7711342285688777,1.0,3/13,8.98%,BMP4;IL31RA;VEGFA
prerank,regulation of blood circulation (GO:1903522),0.40387316360709147,1.0550595746207092,0.3868312757201646,0.7890401507012392,1.0,3/34,4.95%,KCNQ1;ACE;CAMK2D
prerank,positive regulation of cell cycle process (GO:0090068),0.3539597859521523,1.0550232704468754,0.3837902264600715,0.7885371942508386,1.0,18/91,16.70%,EDN1;PDGFB;INSR;CUL3;IL1A;RAD21;PLSCR1;FEN1;CDC14A;RANBP1;NUMA1;E2F7;PHIP;LRP5;MAP3K20;PKN2;NDC80;CEP120
prerank,nucleic acid-templated transcription (GO:0097659),0.39003847089353566,1.0544454242008838,0.38482758620689655,0.7893909375093177,1.0,17/42,23.64%,NR4A2;POLR2G;MLF1;NFKBIB;POLR2D;TAF1B;POLR2I;PWP1;MMS19;HOXD3;MEF2A;PTMA;RRAGC;POLR2C;PAX8;POLR2B;POLR2J
prerank,negative regulation of nucleocytoplasmic transport (GO:0046823),0.49621455278831983,1.0542947488369743,0.4238952536824877,0.7891568796422102,1.0,6/13,19.41%,UFM1;RAB23;RANGAP1;NUP153;CABP1;BARD1
prerank,regulation of organelle assembly (GO:1902115),-0.27906201696410265,-1.0540662625960304,0.3793103448275862,0.7731606818870704,1.0,27/72,20.07%,GSN;DCDC2;TBC1D24;TBC1D2B;STX18;ALMS1;TBC1D9B;ATG3;ATXN2;ATG5;RNF4;ADPRH;TBC1D16;DYNC2LI1;TSG101;TBC1D17;KIF9;CYLD;TBC1D20;CDKL1;IFT20;TRAPPC12;SDCCAG8;EZR;TBC1D19;IFT88;PDCD6IP
prerank,negative regulation of calcineurin-mediated signaling (GO:0106057),0.47929233217267847,1.053752532977134,0.4155629139072848,0.7893386335566344,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),0.47929233217267847,1.053752532977134,0.4155629139072848,0.7893386335566344,1.0,3/12,9.97%,ATP2B4;HOMER2;PRNP
prerank,acyl-CoA metabolic process (GO:0006637),0.40909339079354035,1.0534011145696975,0.38288920056100983,0.7896173019911934,1.0,5/35,12.43%,ACSM3;GLYAT;ACOT13;ACACB;HMGCS1
prerank,thyroid hormone generation (GO:0006590),-0.4320693576961468,-1.053343561119094,0.40294840294840295,0.7737932410739036,1.0,2/10,6.82%,CPQ;SLC5A5
prerank,positive regulation of cellular metabolic process (GO:0031325),0.3539084624425173,1.0533155196342723,0.4039351851851852,0.7892439218609038,1.0,18/98,11.65%,PDGFB;FASN;INSR;SLCO1C1;APOA1;KLF4;ANGPT1;LIPT2;IFNAR1;GATA3;CHCHD2;ZC3H12A;ARRB1;TBC1D5;ACOD1;ACACB;NFKBIA;INPP5F
prerank,multivesicular body assembly (GO:0036258),0.41647061971718424,1.0530368531666185,0.4152542372881356,0.7893349085010789,1.0,11/30,21.85%,RAB11A;VPS36;VPS28;CHMP1B;VPS4A;CHMP3;CHMP2B;CHMP7;MVB12A;STAM2;CHMP1A
prerank,positive regulation of biosynthetic process (GO:0009891),0.3955002419059162,1.052921819928633,0.4008152173913043,0.7890272099683763,1.0,6/40,11.05%,PLCG2;VIM;APOA1;SIRT4;ADGRB1;CYBA
prerank,regulation of protein import into nucleus (GO:0042306),-0.3300975810213131,-1.0528104931325688,0.33448275862068966,0.7738004715006706,1.0,10/36,13.71%,ZIC1;BMP4;APOD;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2
prerank,regulation of fatty acid biosynthetic process (GO:0042304),0.42798499135078205,1.0525778203417602,0.38764044943820225,0.7893000008754614,1.0,9/26,17.27%,ADIPOR2;CEACAM1;APOA1;ADIPOR1;BRCA1;ELOVL5;EIF6;ERLIN2;TRIB3
prerank,cellular response to hormone stimulus (GO:0032870),0.36024728260866984,1.0520881580722892,0.40318627450980393,0.7899492393996321,1.0,12/69,10.55%,LMO2;ATP1A1;ATP1A3;CAV1;PELP1;INPP5K;MEF2C;BRD8;TRIM24;NCOA4;ARID5A;SFR1
prerank,regulation of neuron apoptotic process (GO:0043523),-0.2649578392785663,-1.0520205477955737,0.3448275862068966,0.7746046321986215,1.0,16/96,8.12%,EPHA7;NUPR1;BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;BACE1;NTRK2;NGF;EGLN3;FOXO3;SIX1;PRKCI
prerank,positive regulation of cytosolic calcium ion concentration (GO:0007204),0.33672379874120906,1.0510959941664988,0.3851276359600444,0.7918206232245304,1.0,13/140,7.28%,EDN1;TRPV4;ITPR3;CCR1;CAV1;CACNA1A;F2RL1;SLC8A1;GPR157;IAPP;LPAR6;P2RX7;CMKLR1
prerank,peptidyl-threonine dephosphorylation (GO:0035970),0.432645409395939,1.050960634317622,0.3944954128440367,0.7915443543097279,1.0,6/22,14.97%,DUSP1;PPM1F;DUSP16;PDP1;PPM1D;PPP2CB
prerank,retinoic acid receptor signaling pathway (GO:0048384),0.5081837286124579,1.050752044709271,0.42807625649913345,0.7914692870644638,1.0,3/10,6.30%,TBX1;ACTN4;RXRG
prerank,positive regulation of mitotic cell cycle phase transition (GO:1901992),0.37494458400441344,1.050451461694168,0.3934010152284264,0.7916550917743411,1.0,8/56,8.61%,PLCB1;CCND2;RAB11A;CCND3;CDC25C;CUL3;ADAM17;KMT2E
prerank,positive regulation of vascular endothelial cell proliferation (GO:1905564),0.47181476163154384,1.0504379300878937,0.4232558139534884,0.7911032226853714,1.0,5/13,13.22%,ADAM17;AKT3;HMGB1;PLCG1;APLN
prerank,membrane lipid metabolic process (GO:0006643),0.4428375590021083,1.0504326762325564,0.4177978883861237,0.7905311605179984,1.0,7/22,17.29%,ST3GAL6;B4GALT4;SPTLC1;ALOXE3;AGK;TECR;CERKL
prerank,alpha-amino acid catabolic process (GO:1901606),-0.3326667062680019,-1.0503932283118216,0.3680555555555556,0.7777173872122087,1.0,5/29,10.78%,DDO;ALDH4A1;PRODH;GSTZ1;SARDH
prerank,negative regulation of BMP signaling pathway (GO:0030514),0.38692925837718517,1.050226311872178,0.40318302387267907,0.7904705612441377,1.0,5/51,1.86%,SMAD6;BMPR2;SMAD7;NOTCH1;DAND5
prerank,regulation of cellular biosynthetic process (GO:0031326),0.41682565617425266,1.0494884752283493,0.4034334763948498,0.7917144958025351,1.0,9/28,14.77%,ADIPOR2;NOS1AP;TNFRSF1B;ADIPOR1;CD47;JAK2;RAC1;CX3CR1;EIF6
prerank,cardiac muscle cell differentiation (GO:0055007),0.44652073375742457,1.0489100309302204,0.39599383667180277,0.7925485532691139,1.0,4/21,5.32%,SLC8A1;ACVR1;ALPK3;MEF2C
prerank,aorta development (GO:0035904),0.47660658342132756,1.048849920681085,0.4105754276827372,0.7921102828310579,1.0,2/14,1.26%,JAG1;TBX1
prerank,sterol metabolic process (GO:0016125),-0.2874232724599154,-1.0486892847621943,0.35609756097560974,0.780994950895357,1.0,6/60,2.95%,PRKAG2;CYP27A1;CYP26B1;APOE;LIPA;ABCA1
prerank,response to UV (GO:0009411),-0.2603869109551972,-1.0486644536433796,0.32926829268292684,0.7796312380881256,1.0,22/95,15.27%,EGFR;PTPRK;CREBBP;DDB2;CAT;SCARA3;BRSK1;DCUN1D3;TAF1;USP1;ERCC5;MAP2K7;CDC25A;ATR;REV1;BCL3;MFAP4;UVSSA;MSH6;RHNO1;ERCC2;EIF2AK4
prerank,ERAD pathway (GO:0036503),0.3564486588267963,1.0485257221494833,0.39759036144578314,0.7923544630509288,1.0,27/83,21.24%,RNF103;RHBDD1;RNF185;HSP90B1;UBE4A;TMUB2;TRIM25;BAG6;YOD1;UBE2J2;RNF103-CHMP3;FOXRED2;SGTB;FBXO2;UBQLN2;UGGT1;PSMC6;RNF139;UBXN6;SEL1L;ERLIN2;FBXO6;CCDC47;DNAJC10;RNF5;POMT2;TMEM129
prerank,positive regulation of collagen biosynthetic process (GO:0032967),-0.40613915185635374,-1.0483095780633818,0.3760217983651226,0.7790991151683567,1.0,7/16,20.55%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,regulation of neuron projection arborization (GO:0150011),-0.40149638422676787,-1.0481774977330114,0.4169014084507042,0.7780271448513981,1.0,6/15,17.15%,WNT5A;GRIP1;DLG4;MFSD2A;MYO9A;NTNG1
prerank,axonal fasciculation (GO:0007413),-0.43547217587413084,-1.0479928029986403,0.4114583333333333,0.7771605629573062,1.0,6/12,18.43%,EPHA3;SEMA5A;MEGF8;ARHGAP35;EPHB2;EPHB3
prerank,negative regulation of fat cell differentiation (GO:0045599),0.40197089087647253,1.0479292631148325,0.38235294117647056,0.7932086162566082,1.0,6/34,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZFP36L2
prerank,central nervous system projection neuron axonogenesis (GO:0021952),-0.43696503687748706,-1.0476067037258094,0.41687979539641945,0.7767452232756336,1.0,4/12,18.38%,GLI2;NFIB;EPHB2;SZT2
prerank,positive regulation of mitochondrial fission (GO:0090141),-0.3952124963840344,-1.0475320354357798,0.4005102040816326,0.7755513117926766,1.0,3/18,5.48%,DCN;PRKN;DDHD1
prerank,cellular biogenic amine catabolic process (GO:0042402),-0.46208413332462467,-1.047313367121575,0.4244604316546763,0.7747554613916412,1.0,4/10,10.78%,HNMT;SMOX;ALDH7A1;SARDH
prerank,positive regulation of calcium ion import (GO:0090280),0.48204078845123366,1.0471505740406937,0.42504118616144976,0.7945534493044842,1.0,1/12,0.88%,PDGFB
prerank,regulation of transmembrane transport (GO:0034762),0.40370513770802813,1.0470063030269832,0.3996983408748115,0.7943149060435282,1.0,5/31,11.20%,SLC2A1;OCLN;CTTNBP2NL;NEDD4L;ACTB
prerank,UV protection (GO:0009650),-0.4486661026985773,-1.0469640151409354,0.40404040404040403,0.7743519996418099,1.0,5/10,15.10%,CAT;SCARA3;ERCC5;MFAP4;ERCC2
prerank,protein localization to cell surface (GO:0034394),0.42124322417223187,1.0469142629808728,0.38705035971223023,0.7939745946625575,1.0,7/26,14.24%,FBLN5;EMP2;ANGPT1;PTPRU;SMURF1;MESD;CTNNB1
prerank,negative regulation of macrophage activation (GO:0043031),0.47445243116622815,1.0467057244446383,0.4158878504672897,0.7939297423434406,1.0,4/16,8.68%,FCGR2B;ZC3H12A;CD200;NR1D1
prerank,positive regulation of carbohydrate metabolic process (GO:0045913),0.42819973322349547,1.0462930393373673,0.41194029850746267,0.7943791704303598,1.0,6/23,9.29%,PDGFB;INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,endodermal cell differentiation (GO:0035987),0.4166739894563392,1.0462319650657157,0.39886039886039887,0.7939614668763365,1.0,1/31,0.04%,LAMA3
prerank,regulation of cellular response to heat (GO:1900034),0.3619788208685054,1.0461364356013545,0.3983050847457627,0.7936224125955791,1.0,23/77,21.45%,FKBP4;IER5;CAMK2D;CD34;MAPK1;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;DNAJC7;GSK3B;BAG4;NUP50;MAPKAPK2;AKT1S1
prerank,regulation of response to external stimulus (GO:0032101),0.34040563226322884,1.0458601118834192,0.3864406779661017,0.7937502475806204,1.0,15/121,9.09%,GATA6;SPAAR;NOD2;CAV1;CASP8;F2RL1;SPATA2;TIRAP;STK24;FCGR2B;SEMA7A;BCL6B;NMT1;JAK2;FOXP1
prerank,nitrogen compound transport (GO:0071705),0.33491886823275846,1.0456751073638557,0.3856353591160221,0.7936240905256198,1.0,17/141,10.45%,SLC6A6;EDN1;RHCG;ARL6IP5;SLC7A7;PPT1;SLC44A1;MYH9;ARRDC1;HSP90B1;SLC6A4;SLC7A1;CERT1;SLC15A4;CHMP1B;SLC6A2;SLC22A5
prerank,negative regulation of peptidyl-lysine acetylation (GO:2000757),-0.4527767437400676,-1.0455682567858762,0.4,0.7767399054093223,1.0,4/10,18.94%,SET;KLF15;TAF7;NOC2L
prerank,dopaminergic neuron differentiation (GO:0071542),0.45166342115775565,1.0455037729212182,0.40634920634920635,0.7934610392141674,1.0,3/19,14.24%,NR4A2;PHOX2A;CTNNB1
prerank,regulation of cellular macromolecule biosynthetic process (GO:2000112),0.3177338589537449,1.0454632490928937,0.3799392097264438,0.7929632786687977,1.0,65/366,17.07%,SOX17;SOX13;NANOS3;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;APP;SOX18;BTG1;ING2;WWTR1;NLK;MEF2C;PPIE;ORC3;RYBP;GTF2IRD1;CEBPA;TOM1L1;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;CCDC88A;CYFIP1;NUP35;ASCC1;TRAPPC2;OBI1;TESMIN;SAP30L;GRM5;ORC5;HINFP;SOX6;HIF1A;RHOH;ELAVL2;METTL18;ATXN1;EIF2A;KAT7;ACVR2B;YBX1;TRRAP;TCOF1;ESR1;NFIL3;ESRRG;DAXX;SOX7;SOX12
prerank,intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),-0.3264869273981609,-1.0452790482678656,0.37542662116040953,0.7761490096494312,1.0,12/32,19.41%,DDX5;SNW1;FHIT;RRP8;BCL3;MYBBP1A;BOK;PDK2;DDIT4;AEN;JMY;PML
prerank,amino sugar metabolic process (GO:0006040),-0.445309778544812,-1.0451947956003262,0.4175257731958763,0.7749686734282691,1.0,4/10,14.58%,ST6GAL1;EXTL2;GFPT1;GFPT2
prerank,regulation of cytosolic calcium ion concentration (GO:0051480),0.3325924710820837,1.044425694372679,0.39005524861878454,0.794880993786717,1.0,14/142,7.28%,EDN1;TRPV4;ITPR3;CCR1;ATP2B4;ATP2B2;CAV1;CACNA1A;CAV2;F2RL1;SLC8A1;IAPP;HCRTR1;CMKLR1
prerank,RNA methylation (GO:0001510),0.3702183116125677,1.044396958172141,0.4034440344403444,0.7943622047591704,1.0,18/60,21.08%,TRDMT1;TRMT61A;MRM2;TRMT5;METTL2B;METTL2A;METTL5;ALKBH8;TRMT61B;VIRMA;FBLL1;METTL14;TFB2M;RBM15;NSUN5;FTSJ3;NSUN4;NSUN6
prerank,spindle assembly (GO:0051225),0.35970204446655296,1.044192151689734,0.3851851851851852,0.7942900385879103,1.0,13/67,11.08%,RAB11A;CSNK1D;KIF2A;CLASP1;MAPRE3;KPNB1;STARD9;NEK7;HAUS3;STAG1;CLASP2;TNKS;NUMA1
prerank,miRNA metabolic process (GO:0010586),-0.36767334824860554,-1.044142781614888,0.4034090909090909,0.7765378255141123,1.0,6/20,18.39%,DDX17;DICER1;LIN28B;TENT4B;TUT4;DGCR8
prerank,regulation of defense response to virus by host (GO:0050691),0.4117271232916341,1.044041528240731,0.4096209912536443,0.7940694639227517,1.0,6/30,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DHX9;DTX3L
prerank,regulation of DNA binding (GO:0051101),-0.306014459800344,-1.0439659645559527,0.36363636363636365,0.7756444502178717,1.0,12/44,14.40%,IGF1;SMO;PRKN;RSF1;NGF;DOT1L;PPARG;TXN;MDFI;BCL3;HMGA2;SIRT2
prerank,regulation of exosomal secretion (GO:1903541),-0.3743906150904833,-1.0437026208716575,0.37604456824512533,0.7750128905840372,1.0,9/19,26.72%,PRKN;SDCBP;TSG101;ATP9A;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,positive regulation of cell development (GO:0010720),-0.33170162714024387,-1.0432860945461375,0.3806228373702422,0.7747942065186441,1.0,10/31,17.52%,PDE3A;BMP4;SNW1;ATP6AP1;NUMBL;NAP1L1;SERPINF1;GPER1;RFX3;NKX6-1
prerank,regulation of NIK/NF-kappaB signaling (GO:1901222),0.35925490401210847,1.0432441783848636,0.4004914004914005,0.7954713346337506,1.0,14/76,11.23%,NOD1;NOD2;LGALS9;APP;HDAC7;ACTN4;TLR3;TRIM6;PDCD4;ADIPOR1;ZC3H12A;NMI;NFKBIA;LAPTM5
prerank,interleukin-35-mediated signaling pathway (GO:0070757),0.49773945634076466,1.0432432728283074,0.43856655290102387,0.7948938645725232,1.0,3/11,15.20%,STAT1;JAK2;IL27RA
prerank,cellular response to oxygen-containing compound (GO:1901701),0.3173671593285213,1.0430957013166413,0.40560165975103735,0.7946880772550612,1.0,39/291,10.37%,KCNQ1;RAPGEF2;PDGFB;SPAAR;TBX1;NOD2;ATP2B4;RAPGEF1;FOXO1;DAB2IP;PRKD1;VIM;FES;INPP5K;TIRAP;DEFA6;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;SH3BP4;MAPK1;NFKBIL1;SETX;P2RX7;IRGM;ZC3H12A;HSP90B1;NR1D1;ACOD1;CACTIN;STAP1;JUN;EGR1;HMGB1;RRAGD;NFKBIB;CASP1
prerank,inflammatory response (GO:0006954),0.3253015981322372,1.0430734612754282,0.3941368078175896,0.7941716905899396,1.0,19/195,11.05%,AFAP1L2;F11R;NOD1;ADGRE5;CCR1;LGALS9;HDAC9;FCGR2B;LY75;IL1A;PXK;MFHAS1;HNRNPA0;CMKLR1;HMGB1;CCL4;GPR68;RAC1;CYBA
prerank,regulation of macrophage activation (GO:0043030),0.4115990206294652,1.0428103637515918,0.3994252873563218,0.7942420621203058,1.0,7/30,8.02%,GPR137B;FCGR2B;KARS1;MFHAS1;ZC3H12A;CEBPA;CD200
prerank,negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.4021641687014202,1.0428027064478997,0.42482758620689653,0.7936914370635244,1.0,11/38,16.66%,DAB2IP;CASP8;ZC3H12A;STAT1;NR1D1;CACTIN;RIOK3;RHOH;CARD19;ESR1;PYCARD
prerank,response to organonitrogen compound (GO:0010243),0.3980218403298228,1.0421691364164798,0.3807531380753138,0.7946816942448732,1.0,18/38,28.25%,RHBDD1;RNF185;TRPM2;IRF5;KAT7;GLRA2;RNF139;UBXN6;SEL1L;CCDC47;RNF5;RRAGC;KYNU;BRSK2;MEAK7;GLRB;DNAJB12;IRAK3
prerank,negative regulation of mitotic cell cycle phase transition (GO:1901991),0.3504091945971596,1.0417430897765134,0.3973268529769137,0.7951805442316523,1.0,29/87,21.23%,FAM107A;KLF4;PSMD13;PSMD4;RBL1;APC;ZFP36L2;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;E2F7;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;CDKN2D;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;ZFP36L1;USP47
prerank,epidermal growth factor receptor signaling pathway (GO:0007173),-0.3057324203101863,-1.0404167442684102,0.3511450381679389,0.7811966876624928,1.0,15/45,16.22%,EGFR;PLCE1;EFEMP1;REPS2;SLC30A10;SHC1;PIK3R1;SRC;TGFA;GAREM1;DGKD;HBEGF;SHC3;GAB1;AAMP
prerank,regulation of stem cell population maintenance (GO:2000036),-0.38167373527751036,-1.0402123224019344,0.3954154727793696,0.7803514427003669,1.0,4/18,13.29%,PTN;REST;TAF6L;HMGA2
prerank,photoreceptor cell development (GO:0042461),-0.40612044483165594,-1.0399054849444247,0.41732283464566927,0.779736682420831,1.0,7/14,32.14%,VEGFA;MFSD2A;TOPORS;ARL3;TULP1;AHI1;CDHR1
prerank,regulation of lipid catabolic process (GO:0050994),0.4445391361199882,1.0397752260654627,0.40644171779141103,0.7993680514845877,1.0,5/19,17.76%,PDE3B;ALK;PRKAA1;LONP2;TYSND1
prerank,response to muscle stretch (GO:0035994),-0.4019920255267429,-1.039538422684031,0.41379310344827586,0.7793081724803169,1.0,2/15,0.82%,DMD;GSN
prerank,regulation of DNA-dependent DNA replication (GO:0090329),0.4839494007434191,1.0392800207436061,0.4280821917808219,0.7999984911708606,1.0,5/12,20.67%,WRNIP1;KAT7;METTL4;WDR18;BLM
prerank,negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.3142260789661908,-1.0384451482092,0.3654485049833887,0.7809813143288722,1.0,6/37,10.20%,OGT;FHIT;MAP1A;TAF1;TRIM39;SDCBP
prerank,synaptic vesicle endocytosis (GO:0048488),0.4061060232136476,1.038353793311498,0.4178272980501393,0.8016996611979677,1.0,11/33,18.29%,ITSN2;DNM3;SNCG;FCHO2;PACSIN1;PIP5K1C;STON1;OPHN1;SYNJ1;SYT1;SYT2
prerank,pathway-restricted SMAD protein phosphorylation (GO:0060389),0.4966155966063295,1.038331870662296,0.41408934707903783,0.8011782633828199,1.0,3/11,4.11%,SMAD7;TGFB2;ACVR1
prerank,negative regulation of peptide hormone secretion (GO:0090278),-0.3788264826770953,-1.0383237626746562,0.3956043956043956,0.7799693046382565,1.0,6/18,15.29%,PRKN;CCN3;IRS1;REST;ADRA2A;KCNB1
prerank,protein localization to lysosome (GO:0061462),0.41334164986019756,1.0382673698430236,0.41244573082489144,0.8007761925761282,1.0,15/28,26.54%,SH3BP4;NCOA4;RNF128;RTN4;LAPTM5;VPS4A;NAGPA;AP3M1;ZFYVE16;SORL1;ATP13A2;SCARB2;LMBRD1;GLMP;LAMTOR4
prerank,regulation of sensory perception of pain (GO:0051930),0.4862462127843993,1.0381366919206978,0.41518578352180935,0.8005026988336439,1.0,2/11,4.16%,TMEM100;SCN11A
prerank,heparan sulfate proteoglycan metabolic process (GO:0030201),-0.36347986699910323,-1.0376687524268782,0.4094955489614243,0.7803776861185188,1.0,10/21,22.61%,SULF1;SULF2;XYLT1;B3GAT3;HS2ST1;NDST3;GPC1;SGSH;HS3ST4;EXT2
prerank,rRNA modification (GO:0000154),0.4424500857642092,1.0374916794705378,0.45103857566765576,0.8015130306807675,1.0,10/21,25.27%,MRM2;DKC1;METTL5;NHP2;FBLL1;TFB2M;FTSJ3;NSUN4;FBL;ZCCHC4
prerank,negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),0.40065955797792185,1.037479051331717,0.40646976090014064,0.8009640556405725,1.0,6/33,11.55%,PLK3;FAM107A;KLF4;RBL1;APC;E2F7
prerank,regulation of establishment of planar polarity (GO:0090175),0.3475446442985463,1.0374472153756973,0.420256111757858,0.8004640399069411,1.0,25/88,18.86%,FZD6;AP2B1;PSMD13;PSMD4;PSMA5;AP2M1;PSMB10;RAC1;PSMB8;PSMD14;SMURF1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;FZD3;PSMB9;PSMC6;PRICKLE2;PSMA4;PSMD5;PSMD9;PSMB6
prerank,positive regulation of chromatin organization (GO:1905269),0.48527097850186024,1.0372159440818263,0.44246353322528365,0.8004584837403218,1.0,7/12,25.77%,TAL1;DAXX;SIN3A;TERF2IP;H3-3A;TERF2;TINF2
prerank,regulation of myoblast differentiation (GO:0045661),0.3991734384338964,1.0371606611421496,0.40830945558739257,0.8000142090184712,1.0,5/32,6.06%,PLCB1;NOTCH1;BTG1;MEF2C;EID2B
prerank,positive regulation of leukocyte activation (GO:0002696),-0.37688172823293115,-1.0371523653677739,0.4115942028985507,0.7804003019984485,1.0,3/18,3.41%,LBP;WNT5A;THBS1
prerank,N-glycan processing (GO:0006491),0.44594334326060864,1.0371187131251498,0.44272445820433437,0.7995312466858085,1.0,3/18,8.17%,ST8SIA6;PRKCSH;GNPTAB
prerank,transepithelial transport (GO:0070633),-0.39547436120855206,-1.0369447217194923,0.40285714285714286,0.7796384902566023,1.0,3/15,1.69%,SLC1A3;CXADR;SLC12A2
prerank,regulation of cell cycle phase transition (GO:1901987),0.3476147368585399,1.036688487081677,0.4133811230585424,0.800002310991241,1.0,27/91,19.11%,ATP2B4;PSMD13;UBE2D1;PSMD4;PSMA5;FBXW7;PSMB10;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;ANAPC4
prerank,ribonucleoside bisphosphate metabolic process (GO:0033875),0.41240481479008945,1.0366627313462575,0.41480446927374304,0.7989193031635227,1.0,7/29,22.62%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,purine nucleoside bisphosphate metabolic process (GO:0034032),0.41240481479008945,1.0366627313462575,0.41480446927374304,0.7989193031635227,1.0,7/29,22.62%,ACSM3;GLYAT;ACOT13;CROT;ACAT1;OXSM;ACLY
prerank,"retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",-0.26961983030325865,-1.036527621819309,0.35502958579881655,0.7794070096089687,1.0,28/80,21.59%,PLPP3;KIF3C;ERGIC2;STX18;COPZ2;COPA;SURF4;PITPNB;ARFGAP1;ERGIC3;COPG1;ARCN1;COPB2;ARF5;TMED3;BICD2;COG3;ATP9A;KIF3A;NAPA;ZW10;RER1;LMAN2;PICK1;KDELR1;KIF11;RACGAP1;RINT1
prerank,intrinsic apoptotic signaling pathway (GO:0097193),0.3431052860636011,1.0363051529739729,0.42303172737955347,0.7991668588928478,1.0,24/94,19.51%,ATP2A3;DAB2IP;ARL6IP5;PPP1R13B;PPM1F;STK24;CASP2;TNFRSF1B;CUL3;BBC3;CIDEB;BCL2L1;CUL2;BAG6;BRCA1;ATM;BNIP3;PYCARD;TRIB3;SELENOK;CD24;DNAJC10;ERN1;MCL1
prerank,regulation of brown fat cell differentiation (GO:0090335),0.4555763588363861,1.0361016726996974,0.4371941272430669,0.7990664731061189,1.0,1/16,0.24%,SOX13
prerank,positive regulation of response to biotic stimulus (GO:0002833),0.39060593820192197,1.0359639122946025,0.428,0.7988175787675931,1.0,10/38,13.70%,GBP5;PUM2;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;CYBA;RIOK3
prerank,regulation of protein modification process (GO:0031399),0.37319522416420187,1.0355892850782782,0.42140026420079263,0.7992153961051771,1.0,14/50,17.92%,CCDC88C;PPP1R16B;WARS1;HSPB1;NDUFS4;PTK2;CCDC88A;GRM5;PIN1;PHIP;ASPSCR1;KDM4D;ATG14;PPP1R16A
prerank,regulation of T cell chemotaxis (GO:0010819),0.4925190599112988,1.0347523891307884,0.4556113902847571,0.8007241334281778,1.0,4/11,9.41%,OXSR1;ADAM17;STK39;ADAM10
prerank,positive regulation of T cell migration (GO:2000406),0.4407141428001949,1.0338919174566328,0.41973490427098675,0.8022509771840508,1.0,5/20,9.41%,OXSR1;APP;ADAM17;STK39;ADAM10
prerank,carboxylic acid transport (GO:0046942),-0.28859793344254625,-1.0336210866724547,0.3832599118942731,0.7858844728577707,1.0,8/55,4.67%,SLC6A13;SLC16A12;SLC13A3;SLC1A5;SLC6A12;SLC16A6;SLC16A9;SLC17A5
prerank,cellular response to oxidative stress (GO:0034599),-0.2537790644760352,-1.0335210301983038,0.3333333333333333,0.7847981837155424,1.0,41/118,23.06%,EGFR;DAPK1;PDGFRA;PTPRK;PRKAA2;PLA2R1;STX4;TPM1;MGAT3;CAT;FOXO3;ERMP1;SOD3;GPX8;PPIA;SESN2;NOX4;PRDX3;CPEB2;CHUK;FER;MPV17;SIRT2;WNT16;PDK2;ETV5;GPX7;NUDT2;MAPK9;PRKCD;HTRA2;ALDH3B1;ROMO1;TXNRD2;ABL1;MAPK8;PARP1;CYCS;CYBB;SRXN1;GPX1
prerank,regulation of mRNA catabolic process (GO:0061013),0.3342680533777464,1.0331201638373757,0.40765765765765766,0.8035384779651104,1.0,41/121,21.60%,VIM;PSMD13;PUM2;APEX1;PSMD4;ZC3H12A;ELAVL1;HSPB1;PRR5L;EXOSC3;UBA52;RPS27A;ZFP36L2;PSMA5;XPO1;PSMB10;CNOT1;GTPBP1;EXOSC8;PSMB8;PSMD14;XRN1;PSMA7;PSMC3;FXR1;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6;ZC3HAV1;PSMB2;ZFP36L1;MAPKAPK2;UBB
prerank,positive regulation of wound healing (GO:0090303),-0.3163010157594037,-1.0331122902203382,0.39636363636363636,0.7845267262543328,1.0,10/36,12.81%,PLPP3;VTN;THBS1;RREB1;FOXC2;ANXA1;ST3GAL4;SERPINE1;ADRA2A;HBEGF
prerank,organophosphate biosynthetic process (GO:0090407),0.3943665089799737,1.0327754153176834,0.41379310344827586,0.8037880091416026,1.0,4/37,3.81%,ITPKB;IP6K3;IPPK;GPHN
prerank,regulation of cytokine-mediated signaling pathway (GO:0001959),0.3630119704128693,1.0326799821818275,0.4315659679408138,0.8034458392959852,1.0,19/72,20.99%,LIFR;IFNGR1;CASP8;SPATA2;SPPL2A;TRAF1;IRAK2;MADD;STAT1;JAK2;PTPN1;CBFB;RACK1;PYCARD;PTPN2;AGPAT1;CD24;SIGIRR;SPPL2B
prerank,regulation of osteoclast differentiation (GO:0045670),0.4077650745199214,1.0326547421264274,0.42592592592592593,0.8029360424223287,1.0,3/33,3.64%,CCR1;GPR137B;TLR3
prerank,positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),0.4995485354738606,1.0324878662196901,0.451114922813036,0.8027824269667138,1.0,2/10,3.82%,F2RL1;TIRAP
prerank,regulation of cilium movement (GO:0003352),0.5043248492152743,1.0316076496900193,0.44755244755244755,0.8043596567918596,1.0,2/10,8.62%,CFAP206;CFAP43
prerank,negative regulation of reproductive process (GO:2000242),-0.37603713793829036,-1.030851749958966,0.4152542372881356,0.789255903543405,1.0,3/17,3.09%,IGF1;SULF1;GJA1
prerank,regulation of amyloid precursor protein biosynthetic process (GO:0042984),-0.42309829034399005,-1.0308452973547009,0.4068627450980392,0.7878960787868784,1.0,3/11,6.17%,BACE2;ITM2A;NECAB1
prerank,positive regulation of mitotic metaphase/anaphase transition (GO:0045842),0.4915533380501703,1.030626997378548,0.41262135922330095,0.8050028511075524,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),0.4915533380501703,1.030626997378548,0.41262135922330095,0.8050028511075524,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,positive regulation of mitotic sister chromatid separation (GO:1901970),0.4915533380501703,1.030626997378548,0.41262135922330095,0.8050028511075524,1.0,5/12,23.29%,CUL3;CDC27;ANAPC7;ANAPC4;ANAPC11
prerank,"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.34037535060387386,1.0306052611644303,0.42473745624270715,0.8044847786925308,1.0,44/110,25.82%,RPS21;RPL27;RPL7;UBA52;RPS14;RPS27A;RPL35;ETF1;RPL21;RPL37;RPS28;RPL34;RPS9;RPLP2;RPS25;HELZ2;RPL30;RPS5;RPL27A;RPL23A;RPS15;RPL19;RPS18;RPL32;RPL37A;RPL18A;CTIF;SMG7;RPL18;RPL39;RPS19;SMG9;RPL31;RPS8;SMG8;EIF4G1;RPL3;PPP2R2A;PPP2R1A;RPL28;RPS16;RPLP1;RPL26;RPL9
prerank,endosome transport via multivesicular body sorting pathway (GO:0032509),0.42241032010109847,1.030067666727267,0.44379562043795623,0.8051908146464501,1.0,13/25,27.34%,CHMP1B;CHMP3;LYST;CHMP2B;CHMP7;UBXN6;MVB12A;SORT1;LEPROT;CHMP1A;VPS4B;CHMP4A;CHMP4B
prerank,establishment of epithelial cell apical/basal polarity (GO:0045198),0.5002094667891458,1.0299601892621641,0.43434343434343436,0.8048677673092866,1.0,2/10,4.47%,MSN;SYNE4
prerank,myeloid leukocyte differentiation (GO:0002573),0.3574842182480991,1.0297865703370825,0.42839352428393523,0.804698599349027,1.0,11/65,10.12%,CASP8;F2RL1;LGALS9;LEF1;PIR;SNX10;MYH9;OSCAR;CEBPA;FOXP1;TYROBP
prerank,membrane fusion (GO:0061025),0.39422379882955594,1.0286513904813597,0.42318840579710143,0.8069003065054069,1.0,11/33,24.61%,DYSF;DNM3;VTI1B;MYOF;NSF;VAPA;GCA;NAPG;USO1;RIMS1;UBXN2A
prerank,TOR signaling (GO:0031929),0.41704250388381464,1.0283681249470653,0.42152466367713004,0.8070027055849367,1.0,13/26,26.01%,GATA3;PRR5L;SYAP1;RHEBL1;CCDC88A;RPS6KB1;RICTOR;TIPRL;NPRL3;EIF4EBP2;MEAK7;MLST8;RPTOR
prerank,positive regulation of intracellular transport (GO:0032388),0.39329269405174205,1.0280507772048195,0.43258426966292135,0.8071807935414752,1.0,10/38,16.40%,PLK3;EHD1;PGAP1;PRR5L;PCM1;RIPOR1;NUMA1;ICE1;PDCD10;TENM1
prerank,exit from mitosis (GO:0010458),0.4923961433797006,1.027371848678391,0.44833625218914186,0.8082515466290566,1.0,3/12,15.38%,CLASP1;CLASP2;CHMP7
prerank,cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.43484845849231757,-1.0273230572172158,0.4496487119437939,0.7959446905373039,1.0,6/10,35.82%,TICAM1;MYD88;CD68;TREM2;CD36;TLR6
prerank,striated muscle tissue development (GO:0014706),-0.32833754578184615,-1.0272733764822506,0.3943217665615142,0.7946906302124092,1.0,10/29,12.50%,BMP5;BMP7;SVIL;RBP4;SGCD;SIX1;CFLAR;PGM5;TBX2;NDUFV2
prerank,regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.3917597129762408,1.0270503778720743,0.4438122332859175,0.8084642235536867,1.0,5/35,8.22%,NOTCH1;CAV1;NLK;ADIPOR1;JAK2
prerank,regulation of protein sumoylation (GO:0033233),-0.3773239979307109,-1.02577385760736,0.43352601156069365,0.7974777290374159,1.0,6/17,22.91%,ZMIZ1;GNL3L;PIAS3;HDAC4;GNL3;PIAS4
prerank,regulation of protein polymerization (GO:0032271),0.39296564162822223,1.025461785033935,0.4273972602739726,0.8117813436219838,1.0,5/35,7.56%,FCHSD2;ESAM;CAMSAP2;PRUNE1;MAPRE3
prerank,long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.43236129891167874,1.0254368452202163,0.44970414201183434,0.8112621468098022,1.0,7/23,15.26%,FAR2;ACSL5;FAR1;ACSBG1;ELOVL7;ELOVL5;TECR
prerank,brain morphogenesis (GO:0048854),0.48393334699880364,1.0254262371622738,0.4435215946843854,0.8107208676245613,1.0,3/12,12.41%,SHANK3;SLC6A4;CTNNA2
prerank,mitotic G1/S transition checkpoint signaling (GO:0044819),0.4794750087441749,1.0252817049753633,0.4469820554649266,0.8105208730560356,1.0,1/12,1.46%,PLK3
prerank,ventricular cardiac muscle tissue development (GO:0003229),0.42038905627879436,1.0250832087850095,0.41369047619047616,0.810444316821785,1.0,3/23,2.67%,SMAD7;MYBPC3;FKBP1A
prerank,negative regulation of mononuclear cell migration (GO:0071676),0.48814218308662205,1.024833427613781,0.44660194174757284,0.8105008985558778,1.0,2/12,2.05%,PLCB1;DUSP1
prerank,regulation of actin cytoskeleton organization (GO:0032956),0.3488921292884989,1.0245937747399283,0.433252427184466,0.8104834679268281,1.0,15/87,11.28%,EFNA5;HIP1R;F11R;RND1;FAM107A;RHOB;IQGAP1;ESAM;CRK;ARHGDIA;ROCK1;TAOK2;CCDC88A;RAC1;TRPM2
prerank,response to hydroxyurea (GO:0072710),0.48147898636354614,1.0244627565552296,0.43728813559322033,0.8102593364585802,1.0,5/11,25.13%,NSMCE3;SPIDR;KAT7;BLM;RTF2
prerank,regulation of amyloid precursor protein catabolic process (GO:1902991),0.46852137893442986,1.0242331317490905,0.43456375838926176,0.8102350004169391,1.0,6/12,15.39%,FKBP1A;TMED10;ROCK1;PRNP;RANBP9;ABCA7
prerank,cytoskeleton organization (GO:0007010),0.338036581783236,1.0242252187785816,0.4200700116686114,0.8096857410613917,1.0,17/114,6.86%,FGD5;RND1;RHOB;MAST4;NEDD9;DIAPH1;SIPA1L3;PACSIN2;SH3KBP1;ARAP3;DST;FMNL3;FGD6;PACSIN1;LRCH3;MAST1;KLHL20
prerank,regulation of catecholamine secretion (GO:0050433),0.41208112312313766,1.0241538375345565,0.44166666666666665,0.8092861201128126,1.0,7/29,18.29%,SYT15;SYT7;CHGA;FGF20;HRH3;SYT1;SYT2
prerank,positive regulation of reproductive process (GO:2000243),-0.3141620993104971,-1.0241531229651617,0.43521594684385384,0.800514902580263,1.0,12/31,23.57%,PDE3A;SYDE1;VEGFA;LHFPL2;ACVR1B;SIRT2;CACNA1H;INHBA;CFAP69;TACR3;INHBB;C1QBP
prerank,regulation of androgen receptor signaling pathway (GO:0060765),-0.3180278230197415,-1.02374705514151,0.4371069182389937,0.8003149268822869,1.0,6/30,12.71%,DDX5;DAB2;HEYL;KLK2;HDAC1;HDAC6
prerank,positive regulation of fatty acid metabolic process (GO:0045923),-0.3878039537341483,-1.0226957095707012,0.444141689373297,0.8018272127153679,1.0,7/15,22.97%,LPGAT1;PPARA;PPARG;SLC45A3;NR1H3;PPARD;MLXIPL
prerank,regulation of proteolysis (GO:0030162),0.36879816815894784,1.0219913047312519,0.4157754010695187,0.8139125209188481,1.0,3/48,2.41%,LTBP4;CAV1;CASP8
prerank,cellular macromolecule catabolic process (GO:0044265),0.36718054471334455,1.0219441121654118,0.4296977660972405,0.8134673235817012,1.0,15/49,21.06%,DENND3;DAB2IP;MANBA;DFFB;SIAH2;RNASEH2B;XRN2;RNASE6;FBXO2;OGA;FBXO6;NGLY1;NEU4;RNF5;RAB12
prerank,regulation of interferon-beta production (GO:0032648),0.37824959789744994,1.021919190844913,0.41271989174560214,0.8129470534759152,1.0,9/46,13.70%,IFIH1;TLR3;TIRAP;OAS2;POLR3B;CACTIN;DHX9;IRF5;RIOK3
prerank,superoxide metabolic process (GO:0006801),0.40276638455596503,1.0216630525324886,0.4099290780141844,0.8129782061753993,1.0,4/29,11.05%,NOS3;ATP7A;TAFA4;CYBA
prerank,regulation of double-strand break repair (GO:2000779),-0.3132315987336784,-1.0216299445275687,0.37777777777777777,0.8034143064530708,1.0,17/39,30.63%,TRIP12;SLF1;FMN2;ACTR2;RTEL1;DEK;TWIST1;PML;TIMELESS;SLF2;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6;MGMT;OTUB2
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",0.3729726348402061,1.021589877936354,0.44640605296343,0.8125847475906981,1.0,9/54,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,regulation of interleukin-4 production (GO:0032673),0.4302704096790399,1.0215823473740995,0.45,0.812034411537765,1.0,5/21,16.90%,LGALS9;LEF1;GATA3;HAVCR2;RARA
prerank,regulation of dendritic spine development (GO:0060998),0.4349526145550597,1.0215320310653768,0.4169184290030212,0.8116026520049816,1.0,5/19,10.91%,TANC2;MEF2C;SHANK3;PPFIA2;GRIN3A
prerank,meiosis I (GO:0007127),0.4193579154450981,1.0214222068109136,0.4538904899135447,0.8112814670331341,1.0,6/23,18.63%,DDX4;ING2;PTTG1;SYCP3;SGO1;TDRD9
prerank,transferrin transport (GO:0033572),-0.3114230125648281,-1.021159643093106,0.4178082191780822,0.8033085609600431,1.0,6/33,8.33%,STEAP3;ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6AP1
prerank,regulation of heterotypic cell-cell adhesion (GO:0034114),0.419171723528844,1.0211096334650795,0.4413075780089153,0.8114961272056025,1.0,3/22,4.59%,APOA1;KLF4;GCNT2
prerank,ureteric bud morphogenesis (GO:0060675),-0.3744198517536966,-1.0210692072607515,0.44321329639889195,0.802146633588209,1.0,4/16,11.08%,BMP4;FGF2;SIX1;SALL1
prerank,ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.48929687402571426,1.0197581682625723,0.4381107491856677,0.813045902653877,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,coenzyme A biosynthetic process (GO:0015937),0.48929687402571426,1.0197581682625723,0.4381107491856677,0.813045902653877,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.48929687402571426,1.0197581682625723,0.4381107491856677,0.813045902653877,1.0,4/11,18.32%,SLC25A16;PANK3;PPCS;ACAT1
prerank,gonad development (GO:0008406),0.38601635831269043,1.0197258851635642,0.4410994764397906,0.8125716812225198,1.0,6/41,8.81%,GATA6;KITLG;TGFB2;GATA3;COL9A3;NCOA4
prerank,protein localization to synapse (GO:0035418),-0.4130735621882622,-1.019712772764195,0.4289405684754522,0.804627191183382,1.0,2/12,4.01%,DLG4;NLGN2
prerank,glycosaminoglycan metabolic process (GO:0030203),-0.29533102478035916,-1.0196111370144885,0.400990099009901,0.8035183043268174,1.0,9/54,7.08%,GPC6;SDC2;HSPG2;GPC3;HS3ST3A1;GNS;PXYLP1;XYLT1;HEXA
prerank,mitochondrial RNA metabolic process (GO:0000959),0.4605756126824116,1.0192052504041609,0.45292207792207795,0.8132613848313697,1.0,5/14,15.47%,SLC25A33;MTERF2;FASTKD5;TFB2M;TEFM
prerank,regulation of telomere maintenance (GO:0032204),-0.33217542081766993,-1.0184836673257467,0.4153846153846154,0.8052393688357258,1.0,13/26,31.47%,RAD50;PPP1R10;YLPM1;XRCC5;RTEL1;PML;GNL3;ATRX;HDAC8;HNRNPD;SMG6;SIRT6;UPF1
prerank,neurotrophin TRK receptor signaling pathway (GO:0048011),-0.3869800465965877,-1.0184445714912718,0.43410852713178294,0.803988024843897,1.0,5/15,16.11%,NTRK2;NGF;CASP3;ZFYVE27;DDIT4
prerank,positive regulation of DNA replication (GO:0045740),-0.38846038711279735,-1.0182600890297622,0.4602739726027397,0.8031395371577671,1.0,2/16,0.88%,EGFR;GLI2
prerank,cellular transition metal ion homeostasis (GO:0046916),-0.25829080309890595,-1.0178667062822127,0.40718562874251496,0.8028365532570365,1.0,17/91,8.33%,BMP6;SLC39A14;SCARA5;SLC30A10;SLC39A8;ACO1;SLC39A13;MT1H;MT1M;MT1A;MT1B;MT1X;MT1F;MT1E;MT1G;ARF1;ATP6AP1
prerank,stem cell development (GO:0048864),0.45692402331460297,1.0172752206231273,0.4592476489028213,0.8172817800056688,1.0,6/16,21.33%,SNAI2;CDH2;CYP26C1;TCOF1;SOX11;NOLC1
prerank,nucleotide biosynthetic process (GO:0009165),-0.36978509193633835,-1.0169704542424742,0.4281842818428184,0.8039364580542265,1.0,5/18,13.04%,NMNAT2;ME1;PRPSAP2;MTHFD1;PNP
prerank,response to amino acid (GO:0043200),0.3986978053401804,1.0167954707402427,0.4375,0.8178487929064568,1.0,16/31,28.69%,SPAAR;SH3BP4;RRAGD;TMBIM6;GLRA2;RRAGA;RRAGC;LAMTOR3;MEAK7;NSMF;RPTOR;GLRB;LAMTOR4;CAPN2;SLC38A9;LAMTOR1
prerank,positive regulation of protein import (GO:1904591),-0.3383196281951674,-1.0166252471439747,0.4033333333333333,0.8035790724131952,1.0,10/30,18.45%,ZIC1;CDH1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD
prerank,negative regulation of programmed cell death (GO:0043069),0.30993555617745194,1.0165563564606828,0.44873096446700506,0.8178699730131238,1.0,62/355,14.80%,MECOM;TEK;GATA6;SMAD6;FLT4;FAS;TNFAIP8;PLK3;CCND2;EGR3;FOXO1;CBL;PPT1;ANGPT1;CASP2;LEF1;MAP4K4;AMIGO2;RHBDD1;TAF9B;UFM1;ARHGDIA;SETX;KLHL20;FANK1;HSPB1;HSP90B1;HSPA1B;AATF;DCPS;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;TJP1;PTK2;ADAM10;BABAM2;SIAH2;RPS6KA1;RNF144B;HNRNPK;NFKBIA;LAPTM5;NPM1;TMBIM6;CD38;TMEM14A;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;BNIP3;CTNNB1;PSMC5;TM7SF3
prerank,regulation of response to oxidative stress (GO:1902882),0.4744499960062062,1.0162543212813555,0.45254237288135596,0.8180199410524199,1.0,1/11,1.49%,MCTP1
prerank,proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),0.3108498147468991,1.016181876246018,0.4553846153846154,0.8176324014237832,1.0,84/314,20.43%,RNF103;FBXL2;ZNRF1;PSMD13;FBXL14;FBXL5;RNF185;CUL3;UBE2D1;PSMD4;KLHL20;FBXL18;PTTG1;HSP90B1;ARRB1;WWP1;UBE4A;UBA52;FEM1C;NFE2L2;TMUB2;RPS27A;PPP2R5C;FBXL16;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;CUL2;TRIM25;NEDD4L;BAG6;PSMB8;PSMD14;FBXO4;SMURF1;KCTD10;RMND5B;YOD1;UBE2J2;PSMA7;RNF103-CHMP3;PSMC3;FOXRED2;SGTB;PSMA8;PSMC1;FBXO2;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;UBQLN2;SPOPL;FBXL13;ANAPC7;PSMC6;AMN1;SEL1L;ERLIN2;PSMA4;FBXO6;GSK3A;PSMD5;PSMD9;FEM1A;FBXL6;PSMB6;DNAJC10;FBXL15;ANAPC4;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,fat-soluble vitamin metabolic process (GO:0006775),-0.34808033958150375,-1.01600591330332,0.44642857142857145,0.8039492685975133,1.0,2/22,1.85%,ALDH1A2;RBP1
prerank,positive regulation of catalytic activity (GO:0043085),0.3868795163509499,1.0156757376407934,0.438957475994513,0.8182521403085428,1.0,15/37,24.22%,NOD2;CAV1;APOA1;ATP7A;SSBP1;APH1A;CHTOP;PSEN2;MAPK14;ABL2;XRCC4;SOD1;NCSTN;WRN;NHEJ1
prerank,mitotic cytokinetic process (GO:1902410),0.43260856067595216,1.0155248913884365,0.44296296296296295,0.8180277593250387,1.0,12/20,27.34%,CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;CHMP1A;CNTROB;VPS4B;MITD1;CHMP4A;CHMP4B
prerank,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),0.48799179533254766,1.015270608175571,0.4707846410684474,0.8180508377366704,1.0,4/10,20.59%,RNF125;RIOK3;SEC14L1;DHX58
prerank,mRNA splice site selection (GO:0006376),-0.33372224332294853,-1.0152441288995764,0.44666666666666666,0.8046677252341956,1.0,5/30,10.79%,CELF2;SRSF5;SRSF1;PUF60;SRSF6
prerank,purine ribonucleotide metabolic process (GO:0009150),0.3557624260204282,1.0150136919499209,0.4260869565217391,0.8180990010156841,1.0,19/68,22.62%,ACSM3;GLYAT;SULT6B1;RAB23;LRRK2;ACOT13;GTPBP1;MFN1;BPNT1;RAN;EFL1;NT5C2;CROT;ACAT1;SULT1A1;OXSM;EPHA2;ADSS2;ACLY
prerank,carboxylic acid metabolic process (GO:0019752),0.39852028045841154,1.0149864303507063,0.43089430894308944,0.8175956093344869,1.0,9/33,16.28%,SLC2A1;GLYAT;LIPT2;GLUD1;SIRT4;LIPT1;ST3GAL1;PTGIS;PON3
prerank,mitochondrial translational elongation (GO:0070125),0.3404846084532436,1.014859725082118,0.45659928656361476,0.8173339765406465,1.0,39/88,28.55%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,lipid catabolic process (GO:0016042),0.4455706807881997,1.0146431866999621,0.4745762711864407,0.8173094270241464,1.0,2/18,3.24%,PNLIP;PPT1
prerank,positive regulation of cardiocyte differentiation (GO:1905209),0.4876655246256717,1.0145637718493383,0.4540636042402827,0.8169405056123182,1.0,2/11,5.32%,TGFB2;MEF2C
prerank,transport across blood-brain barrier (GO:0150104),0.34290926660119964,1.0145198809240397,0.4328899637243047,0.8164830929318785,1.0,8/83,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,intermediate filament organization (GO:0045109),0.4456679116514452,1.0144708228048853,0.4434108527131783,0.8160506258026631,1.0,4/17,15.90%,VIM;DSP;DNAJB6;KLHL24
prerank,L-serine metabolic process (GO:0006563),0.49479666306933606,1.0141563950585832,0.44876325088339225,0.8162478224227694,1.0,2/10,11.61%,SERINC3;SERINC5
prerank,"negative regulation of transcription, DNA-templated (GO:0045892)",0.3017118762241165,1.014124654580095,0.46146146146146144,0.815782109008367,1.0,86/807,9.99%,PRDM16;MECOM;SOX13;NOTCH4;KLF8;EDN1;GATA6;PLCB1;PDGFB;LDB2;DACH1;RPS6KA5;SMAD7;KLF2;SMARCA2;NR4A2;TBXT;PLK3;NOTCH1;ZFP69;FOXO1;ELK3;NR1I3;KLF12;HEY1;KLF7;DAB2IP;IRF2;CAV1;LRRFIP1;SAP30;HNF4A;ID1;DLL4;HDAC9;ZGLP1;SOX18;HHEX;INPP5K;HEY2;HMBOX1;KLF4;PPM1F;LEF1;MAFK;EFNA1;MEF2C;SMAD2;BTAF1;DAP;TAF9B;COMMD7;PHF6;GATA3;EID2B;BCL6B;RTF1;PDCD4;UBE2D1;ZBTB16;GTF2IRD1;PHC3;STAT1;PURA;TMPRSS6;CEBPA;WWP1;UBA52;ZHX3;WWC2;RPS14;GATAD2A;RPS27A;NR1D1;SNAI2;ERF;KLF11;FOXP1;UXT;MBD1;JUN;TCF3;HMGB1;ARID5A;MAD2L2;ZBTB14
prerank,positive regulation of receptor signaling pathway via STAT (GO:1904894),0.4210813039886809,1.0139696657352413,0.4617737003058104,0.8156144967229784,1.0,2/22,3.71%,NOTCH1;MGAT5
prerank,regulation of lymphocyte differentiation (GO:0045619),0.43366357228719626,1.0138854982092866,0.45937961595273263,0.8152503255944946,1.0,2/18,9.31%,CRTAM;ZFP36L2
prerank,regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),0.3758568857058629,1.0137853992133972,0.45100671140939597,0.8149281984943388,1.0,9/43,13.57%,GATA2;PDGFB;TGFB2;KLF4;GATA3;JUN;EGR1;APLN;HIF1A
prerank,phosphatidylethanolamine metabolic process (GO:0046337),-0.3357032240796319,-1.0137733412878636,0.44039735099337746,0.807310978514676,1.0,8/27,17.37%,NAPEPLD;NAAA;SLC27A1;CHKB;ETNK2;PLA2G15;SELENOI;PLA2G6
prerank,cytosolic transport (GO:0016482),0.3373829143970201,1.0135105155576387,0.4418331374853114,0.8149649513365443,1.0,25/108,20.35%,MYO1D;RAB6B;EMP2;DOP1B;VTI1B;SPAG9;KLHL20;LMTK2;HOOK1;TBC1D5;PIK3C3;HEATR5A;LAPTM5;VPS35;TBC1D10A;KIF16B;GOSR1;DENND5A;MON2;VTI1A;PHETA1;HOOK2;SORT1;CCDC91;EPS15
prerank,positive regulation of cellular protein localization (GO:1903829),0.3496395259169841,1.0134411153788887,0.45859085290482077,0.8145625531612102,1.0,16/69,16.03%,FYN;GPR137B;CARD10;WWTR1;PRKAA1;APC;VPS28;RTN4;TYROBP;CCDC88A;LIMK2;NUMA1;DTX3L;KAT7;ABCA7;NDC80
prerank,positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.3565554417472072,-1.013180756325734,0.4208955223880597,0.8076209486976127,1.0,3/23,1.76%,PRKAG2;CEMIP;BMP7
prerank,regulation of protein localization to nucleus (GO:1900180),0.3757275140080843,1.0130614387707197,0.44972067039106145,0.8148821348093913,1.0,18/43,26.17%,CARD10;WWTR1;SUMO3;MFHAS1;CTNNA1;NVL;LIMK2;DTX3L;PIN1;KAT7;SIN3A;GSK3B;YAP1;GLUL;ATP13A2;TPR;TGFB1;PARP9
prerank,positive regulation of actin filament polymerization (GO:0030838),0.3719917116346171,1.0129670783411981,0.4366576819407008,0.814552159031367,1.0,5/44,8.42%,FCHSD2;EVL;CDC42EP1;WHAMM;NCKAP1
prerank,smooth muscle contraction (GO:0006939),0.465120427137305,1.0128671099108015,0.4606741573033708,0.8142364342108838,1.0,5/14,10.82%,MYLK;PIK3C2A;SLC8A1;ROCK1;TPCN2
prerank,positive regulation of histone H3-K4 methylation (GO:0051571),-0.3914414076021196,-1.0128136162630912,0.3963254593175853,0.8072766292144907,1.0,4/14,11.20%,AUTS2;SNW1;WDR5;CTR9
prerank,protein K63-linked deubiquitination (GO:0070536),-0.3228899859565324,-1.0127551170891729,0.3920265780730897,0.8060882570127561,1.0,11/31,16.72%,USP33;USP20;USP13;USP50;ABRAXAS2;OTUD7B;CYLD;USP8;ZRANB1;STAMBPL1;OTUD1
prerank,focal adhesion assembly (GO:0048041),-0.35188164481687983,-1.0123057538357108,0.43154761904761907,0.8060019236729841,1.0,4/21,6.78%,SORBS1;PTPRK;ACTN2;SRC
prerank,regulation of vascular associated smooth muscle cell migration (GO:1904752),-0.41310830231857065,-1.0121902029008998,0.44389027431421446,0.8049619310779369,1.0,4/12,3.47%,DOCK5;IGFBP5;DOCK7;TPM1
prerank,cellular protein metabolic process (GO:0044267),0.3056872252850203,1.011976282380632,0.45565749235474007,0.8158630970936294,1.0,101/396,21.23%,GATA6;LMCD1;DENND3;ST3GAL6;FBXL2;DUSP12;MSRB3;MMP1;DAB2IP;GOLM1;APP;CSF2RB;UBA7;APOA1;RPS21;RPL27;MANBA;OMA1;PCSK5;STK38;TMEM132A;RPL7;FURIN;FARSB;CHRM3;WARS1;ADAM17;MRPL18;MRPL41;PRKCSH;IGFBP7;HSP90B1;UBA52;PCMT1;PROC;RPS14;RPS27A;RPL35;APH1A;YES1;CSNK1G3;IGFBP4;ADAM10;RPL21;SIAH2;RPL37;RPS28;RPL34;MRPL36;APLP2;MRPL52;RPS9;FBXW2;LIPT1;CDH2;RPLP2;MRPL23;RPS25;CP;RPL30;RPS5;RPL27A;NAGPA;MRPL24;ST3GAL1;FBXO2;MRPL32;MRPS12;RPL23A;RPS15;MSRA;UBE2D3;RPL19;RPS18;RPL32;PSEN2;CST3;RPL37A;RPL18A;MEN1;CALU;MRPS18B;COPS5;CDKL3;PENK;TIMP1;VGF;DARS1;RNF5;GNMT;MRPL11;CTSH;RSL24D1;RPL18;LCMT1;APH1B;WWP2;PNPLA2;RPL39;RAB12;RPS19
prerank,vascular transport (GO:0010232),0.3440547158202285,1.0116307304744767,0.44282238442822386,0.8161478465441916,1.0,8/81,2.99%,ATP2A3;SLC6A6;ABCC4;SLC2A1;ATP2B4;INSR;ATP1A4;SLCO1C1
prerank,monoacylglycerol metabolic process (GO:0046462),-0.42113208497841176,-1.0115663956996377,0.4297297297297297,0.8052554774353977,1.0,6/13,22.39%,MOGAT3;PLA2G4A;DGAT1;ABHD12;DGAT2;FAAH
prerank,relaxation of cardiac muscle (GO:0055119),-0.4009477877461764,-1.0112909287114995,0.44155844155844154,0.8046923512516847,1.0,2/13,0.82%,ATP1A2;GSN
prerank,positive regulation of neurogenesis (GO:0050769),-0.27812153557688923,-1.0109869847620445,0.40404040404040403,0.8041745335933186,1.0,24/68,21.78%,ROBO1;PLXNA2;CUX1;SLIT2;SNW1;OBSL1;NTRK2;PLXNB2;NGF;NUMBL;VEGFA;PLXNB1;NAP1L1;SLITRK1;SERPINF1;DRD2;GPER1;PTPRD;FBXW8;PLXNC1;SS18L2;CUX2;DISC1;FAIM
prerank,organic acid transport (GO:0015849),0.3374669580455532,1.0108568575588444,0.45195729537366547,0.817423217958757,1.0,6/94,2.99%,SLC6A6;ABCC4;CEACAM1;SLC25A32;SLC7A7;SLCO1C1
prerank,cardiac muscle contraction (GO:0060048),0.394423106358836,1.0105258103475832,0.449438202247191,0.8176177423804809,1.0,4/34,4.95%,KCNQ1;MYBPC3;SLC8A1;CAMK2D
prerank,retinal metabolic process (GO:0042574),-0.40757208469493644,-1.0103808662191627,0.4267990074441687,0.8044807743992937,1.0,8/12,45.75%,ABCA4;ALDH1A3;DHRS13;BCO2;ALDH8A1;CYP1B1;RDH10;BCO1
prerank,production of siRNA involved in RNA interference (GO:0030422),-0.4349367900412576,-1.0100908345813362,0.4345679012345679,0.8038720200776253,1.0,4/10,25.18%,DICER1;TERT;TSNAX;MRPL44
prerank,negative regulation of apoptotic process (GO:0043066),0.3048254965024176,1.0085449780191493,0.46285140562248994,0.8217266440169819,1.0,82/444,15.79%,TEK;GATA6;SMAD6;FLT4;FAS;TBX1;TNFAIP8;NR4A2;MERTK;PLK3;CCND2;NOTCH1;FOXQ1;EGR3;FOXO1;CAV1;CBL;PPT1;KLF4;ANGPT1;CASP2;LEF1;MAP4K4;MEF2C;RHBDD1;TAF9B;ASAH2;TOX3;MAPK1;UFM1;ARHGDIA;SETX;KLHL20;FANK1;ZC3H12A;HSPB1;HSP90B1;HSPA1B;AATF;BCL2L1;UBA52;PRKAA1;PROC;PIM3;RPS27A;SNAI2;TJP1;PTK2;ADAM10;BABAM2;SIAH2;PRKCG;RPS6KA1;RNF144B;HNRNPK;NFKBIA;NPM1;TMBIM6;CD38;TMEM14A;CX3CR1;RPS6KA3;RPS6KB1;PHIP;HYPK;BNIP3L;NOL3;LTK;CFL1;APOH;ITGA5;BNIP3;CTNNB1;FZD9;FZD3;FGF20;DFFA;PDCD10;CDKN2D;PAK2;DNAJB6;VDAC1
prerank,positive regulation of exosomal secretion (GO:1903543),-0.38180560968899113,-1.0082504060971678,0.4315245478036176,0.8074882550848111,1.0,7/15,26.72%,SDCBP;TSG101;SDC1;SNF8;PDCD6IP;SMPD3;STAM
prerank,negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.4075319198184907,1.008025692039417,0.4501510574018127,0.8224045800215117,1.0,7/24,15.49%,AQP11;LRRK2;BCL2L1;LPCAT3;TMBIM6;CLU;RACK1
prerank,negative regulation of neuron projection development (GO:0010977),0.36249944471042284,1.0075421663921902,0.4684343434343434,0.8229511030381075,1.0,10/56,12.58%,TRPV4;STMN2;FKBP4;EFNA1;ARHGDIA;PTPRO;RTN4;SPOCK1;DCC;TSKU
prerank,hexose metabolic process (GO:0019318),-0.3051839901530786,-1.0073661844087742,0.4233576642335766,0.8084827215213446,1.0,13/39,22.90%,APOD;GALK2;CHST15;IRS2;ADPGK;PGM1;GALK1;AKR1A1;PMM1;GDPGP1;SLC35A2;FUCA2;PPARD
prerank,neuron maturation (GO:0042551),0.44401124120548785,1.0072024489799078,0.46615384615384614,0.8231351808788911,1.0,3/18,9.87%,RND1;APP;B4GALT6
prerank,positive regulation of proteolysis (GO:0045862),-0.28734895974393326,-1.0071794410725128,0.43457943925233644,0.8077156144617602,1.0,15/55,17.47%,OGT;CCBE1;APOE;CYFIP2;ADAM9;IST1;ATP5IF1;GPLD1;NDUFA13;ADRA2A;PACSIN3;CTSC;RCN3;STUB1;FBXW11
prerank,regulation of bone mineralization (GO:0030500),0.3605516730920302,1.006994033004222,0.4764930114358323,0.8230453422637455,1.0,9/55,6.78%,SGMS2;S1PR1;BMPR2;CCR1;SLC8A1;ANO6;ACVR1;MEF2C;P2RX7
prerank,regulation of nucleic acid-templated transcription (GO:1903506),0.3066364201574881,1.0069180589528792,0.45223577235772355,0.8226526697710774,1.0,40/327,12.21%,SOX17;SOX13;ENG;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;FOXO4;ACVRL1;NOTCH1;INSR;IRF2;SAP30;SOX18;BTG1;ACTN4;ING2;WWTR1;NLK;MEF2C;PPIE;RYBP;GTF2IRD1;CEBPA;WWC2;SNAI2;SERTAD3;TCF7L1;TCF3;MLF1;HP1BP3;PLAG1;NUP35;ASCC1;TRAPPC2;TESMIN;SAP30L;HINFP;SOX6
prerank,regulation of RNA metabolic process (GO:0051252),-0.28057763822506565,-1.0067583408546719,0.46411483253588515,0.8075531569623707,1.0,18/59,16.15%,MITF;SON;SNRNP70;NOVA1;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;CLK1;FUS;CLK4;YTHDF2;RBM20;HNRNPLL;HNRNPL;PCBP4;CLK2
prerank,positive regulation of mitochondrion organization (GO:0010822),0.35780333477961945,1.0057790375976083,0.45113788487282463,0.8248119899571946,1.0,16/57,20.25%,HIP1R;FBXO7;HRK;TNFSF10;BBC3;CIDEB;VPS35;BNIP3;PYCARD;PLAUR;BMF;GSK3A;BID;PPIF;SPIRE1;GSK3B
prerank,positive regulation of defense response to virus by host (GO:0002230),0.4137337007293333,1.0057668854328157,0.4484304932735426,0.8242824406122833,1.0,5/24,11.98%,AIM2;TRIM6;ZC3H12A;STAT1;DTX3L
prerank,histone H3 acetylation (GO:0043966),-0.2972036207859652,-1.0055963645511117,0.4266666666666667,0.8093552667786064,1.0,14/40,21.87%,LDB1;TADA2A;KAT2B;DR1;WDR5;MEAF6;TAF6L;NAA60;TAF5;TADA3;BRPF3;SUPT7L;MAP3K7;TAF10
prerank,zinc ion transmembrane transport (GO:0071577),-0.3613188356735843,-1.0055962134960996,0.45244956772334294,0.8080284548658547,1.0,5/22,8.22%,SLC39A14;SLC30A10;SLC39A8;SLC39A13;SLC30A6
prerank,sodium ion export across plasma membrane (GO:0036376),0.4689482234220193,1.0054253947907532,0.4442508710801394,0.8245279300026972,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,positive regulation of nucleocytoplasmic transport (GO:0046824),-0.2949288553727072,-1.0051425091536192,0.40823970037453183,0.8080311339534353,1.0,15/46,22.80%,ZIC1;TCF7L2;CDH1;CAMK1;SMAD3;PIK3R1;FLNA;IPO5;BAG3;PIK3R2;ZPR1;PRKCD;EFCAB7;KHDRBS1;NCBP2
prerank,potassium ion transmembrane transport (GO:0071805),0.3233127000577751,1.0049293789834544,0.4603174603174603,0.8251299121939152,1.0,10/135,3.90%,KCNN4;KCNQ1;KCNE3;KCNH8;ATP1A4;ATP1A1;ATP1A3;KCNN3;KCNG3;SLC12A8
prerank,positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4622193465274357,1.0049253891061016,0.45182724252491696,0.824586873823042,1.0,1/13,1.35%,DOC2B
prerank,regulation of protein dephosphorylation (GO:0035304),0.38308725131724636,1.004891666675765,0.4563380281690141,0.8241169277172343,1.0,19/37,27.96%,PPP1R16B;MFHAS1;HSP90B1;ARPP19;CDCA2;CALM3;PIN1;CNEP1R1;TIPRL;PPP1R16A;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,mitochondrial transcription (GO:0006390),0.48654636007530305,1.0044205417986145,0.45884413309982486,0.8246872726065008,1.0,4/10,15.47%,SLC25A33;MTERF2;TFB2M;TEFM
prerank,nuclear export (GO:0051168),-0.26277947856448686,-1.0043066281975634,0.44387755102040816,0.809071934206473,1.0,29/80,26.04%,RANBP3L;SRSF5;PHAX;NEMF;NCBP1;SRRM1;SRSF1;CSE1L;NUP155;SRSF6;PKD1;THOC1;RANBP17;NXF1;MAGOH;RANBP3;U2AF2;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;SRSF2;POM121;EIF4A3;U2AF1;ZC3H11A;THOC7;NUP188
prerank,sodium ion homeostasis (GO:0055078),0.4233645655176142,1.0039236381174812,0.44992295839753466,0.8253216149129242,1.0,4/21,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.34637500219987655,-1.0038200558558894,0.42592592592592593,0.8090571029676782,1.0,6/21,22.24%,SAMD4A;CNOT10;TUT4;ZFP36;PNLDC1;SAMD4B
prerank,transport along microtubule (GO:0010970),0.4747221894340515,1.0037582389437625,0.4722222222222222,0.8251423450942511,1.0,2/13,2.98%,APBA1;APP
prerank,microtubule depolymerization (GO:0007019),0.4364920514333446,1.0036893910036149,0.47104851330203446,0.824760432853864,1.0,2/17,6.54%,STMN2;KIF2A
prerank,phosphate ion homeostasis (GO:0055062),-0.43403903397509613,-1.0033710414270065,0.47804878048780486,0.8090123501924469,1.0,2/10,6.74%,ENPP1;SFRP4
prerank,positive regulation of double-strand break repair via homologous recombination (GO:1905168),-0.386646973991928,-1.003352356954436,0.4498714652956298,0.8077441268224709,1.0,5/14,22.29%,FUS;ACTR2;FANCB;TIMELESS;PARP1
prerank,phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.4053218127562257,1.0028728455785294,0.4446043165467626,0.8262044370630466,1.0,6/23,21.74%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3;ABHD4
prerank,regulation of cation transmembrane transport (GO:1904062),-0.3197430158089192,-1.0028178363392706,0.4383561643835616,0.8079469200951496,1.0,5/29,4.30%,SNTA1;WNK1;KCNIP3;CD63;SLMAP
prerank,regulation of neuron differentiation (GO:0045664),0.3486627844356029,1.0026719739694774,0.45165238678090575,0.8261262413825964,1.0,24/76,21.61%,CASZ1;HEY1;ARHGEF2;MEF2C;ALK;LRRK2;NRCAM;ROCK1;TCF3;ZC4H2;MMD;PCP4;YWHAH;HES3;LTK;SIN3A;HOXD3;SOX11;MMD2;BDNF;CNTN4;CDK5RAP1;NLGN1;ECT2
prerank,negative regulation of neuron differentiation (GO:0045665),0.4197049608175041,1.0024067949530209,0.46176470588235297,0.826204423382901,1.0,2/22,1.98%,B2M;HEY1
prerank,positive regulation of kinase activity (GO:0033674),0.33037324888849295,1.0023632582680058,0.463302752293578,0.8257603557020202,1.0,12/107,7.56%,TEK;RAPGEF2;FLT1;TIE1;FLT4;MERTK;INSR;IQGAP1;FGFR3;ALK;LMTK2;MAPRE3
prerank,microtubule polymerization (GO:0046785),0.39868260735779937,1.002296824781371,0.44984802431610943,0.8253650586626163,1.0,6/28,13.11%,TRPV4;CSNK1D;CLASP1;CLASP2;RANBP9;PIN1
prerank,regulation of p38MAPK cascade (GO:1900744),0.38191070733814075,1.001967964166311,0.467966573816156,0.8255473397468795,1.0,7/35,10.64%,DUSP1;DAB2IP;LGALS9;MFHAS1;ZC3H12A;GADD45G;MINK1
prerank,positive regulation of transferase activity (GO:0051347),0.31942343077293156,1.0018652128773302,0.4652701212789416,0.825244193689607,1.0,27/142,14.24%,TEK;FLT1;TIE1;FLT4;MERTK;INSR;HMBOX1;KLF4;FGFR3;MAPK1;ALK;LMTK2;NVL;CD200;NEK7;FBXW7;DKC1;PTGES3;TNKS;POLG2;CCT2;SERINC5;DTX3L;CCT4;PIN1;LTK;CTNNB1
prerank,nuclear pore organization (GO:0006999),0.4544854946874048,1.0008791331078444,0.4712460063897764,0.8269878841242908,1.0,5/14,15.93%,RTN4;NUP54;NUP35;NUP153;NUP205
prerank,digestive tract morphogenesis (GO:0048546),0.4576425257083819,1.0003812931871117,0.46730462519936206,0.8275544505395492,1.0,2/14,5.57%,SOX17;BBS7
prerank,negative regulation of programmed necrotic cell death (GO:0062099),0.4799567835593025,0.9995856881194342,0.46256239600665555,0.8288817459492777,1.0,2/11,2.41%,ARHGEF2;CASP8
prerank,"mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.46761951781058,0.9993864068618487,0.46153846153846156,0.8288029103938218,1.0,5/11,19.66%,UQCC3;UQCRB;UQCRFS1;UQCRC1;UQCRC2
prerank,copper ion transport (GO:0006825),0.4759475260602051,0.9993024513625136,0.47651006711409394,0.8284466014751988,1.0,3/11,4.64%,ATOX1;ATP7A;SLC31A1
prerank,phosphatidylinositol 3-kinase signaling (GO:0014065),0.3898651775727056,0.9988861169002676,0.46473029045643155,0.8288939260916008,1.0,7/33,13.92%,EDN1;PIK3C2A;PLEKHA1;GATA3;HTR2A;PIK3CB;LTK
prerank,cardiac muscle cell action potential involved in contraction (GO:0086002),0.40323774875208795,0.9988746466908112,0.4705056179775281,0.8283680631598275,1.0,3/30,2.15%,KCNQ1;KCNE3;ATP1A1
prerank,regulation of macroautophagy (GO:0016241),-0.24877874960681723,-0.9984687832004971,0.4444444444444444,0.8184980277976951,1.0,33/105,22.55%,PRKAG2;DCN;PRKAA2;GPSM1;SNX6;VPS26B;SESN1;ATP6V1B2;SNX32;TBK1;ATP6V0B;PRKACA;CASP3;SESN2;PRKAB2;HDAC6;UCHL1;TSC1;WAC;ATP6V1A;LAMTOR2;LARP1;PRKAG3;TSC2;SNX5;CLN3;MAP3K7;MAPK8;LAMTOR5;CDK5;ATP6V1H;ATP6V0D2;PAFAH1B2
prerank,tRNA modification (GO:0006400),0.3501815760531317,0.997986706027913,0.45149253731343286,0.829904745352117,1.0,11/62,13.52%,ADAT2;TRDMT1;OSGEP;TRMT61A;TRMT5;TRUB1;METTL2B;METTL2A;ALKBH8;TRMT61B;TYW1
prerank,protein K48-linked ubiquitination (GO:0070936),0.35187446951591256,0.9978103283363674,0.4497422680412371,0.8297641963549987,1.0,12/54,14.78%,ZNRF1;KLHL3;CUL3;UBE2D1;UBE3A;RNF115;RBX1;NEDD4L;DTX3L;UBE2T;UBE2E1;UBE2D3
prerank,regulation of cell projection organization (GO:0031344),0.4589657410428896,0.9976634873903849,0.48333333333333334,0.8295645984838288,1.0,2/13,10.30%,MACF1;ERMN
prerank,regulation of protein secretion (GO:0050708),0.32534745776041957,0.9973084320526105,0.45952109464082097,0.8298321084173921,1.0,11/119,6.22%,CD2AP;UNC13B;ITPR3;SLC2A1;CACNA1A;TGFB2;HNF4A;SYT7;RAPGEF4;TMED10;IL1A
prerank,regulation of cAMP-mediated signaling (GO:0043949),0.40452123509159404,0.9970746884296129,0.4603174603174603,0.8298249903646614,1.0,2/24,3.79%,RAPGEF2;PDE3B
prerank,polarized epithelial cell differentiation (GO:0030859),0.457991764825502,0.9970659485733946,0.487012987012987,0.8292958987824854,1.0,2/13,4.47%,MSN;SYNE4
prerank,cardiac left ventricle morphogenesis (GO:0003214),0.4576337410226348,0.9969054752827554,0.4423076923076923,0.8291548756933459,1.0,5/13,18.13%,NOTCH1;HEY2;NPY5R;GSK3A;SMAD4
prerank,regulation of gene expression (GO:0010468),0.29753430295421274,0.9968173560571474,0.513,0.8288000210358963,1.0,122/903,12.61%,NANOS1;PLCG2;SOX17;SOX13;NOS3;ENG;CLDN5;GATA2;PDGFB;TRIM14;RPS6KA5;SMARCA2;CASZ1;APBB2;MLF2;CCR1;FOXO4;ESRP2;NOVA2;OCLN;ACVRL1;NOTCH1;ATP2B4;INSR;HEY1;IRF2;IFNGR1;CASP8;TGFB2;TNRC6C;SAP30;LGALS9;DLL4;APP;SOX18;BTG1;AFF1;HEY2;TLR3;NOS1AP;MED26;SLC8A1;KLF4;PPM1F;KRAS;ING2;PUM2;MSN;ANGPT1;WWTR1;LEF1;GCNT2;MBNL1;YBX2;TRIM11;TRIM6;NLK;NKAPL;MEF2C;CD34;PPIE;GATA3;BCL6B;WARS1;IL1A;SMCR8;MAPK1;RYBP;P2RX7;GTF2IRD1;ZC3H12A;HSPA1B;RBL1;CEBPA;PLSCR1;ZC3H7A;CDH3;NFE2L2;PRKAA1;WWC2;CAVIN4;ACTG1;SNAI2;ROCK1;CACTIN;FOXP1;STAP1;NDFIP2;SERTAD3;TCF7L1;TCF3;ADAM10;DHH;EGR1;MLF1;FBXW7;HP1BP3;PLAG1;TCEAL1;TYROBP;HNRNPK;AGO4;TRIM17;NUP35;VSIR;ASCC1;PTBP3;NWD1;TRAPPC2;VPS35;PCBP1;BRCA1;TESMIN;VSTM2A;CLU;SAP30L;HINFP;SOX6;TOB1;PIK3CB;TSKU;TTBK1
prerank,protein homotrimerization (GO:0070207),-0.38938098485346445,-0.9964958136623188,0.4566929133858268,0.8212247836743201,1.0,4/14,15.74%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,protein trimerization (GO:0070206),-0.38938098485346445,-0.9964958136623188,0.4566929133858268,0.8212247836743201,1.0,4/14,15.74%,SLC1A5;SCARA5;CLYBL;SIGMAR1
prerank,motile cilium assembly (GO:0044458),0.46695383361630816,0.9956436057990159,0.4848993288590604,0.8309538259637571,1.0,2/12,6.69%,DNAAF3;SPATA6
prerank,purine ribonucleotide catabolic process (GO:0009154),-0.35475537099562693,-0.9954993257508972,0.43783783783783786,0.8224745610758606,1.0,10/21,31.37%,AMPD3;NUDT4;XDH;NT5E;PNP;NT5C1A;FITM2;PDE2A;NUDT18;NUDT11
prerank,negative regulation of protein ubiquitination (GO:0031397),0.3626993249691189,0.9952090690128671,0.47674418604651164,0.8314277320485329,1.0,9/50,11.98%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;DTX3L
prerank,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),0.46008007436099385,0.99512015104427,0.4688995215311005,0.8310968535548878,1.0,2/11,5.76%,ING2;TAF9B
prerank,fatty acid derivative biosynthetic process (GO:1901570),0.3744341445604984,0.9945972451551872,0.4822404371584699,0.8317440139803715,1.0,4/35,5.27%,FASN;FAR2;PPT1;FAR1
prerank,cellular response to reactive oxygen species (GO:0034614),-0.27722970722583823,-0.9945416733094219,0.43829787234042555,0.8238076499161938,1.0,20/59,22.61%,EGFR;PDGFRA;PTPRK;TPM1;ANXA1;PRDX3;HDAC6;CHUK;FER;MPV17;FXN;PDK2;MAPK9;PRKCD;PAX2;TNFAIP3;ROMO1;ABL1;MAPK8;NET1
prerank,regulation of vascular associated smooth muscle cell proliferation (GO:1904705),-0.3091840792278799,-0.9941658359739697,0.43137254901960786,0.8235186537020716,1.0,8/37,8.48%,IGF1;BMPR1A;IGFBP5;GJA1;TPM1;FGF2;MMP2;EFEMP2
prerank,regulation of transforming growth factor beta production (GO:0071634),0.4374370922178915,0.9937521877302762,0.47480916030534354,0.8331813818492219,1.0,4/18,8.02%,TGFB2;LGALS9;CD34;CD200
prerank,positive regulation of monooxygenase activity (GO:0032770),0.40852447228086763,0.9936826338762382,0.4807121661721068,0.8327851814479182,1.0,7/26,13.57%,GCH1;NOS1AP;ATP7A;NUS1;CDH3;PIK3CB;HIF1A
prerank,protein methylation (GO:0006479),-0.29349727826467936,-0.9935205255437015,0.4716981132075472,0.823923925000411,1.0,10/40,18.20%,NSD3;NSD1;EHMT1;GSPT1;METTL21A;FAM98B;EEF1AKMT1;N6AMT1;EEF1AKMT2;SNRPD3
prerank,"regulation of transcription, DNA-templated (GO:0006355)",0.29422596957740804,0.9934767186369504,0.531,0.8327033736487157,1.0,229/1646,14.31%,PRDM16;NOS1;MECOM;EPAS1;SOX17;SOX13;NOTCH4;KLF8;AFAP1L2;ERG;ENG;IRF6;GATA6;GATA2;SMAD6;TAL2;MSX1;PLCB1;PDGFB;DACH1;EBF1;RPS6KA5;SMAD7;KLF2;SMARCA2;CASZ1;CDK17;TBX1;APBB2;MLF2;NR4A2;FOXO4;TBXT;NEUROG2;BACH2;ACVRL1;NOTCH1;FOXQ1;ATP2B4;ZFP69;EGR3;FOXO1;ELK3;INSR;KLF12;HEY1;TAL1;OLIG2;KLF7;DAB2IP;IRF2;CDK14;ZNF296;ZNF235;LRRFIP1;SAP30;HNF1A;HNF4A;KLF3;ID1;KLF6;ARID3B;HDAC9;ZGLP1;SOX18;BTG1;CRK;HHEX;TEAD4;FLI1;INPP5K;RBBP8;HEY2;HMBOX1;MED26;KLF4;PPM1F;ACVR1;ING2;SIM2;WWTR1;LEF1;MAFK;IRF9;CCNE1;ZBTB46;CAMK2D;PKN1;SP4;MAFF;KARS1;NLK;ELOC;FOXF2;MEF2C;SMAD2;BTAF1;DAP;PPIE;BBS7;ZBTB48;FOSL2;COMMD7;PHF6;GATA3;EID2B;BCL6B;TOX3;RXRG;PDCD4;RAD21;SRCAP;RYBP;ZBTB16;FANK1;GTF2IRD1;MRGBP;PHC3;KDM3A;LCORL;STAT1;ELP4;TOX4;AATF;PURA;MAPRE3;EBF3;ELP2;TMPRSS6;ARRB1;CEBPA;WWP1;DNAJC2;ZHX3;NFE2L2;WWC2;GATAD2A;KMT2E;NR1D1;SNAI2;ERF;KLF11;ZBTB40;FOXP1;UXT;MBD1;KMT2B;JUN;BRF2;SERTAD3;TCF7L1;TCF3;ELOA;EGR1;HMGB1;MLF1;ZNF182;DHX9;HP1BP3;ARID5A;PLAG1;SEC14L2;MAD2L2;ZBTB14;CHD5;ZXDB;RPS6KA1;HNRNPK;SFR1;BRIP1;NUP35;ZBTB34;POLA1;DEAF1;ASCC1;RAI1;SAMD1;NPM1;PHOX2A;HDX;TRAPPC2;DMAP1;E2F7;BRCA1;TIAL1;NR4A1;TESMIN;CD38;SAP30L;ILF2;DTX3L;ARID5B;KLF13;SOX10;HINFP;SOX6;TLX3;MED30;SUV39H2;IRF5;SETD3;ELF2;CBFB;CTBP2;ATP8B1;RPS6KA3;TGIF1;ASCL4;YWHAH;POU3F2;ZNF32;PHIP;RIOX1;TBX20;HIF1A;NFATC1;IKZF5;RHOH;ETV6;MYT1L;HES3;LRP5;USF2;MED27;SMARCC1;ELAVL2;CTNNB1;MED17;MLLT3
prerank,cytoplasmic sequestering of transcription factor (GO:0042994),0.45426613897998064,0.9933194365665202,0.49074074074074076,0.83250221430587,1.0,5/14,16.19%,NFKBIE;NFKBIB;NFKBIA;KEAP1;TMSB4X
prerank,gastrulation (GO:0007369),-0.39153917718860837,-0.9931851992587741,0.4905149051490515,0.8235316792145632,1.0,3/15,6.51%,GPC3;NPHP3;MEGF8
prerank,interleukin-6-mediated signaling pathway (GO:0070102),0.4366580680195487,0.9927450664942723,0.47213622291021673,0.8333170556932221,1.0,4/18,8.22%,CBL;STAT1;CEBPA;JAK2
prerank,cortical cytoskeleton organization (GO:0030865),0.37255057804995734,0.9923884827641384,0.4559789750328515,0.8335962985558193,1.0,10/41,14.80%,TRPV4;RND1;RHOB;FMNL3;NCKAP1;ROCK1;RAC1;RND2;RHOH;LCP1
prerank,transcription elongation from RNA polymerase II promoter (GO:0006368),0.3505243997847522,0.9922269535359817,0.45875,0.8333982793111266,1.0,23/62,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,"regulation of phagocytosis, engulfment (GO:0060099)",0.46494109598675015,0.9918141581710079,0.4666666666666667,0.8338195442583756,1.0,3/10,9.11%,F2RL1;ANO6;STAP1
prerank,"alternative mRNA splicing, via spliceosome (GO:0000380)",-0.3707807005059999,-0.9917735212266015,0.46458923512747874,0.8261221167225494,1.0,6/16,14.90%,DDX5;DDX17;SRSF1;PUF60;SRSF6;SCNM1
prerank,regulation of protein kinase A signaling (GO:0010738),0.4180744343244382,0.9914305414210978,0.4666666666666667,0.8341604346909756,1.0,4/20,7.14%,ADRB2;AKAP5;IAPP;LRRK2
prerank,negative regulation of cell cycle G2/M phase transition (GO:1902750),0.35720998717520014,0.9912079121204728,0.4879679144385027,0.8341206442410064,1.0,21/55,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,regulation of cellular ketone metabolic process (GO:0010565),0.3474880084900946,0.9908795272129333,0.4770992366412214,0.8343340076000262,1.0,24/61,22.45%,AZIN1;CAV1;PSMD13;PSMD4;PSMA5;PSMB10;PSMB8;PSMD14;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;OAZ2;NCOR2;NQO1
prerank,fatty-acyl-CoA biosynthetic process (GO:0046949),0.3962333423645673,0.9906752201711891,0.47863247863247865,0.834236398578301,1.0,11/29,22.62%,FASN;PPT1;ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;SLC25A1;ACSL4;ACLY
prerank,regulation of nucleocytoplasmic transport (GO:0046822),0.4561989827657775,0.9904384549568247,0.466557911908646,0.8342629804665657,1.0,2/12,6.71%,PTPN14;UHMK1
prerank,import into cell (GO:0098657),0.36783575662640455,0.9901208147751738,0.47586206896551725,0.8344499748908617,1.0,2/41,0.35%,SLC6A6;LRRC8C
prerank,regulation of anoikis (GO:2000209),0.4232999589331637,0.9900962211854873,0.47875816993464054,0.8339655393800378,1.0,5/19,14.00%,NOTCH1;CAV1;SNAI2;PTK2;ITGA5
prerank,inositol phosphate-mediated signaling (GO:0048016),0.42432827099194714,0.9900188507213434,0.4552238805970149,0.8335995974983192,1.0,2/19,7.29%,EDN1;PPP3CA
prerank,cellular sodium ion homeostasis (GO:0006883),0.4445995047842755,0.9898595680006511,0.4886731391585761,0.8334147793816092,1.0,4/15,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,long-term synaptic potentiation (GO:0060291),-0.34913605707769113,-0.9898151724684009,0.4685714285714286,0.8299775606395511,1.0,5/21,9.76%,STX4;SLC8A3;TSHZ3;GRIN2D;PRKCZ
prerank,actin crosslink formation (GO:0051764),-0.4149311636369483,-0.9895805082218899,0.5,0.8292763288041775,1.0,4/12,19.64%,DPYSL3;FLNA;BAIAP2;GAS2L1
prerank,cellular response to alkaloid (GO:0071312),0.4348101486574134,0.9892953496657327,0.4587301587301587,0.8342022772851265,1.0,6/17,23.13%,SLC8A1;HTR1B;SPIDR;CASP7;BLM;RYR2
prerank,pharyngeal system development (GO:0060037),0.4427352493013683,0.9885916043512393,0.4689863842662632,0.8352755549176206,1.0,4/15,6.03%,BMPR2;TBX1;TGFB2;GATA3
prerank,regulation of retinoic acid receptor signaling pathway (GO:0048385),0.454185376264685,0.9882384331834149,0.4882943143812709,0.8355628624937443,1.0,4/12,13.01%,KLF2;CNOT1;CTBP2;CYP26C1
prerank,myotube cell development (GO:0014904),-0.42093431192499847,-0.9881698470210943,0.4894117647058824,0.8317681342661838,1.0,2/10,7.10%,IGF1;SIX1
prerank,cellular response to virus (GO:0098586),0.3897958544167872,0.9880663705287593,0.48691860465116277,0.8354524856702508,1.0,8/30,17.65%,IFIH1;LGALS9;IRGM;ZC3H12A;HIF1A;RIOK3;MAPK14;CXCL10
prerank,positive regulation of response to external stimulus (GO:0032103),0.31842255300157685,0.9879075885159602,0.49944258639910816,0.8352690419245052,1.0,23/128,13.99%,PDGFB;GBP5;F2RL1;APP;TLR3;PPM1F;PUM2;HYAL2;PDCD4;CD47;CEBPA;PLSCR1;NMI;POLR3B;SLC15A4;ACOD1;DHX9;NFKBIA;CYBA;DDT;ABCC1;RIOK3;APOH
prerank,mesenchymal cell differentiation (GO:0048762),0.3638905897998986,0.9876369376289678,0.483160621761658,0.8353567373703827,1.0,8/51,5.32%,NOTCH4;ENG;NOTCH1;TGFB2;HEY2;LEF1;FOXF2;MEF2C
prerank,acidic amino acid transport (GO:0015800),0.43190938566356263,0.9871191009739079,0.462992125984252,0.8360404399725995,1.0,2/17,2.39%,SLC6A6;ARL6IP5
prerank,vesicle transport along microtubule (GO:0047496),-0.3374686959589108,-0.9869702155220749,0.4563106796116505,0.833731583036308,1.0,9/23,23.50%,TRAK1;NDE1;KIF13A;NDEL1;KIF3A;FBXW11;CLN3;KIF5B;KIF1C
prerank,spliceosomal snRNP assembly (GO:0000387),-0.29708393685503964,-0.9865545399026151,0.4835164835164835,0.8335027574596285,1.0,13/38,25.43%,PRPF8;COIL;GEMIN5;SMN1;PRPF31;PRPF3;SNRPF;SNUPN;SNRPD3;GEMIN7;CD2BP2;WDR77;SNRPD1
prerank,tRNA methylation (GO:0030488),0.3796442568767008,0.9865365865713586,0.47547683923705725,0.8367910564228129,1.0,7/34,11.54%,TRDMT1;TRMT61A;TRMT5;METTL2B;METTL2A;ALKBH8;TRMT61B
prerank,regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),0.44082525451807275,0.9865273460940845,0.48214285714285715,0.8362690891753708,1.0,1/14,1.84%,PAEP
prerank,regulation of collagen biosynthetic process (GO:0032965),-0.36461116036335484,-0.9864803613078521,0.46005509641873277,0.8323844359766359,1.0,7/19,20.55%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.3919982079433635,-0.986389142483745,0.4487534626038781,0.8313386130845476,1.0,8/14,34.87%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,pore complex assembly (GO:0046931),0.42259845852862543,0.9862368818578193,0.4794520547945205,0.8363328990421888,1.0,7/19,15.93%,ANO6;P2RX7;ADAM10;RTN4;PDZD11;NUP153;NUP205
prerank,early endosome to late endosome transport (GO:0045022),0.4220572032027083,0.9861038740870287,0.48377125193199383,0.8360773291598312,1.0,6/20,18.80%,EMP2;LMTK2;HOOK1;PIK3C3;KIF16B;HOOK2
prerank,regulation of interferon-alpha production (GO:0032647),0.40446529186318686,0.9859078180646803,0.47619047619047616,0.8359501203618096,1.0,6/23,14.84%,IFIH1;TLR3;STAT1;DHX9;IRF5;HAVCR2
prerank,stress granule assembly (GO:0034063),-0.34490143145292024,-0.9856265659532096,0.489010989010989,0.8321290520464202,1.0,6/20,13.48%,YTHDF1;ATXN2;UBAP2L;YTHDF2;DDX3X;PRRC2C
prerank,protein-containing complex disassembly (GO:0032984),0.3483197861147857,0.9851871305914889,0.5109961190168176,0.8370520251868088,1.0,12/54,14.36%,CAV1;VTI1B;GABARAPL1;TECPR1;VAMP8;APC;VAMP7;LIX1;VPS4A;CHMP3;CTNNB1;MAP1LC3A
prerank,response to interleukin-1 (GO:0070555),0.34198172614896033,0.9849536079581718,0.47625,0.8370436906046488,1.0,13/73,11.38%,DAB2IP;LGALS9;APP;HYAL2;IRAK2;GBP3;CD47;ZC3H12A;NR1D1;ACOD1;CACTIN;CCL4;GBP2
prerank,heterochromatin assembly (GO:0031507),-0.3428413015348392,-0.9848428373461785,0.47277936962750716,0.8328513106519855,1.0,5/20,14.40%,HDAC1;RRP8;HMGA2;SUV39H1;SIRT2
prerank,regulation of mononuclear cell migration (GO:0071675),0.41027560100173577,0.9840261958985697,0.4948453608247423,0.8385648161071944,1.0,5/23,9.21%,STK10;MSN;MAPK1;CMKLR1;PTK2
prerank,regulation of type I interferon production (GO:0032479),0.3330509311707417,0.9838947342859249,0.47393364928909953,0.838310594505268,1.0,16/84,14.24%,IFIH1;LRRFIP1;UBA7;TIRAP;DDX41;RNF125;NLRC5;POLR3B;ACOD1;GAPDH;DHX9;TRIM25;POLA1;IRF5;PIN1;CTNNB1
prerank,cholesterol efflux (GO:0033344),0.4261789772204897,0.9832339417699163,0.5085536547433903,0.8393034188047556,1.0,7/20,18.32%,APOA1;STX12;ABCG4;TSKU;ABCA7;SCARB1;SOAT1
prerank,inorganic cation import across plasma membrane (GO:0098659),0.3364141029072791,0.9829830465739047,0.4814356435643564,0.8393368187203036,1.0,7/75,3.90%,TRPV4;ATP2B4;ATP1A4;ATP1A1;ATP1A3;SLC8A1;SLC12A8
prerank,entry into host (GO:0044409),-0.3840586230206313,-0.9828472328264666,0.4860759493670886,0.8368489399383251,1.0,5/13,10.95%,ITGAV;CDH1;SRC;PPIA;MET
prerank,protein localization to phagophore assembly site (GO:0034497),0.4702536345690934,0.9827444004867213,0.4765886287625418,0.8393335739072688,1.0,1/11,1.80%,TRAPPC8
prerank,androgen metabolic process (GO:0008209),-0.355462284564551,-0.9826176387109812,0.48441926345609065,0.8361422587467467,1.0,15/18,54.16%,SPP1;SRD5A1;HSD17B10;HSD17B11;SRD5A3;SHH;HSD17B7;SRD5A2;HSD3B2;CYP19A1;MED1;DHRS9;HSD17B6;HSD17B3;AKR1D1
prerank,regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),0.4485008052706315,0.9824094338416334,0.48417721518987344,0.8395269404350564,1.0,5/13,25.32%,DUSP1;NDC80;LCMT1;GEN1;TPR
prerank,negative regulation of extracellular matrix organization (GO:1903054),0.46842036322304603,0.982149578025654,0.4789915966386555,0.8395797146817251,1.0,2/10,5.71%,NOTCH1;TNFRSF1B
prerank,TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.391643994886374,0.9817633275296584,0.4565826330532213,0.83994945790185,1.0,5/29,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,neurotransmitter transport (GO:0006836),0.3404218641071777,0.9816712032011188,0.49563046192259674,0.8396309502030194,1.0,22/73,21.06%,UNC13B;APBA1;SYN3;GLS2;GLS;SLC6A4;PPFIA2;SLC6A2;PDZD11;SLC1A1;GABRA2;SLC1A2;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYNJ1;SYT1;SLC1A6;NRXN1;SLC29A4
prerank,tRNA aminoacylation (GO:0043039),0.37310619285703894,0.9816166479593057,0.49019607843137253,0.8392177327794932,1.0,10/37,19.48%,GARS1;VARS1;KARS1;FARSB;WARS1;FARS2;GATB;RARS1;EEF1E1;DARS1
prerank,positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),-0.28157337339822003,-0.9811843071901906,0.4700854700854701,0.83875988561651,1.0,6/49,8.98%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,lipid droplet formation (GO:0140042),-0.4294549340799393,-0.9809304900909924,0.5060240963855421,0.8381602042114941,1.0,5/10,28.24%,BSCL2;SQLE;PLA2G4C;FITM2;AUP1
prerank,myelination (GO:0042552),0.36947052745042214,0.980855931559813,0.4939271255060729,0.8404223347552995,1.0,15/46,18.78%,MALL;MPZ;ACSBG1;CMTM8;MARVELD1;MAL;EIF2B2;NFASC;B4GALT6;SOX10;ARHGEF10;CXCR4;PLLP;MAL2;SKI
prerank,regulation of transcription regulatory region DNA binding (GO:2000677),0.4028318132669789,0.9807910437732601,0.5052160953800298,0.8400358170722687,1.0,5/25,9.89%,HEY1;HEY2;TRIM6;GATA3;MAD2L2
prerank,postsynaptic membrane organization (GO:0001941),-0.3595305251049104,-0.9805688924496793,0.47941176470588237,0.837785200041736,1.0,5/17,8.95%,APOE;DLG4;NLGN2;DNAJA3;LRRC4
prerank,regulation of neuron projection development (GO:0010975),0.31147323076794475,0.9801797837206007,0.5153846153846153,0.8409275308252014,1.0,32/163,14.06%,TRPV4;STMN2;RAPGEF2;TANC2;RAPGEF1;FKBP4;DAB2IP;PRKD1;SERPINI1;FES;FBXO7;PDLIM5;SHANK3;CAMSAP2;SETX;LRRK2;PTPRO;TENM3;LRRC4C;SCN1B;PPFIA2;CCDC88A;CDH2;SPOCK1;DCC;CSMD3;MARK2;CTNNA2;TSKU;LTK;CFL1;EFHC2
prerank,negative regulation of binding (GO:0051100),0.33120276253215103,0.9789308778063778,0.4805352798053528,0.843228882916618,1.0,20/81,15.64%,PDGFB;CAV1;SUMO3;LEF1;BTAF1;LRRK2;JAK2;CTNNBIP1;ROCK1;JUN;NFKBIA;ACTB;TMBIM6;TTBK1;ITGB1BP1;PIN1;HABP4;NES;RACK1;SLPI
prerank,zymogen activation (GO:0031638),0.37660532351073933,0.978619370586733,0.49860335195530725,0.8433933120436051,1.0,8/39,13.99%,CASP8;OMA1;FURIN;PGK1;CIDEB;VSIR;TBC1D10A;APOH
prerank,regulation of ubiquitin-protein transferase activity (GO:0051438),0.3839815811149856,0.9783767991063782,0.4993045897079277,0.8433926850805377,1.0,9/29,21.18%,SMAD7;FBXW7;DTX3L;PIN1;BMI1;TRIB3;FEM1A;ARRDC4;DCUN1D2
prerank,positive regulation of production of molecular mediator of immune response (GO:0002702),0.3812370484662464,0.9780820543501052,0.48246844319775595,0.8435075066965263,1.0,4/34,5.16%,NOD2;F2RL1;TRIM6;GPI
prerank,maintenance of protein location in nucleus (GO:0051457),0.4182947390724988,0.9778644340654512,0.5031055900621118,0.8434309718271948,1.0,7/20,21.56%,SYNE1;RANGAP1;ARL2BP;TAF8;TAF3;BARD1;SUN1
prerank,regulation of cartilage development (GO:0061035),0.41250578391982684,0.9773161641838027,0.48382126348228044,0.8441700572479632,1.0,4/18,12.21%,BMPR2;MBOAT2;ZBTB16;SOX6
prerank,myeloid cell development (GO:0061515),0.42793696122039737,0.9771713544887468,0.48628048780487804,0.8439740863840769,1.0,4/18,9.09%,APP;ALAS1;THPO;FOXP1
prerank,positive regulation of extracellular matrix organization (GO:1903055),-0.374664751219503,-0.9770323824972403,0.47480106100795755,0.846141480577912,1.0,4/18,8.48%,PDPN;RUNX1;SMAD3;EFEMP2
prerank,negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.40032216426172207,-0.9769568256041263,0.4959785522788204,0.8450359976039115,1.0,4/13,10.32%,ERRFI1;CBLB;SNX6;TSG101
prerank,MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.38730358605717624,0.9764135189774632,0.4622905027932961,0.8451912551089364,1.0,5/30,8.54%,CASP8;TLR3;UBE2D1;UBA52;RPS27A
prerank,skin development (GO:0043588),0.3453452389764989,0.9764015851357755,0.48635235732009924,0.8446806767263147,1.0,7/65,5.79%,JAG1;GATA6;CLIC4;LSR;BCR;ATP7A;COL5A2
prerank,regulation of canonical Wnt signaling pathway (GO:0060828),0.30125245291993724,0.9763699839219627,0.5353430353430353,0.8442166224735654,1.0,50/248,14.81%,DKK2;SOX17;SOX13;CCDC88C;FZD6;CCNY;GNAQ;TMEM88;DAB2IP;CDK14;CAV1;HHEX;LGR5;PSMD13;WWTR1;CSNK1D;CUL3;PSMD4;SHISA6;LRRK2;PTPRU;PTPRO;CDH3;APC;SNAI2;MCC;CSNK1G3;IGFBP4;AMER3;PSMA5;RBX1;PSMB10;ZNRF3;SIAH2;MAD2L2;NKD2;TNKS;PSMB8;PSMD14;PSMA7;PSMC3;PIN1;ADGRA2;PSMA8;PSMC1;PSMB5;CTNNB1;MLLT3;PSMC5;FZD9
prerank,membrane raft organization (GO:0031579),0.43193154457524763,0.9760065828034836,0.49122807017543857,0.8444931215387256,1.0,2/15,3.24%,EMP2;PPT1
prerank,negative regulation of viral entry into host cell (GO:0046597),0.4545158835091484,0.9759732459248973,0.5042735042735043,0.8440330038486503,1.0,2/12,4.67%,LY6E;TRIM11
prerank,cellular protein localization (GO:0034613),0.2983058335092096,0.9756650262971056,0.5447070914696814,0.8441899670350451,1.0,54/285,14.48%,FBLN5;RABGAP1;OCLN;TRAPPC8;ARHGEF2;RAB6B;HERC2;EMP2;ID1;ESAM;HHEX;HEY2;STX7;TBC1D30;SCG5;EHD1;SGSM1;ANGPT1;TBC1D8;TMED10;PACSIN1;RAB23;CEP68;RAB3GAP2;LRRK2;TBC1D12;PTPRU;TLK1;TBC1D5;STX12;TBC1D1;ARF3;RRAGD;TM9SF1;REEP1;LAPTM5;NPM1;VPS35;TMED9;SMURF1;RAB19;STX19;TM9SF3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;MESD;TBC1D9;NSF;CTNNB1;TMED4
prerank,negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.33289761459829836,-0.9756612193133773,0.4955223880597015,0.8472663803943427,1.0,9/23,16.45%,UACA;BMP7;CCN3;PPM1A;C1QTNF3;DDX3X;PPM1B;CYLD;NLRC3
prerank,ncRNA catabolic process (GO:0034661),0.38776539860019404,0.975496816005168,0.5035360678925035,0.8440148338565506,1.0,11/28,24.98%,RBM7;TRIR;EXOSC3;EXOSC8;XRN1;EXOSC9;POP1;EXOSC10;DIS3L2;NUDT16;NUDT16L1
prerank,"regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.2866907833462209,-0.9749461534156029,0.4959016393442623,0.8478073783734519,1.0,10/46,16.30%,ATP1A2;NLGN2;GRM3;CACNG4;TSHZ3;ATAD1;HOMER1;DRD2;CACNG8;UNC13A
prerank,positive regulation of lamellipodium organization (GO:1902745),-0.30081319733419914,-0.9748952839167891,0.5099337748344371,0.8466352798488078,1.0,5/32,6.78%,AUTS2;PLCE1;RREB1;PIK3R1;SRC
prerank,cellular response to insulin stimulus (GO:0032869),0.31576132712077976,0.9747601361274172,0.5112866817155757,0.8451499216260585,1.0,16/124,8.51%,CEACAM1;FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;HDAC9;INPP5K;PDE3B;BCAR3;PCK2;SLC25A33;SYAP1;APC;NAMPT
prerank,glycosphingolipid metabolic process (GO:0006687),0.3590172706506141,0.9747287181859494,0.48760330578512395,0.8446744644371473,1.0,5/42,9.87%,ST6GALNAC3;ESYT2;GLTP;A4GALT;B4GALT6
prerank,water transport (GO:0006833),0.45241191870751046,0.9746982137585735,0.5126475548060708,0.8442144049799686,1.0,1/12,2.23%,AQP11
prerank,regulation of execution phase of apoptosis (GO:1900117),0.45907440453204806,0.9746677923955039,0.5041459369817579,0.8437433581317624,1.0,5/11,16.01%,ZC3H12A;BCL2L1;FZD3;DFFA;PTGIS
prerank,positive regulation of neuron death (GO:1901216),0.35847344477714954,0.9745856023543452,0.5068870523415978,0.8434219492255898,1.0,13/46,16.68%,FYN;TGFB2;FCGR2B;ITGAM;GRIN2B;EGR1;PRNP;TYROBP;CLU;CTNNB1;SARM1;EIF2S1;DAXX
prerank,kinetochore organization (GO:0051383),-0.3728722265637204,-0.9739154768667525,0.5012658227848101,0.8479368642263546,1.0,9/13,39.75%,CENPC;MIS12;CENPE;CENPH;CENPF;CENPA;DLGAP5;NUF2;CENPW
prerank,midbrain dopaminergic neuron differentiation (GO:1904948),0.46493531297993773,0.9735432125687287,0.494077834179357,0.8452266456027886,1.0,1/11,1.35%,NR4A2
prerank,cellular response to radiation (GO:0071478),0.36414506670388413,0.9731720585495515,0.5020519835841313,0.8454962641865843,1.0,12/40,21.61%,RHOB;RRH;NSMCE3;SPIDR;RAD1;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2
prerank,homotypic cell-cell adhesion (GO:0034109),-0.29570080631530293,-0.973141742080648,0.5202952029520295,0.8487351770547545,1.0,7/39,10.00%,PLPP3;PDGFRA;MEGF11;UBASH3B;FLNA;MYL9;PPIA
prerank,positive regulation of gene expression (GO:0010628),0.2920522646293701,0.9729581950352841,0.5614213197969543,0.8454673842693766,1.0,74/442,13.64%,PLCG2;NOS3;CLDN5;GATA2;PDGFB;CRTAM;OCLN;NOTCH1;HEY1;IFNGR1;TNRC6C;LGALS9;VIM;CADM1;DLL4;APP;HEY2;TLR3;NOS1AP;MED26;KLF4;PPM1F;KRAS;MSN;ANGPT1;LEF1;MEF2C;CD34;TAF1A;WARS1;IL1A;MAPK1;SETX;P2RX7;ZC3H12A;PLD1;ELAVL1;HSPA1B;TENT4A;PLSCR1;MYO1C;CDH3;NFE2L2;PRKAA1;PASK;ACTG1;GAPDH;ELAVL4;ROCK1;STAP1;POLR1F;EGR1;TYROBP;LURAP1;AGO4;VSIR;METTL5;ACTB;NPM1;EEF2;NWD1;VPS35;BRCA1;VSTM2A;CLU;HINFP;PIK3CB;TTBK1;RPS6KB1;FXR1;METTL14;HABP4;HIF1A;DDX21
prerank,regulation of G1/S transition of mitotic cell cycle (GO:2000045),0.33670689872492315,0.9728878614043507,0.49753086419753084,0.8450816189056367,1.0,11/66,11.55%,PLCB1;CCND2;FAM107A;CCND3;KLF4;ADAM17;RBL1;APC;KMT2E;ADAMTS1;E2F7
prerank,regulation of cell death (GO:0010941),0.3317730907249514,0.9725273839037875,0.5196195005945303,0.845352098918019,1.0,19/94,14.86%,ACER2;PRKD1;SNCG;TMEM109;TNFRSF1B;ZC3H12A;LRRK2;HSPA1B;PDE8A;CIDEB;APC;RRAS2;DCC;VPS35;CLU;BNIP3L;BNIP3;RAD18;SARM1
prerank,positive regulation of nervous system process (GO:0031646),0.4283039456991755,0.9724084496767771,0.5046296296296297,0.8450929703352358,1.0,3/18,10.75%,UNC13B;TNFRSF1B;TENM4
prerank,response to progesterone (GO:0032570),0.4259463743658928,0.9723927759332871,0.5063694267515924,0.844599442647783,1.0,4/18,8.74%,CAV1;TGFB2;UBE3A;ACOD1
prerank,neuropeptide signaling pathway (GO:0007218),0.3473859552685599,0.9723661693906112,0.5032010243277849,0.844126351812938,1.0,14/58,23.17%,RAPGEF2;HCRTR1;GAL;NXPH2;NMU;GLRA2;GPR149;PENK;SORCS1;SORT1;HCRTR2;SORL1;PDYN;NTS
prerank,regulation of lipid biosynthetic process (GO:0046890),0.3811596169056013,0.9717258565505185,0.4847605224963715,0.8450636326771099,1.0,5/32,6.44%,ADIPOR2;CEACAM1;APOA1;SIRT4;ADIPOR1
prerank,"DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.40836315097953046,-0.9715916526049273,0.5161290322580645,0.8517030351593388,1.0,2/10,16.86%,RPS6KA6;TFAP4
prerank,positive regulation of mRNA metabolic process (GO:1903313),0.45574761519600426,0.9715427852932101,0.5071542130365659,0.8449604629401668,1.0,4/13,10.52%,ZC3H12A;PRR5L;CNOT1;GTPBP1
prerank,regulation of cellular response to stress (GO:0080135),0.3184063101539671,0.9711650642893129,0.5428893905191874,0.8452944329062959,1.0,22/115,16.99%,NUAK1;FKBP4;ING2;CAMK2D;MAPK1;CHCHD2;MBTPS2;HSPA1B;DNAJC2;NUP54;PTGES3;NUP35;RANBP2;NPM1;NUP153;NUP160;ATM;NUP42;DNAJB6;NUP205;ARMT1;DNAJC7
prerank,GPI anchor metabolic process (GO:0006505),-0.31763280508011316,-0.970967729260205,0.5096153846153846,0.8520566495631726,1.0,14/26,26.51%,GPLD1;PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW
prerank,negative regulation of interleukin-10 production (GO:0032693),0.42027953329247186,0.9702952440858396,0.500780031201248,0.8467073876802196,1.0,5/16,23.33%,FCGR2B;TYROBP;VSIR;AGER;DLL1
prerank,regulation of lamellipodium assembly (GO:0010591),-0.3003768013789807,-0.9702900298290927,0.47959183673469385,0.8525613883047978,1.0,7/34,13.50%,AUTS2;PLCE1;SLIT2;PIK3R1;CAPZB;ACTR2;FER
prerank,potassium ion homeostasis (GO:0055075),0.4011586562534196,0.9702881561659615,0.5037147102526003,0.8461917684023522,1.0,4/23,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,regulation of voltage-gated calcium channel activity (GO:1901385),-0.3336065309728289,-0.9700897789448283,0.47058823529411764,0.8517608250067074,1.0,9/22,23.09%,DMD;AHNAK;CACNB1;CACNB2;DRD2;PDE4B;CACNB3;STAC3;CBARP
prerank,cellular response to starvation (GO:0009267),0.30693914003531203,0.9699695508486113,0.5413870246085011,0.8463912510045614,1.0,18/147,10.04%,NUAK1;BMPR2;FAS;CASTOR1;FOXO1;PRKD1;STK24;DAP;GABARAPL1;MAPK1;ZC3H12A;SIK2;WDR59;LRRK2;PRKAA1;PIK3C3;RIPOR1;RRAGD
prerank,pyrimidine nucleobase metabolic process (GO:0006206),-0.39187605556505223,-0.969116100155966,0.5077319587628866,0.8531764337798733,1.0,2/12,4.04%,DPYSL3;DPYD
prerank,nucleotide metabolic process (GO:0009117),-0.3366352190709618,-0.9690515705032322,0.49859943977591037,0.8520208800828019,1.0,10/23,19.85%,NMNAT2;FHIT;ME1;ENPP3;AK5;PNP;CMPK2;CTPS2;AK1;NME2
prerank,regulation of autophagy (GO:0010506),0.2992445837001883,0.9688233348078331,0.5557872784150156,0.848499589096765,1.0,56/216,20.82%,ACER2;RASIP1;TRIM14;FBXL2;DRAM1;FOXO1;PRKD1;PIK3C2A;ATG101;GPR137B;TRIM6;DAP;SMCR8;SH3BP4;DEPP1;IRGM;ZC3H12A;LRRK2;HSPB1;PRKAA1;GAPDH;ROCK1;HMGB1;FBXW7;RRAGD;EXOC8;TPCN2;TAB2;VPS35;TRIM8;DRAM2;PIK3CB;KEAP1;ATM;BNIP3;RHEB;RUBCN;UBQLN2;VDAC1;RMC1;TRIB3;ATP6V1G1;BMF;GSK3A;EXOC4;ATP6V1C1;CAPN1;RRAGA;ERN1;MCL1;ATP6V0A1;RRAGC;GSK3B;LAMTOR3;ATP6V1D;MID2
prerank,antibacterial humoral response (GO:0019731),0.43507698797875266,0.9686837533582995,0.49363057324840764,0.8482642784156665,1.0,6/16,24.08%,DEFA6;RNASE6;SLPI;ANG;RPL39;RNASE7
prerank,"RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.3685251444687404,-0.9684388037183735,0.4684931506849315,0.8524217273468739,1.0,3/15,5.02%,LACTB2;DICER1;NYNRIN
prerank,dendritic spine organization (GO:0097061),0.39862069976570547,0.9680916745297162,0.49558823529411766,0.8490824034314699,1.0,4/26,9.97%,FYN;INSR;SHANK3;PRNP
prerank,"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.274995377366052,-0.9679825069277989,0.5021834061135371,0.8523770830649228,1.0,6/52,4.18%,CELF2;DDX5;NOVA1;FXR2;RBMX;DDX17
prerank,membrane lipid catabolic process (GO:0046466),0.45983249665419235,0.9679719321059251,0.4965277777777778,0.8488298727974769,1.0,1/10,3.24%,PPT1
prerank,positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.3999598061167428,0.9677400012273945,0.4947994056463596,0.8488360117373593,1.0,8/22,16.29%,HNF1A;MED30;PSMC3;MED17;MED4;PSMC5;PSMC6;ESR1
prerank,regulation of dephosphorylation (GO:0035303),0.43153609980801466,0.9675618672108915,0.5070643642072213,0.8487266862879844,1.0,8/15,28.52%,INPP5K;PPP1R16B;PPP1R16A;SMG7;IGBP1;MTMR2;MTMR9;SMG5
prerank,DNA-dependent DNA replication (GO:0006261),0.31027809920268873,0.9673774384050334,0.5416666666666666,0.8486073538885416,1.0,33/128,18.86%,PSMD13;WRNIP1;SSBP1;ORC3;PSMD4;PURA;UBA52;RPS27A;PSMA5;PSMB10;POLA1;POLG2;POLB;PSMB8;PSMD14;WDHD1;ORC5;PSMA7;PSMC3;DDX21;PSMA8;PSMC1;PSMB5;PSMC5;RFC2;TEFM;PSMB9;PSMC6;MCMBP;PSMA4;PSMD5;PSMD9;PSMB6
prerank,regulation of telomere maintenance via telomerase (GO:0032210),0.351286928431922,0.9672590136139985,0.5139813581890812,0.8483304081057584,1.0,25/51,28.73%,HMBOX1;MAPK1;CCT8;NEK7;STN1;TNKS;CCT2;FBXO4;CCT4;XRN1;ATM;CTNNB1;CCT6A;CTC1;MAPKAPK5;EXOSC10;TERF2;TCP1;CCT3;TINF2;MAP3K4;TNKS2;HNRNPC;SMG5;HNRNPA1
prerank,positive regulation of cell growth (GO:0030307),0.31878274826161296,0.9671945893450149,0.5124260355029586,0.847941100684266,1.0,24/96,18.70%,EDN1;MACF1;ITSN2;TGFB2;NTN1;SHTN1;SEMA7A;BRAT1;TAF9B;ADAM17;SLC25A33;ISLR2;ADAM10;RPS6KA1;NEDD4L;SMURF1;RPS6KA3;RASAL1;EXOSC9;ADNP2;SYT1;SYT2;CDKN2AIP;H3-3A
prerank,"positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.4540955238119253,0.9667537736346322,0.534453781512605,0.8483850355902178,1.0,8/12,25.54%,CCT8;DKC1;CCT2;CCT4;CCT6A;TCP1;CCT3;WRAP53
prerank,heterotypic cell-cell adhesion (GO:0034113),0.3956617564204652,0.9659108219502399,0.502906976744186,0.8497378060699988,1.0,4/25,9.23%,VCAM1;IZUMO1;CD200;DSP
prerank,apical protein localization (GO:0045176),0.4612257927376197,0.9658827220583466,0.5173553719008265,0.849273772815824,1.0,4/10,12.78%,GOPC;MAL;ACTB;ATP8B1
prerank,fatty acid elongation (GO:0030497),0.44663665002822844,0.9658578563594253,0.5169082125603864,0.8488046332994844,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,positive regulation of lipid catabolic process (GO:0050996),-0.3408301096648032,-0.9655688061157595,0.4971751412429379,0.8576541458183298,1.0,7/19,23.33%,PPARA;IRS2;IRS1;TWIST1;PRKCD;MTLN;ANGPTL3
prerank,intracellular protein transport (GO:0006886),-0.21032726154000722,-0.9655476557497694,0.6296296296296297,0.8564102301508858,1.0,79/304,18.40%,RANBP3L;WLS;APPL2;STX4;SGSM2;GGA2;TRAK1;TBC1D2B;SNX6;VPS26B;UNC93B1;SIL1;COPZ2;TBC1D9B;NUP107;COPA;C2CD5;SURF4;VIPAS39;CLIP3;VPS45;LMAN1;SEC31A;HEATR3;KIF13B;ARF1;CSE1L;GRTP1;PPP1R10;ARCN1;STX3;KIF13A;COPB2;NUP155;ADPRH;RAB22A;COX18;TBC1D16;TNPO3;ARF5;ARL6;EIF2D;RABGAP1L;RANBP6;STX5;ARL4A;SNX1;TMED3;HOMER3;PKD1;VPS33A;STX16;IPO5;TBC1D17;FAM53C;SAR1A;BAG3;HDAC6;NUP93;SNX8;NAPA;TRIM23;HPS4;TNPO2;IFT27;SEC16A;RANBP17;GGA1;STX17;ARL5A;TMED1;RANBP3;TSC2;GABARAP;CD74;PHB2;VPS33B;RAB29;AP1S3
prerank,triglyceride metabolic process (GO:0006641),-0.27668588078857154,-0.9654250232755598,0.5141509433962265,0.8554722964905322,1.0,6/48,9.81%,AGMO;LPGAT1;APOE;MOGAT3;GK;DGAT1
prerank,regulation of epithelial to mesenchymal transition (GO:0010717),0.3323036869546773,0.9652272347222527,0.511166253101737,0.8496919331379025,1.0,15/74,11.14%,SMAD7;DAB2IP;TGFB2;IL17RD;WWTR1;LEF1;GCNT2;EFNA1;SMAD2;GATA3;ADIPOR1;CLASP1;MAD2L2;CLASP2;MCRIP1
prerank,"DNA-templated transcription, elongation (GO:0006354)",0.3404665810584893,0.9648707128132454,0.5105067985166872,0.8499567663774021,1.0,23/64,24.60%,ELOC;RTF1;EAF1;ELP4;ELP2;POLR2G;ELOA;POLR2D;EAF2;GTF2H3;MLLT3;ELOF1;NELFB;POLR2I;AFF4;NELFA;SETD2;MNAT1;IWS1;POLR2C;POLR2B;POLR2J;CCNH
prerank,modification-dependent macromolecule catabolic process (GO:0043632),0.4701049950230062,0.9631329160182605,0.49744463373083475,0.8532794976571252,1.0,5/10,22.04%,UBA52;RPS27A;TUT7;UBB;DIS3L2
prerank,sulfur compound transport (GO:0072348),0.38173492193093467,0.9630495404654026,0.5042613636363636,0.8529476437772143,1.0,1/27,0.19%,SLC6A6
prerank,gluconeogenesis (GO:0006094),-0.2880329286308299,-0.9629382236252266,0.5127272727272727,0.8608913341860693,1.0,13/39,21.23%,SLC39A14;SLC25A13;RBP4;ENO2;PGM1;MDH2;SLC25A12;GOT1;PFKFB1;CRTC2;G6PC3;TPI1;ENO3
prerank,regulation of sequestering of calcium ion (GO:0051282),-0.3922469052750126,-0.9626267715586234,0.5167958656330749,0.860466763956867,1.0,2/12,6.03%,ANK2;UBASH3B
prerank,regulation of presynapse organization (GO:0099174),-0.34892592944754874,-0.9625889960642231,0.5279329608938548,0.8579877759217405,1.0,1/18,0.01%,GPC6
prerank,regulation of presynapse assembly (GO:1905606),-0.34892592944754874,-0.9625889960642231,0.5279329608938548,0.8579877759217405,1.0,1/18,0.01%,GPC6
prerank,regulation of lipase activity (GO:0060191),0.44819455936915975,0.9624777081916398,0.5175718849840255,0.8537457928492893,1.0,2/13,5.65%,PCSK5;FURIN
prerank,rRNA 3'-end processing (GO:0031125),0.4614555833317233,0.962234991472051,0.5092436974789916,0.8537658169453707,1.0,5/10,21.35%,RPS21;EXOSC3;EXOSC8;EXOSC9;EXOSC10
prerank,COPII-coated vesicle budding (GO:0090114),-0.2562902368016246,-0.9622275428249603,0.5612244897959183,0.8576807029921605,1.0,35/68,29.47%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;SAR1A;TRAPPC3;VAPB;NAPA;SEC16A;CTSC;F5;SCAP;SEC23B;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8;SEC31B;GORASP1;TRAPPC2L;PPP6R3
prerank,regulation of viral genome replication (GO:0045069),0.34180780484393747,0.962191013463923,0.5227272727272727,0.8533286291447083,1.0,17/56,20.97%,ADARB1;IFIH1;TRIM6;PPIE;PLSCR1;OAS2;ADAR;PPIH;SLPI;PKN2;RSAD2;SRPK1;IFITM3;PPID;ZC3HAV1;EIF2AK2;BANF1
prerank,mitotic cell cycle phase transition (GO:0044772),0.3020437146483348,0.9620467641576049,0.5633047210300429,0.8531358329460257,1.0,45/203,21.20%,PLCB1;CCNY;PLK3;CCND2;CCND3;CDK14;ACVR1;CCNE1;TUBB;CSNK1D;CDC25C;CUL3;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;CLASP2;CUL2;DYNLL1;CEP76;USP29;ARPP19;HINFP;RPS6KB1;TUBA1A;CDC27;NES;CHMP7;CDKN2D;ANAPC7;CACUL1;E2F3;FBXL6;FBXL15;ACTR1A;PPME1;CEP192;MAX;LCMT1;DYNC1I2;MNAT1;BCAT1
prerank,positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.36764402472406954,-0.9620307938101708,0.5149051490514905,0.8569173312374977,1.0,5/15,13.54%,APOE;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,regulation of G protein-coupled receptor signaling pathway (GO:0008277),0.33106732584486886,0.9615639339700818,0.5283732660781841,0.853626636219649,1.0,11/75,13.82%,EDN1;RGS3;PLCB1;GIT2;MRAP2;NMT1;ROCK1;GNG4;KCTD8;METAP2;RGS12
prerank,DNA double-strand break processing (GO:0000729),0.4055746360511633,0.9615631102747613,0.5092592592592593,0.8530999579345352,1.0,7/18,20.67%,RBBP8;EXD2;BRCA1;SMARCAD1;ATM;BARD1;BLM
prerank,protein localization to cilium (GO:0061512),-0.2944681608772593,-0.9615367555709925,0.49818181818181817,0.8569030534017964,1.0,14/32,20.71%,TULP3;INVS;BBS9;WDR35;ARL6;TCTN2;TTC21B;WDR19;ZNF423;IFT20;RAB29;ARL3;NPHP4;RABEP1
prerank,ncRNA transcription (GO:0098781),0.441562885602204,0.9615054815887696,0.5176470588235295,0.8527106853683895,1.0,6/13,24.73%,CAVIN1;SPIN1;USPL1;ANG;BRF1;SNAPC3
prerank,organophosphate ester transport (GO:0015748),-0.31894915636119475,-0.9614669806734805,0.5126582278481012,0.8558212847414081,1.0,10/24,23.13%,OSBPL8;PITPNB;SCP2;TNFAIP8L3;MTTP;PITPNC1;PRELID2;PCTP;PRELID1;PITPNM1
prerank,positive regulation of cellular amide metabolic process (GO:0034250),-0.24861700786334537,-0.9614523486574641,0.5614035087719298,0.8545769854837582,1.0,23/80,19.43%,SAMD4A;ROCK2;SLC2A13;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;SIRT3;CASP3;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;RPS4X;EIF3E;PLA2G6;PRKCD;LARP6;UPF3B
prerank,proteasomal protein catabolic process (GO:0010498),0.2989998611797745,0.9613448655795327,0.559748427672956,0.8525532290383021,1.0,56/201,20.43%,ZNRF1;PSMD13;RHBDD1;RNF185;CUL3;PSMD4;KLHL20;SOCS6;ARRB1;WWP1;FEM1C;NFE2L2;NR1D1;PPP2R5C;PSMA5;FBXW7;RBX1;PSMB10;SIAH2;ENC1;NEDD4L;BAG6;PSMB8;PSMD14;SMURF1;KCTD10;RMND5B;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;CTNNB1;PSMC5;TRIM2;NHLRC1;UBE2D3;PSMB9;SPOPL;PSMC6;RNF139;UBXN6;SEL1L;PSMA4;CCDC47;GSK3A;PSMD5;PSMD9;PSMB6;FBXO45;ZFAND2A;MAEA;RNF5;KCTD2;RNF34;PSMB2
prerank,regulation of triglyceride biosynthetic process (GO:0010866),-0.37162284580054517,-0.9607596061215279,0.5041095890410959,0.855208074739624,1.0,8/15,24.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;SIK1;NR1H3;FITM2;C3
prerank,positive regulation of insulin secretion (GO:0032024),0.367663585095168,0.9605838764514226,0.49166666666666664,0.8537167052343115,1.0,3/36,5.83%,MYRIP;DOC2B;GLUD1
prerank,regulation of transcription by RNA polymerase III (GO:0006359),0.40874626349036114,0.9600942995264444,0.4944,0.8542707534601998,1.0,10/19,27.97%,CEBPA;BRF2;ICE1;TENM1;ZC3H8;POLR3C;DHX36;RPTOR;PRDX5;ICE2
prerank,regulation of fibroblast proliferation (GO:0048145),-0.27623775574447773,-0.9599664903594084,0.5087108013937283,0.8560692503762175,1.0,16/45,21.65%,IGF1;PDGFRA;PDGFC;WNT5A;S100A6;PEX2;SPHK1;CD300A;CDKN1A;NLRC3;CD74;MORC3;NF1;AGT;E2F1;CDK4
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),0.4375839470351812,0.9599565010508481,0.5205696202531646,0.8540456691231769,1.0,2/12,5.76%,ING2;TAF9B
prerank,sensory perception of chemical stimulus (GO:0007606),0.43673521332313225,0.9598047297571983,0.5249221183800623,0.8538565089552649,1.0,2/15,14.01%,GNAL;SLC24A4
prerank,RNA biosynthetic process (GO:0032774),-0.302433074966009,-0.9594339763070846,0.5034013605442177,0.8560968820310788,1.0,10/31,15.81%,RSF1;TAF4;SMN1;HELB;SMARCA5;TTF1;GTF2B;TERT;TAF7;TAF5
prerank,cellular defense response (GO:0006968),-0.28760706232620104,-0.9590211616101566,0.5090252707581228,0.855857009767241,1.0,5/40,8.08%,DCDC2;LBP;LSP1;CCR9;TCIRG1
prerank,cilium organization (GO:0044782),0.2979713309080602,0.9589846251714271,0.5500526870389885,0.8550913113200349,1.0,24/209,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;TEKT5;TTC29;EHD1;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;RAB23;TMEM216;IFT140;CFAP43;PCM1;CFAP52;CDC14A;DYNLL1;EXOC8
prerank,regulation of long-term neuronal synaptic plasticity (GO:0048169),0.4759645411374409,0.9587053612875305,0.5351882160392799,0.855214042898847,1.0,2/10,5.58%,APP;SHANK3
prerank,transition metal ion transport (GO:0000041),0.3673365645643034,0.9585753176489108,0.5111111111111111,0.8549608421588057,1.0,10/35,17.78%,ATOX1;ATP2C1;ATP7A;SLC31A1;SLC30A1;TRPC7;CP;TRPC5;HEPH;ATP7B
prerank,negative regulation of cellular catabolic process (GO:0031330),-0.26326144224183157,-0.958523344156721,0.5641025641025641,0.8558228105865195,1.0,17/63,15.30%,LEPR;NUPR1;BCL2;KLHL22;GOLGA2;TIMP2;PTPN3;PTPN22;TAB3;GPLD1;DAPL1;MET;FOXK2;KDM4A;SIRT2;MFSD2A;ATRAID
prerank,positive regulation of protein targeting to membrane (GO:0090314),0.3911739741537845,0.9584100397846985,0.49177877428998507,0.8547965379156811,1.0,6/24,16.23%,FYN;ITGAM;MYO1C;PRNP;ITGB1BP1;ANK3
prerank,receptor signaling pathway via STAT (GO:0097696),0.39616592264516376,0.9577811226204145,0.5230312035661219,0.8556181156186877,1.0,6/25,8.46%,IFNAR1;SOCS6;STAT1;THPO;JAK2;NMI
prerank,termination of RNA polymerase II transcription (GO:0006369),-0.2963845192139768,-0.9572238844798581,0.5369127516778524,0.8579606304177068,1.0,13/33,23.82%,SCAF8;NUDT21;NCBP1;PABPN1;SNRPF;CSTF2T;PCF11;SNRPD3;LSM11;SLBP;NCBP2;PAPOLA;LSM10
prerank,blood vessel endothelial cell migration (GO:0043534),0.4030742027632055,0.9571426664611099,0.5195369030390738,0.8564760676055355,1.0,5/22,6.05%,EGR3;EMP2;ID1;SOX18;MYH9
prerank,negative regulation of peptidyl-threonine phosphorylation (GO:0010801),0.41914010252956024,0.9571134100699917,0.5189873417721519,0.8560041504676097,1.0,2/17,3.52%,SMAD7;INPP5K
prerank,negative regulation of microtubule polymerization (GO:0031115),0.45219363581434047,0.957030587506646,0.5219512195121951,0.8556597629957413,1.0,1/12,0.60%,STMN2
prerank,gene expression (GO:0010467),0.28868984217442195,0.9568248650593079,0.5785714285714286,0.855594419799058,1.0,122/348,26.43%,NR4A2;ADARB1;RBPMS;HHEX;RPS21;RPL27;TSPAN14;DDX39A;RPL7;TSPAN32;FARSB;WARS1;MRPL18;SETX;CPSF1;MRPL41;POLR2G;RPS14;RPS27A;RPL35;ADAR;ELAVL4;MLF1;NUP54;RPL21;DKC1;DUSP11;NFKBIB;POLR2D;RPL37;RPS28;RPL34;HNRNPK;MRPL36;MRPL52;NUP35;RPS9;XRN2;RANBP2;FIP1L1;RPLP2;MRPL23;RPS25;CHTOP;RPL30;SRSF9;RPS5;NUP153;RPL27A;NUP160;MRPL24;MRPL32;MRPS12;TAF1B;RPL23A;THOC3;NUP42;ATXN1;RPS15;PRPF4;RPL19;RPS18;RPL32;POLR2I;DHX38;NUP205;DROSHA;PWP1;RPL37A;RPL18A;POLDIP3;MMS19;MRPS18B;COPS5;DDX39B;HOXD3;GOLPH3;MEF2A;HNRNPUL1;LMF2;PTMA;DARS1;SMG7;RRAGC;SYNCRIP;YTHDC1;CPSF3;MRPL11;RSL24D1;SORL1;RPL18;RPL39;RPS19;NUP50;RPL31;RPS8;POLR2C;PAX8;EIF4G1;POLR2B;POLR2J;MRPL34;EIF4EBP2;RPL3;RAE1;TESC;ALYREF;SEH1L;THOC5;RPL28;TPR;WDR33;MRPL35;RPS16;RPLP1;RPL26;RPL9;MRPL10;HNRNPF;SYMPK;MRPS18C;MRPL27
prerank,homologous chromosome pairing at meiosis (GO:0007129),0.38224645939462015,0.9564122477518747,0.5248538011695907,0.8559474545987318,1.0,6/29,20.03%,SYCP2;RAD21;MEI4;BAG6;TERB1;PRDM9
prerank,regulation of astrocyte differentiation (GO:0048710),0.45413147737288106,0.9563243950486828,0.5291181364392679,0.8556316871910153,1.0,1/12,1.60%,NOTCH1
prerank,regulation of nuclear division (GO:0051783),0.40133346898599565,0.9562897486260408,0.5158371040723982,0.8551822178359876,1.0,3/20,13.11%,CAV2;CDC25C;PIN1
prerank,cellular protein catabolic process (GO:0044257),0.3405724104570454,0.9562226125439198,0.5297157622739018,0.8547984407333078,1.0,17/59,21.06%,DENND3;DAB2IP;CASP8;AP2B1;AP2M1;SIAH2;RSPRY1;BNIP3L;VLDLR;BNIP3;CTSK;CTSO;MALT1;PISD;RNF5;CTSH;RAB12
prerank,neuron apoptotic process (GO:0051402),0.399433724470209,0.9561109073107841,0.5092592592592593,0.8545099963817012,1.0,5/19,14.44%,FAS;APP;GAPDH;BNIP3;TRPC5
prerank,G1/S transition of mitotic cell cycle (GO:0000082),0.32413621827891803,0.9558347275947042,0.525748502994012,0.8545874937711218,1.0,12/83,12.94%,CDK17;PLK3;CDK14;ACVR1;CCNE1;CUL3;KLF11;CUL2;POLA1;USP29;HINFP;RPS6KB1
prerank,prostanoid biosynthetic process (GO:0046457),0.438675866366844,0.9554841845353311,0.5231259968102073,0.8548599646548011,1.0,1/15,0.47%,EDN1
prerank,protein localization to Golgi apparatus (GO:0034067),0.38616403599307714,0.9550522315418823,0.515850144092219,0.8552676388832716,1.0,5/27,9.54%,GBP5;CSNK1D;TMED10;VPS13D;RIPOR1
prerank,regulation of protein processing (GO:0070613),-0.32584020150787735,-0.9546362361149433,0.4986301369863014,0.8634969548525001,1.0,4/21,5.93%,CCBE1;GAS1;SERPINE2;RUNX1
prerank,regulation of IRE1-mediated unfolded protein response (GO:1903894),0.4418858061919153,0.9543112336244923,0.5283018867924528,0.8563669265347493,1.0,3/14,17.63%,DAB2IP;PTPN1;COPS5
prerank,negative regulation of immune system process (GO:0002683),-0.3688173010034876,-0.95376342440238,0.5298701298701298,0.8646787215715248,1.0,4/16,17.03%,COL3A1;IL17D;HOXA7;GPER1
prerank,monocarboxylic acid transport (GO:0015718),0.3450613192619557,0.9533776515915495,0.528476821192053,0.8579198181931408,1.0,6/51,7.46%,ABCC4;CEACAM1;SLCO1C1;ABCB4;SLC16A2;SLC16A4
prerank,fatty acid metabolic process (GO:0006631),0.3125646735391898,0.9532777654578005,0.541095890410959,0.857619406781257,1.0,10/115,8.59%,ADIPOR2;ACSM3;FASN;AOAH;SLC27A6;ACSL5;ACSBG1;ADIPOR1;ACOX1;ELOVL4
prerank,negative regulation of phosphatase activity (GO:0010923),0.3884904599764233,0.9531575810660713,0.511177347242921,0.857362577763146,1.0,4/25,6.45%,TGFB2;FKBP1A;ZCCHC9;GPATCH2
prerank,positive regulation of viral life cycle (GO:1903902),0.39580720276364334,0.9523473367711526,0.5059523809523809,0.8585850165848938,1.0,5/22,15.24%,LGALS9;TRIM11;VPS4A;CHMP3;CHMP2B
prerank,proteolysis (GO:0006508),-0.20648393726216188,-0.9523323187254507,0.7142857142857143,0.8672458864322244,1.0,42/252,14.06%,TRABD2B;AEBP1;ADAMTS12;CPQ;OGT;ADGRV1;BACE2;MMP14;HTRA3;ANPEP;CPE;DPP4;BACE1;ADAMTS3;HM13;CLPX;FAP;ADAM19;UFSP2;ADAMTS9;F3;MMP2;ERMP1;ADAM33;PRCP;CPXM2;CASP3;NAALAD2;PTCH1;ATG4D;YME1L1;MMP16;GGT5;CPXM1;ZMPSTE24;ENPEP;MMP19;MDM2;SENP1;RNPEP;SPCS3;PCSK7
prerank,ribosome assembly (GO:0042255),0.35060661216681155,0.9519412921280956,0.5230352303523035,0.858965505267782,1.0,18/47,25.04%,BOP1;DHX37;RPS14;RPS28;NPM1;RPS5;RPL23A;RPS15;EIF6;EIF2A;EFL1;PWP2;RSL24D1;RPS19;NOP53;RPF2;RPL3;MDN1
prerank,neuromuscular junction development (GO:0007528),0.38994518772670816,0.951762324749073,0.5030864197530864,0.8588543781607156,1.0,5/24,7.14%,UNC13B;AGRN;PPFIBP1;GPHN;LRRK2
prerank,negative regulation of protein dephosphorylation (GO:0035308),0.3964828042590469,0.9510696976021249,0.5176110260336907,0.859903084429543,1.0,7/21,20.25%,FKBP1A;PPP1R16B;MFHAS1;ARPP19;BOD1;TIPRL;GSK3B
prerank,gliogenesis (GO:0042063),0.4281500312948056,0.9507209435137994,0.5176282051282052,0.8601626719751579,1.0,4/15,14.36%,TGFB2;CDH2;METTL14;CD9
prerank,peptidyl-lysine acetylation (GO:0018394),-0.41829724035850946,-0.9506118061359251,0.5144927536231884,0.8705389940280714,1.0,3/10,12.70%,CREBBP;KAT2B;ESCO1
prerank,nuclear membrane organization (GO:0071763),-0.3412106882547998,-0.9499837506349633,0.5382436260623229,0.87101272385069,1.0,7/19,17.03%,TOR1AIP1;TOR1B;UBXN2B;TARDBP;AKAP8L;SPAST;GPER1
prerank,negative regulation of coagulation (GO:0050819),0.428087852197393,0.9499386534836898,0.5387096774193548,0.8613231108383796,1.0,5/14,13.99%,EDN1;CD34;PROC;HS3ST5;APOH
prerank,negative regulation of neuron apoptotic process (GO:0043524),-0.2480261915277382,-0.9498870445841953,0.5858585858585859,0.8699780256881761,1.0,11/69,8.12%,BCL2;SLC30A10;NDNF;APOE;SET;PRKN;SNX6;NTRK2;NGF;SIX1;PRKCI
prerank,microtubule anchoring at microtubule organizing center (GO:0072393),-0.3942068220926915,-0.949831199203599,0.5242718446601942,0.8688493826758374,1.0,6/12,26.90%,NINL;BICD2;KIF3A;CCDC68;CCDC120;CEP19
prerank,glycerophospholipid catabolic process (GO:0046475),0.3853451347805037,0.9496042886519528,0.512630014858841,0.8615587763670857,1.0,5/27,11.65%,GPCPD1;PNPLA6;GDPD1;ENPP6;INPP5F
prerank,organic anion transport (GO:0015711),0.3249603566755692,0.9495135825707259,0.5265760197775031,0.861234451503624,1.0,8/76,9.08%,LRRC8C;ABCC4;SLCO1C1;SLC17A9;CYB5R1;SLC16A2;MFSD10;SLC4A9
prerank,regulation of mast cell activation (GO:0033003),0.46388599239379874,0.9494089086110331,0.5303030303030303,0.8609375360895172,1.0,2/10,7.88%,MILR1;PLSCR1
prerank,spliceosomal tri-snRNP complex assembly (GO:0000244),-0.369605004307617,-0.9492728690125043,0.5201072386058981,0.8689916538152418,1.0,3/13,10.96%,PRPF8;PRPF31;PRPF3
prerank,positive regulation of calcineurin-mediated signaling (GO:0106058),0.4320969903685147,0.9492560192296498,0.5336617405582923,0.8602405271000058,1.0,1/12,0.75%,LMCD1
prerank,positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),0.4320969903685147,0.9492560192296498,0.5336617405582923,0.8602405271000058,1.0,1/12,0.75%,LMCD1
prerank,regulation of T cell activation (GO:0050863),0.3602581070150916,0.949178267579893,0.543448275862069,0.8599036869027403,1.0,5/42,11.23%,CRTAM;TNFRSF1B;CD47;DUSP3;LAPTM5
prerank,positive regulation of apoptotic signaling pathway (GO:2001235),0.33945740446840666,0.9491596748681722,0.5355329949238579,0.8594184092515611,1.0,9/55,8.72%,FAS;DAB2IP;CAV1;TNFSF10;HYAL2;BBC3;CRADD;BCL2L1;TPD52L1
prerank,regulation of purine nucleotide metabolic process (GO:1900542),-0.27740864344729166,-0.9487911525248037,0.5789473684210527,0.8690097781448303,1.0,7/41,14.03%,PRKAG2;OGT;LACC1;NUP107;NUP155;AAAS;NUP93
prerank,mRNA modification (GO:0016556),0.3944486551546473,0.9487441805878396,0.5365126676602087,0.8597644174061919,1.0,7/22,17.96%,TRMT61A;DKC1;TRUB1;TRMT61B;VIRMA;METTL14;RPUSD2
prerank,endocytic recycling (GO:0032456),0.3432424688401939,0.9487321799190861,0.5288713910761155,0.8592749152183623,1.0,6/50,13.84%,EHD4;EHD1;LMTK2;RAB35;VPS35;RAB11FIP4
prerank,neuron migration (GO:0001764),0.3490754036143581,0.9483769647364758,0.538562091503268,0.8595197081503647,1.0,9/48,12.15%,RAPGEF2;CEP85L;NR4A2;MEF2C;NRCAM;RAC1;SPOCK1;NAV1;MARK2
prerank,negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),-0.3072503840732093,-0.9483622904998271,0.5299684542586751,0.8688872607223256,1.0,5/30,10.20%,OGT;FHIT;MAP1A;TRIM39;SDCBP
prerank,ER-associated misfolded protein catabolic process (GO:0071712),0.4444006090283513,0.9481903202492619,0.5229982964224872,0.8594018521424986,1.0,5/11,21.01%,RNF185;BAG6;UGGT1;RNF5;POMT2
prerank,protein processing (GO:0016485),-0.2350762919864161,-0.9480653983116568,0.5447761194029851,0.8683779859618493,1.0,21/102,14.38%,AEBP1;OGT;MMP14;CPE;BACE1;ADAMTS3;HM13;ADAM19;F3;CPXM2;TMEM208;PTCH1;YME1L1;MMP16;KLK2;CPXM1;ZMPSTE24;SPCS3;PCSK7;CLN5;FXN
prerank,eye photoreceptor cell development (GO:0042462),-0.36259431834629613,-0.9473090617493959,0.5232876712328767,0.8691558689108404,1.0,8/15,41.57%,VEGFA;TOPORS;TULP1;RPGRIP1L;THY1;BBS4;CRB2;NRL
prerank,regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.31894577250687106,-0.9471224221713598,0.515625,0.8683719847876804,1.0,8/26,12.81%,ERRFI1;CBLB;SHC1;SNX6;TGFA;TSG101;ADRA2A;HBEGF
prerank,RNA splicing (GO:0008380),-0.24074948327331386,-0.9470683236940289,0.5987261146496815,0.8672430816433221,1.0,32/95,25.43%,NOVA1;SNRNP40;SCAF11;NCBP1;PRPF8;SRRM1;FUS;CDK12;PRPF3;TARDBP;SNRPF;WBP4;SNRPA1;SCNM1;MAGOH;PPP2CA;BCAS2;SNRPD3;MAGOHB;MPHOSPH10;LSM6;DHX8;SF3B1;SRPK2;SRSF11;NCBP2;DHX15;TCERG1;SRSF2;U2AF1;WDR83;SNRPD1
prerank,positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.3258822742076391,-0.9470176062731905,0.5194029850746269,0.8661118259651468,1.0,9/22,22.28%,ANK2;CALM2;ATP1B1;GSTM2;JPH2;SLC9A1;P2RY6;STAC3;GSTO1
prerank,semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),0.440064840566188,0.9467860867580671,0.5422077922077922,0.8619338955185698,1.0,3/13,3.97%,PLXNA4;SEMA3F;PLXND1
prerank,positive regulation of cell aging (GO:0090343),0.4378116107236893,0.9466109244291075,0.5177664974619289,0.8618086248039678,1.0,1/11,1.74%,B2M
prerank,cranial nerve development (GO:0021545),-0.39419652201344135,-0.9464592484144284,0.5134474327628362,0.866366222583481,1.0,7/11,44.25%,SALL1;PAX2;CHRNB2;TFAP2A;POU4F1;TIFAB;ISL1
prerank,gas transport (GO:0015669),-0.4019337946818977,-0.9461631607490034,0.5285714285714286,0.8659029945089164,1.0,7/10,46.11%,CA2;CYGB;MYC;AQP1;MB;NGB;RHAG
prerank,positive regulation of embryonic development (GO:0040019),0.3988899828434183,0.945993992136744,0.5162790697674419,0.862634415341937,1.0,5/19,18.50%,PLCB1;TENM4;CFL1;RACK1;ZBED3
prerank,positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),0.4370774175185943,0.9458461542298054,0.5467741935483871,0.8624143887988921,1.0,2/12,10.63%,DAB2IP;PTPN1
prerank,regulation of centrosome cycle (GO:0046605),0.3968783455722579,0.9450701399910345,0.5246913580246914,0.8635958232752822,1.0,10/21,27.34%,CHMP1B;NPM1;CHMP3;CHMP2B;MARK4;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,regulation of actin filament bundle assembly (GO:0032231),0.38317189139909386,0.9450345512280086,0.5168374816983895,0.8631587330054357,1.0,5/26,10.68%,SYNPO;SHANK3;ACTG1;ROCK1;RAC1
prerank,negative regulation of lipid catabolic process (GO:0050995),0.41474440908293014,0.9449290339721529,0.5411954765751211,0.8628633358684655,1.0,3/17,8.29%,PDE3B;ALK;PRKAA1
prerank,negative regulation of interleukin-17 production (GO:0032700),0.4456583049604311,0.9446779270925525,0.5147826086956522,0.8628936370847912,1.0,2/10,10.88%,PRNP;VSIR
prerank,negative regulation of cell cycle (GO:0045786),0.3254536060423727,0.944613873107832,0.5373134328358209,0.862511236358899,1.0,14/73,11.76%,DUSP1;RHOB;BTG2;BTG1;HHEX;PPP1R13B;GMNC;GATA3;PDCD4;CEBPA;APC;ANGEL2;NPPC;NR4A1
prerank,antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.3211816999540121,0.9437475212037957,0.5488095238095239,0.8638548911494217,1.0,14/79,13.57%,MFSD6;AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1
prerank,sodium ion transmembrane transport (GO:0035725),0.3196578986411396,0.9433058882328058,0.5641025641025641,0.8643507409979784,1.0,13/84,9.99%,SLC6A6;ATP1A4;ATP1A1;ATP1A3;SLC8A1;ANO6;SCN11A;SLC6A4;SCN1B;ASIC2;SLC9A7;SLC6A17;SLC6A2
prerank,negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.43821638026176146,0.9432232615032966,0.5148026315789473,0.8640282145320323,1.0,4/13,15.49%,LRRK2;PDE8A;NFE2L2;RACK1
prerank,positive regulation of vascular endothelial growth factor production (GO:0010575),-0.32155646231333945,-0.9432082974313256,0.5297805642633229,0.8724634305359412,1.0,4/24,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,cellular response to hydrogen peroxide (GO:0070301),0.36933494718616067,0.9430575593589201,0.55,0.8638618932174641,1.0,6/33,11.28%,RHOB;PLEKHA1;SETX;NFE2L2;OSER1;TRPM2
prerank,regulation of alcohol biosynthetic process (GO:1902930),0.43401853443157584,0.9430389349440265,0.5355987055016181,0.8633903776858134,1.0,5/12,14.19%,MBTPS2;KPNB1;SEC14L2;LPCAT3;RAN
prerank,heterocycle biosynthetic process (GO:0018130),0.4321393346571115,0.9423774835795845,0.5429936305732485,0.8643443472693098,1.0,2/14,3.81%,GCH1;GPHN
prerank,cation transport (GO:0006812),0.2976530075831219,0.9423618916525769,0.5854465270121278,0.8638579763320899,1.0,21/166,12.72%,SLC6A6;KCNN4;PIEZO1;RHCG;ATP1A4;SLC5A10;SLC8A1;ANO6;SCN11A;MCOLN1;SLC7A1;KCNC1;NDFIP2;SGK1;SLC6A17;NEDD4L;TRPM2;SLC1A1;KCNK9;KCNC4;KCNA1
prerank,positive regulation of exocytosis (GO:0045921),0.3558856203384809,0.9423179754999319,0.5426573426573427,0.8634447682661737,1.0,8/35,17.96%,CADPS2;CLASP1;CLASP2;CADPS;VPS4A;RAB27B;STXBP5;RAB27A
prerank,regulation of monocyte chemotaxis (GO:0090025),0.386558364989872,0.9420607941498441,0.5347826086956522,0.8635126251631283,1.0,3/24,3.92%,CCR1;DUSP1;ANO6
prerank,intracellular steroid hormone receptor signaling pathway (GO:0030518),-0.29505031954500754,-0.9414798893522232,0.5333333333333333,0.8756915176318041,1.0,11/35,17.12%,PPARGC1B;DDX5;ZMIZ1;DDX17;SRC;CALCOCO1;PADI2;SAFB;TADA3;GPER1;AR
prerank,cellular modified amino acid biosynthetic process (GO:0042398),0.40153051995830286,0.9414240964038834,0.5473684210526316,0.8643506708172533,1.0,9/20,22.61%,PLSCR1;PTDSS1;GSS;GAMT;GATM;CHAC2;MTHFS;GGCT;GCLM
prerank,prostaglandin biosynthetic process (GO:0001516),0.41166897433601474,0.9411325465518706,0.5325264750378215,0.8644976054015985,1.0,1/18,0.47%,EDN1
prerank,regulation of intracellular transport (GO:0032386),0.3644616271882706,0.9410453286613478,0.5454545454545454,0.8641791329920833,1.0,10/38,18.42%,MYBPC3;LRRK2;NEFH;PTPN1;NUMA1;INPP5F;LCP1;MAP2;RNF139;HAP1
prerank,mRNA methylation (GO:0080009),0.4193593718635616,0.9409326111233817,0.533751962323391,0.8639008411129406,1.0,4/15,13.27%,TRMT61A;TRMT61B;VIRMA;METTL14
prerank,keratan sulfate metabolic process (GO:0042339),-0.2971336355647037,-0.9406357562118094,0.5430711610486891,0.8766443786172343,1.0,8/31,7.47%,OGN;FMOD;B3GNT2;GNS;PRELP;HEXA;ST3GAL4;B4GALT1
prerank,cellular response to glucocorticoid stimulus (GO:0071385),0.40597659435491673,0.9405305245365433,0.527047913446677,0.8642466708575923,1.0,3/18,9.31%,FAM107A;PCK2;ZFP36L2
prerank,"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.3972787325127792,-0.940515114352061,0.5245535714285714,0.8756644788617524,1.0,4/10,19.56%,SH3RF1;RUNX1;NCKAP1L;ZBTB7B
prerank,positive regulation of muscle hypertrophy (GO:0014742),0.42022356314020265,0.9403493336765925,0.5333333333333333,0.8641373242647821,1.0,3/15,9.04%,EDN1;CAMK2D;ROCK1
prerank,extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.3792367140430996,0.9401899165780581,0.5362318840579711,0.8639642975985188,1.0,9/28,19.74%,DAB2IP;CASP8;CRADD;DELE1;CASP8AP2;DAXX;DDX47;BID;SORT1
prerank,response to nutrient levels (GO:0031667),0.41453782367135183,0.9401093021087399,0.5337423312883436,0.8636194120425263,1.0,7/17,27.01%,FAM107A;PRKAA1;RPS6KB1;EIF4G1;MEAK7;RPTOR;ULK1
prerank,positive regulation of macrophage activation (GO:0043032),-0.3406693413808458,-0.9397990918169665,0.5405405405405406,0.8763034291596921,1.0,3/17,3.41%,LBP;WNT5A;THBS1
prerank,amyloid precursor protein catabolic process (GO:0042987),0.41461088431296284,0.9391099211571524,0.5393258426966292,0.8652488933955745,1.0,8/14,24.03%,ADAM17;APH1A;ADAM10;ABCA7;PSEN2;DYRK1A;APH1B;NCSTN
prerank,negative regulation of signal transduction (GO:0009968),0.2864378260107481,0.9385570651180496,0.6116303219106958,0.8659564496532169,1.0,46/249,13.93%,PTPRJ;MMRN2;GATA2;NR4A2;EGFL7;HEY1;DAB2IP;DLL4;HHEX;INPP5K;NTN1;ACVR1;KIF26A;PTPRE;NLK;ASAH2;GATA3;ARRDC1;NFKBIL1;CD47;LRRK2;PTPN12;ARRB1;SNAI2;CTNNBIP1;CACTIN;FBXW7;SIAH2;TAX1BP3;EPN2;CNOT1;NKD2;PTPN1;NXN;HIF1AN;DCC;TMBIM6;HMGXB4;PIK3CB;TSKU;CX3CR1;RPS6KB1;CYP26C1;APLN;NFATC1;GRB14
prerank,fatty acid transport (GO:0015908),-0.35063083144582396,-0.9384048957537492,0.5544041450777202,0.878696381128138,1.0,5/17,15.02%,ACSL1;APOE;SLC27A1;PPARG;MFSD2A
prerank,positive regulation of cellular protein metabolic process (GO:0032270),-0.23908634090803865,-0.9379410195275076,0.6838709677419355,0.8786431188747935,1.0,30/101,19.68%,SAMD4A;OGT;CYFIP2;THBS1;FXR2;NIBAN1;DACT1;PLXNB2;YTHDF1;IST1;ERBB2;PCIF1;LARP4B;DDX3X;BCL3;EIF3D;CPEB3;AGTR1;ATG7;RPS4X;NR1H3;EIF3E;AMER1;STUB1;FBXW11;EZR;LARP6;UPF3B;FGFR4;INHBA
prerank,negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.35984675817023026,-0.9378415043238864,0.5424164524421594,0.8776298473519202,1.0,2/15,4.31%,IGF1;PRKN
prerank,regulation of amyloid-beta formation (GO:1902003),0.35686247887703404,0.937743808158989,0.5458333333333333,0.8672036662282255,1.0,16/34,21.58%,IFNGR1;EFNA1;TMED10;RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;GSK3A;HAP1;RELA;SORL1;EPHA4
prerank,positive regulation of interleukin-17 production (GO:0032740),0.3809557523228852,0.9372287979859417,0.5220700152207002,0.8677435725063899,1.0,1/22,1.72%,NOD2
prerank,regulation of hippo signaling (GO:0035330),0.40871627337757505,0.937170763050809,0.5224358974358975,0.8673734773307101,1.0,7/17,19.90%,WWC2;MARK3;NF2;SCHIP1;MAPK14;SOX11;SHANK2
prerank,autonomic nervous system development (GO:0048483),0.40796171793611624,0.9364006539902847,0.5526717557251909,0.8684929496063994,1.0,4/17,12.09%,KIF26A;GATA3;PHOX2A;SOX10
prerank,negative regulation of gluconeogenesis (GO:0045721),-0.39475891753268283,-0.9358956907234358,0.5306122448979592,0.8813981488635448,1.0,3/11,16.15%,C1QTNF3;SIK1;CLK2
prerank,regulation of TORC1 signaling (GO:1903432),0.35526161995999433,0.9358847729720751,0.528169014084507,0.8691114206137414,1.0,5/33,10.04%,SPAAR;CASTOR1;GPR137B;SMCR8;RRAGD
prerank,cellular response to nitrogen compound (GO:1901699),0.38392376344390966,0.9356747744535222,0.5352323838080959,0.869036372052024,1.0,6/20,20.67%,ATP2B4;NSMCE3;SPIDR;RIOK3;DAXX;BLM
prerank,positive regulation of stress fiber assembly (GO:0051496),0.3492448118006358,0.9350615304865624,0.5512465373961218,0.8697794617363395,1.0,12/44,13.86%,LIMCH1;ARHGEF15;APOA1;EVL;PPM1F;CD47;CCDC88A;RAC1;SORBS3;NF2;ITGB1BP1;ARHGEF10
prerank,generation of neurons (GO:0048699),0.2939075766068001,0.9347216447993424,0.6101511879049676,0.8699517101958534,1.0,32/190,16.89%,RAPGEF2;CEP85L;NR4A2;NEUROG2;ATP2B2;EML1;HEY1;OLIG2;TGFB2;TAFA1;HEY2;MEF2C;MYEF2;PRUNE1;NGRN;NRCAM;RAC1;SPOCK1;NAV1;MARK2;CX3CR1;PIN1;POU3F2;MYT1L;HES3;CTNNB1;HMGB2;FZD3;ASTN1;SNPH;OPHN1;LRP12
prerank,negative regulation of sodium ion transmembrane transport (GO:1902306),0.44996899737466634,0.9346479190527088,0.5371329879101899,0.869585806399973,1.0,3/10,10.96%,CAMK2D;STK39;NEDD4L
prerank,negative regulation of biosynthetic process (GO:0009890),0.4128332831013182,0.9345626393256442,0.5402298850574713,0.8692770838985432,1.0,1/16,0.80%,CEACAM1
prerank,homocysteine metabolic process (GO:0050667),0.4430834144582237,0.9343101142768496,0.5355371900826447,0.8693066367790533,1.0,1/11,2.88%,TST
prerank,"wound healing, spreading of cells (GO:0044319)",0.3881811062224954,0.9342416673195345,0.5295857988165681,0.8689268421082257,1.0,7/24,15.45%,CEACAM1;ACVRL1;ADAM17;MRTFA;ITGA5;LCP1;PDCD10
prerank,regulation of NMDA receptor activity (GO:2000310),-0.2932445854834371,-0.9342195644342296,0.5714285714285714,0.8845446409694723,1.0,5/32,7.04%,DAPK1;GRIA3;ACTN2;DLG4;SLC6A9
prerank,positive regulation of collagen metabolic process (GO:0010714),-0.35793591048867246,-0.9340949193895429,0.5611111111111111,0.8836435012036186,1.0,7/17,20.55%,WNT4;BMP4;RUNX1;CREB3L1;LARP6;TGFB3;RGCC
prerank,mitochondrial translation (GO:0032543),0.30858647026741637,0.9339173172737203,0.586483390607102,0.8691467906839853,1.0,46/104,29.88%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;TUFM;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MTIF2;GATB;MRPL54;MRPS18B;MRPS30;GFM1;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;TSFM;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40;MRPS18A;MRPS5;FASTKD2;IARS2
prerank,regulation of aerobic respiration (GO:1903715),0.4239314809629521,0.9338726851585637,0.5535714285714286,0.8687419100751991,1.0,5/15,22.20%,ATP7A;SLC25A33;CBFA2T3;UQCC2;NOP53
prerank,cellular response to purine-containing compound (GO:0071415),0.4563486991325651,0.9334080939884928,0.5302013422818792,0.8692350957345537,1.0,4/10,23.13%,SLC8A1;TRPM2;P2RY1;RYR2
prerank,fluid transport (GO:0042044),0.43576077748055986,0.9334051584311593,0.5409556313993175,0.8687306343468856,1.0,1/12,2.23%,AQP11
prerank,long-chain fatty acid import into cell (GO:0044539),0.444361298332304,0.9332846922402183,0.5648464163822525,0.8685034005505873,1.0,3/10,14.78%,SLC2A1;RPS6KB1;SLC27A2
prerank,negative regulation of endopeptidase activity (GO:0010951),0.34753903184644824,0.9331338097429398,0.5571808510638298,0.868339457314097,1.0,7/47,11.08%,RECK;SERPINI1;SPOCK2;TIMP3;SPOCK3;GAPDH;SPOCK1
prerank,canonical Wnt signaling pathway (GO:0060070),0.3198404895268788,0.9328797553951362,0.5616438356164384,0.8683908130508026,1.0,13/68,14.82%,FZD6;NR4A2;CAV1;LEF1;GATA3;LRRK2;CDH3;APC;TCF7L1;LRP5;CTNNB1;FZD9;FZD3
prerank,acetyl-CoA metabolic process (GO:0006084),0.40931168406860186,0.9328397236484539,0.5299837925445705,0.8679545417490376,1.0,7/15,23.75%,ACACB;HMGCS1;PPCS;MVD;ACAT1;ACLY;MVK
prerank,adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.29680805848979286,0.9328016517250267,0.5951595159515951,0.867531838783445,1.0,18/152,12.93%,ADGRL4;S1PR1;ADGRE5;GNAQ;ADRB2;GNAL;LGR5;AKAP5;IAPP;GNAI2;MC4R;HTR1B;ADCY4;ADGRB1;GLP1R;HTR1F;WASF2;GPR26
prerank,atrial cardiac muscle cell action potential (GO:0086014),0.4319753394604558,0.9325100565677361,0.5416012558869702,0.8676494193091904,1.0,1/13,0.28%,KCNQ1
prerank,"regulation of DNA-templated transcription, elongation (GO:0032784)",-0.31983676429583574,-0.932216635782644,0.5538922155688623,0.8872434111589935,1.0,7/25,15.60%,SCAF8;LDB1;CCNK;ELL;THOC1;HMGN1;HTATSF1
prerank,negative regulation of cell communication (GO:0010648),0.38951967638167734,0.9321825249003779,0.5382308845577212,0.8678415585956962,1.0,6/21,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,cellular response to nutrient levels (GO:0031669),0.3284060806158027,0.9319122454904696,0.5627425614489003,0.8679280116439135,1.0,8/62,10.04%,BMPR2;FOXO1;FAM107A;STK24;LRRK2;PRKAA1;RIPOR1;RRAGD
prerank,anterior/posterior pattern specification (GO:0009952),0.33609769731919964,0.9317984632003492,0.5603674540682415,0.8676478320822784,1.0,7/53,5.38%,BMPR2;TBX1;HEY1;HHEX;HEY2;PCSK5;SMAD2
prerank,negative regulation of protein phosphorylation (GO:0001933),0.297473529751771,0.9316005634664454,0.578021978021978,0.8675614947781135,1.0,18/150,7.53%,ENG;SMAD6;CEACAM1;CNKSR3;SMAD7;OCLN;GNAQ;DAB2IP;CAV1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;ZC3H12A;LRRK2;HSPB1;PRR5L
prerank,protein-containing complex assembly (GO:0065003),0.28753096551255086,0.9313825779512069,0.6375,0.867535585519733,1.0,48/259,16.22%,CD2AP;SKAP2;MAGI1;FAS;SLC2A1;OCLN;AIM2;CASP8;ANO6;CARD10;LEF1;CSNK1D;TRAF1;TMED10;MCFD2;CUL3;CD247;P2RX7;ZC3H12A;LRRK2;IL1RAP;GRIA1;APC;TCF7L1;ADAM10;DHX9;RBX1;AP2M1;PDZD11;RANBP9;TRAPPC2;TRAPPC6B;ITGB1BP1;SEC24B;TAPBP;CAPG;NOL3;NSF;PPIH;CTNNB1;CSNK2B;TRAPPC5;KPNA3;CLDN14;TRRAP;SAMM50;VIL1;FERMT3
prerank,regulation of humoral immune response (GO:0002920),0.3415077050382982,0.9312233978284351,0.5663956639566395,0.8673838023310331,1.0,7/44,13.34%,GATA6;FCGR2B;SUSD4;CR1L;CLU;CFB;CR2
prerank,high-density lipoprotein particle assembly (GO:0034380),-0.39515426599552667,-0.9306085582602682,0.5566502463054187,0.8901446303048618,1.0,3/10,8.66%,APOE;ABCA1;PRKACA
prerank,positive regulation of protein export from nucleus (GO:0046827),-0.36227816275056335,-0.9301419149632492,0.581267217630854,0.890056326226515,1.0,3/15,12.70%,TCF7L2;CAMK1;BAG3
prerank,regulation of vascular endothelial growth factor production (GO:0010574),-0.3122635982054033,-0.9295542783937553,0.5344262295081967,0.8902874375393209,1.0,4/26,5.15%,SULF1;CCBE1;SULF2;RORA
prerank,regulation of muscle cell differentiation (GO:0051147),0.37088014795284546,0.9294403531129823,0.5492753623188406,0.8706059967644901,1.0,11/31,18.66%,HDAC9;MEF2C;SPAG9;CTNNA1;CDH15;TCF3;CDH2;CTNNA2;CTNNB1;MAPK14;MEF2A
prerank,regulation of axon regeneration (GO:0048679),-0.3786783067910481,-0.9284606148027512,0.5552631578947368,0.8918889035104249,1.0,1/12,0.29%,PTN
prerank,positive regulation of inflammatory response (GO:0050729),0.3155681459368305,0.9281937318356912,0.5737898465171193,0.8726630999733251,1.0,14/86,12.95%,APP;TLR3;KARS1;HYAL2;PDCD4;CD47;VAMP8;CEBPA;NMI;VAMP7;DHX9;NFKBIA;DDT;ABCC1
prerank,DNA synthesis involved in DNA repair (GO:0000731),0.3469979237047076,0.9280777137080469,0.553763440860215,0.8724218573858099,1.0,10/42,15.87%,WRNIP1;USP43;POLK;UBA52;RPS27A;TRIM25;POLA1;RFC2;CDKN2D;SPRTN
prerank,regulation of necroptotic process (GO:0060544),0.38736453863510134,0.9277831821872312,0.5552193645990923,0.8725530112091087,1.0,3/23,2.47%,ARHGEF2;CASP8;SPATA2
prerank,regulation of signal transduction by p53 class mediator (GO:1901796),0.2936275637195625,0.9276545878615385,0.6111111111111112,0.8723244901415146,1.0,35/148,20.67%,NUAK1;PLK3;BOP1;PPP1R13B;RBBP8;ING2;TAF9B;PAK1IP1;PRKAA1;PPP2R5C;SGK1;RPL37;CHD5;BRIP1;BRCA1;PIN1;RAD1;ATM;RPS15;CSNK2B;RFC2;TAF11;RAD9B;RICTOR;DAXX;MAPK14;ATRIP;TAF3;MAPKAPK5;BARD1;HUS1;RBBP4;RNF34;SMYD2;BLM
prerank,ERBB signaling pathway (GO:0038127),0.3254297399373654,0.927074451029879,0.5791505791505791,0.8730469427760861,1.0,14/64,15.85%,PTPRR;RPS6KA5;PIK3C2A;CBL;IQGAP1;ADAM17;MAPK1;PTPN12;PTK2;PLCG1;MATK;SOS1;KIF16B;VIL1
prerank,negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.4251390136659568,0.9269943337379917,0.5652866242038217,0.8727041931785108,1.0,5/13,16.50%,PTPN1;PPP1R15B;ABCA7;RACK1;NCK1
prerank,snRNA metabolic process (GO:0016073),0.41091760382993275,0.9269099901094147,0.5504885993485342,0.8723724318187527,1.0,4/17,14.07%,RBM7;INTS11;INTS12;INTS5
prerank,protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.37272142184628776,0.926745719327474,0.5578635014836796,0.8722256915682446,1.0,8/25,21.01%,OMA1;RNF185;CUL3;BAG6;UGGT1;NGLY1;RNF5;POMT2
prerank,modification-dependent protein catabolic process (GO:0019941),0.2899084606927563,0.9264818703486024,0.6274298056155507,0.8722554232345928,1.0,52/193,21.13%,CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PTTG1;ARRB1;UBE4A;UBA52;FEM1C;RPS27A;NDFIP2;RNF128;RBX1;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMD14;DTX3L;SMURF1;KCTD10;KEAP1;UBE2E1;CDC27;UBE3B;UBQLN2;KLHL25;ANAPC7;RNF150;FBXO8;UBQLN4;FBXO10;PSMD9;FEM1A;ANAPC4;RNF166;FBXO45;RNF5;RNF34;RNF11;KCTD21;UBA1
prerank,extracellular transport (GO:0006858),0.4366031605803391,0.9260832827879582,0.540495867768595,0.8725793738457356,1.0,3/12,14.14%,ADCY10;ARRDC1;SPA17
prerank,amyloid precursor protein metabolic process (GO:0042982),0.3928392810228776,0.9256377478352946,0.549079754601227,0.8730221086811146,1.0,9/18,20.86%,ADAM17;APH1A;ADAM10;ACHE;LDLRAP1;TMCC2;PSEN2;NSG1;APH1B
prerank,regulation of complement activation (GO:0030449),-0.2747223942978034,-0.9256066585964111,0.5985401459854015,0.8979689142891355,1.0,15/40,27.37%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,peripheral nervous system development (GO:0007422),0.3908231500179442,0.9252792150147323,0.5620328849028401,0.8732613493802598,1.0,6/23,14.59%,SERPINI1;NFASC;ASIC2;ADGRB1;SOX10;GFRA3
prerank,alpha-amino acid metabolic process (GO:1901605),0.3387293868522141,0.9250983733898087,0.5563002680965148,0.8731244866792032,1.0,6/45,6.07%,HNF4A;GLS2;GLS;ATP7A;GLUD1;ASS1
prerank,L-amino acid transport (GO:0015807),-0.29528797574538246,-0.9249969175014678,0.5806451612903226,0.8983084018571889,1.0,3/28,3.00%,SLC1A3;SLC7A2;SLC25A13
prerank,chromosome organization (GO:0051276),-0.23468428604303754,-0.9239386946665833,0.664179104477612,0.8997645347873775,1.0,33/99,24.12%,TCF7L2;LDB1;NUCKS1;TOP2B;MTF2;DDB2;EHMT1;SETD7;DOT1L;CUL4B;CUL4A;NUP155;HDAC1;HMGN1;PADI2;AXIN2;COPS7B;MSH6;HMGA2;SAFB;SUV39H1;LATS1;RFWD3;COPS6;SOX2;GPS1;MTHFR;ABL1;HDAC8;PARP1;HDAC10;TOP2A;BRWD1
prerank,metanephros development (GO:0001656),0.3645321259797341,0.9235827516346616,0.5393759286775631,0.875775847135358,1.0,1/26,0.23%,SOX17
prerank,positive regulation of cell morphogenesis involved in differentiation (GO:0010770),-0.2652307714598599,-0.9235403435795267,0.5936254980079682,0.8995104168915427,1.0,16/48,21.33%,DOCK5;CUX1;RREB1;OBSL1;FLNA;MDK;TRIOBP;S100A10;PTPRD;FBXW8;SS18L2;TESK1;P4HB;CUX2;CIB1;ABL1
prerank,negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),0.3232230281460871,0.9232013291992971,0.5858064516129032,0.876079259193893,1.0,22/65,21.23%,PSMD13;PSMD4;PSMA5;RBX1;PSMB10;PSMB8;PSMD14;VPS4A;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;PSMD5;PSMD9;PSMB6;PSMB2;USP47
prerank,regulation of erythrocyte differentiation (GO:0045646),0.35491134803934465,0.9230260274265019,0.5592991913746631,0.8759427624766992,1.0,10/35,18.10%,TAL1;STAT1;HSPA1B;BRD1;HIF1A;ACVR2A;HMGB2;MAPK14;ETS1;FAM210B
prerank,positive regulation of viral transcription (GO:0050434),0.38116730279658295,0.9230077504230748,0.5742128935532234,0.8754794307835555,1.0,9/25,23.64%,POLR2G;DHX9;POLR2D;NELFB;POLR2I;NELFA;POLR2C;POLR2B;POLR2J
prerank,response to glucocorticoid (GO:0051384),-0.3067467530771252,-0.9225418861813617,0.5754716981132075,0.9008229826306418,1.0,8/26,19.02%,SLIT2;ANXA1;ADAM9;REST;UBE2L3;GOT1;HNRNPU;ZFP36
prerank,regulation of extracellular matrix organization (GO:1903053),0.40920276682642065,0.9222513377240008,0.5405405405405406,0.8766529916153138,1.0,2/15,1.60%,TIE1;NOTCH1
prerank,positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.29129156606597123,0.9221759691818304,0.6088397790055249,0.8763083946142309,1.0,21/158,11.13%,TRIM14;NOD1;NOD2;PRKD1;CASP8;F2RL1;LGALS9;FKBP1A;TIRAP;ATP2C1;TRIM6;TNFSF10;PLEKHG5;JMJD8;GAPDH;NDFIP2;TRIM25;LURAP1;CASP1;TAB2;MAP3K3
prerank,B cell mediated immunity (GO:0019724),0.44811649518274876,0.9219970112895678,0.5672413793103448,0.8761674088241223,1.0,1/10,4.30%,FCGR2B
prerank,ribonucleoprotein complex assembly (GO:0022618),-0.2172770321715962,-0.9219578812830855,0.6865671641791045,0.9010475729286069,1.0,38/132,24.09%,CELF2;SRSF5;SCAF11;DICER1;NUDT21;NCBP1;TRAF7;RPL24;COIL;DENR;SRSF1;EIF2S2;GEMIN5;SMN1;EIF2D;PUF60;SRSF6;DDX1;SNRPF;RRP7A;XRCC5;RPLP0;RAMAC;SNUPN;SNRPD3;MRPS11;XAB2;SF1;RRS1;LUC7L;SF3B1;SRPK2;SF3A2;GEMIN7;CELF1;NAF1;CELF5;WDR77
prerank,myeloid dendritic cell activation (GO:0001773),0.4232861508028891,0.9211751942590422,0.5541195476575121,0.8773548878634596,1.0,4/12,22.63%,HMGB1;DOCK2;PYCARD;CAMK4
prerank,regulation of defense response to virus (GO:0050688),-0.35821759694315797,-0.9209670331127301,0.5761421319796954,0.9023746965347191,1.0,8/14,34.10%,ZMPSTE24;PPM1B;TNFAIP3;ELMOD2;C1QBP;TRAF3IP1;RNF26;IFNLR1
prerank,cell cycle checkpoint signaling (GO:0000075),-0.38142428193001565,-0.9205666518219868,0.5600961538461539,0.9021319268890784,1.0,7/12,28.66%,NABP1;ZWILCH;ZW10;CHFR;BUB1B;ZWINT;NABP2
prerank,regulation of spindle organization (GO:0090224),-0.33440209914949676,-0.9203413003941873,0.5769230769230769,0.9014422115642546,1.0,8/18,29.85%,GNAI1;GPSM2;RNF4;PARP3;BORA;TPX2;FSD1;NUP62
prerank,chemical homeostasis (GO:0048878),-0.25120976033879333,-0.9201375166260123,0.5741626794258373,0.9007124346362665,1.0,15/61,16.82%,ZBTB20;SLC4A10;RBP1;WNK1;WNK4;TLCD2;IRS2;NR1D2;SLC4A2;PPARG;DDX3X;TENT4B;SLC4A3;NR1H3;ABHD8
prerank,dendritic cell differentiation (GO:0097028),0.38051489747046296,0.9200968113883069,0.5601217656012176,0.8791231107606811,1.0,2/22,2.67%,F2RL1;LGALS9
prerank,receptor catabolic process (GO:0032801),0.3809260530427645,0.9199605080132935,0.5769805680119582,0.878916626042067,1.0,15/24,29.94%,AP2B1;AP2M1;ZNRF3;SMURF1;VLDLR;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;GPRASP1;AP2A1;CLTC;SH3GLB1;AP2S1
prerank,regulation of mitochondrial fission (GO:0090140),-0.3143903568575119,-0.9197885228920816,0.5510204081632653,0.9003742601375575,1.0,4/24,8.53%,DCN;PRKN;DDHD1;MYO19
prerank,very long-chain fatty acid biosynthetic process (GO:0042761),0.4239178018718848,0.9194231419619037,0.5786061588330632,0.8795394276655757,1.0,6/13,19.38%,ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;HACD2
prerank,phosphatidylethanolamine biosynthetic process (GO:0006646),-0.3557404103195218,-0.9193711548628851,0.5570652173913043,0.9001450902265982,1.0,8/14,30.68%,SLC27A1;CHKB;ETNK2;SELENOI;CHKA;LPIN3;LPIN1;ETNK1
prerank,organelle organization (GO:0006996),0.2772639053380699,0.9193603722780096,0.6811740890688259,0.879154183572855,1.0,67/388,15.51%,NOS3;FGD5;SYNE1;IRAG2;TRAPPC8;CAV1;PRKD1;ATL2;CAV2;MAST4;NEDD9;DIAPH1;SIPA1L3;DOP1B;PACSIN2;SH3KBP1;ARAP3;STX7;DST;TTC29;ATP7A;RAB34;SSBP1;CSNK1D;FMNL3;FAM161A;FGD6;FNBP1L;TMED10;ATL1;PACSIN1;SIRT4;CHCHD2;SLC25A33;CLASP1;MAST1;ALAS1;KLHL20;LRRK2;MCOLN1;VPS13D;CHMP1B;HPS3;CLASP2;RANBP9;POLG2;NUMA1;SNX11;CHGA;TMED9;ATP8B1;VPS4A;TTC17;CHMP3;CYP26C1;USP6NL;RHOT2;PHIP;CEP55;CFL1;TFB2M;TMED4;VAPA;ANK1;CHMP2B;CHMP7;PTCD2
prerank,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),0.30666728782762365,0.9193528163036769,0.6007025761124122,0.8786698704559222,1.0,10/86,6.32%,ENG;BMPR2;ACVRL1;NOTCH1;RBPMS;TGFB2;ACVR1;ING2;SMAD2;ADAM17
prerank,regulation of signal transduction (GO:0009966),0.28957224516137453,0.9192157394542967,0.6461038961038961,0.8784391106732088,1.0,35/190,14.23%,RGS3;PLCB1;FYN;MFNG;LIFR;CASTOR1;KAZALD1;PRKD1;APP;CRK;LRIT3;ACVR1;KIF26A;GIT2;WWTR1;TMEM204;TSPAN12;IRAK2;GATA3;SIK2;LRRK2;IGFBP7;PLSCR1;IGFBP4;TCF7L1;PRNP;GNG4;PTPN1;KCTD8;CLU;CBFB;ITGB1BP1;WDR11;RGS12;ITGA3
prerank,negative regulation of hemostasis (GO:1900047),0.4307747497796629,0.9189791125448254,0.5682967959527825,0.8784329858259603,1.0,3/12,8.44%,EDN1;CD34;PROC
prerank,response to ketone (GO:1901654),-0.30956931883716793,-0.9180873459465148,0.5740740740740741,0.9020747742824912,1.0,4/24,7.08%,TGFBR3;SLIT2;THBS1;CATSPER2
prerank,positive regulation of sprouting angiogenesis (GO:1903672),-0.3504275183507551,-0.9177053049720509,0.5815789473684211,0.9017563211644198,1.0,4/15,8.98%,BMPER;FGF1;FGF2;VEGFA
prerank,receptor recycling (GO:0001881),0.4351857099888198,0.9175609165543596,0.5632582322357019,0.8809034028903119,1.0,5/10,20.71%,LMTK2;PHETA1;NSG1;REP15;SORL1
prerank,regulation of B cell apoptotic process (GO:0002902),-0.3687697525819992,-0.9173495021139402,0.5788177339901478,0.9013849471241634,1.0,3/12,9.57%,IRS2;BCL6;FNIP1
prerank,regulation of RIG-I signaling pathway (GO:0039535),0.3935582360293499,0.9171099278267714,0.5560747663551402,0.8813783559085899,1.0,7/18,24.23%,PUM2;RNF125;SEC14L1;DHX58;ANKRD17;NOP53;OASL
prerank,male meiosis I (GO:0007141),0.4038614813056047,0.9170573262005729,0.58887171561051,0.8809782952272717,1.0,4/16,18.63%,DDX4;ING2;SYCP3;TDRD9
prerank,regulation of histone H3-K9 acetylation (GO:2000615),-0.3890721667295245,-0.9169569838061039,0.5603864734299517,0.9010790803132159,1.0,5/10,27.39%,SMARCB1;CAMK1;PIH1D1;SPHK2;CHEK1
prerank,protein depolymerization (GO:0051261),-0.30553584332583805,-0.916943299474977,0.5927051671732523,0.8998592179919511,1.0,6/27,9.46%,MICAL3;GSN;MICAL2;NCKAP5;CKAP5;STMN4
prerank,negative regulation of viral life cycle (GO:1903901),0.4087266607093021,0.9169097988136636,0.5542949756888168,0.8807555740045961,1.0,2/15,4.67%,LY6E;TRIM11
prerank,response to reactive oxygen species (GO:0000302),-0.2626425526111532,-0.9167331550041635,0.6205357142857143,0.8991383659737014,1.0,14/54,15.35%,EGFR;PDGFRA;APOD;PTPRK;APOE;TPM1;CAT;ADAM9;HYAL1;PRDX3;CHUK;FER;MPV17;PDK2
prerank,activation of cysteine-type endopeptidase activity (GO:0097202),0.41823474049225934,0.9164521950599435,0.5555555555555556,0.8811886446711452,1.0,4/13,17.26%,CASP8;CIDEB;TBC1D10A;GRIN2A
prerank,positive regulation of chondrocyte differentiation (GO:0032332),0.4447558748655856,0.9162548651091995,0.5502555366269165,0.8810778583038663,1.0,3/10,12.21%,ACVRL1;ZBTB16;SOX6
prerank,response to steroid hormone (GO:0048545),0.36172401913515084,0.9161389883419805,0.5801749271137027,0.8808108829327415,1.0,6/31,8.67%,ATP1A1;ATP1A3;CAV1;TGFB2;PAQR8;UBE3A
prerank,mRNA 3'-end processing (GO:0031124),-0.2355775175924401,-0.9158934963542272,0.7093596059113301,0.8999872968714373,1.0,33/78,26.16%,SRSF5;SCAF8;NUDT21;NCBP1;SRRM1;SRSF1;PAF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;CSTF2T;PCF11;MAGOH;AHCYL1;U2AF2;MAGOHB;PABPC1;LSM11;UPF3B;SRSF3;SLBP;PAPOLB;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7;GRSF1
prerank,regulation of transposition (GO:0010528),0.4140684824725932,0.9158761771926848,0.5514950166112956,0.8808578222067005,1.0,1/13,3.84%,DDX4
prerank,negative regulation of leukocyte activation (GO:0002695),0.4194084460402291,0.9157641081727764,0.5566343042071198,0.8805941683775647,1.0,4/15,8.02%,FCGR2B;MILR1;ZC3H12A;CD200
prerank,negative regulation of protein modification by small protein conjugation or removal (GO:1903321),0.32877620227109783,0.9157180116278184,0.5911392405063292,0.8801892158999282,1.0,13/54,20.23%,SMAD7;CAV1;HSPA1B;ARRB1;VPS28;PRKCG;ADGRB1;NXN;CTNNB1;SPOPL;CRY1;COPS9;DNAJA1
prerank,regulation of T cell proliferation (GO:0042129),0.3166878988501889,0.9156321524636132,0.5707070707070707,0.8798465309875846,1.0,4/61,7.82%,VCAM1;TNFRSF1B;ARG1;SLC7A1
prerank,glucose metabolic process (GO:0006006),-0.2527292643094856,-0.9154650557356112,0.6239669421487604,0.8998560356083061,1.0,18/58,21.23%,APOD;SLC39A14;SLC25A13;RBP4;IRS2;ENO2;ADPGK;PGM1;MDH2;SLC25A12;GOT1;AKR1A1;PFKFB1;GDPGP1;CRTC2;G6PC3;TPI1;ENO3
prerank,endomembrane system organization (GO:0010256),0.28927844219893395,0.9154477552972962,0.628696604600219,0.8797143728418303,1.0,41/178,20.00%,SYNE1;ALS2CL;DYSF;TRAPPC8;PRKD1;ATL2;CAV2;DOP1B;CSNK1D;TMED10;SNX10;ATL1;CLASP1;LRRK2;SUN3;HOOK1;A4GALT;CLASP2;MYOF;EXOC8;TMED9;REEP3;ATP8B1;VPS4A;USP6NL;TMED4;VAPA;CHMP2B;ANK3;PLEKHM2;SRGN;SPTBN1;GOLPH3L;PHETA1;GOLPH3;TOR1AIP2;HOOK2;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,protein acylation (GO:0043543),0.34197234757214345,0.9150328888946664,0.5537190082644629,0.8800254776391877,1.0,3/38,2.79%,FOXO1;ZDHHC22;NAT9
prerank,protein prenylation (GO:0018342),0.4367486538403277,0.914625013714119,0.5804195804195804,0.8803402649946683,1.0,1/10,6.42%,PGGT1B
prerank,tRNA transport (GO:0051031),0.35568939324858384,0.9145320092800974,0.5827633378932968,0.8800305470321572,1.0,10/35,15.93%,TOMM20L;NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;YBX1;NUP205
prerank,regulation of inclusion body assembly (GO:0090083),0.4267314043501832,0.9142653235177477,0.5737179487179487,0.8800368213167438,1.0,4/11,17.60%,HSPA1B;SNCAIP;DNAJB6;DNAJB8
prerank,negative regulation of osteoclast differentiation (GO:0045671),0.39277507855082244,0.9141828342729746,0.5574018126888217,0.8796948148648223,1.0,3/18,9.67%,GPR137B;TLR3;FBXW7
prerank,negative regulation of organelle assembly (GO:1902116),-0.28367786330680705,-0.9141716664900101,0.6161971830985915,0.901875577818959,1.0,10/35,12.89%,NUPR1;KAT2B;RBM14;ODF2L;MDM1;FEZ2;CEP97;TMEM39A;CCP110;CDK10
prerank,renal system development (GO:0072001),0.3283735975284446,0.9136280901039742,0.5834428383705651,0.8803352886006304,1.0,7/52,7.31%,SOX17;ACE;TGFB2;PCSK5;HYAL2;GATA3;STAT1
prerank,cellular response to hydroxyurea (GO:0072711),0.4350476396909909,0.9135311716826862,0.575809199318569,0.880046976376845,1.0,4/10,25.13%,NSMCE3;SPIDR;BLM;RTF2
prerank,regulation of actin nucleation (GO:0051125),-0.373362791402509,-0.9133601385152186,0.5604113110539846,0.9026932611360444,1.0,5/12,21.74%,GSN;ARF1;ARPIN;PICK1;ARFIP1
prerank,regulation of smooth muscle contraction (GO:0006940),0.3842504889137644,0.9133252401174916,0.585949177877429,0.8799509341072241,1.0,5/20,15.88%,CAV1;ADRB2;CHRM3;SETD3;NMU
prerank,tetrahydrofolate metabolic process (GO:0046653),-0.39664842068456,-0.9129113275270093,0.5710955710955711,0.9025668059375512,1.0,7/10,34.15%,MTHFD1;MTHFD2L;TYMS;MTHFR;DHFR;SHMT2;SHMT1
prerank,regulation of cellular protein localization (GO:1903827),-0.26139450111693535,-0.9128402061702089,0.6513409961685823,0.9014814981301638,1.0,3/45,2.96%,GPC6;GPC3;PRKAA2
prerank,alpha-linolenic acid metabolic process (GO:0036109),-0.36653954299375263,-0.9127204448179921,0.5879518072289157,0.9005318348996784,1.0,4/12,18.63%,ACSL1;SCP2;FADS2;ELOVL1
prerank,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.38111025954472477,0.9125026070131781,0.5756630265210608,0.8806288298413708,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.38111025954472477,0.9125026070131781,0.5756630265210608,0.8806288298413708,1.0,4/23,7.71%,CASP8;PPP1R13B;BBC3;NMT1
prerank,mitochondrial translational termination (GO:0070126),0.3061607712389438,0.9122190208922278,0.574793875147232,0.8807104696328459,1.0,37/88,28.55%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),0.39237865238403885,0.9116988211801913,0.5763473053892215,0.8812748027523406,1.0,7/20,20.25%,FAS;CASP2;BCL2L1;DCC;GSK3A;MCL1;GSK3B
prerank,phosphatidylserine metabolic process (GO:0006658),0.352607350583138,0.9116062474999895,0.5682451253481894,0.8809760492562957,1.0,8/32,18.28%,MBOAT2;LPCAT4;PLSCR1;LPCAT3;PTDSS1;SERINC5;PLA2G12A;PLAAT3
prerank,mitotic G1 DNA damage checkpoint signaling (GO:0031571),0.3271779938894091,0.9113394315914345,0.6164383561643836,0.8810023722550399,1.0,9/63,13.96%,PLK3;BTG2;CASP2;CDC25C;CRADD;CNOT6L;CNOT1;E2F7;ATM
prerank,establishment of protein localization to plasma membrane (GO:0061951),-0.2755820266064767,-0.9110779913232864,0.6223021582733813,0.9034031212999072,1.0,10/36,16.98%,AFDN;VAMP5;GGA2;GCC2;OPTN;KIF13A;GORASP2;GOLGA4;GGA1;NECTIN3
prerank,tRNA aminoacylation for protein translation (GO:0006418),0.3329387605456692,0.9107658775817237,0.576,0.8816875075806518,1.0,11/42,19.48%,GARS1;VARS1;VARS2;KARS1;FARSB;WARS1;FARS2;TARS3;RARS1;EEF1E1;DARS1
prerank,positive regulation of acute inflammatory response (GO:0002675),0.412518048841735,0.9106654402207756,0.5728314238952537,0.8814016128494142,1.0,14/14,58.78%,PTGER3;OSMR;PTGS2;C2CD4A;C2CD4B;IL1B;FFAR2;OSM;IL6;ADAM8;CREB3L3;IL6ST;TNF;PARK7
prerank,negative regulation by host of viral transcription (GO:0043922),0.4279679925049294,0.9105818546908475,0.5694915254237288,0.8810720148891502,1.0,4/12,13.02%,INPP5K;JUN;CCL4;PSMC3
prerank,response to interferon-alpha (GO:0035455),0.39625267785218754,0.9101908456237007,0.5718849840255591,0.8813776587905872,1.0,4/16,8.99%,IFNAR1;GATA3;KLHL20;ADAR
prerank,response to ATP (GO:0033198),-0.33509136432074627,-0.910004066264025,0.5842696629213483,0.9048323369822716,1.0,4/18,8.20%,TRPC3;ABCC9;P2RX4;TAF1
prerank,regulation of posttranscriptional gene silencing (GO:0060147),0.3324263753862934,0.9099994010256853,0.5940337224383917,0.8807880989772157,1.0,20/50,25.32%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,regulation of gene silencing by RNA (GO:0060966),0.3324263753862934,0.9099994010256853,0.5940337224383917,0.8807880989772157,1.0,20/50,25.32%,PUM2;POLR2G;NUP54;POLR2D;NUP35;RANBP2;NUP153;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR
prerank,receptor internalization (GO:0031623),0.33902917086940615,0.9099347820321122,0.572987721691678,0.8804236482227689,1.0,7/44,14.36%,CEACAM1;CAV1;DNM3;ARRB1;AP2M1;LDLRAP1;CD9
prerank,positive regulation of cholesterol transport (GO:0032376),0.3612735043231058,0.908649922498105,0.5669064748201439,0.8825437719347977,1.0,8/27,16.84%,CAV1;APOA1;PLTP;ABCB4;LPCAT3;NFKBIA;ABCA7;EEPD1
prerank,regulation of actin polymerization or depolymerization (GO:0008064),0.36194633611760474,0.9085581837607736,0.5652818991097923,0.8822368671187532,1.0,3/28,7.47%,FCHSD2;ESAM;WDR1
prerank,negative regulation of type I interferon production (GO:0032480),0.3457802229854345,0.9083579990235812,0.5835616438356165,0.8821689335841049,1.0,10/40,16.66%,IFIH1;UBA7;RNF125;NLRC5;ACOD1;CACTIN;TRIM25;PIN1;HAVCR2;PYCARD
prerank,stem cell differentiation (GO:0048863),0.3388477657224229,0.9082753874822144,0.6,0.8818455080439587,1.0,4/39,5.32%,ACE;FOXO4;TGFB2;MEF2C
prerank,regulation of primary metabolic process (GO:0080090),0.29426739986757133,0.9082142689831354,0.6235827664399093,0.8814894507453233,1.0,46/126,24.17%,AZIN1;FASN;ZFP69;HNF4A;PLPP1;PSMD13;ADIPOR1;PSMD4;NR1D1;PSMA5;PSMB10;ACACB;PSMB8;PSMD14;LACTB;HELZ2;HMGCS1;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;PSMC5;ABCA7;PSMB9;PSMC6;PSMA4;MVD;SIN3A;NCOA6;PSMD5;PSMD9;PSMB6;PSMB2;DHCR7;SREBF2;GGPS1;OAZ2;NCOR2;NQO1;EDF1;IDI1;CERS2;MVK;NCOA2;PSMD2
prerank,prostaglandin metabolic process (GO:0006693),0.37481961581789736,0.9081489783629026,0.5874635568513119,0.8811281072784666,1.0,3/26,10.15%,EDN1;ACOX1;PTGES3
prerank,histone H3-K36 demethylation (GO:0070544),-0.38418708264547824,-0.9081149303521197,0.5510688836104513,0.9083029966151698,1.0,5/10,20.14%,KDM7A;KDM4A;RIOX2;KDM8;PHF8
prerank,negative regulation of translation (GO:0017148),0.3076139004311287,0.9081116895154855,0.5928994082840237,0.8807194369762017,1.0,3/87,2.84%,NANOS1;NANOS3;BTG2
prerank,regulation of release of cytochrome c from mitochondria (GO:0090199),0.3452610018450454,0.9080256852367808,0.5848787446504993,0.8803964124042691,1.0,14/40,19.44%,HRK;TNFSF10;BBC3;CIDEB;BCL2L1;CLU;NOL3;BNIP3;PYCARD;PLAUR;BMF;BID;PLSCR3;PPIF
prerank,positive regulation of protein metabolic process (GO:0051247),0.29572308244767337,0.9076242151441053,0.6124567474048442,0.8807094625989452,1.0,15/110,12.34%,KLF2;PAEP;FOXO1;DAB2IP;APP;KLF4;WWP1;ASB5;APC;VPS28;NFKBIA;RANBP9;NEDD4L;CLU;SMURF1
prerank,pyruvate metabolic process (GO:0006090),0.3251958461968426,0.9073827062653204,0.5801324503311258,0.8807141275988323,1.0,11/52,16.13%,GPI;PGK1;PCK2;BSG;GAPDH;LDHC;DLD;ME3;LDHAL6B;VDAC1;PFKM
prerank,positive regulation of cellular biosynthetic process (GO:0031328),0.2916945415609558,0.9073533771807776,0.6471226927252985,0.8802771208467366,1.0,39/166,17.47%,EDN1;PDGFB;KLF2;INSR;VIM;APOA1;NOS1AP;KLF4;ATP7A;PAOX;BCAR3;ASS1;PLD1;ELAVL1;CDH3;PASK;NR1D1;STN1;EGR1;DHX9;METTL5;NPM1;EEF2;CLU;PRKD2;ARPP19;RPS6KB1;FXR1;METTL14;HIF1A;CNEP1R1;ELOVL5;EIF6;KAT7;POLDIP3;NSUN5;SCARB1;PTPN2;FABP3
prerank,regulation of supramolecular fiber organization (GO:1902903),-0.3144224224534859,-0.9073297038578939,0.5605095541401274,0.9090856524232783,1.0,4/22,8.48%,AEBP1;APOE;MAP1A;EFEMP2
prerank,regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),-0.2774734874778471,-0.9072610107068337,0.6195286195286195,0.9080121942671233,1.0,8/33,17.12%,DDX5;UBA5;RUNX1;UFSP2;KLK2;HDAC6;LATS1;AR
prerank,negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4016095517622125,0.9070772116174992,0.5780998389694042,0.88034095380533,1.0,3/17,6.31%,PRKG1;MEF2C;PDCD4
prerank,tRNA wobble uridine modification (GO:0002098),0.41654980423386556,0.9068497731543961,0.5707395498392283,0.880320898225684,1.0,6/14,20.60%,ELP4;ALKBH8;ELP3;DPH3;TRMU;KTI12
prerank,ERK1 and ERK2 cascade (GO:0070371),0.3912064765453618,0.9067451244543456,0.5808936825885979,0.8800342713488404,1.0,5/21,9.31%,LGALS9;APOA1;KARS1;MAPK1;ZFP36L2
prerank,regulation of fat cell differentiation (GO:0045598),0.31329900755063816,0.9065882482505455,0.6185185185185185,0.8798548817580918,1.0,11/74,9.31%,GATA2;FOXO1;TRIO;WWTR1;GATA3;ZBTB16;ZC3H12A;CMKLR1;SYAP1;NR1D1;ZFP36L2
prerank,negative regulation of reactive oxygen species biosynthetic process (GO:1903427),0.4298684446525295,0.9059967280077509,0.5962837837837838,0.8805656082121451,1.0,1/11,0.92%,FYN
prerank,protein localization to chromatin (GO:0071168),0.39129425645061783,0.9059901123281106,0.5694227769110765,0.8800872005016471,1.0,6/18,19.96%,RAD21;TASOR;SGF29;CHMP7;ESR1;PPHLN1
prerank,regulation of cellular protein catabolic process (GO:1903362),0.3978981737618903,0.9058542595666516,0.5838607594936709,0.8798623360830873,1.0,4/18,14.15%,DAB2IP;MSN;VPS35;NELL1
prerank,regulation of protein kinase activity (GO:0045859),0.29732955964210395,0.9054636863221034,0.6283084004602992,0.8801705539630932,1.0,14/106,11.10%,RAPGEF2;CEACAM1;GNAQ;IQGAP1;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1;MAPRE3;PTK2;TAB2;MMD
prerank,regulation of peptidyl-lysine acetylation (GO:2000756),-0.38536366031342484,-0.9052123405192534,0.5757575757575758,0.9117170387109206,1.0,3/10,9.96%,PRKAA2;FLCN;KLF15
prerank,establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.3565266627948318,0.9049864808606819,0.5821529745042493,0.8806741806896411,1.0,11/31,21.37%,MSN;SYNE4;WDR1;PDZD11;MARK2;ANK1;OPHN1;LRRC7;ERBIN;MTCL1;CRB1
prerank,peptidyl-amino acid modification (GO:0018193),0.44980381584648266,0.9049644652829356,0.5962199312714777,0.8802300418547417,1.0,3/10,12.51%,APOA1;ATP7A;METAP2
prerank,phospholipid homeostasis (GO:0055091),0.4394791424323785,0.9049433492912756,0.5869565217391305,0.8797807617886773,1.0,2/11,3.48%,HNF4A;APOA1
prerank,axon development (GO:0061564),0.31322954051881396,0.9045250731081947,0.6296743063932448,0.8801474746155729,1.0,17/78,12.57%,KLF7;APP;VASH2;SHTN1;CAMSAP2;ATL1;LMTK2;NRCAM;TAOK2;RTN4;NEFH;ADGRB1;ACTB;DCC;MARK2;CTNNA2;SLITRK2
prerank,negative regulation of cation channel activity (GO:2001258),0.360298691064032,0.9039907051187076,0.5603932584269663,0.8807197919272879,1.0,2/26,2.67%,KCNE3;FKBP1A
prerank,contractile actin filament bundle assembly (GO:0030038),-0.35051836270902303,-0.9033582538137795,0.6282051282051282,0.9137646116897239,1.0,5/15,8.80%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,stress fiber assembly (GO:0043149),-0.35051836270902303,-0.9033582538137795,0.6282051282051282,0.9137646116897239,1.0,5/15,8.80%,SORBS1;ITGB5;PHACTR1;SRC;FAM171A1
prerank,regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.3427091891839425,0.9032779084576706,0.5938375350140056,0.8816402619707461,1.0,10/40,17.71%,FOXF2;UBE3A;PTK2;XPO1;FBXW7;LAPTM5;CLU;SMURF1;RNF139;UBQLN4
prerank,negative regulation of cell cycle process (GO:0010948),0.31549976472256025,0.9031387730600133,0.5997474747474747,0.8814155339104109,1.0,10/61,12.82%,FOXO4;DAB2IP;RBBP8;RYBP;PHC3;TOM1L1;UXT;E2F7;BRCA1;VPS4A
prerank,ESCRT III complex disassembly (GO:1904903),0.43873603282824486,0.9022521541768024,0.590443686006826,0.8822731673012137,1.0,6/10,26.19%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,ESCRT complex disassembly (GO:1904896),0.43873603282824486,0.9022521541768024,0.590443686006826,0.8822731673012137,1.0,6/10,26.19%,CHMP1B;VPS4A;CHMP2B;CHMP7;CHMP1A;VPS4B
prerank,negative regulation of protein localization to cell surface (GO:2000009),0.4215408332194929,0.9019802574837591,0.5814332247557004,0.882314525502812,1.0,3/11,10.96%,GOPC;TAX1BP3;NEDD4L
prerank,regulation of protein export from nucleus (GO:0046825),0.375924331563655,0.901889347344625,0.5859969558599696,0.8820214792066006,1.0,3/23,7.21%,PTPN14;UHMK1;RANGAP1
prerank,establishment of apical/basal cell polarity (GO:0035089),0.40499901517819714,0.9017542546415891,0.5750394944707741,0.8818123005239826,1.0,2/14,4.47%,MSN;SYNE4
prerank,positive regulation of phospholipid transport (GO:2001140),0.43017026331013386,0.9016777653429875,0.5816993464052288,0.881490155471072,1.0,3/10,15.39%,APOA1;ABCB4;ABCA7
prerank,tRNA processing (GO:0008033),0.3172735388665883,0.9012841348600998,0.6158690176322418,0.881797890371277,1.0,14/61,21.08%,ADAT2;TRDMT1;TRMT61A;KARS1;TRPT1;CPSF1;FARS2;TRUB1;TRMT10B;ELAC2;POP1;CSTF2;TRMT1;NSUN6
prerank,regulation of membrane protein ectodomain proteolysis (GO:0051043),-0.3119334297502456,-0.9008917261834107,0.6025236593059937,0.9185619133939437,1.0,7/22,13.54%,APOE;TIMP2;PTPN3;ADAM9;GPLD1;ADRA2A;PACSIN3
prerank,dicarboxylic acid metabolic process (GO:0043648),-0.2604430311547835,-0.9005956276077495,0.6570247933884298,0.918046987952406,1.0,13/52,14.98%,ME1;IDH2;ADHFE1;SLC19A1;GCLC;L2HGDH;MTHFD1;MDH2;IDH1;MTHFD2L;ALDH18A1;GOT1;DLST
prerank,regulation of fatty acid metabolic process (GO:0019217),0.3986215497652118,0.900592339660462,0.5698924731182796,0.8826840829094774,1.0,3/17,6.44%,ADIPOR2;CAV1;ADIPOR1
prerank,regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),0.3157804634920472,0.9005535900353743,0.621656050955414,0.8822724770465222,1.0,13/60,14.45%,TNRC6C;HNF1A;HEY2;MED26;LEF1;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,regulation of T cell differentiation (GO:0045580),0.34738535603356124,0.9003886248599493,0.5919220055710307,0.8821162967143791,1.0,5/33,13.75%,CRTAM;TNFRSF18;GATA3;CBFB;RHOH
prerank,phosphatidylcholine metabolic process (GO:0046470),0.3112485049521565,0.9003687682018746,0.6047087980173482,0.881668574242374,1.0,14/70,18.28%,APOA1;SLC44A1;MBOAT2;LPCAT4;LCAT;PCYT1A;TMEM86B;CEPT1;LPCAT3;ACHE;STARD10;CSNK2B;PLA2G12A;PLAAT3
prerank,positive regulation of growth (GO:0045927),0.3118405453363478,0.9003311291791519,0.6185044359949303,0.8812537399740342,1.0,10/64,10.40%,PLCB1;INSR;TGFB2;PPM1F;BRAT1;TAF9B;ADAM17;SLC25A33;ADAM10;RPS6KA1
prerank,regulation of mRNA processing (GO:0050684),-0.2786897399826321,-0.9001495093164699,0.6366366366366366,0.9179085660697563,1.0,16/32,25.89%,SON;NCBP1;JMJD6;PABPN1;RBM39;SAFB;AHCYL1;SRSF3;SF1;SRPK2;SLTM;KHDRBS1;CDK11B;PAPOLA;QKI;LARP7
prerank,positive regulation of interleukin-4 production (GO:0032753),0.3905406110618581,0.9000369484884534,0.5811023622047244,0.8813557200108191,1.0,4/17,16.90%,LGALS9;GATA3;HAVCR2;RARA
prerank,regulation of cell cycle process (GO:0010564),0.29757420627437486,0.8996958860306867,0.6533018867924528,0.8815714028718517,1.0,16/104,14.24%,PLK3;RAB11A;CAV2;TTL;CDC25C;BCL2L1;APC;PIK3C3;RPRD1B;NUMA1;CALM3;PRC1;PIN1;BUB1;RAB11FIP4;CTNNB1
prerank,regulation of RNA splicing (GO:0043484),-0.23861004226331572,-0.8996954526021054,0.6666666666666666,0.9177065597939243,1.0,20/69,17.82%,SON;SNRNP70;AFF2;HNRNPH1;AHNAK2;BRDT;AHNAK;PIK3R1;CLK1;FUS;JMJD6;CLK4;RBM39;RBM20;HNRNPLL;HNRNPL;RPS26;CLK2;ZPR1;U2AF2
prerank,organelle disassembly (GO:1903008),-0.28337222033133347,-0.8994304076047797,0.65,0.9171179582741441,1.0,11/33,15.95%,GOLGA2;TEX264;UBA5;DENR;ATG2A;MRRF;EIF2D;ULK2;STX5;KIF9;PLK5
prerank,positive regulation of mesenchymal cell proliferation (GO:0002053),0.4380394756422109,0.8993590443478824,0.5711775043936731,0.8818080376437283,1.0,3/10,13.91%,TBX1;STAT1;LRP5
prerank,megakaryocyte differentiation (GO:0030219),0.4357794786394801,0.8992295986574292,0.5919732441471572,0.8815996839593612,1.0,2/11,7.97%,TAL1;THPO
prerank,detection of mechanical stimulus (GO:0050982),0.38818776154497425,0.8992138844560902,0.6022012578616353,0.8811442523930023,1.0,4/19,14.24%,PIEZO1;PTK2;CDH2;CTNNB1
prerank,tube closure (GO:0060606),-0.2835596056531072,-0.8991995460085287,0.6583850931677019,0.9164476272526225,1.0,10/31,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,membrane depolarization (GO:0051899),0.3499086828479383,0.898958682030817,0.5997267759562842,0.8811847764767406,1.0,9/32,18.28%,CAV1;CACNA1A;SCN11A;P2RX7;SCN1B;YWHAH;SCN9A;CACNA1E;SCN1A
prerank,primary neural tube formation (GO:0014020),-0.2879215606779185,-0.8988339454964014,0.6503067484662577,0.9161404954995557,1.0,10/30,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,histone ubiquitination (GO:0016574),-0.32244840375556416,-0.8987940274406304,0.5981308411214953,0.9150033030764552,1.0,6/21,16.43%,UBE2N;PAF1;CTR9;USP22;ATXN7L3;WAC
prerank,glutamine family amino acid metabolic process (GO:0009064),0.34443623371055465,0.8987599050256033,0.5864553314121037,0.8810627913715571,1.0,6/33,8.75%,DGLUCY;GLS2;GLS;GLUD1;SIRT4;CAD
prerank,positive regulation of histone deacetylation (GO:0031065),0.42487231229589284,0.8985815744215759,0.5752961082910322,0.8809465009030969,1.0,3/12,11.99%,PRKD1;ING2;PRKD2
prerank,axonal transport (GO:0098930),0.34745922489761316,0.8984753973368462,0.5928571428571429,0.880691393969472,1.0,10/36,22.31%,BLOC1S6;DST;AP3S1;HIF1A;SYBU;KIF1A;AP3M1;HAP1;AP3D1;SOD1
prerank,regulation of organelle organization (GO:0033043),0.3036940458896395,0.8984274945426295,0.6203931203931204,0.8803126964891715,1.0,15/80,15.69%,F11R;DIAPH1;CLIC4;MSN;CAMSAP2;MAPK1;TJP1;PTK2;VPS35;MARK2;TMED9;USP6NL;RHOT2;PDCD10;PAK2
prerank,secondary alcohol biosynthetic process (GO:1902653),0.3596017482482354,0.8984205360254179,0.5814285714285714,0.8798444767108858,1.0,14/30,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,steroid hormone mediated signaling pathway (GO:0043401),-0.35947287118965,-0.898236137606503,0.5979381443298969,0.9151449294645978,1.0,5/13,17.12%,BMP7;BMP4;CALCOCO1;GPER1;AR
prerank,regulation of microglial cell activation (GO:1903978),0.40533065338389246,0.8980616857887068,0.5836012861736335,0.880100311234864,1.0,3/15,12.61%,NR1D1;STAP1;TTBK1
prerank,positive regulation of protein catabolic process (GO:0045732),0.3059000205652494,0.8979010880736772,0.6304878048780488,0.8799438279456782,1.0,14/84,13.89%,PLK3;FOXO1;DAB2IP;MSN;FURIN;TNFRSF1B;WWP1;ASB5;APC;VPS28;NEDD4L;VPS35;SMURF1;NSF
prerank,regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.39121991928688704,0.8975456257067518,0.6058158319870759,0.8801339261218125,1.0,4/16,15.59%,BCL2L1;SNAI2;CLU;CDKN2D
prerank,negative regulation of response to wounding (GO:1903035),-0.3153826689336574,-0.8974065028103565,0.56973293768546,0.9159426332185541,1.0,5/19,13.89%,CASK;FGF2;SERPINE1;MDK;PTPRS
prerank,cell cycle G2/M phase transition (GO:0044839),0.2912042336112183,0.8971297137367439,0.6359550561797753,0.8804484561207366,1.0,16/129,10.47%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,"RNA splicing, via transesterification reactions (GO:0000375)",-0.29685040242022886,-0.8969747574756325,0.5950155763239875,0.91571669235416,1.0,8/25,21.14%,SNRNP40;SCAF11;PRPF8;SRRM1;PRPF3;BCAS2;MPHOSPH10;SF3B1
prerank,positive regulation of cell communication (GO:0010647),0.3590936468539804,0.896969712312938,0.6165951359084406,0.8803125241747317,1.0,9/28,18.99%,EDN1;GATA3;GRIK2;RIMS3;NMU;ANK3;SYT1;CDKN2AIP;SOX11
prerank,lipid homeostasis (GO:0055088),-0.2546163880189874,-0.8969384924483214,0.6666666666666666,0.9145693427077524,1.0,19/57,23.75%,ZBTB20;RBP1;APOE;ABCA1;PRKAA2;TLCD2;IRS2;NR1D2;PPARG;DDX3X;NR1H3;RCN3;ABHD8;ORMDL2;TLCD1;DGAT2;MLXIPL;ANGPTL3;FITM2
prerank,G2/M transition of mitotic cell cycle (GO:0000086),0.2912079028608018,0.8963746568222403,0.6385135135135135,0.8810139575685582,1.0,16/128,10.47%,PLCB1;CCNY;PLK3;CDK14;TUBB;CSNK1D;CDC25C;TUBB4B;CLASP1;NEDD1;TPD52L1;CEP135;HAUS3;PCM1;DYNLL1;CEP76
prerank,regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.3291437214713799,0.8962682616129783,0.6284584980237155,0.8807722334397975,1.0,12/49,19.51%,SGMS1;CAV1;BBC3;BCL2L1;RTKN2;RACK1;PYCARD;PLAUR;BMF;BID;PPIF;MCL1
prerank,negative regulation of bone remodeling (GO:0046851),0.42269637335320265,0.895653583549116,0.5970149253731343,0.8815284785482149,1.0,2/11,6.78%,GPR137B;P2RX7
prerank,regulation of cytokinesis (GO:0032465),0.3080507797282968,0.8955484610060389,0.6262135922330098,0.8812497237193383,1.0,21/78,21.88%,PLK3;RAB11A;CUL3;BCL2L1;PIK3C3;CDC14A;E2F7;CALM3;VPS4A;PRC1;PIN1;RAB11FIP4;PKN2;KLHL9;GIT1;MAP10;RAB11FIP3;GIPC1;SETD2;ECT2;KIF23
prerank,"DNA-templated transcription, initiation (GO:0006352)",0.28375968289076214,0.8954065645972595,0.6608315098468271,0.8810375297510765,1.0,39/166,19.01%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;TAF1A;RXRG;POLR2G;NR1D1;POLR1F;BRF2;POLR2D;TBPL1;MAML2;CAVIN1;GTF2H3;NR4A1;GTF2A1;TFB2M;MED27;TAF1B;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8;E2F3;NCOA6;NR2C2AP;TAF3
prerank,extracellular matrix disassembly (GO:0022617),-0.2584951334747385,-0.8947650088870239,0.6822033898305084,0.9186853794280582,1.0,13/53,13.94%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,regulation of response to DNA damage stimulus (GO:2001020),-0.2723168220208888,-0.8940758017734649,0.65,0.9190581409952849,1.0,16/40,25.55%,FXR2;UBE2V2;UBE2N;USP1;BCLAF1;HMGA2;WDR76;NEK4;RFWD3;PRKCD;PARG;ABL1;CASP9;FEM1B;RPA2;KMT5A
prerank,membrane protein proteolysis (GO:0033619),0.33232272523116735,0.8939534373170902,0.6114911080711354,0.8834435091257433,1.0,19/37,26.00%,SPPL2A;RHBDD1;MYH9;ADAM17;MBTPS2;TMPRSS6;APH1A;ADAM10;PSEN2;RELA;CTSH;APH1B;SPPL2B;ERAP1;AFG3L2;NCSTN;PARL;TGFB1;RET
prerank,amino acid transmembrane transport (GO:0003333),0.3280238552149706,0.8938670955820499,0.603641456582633,0.8831525849789035,1.0,5/45,7.82%,SLC6A6;SLC7A7;SFXN1;SLC16A2;SLC7A1
prerank,positive regulation of translation (GO:0045727),-0.22335702918004954,-0.8925729619912763,0.6862745098039216,0.9215482634526044,1.0,24/94,17.05%,SAMD4A;THBS1;FXR2;NIBAN1;PLXNB2;YTHDF1;RMND1;TRUB2;YBX3;CDC123;ERBB2;PCIF1;LARP4B;YTHDF2;DDX3X;BCL3;EIF3D;CPEB3;RCC1L;RPS4X;EIF3E;RPUSD4;JMJD4;LARP1
prerank,protein sumoylation (GO:0016925),0.32848760204183436,0.8924715559398064,0.6093552465233881,0.8854269093275727,1.0,11/49,15.93%,IFIH1;SUMO2;SUMO3;RANGAP1;NUP54;NUP35;RANBP2;NUP153;NUP160;NUP42;NUP205
prerank,cellular component disassembly (GO:0022411),-0.2588509064225062,-0.8924518804804099,0.6905829596412556,0.9206368954901569,1.0,13/53,13.94%,GSN;MMP14;TLL1;ADAMTS5;SH3PXD2B;TIMP2;ADAMTS15;MMP2;SCUBE1;MMP16;KLK2;MMP19;KIF9
prerank,regulation of interleukin-17 production (GO:0032660),0.3422332316426967,0.8924132655225447,0.5982008995502249,0.8850580914375752,1.0,3/31,10.88%,NOD2;PRNP;VSIR
prerank,mitochondrial calcium ion transmembrane transport (GO:0006851),0.3781620866400522,0.8918210235455384,0.6087613293051359,0.8857700373733899,1.0,3/20,8.35%,MCUB;SMDT1;MCUR1
prerank,cilium movement (GO:0003341),0.32591111366292813,0.8914337492538984,0.6275033377837116,0.8860205716375842,1.0,4/47,4.33%,CFAP206;ADCY10;TEKT5;TTC29
prerank,activation of protein kinase activity (GO:0032147),0.29357562283697997,0.8912074056282767,0.6435185185185185,0.8859980110812096,1.0,19/106,13.05%,PDGFB;INSR;TGFB2;ADRB2;EMP2;TLR3;TIRAP;CARD10;ANGPT1;MAP4K4;TOM1L1;JAK2;TAOK2;ADCY4;CCDC88A;MINK1;MARK2;COPS8;ITGB1BP1
prerank,positive regulation of epithelial cell apoptotic process (GO:1904037),-0.32061467881333305,-0.8911788851378537,0.6170798898071626,0.9224448707840213,1.0,10/20,22.91%,GSN;PLA2R1;THBS1;SFRP4;PRKCI;ITGA4;GPER1;CD40;RGCC;PIAS4
prerank,positive regulation of synaptic transmission (GO:0050806),-0.23467271576569743,-0.89104770112324,0.6633165829145728,0.9215052629349639,1.0,19/72,19.58%,ADCY1;STX4;SLC8A3;DLG4;NLGN2;CLSTN2;CACNG4;TSHZ3;GRIN2D;PRKCZ;DTNBP1;ADRA1A;EIF2AK4;CACNG8;GPER1;EPHB2;SLC8A2;KCTD13;LGMN
prerank,positive regulation of nitric-oxide synthase activity (GO:0051000),0.4055646230828819,0.8909303879629838,0.6112,0.8860403452542471,1.0,6/16,17.41%,GCH1;NOS1AP;NUS1;PIK3CB;HIF1A;SCARB1
prerank,DNA strand elongation (GO:0022616),-0.32461251963089605,-0.8908435694719524,0.6297376093294461,0.920788192850238,1.0,11/18,40.00%,RAD50;TERT;DCLRE1B;POLD2;GINS1;RFC4;MCM7;POLD3;GINS3;GINS2;MRE11
prerank,lysosome localization (GO:0032418),0.3422718807036465,0.8903955236624855,0.6205923836389281,0.8866183472884787,1.0,9/37,16.27%,RAB34;MILR1;SPAG9;MYH9;PLEKHM1;KLC2;CHGA;TMEM106B;PLEKHM2
prerank,secretory granule organization (GO:0033363),-0.3922414530678836,-0.890355221197572,0.6052009456264775,0.9207003671909612,1.0,4/10,19.44%,ABCA1;DTNBP1;VPS33B;BLOC1S2
prerank,negative regulation of complement activation (GO:0045916),-0.3723991754176763,-0.890184589256476,0.6063569682151589,0.9198905455802415,1.0,2/10,4.85%,SERPING1;CD55
prerank,transition metal ion homeostasis (GO:0055076),0.36231039384112573,0.8899406507803368,0.6207407407407407,0.8870375672224383,1.0,8/28,18.52%,B2M;FBXL5;TMPRSS6;HMOX2;CP;CYBRD1;HEPH;XIAP
prerank,glycolipid biosynthetic process (GO:0009247),-0.26425879025739485,-0.8897450698762595,0.6872727272727273,0.9197913887446967,1.0,18/38,20.25%,LARGE1;ST3GAL5;ST3GAL4;PIGA;GBGT1;SCCPDH;PIGB;PIGN;ST6GALNAC5;PIGH;PGAP2;DPM2;PIGG;ST8SIA1;ST8SIA3;PIGP;PGAP4;PIGZ
prerank,cellular potassium ion homeostasis (GO:0030007),0.41391212084168183,0.8896310952763176,0.6152542372881356,0.8871264713322102,1.0,3/13,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,sno(s)RNA 3'-end processing (GO:0031126),0.4205983111152055,0.8895505098705607,0.6046511627906976,0.8867950837685686,1.0,5/11,22.52%,EXOSC3;DKC1;FBLL1;EXOSC10;FBL
prerank,cell projection organization (GO:0030030),0.3447815804388982,0.8892661716190824,0.6162790697674418,0.8868779919818803,1.0,8/30,13.75%,PARVB;PACSIN2;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,negative regulation of bone mineralization (GO:0030502),0.40702246876269865,0.8892211779121987,0.6035313001605136,0.8864933964180364,1.0,1/13,1.34%,CCR1
prerank,cyclic purine nucleotide metabolic process (GO:0052652),0.3820545026653258,0.8891001470559138,0.5993975903614458,0.8862510626704038,1.0,5/21,11.52%,NPR2;ADCY10;NPR1;ADCY4;NPPC
prerank,protein deneddylation (GO:0000338),0.43900388678337254,0.8890049063766788,0.5938566552901023,0.8859652007625165,1.0,3/10,17.63%,COPS4;COPS8;COPS5
prerank,positive regulation of myoblast differentiation (GO:0045663),0.397200502319821,0.8885564478154279,0.6131147540983607,0.8863886602860737,1.0,3/16,5.32%,PLCB1;BTG1;MEF2C
prerank,response to sterol (GO:0036314),-0.37184338390679195,-0.8885478082370178,0.6064356435643564,0.9214538630299377,1.0,2/11,5.15%,TGFBR1;RORA
prerank,ribosomal small subunit assembly (GO:0000028),0.3889973323072917,0.8884096752776626,0.6137820512820513,0.8862069212608088,1.0,6/16,21.23%,RPS14;RPS28;RPS5;RPS15;PWP2;RPS19
prerank,positive regulation of signal transduction by p53 class mediator (GO:1901798),0.36618204312052105,0.888371095978555,0.6123348017621145,0.8858117013697204,1.0,8/22,21.70%,MSX1;RPL37;CHD5;ATM;RPS15;EEF1E1;UBB;HEXIM1
prerank,protein localization to vacuole (GO:0072665),0.4014201106988153,0.8880226456614387,0.5924713584288053,0.8859882258294055,1.0,3/13,9.49%,SH3BP4;RNF128;RTN4
prerank,negative regulation of interleukin-8 production (GO:0032717),-0.327496263765768,-0.8877152396400779,0.6191780821917808,0.9222146504086599,1.0,7/17,16.38%,PTPN22;ANXA1;SSC5D;OTUD7B;MAPKBP1;BCL3;ANXA4
prerank,phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),-0.23534966860994358,-0.8877032904766398,0.6881720430107527,0.921032637084874,1.0,18/76,20.86%,LPAR1;PLCE1;ADRA1B;ACTN2;ANO1;GPR4;PTH1R;HOMER1;ADRA2A;AGTR1;DRD2;ADRA1A;LPAR4;TRHR;P2RY6;AGT;OPRK1;HRH1
prerank,negative regulation of protein localization to nucleus (GO:1900181),0.38190835941040013,0.8872806287792742,0.5869565217391305,0.8869337324772364,1.0,7/18,20.25%,UFM1;RAB23;MFHAS1;CTNNA1;CABP1;SIN3A;GSK3B
prerank,regulation of phosphorylation (GO:0042325),0.28918727726643645,0.8872459599662488,0.6835585585585585,0.8865267562206356,1.0,28/120,16.04%,CCDC88C;LDB2;EMP2;APP;JMJD8;HSPB1;NLRC5;NDUFS4;ROCK1;STAP1;PTK2;NUP54;PTGES3;CCDC88A;DYNLL1;NUP35;RANBP2;GRM5;NUP153;PIN1;PHIP;NUP160;HIF1A;NUP42;EIF6;CDKN2D;NUP205;KDM4D
prerank,histone H2A acetylation (GO:0043968),0.39779620744138433,0.8869942605927573,0.6095238095238096,0.8865308378437902,1.0,4/16,15.52%,ING3;BRD8;DMAP1;TRRAP
prerank,RNA phosphodiester bond hydrolysis (GO:0090501),0.36149734156284397,0.8868161776599508,0.6017441860465116,0.8864062906050668,1.0,13/27,24.62%,ZC3H12A;TRIR;RNASE1;NHP2;XRN1;RNASE6;POP1;KHNYN;ERN1;RNASE4;CPSF3;NUDT16;RNASEH1
prerank,negative regulation of osteoblast differentiation (GO:0045668),0.3494265056436039,0.886767721658126,0.6171761280931587,0.8860198639668277,1.0,3/31,3.11%,SMAD6;NOTCH1;HDAC7
prerank,apoptotic DNA fragmentation (GO:0006309),0.3960327074722225,0.8866807814526965,0.5906976744186047,0.8857100730905536,1.0,6/16,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,regulation of reactive oxygen species metabolic process (GO:2000377),-0.24581013587231149,-0.8863144109173889,0.7012448132780082,0.9231433195647344,1.0,17/55,21.82%,PID1;PDGFRB;THBS1;PRKN;XDH;DHRS4;PDK3;AGTR1;MPV17;SIRT2;TGFBR2;CDKN1A;ACE2;PAX2;AGT;ROMO1;SPHK2
prerank,lipid droplet organization (GO:0034389),-0.3126423515485528,-0.8859440187592936,0.62,0.9228278687884228,1.0,7/22,28.24%,PPIA;BSCL2;SQLE;PLA2G4C;FITM2;RAB3GAP1;AUP1
prerank,sensory organ development (GO:0007423),-0.24447823336529764,-0.885858303262846,0.676056338028169,0.9218241658025145,1.0,6/51,6.70%,SMOC1;PBX3;RBP4;SH3PXD2B;MEIS1;SHROOM2
prerank,cellular response to topologically incorrect protein (GO:0035967),0.35190835178560537,0.8856854922831887,0.6055312954876274,0.8871734271621826,1.0,8/31,19.18%,DAB2IP;RHBDD1;HSPA1B;PTPN1;TMBIM6;TM7SF3;DAXX;ERN1
prerank,vitamin transport (GO:0051180),0.34615698907391423,0.8853795855810503,0.5712209302325582,0.8872929908293057,1.0,3/29,3.48%,SLC25A32;TTPA;APOA1
prerank,regulation of peptidyl-threonine phosphorylation (GO:0010799),0.3407459387646871,0.8853413742884436,0.6116642958748222,0.8868955028323552,1.0,6/37,6.97%,SMAD7;APP;INPP5K;TRIM6;MAPK1;IRGM
prerank,organelle assembly (GO:0070925),0.2664188796683418,0.8851115651172362,0.77079107505071,0.8868738380059425,1.0,59/384,15.56%,EXOC6;EHD4;SYNPO;ABCC4;ABLIM1;NOTCH1;RAB11A;ATG101;FLII;STX7;TEKT5;EHD1;DHX37;CSNK1D;FAM161A;TTBK2;CD34;TTC36;FNBP1L;BBS7;SNX10;GABARAPL1;VPS36;RAB23;IRGM;MAPRE3;TMEM216;IFT140;STARD9;STX12;CFAP43;NEK7;HAUS3;PCM1;VPS28;CHMP1B;PIK3C3;CFAP52;CDC14A;DYNLL1;EXOC8;TNKS;NPM1;OCRL;RAB19;VPS4A;TMOD3;CHMP3;WDR11;KIF24;CEP83;MAP1LC3A;EIF2S1;EIF2A;EDC3;CHMP2B;CHMP7;DDX6;UBQLN2
prerank,regulation of mesenchymal cell proliferation (GO:0010464),0.4221326154042476,0.885001744681312,0.614853195164076,0.8866257756052967,1.0,4/11,13.91%,TBX1;STAT1;CTNNBIP1;LRP5
prerank,regulation of neuronal synaptic plasticity (GO:0048168),0.35624450010312664,0.8849638419177605,0.6195804195804195,0.8862173440878086,1.0,5/29,10.51%,MCTP1;APP;SHISA8;SHISA6;GRIK2
prerank,positive regulation of protein deacetylation (GO:0090312),-0.34205384686999063,-0.8847916560169281,0.5985037406483791,0.9231224765711786,1.0,6/14,23.05%,NIPBL;AKAP8L;SAP30BP;NNMT;ZBTB7B;APLNR
prerank,resolution of meiotic recombination intermediates (GO:0000712),-0.33702184663780954,-0.8847862022656947,0.6233062330623306,0.9219293216469799,1.0,13/16,45.57%,TOP2B;HFM1;TOP2A;EME2;CENPX;FANCM;SLX4;MEIOB;MSH4;MUS81;EME1;SHOC1;CENPS
prerank,negative regulation of kinase activity (GO:0033673),0.31474929138077234,0.8847252868986418,0.6344221105527639,0.8861982464600253,1.0,8/62,7.36%,CEACAM1;GNAQ;INPP5K;PPM1F;WWTR1;WARS1;SMCR8;HSPB1
prerank,negative regulation of amyloid-beta formation (GO:1902430),0.3783359686886514,0.8843337340640997,0.6163522012578616,0.8864805793115205,1.0,10/17,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,cellular monovalent inorganic cation homeostasis (GO:0030004),0.37956396563483685,0.8840819692958253,0.6296296296296297,0.8864852012514495,1.0,4/20,3.81%,ATP1A4;ATP1A1;ATP1A3;SLC8A1
prerank,substantia nigra development (GO:0021762),-0.27050991889218134,-0.8840569306222557,0.6536964980544747,0.9223954161772472,1.0,14/37,17.91%,NDRG2;NDUFS3;CALM2;PLP1;MAPKAP1;CKB;PADI2;YWHAQ;SIRT2;MBP;SEC16A;CNP;BASP1;FGF9
prerank,small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.3803809281221919,-0.8838814675790124,0.610126582278481,0.9215899309193983,1.0,6/10,29.70%,PIH1D1;ZNHIT6;NAF1;ZNHIT3;TAF9;PIH1D2
prerank,synapse organization (GO:0050808),0.2858719982762532,0.8837951287726798,0.6754587155963303,0.8865699639892689,1.0,26/125,13.23%,UNC13B;APBB2;AGRN;APP;PPFIBP1;DNM3;SNCG;GPHN;SPOCK2;PLXND1;SHANK3;LRRK2;NRCAM;FLRT3;LRRC4C;PPFIA2;CYFIP1;KIRREL3;ZC4H2;CDH2;ACHE;GRM5;SLITRK2;CX3CR1;PIN1;PCDHB16
prerank,positive regulation of cellular protein catabolic process (GO:1903364),-0.32134315773587224,-0.8836278770972071,0.632768361581921,0.9210025946141002,1.0,7/18,18.62%,APOE;DACT1;ATP5IF1;CD81;CTSC;AMER1;EZR
prerank,spermatid development (GO:0007286),0.3441210268557835,0.8834734370051184,0.6148555708390646,0.8866930639815088,1.0,2/32,4.15%,JAM2;ING2
prerank,epithelial structure maintenance (GO:0010669),0.42177972693988935,0.8834056508177338,0.6160267111853088,0.8863481131763429,1.0,1/11,1.72%,NOD2
prerank,transcription initiation from RNA polymerase II promoter (GO:0006367),0.2851324838198527,0.882895962526037,0.6685456595264938,0.8868907514126428,1.0,28/138,17.09%,NOTCH4;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;TAF9B;RXRG;POLR2G;NR1D1;POLR2D;MAML2;GTF2H3;NR4A1;GTF2A1;MED27;MED17;TAF11;NR2C1;POLR2I;ESR1;ESRRG;RARA;TAF8
prerank,cardiac myofibril assembly (GO:0055003),0.39715934367186595,0.8827823332676893,0.6090468497576736,0.8866298204254329,1.0,1/15,0.60%,NEBL
prerank,insulin-like growth factor receptor signaling pathway (GO:0048009),-0.36877922873031754,-0.8825569226300882,0.6101694915254238,0.9223399785560659,1.0,4/11,8.42%,IGF1;IRS1;PIK3R1;GHR
prerank,cellular response to amino acid starvation (GO:0034198),0.3031351298456555,0.8824772276308859,0.6495507060333762,0.8867418245404874,1.0,19/71,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,mitochondrion localization (GO:0051646),0.3746976067889027,0.8820024429618694,0.6028708133971292,0.8871624721895263,1.0,7/19,18.66%,BRAT1;LRRK2;MFN1;MARK2;HAP1;ZBED3;MEF2A
prerank,positive regulation of organelle assembly (GO:1902117),0.32169724683890477,0.8819545168246687,0.6300653594771242,0.8867658572152382,1.0,13/44,21.43%,SAXO1;RAB3GAP2;CNOT6L;CNOT1;CCDC88A;NUMA1;CAPG;LCP1;CEP120;CNOT2;G3BP1;MARK4;RALB
prerank,regulation of chromosome segregation (GO:0051983),0.3950955457433965,0.8814400578056267,0.6133122028526149,0.8873267812330077,1.0,4/16,14.43%,PUM2;NUMA1;BUB1;RAD18
prerank,positive regulation of cardiac muscle hypertrophy (GO:0010613),0.3825666756587723,0.880843038399986,0.6022187004754358,0.8880169919855347,1.0,3/16,9.04%,EDN1;CAMK2D;ROCK1
prerank,positive regulation of response to wounding (GO:1903036),0.35838491929131167,0.8807756092316,0.5945165945165946,0.8876695721404729,1.0,4/24,9.21%,OCLN;MYLK;ACTG1;PTK2
prerank,nuclear body organization (GO:0030575),-0.3548449159237844,-0.8805755726008356,0.6035353535353535,0.9257838023142465,1.0,5/12,21.60%,AFF2;USP50;ZPR1;PML;SRPK2
prerank,porphyrin-containing compound catabolic process (GO:0006787),-0.3426209642191629,-0.8804411907798633,0.6253602305475504,0.9237245974094128,1.0,2/14,11.57%,SLCO2B1;BLVRB
prerank,heme catabolic process (GO:0042167),-0.3426209642191629,-0.8804411907798633,0.6253602305475504,0.9237245974094128,1.0,2/14,11.57%,SLCO2B1;BLVRB
prerank,regulation of nucleobase-containing compound metabolic process (GO:0019219),0.41976753035719766,0.8804130615208807,0.6170940170940171,0.8878856477361671,1.0,2/11,11.45%,NOVA2;PCBP1
prerank,regulation of gene silencing by miRNA (GO:0060964),0.3127543257409237,0.8803871432307661,0.649810366624526,0.8874617215443303,1.0,24/62,25.90%,PUM2;ELAVL1;POLR2G;NUP54;DHX9;POLR2D;NUP35;RANBP2;NUP153;FXR1;NUP160;NUP42;POLR2I;NUP205;H3-3A;NUP50;POLR2C;EIF4G1;POLR2B;POLR2J;RAE1;SEH1L;TPR;TGFB1
prerank,positive regulation of cellular component organization (GO:0051130),0.291835324686388,0.8803768808591961,0.6686046511627907,0.8870135067746255,1.0,11/107,6.20%,ATP10A;INSR;TAL1;MMP1;DAB2IP;TGFB2;TIRAP;HRK;SHANK3;ABCB4;WARS1
prerank,GPI anchor biosynthetic process (GO:0006506),-0.2777000073533349,-0.8803480790682433,0.6666666666666666,0.9227414096245673,1.0,14/30,26.76%,PIGA;PIGB;PIGN;PIGH;PGAP2;DPM2;PIGG;PIGP;PGAP4;PIGZ;PGAP3;PIGL;PIGW;GPAA1
prerank,amyloid-beta metabolic process (GO:0050435),0.3936775601233092,0.8803397471471082,0.6102819237147595,0.8866184428450008,1.0,8/16,24.03%,ACE;APH1A;ABCA7;PSEN2;DYRK1A;APH1B;MME;NCSTN
prerank,sister chromatid segregation (GO:0000819),-0.28303683291718224,-0.8802992766231038,0.6493055555555556,0.9216797326813939,1.0,16/31,32.35%,KLHL22;TOP2B;NCAPG2;MIS12;LATS1;CENPK;ZW10;NUSAP1;TOP2A;ZWINT;SPAG5;KIF18B;KIFC1;NSL1;TUBG2;CDCA8
prerank,cellular response to decreased oxygen levels (GO:0036294),0.310499400211528,0.8796182936161333,0.6469104665825978,0.8875356903181965,1.0,2/65,0.62%,EPAS1;GATA6
prerank,positive regulation of mitochondrial translation (GO:0070131),-0.3388585483469519,-0.8795666240879887,0.6443850267379679,0.9222577728005883,1.0,7/14,25.75%,RMND1;TRUB2;RCC1L;RPUSD4;MPV17L2;C1QBP;FASTKD3
prerank,negative regulation of cilium assembly (GO:1902018),0.4178136809249515,0.8794901100409972,0.5983471074380166,0.8873227896275984,1.0,3/12,10.83%,MAP4;TBC1D30;LIMK2
prerank,positive regulation of dendritic spine development (GO:0060999),-0.31860145748310575,-0.8788249124084683,0.6189111747851003,0.9228218962666495,1.0,5/20,13.86%,APOE;CAMK1;DBN1;LLPH;CPEB3
prerank,positive regulation of receptor internalization (GO:0002092),0.3664519455150628,0.8786689286516952,0.6110283159463488,0.8884656967993324,1.0,4/22,8.03%,INSR;ANGPT1;ARRB1;TBC1D5
prerank,cilium assembly (GO:0060271),0.2685184447701111,0.8782964327668691,0.7556701030927835,0.8886944964493994,1.0,34/296,10.78%,EXOC6;EHD4;ABCC4;ABLIM1;NOTCH1;RAB11A;CFAP206;TEKT5;EHD1;DNAAF3;TUBB;CSNK1D;FAM161A;TTBK2;TTC36;FNBP1L;BBS7;SNX10;TUBB4B;RAB23;SPATA6;CLASP1;TMEM216;NEDD1;IFT140;CFAP43;CEP135;HAUS3;PCM1;CFAP52;CDC14A;DYNLL1;CEP76;EXOC8
prerank,histone lysine methylation (GO:0034968),-0.2733964678488705,-0.8776395948474717,0.6445182724252492,0.9243009225576239,1.0,9/33,17.26%,PRDM5;ASH2L;SETD1B;DOT1L;WDR5;DPY30;SUV39H1;N6AMT1;SETDB2
prerank,neuron cell-cell adhesion (GO:0007158),0.40696960060312065,0.8775981775509436,0.5877616747181964,0.889536870539476,1.0,7/14,26.00%,NCAM2;ASTN1;NRXN3;CNTN4;NRXN1;NLGN1;RET
prerank,protein deubiquitination (GO:0016579),0.2691659823181912,0.8775055783282362,0.7448132780082988,0.8892344193047159,1.0,53/242,18.93%,SMAD7;FOXO4;SPATA2;USP38;IFIH1;ADRB2;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;MINDY1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SMAD4;PSMD5;PSMD9;PSMB6;INO80D
prerank,tryptophan metabolic process (GO:0006568),0.4291753386230712,0.877404975947159,0.6190476190476191,0.8889719159364295,1.0,3/11,21.83%,ATP7A;KYAT1;KYNU
prerank,regulation of secretion by cell (GO:1903530),0.32232652177748694,0.8773289849434274,0.6481958762886598,0.8886572367243655,1.0,11/54,18.42%,MCTP1;SCG5;MEF2C;VAMP8;SNCAIP;NSF;CPLX1;STXBP5L;STXBP5;SYT1;HAP1
prerank,very long-chain fatty acid metabolic process (GO:0000038),0.3503143595713649,0.8772580204599761,0.6385372714486639,0.8883129322797014,1.0,9/30,15.26%,SLC27A6;ACSBG1;ACOX1;ELOVL4;HACD4;ELOVL7;ELOVL5;SLC27A2;TECR
prerank,desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.41928702391889705,0.8769192906438886,0.6174496644295302,0.8885020575063017,1.0,2/11,7.74%,ADRB2;ARRB1
prerank,negative regulation of myotube differentiation (GO:0010832),0.40754954968915047,0.8767722218518496,0.605,0.8883019484076171,1.0,1/12,1.60%,NOTCH1
prerank,inner ear receptor cell stereocilium organization (GO:0060122),-0.38081464886430366,-0.876527858351188,0.6241299303944315,0.925717877763351,1.0,2/10,10.07%,ADGRV1;WHRN
prerank,positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.37484375220078464,0.876279485530897,0.5975609756097561,0.888737637607124,1.0,2/18,6.02%,RAB11A;CDC25C
prerank,inorganic anion transmembrane transport (GO:0098661),0.3092554662971789,0.8753404152735198,0.6641221374045801,0.8900627556056475,1.0,17/63,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;SLC25A30;CLCN1;GABRA4;XPR1;SLC1A1;GABRA2;SLC37A2;GABRE;SLC37A3;GLRA2;SLC25A10;GABRG3;GABRB1
prerank,glycerol metabolic process (GO:0006071),-0.3757682546992871,-0.8751634922640965,0.6039603960396039,0.927672429214765,1.0,5/10,23.33%,GK;GOT1;COQ2;TPI1;ANGPTL3
prerank,regulation of cell killing (GO:0031341),0.38493743577085565,0.8749720885837414,0.6273006134969326,0.8903103187397055,1.0,4/16,11.05%,TGFB2;CR1L;RAC1;CYBA
prerank,phosphatidylcholine acyl-chain remodeling (GO:0036151),0.3402974112114484,0.8747341598621171,0.6225352112676056,0.8902744581252502,1.0,6/29,18.28%,MBOAT2;LPCAT4;TMEM86B;LPCAT3;PLA2G12A;PLAAT3
prerank,negative regulation of cellular component movement (GO:0051271),0.3911512742914044,0.8745022892715719,0.6082949308755761,0.8902386352191173,1.0,7/15,15.25%,CRK;SPOCK3;GATA3;SPINT2;PIN1;CD9;FRMD5
prerank,positive regulation of macrophage migration (GO:1905523),-0.3119139944893614,-0.8740691320327575,0.6453488372093024,0.9290789854223068,1.0,4/19,12.66%,IL34;THBS1;P2RX4;MDK
prerank,nervous system development (GO:0007399),0.2636579238438999,0.8740264980288468,0.8020304568527918,0.8906700311586013,1.0,68/429,14.81%,JAG1;KALRN;EFNA5;LDB2;RNF103;SLC2A1;MERTK;APBA1;MPZ;GDA;RAPGEF5;NRGN;GJB1;SERPINI1;PPT1;DNM3;EVL;SNTG2;SPOCK2;PLXND1;WWTR1;MBNL1;MEF2C;PCDH1;SHANK3;SH3GL1;CHRM3;ZBTB16;WWP1;NRCAM;FLRT3;NCKAP1;APC;MAL;EIF2B2;NFASC;ASIC2;FAT4;ADGRB1;KIRREL3;ZC4H2;CDH2;SPOCK1;NCAN;BPNT1;NAV1;GSS;ACHE;SOX10;SOX6;RPS6KA3;CYP26C1;POU3F2;PCDHB16;RBM45;SDCBP2;CAPG;ADGRA2;MYT1L;VLDLR;NELL1;NAV3;TRPC5;PCDHB14;ATXN1;GFRA3;CXCR4;FZD9
prerank,regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),0.3509720234005438,0.8739238215035521,0.6118012422360248,0.8903944473326492,1.0,4/26,8.68%,EFNA5;KLF7;PIM3;NR1D1
prerank,defense response to Gram-negative bacterium (GO:0050829),0.3227800851205261,0.8729476915398305,0.6266846361185984,0.8917262291935675,1.0,10/42,16.66%,DEFA6;IRGM;GALP;ADGRB1;CHGA;RPL30;RNASE6;HMGB2;DROSHA;PYCARD
prerank,microtubule anchoring at centrosome (GO:0034454),-0.37965029024717567,-0.8727641095072391,0.6359338061465721,0.9308130220992215,1.0,5/10,26.90%,NINL;KIF3A;CCDC68;CCDC120;CEP19
prerank,negative regulation of sprouting angiogenesis (GO:1903671),0.4168125309514355,0.8727014738267737,0.5985915492957746,0.8917062076061215,1.0,3/11,12.49%,KLF2;EPN2;PIK3CB
prerank,establishment of protein localization to organelle (GO:0072594),-0.2271357770403386,-0.8726296046689596,0.7619047619047619,0.9299209071955872,1.0,21/72,24.39%,APPL2;NUP107;HEATR3;CSE1L;PPP1R10;NUP155;TNPO3;RANBP6;HK2;IPO5;FAM53C;NUP93;TNPO2;RANBP17;TSC2;PHB2;SEC13;SYK;IPO7;POM121;IPO8
prerank,aromatic amino acid family metabolic process (GO:0009072),0.4268478331844833,0.8724674359505891,0.626465661641541,0.8916979019173403,1.0,4/10,22.19%,ATP7A;KYAT1;KYNU;QDPR
prerank,B cell activation involved in immune response (GO:0002312),0.4048810077989945,0.8719284952304569,0.617693522906793,0.8922602294957142,1.0,2/13,7.65%,FCGR2B;EXOSC3
prerank,"vesicle targeting, rough ER to cis-Golgi (GO:0048207)",-0.23657140518065664,-0.8715751923471653,0.7081339712918661,0.9286691088347538,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,vesicle coating (GO:0006901),-0.23657140518065664,-0.8715751923471653,0.7081339712918661,0.9286691088347538,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,COPII vesicle coating (GO:0048208),-0.23657140518065664,-0.8715751923471653,0.7081339712918661,0.9286691088347538,1.0,27/61,26.37%,SEC24D;GOLGA2;TGFA;TRAPPC10;LMAN1;SEC31A;STX5;SEC24C;SEC16B;TRAPPC3;NAPA;SEC16A;CTSC;F5;TBC1D20;SAR1B;SEC23A;PPP6R1;SEC13;BET1;TRAPPC6A;PREB;COL7A1;TRAPPC4;CTSZ;CNIH3;F8
prerank,cell cycle G1/S phase transition (GO:0044843),0.30733717299985175,0.8714996889705114,0.6446700507614214,0.8925915011520271,1.0,15/61,21.20%,PLK3;ACVR1;CCNE1;CUL3;MAP3K11;CUL2;USP29;HINFP;RPS6KB1;CDKN2D;CACUL1;E2F3;MAX;MNAT1;BCAT1
prerank,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.35072618257319227,-0.8712288289724459,0.6432038834951457,0.9282838273528686,1.0,10/12,53.71%,CCR2;SLC11A1;PRKCQ;IL12RB1;CARD9;IL23A;IL23R;IL12B;CLEC6A;IL1B
prerank,negative regulation of leukocyte cell-cell adhesion (GO:1903038),-0.31553932059876916,-0.8711823958318696,0.6495726495726496,0.9272277015305966,1.0,3/18,5.49%,WNK1;PPARA;PTPN22
prerank,cellular polysaccharide biosynthetic process (GO:0033692),-0.2869134181950683,-0.8701296422140308,0.6726726726726727,0.9283659194738335,1.0,4/25,11.07%,B3GALT1;B3GNT2;HS2ST1;NDST3
prerank,lymphocyte chemotaxis (GO:0048247),-0.2626547070096882,-0.8699136940337889,0.7006578947368421,0.9276755442050069,1.0,23/34,51.87%,SLC12A2;CXCL16;CCL25;CKLF;GPR183;CCL19;HSD3B7;PIK3CG;CCL2;CCL14;CX3CL1;GAS6;CCL5;CCL11;CCL7;CCL8;MSMP;ADAM8;CCL1;CCL3;XCL1;CXCL13;CCL13
prerank,positive regulation of type I interferon production (GO:0032481),0.30051786750027776,0.8697285046016363,0.6609336609336609,0.8954281034831455,1.0,17/73,20.59%,IFIH1;LRRFIP1;TLR3;DDX41;STAT1;OAS2;POLR3B;GAPDH;DHX9;IRF5;RIOK3;CTNNB1;RELA;G3BP1;SETD2;POLR3C;DHX58
prerank,phospholipid transport (GO:0015914),0.3160698253915827,0.8688934650828323,0.6566579634464752,0.8965313318729409,1.0,8/52,12.95%,ATP10A;APOA1;PLTP;ABCB4;PITPNA;ATP11C;ATP8B1;ABCC1
prerank,nucleoside triphosphate metabolic process (GO:0009141),-0.3401862465854427,-0.8688081966048418,0.6403940886699507,0.9290716871949771,1.0,6/14,19.85%,ENPP1;ENPP3;AK5;CMPK2;AK1;NME2
prerank,endoplasmic reticulum to cytosol transport (GO:1903513),0.38796701872505235,0.8688026124795943,0.6442622950819672,0.8962564865648555,1.0,6/15,28.88%,HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,RNA 3'-end processing (GO:0031123),-0.2327648981509009,-0.8687203161310167,0.7788461538461539,0.9280906364359931,1.0,28/69,25.48%,SRSF5;NUDT21;NCBP1;LIN28B;SRRM1;SRSF1;SRSF6;PABPN1;THOC1;TENT4B;TUT1;SUPV3L1;CSTF2T;PCF11;MAGOH;U2AF2;TUT4;MAGOHB;UPF3B;SRSF3;SRSF11;NCBP2;PAPOLA;SRSF2;EIF4A3;U2AF1;ZC3H11A;THOC7
prerank,positive regulation of voltage-gated potassium channel activity (GO:1903818),0.4080991785342538,0.8685492723875893,0.6288135593220339,0.8962749738682966,1.0,1/11,3.68%,NOS1AP
prerank,regulation of transcription by RNA polymerase I (GO:0006356),-0.3253563351163362,-0.8684477368809298,0.6401098901098901,0.9275274729066362,1.0,10/18,39.63%,FLNA;ERBB2;MAF1;UBTF;PHF8;DHX33;POLR2L;HEATR1;POLR2K;EIF2AK3
prerank,negative regulation of B cell activation (GO:0050869),0.3662895333850255,0.8681102852627275,0.6331360946745562,0.8965889822254972,1.0,6/21,19.95%,FCGR2B;TYROBP;LAPTM5;ATM;BANK1;FOXJ1
prerank,ubiquitin-dependent protein catabolic process (GO:0006511),0.26403816416651243,0.8675776689306619,0.7926455566905005,0.8971128208066979,1.0,88/341,21.13%,ZNRF1;CBL;FBXO7;PSMD13;FBXL14;KLHL3;ELOC;RNF125;RNF185;ARIH1;CUL3;ARRDC1;UBE2D1;PSMD4;KLHL20;PTTG1;ARRB1;WWP1;UBE4A;TOM1L1;FEM1C;NFE2L2;PPP2R5C;NDFIP2;VPS28;RNF128;PSMA5;RNF115;FBXW7;RBX1;PSMB10;ZNRF3;SIAH2;TRIM25;RNF144B;NEDD4L;BAG6;PSMB8;PSMD14;DTX3L;SMURF1;KCTD10;RMND5B;VPS4A;PSMA7;PSMC3;KEAP1;PSMA8;PSMC1;PSMB5;CTNNB1;UBE2E1;CDC27;PSMC5;TRIM2;UBE3B;NHLRC1;UBE2D3;PSMB9;UBQLN2;KLHL25;SPOPL;ANAPC7;PSMC6;RNF150;PSMA4;FBXO8;UBQLN4;GSK3A;FBXO10;PSMD5;PSMD9;FEM1A;PSMB6;ANAPC4;RNF166;FBXO45;ZFAND2A;MAEA;MVB12A;RNF5;KCTD2;RNF34;PSMB2;RNF11;WWP2;KCTD21;UBA1
prerank,histone mRNA catabolic process (GO:0071044),0.38262906905466754,0.8675623224959308,0.6365054602184087,0.8966758153574051,1.0,7/15,21.35%,LSM1;MTPAP;XRN1;ATM;TENT2;TUT7;EXOSC10
prerank,protein modification by small protein removal (GO:0070646),0.2664835195864778,0.8673558247971186,0.7691511387163561,0.8965935708005498,1.0,65/252,21.84%,SMAD7;FOXO4;USP38;IFIH1;ADRB2;COPS4;PSMD13;SMAD2;TAF9B;GATA3;UBE2D1;PSMD4;ZC3H12A;SENP5;UBA52;APC;RPS27A;RNF128;PSMA5;BABAM2;PSMB10;SIAH2;NFKBIA;USP12;POLB;PSMB8;ACTB;PSMD14;BRCA1;EIF3F;USP29;COPS8;YOD1;PSMA7;PSMC3;KEAP1;HIF1A;PSMA8;PSMC1;PSMB5;USP9Y;PSMC5;PSMB9;TRRAP;PSMC6;ESR1;USP35;PSMA4;COPS5;SENP7;SMAD4;PSMD5;PSMD9;USPL1;PSMB6;INO80D;BARD1;STAM2;PSMB2;TAB1;SENP6;USP47;UBB;USP14;USP30
prerank,positive regulation by host of viral transcription (GO:0043923),-0.3370051418292711,-0.8668674710811614,0.6225352112676056,0.9299052899397285,1.0,3/15,5.29%,SNW1;NUCKS1;SMARCB1
prerank,aerobic respiration (GO:0009060),-0.3136579438833983,-0.8665918295664219,0.6867469879518072,0.9293825789175648,1.0,10/20,25.94%,SIRT3;MDH2;NDUFS7;SDHB;MTFR1L;UQCRH;ATP5F1D;SLC25A14;MTFR2;NDUFS8
prerank,vitamin D metabolic process (GO:0042359),-0.34810681445824093,-0.8662123005596243,0.6534391534391535,0.9290577905788506,1.0,10/13,49.38%,LGMN;PIAS4;CYP2R1;CUBN;LRP2;VDR;CYP1A1;CYP27B1;CYP24A1;FGF23
prerank,glycogen biosynthetic process (GO:0005978),0.39738496136097595,0.8660457123893529,0.6326194398682042,0.8981403802557367,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,glucan biosynthetic process (GO:0009250),0.39738496136097595,0.8660457123893529,0.6326194398682042,0.8981403802557367,1.0,3/12,14.76%,PGM2L1;NR1D1;NHLRC1
prerank,response to amino acid starvation (GO:1990928),0.2965895689507528,0.8657329030725384,0.6679487179487179,0.8982866478180638,1.0,19/72,20.88%,FAS;CASTOR1;PRKD1;DAP;MAPK1;WDR59;RRAGD;GCN1;RHEB;EIF2S1;MIOS;ATP6V1G1;ATP6V1C1;RRAGA;RRAGC;NPRL3;LAMTOR3;ATP6V1D;EIF2AK2
prerank,response to nitric oxide (GO:0071731),0.4065829483367029,0.865285953510242,0.6366612111292962,0.8986723444642035,1.0,1/13,1.88%,FOXO1
prerank,regulation of cilium assembly (GO:1902017),0.30058619601048514,0.8652555519249827,0.6478696741854637,0.8982606814009445,1.0,11/62,13.12%,RABGAP1;SAXO1;TBC1D30;TBC1D8;IFT140;TBC1D5;TBC1D1;CCDC88A;LIMK2;USP6NL;TBC1D10A
prerank,"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",0.3132335894266435,0.8651766538483939,0.66541822721598,0.8979374827752703,1.0,15/52,18.99%,LSM1;EXOSC3;CNOT6L;DCPS;DCP1B;POLR2D;CNOT1;EXOSC8;EDC3;NT5C3B;DDX6;CNOT2;EXOSC9;TUT7;LSM2
prerank,'de novo' posttranslational protein folding (GO:0051084),0.3430005273747533,0.8651514757679905,0.6391184573002755,0.8975234682443887,1.0,7/30,18.60%,HSPA1B;HSPE1;PTGES3;CCT2;UGGT1;DNAJC7;DNAJB5
prerank,positive regulation of leukocyte degranulation (GO:0043302),0.4110637215828051,0.8650599508271436,0.6328257191201354,0.8972541765646991,1.0,2/13,7.12%,F2RL1;ITGAM
prerank,regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),0.28522670706313935,0.8645988331972241,0.6967895362663495,0.8976373026225773,1.0,24/100,17.93%,SMAD7;SUMO2;CSNK1D;FOXF2;BBS7;ARIH1;RYBP;LRRK2;HSPA1B;CEBPA;XPO1;RBX1;NKD2;RNF144B;BAG6;CLU;KEAP1;RACK1;EIF3H;CBFA2T3;TRIB3;SOCS5;UBQLN4;GSK3A
prerank,lipid transport (GO:0006869),0.28817705637469,0.8644606905364857,0.6957040572792362,0.897424520761837,1.0,10/97,8.62%,ABCC4;CEACAM1;TTPA;SLCO1C1;APOA1;SPNS2;PLTP;GLTP;CERT1;PITPNA
prerank,positive regulation of DNA-dependent DNA replication (GO:2000105),0.4190304022695268,0.8643845851367414,0.6414141414141414,0.897100490814977,1.0,2/10,11.55%,SSBP1;E2F7
prerank,regulation of lipid metabolic process (GO:0019216),-0.22155734003465918,-0.8638943233696833,0.8132530120481928,0.9329556962109318,1.0,14/88,10.78%,PRKAG2;CHD9;TBL1XR1;PPARA;CREBBP;RORA;NFYC;IRS2;OPA3;NR1D2;C1QTNF2;CCDC3;TNFAIP8L3;PPARG
prerank,bone morphogenesis (GO:0060349),0.39181603654413666,0.8636125573109716,0.6594090202177294,0.8980648554593238,1.0,2/14,5.43%,BMPR2;FGFR3
prerank,negative regulation of transferase activity (GO:0051348),0.34961060227471136,0.8635356453932118,0.6406926406926406,0.8977497587894105,1.0,7/28,20.25%,SMAD7;INPP5K;DTX3L;ERCC4;MEN1;GSK3A;GSK3B
prerank,steroid metabolic process (GO:0008202),-0.23093542396559466,-0.8630326330084268,0.7514792899408284,0.9336320714237551,1.0,21/72,29.74%,CYP27A1;CYP26B1;LIPA;SCP2;DHRS4;FDX1;GBA2;AMACR;CYP2A6;LGMN;CYP51A1;PIAS4;STAR;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP2R1;ARV1;CYP46A1
prerank,transcription by RNA polymerase II (GO:0006366),0.2624459932294313,0.8626405789057944,0.7670807453416149,0.8989595287014549,1.0,67/305,17.58%,NOTCH4;TSC22D1;NR4A2;NOTCH1;NR1I3;HNF4A;HDAC9;HDAC7;TEAD4;MED26;WWTR1;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;INTS11;RTF1;RXRG;TRIM24;EAF1;SETX;CPSF1;ELP4;ELP2;POLR2G;NR1D1;MBD1;ELOA;POLR2D;ELL2;SNRPE;RPRD1B;FIP1L1;DEAF1;TBPL1;MAML2;INTS12;EAF2;GTF2H3;NR4A1;KLF13;CBFB;GTF2A1;DDX21;INTS5;MED27;MED17;MLLT3;MED4;ICE1;ELOF1;TAF11;SNAPC4;NELFB;NR2C1;POLR2I;AFF4;ESR1;ESRRG;NELFA;RARA;TAF8;RPAP1;DRAP1;RPRD2
prerank,autophagosome assembly (GO:0000045),0.31315398111999915,0.8625953106396649,0.6472114137483788,0.8985781819684697,1.0,12/52,16.99%,TRAPPC8;ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;SMURF1;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,negative regulation of oxidative stress-induced neuron death (GO:1903204),0.41826262141458215,0.8625358892319763,0.6034782608695652,0.8982239760484173,1.0,3/11,15.49%,FBXO7;HIF1A;RACK1
prerank,negative regulation of protein catabolic process (GO:0042177),0.3263560536052635,0.8624080146142493,0.6534788540245566,0.8980069435063519,1.0,9/40,14.15%,AZIN1;DAB2IP;TIMP3;ROCK1;MAD2L2;PRKCG;ADGRB1;PIN1;NELL1
prerank,DNA damage checkpoint signaling (GO:0000077),0.345531028911216,0.862343880126029,0.6213450292397661,0.8976533989042852,1.0,10/28,19.44%,BRIP1;HINFP;STK33;RAD1;ATM;MAP3K20;FBXO6;TIPRL;ATRIP;HUS1
prerank,chromatin organization involved in regulation of transcription (GO:0034401),-0.34017044544489994,-0.86212124827223,0.6207792207792208,0.9344953793873791,1.0,5/13,12.82%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,positive regulation of cellular component biogenesis (GO:0044089),0.2923957290553142,0.8620281091968969,0.6768507638072856,0.8977845713470393,1.0,14/88,15.85%,SYNPO;TAL1;MMP1;DAB2IP;TIRAP;HRK;WARS1;SPIDR;CLU;CHGA;VPS4A;ICE1;RACK1;VIL1
prerank,regulation of pH (GO:0006885),0.40802610296197145,0.8619112751808023,0.6133333333333333,0.89753146706237,1.0,3/11,9.59%,ATP1A4;CLCN3;SLC9A7
prerank,protein auto-ADP-ribosylation (GO:0070213),-0.35598315761423044,-0.861879277715282,0.6634146341463415,0.933901370370346,1.0,5/12,24.63%,PARP8;PARP3;PARP1;PARP6;PARP2
prerank,regulation of protein transport (GO:0051223),0.34014226871439435,0.8618302330072898,0.6389684813753582,0.8972121924120471,1.0,8/27,20.91%,PPM1F;NDFIP2;PTPN1;LCP1;STXBP5L;STXBP5;DNAJA1;WWP2
prerank,pseudouridine synthesis (GO:0001522),0.40941724313847866,0.8616787761769834,0.6282467532467533,0.8970349295219221,1.0,4/13,17.96%,DKC1;TRUB1;NHP2;RPUSD2
prerank,negative regulation of mRNA processing (GO:0050686),-0.33161867047592003,-0.8614708848716749,0.6191780821917808,0.9336381064525826,1.0,8/15,34.87%,RBMX;SRSF6;PCBP4;U2AF2;C1QBP;SAP18;SRSF10;RNPS1
prerank,keratan sulfate biosynthetic process (GO:0018146),0.34959801600208196,0.8612990181899975,0.6435643564356436,0.8972440093525094,1.0,8/26,15.67%,ST3GAL6;B4GALT4;SLC35D2;B3GNT3;B4GALT6;CHST1;ST3GAL1;ST3GAL2
prerank,ribosomal subunit export from nucleus (GO:0000054),0.39956258204671535,0.8612027769010463,0.655,0.8969624577751724,1.0,5/13,14.77%,XPO1;NPM1;RAN;RPS15;EIF6
prerank,T cell differentiation in thymus (GO:0033077),-0.34525771532830174,-0.860976216178008,0.6282051282051282,0.9335598013829369,1.0,1/14,0.41%,GLI3
prerank,regulation of histone deacetylation (GO:0031063),0.3967256455984197,0.8607715487022283,0.6389351081530782,0.8973143891874119,1.0,2/13,4.95%,ING2;CAMK2D
prerank,negative regulation of leukocyte chemotaxis (GO:0002689),-0.366572817462544,-0.8607342500370389,0.65,0.9329318720281934,1.0,3/11,6.10%,NBL1;SLIT2;CCN3
prerank,mitotic metaphase plate congression (GO:0007080),0.3076384903401223,0.8599377850331991,0.6727037516170763,0.898400042493102,1.0,11/51,16.03%,RAB11A;CUL3;KPNB1;CHMP1B;VPS4A;CHMP3;CEP55;CHMP2B;CHMP7;BOD1;NDC80
prerank,androgen receptor signaling pathway (GO:0030521),-0.3472177230623274,-0.8598591130973203,0.6381909547738693,0.9336585158993874,1.0,3/11,4.18%,DDX5;ZMIZ1;DDX17
prerank,positive regulation of coagulation (GO:0050820),-0.3626400593927249,-0.8597023699508147,0.6587677725118484,0.9316807012473539,1.0,3/10,11.24%,THBS1;ST3GAL4;SERPINE1
prerank,positive regulation of hemostasis (GO:1900048),-0.3626400593927249,-0.8597023699508147,0.6587677725118484,0.9316807012473539,1.0,3/10,11.24%,THBS1;ST3GAL4;SERPINE1
prerank,cellular response to interleukin-6 (GO:0071354),0.34986682850996476,0.8595723686036001,0.6290322580645161,0.8986069469621664,1.0,9/26,19.14%,ST3GAL6;CBL;STAT1;CEBPA;JAK2;PTGIS;SMAD4;RELA;SELPLG
prerank,reverse cholesterol transport (GO:0043691),0.40030625393864117,0.8592460038216206,0.6292517006802721,0.898777154630876,1.0,4/13,17.41%,APOA1;LCAT;CLU;SCARB1
prerank,regulation of oligodendrocyte differentiation (GO:0048713),-0.30834364701052147,-0.8591621830741273,0.6820809248554913,0.9317178323464915,1.0,5/18,13.92%,PTN;IL34;DAAM2;MDK;SLC45A3
prerank,Golgi inheritance (GO:0048313),0.41106967137252926,0.8591523074603836,0.6320272572402045,0.8984866827623251,1.0,3/11,15.45%,PLK3;VRK1;PDCD10
prerank,morphogenesis of an epithelial sheet (GO:0002011),0.41898340267955403,0.8580560158165833,0.6388415672913118,0.9000594495589392,1.0,2/10,2.96%,NOTCH1;DLL4
prerank,cholesterol biosynthetic process (GO:0006695),0.3410430090408811,0.8580093848776735,0.6415362731152204,0.8996832723860866,1.0,14/31,26.49%,APOA1;PLPP6;HMGCS1;MVD;ACAA2;DHCR7;GGPS1;ACLY;IDI1;MVK;INSIG1;HMGCR;FDFT1;LBR
prerank,L-glutamate transmembrane transport (GO:0015813),-0.3654376526554503,-0.857647013044204,0.6456310679611651,0.933864047919751,1.0,2/10,3.00%,SLC1A3;SLC25A13
prerank,insulin receptor signaling pathway (GO:0008286),0.29679100407945186,0.8575364192567514,0.6781750924784217,0.9001038017435519,1.0,25/69,23.28%,FOXO4;IRS4;FOXO1;INSR;CAV2;PIK3C2A;BCAR3;APC;NAMPT;AP3S1;PHIP;GRB14;SOS1;PTPN2;ATP6V1G1;GSK3A;ATP6V1C1;ATP6V0A1;GSK3B;ATP6V1D;PIK3R3;BCAR1;ZNF106;PIK3CA;IGF1R
prerank,cellular response to UV-A (GO:0071492),0.4186714346217818,0.8565095993919142,0.6039933444259568,0.9015397144993746,1.0,4/11,22.89%,MMP1;PPID;TIMP1;MME
prerank,regulation of cholesterol storage (GO:0010885),-0.3303834685276592,-0.8564455638356667,0.6657534246575343,0.9352800890428561,1.0,7/15,24.33%,ABCA1;PPARA;PPARG;NR1H3;LPL;PPARD;MSR1
prerank,attachment of mitotic spindle microtubules to kinetochore (GO:0051315),-0.3427470243748082,-0.85636641583571,0.6436170212765957,0.9343000198356038,1.0,3/12,11.29%,CENPC;RMDN1;MIS12
prerank,positive regulation of vasoconstriction (GO:0045907),0.39310132684128224,0.8556066078698427,0.6111111111111112,0.9027341011082628,1.0,1/13,2.28%,CAV1
prerank,"nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.3623742327359942,0.8550920680520805,0.6550680786686838,0.9032178570155015,1.0,7/23,17.63%,COPS4;UBA52;RPS27A;RBX1;COPS8;XPC;COPS5
prerank,regulation of carbohydrate catabolic process (GO:0043470),-0.252040608321754,-0.8540543532512759,0.7489539748953975,0.9381529452389271,1.0,2/41,0.78%,PRKAG2;OGT
prerank,regulation of glycogen metabolic process (GO:0070873),0.3965584597106153,0.8539169527823478,0.619281045751634,0.9049255934406104,1.0,1/12,3.52%,INPP5K
prerank,peptidyl-proline modification (GO:0018208),-0.2893534518861981,-0.8535876206625459,0.7286135693215339,0.9380177043519347,1.0,8/25,11.70%,FKBP5;NKTR;PPIC;FKBP10;PPIA;FKBP7;P3H2;PPIL2
prerank,innate immune response in mucosa (GO:0002227),0.4266379368625349,0.8534702116164355,0.6440972222222222,0.905305010256571,1.0,1/10,4.04%,DEFA6
prerank,acute inflammatory response (GO:0002526),-0.29566844856456814,-0.8533940811814241,0.6822429906542056,0.9373420994411894,1.0,4/23,8.52%,LBP;IL6R;F3;CEBPB
prerank,positive regulation of epidermal cell differentiation (GO:0045606),-0.3383172999325641,-0.8533811820059304,0.657608695652174,0.9362159467284544,1.0,4/15,21.25%,BMP4;SFRP4;NME2;ETV4
prerank,positive regulation of cellular component movement (GO:0051272),0.3551560643197021,0.8527038198805981,0.6651718983557549,0.906224352034479,1.0,5/24,11.30%,ACTN4;SPOCK2;NTN1;ADAM17;CAVIN1
prerank,negative regulation of transmembrane transport (GO:0034763),0.4128736814060584,0.8525958159532272,0.6600660066006601,0.905962135739161,1.0,2/10,5.41%,INPP5K;CTTNBP2NL
prerank,cell projection assembly (GO:0030031),0.3472283481924733,0.8525691300389366,0.6371951219512195,0.9055447860031245,1.0,7/22,13.75%,PARVB;NCKAP1;NEFH;CYFIP1;RAC1;CAPG;RHOH
prerank,negative regulation of cell cycle G1/S phase transition (GO:1902807),0.32879906413568133,0.8522212719168011,0.6699029126213593,0.9057206750642438,1.0,5/31,11.55%,FAM107A;KLF4;RBL1;APC;E2F7
prerank,positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.3279633899148537,0.8519838461180451,0.6532593619972261,0.9057080233339243,1.0,4/34,4.06%,NEDD9;CRK;APOA1;LIMS2
prerank,response to interleukin-6 (GO:0070741),-0.3773713418996135,-0.851838894804125,0.674364896073903,0.9384058377413144,1.0,1/10,0.13%,PID1
prerank,positive regulation of DNA binding (GO:0043388),-0.26976323621213555,-0.851629506173454,0.71,0.9376659329809965,1.0,6/31,14.40%,IGF1;PRKN;NGF;PPARG;TXN;SIRT2
prerank,regulation of protein serine/threonine kinase activity (GO:0071900),0.2803995545041155,0.8514702867243035,0.7080459770114943,0.9061722538522115,1.0,22/104,21.43%,CCND2;CCND3;DAB2IP;ADRB2;SLC8A1;CCNE1;SERTAD1;CDC25C;IRGM;SYAP1;ACTB;CALM3;LRP5;PDCD10;CDKN2D;PYCARD;TRIB3;MAP2K1;CAB39;BLM;MNAT1;RALB
prerank,ovarian follicle development (GO:0001541),-0.3418098279389766,-0.8514127548274691,0.6807387862796834,0.9369644937718788,1.0,8/13,34.17%,KIT;CEBPB;VEGFA;INHBA;INHBB;FOXL2;LHCGR;EIF2B5
prerank,positive regulation of neuron differentiation (GO:0045666),0.32411275131069034,0.851363808583783,0.6652892561983471,0.9059107327020535,1.0,13/40,21.61%,ARHGEF2;MEF2C;NRCAM;TCF3;ZC4H2;MMD;PCP4;FGF20;SIN3A;HOXD3;SOX11;MMD2;ECT2
prerank,regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.3477883416004648,-0.8503050811277018,0.6751152073732719,0.9381238115214933,1.0,5/12,24.04%,PTPN22;RUNX1;CD300A;RC3H1;PTPRC
prerank,protein O-linked glycosylation via serine (GO:0018242),-0.380385735038874,-0.8503037891017814,0.6727688787185355,0.9369846905546774,1.0,5/10,20.74%,GALNT1;POGLUT2;POGLUT3;GALNT16;GALNT3
prerank,carbohydrate catabolic process (GO:0016052),0.31469946947278715,0.8492260387148459,0.6675712347354138,0.909351006862297,1.0,8/38,19.34%,MANBA;GPI;PGK1;GAPDH;MAN2C1;PFKM;MAN2B2;NEU4
prerank,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.34387220724635487,0.8490406715708437,0.6570605187319885,0.9092177546056393,1.0,3/27,5.59%,F2RL1;GPR157;LPAR6
prerank,antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2888840354860558,0.8489672758181023,0.7020262216924911,0.9084197683961864,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.2888840354860558,0.8489672758181023,0.7020262216924911,0.9084197683961864,1.0,20/78,21.88%,AP1S2;AP2B1;FCGR2B;KIF26A;ACTR1B;KIF2A;OSBPL1A;AP2M1;DYNLL1;KLC2;DYNC1LI2;SEC24B;AP1B1;DYNLL2;SEC24A;ACTR1A;CAPZA2;DYNC1I2;DCTN4;KIF23
prerank,natural killer cell activation (GO:0030101),0.3423274480396574,0.8484177373731545,0.6490455212922174,0.9089528758585614,1.0,4/23,16.30%,CASP8;BAG6;KAT7;NFIL3
prerank,potassium ion import across plasma membrane (GO:1990573),0.31481112441247483,0.8480830822507965,0.6920980926430518,0.9091169508241188,1.0,4/41,3.90%,ATP1A4;ATP1A1;ATP1A3;SLC12A8
prerank,anterograde synaptic vesicle transport (GO:0048490),0.3808411550905741,0.8476865703055736,0.62248322147651,0.9089338717956842,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,synaptic vesicle transport along microtubule (GO:0099517),0.3808411550905741,0.8476865703055736,0.62248322147651,0.9089338717956842,1.0,7/15,28.66%,BLOC1S6;AP3S1;AP3M1;AP3D1;AP3B1;BLOC1S5;AP3M2
prerank,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),0.35895901446253803,0.8476159506124046,0.6579352850539292,0.9086021598221353,1.0,5/22,12.82%,VPS36;TOM1L1;VPS28;RNF115;VPS4A
prerank,intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.39508462355489915,0.8475348567192519,0.6505190311418685,0.9082836425747592,1.0,2/11,4.13%,ARL6IP5;STK24
prerank,genitalia development (GO:0048806),-0.3355913972505685,-0.8472440991621702,0.6792929292929293,0.9423321020008776,1.0,3/12,11.67%,WNT5A;STRA6;PKD1
prerank,endosome organization (GO:0007032),0.3188825074311092,0.8465478037932869,0.6906077348066298,0.9096459253164679,1.0,9/41,18.80%,ALS2CL;SNX10;HOOK1;CLCN3;EXOC8;CHMP2B;PHETA1;RAB27A;HOOK2
prerank,regulation of receptor recycling (GO:0001919),-0.306894954250924,-0.8465021761921944,0.6639344262295082,0.9427275253582329,1.0,3/16,9.52%,ANXA2;OPTN;TBC1D16
prerank,ether lipid metabolic process (GO:0046485),-0.33791152177842104,-0.8464448973540831,0.689922480620155,0.9416962734203015,1.0,3/14,7.84%,AGMO;GNPAT;PEDS1
prerank,translational termination (GO:0006415),0.28208822274786793,0.8461425998080885,0.6895348837209302,0.9099088280265489,1.0,39/95,28.55%,MRPL4;MRPL18;MRPL41;MRPS31;MRPL1;ETF1;MRPL19;MRPL15;MRPL36;MRPL47;MRPL52;MRPL23;MRPL24;MRPL14;MRPL32;MRPS34;MRPS12;MRPL39;MRPL54;MRPS18B;MRPS30;MRPL11;MTRF1L;MRPS35;MRPS28;MRPS9;MRPS27;MRPL34;MRPS24;MRPL35;MRPL10;MRPS18C;MRPL27;MRPL38;APEH;MRPL13;AURKAIP1;ERAL1;MRPL40
prerank,histone methylation (GO:0016571),-0.28627270709453495,-0.8458502727470321,0.7418397626112759,0.9417675018533184,1.0,6/26,16.44%,CREBBP;NSD3;NSD1;EHMT1;SUV39H1;N6AMT1
prerank,regulation of proteasomal protein catabolic process (GO:0061136),0.3069536572610177,0.8454899328265345,0.6746987951807228,0.9106315995217338,1.0,17/53,22.21%,ECSCR;DAB2IP;FOXF2;XPO1;FBXW7;PRKCG;PSMD14;PSMC3;PSMC5;PSMC6;OPHN1;UBQLN4;PSME3IP1;TMF1;UBB;USP14;GLMN
prerank,negative regulation of RNA metabolic process (GO:0051253),0.3655900495954802,0.8454449598065477,0.6476190476190476,0.9102439197960333,1.0,10/18,27.91%,ZC3H12A;PTBP3;TMBIM6;ESR1;PTBP2;SHQ1;NCOR2;NUDT16;TGFB1;RPS13
prerank,respiratory chain complex IV assembly (GO:0008535),-0.2918443272179517,-0.8448714157516412,0.7138888888888889,0.9427296709365935,1.0,10/21,30.02%,COX17;COX16;COX18;COX10;SMIM20;TIMM21;COA6;FASTKD3;COX14;COX19
prerank,regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),-0.2781745520899954,-0.8444261727851559,0.6833855799373041,0.9425230980653563,1.0,10/24,23.20%,APOE;ATP5IF1;PRKACA;PKD1;CTSC;NUB1;LATS1;RHBDF1;GPX1;PSME1
prerank,acylglycerol homeostasis (GO:0055090),0.3580183240456542,0.8436538009967606,0.6513353115727003,0.9130722663501626,1.0,2/20,3.48%,HNF4A;APOA1
prerank,signal peptide processing (GO:0006465),0.4005479088970716,0.8433866733226392,0.6327212020033389,0.9130924175246811,1.0,2/11,5.65%,PCSK5;FURIN
prerank,regulation of lamellipodium organization (GO:1902743),-0.3266196994611371,-0.8431424966729117,0.6764705882352942,0.9440493277819783,1.0,3/14,13.50%,PDPN;CAPZB;FER
prerank,fatty acid catabolic process (GO:0009062),-0.22787133632675177,-0.843033148942544,0.8159203980099502,0.9431558844958716,1.0,27/67,30.18%,PCCA;ABCD3;SCP2;PEX2;BDH2;ACAT2;EHHADH;ACADM;ECHDC2;PLA2G15;ECI2;HACL1;CPT2;ACAD11;ACADVL;PEX13;NUDT19;FAAH;MTLN;PPARD;PHYH;ECHS1;HSD17B10;LPIN3;PCCB;LPIN1;PECR
prerank,regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.3427014059855759,-0.8426891217953403,0.6675324675324675,0.9427838497099488,1.0,1/12,0.28%,CACNA1C
prerank,NLS-bearing protein import into nucleus (GO:0006607),0.38225829254491184,0.8426353061215256,0.6339144215530903,0.9140201950044351,1.0,5/13,15.32%,KPNB1;NUP54;NUP35;RANBP2;KPNA3
prerank,secondary palate development (GO:0062009),0.37915557294398416,0.8422849835505292,0.6577287066246057,0.9141837880057625,1.0,3/14,5.38%,TGFB2;LEF1;SMAD2
prerank,"positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.3059638140868381,-0.8421269000322669,0.7054054054054054,0.9427903201325317,1.0,3/18,6.76%,NLGN2;CACNG4;TSHZ3
prerank,positive regulation of macrophage chemotaxis (GO:0010759),-0.32672859024592876,-0.841676055192958,0.6518105849582173,0.9425174002160499,1.0,2/14,3.41%,IL34;THBS1
prerank,positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.34661681276830475,0.8413617768103755,0.6471471471471472,0.9153957661653459,1.0,8/22,21.58%,IFNGR1;EFNA1;RANBP9;CLU;GSK3A;RELA;AGER;EPHA4
prerank,cellular response to glucose starvation (GO:0042149),0.31028798227947235,0.8407122542479166,0.6867627785058977,0.9161720627567234,1.0,5/41,9.53%,NUAK1;ZC3H12A;SIK2;PRKAA1;PIK3C3
prerank,mitochondrion organization (GO:0007005),0.2633204590026526,0.8405238221151539,0.7731277533039648,0.9160637543474026,1.0,28/165,15.75%,NOS3;CAV2;DNM3;FBXO7;ATP7A;OMA1;SSBP1;CHCHD3;SIRT4;CHCHD2;SLC25A33;ALAS1;AKT3;LRRK2;IMMP2L;BCL2L1;VPS13D;TSPO;MIGA1;MFN1;POLG2;RHOT2;BNIP3L;BNIP3;TFB2M;NUBPL;PTCD2;SAMM50
prerank,positive regulation of protein dephosphorylation (GO:0035307),0.3258293585049796,0.8403663426368654,0.6685633001422475,0.915857402291148,1.0,17/32,27.96%,ITGA1;PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R15B;DUSP26;PPP1R7;PPP1R15A;CDH5;NSMF;TGFB1;CALM1;SYMPK;SPPL3;SMPD1
prerank,negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.24335551315067666,-0.8398825699089876,0.7489878542510121,0.9449983243286588,1.0,8/44,12.90%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;DDX3X
prerank,negative regulation of transposition (GO:0010529),0.36706471806040347,0.839803878134003,0.6614420062695925,0.9163870338383608,1.0,3/16,18.63%,DDX4;TUT7;TDRD9
prerank,positive regulation of TORC1 signaling (GO:1904263),-0.31612210441438,-0.8394915916483043,0.6777493606138107,0.9447059923579901,1.0,8/16,25.08%,SIK3;KLHL22;FLCN;PIH1D1;TELO2;GPR137;LAMTOR5;RRAGB
prerank,response to hexose (GO:0009746),-0.28149372952161533,-0.8394812187040144,0.7160883280757098,0.9435978055229565,1.0,4/25,7.53%,TCF7L2;THBS1;IRS2;GPLD1
prerank,negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.4047633594126636,0.8389940977448352,0.6706896551724137,0.9173670779628151,1.0,5/10,25.05%,INPP5F;NF2;PTPN2;PARP14;PPP2R1A
prerank,regulation of ubiquitin protein ligase activity (GO:1904666),-0.2980917772254108,-0.8383683673276321,0.7220630372492837,0.9448555933940854,1.0,12/21,41.86%,GOLGA2;CDC14B;FZR1;BTRC;BAG2;MAD2L1;GORASP1;PLK1;CDC20;UBE2C;RPL5;RAB1A
prerank,plasma membrane bounded cell projection morphogenesis (GO:0120039),0.30442006366882307,0.8382279212874362,0.6803594351732991,0.9183109147253629,1.0,11/51,10.64%,DAB2IP;TRIO;ATP7A;SHTN1;MAP4K4;PACSIN1;LRRK2;NCKAP1;SGK1;TAOK2;MINK1
prerank,regulation of cytokine production involved in inflammatory response (GO:1900015),0.314763195182569,0.8376407980342133,0.6875,0.9188844283892075,1.0,4/37,7.01%,GBP5;NOD2;PDCD4;ZC3H12A
prerank,negative regulation of amyloid precursor protein catabolic process (GO:1902992),0.35605159543341747,0.8372103255880587,0.6915739268680445,0.9191937327203393,1.0,10/19,20.71%,RTN1;ROCK1;RTN4;PRNP;CLU;RTN3;PIN1;ABCA7;HAP1;SORL1
prerank,mitotic spindle assembly (GO:0090307),0.3129955412234492,0.8371264733025908,0.7017783857729138,0.9188906113862012,1.0,8/42,13.86%,RAB11A;KIF2A;CLASP1;KPNB1;STAG1;CLASP2;PRC1;ARHGEF10
prerank,regulation of cholesterol metabolic process (GO:0090181),0.35115119927854627,0.8370552823550935,0.669683257918552,0.9185526450822995,1.0,9/20,23.34%,MBTPS2;KPNB1;SEC14L2;LPCAT3;LDLRAP1;RAN;FMO5;SREBF2;TTC39B
prerank,tricarboxylic acid metabolic process (GO:0072350),0.39735836805148417,0.8366721204936849,0.6650246305418719,0.9187725472039565,1.0,3/12,6.37%,GLUD1;ASS1;SIRT4
prerank,piRNA metabolic process (GO:0034587),0.36001110703491185,0.8358963697006819,0.6570121951219512,0.9196940061079705,1.0,3/19,18.63%,DDX4;EXD1;TDRD9
prerank,negative regulation of cell development (GO:0010721),0.3395475236408728,0.8358487001183194,0.6598240469208211,0.9193124017069195,1.0,4/25,9.67%,NOTCH1;B2M;PCM1;FBXW7
prerank,detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.3417738351483488,-0.8356928882735535,0.6707920792079208,0.9492079534641696,1.0,8/11,55.79%,RTP4;LPO;RTP3;TAS1R2;GNAT3;GNAT2;PIGR;TAS1R3
prerank,oxoacid metabolic process (GO:0043436),0.332441776961039,0.8356503414031444,0.6600284495021337,0.9192021534237046,1.0,5/27,11.49%,MINPP1;SULT6B1;LIPT2;LIPT1;BPNT1
prerank,positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),0.3631412929071036,0.8356363200324707,0.6442307692307693,0.9187683317770962,1.0,10/16,27.33%,MAD2L2;DTX3L;KDM4D;RIF1;SHLD3;SHLD2;WRAP53;SHLD1;PARP9;SMCHD1
prerank,muscle cell migration (GO:0014812),-0.36479251670633983,-0.8353985834265875,0.6888361045130641,0.948679692315034,1.0,4/10,16.22%,CCN3;SIX1;DDR1;AAMP
prerank,positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.2611779994528834,-0.8352492341373458,0.7333333333333333,0.947866411746351,1.0,9/31,23.33%,GOLGA2;UBE2N;DCUN1D3;UBE2L3;CDC14B;TOPORS;DCUN1D4;FZR1;BTRC
prerank,positive regulation of type 2 immune response (GO:0002830),0.38037370564907286,0.8346371080727015,0.6530612244897959,0.9201145682326257,1.0,3/14,16.90%,NOD2;RSAD2;RARA
prerank,mitochondrial protein processing (GO:0034982),0.3948801335924492,0.8344722515780325,0.6689774696707106,0.9199462141704496,1.0,2/11,7.63%,OMA1;IMMP2L
prerank,chromatin-mediated maintenance of transcription (GO:0048096),-0.34744787133776966,-0.8341525859811305,0.6683046683046683,0.9489228875522159,1.0,5/11,12.82%,ZMIZ1;ARID1B;SMARCD1;ZMIZ2;PADI2
prerank,regulation of lysosomal lumen pH (GO:0035751),0.38625021302987633,0.8338100075130137,0.6638795986622074,0.9206461472589312,1.0,6/12,24.49%,PPT1;LRRK2;CCDC115;ATP6AP2;TMEM199;GRN
prerank,gland development (GO:0048732),0.29548539436990395,0.8332227858525282,0.706786171574904,0.9211881724960926,1.0,7/59,7.78%,NOTCH4;TBX1;CAV1;LSR;MSN;PRKCSH;CEBPA
prerank,ribonucleoprotein complex biogenesis (GO:0022613),0.29999558869784676,0.8326648075229799,0.7097186700767263,0.9217337106490311,1.0,10/57,11.69%,BOP1;DHX37;RPL7;PAK1IP1;NVL;XPO1;RPS28;MRPL36;NPM1;RPS25
prerank,fatty acid biosynthetic process (GO:0006633),0.2911307709949461,0.8326077355317418,0.6897856242118537,0.9213713572899842,1.0,11/63,19.38%,ACSM3;ASAH2;ACSBG1;ELOVL4;HACD4;ELOVL7;ELOVL5;TECR;ABHD2;DECR2;HACD2
prerank,phosphatidylinositol-mediated signaling (GO:0048015),0.29125283870548774,0.8325155326356414,0.6980440097799511,0.9210736738030271,1.0,13/69,13.92%,EDN1;PLCB1;PLCB4;PIK3C2A;PLEKHA1;GATA3;GPR143;HTR2A;PIK3C3;INPP5F;PIK3CB;RPS6KB1;LTK
prerank,regulation of chemotaxis (GO:0050920),0.32091097708249045,0.8325132596206192,0.6686567164179105,0.920618887821366,1.0,8/30,14.74%,PDGFB;F2RL1;PPM1F;DUSP3;ZSWIM6;ZSWIM4;ADGRA2;CXCR4
prerank,neural tube closure (GO:0001843),-0.2558025590890781,-0.8324175630964755,0.77491961414791,0.9512735574244119,1.0,10/34,22.74%,LMO4;COBL;PLXNB2;MTHFD1;TSC2;SEMA4C;PAX2;MTHFR;STIL;PHACTR4
prerank,regulation of amyloid-beta clearance (GO:1900221),-0.3120374374887882,-0.8322976420133287,0.7044854881266491,0.9503876290214257,1.0,2/16,2.91%,LRP1;APOE
prerank,organelle transport along microtubule (GO:0072384),-0.2671172493454453,-0.832195197022139,0.7335526315789473,0.949465889682951,1.0,9/31,22.04%,TRAK1;COPG1;NDE1;NDEL1;BICD2;ARHGAP21;FBXW11;CLN3;KIF5B
prerank,positive regulation of cell cycle G2/M phase transition (GO:1902751),0.3502748597128278,0.8321115073919323,0.6646153846153846,0.9208626368805809,1.0,3/21,11.25%,RAB11A;CDC25C;NPM1
prerank,regulation of ATP metabolic process (GO:1903578),-0.22968145319434663,-0.8320828244852757,0.8325581395348837,0.9485601046925094,1.0,9/54,14.03%,PRKAG2;OGT;NUP107;ATP5IF1;NUP155;COX7A2;AAAS;COX7A2L;NUP93
prerank,regulation of intracellular estrogen receptor signaling pathway (GO:0033146),0.3302127993453796,0.8320662720526472,0.6910919540229885,0.9204822279342862,1.0,9/29,19.36%,SRARP;UFM1;CNOT1;STRN3;BRCA1;CBFB;ESR1;CNOT2;WBP2
prerank,regulation of endothelial cell chemotaxis (GO:2001026),0.36952053535748286,0.8296629291363486,0.6755905511811023,0.9243663548243185,1.0,4/15,11.99%,NOTCH1;PRKD1;HSPB1;PRKD2
prerank,positive regulation of signaling (GO:0023056),0.3197685368048044,0.8289085267617289,0.6967654986522911,0.9252448031563757,1.0,10/37,18.99%,EDN1;GATA3;GRIK2;INPP5F;RIMS3;NSF;NMU;SYT1;CDKN2AIP;SOX11
prerank,chromatin remodeling (GO:0006338),-0.2053428974850123,-0.8287368165743154,0.9013157894736842,0.9541345201287854,1.0,20/100,14.56%,CHD4;TADA2A;JARID2;BAZ1B;KAT2B;BRDT;SMARCB1;RSF1;ARID1B;DR1;SMARCD1;SMARCA5;HDAC4;HDAC1;TAF6L;HMGA2;BPTF;KDM4A;MTA2;PIH1D1
prerank,regulation of receptor signaling pathway via STAT (GO:1904892),0.384101485494335,0.8286320464925663,0.6566164154103853,0.9252772605964152,1.0,2/13,8.22%,MGAT5;JAK2
prerank,ATP-dependent chromatin remodeling (GO:0043044),0.311472203641628,0.8282647695436115,0.6958831341301461,0.9254499636738951,1.0,8/42,14.17%,SMARCA2;SRCAP;ACTB;DMAP1;SMARCAD1;ACTR6;VPS72;SMARCC1
prerank,phosphatidylserine acyl-chain remodeling (GO:0036150),0.3473187299103929,0.8279152241388278,0.682089552238806,0.9256048428011111,1.0,5/21,18.28%,MBOAT2;LPCAT4;LPCAT3;PLA2G12A;PLAAT3
prerank,regulation of cellular metabolic process (GO:0031323),-0.2426658975238214,-0.8275297130012386,0.7764705882352941,0.9555172439427388,1.0,15/45,25.28%,PID1;PPARA;PRKN;ARF1;TBC1D16;PDK3;MPV17;PDK2;STUB1;PANK2;ACACA;MKLN1;SSH1;MBOAT7;PDK4
prerank,microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.2664535300510014,0.8274217033056325,0.7579185520361991,0.9260373242985275,1.0,24/125,16.20%,EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;DYNC1LI2;NUP160;BUB1;ITGB3BP;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,positive regulation of regulated secretory pathway (GO:1903307),0.3641598379220799,0.8270475428650401,0.6722054380664653,0.9262310574172447,1.0,1/17,1.35%,DOC2B
prerank,regulation of clathrin-dependent endocytosis (GO:2000369),-0.31803123206123673,-0.8266732964868133,0.7023498694516971,0.9561054377304212,1.0,5/15,11.64%,DAB2;BMP2K;AAK1;SNAP91;DGKD
prerank,response to purine-containing compound (GO:0014074),0.35999169519858776,0.8262863470328358,0.6857142857142857,0.9270490549414326,1.0,6/17,19.39%,P2RX7;STAT1;NDUFS4;TRPM2;P2RY1;VGF
prerank,photoperiodism (GO:0009648),-0.26338819298613947,-0.826121415641689,0.7428571428571429,0.9561040637067568,1.0,13/28,36.84%,CLOCK;CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,"retrograde protein transport, ER to cytosol (GO:0030970)",0.3594680173288142,0.8259809306872659,0.6810897435897436,0.9271006535998031,1.0,7/17,28.88%,RHBDD1;HSP90B1;SEL1L;TMEM129;SELENOS;HERPUD1;UFD1
prerank,mitotic cytokinesis (GO:0000281),-0.23727671091620228,-0.8257375878826798,0.7668161434977578,0.955741074234491,1.0,16/47,21.93%,ROCK2;SON;JTB;KLHDC8B;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19
prerank,cellular response to peptide hormone stimulus (GO:0071375),0.27598325992616957,0.8248295395942384,0.7378752886836027,0.9286343172009798,1.0,10/102,6.64%,CEACAM1;NR4A2;FOXO1;INSR;CAV1;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33
prerank,monocarboxylic acid biosynthetic process (GO:0072330),0.29267975421413356,0.8247524452101129,0.7418086500655308,0.9283200129557383,1.0,8/59,14.78%,ACSM3;CYP39A1;OSBPL1A;ELOVL4;OSBPL9;GAMT;GATM;SLC27A2
prerank,regulation of peptidase activity (GO:0052547),0.35252825553062395,0.8245354314850177,0.6713395638629284,0.9282527947878407,1.0,5/19,20.46%,CAV1;FURIN;PSMB8;CST3;CTSH
prerank,B cell proliferation (GO:0042100),0.37009071183988684,0.8245330141969063,0.6920684292379471,0.9277958223481647,1.0,4/17,15.89%,CTPS1;MEF2C;CR2;CD79A
prerank,pyrimidine nucleoside metabolic process (GO:0006213),-0.3237208170093326,-0.8242262229222991,0.6910994764397905,0.9575768624590433,1.0,6/14,20.36%,DPYD;NT5M;NT5E;UPB1;DHODH;NT5C1A
prerank,positive regulation of glycolytic process (GO:0045821),0.34419281802308727,0.8241044664034239,0.6731927710843374,0.9276375140632589,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,positive regulation of purine nucleotide metabolic process (GO:1900544),0.34419281802308727,0.8241044664034239,0.6731927710843374,0.9276375140632589,1.0,5/20,9.29%,INSR;APP;P2RX7;PRKAA1;PFKFB3
prerank,regulation of DNA damage checkpoint (GO:2000001),-0.3600957025388055,-0.8240080754575487,0.706855791962175,0.956884092605378,1.0,5/10,24.65%,THOC1;WDR76;RFWD3;FEM1B;RPA2
prerank,autophagosome maturation (GO:0097352),0.31849047036630246,0.8238868169413518,0.6945244956772334,0.9275451849966135,1.0,10/32,18.43%,VTI1B;GABARAPL1;TECPR1;VAMP8;VAMP7;LIX1;CHMP3;MAP1LC3A;ATG14;LAMP2
prerank,establishment of protein localization to endoplasmic reticulum (GO:0072599),0.361876923502816,0.8234235806951274,0.6926751592356688,0.9279182026032934,1.0,6/15,24.79%,SRP14;RAB3GAP2;SRPRA;ZFAND2A;RYR2;SPCS2
prerank,"mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",-0.2482543278259068,-0.8229485139551254,0.8081180811808119,0.9578821389876147,1.0,16/38,27.31%,NDUFS3;NDUFA13;NDUFC2;NDUFV2;NDUFAF1;NDUFB10;NDUFS7;NDUFS6;NDUFB8;NDUFA1;NDUFB3;NDUFB11;NDUFS5;NDUFS8;NDUFB2;NDUFS2
prerank,steroid biosynthetic process (GO:0006694),-0.2273367392514669,-0.8227754829657217,0.8201754385964912,0.9570941262576113,1.0,19/56,31.07%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE;CYP51A1;STAR;SC5D;HSD11B1;SRD5A1;HSD17B10;LSS;PRLR;CYP46A1;PMVK;HSD3B7;EBP
prerank,response to histamine (GO:0034776),0.4136907161893137,0.8227542854902486,0.6888519134775375,0.9286220817855583,1.0,3/10,21.41%,DIAPH1;GABRB1;GABRB3
prerank,positive regulation of leukocyte proliferation (GO:0070665),-0.3435560268788309,-0.822257309970815,0.705,0.9569611856546291,1.0,1/12,1.10%,IL34
prerank,establishment of protein localization to membrane (GO:0090150),0.28233108749174873,0.822086591328507,0.7166882276843467,0.9293242637203569,1.0,8/66,11.06%,RAB11A;AQP11;ZDHHC22;NACAD;RAB3GAP2;MYO1C;TAOK2;REEP1
prerank,"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",0.3759762800097074,0.8219709105113504,0.69377990430622,0.9290700876487508,1.0,1/13,0.81%,MSX1
prerank,cellular response to ATP (GO:0071318),0.3728339585188265,0.8218832118762626,0.6861435726210351,0.928762123297162,1.0,4/14,17.03%,P2RX7;HSP90B1;P2RY1;CIB2
prerank,regulation of cell morphogenesis (GO:0022604),0.32298917082854317,0.8218625392869864,0.6988636363636364,0.9283409364621685,1.0,2/30,2.08%,EFNA5;MACF1
prerank,calcineurin-mediated signaling (GO:0097720),0.4024188214860583,0.8216837604261236,0.6783333333333333,0.9277396273770672,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,calcineurin-NFAT signaling cascade (GO:0033173),0.4024188214860583,0.8216837604261236,0.6783333333333333,0.9277396273770672,1.0,5/10,22.72%,PPP3CA;NFATC1;NFATC3;PPP3CC;PPP3R1
prerank,potassium ion transport (GO:0006813),0.26658981188450703,0.8215660295618794,0.7655719139297849,0.9274983436342954,1.0,6/120,3.68%,KCNN4;KCNQ1;KCNH8;ATP1A4;KCNN3;KCNG3
prerank,negative regulation of lymphocyte migration (GO:2000402),-0.344462168394246,-0.8211814132919686,0.7302798982188295,0.9580371977844458,1.0,3/10,12.82%,APOD;RIPOR2;PADI2
prerank,negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),0.37601727741329066,0.8211508304490442,0.6801292407108239,0.9277589242427505,1.0,1/13,0.88%,PDGFB
prerank,regulation of synapse assembly (GO:0051963),-0.23307524105348248,-0.8207296589503934,0.8158995815899581,0.9578005064541888,1.0,13/46,20.72%,GPC6;NLGN2;CLSTN2;SLITRK1;MDGA1;SRPX2;EPHB2;EPHB3;PTPRD;GPC4;LHFPL4;CUX2;IL1RAPL2
prerank,neurogenesis (GO:0022008),-0.24199946073188322,-0.8204820462583201,0.8293650793650794,0.9571530095857221,1.0,5/43,7.80%,LPAR1;TRAK1;ANXA1;SIX1;BTBD2
prerank,regulation of endopeptidase activity (GO:0052548),0.2954010182011384,0.8202842372714895,0.7275031685678074,0.9287720665325284,1.0,10/59,11.08%,SERPINI1;SPOCK2;TIMP3;SPOCK3;FURIN;GAPDH;APH1A;VSIR;PSMB8;SPOCK1
prerank,positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.3113209056000542,0.8202374250097363,0.730820995962315,0.9284044750636941,1.0,4/37,7.97%,MSX1;CAV1;BBC3;BCL2L1
prerank,protein peptidyl-prolyl isomerization (GO:0000413),0.34411705636605827,0.8199642152369155,0.6837881219903692,0.9284140315961628,1.0,7/20,19.44%,FKBP4;FKBP1A;PPIE;PIN1;PPIH;PPID;PPIF
prerank,mitochondrial outer membrane permeabilization (GO:0097345),0.38243942826570576,0.8197026013062918,0.6844741235392321,0.9284056453363986,1.0,4/13,17.52%,RHOT2;BNIP3L;BNIP3;BMF
prerank,chloride transmembrane transport (GO:1902476),0.29914125660144975,0.8195227442976449,0.716710182767624,0.9282638286859457,1.0,12/48,18.08%,SLC12A8;ANO6;GABRQ;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;GABRB1
prerank,regulation of centriole replication (GO:0046599),-0.30010619967960017,-0.8193945966394063,0.7202072538860104,0.9582464828175541,1.0,4/17,10.84%,ALMS1;KAT2B;RBM14;MDM1
prerank,"nucleotide-excision repair, DNA incision (GO:0033683)",-0.24890718557741348,-0.8181218350050137,0.7753623188405797,0.9596001113229674,1.0,16/39,24.65%,DDB2;FAN1;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,protein localization to organelle (GO:0033365),0.2636153710038788,0.8180426650780872,0.7774049217002237,0.9304422463926505,1.0,25/133,15.39%,MSX1;GBP5;RAB11A;APP;HHEX;PACSIN2;EHD1;CSNK1D;SNX10;CEP68;LRRK2;IFT140;RAB35;RIPOR1;DHX9;PRNP;GET1;GBP2;VPS35;UBE2J2;CNEP1R1;VAPA;TUB;YBX1;ABCA7
prerank,negative regulation of immune effector process (GO:0002698),-0.3290130612427641,-0.8175084508802821,0.7094430992736077,0.9596723980705852,1.0,5/13,17.99%,CD55;ENPP3;FER;CD300A;RC3H1
prerank,glial cell differentiation (GO:0010001),-0.26592359613159555,-0.8172156253350346,0.7450331125827815,0.9590662299698839,1.0,9/28,21.92%,ADGRG6;SLC8A3;NFIB;GPC1;PICK1;SOX2;PAX2;TPPP;CDK5
prerank,positive regulation of glycoprotein biosynthetic process (GO:0010560),0.3772129259355187,0.8168681774710433,0.6830122591943958,0.9319882993291347,1.0,1/13,0.84%,PLCB1
prerank,response to insulin (GO:0032868),0.28288099987893994,0.8167576950045943,0.7439024390243902,0.9317102004531966,1.0,9/80,8.36%,CEACAM1;FOXO1;INSR;HDAC9;INPP5K;PDE3B;PCK2;SLC25A33;SYAP1
prerank,Arp2/3 complex-mediated actin nucleation (GO:0034314),0.3643837623525291,0.8167428238653802,0.6898148148148148,0.9312803139351773,1.0,4/15,15.24%,WHAMM;ARPC5;ARPC3;ARPC2
prerank,positive regulation of posttranscriptional gene silencing (GO:0060148),0.387620336461925,0.8166940149490599,0.7102966841186736,0.9309124376790302,1.0,3/11,13.08%,PUM2;DHX9;FXR1
prerank,regulation of T cell migration (GO:2000404),0.35601805836813083,0.8164759815200918,0.6923076923076923,0.930854205309023,1.0,6/18,20.47%,APP;LRCH1;CD200;PYCARD;CXCL10;CD200R1
prerank,regulation of DNA replication (GO:0006275),0.3005890208080681,0.8162158132691364,0.7208994708994709,0.9308456498798376,1.0,10/49,12.09%,ACVRL1;BCAR3;GMNC;ORC3;STN1;DHX9;CCDC88A;CDAN1;OBI1;ORC5
prerank,regulation of protein targeting to mitochondrion (GO:1903214),-0.24724929950031205,-0.816056241107634,0.79182156133829,0.9601569037628639,1.0,12/38,19.47%,PRKN;ATP5IF1;LMAN1;RNF31;UBL5;UBE2L3;SREBF1;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,mitochondrion disassembly (GO:0061726),-0.26152803470885555,-0.8159567742612759,0.7517241379310344,0.9592227606317164,1.0,13/34,22.25%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;WDR45;BECN1
prerank,double-strand break repair via nonhomologous end joining (GO:0006303),0.28548763389793347,0.8151072970093076,0.7396373056994818,0.932222805511995,1.0,21/58,25.42%,HERC2;HMGB1;BABAM2;POLA1;POLB;PSMD14;BRCA1;ERCC4;ATM;HMGB2;KDM2A;BARD1;NSD2;MDC1;RIF1;CYREN;XRCC4;PAXIP1;NHEJ1;UVRAG;BABAM1
prerank,regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.35962844454964243,0.8150551697831997,0.7025210084033613,0.9318502308015257,1.0,1/15,1.56%,GBP5
prerank,positive regulation of transcription regulatory region DNA binding (GO:2000679),-0.2964858315163811,-0.8147525572310159,0.7347560975609756,0.9603365103559723,1.0,1/20,0.34%,IGF1
prerank,organic substance transport (GO:0071702),0.26560290754791066,0.814673545350784,0.7875,0.9320671362308113,1.0,15/120,10.45%,RHCG;ARL6IP5;PPT1;APOA1;SPNS2;PLTP;MYH9;ARRDC1;HSP90B1;SLC6A4;CHMP1B;TAP1;SLC6A2;ABCG4;SLC22A5
prerank,lymphocyte proliferation (GO:0046651),0.3481154810310076,0.814606199468899,0.7048192771084337,0.9317341247366274,1.0,5/22,15.89%,MSN;CTPS1;MEF2C;CR2;CD79A
prerank,amino acid transport (GO:0006865),0.29965072198178666,0.8143411784874971,0.7259358288770054,0.9317390202082324,1.0,5/49,9.72%,SLC6A6;SLC7A7;SH3BP4;SLC7A1;SLC6A17
prerank,positive regulation of fat cell differentiation (GO:0045600),0.2980576976192222,0.814032469571182,0.7205298013245033,0.9318210913306996,1.0,5/47,8.36%,SOX13;ZBTB16;ZC3H12A;CMKLR1;SYAP1
prerank,negative regulation of centrosome duplication (GO:0010826),-0.3380191219014231,-0.8138258233943043,0.7193396226415094,0.9609326448699888,1.0,3/11,10.84%,KAT2B;RBM14;MDM1
prerank,negative regulation of interferon-beta production (GO:0032688),-0.3503286060833711,-0.8137862774739334,0.7188264058679706,0.9598923611620841,1.0,4/10,16.45%,PTPRS;PPM1B;RELB;NLRC3
prerank,DNA unwinding involved in DNA replication (GO:0006268),0.35588577818842776,0.8137785671271501,0.6960486322188449,0.9318071484134395,1.0,5/16,24.47%,SSBP1;PURA;BLM;WRN;MCMDC2
prerank,negative regulation of receptor internalization (GO:0002091),-0.3358597323413093,-0.8136967703774908,0.7032085561497327,0.9589438427457998,1.0,4/12,14.51%,DLG4;ATXN2;SDCBP;ANKRD13D
prerank,proton transmembrane transport (GO:1902600),0.3139103084947973,0.8134169851036438,0.7244318181818182,0.9319543491229486,1.0,3/36,2.16%,ATP1A4;ATP1A1;ATP1A3
prerank,negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),-0.2744258700452777,-0.8130180931503646,0.7710843373493976,0.9590530401501216,1.0,10/25,20.17%,SLIT2;ARHGAP24;CAPZB;ODF2L;CEP97;CCP110;CDK10;PFN2;PRKCD;TESK1
prerank,regulation of cholesterol transport (GO:0032374),0.3452628401224156,0.812860105852931,0.7132018209408194,0.9324714296100013,1.0,4/20,8.90%,APOA1;ABCB4;NUS1;TSPO
prerank,ncRNA 3'-end processing (GO:0043628),-0.32279208196006076,-0.812636100961815,0.6853932584269663,0.9586794083572905,1.0,6/14,19.74%,INTS14;SSB;INTS2;PTCD1;TOE1;TRNT1
prerank,thymus development (GO:0048538),0.37411277795753173,0.8125845338790212,0.6866883116883117,0.932497680448838,1.0,1/13,1.26%,TBX1
prerank,mitochondrial ATP synthesis coupled proton transport (GO:0042776),-0.306587124055424,-0.81243973310635,0.7093333333333334,0.9579737834452293,1.0,7/16,18.06%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,negative regulation of insulin secretion (GO:0046676),0.3541400681382379,0.8115222026394896,0.6934189406099518,0.9338465982681708,1.0,4/17,11.92%,KLF7;SIRT4;PIM3;CHGA
prerank,negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.3795077778225592,0.8114942102693377,0.7047781569965871,0.9334439683914597,1.0,2/12,2.21%,ATP2B4;DAB2IP
prerank,I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.28811771498005495,0.8111052713815563,0.7278562259306803,0.9336393211933005,1.0,9/59,10.93%,DAB2IP;TLR3;IRAK2;NFKBIL1;UBA52;RPS27A;ROCK1;NFKBIA;TAB2
prerank,receptor signaling pathway via JAK-STAT (GO:0007259),0.3209523240635502,0.8110696194518681,0.7008547008547008,0.9332450687112833,1.0,5/29,8.46%,IFNAR1;SOCS6;STAT1;JAK2;NMI
prerank,positive regulation of phosphoprotein phosphatase activity (GO:0032516),-0.30559078211105406,-0.8103915265110114,0.7408450704225352,0.9605866941568124,1.0,3/17,7.03%,PDGFRB;MAGI2;CALM2
prerank,regulation of lipid kinase activity (GO:0043550),-0.343717143269779,-0.8101963659718373,0.7168367346938775,0.9598360738248145,1.0,4/11,15.47%,PIK3R1;PIK3R2;WDR81;WDR91
prerank,Golgi organization (GO:0007030),0.26417228035325857,0.8095422163818861,0.7743055555555556,0.935460902661956,1.0,25/112,20.00%,SYNE1;PLK3;TRAPPC8;PRKD1;ATL2;VTI1B;CSNK1D;TMED10;CLASP1;LRRK2;CLASP2;VRK1;TMED9;ATP8B1;USP6NL;TMED4;PDCD10;PLEKHM2;VTI1A;GOLPH3L;GOLPH3;MYO18A;ATP8B2;TMED7;DNAJC28
prerank,ganglion development (GO:0061548),-0.3351869428884592,-0.8094811595307362,0.7205128205128205,0.9600911729276997,1.0,2/11,5.38%,NRP2;SEMA3A
prerank,regulation of cholesterol biosynthetic process (GO:0045540),0.34960419336092885,0.8092262357236962,0.6821086261980831,0.9355323977314902,1.0,9/17,22.31%,MBTPS2;KPNB1;PRKAA1;SEC14L2;LPCAT3;RAN;ERLIN2;SREBF2;SOD1
prerank,embryonic appendage morphogenesis (GO:0035113),0.384312533683415,0.8091679860512094,0.6815834767641996,0.9351668345994099,1.0,2/12,4.60%,TGFB2;MBNL1
prerank,positive regulation of cytoplasmic transport (GO:1903651),-0.3279287262157037,-0.8088558666914002,0.7369668246445498,0.9601406855770099,1.0,4/11,18.62%,DAB2;PRKN;PTPN23;EZR
prerank,fatty acid oxidation (GO:0019395),0.28828129155390575,0.8087973526183188,0.7423469387755102,0.935304312978941,1.0,17/57,22.69%,ADIPOR2;ADIPOR1;ACOX1;ACAD10;SLC27A2;ADH5;HADHB;CROT;ECI1;ACAT1;HADHA;HADH;ILVBL;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,autophagy of mitochondrion (GO:0000422),-0.25059735741408523,-0.8083387374986221,0.8076923076923077,0.9599985989160865,1.0,14/38,22.25%,PRKN;ATG3;AMBRA1;ATG5;ATG2A;FUNDC2;ULK2;ATG7;WIPI2;MAP1LC3B;GABARAP;PHB2;WDR45;BECN1
prerank,myelin assembly (GO:0032288),-0.3475760150790205,-0.8080853103560905,0.7033248081841432,0.9593747982118283,1.0,6/10,31.04%,DICER1;EPB41L3;GPC1;TPPP;NCMAP;CNTNAP1
prerank,"positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.3352734874924862,0.8079216253392358,0.6894977168949772,0.936367392001415,1.0,6/21,14.45%,HNF1A;SETX;JUN;MED30;MED17;MED4
prerank,erythrocyte development (GO:0048821),0.390718236545855,0.8078994101972661,0.6867256637168142,0.9359469201668259,1.0,1/10,6.79%,ALAS1
prerank,metal ion homeostasis (GO:0055065),0.3052936022876906,0.8077072724322942,0.7235543018335684,0.9358387365249198,1.0,7/40,17.03%,CAV1;SLC8A1;SLC12A8;TESMIN;KCNA1;ANK3;CIB2
prerank,neuron fate commitment (GO:0048663),0.36823271137158975,0.8076502171577321,0.672386895475819,0.9354856920964487,1.0,3/14,13.79%,DLL4;POU3F2;MYT1L
prerank,double-strand break repair via homologous recombination (GO:0000724),-0.2036833444656462,-0.807481030866808,0.891566265060241,0.9594205410090826,1.0,44/95,32.11%,NUCKS1;RAD51B;SMC6;ZFYVE26;NIPBL;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;CDC7;POLN;RFWD3;RPA3;RECQL;RAD54L;FANCB;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;CDC45;RAD51AP2;ZSWIM7;NSMCE2;NABP2;XRCC3;FANCM;AP5S1;MCM7;SLX4;MORF4L1;MCM5;POLL;MCM2
prerank,protein-DNA complex assembly (GO:0065004),0.2626203310852353,0.8071707770642513,0.783256880733945,0.9358523194833781,1.0,36/116,21.60%,PSMD13;ORC3;PSMD4;UBA52;RPS27A;PSMA5;RBX1;PSMB10;ASF1A;PSMB8;NPM1;PSMD14;GTF2H3;ORC5;PSMA7;PSMC3;PSMA8;PSMC1;PSMB5;ANP32B;HMGB2;PSMC5;XPC;PSMB9;PSMC6;DAXX;PSMA4;PSMD5;PSMD9;H3-3A;NAP1L4;PSMB6;PSMB2;MNAT1;NAP1L3;UBB
prerank,cellular response to lipid (GO:0071396),0.25082370754517447,0.807107819244907,0.8342361863488624,0.9355118710332516,1.0,27/191,10.37%,TBX1;NOD2;ATP1A1;ATP1A3;DAB2IP;VIM;FES;DEFA6;ADAM15;MSN;MEF2C;TNFRSF1B;ABCB4;IL1A;PDCD4;NFKBIL1;SETX;IRGM;ZC3H12A;NR1D1;ACOD1;NCOA4;CACTIN;STAP1;HMGB1;NFKBIB;CASP1
prerank,positive regulation of translational initiation (GO:0045948),0.3532892908749795,0.8070750859738979,0.6931637519872814,0.9351227317569846,1.0,5/18,13.35%,UHMK1;POLR2G;POLR2D;RPS6KB1;HABP4
prerank,cell junction maintenance (GO:0034331),0.35958026999809567,0.8069678989352771,0.707395498392283,0.9348554796829611,1.0,1/14,2.44%,F2RL1
prerank,cellular glucose homeostasis (GO:0001678),0.3000059705669423,0.8055403038058095,0.7367706919945726,0.9367638539377243,1.0,5/41,8.68%,UNC13B;FOXO1;PCK2;PRKAA1;NR1D1
prerank,modulation by host of symbiont process (GO:0051851),0.31659926405987854,0.8052739894732429,0.7369901547116737,0.9367486447284133,1.0,7/31,15.42%,SAP30;INPP5K;LEF1;JUN;CCL4;CX3CR1;TAF11
prerank,DNA geometric change (GO:0032392),-0.2654816248950511,-0.8050632569987667,0.8088235294117647,0.9625757461240098,1.0,8/24,21.04%,HNRNPA2B1;ANXA1;RAD50;DDX1;SUPV3L1;RTEL1;RECQL;ZRANB3
prerank,protein mono-ADP-ribosylation (GO:0140289),-0.3393635009216623,-0.8049369560576469,0.7072538860103627,0.9617087422556478,1.0,3/11,22.84%,PARP8;PARP3;PARP6
prerank,"synaptic transmission, cholinergic (GO:0007271)",-0.2881593308323277,-0.8048866686759695,0.7356948228882834,0.9606962328276668,1.0,3/19,15.68%,APOE;RIC3;CHRNB1
prerank,regulation of mitotic metaphase/anaphase transition (GO:0030071),0.3302721508394466,0.8047031697430385,0.7010159651669086,0.93728092594728,1.0,7/26,23.29%,DUSP1;CUL3;CDC27;ANAPC7;ANAPC4;LCMT1;ANAPC11
prerank,positive regulation of leukocyte migration (GO:0002687),0.3214784947041074,0.8042090435541295,0.7082152974504249,0.9376674551484169,1.0,3/27,6.32%,F2RL1;TNFRSF18;ADAM17
prerank,brain development (GO:0007420),0.25914909116986934,0.8034539292251544,0.8018018018018018,0.9384969374915993,1.0,29/136,18.42%,RAPGEF2;SHROOM4;EML1;PPT1;DHX37;AMIGO2;SHANK3;UFM1;MAST1;SLC6A4;NDUFS4;GRIN2B;UBE3A;GRIN2C;SLC6A17;CDH2;BAG6;SOX6;CTNNA2;CX3CR1;ATXN1;CXCR4;NES;MEIS2;ADGRG1;GRIN2A;SYNJ1;NCOA6;HAP1
prerank,regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.39735882995853933,0.803317979421633,0.690846286701209,0.9382908775544027,1.0,5/10,16.29%,HMGB1;PSMC3;PSMC5;PSMC6;ESR1
prerank,positive regulation of actin filament depolymerization (GO:0030836),0.3923831601907405,0.803007499231208,0.7027914614121511,0.938342844752933,1.0,3/10,15.85%,F2RL1;WDR1;VIL1
prerank,negative regulation of DNA replication (GO:0008156),0.3605710317124996,0.8029609006955584,0.684887459807074,0.9379647663603181,1.0,2/13,10.41%,GMNC;CDAN1
prerank,necroptotic process (GO:0070266),0.36167702583824324,0.8029032182730855,0.6930379746835443,0.9376065655263792,1.0,2/16,9.55%,TLR3;MLKL
prerank,ATP synthesis coupled proton transport (GO:0015986),-0.29285504721971145,-0.8028549204264891,0.7169811320754716,0.9632599051223069,1.0,7/17,18.06%,ATP5PD;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;ATP5MG;ATP5F1D
prerank,purine ribonucleotide biosynthetic process (GO:0009152),0.2976563435119036,0.8028042434306254,0.7577319587628866,0.9373306272822773,1.0,13/48,19.73%,NPR2;SLC25A16;ADCY10;NPR1;SLC35B3;ADCY4;NPPC;PAPSS1;PANK3;PPCS;ACAT1;ADSL;GUCY1A1
prerank,positive regulation of dephosphorylation (GO:0035306),0.320827017949596,0.8027822347933834,0.7180232558139535,0.9369126415297331,1.0,14/27,27.96%,PPP1R16B;CDCA2;CALM3;PIN1;CNEP1R1;PPP1R7;CDH5;NSMF;TGFB1;CALM1;SYMPK;MTMR9;SPPL3;SMPD1
prerank,cell chemotaxis (GO:0060326),0.2841897477470867,0.8024957555644201,0.7503250975292588,0.9369437120674629,1.0,5/60,5.26%,PDGFB;CCR1;EGR3;LEF1;PLEKHG5
prerank,negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.27067031097227673,-0.8023668644499331,0.7634069400630915,0.9630198773637366,1.0,6/26,14.88%,DAB2;KANK2;HEYL;HDAC1;CLOCK;CRY2
prerank,tail-anchored membrane protein insertion into ER membrane (GO:0071816),-0.30176368462414704,-0.8022891387105459,0.7480106100795756,0.9620817137387243,1.0,4/17,12.16%,EMC2;EMC7;EMC1;GET4
prerank,protein autoubiquitination (GO:0051865),0.28418435621373545,0.8022756156154935,0.7596996245306633,0.936872989709383,1.0,14/61,15.90%,ASB4;RNF185;CUL3;UBE3A;RNF141;RNF115;TRIM17;OBI1;BRCA1;DTX3L;UBE2T;RAD18;UBE2D3;KLHL24
prerank,protein lipidation (GO:0006497),-0.22450514766724186,-0.8022400600620775,0.825,0.9610755550627108,1.0,23/59,26.51%,GPLD1;PIGA;ATG5;PIGB;PIGN;ZDHHC17;PIGH;ATG7;PGAP2;DPM2;PIGG;WIPI2;ZDHHC1;PIGP;PGAP4;PIGZ;ZDHHC8;WDR45;ZDHHC16;PORCN;PGAP3;PIGL;PIGW
prerank,engulfment of apoptotic cell (GO:0043652),0.35975351557975155,0.802007566272047,0.6955128205128205,0.9368714425076767,1.0,4/15,13.75%,XKR6;ADGRB1;RAC1;RHOH
prerank,regulation of acute inflammatory response (GO:0002673),-0.2827491425957509,-0.8019979638672703,0.7472826086956522,0.9604251450610399,1.0,13/18,54.88%,PTGES;KLKB1;IL4;GSTP1;IL6ST;CREB3L3;ADAM8;IL6;OSM;FFAR2;DNASE1;PLA2G2D;C2CD4B
prerank,phosphatidylglycerol metabolic process (GO:0046471),-0.26674871312402343,-0.8019410895992433,0.7447447447447447,0.9594449896255844,1.0,5/24,15.08%,LPGAT1;PLA2G4A;SLC27A1;PGS1;PLA2G15
prerank,positive regulation of B cell activation (GO:0050871),0.2884993815142622,0.8019178316012194,0.7420634920634921,0.93656733281397,1.0,7/50,12.62%,NOD2;SH3KBP1;TIRAP;MEF2C;MAD2L2;CD38;BTK
prerank,regulation of myelination (GO:0031641),-0.2658498519316511,-0.8018715523638525,0.799373040752351,0.9584888818744306,1.0,3/25,4.46%,PTN;DICER1;PARD3
prerank,positive regulation of cholesterol efflux (GO:0010875),0.3378971694438644,0.8017395547369046,0.707533234859675,0.9364030553683051,1.0,6/21,16.84%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1
prerank,integrated stress response signaling (GO:0140467),0.3599641055906517,0.8016927763019841,0.7003154574132492,0.9360285100367765,1.0,6/14,26.29%,OMA1;NFE2L2;EIF2S1;EIF2AK1;DDIT3;HERPUD1
prerank,"nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.2623114030504228,-0.8014324831642547,0.7672955974842768,0.9581609619476101,1.0,13/29,24.65%,DDB2;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;RPA2
prerank,regulation of vacuole organization (GO:0044088),-0.2834369845307328,-0.8014211775332148,0.727810650887574,0.9571038646741591,1.0,8/20,27.91%,ANXA2;ENO2;ADPRH;IFT20;IFT88;ENO3;NPRL2;MTM1
prerank,positive regulation of rRNA processing (GO:2000234),-0.3405356632981238,-0.8013689532564632,0.7203791469194313,0.9561144349848214,1.0,5/10,33.90%,BUD23;RIOK2;TRMT112;DIMT1;HEATR1
prerank,organic hydroxy compound biosynthetic process (GO:1901617),-0.23585190176728377,-0.8008847722306747,0.8423076923076923,0.95588919927674,1.0,7/44,16.16%,PRKAG2;CYP27A1;SCP2;INSIG2;AMACR;OSBPL7;SQLE
prerank,positive regulation of cellular respiration (GO:1901857),-0.3348585025228953,-0.8006916969995723,0.7257281553398058,0.9551628467698884,1.0,1/11,1.83%,NUPR1
prerank,regulation of G2/M transition of mitotic cell cycle (GO:0010389),0.25564660933842254,0.8003834195119862,0.8153503893214683,0.9377701984643726,1.0,38/145,21.23%,RAB11A;PSMD13;TUBB;CSNK1D;CDC25C;TUBB4B;PSMD4;CLASP1;NEDD1;CEP135;HAUS3;PCM1;PSMA5;RBX1;PSMB10;DYNLL1;CEP76;PSMB8;PSMD14;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;PSMC5;PSMB9;PSMC6;PSMA4;KCNH5;PSMD5;PSMD9;PSMB6;ACTR1A;CEP192;PSMB2;DYNC1I2;USP47
prerank,in utero embryonic development (GO:0001701),0.32230657856034917,0.8000379677126326,0.7095310136157338,0.9379046522844632,1.0,5/25,12.11%,PTPRR;MBNL1;EGFL8;ADAM10;HINFP
prerank,centromere complex assembly (GO:0034508),-0.24201396451888432,-0.7999179476214119,0.8125,0.955425057563461,1.0,18/36,31.93%,RSF1;CENPC;SMARCA5;RBBP7;MIS12;CENPK;CENPQ;MIS18BP1;KNL1;CENPE;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPF;CENPA
prerank,phagosome acidification (GO:0090383),-0.257269867241314,-0.7994616205530833,0.7835365853658537,0.9551330988480707,1.0,8/26,22.20%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2
prerank,regulation of tyrosine phosphorylation of STAT protein (GO:0042509),-0.22402573248953922,-0.7994074740213792,0.8325581395348837,0.9541622198926158,1.0,6/57,8.98%,IGF1;IL31RA;KIT;IL6R;GHR;VEGFA
prerank,epiboly involved in wound healing (GO:0090505),0.36018180287677093,0.7992257743888505,0.7131410256410257,0.9387775628533911,1.0,4/16,15.45%,CEACAM1;MRTFA;LCP1;PDCD10
prerank,protein acetylation (GO:0006473),0.31905404275717064,0.7988034126862568,0.7280453257790368,0.9390399418266738,1.0,2/30,2.79%,FOXO1;NAT9
prerank,central nervous system development (GO:0007417),0.24617631159040884,0.7987389664321053,0.8803777544596013,0.9386999372787211,1.0,65/250,21.97%,SHROOM4;RNF103;SLC2A1;NR4A2;EML1;SERPINI1;PPT1;LSR;SNTG2;DHX37;AMIGO2;SH3GL1;UFM1;MAST1;ZBTB16;ITGAM;WWP1;NRCAM;NDUFS4;GRIN2B;NCKAP1;MAL;UBE3A;GRIN2C;EIF2B2;ASIC2;SLC6A17;CDH2;BAG6;SPOCK1;NCAN;SOX10;SOX6;CX3CR1;RPS6KA3;CYP26C1;CAPG;ADGRA2;ATXN1;CXCR4;NES;GRIK1;MEIS2;ADGRG1;SOX12;GRIN2A;SYNJ1;NPTX1;TBX6;NCOA6;HAP1;SOX11;ELP3;FOXJ1;POU3F3;DCX;CNTN4;EEF1AKMT4-ECE2;CNTN6;CIC;CDK5RAP1;SMG9;BCAN;BTD;ATP6AP2
prerank,cytoplasmic sequestering of protein (GO:0051220),0.37255570577920777,0.7980407265798465,0.6982055464926591,0.9393890149260188,1.0,4/13,13.18%,NFKBIE;GOPC;NFKBIA;KEAP1
prerank,regulation of plasma membrane bounded cell projection organization (GO:0120035),0.32630039862854604,0.7977930548939413,0.7203994293865906,0.939355759232112,1.0,10/27,23.94%,FBXO7;FCGR2B;CCDC88A;VPS35;CTNNA2;EFHC2;GSK3A;GSK3B;IL1RAPL1;BRSK2
prerank,inner mitochondrial membrane organization (GO:0007007),-0.23194798510971829,-0.7976170586442212,0.854251012145749,0.9562697903102788,1.0,21/47,27.60%,MICOS10;ATP5PD;NDUFA13;DMAC2L;ATP5F1B;ATP5MF;ATP5MC2;MICOS13;ATP5MG;MTX3;ATP5F1D;MTX1;MTX2;ROMO1;TIMM29;IMMT;SPG7;APOO;ATP5F1E;OPA1;ATP5MC3
prerank,acylglycerol metabolic process (GO:0006639),0.306950542905555,0.7972893048904195,0.7582417582417582,0.9397093425921711,1.0,12/37,22.83%,CAV1;ABHD6;DGKH;APOH;DGKI;GK5;ABHD2;SEL1L;PLAAT3;DGKA;PNPLA2;MGLL
prerank,negative regulation of inclusion body assembly (GO:0090084),0.38484854685984504,0.7971133331959965,0.7087378640776699,0.9395496722359898,1.0,4/10,20.71%,HSPA1B;DNAJB6;DNAJB8;SORL1
prerank,cardiolipin metabolic process (GO:0032048),0.3717920832634565,0.7969851995081405,0.7368421052631579,0.9393064823864122,1.0,5/13,19.19%,CRLS1;LCLAT1;HADHB;HADHA;PLSCR3
prerank,striated muscle cell differentiation (GO:0051146),0.3547532490127019,0.7967929661693428,0.696875,0.9391776119929846,1.0,5/16,19.74%,MEF2C;MYEF2;POPDC3;SKI;SORT1
prerank,mitotic spindle organization (GO:0007052),0.25309687292011196,0.7964471735160995,0.8182831661092531,0.9393228338920122,1.0,28/153,16.20%,RAB11A;EML1;MAP4;CENPU;CLIP1;KIF2A;CLASP1;RANGAP1;KPNB1;DSN1;XPO1;STAG1;CLASP2;DYNLL1;RANBP2;TNKS;CENPI;PRC1;DYNC1LI2;NUP160;BUB1;ITGB3BP;ARHGEF10;EFHC2;RAN;NDC80;NEK9;SGO1
prerank,positive regulation of ATPase activity (GO:0032781),0.2990004245831083,0.7964036295273882,0.7482806052269602,0.9389453535575093,1.0,11/41,19.72%,MYBPC3;SSBP1;PLSCR1;DHX9;DYNLL1;CHTOP;AHSA1;TOR1AIP2;DYNLL2;DNAJC10;DNAL4
prerank,secondary alcohol metabolic process (GO:1902652),-0.23541288184287718,-0.7961111364170665,0.8413284132841329,0.9579019083130942,1.0,9/42,16.36%,CYP27A1;APOE;ABCA1;IDH2;FDX1;IDH1;GBA2;SQLE;SCAP
prerank,post-transcriptional gene silencing by RNA (GO:0035194),0.3419499287727368,0.7959314871432834,0.7050898203592815,0.9392595036248194,1.0,4/20,14.77%,TNRC6C;CNOT1;AGO4;EIF6
prerank,microtubule-based transport (GO:0099111),0.3723446962100998,0.7952449692859319,0.6930533117932148,0.9399844457606317,1.0,3/12,21.10%,ADCY10;SPA17;DYNC1I2
prerank,negative regulation of lymphocyte activation (GO:0051250),0.3358996266698158,0.7949999357751888,0.7182235834609495,0.9399549073609396,1.0,6/21,19.95%,FCGR2B;DUSP3;LAPTM5;SOX11;BANK1;FOXJ1
prerank,negative regulation of cellular protein localization (GO:1903828),0.301355121205342,0.7943530193073379,0.7335203366058906,0.9405534983536511,1.0,7/34,10.96%,GOPC;TTBK2;ANKRD13A;MFHAS1;CTNNA1;TAX1BP3;NEDD4L
prerank,regulation of protein kinase C signaling (GO:0090036),0.35914415860859117,0.7943448046433083,0.6993464052287581,0.940120439809925,1.0,1/14,1.01%,FLT4
prerank,sympathetic nervous system development (GO:0048485),0.3578812377071566,0.7941448225045828,0.7032457496136012,0.9399873382471109,1.0,5/15,18.99%,SEMA3F;GATA3;CTNNB1;FZD3;SOX11
prerank,regulation of B cell receptor signaling pathway (GO:0050855),0.33321549488769575,0.7939552266799568,0.700920245398773,0.9398461800384346,1.0,5/21,12.73%,FCGR2B;FOXP1;STAP1;ELF2;CBFB
prerank,glycine metabolic process (GO:0006544),0.37375528262392405,0.7932897767494927,0.728,0.9404773651607631,1.0,2/12,14.38%,GLYAT;DLD
prerank,recombinational repair (GO:0000725),-0.20475013346857834,-0.7931184543378329,0.8963730569948186,0.9619376188567577,1.0,30/77,27.53%,NUCKS1;RAD51B;SMC6;ZFYVE26;FBH1;FAN1;UBE2N;SWI5;REV3L;RAD50;XRCC1;ERCC5;LIG3;NABP1;RHNO1;POLN;RFWD3;RPA3;RECQL;PALB2;RPA1;PARP1;POLQ;MMS22L;MCM8;RPA2;RAD51;RAD51AP2;ZSWIM7;NSMCE2
prerank,ncRNA metabolic process (GO:0034660),0.303868278159038,0.7923212460724174,0.7368421052631579,0.9415845224206919,1.0,7/37,18.63%,DTD2;DDX4;RAN;DROSHA;EXD1;TUT7;TDRD9
prerank,signal release from synapse (GO:0099643),0.29956952314884255,0.7921672983506124,0.7436241610738255,0.9414000279639756,1.0,14/43,26.91%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,histone monoubiquitination (GO:0010390),-0.26959681508758426,-0.7921230394836685,0.7752442996742671,0.9625148132309509,1.0,7/24,16.43%,DDB2;CUL4B;PAF1;CTR9;ATXN7L3;BCOR;WAC
prerank,telomere maintenance via recombination (GO:0000722),-0.33233592423867586,-0.7921074191175194,0.7355769230769231,0.9614647223124657,1.0,2/11,6.61%,SMC6;RAD50
prerank,negative regulation of innate immune response (GO:0045824),0.30440796069229764,0.7915878690055449,0.7510316368638239,0.9418950551364,1.0,12/34,24.80%,SUSD4;NLRC5;NMI;ACOD1;CACTIN;FAM3A;PTPN2;DHX58;RPS19;A2M;GRN;TTLL12
prerank,negative regulation of protein tyrosine kinase activity (GO:0061099),0.323328254736443,0.7915464802616792,0.7352517985611511,0.9415204229704354,1.0,7/23,17.42%,CAV1;CBL;HYAL2;GPRC5A;DUSP22;SH3BP5L;SOCS5
prerank,positive regulation of catabolic process (GO:0009896),0.2764832452387248,0.7914260860552728,0.7760814249363868,0.9412733424647605,1.0,15/65,20.91%,FOXO1;DAB2IP;WWP1;ASB5;APC;VPS28;VSIR;NEDD4L;SMURF1;NSF;GSK3A;BARD1;GSK3B;SORL1;WWP2
prerank,superoxide anion generation (GO:0042554),0.3593991819351947,0.7912441421957545,0.7138364779874213,0.9411310837509901,1.0,3/13,14.82%,TAFA4;CYBA;NCF2
prerank,regulation of catabolic process (GO:0009894),-0.2922044796015744,-0.7911894121901185,0.7612903225806451,0.9619809650212899,1.0,13/18,36.96%,FAP;ODC1;MDM2;HPGD;SNF8;RARRES2;CENATAC;TMEM9;ZDHHC2;CHMP6;FAF1;FAM83D;HGS
prerank,negative regulation of TOR signaling (GO:0032007),0.29620601512905564,0.7908130720743075,0.7520215633423181,0.9413812185825664,1.0,10/36,21.45%,SPAAR;CASTOR1;SH3BP4;PRKAA1;ATM;EPM2A;GSK3A;MAPKAPK5;NPRL3;AKT1S1
prerank,"regulation of gene expression, epigenetic (GO:0040029)",-0.20978207873703736,-0.7901546226988109,0.8586956521739131,0.9626914808776035,1.0,14/73,13.57%,JARID2;BAZ1B;MTF2;KAT2B;MECP2;TAF1D;IGF2;DNMT3A;SMARCA5;RBBP7;HDAC4;HDAC6;MYBBP1A;MPHOSPH8
prerank,negative regulation of cation transmembrane transport (GO:1904063),0.34042845141798883,0.7901465247368503,0.7147192716236722,0.9420183972984152,1.0,7/18,19.75%,CAV1;CAMK2D;STK39;NEDD4L;EPO;PPIF;CAB39
prerank,regulation of nervous system development (GO:0051960),0.29884817762294297,0.7900653034310078,0.7276536312849162,0.9416925001721607,1.0,9/37,14.54%,HEY1;HEY2;TNFRSF1B;PRUNE1;TENM4;CX3CR1;HES3;CTNNB1;HMGB2
prerank,positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.3251658413651966,0.7900553900552363,0.7422222222222222,0.9412653937499644,1.0,2/23,8.22%,NOTCH1;JAK2
prerank,regulation of mRNA 3'-end processing (GO:0031440),-0.32633295986499095,-0.7899436500680886,0.7086614173228346,0.961957863256613,1.0,5/11,23.25%,NCBP1;PAF1;AHCYL1;NCBP2;PAPOLA
prerank,response to UV-A (GO:0070141),-0.3058831714761059,-0.7899382237306736,0.7403598971722365,0.9609055354120898,1.0,2/14,7.62%,EGFR;MMP2
prerank,positive regulation of telomere capping (GO:1904355),0.342916185925522,0.7899192033439761,0.715927750410509,0.9410344497128305,1.0,3/17,10.95%,MAPK1;NEK7;TNKS
prerank,cellular response to DNA damage stimulus (GO:0006974),0.2403975624485484,0.7896845031619375,0.8948979591836734,0.9409606397253668,1.0,68/336,19.51%,ACER2;PLK3;FOXO1;HERC2;BTG2;UBA7;RBBP8;CASP2;BRAT1;TNFRSF1B;APEX1;SIRT4;SETX;ENDOV;ZC3H12A;AATF;CIDEB;POLK;BCL2L1;APC;FEN1;ZBTB40;FOXP1;TAOK2;NSMCE3;BABAM2;SPIDR;ASF1A;POLA1;POLB;ALKBH8;NPM1;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;UBE2T;STK33;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;TRAIP;SPRTN;CBX1;FBXO6;MAPK14;MEN1;MMS19;UBQLN4;NCOA6;ATRIP;CDKN2AIP;XIAP;CRY1;BID;FBXO45;BARD1;HUS1;MCL1
prerank,regulation of cytoplasmic transport (GO:1903649),0.3758379112460508,0.7892765536569479,0.7198641765704584,0.9411656765647037,1.0,4/11,19.49%,MAPK1;LRRK2;CHMP3;MAP2K1
prerank,response to metal ion (GO:0010038),0.2764228943479561,0.7888938322900559,0.7958937198067633,0.941345666583265,1.0,12/67,14.97%,ITPR3;CAV1;GPHN;IL1A;PPP3CA;MT2A;PLSCR1;NEDD4L;TESMIN;CALM3;HIF1A;PPP2CB
prerank,DNA conformation change (GO:0071103),0.3432113993420054,0.7886352256198016,0.7242990654205608,0.9413205423681661,1.0,3/17,14.54%,HHEX;HMGB1;HMGB2
prerank,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),-0.31337548802242127,-0.7883964140397687,0.7530864197530864,0.9623618594034258,1.0,4/14,12.31%,PRKN;TXNDC12;CREB3L1;CREB3
prerank,P-body assembly (GO:0033962),-0.32162558634169586,-0.7881469520479348,0.7312661498708011,0.9617047946775219,1.0,2/12,7.56%,LIMD1;ATXN2
prerank,mitochondrion distribution (GO:0048311),-0.32322047452292474,-0.78726968432368,0.7333333333333333,0.9621554249437644,1.0,4/12,18.00%,TRAK1;CLUH;ATCAY;DNM1L
prerank,muscle filament sliding (GO:0030049),0.29225003064503413,0.7872642767093584,0.7736111111111111,0.9426520803336506,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,actin-myosin filament sliding (GO:0033275),0.29225003064503413,0.7872642767093584,0.7736111111111111,0.9426520803336506,1.0,3/38,7.82%,MYBPC3;VIM;MYL6
prerank,metallo-sulfur cluster assembly (GO:0031163),-0.27163247928800693,-0.7868275582213591,0.8057971014492754,0.9618776215617648,1.0,10/22,24.99%,NFU1;NFS1;CIAPIN1;FXN;CIAO3;NDOR1;CIAO1;CIAO2A;NUBP1;LYRM4
prerank,chaperone-mediated protein complex assembly (GO:0051131),0.33905979790340074,0.786368660276608,0.7354260089686099,0.9436515613038959,1.0,12/20,31.26%,PFDN6;PTGES3;CCT2;CLU;PSMG2;HOPX;MKKS;HSP90AA1;HSP90AB1;HSPA1A;TMEM35A;LONP1
prerank,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.3334683019038147,-0.7856791514461526,0.7427184466019418,0.9628033289233582,1.0,1/10,2.84%,WNT5A
prerank,positive regulation of p38MAPK cascade (GO:1900745),-0.2679014072583586,-0.7856699678277513,0.7735849056603774,0.9617633961304083,1.0,6/22,15.32%,RELL1;SASH1;XDH;VEGFA;GADD45B;SPHK1
prerank,positive regulation of T cell proliferation (GO:0042102),-0.21481943240253412,-0.7848814254962946,0.8630705394190872,0.9619929814250848,1.0,7/55,13.16%,IGF1;IGFBP2;ANXA1;IGF2;NCKAP1L;PNP;CD80
prerank,fibroblast growth factor receptor signaling pathway (GO:0008543),0.26399886665599637,0.7847306243078722,0.7938271604938272,0.9458364488352832,1.0,14/72,15.83%,ESRP2;CBL;FGFR3;MAPK1;SETX;SHOC2;FRS3;FLRT3;POLR2G;POLR2D;TIAL1;FGF20;KIF16B;POLR2I
prerank,positive regulation of macroautophagy (GO:0016239),0.2847746513519996,0.7844575891282501,0.7740641711229946,0.9458226172510842,1.0,12/48,15.79%,ADRB2;SPTLC2;SPTLC1;SMCR8;IRGM;FYCO1;RAB3GAP2;VPS13D;BNIP3L;BNIP3;EPM2A;VDAC1
prerank,macroautophagy (GO:0016236),0.2528964538729912,0.7842181512427892,0.8173719376391982,0.9457616371109938,1.0,31/118,19.88%,ATG101;VTI1B;KLHL3;GABARAPL1;VPS36;TECPR1;VAMP8;PLEKHM1;TBC1D5;PRKAA1;NBR1;VAMP7;VPS28;PIK3C3;DYNLL1;MFN1;LIX1;YOD1;VPS4A;CHMP3;MAP1LC3A;CSNK2B;CHMP2B;VDAC1;UBXN6;ATG14;LAMP2;DYNLL2;TOMM7;MVB12A;STAM2
prerank,monosaccharide transmembrane transport (GO:0015749),0.34708965609347275,0.7839786174058986,0.7188498402555911,0.9456916672999134,1.0,2/16,8.42%,SLC5A10;SLC2A9
prerank,regulation of mitotic cell cycle phase transition (GO:1901990),0.24594251629456487,0.783879931778601,0.8690476190476191,0.9453966473314029,1.0,44/184,19.11%,PSMD13;TUBB;CSNK1D;CUL3;UBE2D1;TUBB4B;PSMD4;CLASP1;NEDD1;UBA52;RPS27A;CEP135;HAUS3;PCM1;ZFP36L2;PSMA5;PSMB10;CDC14A;DYNLL1;CEP76;PSMB8;PSMD14;NEK11;PSMA7;PSMC3;TUBA1A;PSMA8;PSMC1;PSMB5;UBE2E1;CDC27;PSMC5;XPC;PSMB9;ANAPC7;PSMC6;PSMA4;KCNH5;PPP1R9B;PSMD5;PSMD9;PSMB6;ACTR1A;ANAPC4
prerank,mitochondrial cytochrome c oxidase assembly (GO:0033617),-0.2876431657554276,-0.7838350835074247,0.7900552486187845,0.9625608255923832,1.0,8/18,30.02%,COX17;COX16;COX18;SMIM20;TIMM21;FASTKD3;COX14;COX19
prerank,negative regulation of proteasomal protein catabolic process (GO:1901799),-0.2411718624479155,-0.7835321412294836,0.825503355704698,0.9619817750346104,1.0,6/36,10.20%,OGT;FHIT;MAP1A;PSMF1;TRIM39;SDCBP
prerank,synaptic vesicle transport (GO:0048489),-0.33390552198322404,-0.7828802549275838,0.7585301837270341,0.9619433417875934,1.0,5/11,23.84%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,"energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.3704806145396462,0.7826785813568923,0.7211703958691911,0.946864405004602,1.0,2/10,7.71%,ATP5MC1;ATP5F1A
prerank,regulation of mitochondrial membrane potential (GO:0051881),-0.2324332608114557,-0.7825757891200182,0.8307086614173228,0.9613694071671826,1.0,3/40,6.52%,PID1;BCL2;ATP5IF1
prerank,regulation of activated T cell proliferation (GO:0046006),0.305988510577813,0.7825000148565231,0.7324929971988795,0.9466922624905532,1.0,8/30,19.95%,CRTAM;LGALS9;HMGB1;PRNP;IL27RA;PYCARD;CD24;AGER
prerank,negative regulation of catabolic process (GO:0009895),0.28317128860757046,0.7823131707223709,0.7647058823529411,0.9465511734582257,1.0,10/47,16.35%,AZIN1;PDE3B;ALK;PRKAA1;MAD2L2;PRKCG;ADGRB1;PIN1;CBFA2T3;CST3
prerank,response to organophosphorus (GO:0046683),0.3486127404233573,0.7822674092647467,0.7389984825493171,0.9461798222797286,1.0,3/16,8.30%,P2RX7;STAT1;NDUFS4
prerank,"maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.3290547371065471,0.7820628496662555,0.7311178247734139,0.946076141194968,1.0,8/22,24.24%,RPS21;EXOSC3;EXOSC8;EXOSC9;FTSJ3;EXOSC10;URB1;UTP20
prerank,regulation of protein catabolic process (GO:0042176),0.26075443381837526,0.7816819115302409,0.7978723404255319,0.9462715521382644,1.0,15/99,13.89%,AZIN1;FOXO1;DAB2IP;FURIN;WWP1;ASB5;APC;VPS28;MAD2L2;PRKCG;ADGRB1;NEDD4L;SMURF1;PIN1;NSF
prerank,beta-catenin destruction complex disassembly (GO:1904886),0.32694735912326606,0.7816300651465119,0.725609756097561,0.9459203024198762,1.0,3/21,14.24%,CAV1;APC;CTNNB1
prerank,protein alkylation (GO:0008213),-0.2669956392581035,-0.7816091747128523,0.8255451713395638,0.9618339503181993,1.0,6/22,18.20%,GSPT1;METTL21A;FAM98B;EEF1AKMT1;EEF1AKMT2;SNRPD3
prerank,rRNA methylation (GO:0031167),0.3335530710855188,0.7806841624592255,0.7643504531722054,0.9469833001409816,1.0,9/22,22.52%,MRM2;METTL5;FBLL1;TFB2M;NSUN5;MRM3;FTSJ3;NSUN4;FBL
prerank,glutathione metabolic process (GO:0006749),-0.23296060134155655,-0.780521207432282,0.8369565217391305,0.9625266671356109,1.0,9/38,16.48%,GSTT1;GCLC;GSTZ1;GGT5;ETHE1;GSTA3;GSTM1;GSTM2;GGT7
prerank,NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.3562910346311071,0.7801144399944274,0.7163934426229508,0.9474519441767506,1.0,6/13,30.41%,NAMPT;PTGIS;NAXE;PARP9;NUDT12;PARP16
prerank,regulation of ion transmembrane transporter activity (GO:0032412),0.29988451157587215,0.779305910280649,0.7731543624161074,0.9482839580193814,1.0,7/39,13.00%,UTRN;CHRM3;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,toxin transport (GO:1901998),-0.33296949842686685,-0.7792835591629387,0.7619047619047619,0.9634352068429396,1.0,4/10,18.82%,ANTXR2;ANTXR1;RAB29;SLC22A2
prerank,regulation of long-term synaptic potentiation (GO:1900271),0.310038102337114,0.7792136918831388,0.751412429378531,0.9479792997923979,1.0,4/28,5.58%,FAM107A;APP;AKAP5;SHANK3
prerank,heparan sulfate proteoglycan biosynthetic process (GO:0015012),0.33309140278855714,0.779094707788892,0.7370820668693009,0.9477198862738854,1.0,5/19,14.99%,EXT1;HS3ST5;EXTL3;NDST4;GLCE
prerank,positive regulation of protein maturation (GO:1903319),0.36608658295397645,0.7789818576161981,0.7250859106529209,0.9474616609483473,1.0,2/11,10.31%,RHBDD1;NKD2
prerank,positive regulation of TOR signaling (GO:0032008),0.29383008693742313,0.7789539077255867,0.7752489331436699,0.9470608835724678,1.0,22/40,28.69%,GPR137B;SMCR8;WDR59;RRAGD;RHEB;RICTOR;MIOS;GPR137C;GOLPH3;RRAGA;HTR6;RRAGC;LAMTOR3;WDR24;PIK3CA;SEH1L;MLST8;RPTOR;LAMTOR4;CLEC16A;SLC38A9;LAMTOR1
prerank,positive regulation of response to endoplasmic reticulum stress (GO:1905898),0.3367647591459059,0.7787349311096933,0.7381316998468607,0.9469818504983092,1.0,7/18,25.39%,FCGR2B;RNF185;BAG6;NCK1;ERN1;RNFT1;DDIT3
prerank,positive regulation of excitatory postsynaptic potential (GO:2000463),-0.28681172695206175,-0.7784156187100334,0.7891737891737892,0.9637431756510422,1.0,3/18,9.76%,DLG4;NLGN2;PRKCZ
prerank,positive regulation of viral process (GO:0048524),0.27206056136583756,0.7781212721646676,0.7943078913324709,0.9475538357119386,1.0,14/60,18.64%,ADARB1;PPIE;POLR2G;ADAR;DHX9;POLR2D;VPS4A;PPIH;NELFB;PKN2;POLR2I;NELFA;SRPK1;PPID
prerank,regulation of cellular component size (GO:0032535),0.2987784144515102,0.7778782958453337,0.748221906116643,0.9474911723852809,1.0,13/30,27.18%,MSN;RAP1GAP2;AP2M1;HP1BP3;RAC1;PEX11A;PEX11G;PPP1R15A;ATP13A2;RDX;RPTOR;LAMTOR4;RIN3
prerank,mitotic spindle checkpoint signaling (GO:0071174),0.3251006126442585,0.7778717033595074,0.7415384615384616,0.9461818223083931,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,mitotic spindle assembly checkpoint signaling (GO:0007094),0.3251006126442585,0.7778717033595074,0.7415384615384616,0.9461818223083931,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,spindle assembly checkpoint signaling (GO:0071173),0.3251006126442585,0.7778717033595074,0.7415384615384616,0.9461818223083931,1.0,5/20,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,peptidyl-lysine methylation (GO:0018022),-0.26048873147553236,-0.7778558107167282,0.8023255813953488,0.9635704362004446,1.0,16/26,35.02%,EHMT1;SETD7;METTL21A;EEF1AKMT1;SUV39H1;SETD4;N6AMT1;EEF1AKMT2;ANTKMT;KMT5A;TRMT112;ATPSCKMT;ETFBKMT;EEF1AKMT3;EHMT2;METTL21C
prerank,purine ribonucleoside monophosphate biosynthetic process (GO:0009168),-0.2943353476324594,-0.7777125588697288,0.7443181818181818,0.9627503025453692,1.0,5/16,17.73%,AMPD3;LHPP;ATIC;NUDT2;IMPDH2
prerank,cell differentiation in hindbrain (GO:0021533),0.37220558431337025,0.77756361821473,0.7275693311582382,0.9462184120429674,1.0,3/11,19.59%,ATP7A;OPHN1;GRID2
prerank,ribosomal large subunit biogenesis (GO:0042273),0.2823303353849968,0.7771207822000429,0.7878378378378378,0.9464636502616824,1.0,19/54,26.14%,BOP1;RPL7;PAK1IP1;NVL;MRPL1;RRP15;NPM1;NHP2;RPL23A;EIF6;LAS1L;RSL24D1;NOP53;RPF2;RPL3;MRTO4;MDN1;RPL26;NIP7
prerank,phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.34831487989011156,0.7770584450440114,0.7275590551181103,0.946124338584373,1.0,2/17,6.77%,LPCAT4;CRLS1
prerank,regulation of monocyte differentiation (GO:0045655),0.35343653416889453,0.7769809252507426,0.739202657807309,0.9457956958016472,1.0,3/14,9.09%,FES;CTNNBIP1;FOXP1
prerank,ERBB2 signaling pathway (GO:0038128),-0.24876501102737728,-0.7764306882774622,0.8439490445859873,0.9637523483660362,1.0,9/31,17.09%,EGFR;SHC1;PIK3R1;SRC;PRKCA;ERBB2;HBEGF;GAB1;STUB1
prerank,posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.3648800089527839,0.7764011784289897,0.7369255150554676,0.9462712900648371,1.0,6/12,27.34%,SGTB;SEC62;SEC63;SGTA;CHMP4A;CHMP4B
prerank,positive regulation of intracellular protein transport (GO:0090316),0.24940733569315598,0.7760991340204404,0.8435072142064373,0.9463204486470078,1.0,38/144,21.66%,FYN;PLK3;CASP8;PPP1R13B;AKAP5;HYAL2;BBC3;ZC3H12A;ITGAM;PRR5L;NMT1;MYO1C;PCM1;RIPOR1;FBXW7;PRNP;DMAP1;UBE2J2;YWHAH;ITGB1BP1;RAN;ANP32B;ICE1;UBE2D3;PDCD10;ANK3;TENM1;GSK3A;BID;TOMM7;JUP;GSK3B;SORL1;MTCL1;PPP3CC;SREBF2;ECT2;LEPROT
prerank,regulation of mRNA stability (GO:0043488),0.24476243493279734,0.7760894931453574,0.8579295154185022,0.9458977071310019,1.0,36/145,18.86%,VIM;PSMD13;PUM2;APEX1;PSMD4;ELAVL1;HSPB1;EXOSC3;UBA52;RPS27A;ROCK1;ZFP36L2;PSMA5;XPO1;PSMB10;EXOSC8;PSMB8;NPM1;PSMD14;XRN1;PSMA7;PSMC3;FXR1;METTL14;PSMA8;PSMC1;PSMB5;PSMC5;YBX1;PSMB9;PSMC6;PSMA4;EXOSC9;PSMD5;PSMD9;PSMB6
prerank,positive regulation of T-helper 17 type immune response (GO:2000318),0.3662440371579213,0.7758297238981723,0.726775956284153,0.945840828224043,1.0,11/11,63.40%,MALT1;NFKBIZ;NLRP10;CLEC6A;IL12B;IL23R;IL23A;CARD9;IL12RB1;PRKCQ;NFKBID
prerank,microtubule nucleation (GO:0007020),-0.2776007691828534,-0.7752002308274321,0.8010899182561307,0.964573842761967,1.0,5/19,9.85%,SLAIN2;GOLGA2;TUBGCP4;NDE1;NDEL1
prerank,regulation of neutrophil migration (GO:1902622),0.369475756222746,0.7749942863928032,0.7096219931271478,0.946699134016972,1.0,2/10,13.75%,RAC1;RHOH
prerank,peptidyl-arginine modification (GO:0018195),-0.2958750223904839,-0.7748524942090498,0.7458563535911602,0.9640749745476389,1.0,3/15,12.82%,ART3;NDUFAF5;PADI2
prerank,mitochondrial membrane organization (GO:0007006),-0.24396283695671736,-0.7746846174900665,0.8433333333333334,0.9633133343593748,1.0,14/32,29.09%,BCL2;MICOS10;SLC25A4;RCC1L;MICOS13;MTX3;MTX1;MTX2;IMMT;SPG7;APOO;OPA1;BAD;TIMM50
prerank,proteoglycan biosynthetic process (GO:0030166),0.3063521713777385,0.7746743208843516,0.7623066104078763,0.9467714695826605,1.0,8/31,19.29%,BMPR2;EXT1;CHST11;B3GAT2;EXTL3;GLCE;CSGALNACT2;CHST9
prerank,peptidyl-methionine modification (GO:0018206),0.3624366563845821,0.7740881996119888,0.7184,0.9472537357085087,1.0,4/12,21.28%,APOA1;METAP2;NAA30;NAA25
prerank,actin filament network formation (GO:0051639),0.36814143870065635,0.7731590089980636,0.7383627608346709,0.9482996276335313,1.0,4/11,21.45%,PLS3;LCP1;SPIRE1;CARMIL1
prerank,regulation of cell division (GO:0051302),0.2644353203026964,0.773043355972172,0.8075471698113208,0.9480299304831191,1.0,16/72,20.67%,PLK3;RAB11A;TAL1;BCL2L1;PIK3C3;CALM3;PRC1;PIN1;RAB11FIP4;MLLT3;RACK1;KLHL9;GIT1;RAB11FIP3;SETD2;BLM
prerank,regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2713359359262205,0.7728428752867295,0.7776381909547738,0.9479202255303846,1.0,8/63,6.59%,FAS;CAV1;CASP8;ACVR1;TNFSF10;HYAL2;TRAF1;MADD
prerank,positive regulation of macromolecule biosynthetic process (GO:0010557),0.25279753486543793,0.7724557167801553,0.8500563697857948,0.9480873505752371,1.0,22/122,13.27%,PDGFB;NOD2;INSR;TGFB2;VIM;KLF4;BCAR3;PLD1;ELAVL1;NLRC5;JAK2;PASK;NAMPT;STN1;DHX9;METTL5;NPM1;EEF2;PRKD2;RPS6KB1;FXR1;METTL14
prerank,cellular response to hexose stimulus (GO:0071331),0.31801510520845455,0.7723192692733765,0.7615499254843517,0.9478752236323259,1.0,3/23,8.29%,UNC13B;PCK2;PRKAA1
prerank,regulation of sodium ion transmembrane transporter activity (GO:2000649),0.29252578865398826,0.7720552057498923,0.7760989010989011,0.9478354450176133,1.0,7/39,13.00%,UTRN;CAMK2D;FXYD5;STK39;SCN1B;NEDD4L;YWHAH
prerank,neurotransmitter secretion (GO:0007269),0.2907635628563064,0.7716622541546293,0.7703604806408545,0.9480112621174458,1.0,14/44,26.91%,SYN3;PIP5K1C;PDZD11;STXBP3;SLC32A1;HRH3;CPLX1;SNPH;SYT1;NRXN1;RIMS1;PTPRN2;SYN2;SNCA
prerank,negative regulation of protein-containing complex assembly (GO:0031333),0.2800500595801547,0.7713829754806725,0.7710843373493976,0.9480060431742455,1.0,12/49,22.20%,SMAD6;IAPP;HMGB1;PMEPA1;AIDA;CLU;RIOK3;PYDC1;GSK3B;SORL1;LCMT1;NOP53
prerank,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),0.33861860898850116,0.7711095402318242,0.7366771159874608,0.9480246541553857,1.0,5/17,22.31%,HSPB1;NFE2L2;NOL3;NME5;SOD1
prerank,cell morphogenesis involved in neuron differentiation (GO:0048667),0.2661569354834646,0.7707315740184293,0.7982989064398542,0.948156715364375,1.0,19/75,16.63%,KLF7;APP;SHTN1;MEF2C;ATL1;LMTK2;NRCAM;TAOK2;NEFH;ADGRB1;MINK1;ACTB;DCC;CTNNA2;SLITRK2;MAP2;TMEM106B;ANK3;OPHN1
prerank,positive regulation of natural killer cell activation (GO:0032816),-0.3038577477505717,-0.7705983808631536,0.7794117647058824,0.9684783373258519,1.0,1/13,1.89%,AXL
prerank,regulation of neurotransmitter receptor activity (GO:0099601),0.2729678261666716,0.7701379485192185,0.781491002570694,0.9486769734465533,1.0,13/57,18.45%,APP;SHISA8;MEF2C;SHISA6;GRIA1;GRIN2B;MINK1;LYNX1;NPTX2;GRIN2A;NPTX1;LRRC7;CAPN1
prerank,positive regulation of calcium ion transport into cytosol (GO:0010524),0.29971744531133393,0.7701026687878246,0.7780859916782247,0.9482954473473711,1.0,4/32,10.49%,CAV1;P2RX7;CASQ1;PLCG1
prerank,neuromuscular process controlling balance (GO:0050885),0.36118452681554036,0.7689014673778951,0.7456279809220986,0.9496600978082779,1.0,3/12,21.02%,PCDH15;NRXN1;MYO7A
prerank,negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3196297342986488,0.7681145659849121,0.7573415765069552,0.950407328818074,1.0,5/21,13.96%,IK;APC;MAD2L2;BUB1;ATM
prerank,covalent chromatin modification (GO:0016569),-0.2915875574862603,-0.767541866531616,0.7795275590551181,0.9721381796225115,1.0,4/14,27.79%,HDAC1;HLCS;PARP2;HELLS
prerank,modulation by host of viral genome replication (GO:0044827),0.3557499070906656,0.7672868704465163,0.7412935323383084,0.9512256171656609,1.0,2/13,7.01%,FBXL2;ZC3H12A
prerank,nuclear pore complex assembly (GO:0051292),0.3733610444600183,0.7670986004484618,0.7206132879045997,0.9510876256248425,1.0,3/10,15.93%,RTN4;NUP153;NUP205
prerank,axoneme assembly (GO:0035082),0.2930759522158326,0.7670786541289805,0.7661971830985915,0.9506742184334075,1.0,3/30,7.77%,CFAP206;DNAAF3;TTC12
prerank,regulation of immune effector process (GO:0002697),-0.22811256515919237,-0.7668957429471098,0.87109375,0.9720361560725348,1.0,15/41,27.37%,SERPING1;VTN;CD55;CD81;C4B;C1QC;C1QA;CFHR2;PHB2;C1QB;C2;C1QBP;C3;C3AR1;C6
prerank,negative regulation of signaling (GO:0023057),0.3120134587122077,0.7668860027493081,0.7682215743440233,0.9505296281560172,1.0,6/25,23.11%,ACVR1;KIF26A;PTPN1;SOCS5;BRAP;HHIP
prerank,positive regulation of secretion (GO:0051047),0.36027168500407847,0.7665777676146132,0.7549342105263158,0.9505553664489792,1.0,1/11,6.82%,NPR1
prerank,mitotic G2/M transition checkpoint (GO:0044818),-0.22515555656618363,-0.7660225207588635,0.8921933085501859,0.9723315515358465,1.0,24/43,38.31%,BRSK1;TRIM39;NABP1;HMGA2;CDC14B;CDKN1A;DONSON;ORC1;TAOK1;CHFR;FZR1;TAOK3;RINT1;CHEK1;NABP2;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;CDK1;CDC6;TICRR
prerank,histone H3-K9 demethylation (GO:0033169),-0.32247244214100274,-0.7653895398462073,0.7674418604651163,0.9722764023317538,1.0,4/11,20.14%,KDM7A;JMJD1C;KDM4A;PHF8
prerank,dolichol-linked oligosaccharide biosynthetic process (GO:0006488),0.33662281581560793,0.7648983089365057,0.7634069400630915,0.9526280733711103,1.0,7/17,20.37%,NUS1;ALG14;DOLK;MVD;DPAGT1;DOLPP1;ALG1
prerank,lytic vacuole organization (GO:0080171),0.29635363708185486,0.764841372917321,0.798581560283688,0.9522718626128609,1.0,9/32,21.02%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,immunoglobulin mediated immune response (GO:0016064),0.3799782710527544,0.7643709676839685,0.7646048109965635,0.952587003143183,1.0,1/10,4.30%,FCGR2B
prerank,divalent inorganic cation homeostasis (GO:0072507),0.3086853955283566,0.7630861860357417,0.7716049382716049,0.9541054336146656,1.0,5/25,17.03%,CAV1;SLC8A1;KCNA1;ANK3;CIB2
prerank,intra-Golgi vesicle-mediated transport (GO:0006891),0.29947499525118426,0.7627113886914406,0.7853107344632768,0.9542681981519751,1.0,7/29,17.69%,RAB6B;VTI1B;COG5;NSF;COG6;GOSR1;VTI1A
prerank,cellular polysaccharide catabolic process (GO:0044247),0.33365289504419715,0.7625937075372317,0.7515923566878981,0.9540009269577426,1.0,2/16,4.25%,AOAH;PGM2L1
prerank,hippo signaling (GO:0035329),0.3150918307544241,0.7625040851276867,0.7645348837209303,0.9536838391814346,1.0,5/26,10.54%,TEAD4;WWTR1;TJP2;TJP1;FAT4
prerank,membrane assembly (GO:0071709),-0.24008019758717464,-0.7624213970667478,0.8118081180811808,0.9754992890585504,1.0,11/34,24.96%,ANXA2;STX4;NLGN2;TLCD2;UBXN2B;SPAST;S100A10;PTPRD;TLCD1;STX2;NLGN3
prerank,histone exchange (GO:0043486),0.28497245023998496,0.7619706009908437,0.7740585774058577,0.9540305096586419,1.0,8/37,13.97%,CENPU;SRCAP;NPM1;DMAP1;ACTR6;CENPI;ITGB3BP;VPS72
prerank,"DNA-templated transcription, termination (GO:0006353)",-0.207898199345678,-0.7619169553095805,0.9466019417475728,0.9751821079299211,1.0,23/68,23.82%,SCAF8;NUDT21;NCBP1;TAF1D;SMN1;PABPN1;SNRPF;TTF1;ERCC2;CSTF2T;PCF11;GTF2H5;UBTF;GTF2H1;SNRPD3;LSM11;SLBP;GTF2H4;POLR1A;POLR1H;NCBP2;PAPOLA;LSM10
prerank,purine nucleotide catabolic process (GO:0006195),0.35547648845192475,0.7617332785415734,0.7256198347107438,0.9539332095036464,1.0,1/13,1.85%,GDA
prerank,regulation of response to stress (GO:0080134),0.3756982363647775,0.7614790243844775,0.7247386759581882,0.9539142270921057,1.0,10/10,62.45%,EIF4G1;ADCY8;MLC1;OPRM1;STOX1;IL10;SLC38A2;CRHBP;DYRK3;CORO2B
prerank,ribonucleoside monophosphate biosynthetic process (GO:0009156),-0.2929429225574327,-0.7612541266761663,0.7984084880636605,0.975081520807022,1.0,4/14,17.73%,ADK;LHPP;ATIC;IMPDH2
prerank,diacylglycerol metabolic process (GO:0046339),-0.2565531666530503,-0.7611822899973416,0.822429906542056,0.9741464147053013,1.0,5/23,15.08%,PLCE1;DGAT1;DGKD;PGS1;PLA2G15
prerank,carboxylic acid catabolic process (GO:0046395),-0.3096372843361399,-0.7603612962263405,0.7966903073286052,0.9742874625499799,1.0,7/12,39.87%,RENBP;NAGK;AMDHD2;NPL;GNPDA1;IL4I1;ACOT8
prerank,negative regulation of cell division (GO:0051782),0.3625641928336384,0.7601204317052559,0.764505119453925,0.9555636916405207,1.0,3/11,20.67%,E2F7;VPS4A;BLM
prerank,negative regulation of ion transmembrane transporter activity (GO:0032413),0.32218919872162544,0.7601105376992102,0.7488789237668162,0.9551388585905415,1.0,4/20,10.96%,GOPC;CAMK2D;STK39;NEDD4L
prerank,nucleic acid metabolic process (GO:0090304),0.2627180074683669,0.760037680432625,0.8110137672090113,0.9548174968710003,1.0,16/69,17.71%,LSM1;EXD2;HNRNPA0;POLR2G;FEN1;DUSP11;POLR2D;HNRNPK;XRN2;PCBP1;METTL14;HNRNPH2;RAN;POLR2I;MMS19;DXO
prerank,positive regulation of response to cytokine stimulus (GO:0060760),-0.29770611755836557,-0.7599778756127944,0.7835820895522388,0.9737918553330565,1.0,2/13,2.84%,AXL;WNT5A
prerank,establishment of vesicle localization (GO:0051650),0.32984439664141346,0.7598432237391592,0.7430769230769231,0.9546918747757556,1.0,4/18,17.96%,RAB11A;LIMK2;SYNJ1;RAB27A
prerank,skeletal muscle organ development (GO:0060538),0.30535810909001276,0.7590778057632847,0.7605839416058394,0.9554216918303224,1.0,5/26,15.28%,CAV1;MEF2C;MYL6;FXR1;POPDC3
prerank,peptidyl-lysine dimethylation (GO:0018027),-0.2816692892543143,-0.7589053796972522,0.8047493403693932,0.9742668388480918,1.0,9/18,25.05%,EHMT1;SETD7;SETD1A;SETD1B;SUV39H1;SETD4;EEF1AKMT2;KMT2D;SETMAR
prerank,regulation of protein-containing complex disassembly (GO:0043244),0.3290198492800218,0.7588941154490448,0.7744945567651633,0.9552557473681238,1.0,3/16,14.04%,INSR;ETF1;BNIP3
prerank,toll-like receptor 9 signaling pathway (GO:0034162),0.3496039234949585,0.7583754973698966,0.7360890302066773,0.9555753656622743,1.0,2/13,9.53%,IRAK2;PIK3C3
prerank,positive regulation of lamellipodium assembly (GO:0010592),0.31097455430183296,0.7578489328315962,0.7572964669738863,0.9559269776921681,1.0,6/24,15.24%,OCLN;NCKAP1;CYFIP1;RAC1;WASF2;ARPC2
prerank,negative regulation of cellular senescence (GO:2000773),0.3420431688345145,0.7576419811264865,0.740983606557377,0.9557992926995339,1.0,4/13,15.27%,AKT3;RBL1;MAP3K3;YBX1
prerank,mitotic recombination (GO:0006312),0.34487063154523023,0.7574161824314776,0.7408026755852842,0.9557131947718127,1.0,1/15,1.69%,RAD54B
prerank,negative regulation of cellular metabolic process (GO:0031324),0.2915426793729924,0.7571944253530754,0.7853260869565217,0.9556105942210684,1.0,3/37,7.48%,EDN1;ANKRD13A;AATF
prerank,protein insertion into mitochondrial membrane (GO:0051204),-0.25131766827894225,-0.757029085033593,0.8375796178343949,0.9759726002356932,1.0,12/23,37.33%,HSPA4;NDUFA13;COX18;TOMM22;ROMO1;TIMM29;BAD;BAX;TIMM10;TIMM9;PMAIP1;TIMM13
prerank,peptidyl-asparagine modification (GO:0018196),0.2923251239412759,0.7565316334538992,0.80835734870317,0.9561820688802947,1.0,13/31,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;HIF1AN;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.21082558147980102,-0.7563921009388466,0.9049773755656109,0.9757727980988739,1.0,10/50,14.56%,SH3RF1;THBS1;NGF;SRC;VEGFA;FNIP1;RAF1;BCL2L12;DDX3X;PIH1D1
prerank,neuronal action potential (GO:0019228),-0.2643267047679281,-0.7563166545629674,0.8042813455657493,0.9748388040847037,1.0,6/22,17.40%,SCN7A;SCN2A;CACNA1G;KCNMB2;GPER1;CACNA1H
prerank,negative regulation of response to DNA damage stimulus (GO:2001021),0.29485262321321903,0.756047680975282,0.7816901408450704,0.956470945872808,1.0,10/30,25.98%,BCL2L1;SNAI2;CLU;CDKN2D;DDX39B;DYRK1A;YJU2;TMEM161A;THOC5;PSMD10
prerank,"transcription, DNA-templated (GO:0006351)",0.2367514894933685,0.7559749715890883,0.9138495092693566,0.9561285059316063,1.0,49/207,19.85%,TSC22D1;NR4A2;YBX2;IRF9;PIR;ELOC;TAF9B;TAF1A;RTF1;TRIM24;EAF1;SLC25A33;SETX;POLR2G;MBD1;BRF2;ELOA;MLF1;NFKBIB;POLR2D;DEAF1;TBPL1;EAF2;GTF2H3;KLF13;CBFB;GTF2A1;DDX21;TFB2M;TAF1B;MLLT3;MED4;TAF11;TEFM;NELFB;POLR2I;AFF4;PWP1;NELFA;MMS19;RPAP1;DRAP1;HOXD3;NCOA6;MEF2A;PTMA;TAF3;PKNOX1;RRAGC
prerank,sodium-independent organic anion transport (GO:0043252),0.372400332473512,0.7558569262732359,0.7491582491582491,0.9558705097234155,1.0,3/10,9.08%,SLCO1C1;SLC16A2;MFSD10
prerank,regulation of isotype switching (GO:0045191),0.34638451991676344,0.7557838471652708,0.75,0.9555332477824711,1.0,7/14,25.96%,SLC15A4;MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,response to unfolded protein (GO:0006986),0.2763202962483365,0.7552589802530655,0.7971576227390181,0.9558669092643274,1.0,12/48,20.23%,DAB2IP;RHBDD1;HSPB1;HSPA1B;HSPE1;PTPN1;TMBIM6;TM7SF3;DAXX;DNAJB5;ERN1;DNAJA1
prerank,regulation of receptor internalization (GO:0002090),0.2936876559461628,0.7552341409456579,0.7921727395411606,0.9554734827799725,1.0,5/35,8.03%,INSR;ANGPT1;ANKRD13A;ARRB1;TBC1D5
prerank,mRNA transport (GO:0051028),-0.18776853175413005,-0.7549513316224288,0.9647887323943662,0.9757285206654289,1.0,35/101,26.04%,SRSF5;HNRNPA2B1;NUP107;NCBP1;UPF2;SRRM1;SRSF1;NUP155;SRSF6;THOC1;AGFG1;AAAS;NUP93;NXF1;MAGOH;U2AF2;MAGOHB;ZFP36;UPF3B;MCM3AP;SRSF3;KIF5C;SLBP;SEC13;SRSF11;NCBP2;DDX25;SRSF2;POM121;EIF4A3;DDX19B;U2AF1;ZC3H11A;THOC7;NUP188
prerank,regulation of defense response (GO:0031347),0.26280010400838016,0.7548446240962132,0.8462484624846248,0.9555966878090876,1.0,10/76,10.37%,NOD2;CASP8;SPATA2;TIRAP;FCGR2B;SEMA7A;BCL6B;JAK2;FOXP1;CASP1
prerank,double-strand break repair via break-induced replication (GO:0000727),-0.3120654481882541,-0.754619913584579,0.8100961538461539,0.9751646274992803,1.0,7/12,40.83%,CDC7;CDC45;MCM7;MCM5;MCM2;GINS2;MUS81
prerank,phosphatidylinositol acyl-chain remodeling (GO:0036149),-0.2740393117730925,-0.7535546161618539,0.8212290502793296,0.9756238356536965,1.0,2/17,6.88%,LPGAT1;PLA2G4A
prerank,myelin maintenance (GO:0043217),-0.3175698823704544,-0.7530932838178958,0.7761557177615572,0.9752510493027626,1.0,2/10,9.11%,EPB41L3;DEGS1
prerank,very-low-density lipoprotein particle assembly (GO:0034379),-0.30768408301382283,-0.7528564808312629,0.7889447236180904,0.9745746664374337,1.0,4/12,20.24%,DGAT1;MTTP;MFSD2A;P4HB
prerank,cellular respiration (GO:0045333),0.27904363661274695,0.7527601679479932,0.8057065217391305,0.9582298081764733,1.0,10/41,16.38%,ETFDH;ETFB;ETFA;NDUFS4;UQCRB;UQCRFS1;UQCRC1;COX15;ME3;SDHC
prerank,synapse assembly (GO:0007416),0.263587484339327,0.7526180877478438,0.8322981366459627,0.9580082414098435,1.0,22/67,21.52%,DNM3;SPOCK2;PLXND1;SHANK3;NRCAM;FLRT3;CBLN4;KIRREL3;CDH2;GABRA2;ACHE;PCDHB16;LGI2;PCDHB14;PCDHB9;DSCAM;GRID2;SHANK2;BDNF;NRXN1;GABRB3;NLGN1
prerank,positive regulation of protein localization to nucleus (GO:1900182),0.26365762415135136,0.7524789185534749,0.8458646616541353,0.9577735845940181,1.0,14/66,15.08%,CARD10;WWTR1;HYAL2;ZC3H12A;CCT8;DKC1;LIMK2;CCT2;DMAP1;DTX3L;CCT4;RAN;CCT6A;KAT7
prerank,pre-mRNA cleavage required for polyadenylation (GO:0098789),-0.294367630065079,-0.7523714761248166,0.7938144329896907,0.974228348082318,1.0,4/13,15.74%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,regulation of store-operated calcium entry (GO:2001256),0.3593119483535909,0.7520728812775375,0.7630252100840336,0.9579115604373878,1.0,2/10,7.79%,HOMER2;CASQ1
prerank,positive regulation of T cell mediated cytotoxicity (GO:0001916),0.34601627815756025,0.7516325495979712,0.7417102966841187,0.95809107826648,1.0,1/13,3.80%,STX7
prerank,positive regulation of chromosome organization (GO:2001252),-0.2858589800441943,-0.7513000850948865,0.7711864406779662,0.9746927414979069,1.0,6/15,20.27%,RAD50;PPP1R10;RTEL1;PML;GNL3;ATRX
prerank,anterior/posterior axis specification (GO:0009948),0.33249711791960757,0.7512785359002017,0.7664,0.9581738659943689,1.0,6/15,25.39%,TBXT;TASOR;SKI;TBX3;RIPPLY2;DDIT3
prerank,negative regulation of gene silencing by miRNA (GO:0060965),0.35269310963001244,0.7512395474106172,0.7766990291262136,0.9577931702442161,1.0,5/12,25.90%,ZC3H12A;ELAVL1;ESR1;NCOR2;TGFB1
prerank,"regulation of DNA-templated transcription, initiation (GO:2000142)",0.26293982217731104,0.7510257148781876,0.8405063291139241,0.957677111556794,1.0,13/59,14.45%,TNRC6C;MED26;LEF1;SETX;JUN;AGO4;MED30;CBFB;PPM1D;MED27;CTNNB1;MED17;MED4
prerank,protein maturation (GO:0051604),0.25495469227321005,0.7509301428998847,0.8471563981042654,0.9573870217538435,1.0,27/95,21.24%,CPD;TSPAN14;CASP2;LIPT2;PCSK5;FURIN;TSPAN32;ADAM17;APH1A;ADAM10;BOLA2;LIPT1;GLRX3;METAP2;CPM;PSEN2;SRGN;LONP2;XPNPEP3;MMS19;TYSND1;LMF2;ECE2;EEF1AKMT4-ECE2;SORL1;APH1B;CCS
prerank,cellular response to misfolded protein (GO:0071218),0.3147212971273194,0.7508760069385169,0.7728658536585366,0.9570318648208085,1.0,6/20,21.01%,RNF185;CUL3;BAG6;UGGT1;RNF5;POMT2
prerank,regulation of fibroblast migration (GO:0010762),0.31322402677683137,0.7501460764775041,0.7636080870917574,0.9576601683899548,1.0,5/20,13.05%,HYAL2;PRR5L;PTK2;RAC1;ITGB1BP1
prerank,negative regulation of cell aging (GO:0090344),0.32981774376999573,0.7500029084273081,0.7564102564102564,0.9574366606781098,1.0,4/16,15.27%,AKT3;RBL1;MAP3K3;YBX1
prerank,cell proliferation in forebrain (GO:0021846),-0.32735088090932307,-0.7497319673257042,0.7850467289719626,0.9758661836429875,1.0,2/10,8.52%,DOCK7;NUMBL
prerank,protein deacylation (GO:0035601),0.3080852085052741,0.7486270678829221,0.7925925925925926,0.9590323291460494,1.0,2/23,3.24%,HDAC7;PPT1
prerank,mitochondrial fusion (GO:0008053),0.3164447463126516,0.7484844292690631,0.767479674796748,0.9588261900934749,1.0,8/18,27.67%,CHCHD3;MIGA1;MFN1;USP30;AFG3L2;STOML2;FIS1;MIEF1
prerank,regulation of RNA export from nucleus (GO:0046831),0.35738292359104556,0.7483992990947174,0.7679465776293823,0.9585176777702383,1.0,5/11,25.32%,DHX9;NUP153;SETD2;IWS1;TPR
prerank,regulation of cholesterol efflux (GO:0010874),0.29650545836507125,0.7477619705940095,0.7946175637393768,0.9589712249385282,1.0,7/30,17.05%,CAV1;APOA1;PLTP;NFKBIA;ABCA7;EEPD1;NAXE
prerank,"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",-0.23071993987778838,-0.7475209655051258,0.8636363636363636,0.977924008262789,1.0,15/37,24.65%,DDB2;RFC1;CUL4B;CUL4A;ERCC5;ERCC2;GTF2H5;GTF2H1;RPA3;GTF2H4;RPA1;PARP1;CHD1L;POLD2;RPA2
prerank,regulation of protein localization to centrosome (GO:1904779),0.35933703929315636,0.7472983801315686,0.7479406919275123,0.9592239856710968,1.0,5/10,27.60%,APC;GSK3B;MARK4;CEP72;BICD1
prerank,cristae formation (GO:0042407),0.2948259995124205,0.7466552187321979,0.8196248196248196,0.9597077621141987,1.0,6/27,15.75%,CHCHD3;UQCC3;ATP5MC1;ATP5F1A;ATP5ME;SAMM50
prerank,negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.2637371934885507,0.7465273664520263,0.8251928020565553,0.9594626526982876,1.0,17/62,20.23%,ARHGEF2;LRRK2;HSPB1;BCL2L1;NFE2L2;SNAI2;TMBIM6;CLU;RTKN2;NOL3;ARMC10;CDKN2D;PLAUR;EPO;PPIF;MCL1;DNAJA1
prerank,negative regulation of autophagosome assembly (GO:1902902),-0.2911660033383176,-0.7462299882433533,0.7864583333333334,0.978604270623598,1.0,3/13,11.82%,NUPR1;FEZ2;TMEM39A
prerank,regulation of endocytic recycling (GO:2001135),0.35404140149790986,0.7456699678322282,0.7654941373534339,0.9602560573257924,1.0,4/11,21.72%,EHD1;INPP5F;SORL1;ARHGAP1
prerank,regulation of myoblast fusion (GO:1901739),0.354114248904867,0.7456016141114714,0.7491166077738516,0.9599263681638959,1.0,3/11,16.98%,EHD1;ADGRB1;MAPK14
prerank,"negative regulation of gene expression, epigenetic (GO:0045814)",-0.24204346599364338,-0.7455234181835021,0.8680351906158358,0.978516246481868,1.0,5/24,13.57%,JARID2;MTF2;DNMT3A;RBBP7;MPHOSPH8
prerank,negative regulation of DNA recombination (GO:0045910),0.2773888908930636,0.7454025872243462,0.8171896316507503,0.9597582815987488,1.0,18/43,25.96%,POLR2G;PARPBP;MAD2L2;POLR2D;POLR2I;DAXX;UBQLN4;TERF2IP;BLM;RIF1;SHLD3;POLR2C;SHLD2;TERF2;POLR2B;POLR2J;TINF2;SHLD1
prerank,mitochondrial gene expression (GO:0140053),0.27977857366584696,0.7453699068623904,0.8122448979591836,0.9593727922498478,1.0,10/42,17.63%,SLC25A33;MRPL47;MRPL23;FASTKD5;MRPS34;MRPS12;TFB2M;TEFM;GATB;MRPS18B
prerank,snRNA 3'-end processing (GO:0034472),0.3193579874581913,0.7448331608916409,0.774885145482389,0.9597535108505667,1.0,6/19,17.49%,EXOSC3;EXOSC8;INTS12;INTS5;INTS6L;EXOSC9
prerank,DNA replication checkpoint signaling (GO:0000076),-0.2806064995955264,-0.7447894568348129,0.8315508021390374,0.9784670658485229,1.0,9/16,38.31%,TIPIN;ORC1;TIMELESS;RAD9A;CDC45;DNA2;HUS1B;CDC6;TICRR
prerank,"regulation of retrograde protein transport, ER to cytosol (GO:1904152)",-0.28851403855123914,-0.7446354891515998,0.7985074626865671,0.9776547744288026,1.0,6/13,30.36%,BCAP31;UBE2G2;ERLEC1;SVIP;EDEM2;DERL2
prerank,catecholamine metabolic process (GO:0006584),0.3352925602745347,0.7444461375593804,0.7700787401574803,0.959859807996331,1.0,2/14,11.63%,ATP7A;SNCAIP
prerank,homologous chromosome segregation (GO:0045143),0.3155450355038881,0.7444277147802812,0.7688821752265861,0.9594566477443005,1.0,5/20,20.03%,PTTG1;MEI4;SGO1;TERB1;PRDM9
prerank,positive regulation of alpha-beta T cell proliferation (GO:0046641),-0.2916966931040422,-0.7443242997851398,0.7628865979381443,0.9770289520314012,1.0,4/14,15.04%,CD55;PTPN22;CD81;TGFBR2
prerank,motor neuron axon guidance (GO:0008045),0.3332758189004942,0.7441075937409913,0.7732283464566929,0.9594727619532806,1.0,6/15,21.58%,NTN1;TMEFF1;RAC1;RHOH;SLIT1;EPHA4
prerank,nucleotide catabolic process (GO:0009166),0.3345080136784278,0.743914160788573,0.7629513343799058,0.9593384102111614,1.0,1/16,1.85%,GDA
prerank,negative regulation of mitochondrion organization (GO:0010823),0.28782179043351686,0.7437518316315187,0.8028368794326242,0.9591289863740414,1.0,8/33,14.81%,OMA1;IAPP;BCL2L1;CLU;TMEM14A;NOL3;BNIP3;FZD9
prerank,glial cell development (GO:0021782),0.3085214407385237,0.7437446752982843,0.7818991097922848,0.9587123843777124,1.0,5/25,18.99%,APP;EIF2B2;SOX10;NSUN5;SOX11
prerank,negative regulation of lipid biosynthetic process (GO:0051055),0.3208275053324535,0.7427796269717512,0.7786259541984732,0.9597466103687688,1.0,5/20,17.27%,CEACAM1;FBXW7;BRCA1;ERLIN2;TRIB3
prerank,regulation of exit from mitosis (GO:0007096),0.2839126118866409,0.7416703238870309,0.8141470180305131,0.9609133590942415,1.0,11/38,23.29%,UBE2D1;UBA52;RPS27A;CDC14A;UBE2E1;CDC27;ANAPC7;PPP1R9B;ANAPC4;UBB;ANAPC11
prerank,regulation of neuroblast proliferation (GO:1902692),0.3277173037056119,0.7415532316243724,0.7719298245614035,0.9606375915459001,1.0,5/15,14.82%,TAFA1;LRRK2;CX3CR1;CTNNB1;FZD3
prerank,mitotic sister chromatid segregation (GO:0000070),0.24437574791146752,0.741510072774553,0.869615832363213,0.9602698710521128,1.0,19/98,16.20%,RAB11A;CUL3;RAD21;KPNB1;TENT4A;DSN1;CHMP1B;VPS4A;PRC1;CHMP3;NCAPG;CEP55;RAN;CSNK2B;CHMP2B;CHMP7;BOD1;NDC80;SGO1
prerank,regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.25097069054193083,0.7415090752347537,0.8616125150421179,0.9598432985631238,1.0,18/80,18.77%,NOD1;ARL6IP5;KLF4;PPM1F;TNFSF10;GRAMD4;DELE1;HMGB1;SIAH2;CASP1;RPS6KA1;RPS6KA3;CDKN2D;DNAJB6;PYCARD;SOX7;XIAP;MALT1
prerank,regulation of short-term neuronal synaptic plasticity (GO:0048172),0.33928820387956743,0.7413255323735702,0.7635782747603834,0.959662299075327,1.0,3/13,10.51%,SHISA8;SHISA6;GRIK2
prerank,regulation of centrosome duplication (GO:0010824),0.28983313949078976,0.7405910715518368,0.8058394160583942,0.9602627500429786,1.0,11/29,27.34%,CHMP1B;CEP76;NPM1;CHMP3;CHMP2B;CEP120;CHMP1A;GEN1;FBXW5;VPS4B;CHMP4B
prerank,positive regulation of immunoglobulin production (GO:0002639),-0.23798698641664212,-0.7404811570757964,0.8482758620689655,0.981002529914666,1.0,6/31,18.02%,STX4;RBP4;KMT5C;KMT5B;EPHB2;PHB2
prerank,transcription-coupled nucleotide-excision repair (GO:0006283),0.2564283946782452,0.7402434864834984,0.8626237623762376,0.9603361738887464,1.0,14/72,15.83%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;GTF2H3;COPS8;LIG1;ERCC4;RFC2;POLR2I
prerank,regulation of phosphatase activity (GO:0010921),0.3014323207662452,0.7402218255096293,0.782798833819242,0.959943250270145,1.0,3/24,7.44%,ZCCHC9;GPATCH2;HSP90B1
prerank,iron ion homeostasis (GO:0055072),0.26169626756179626,0.7392830809013982,0.8391959798994975,0.9608348609266483,1.0,20/58,24.89%,B2M;FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,regulation of macromolecule metabolic process (GO:0060255),0.23535721607134685,0.739171526274502,0.910989010989011,0.9605510977931881,1.0,31/170,16.78%,TRIM14;NOVA2;APP;AFF1;SLC8A1;YBX2;TRIM11;TRIM6;NKAPL;ZC3H12A;CAVIN4;CACTIN;FOXP1;DHH;HNRNPK;TRIM17;PCBP1;HINFP;TOB1;TSKU;PIN1;TAPBP;UNCX;HIF1A;NELL1;ATXN7L3B;YBX1;KIF16B;AFF4;ZNF711;BMI1
prerank,nuclear membrane disassembly (GO:0051081),-0.2906863371957592,-0.7387988149600675,0.8042895442359249,0.9821767745302086,1.0,4/14,15.84%,PRKCB;PRKCA;AKAP8L;NEK6
prerank,negative regulation of neuron death (GO:1901215),0.24435920081302087,0.7387583508130513,0.87995337995338,0.9607309957446719,1.0,33/93,27.53%,FOXQ1;PPT1;FBXO7;MEF2C;CD34;TNFRSF1B;TOX3;LRRK2;CD200;PRKCG;VPS35;CHGA;FZD9;FGF20;KDM2B;UNC5B;NENF;BDNF;GSK3B;CD200R1;SORL1;SOD1;EIF4G1;GRN;ATP13A2;CSF1;CLCF1;GDNF;SNCA;CHMP4A;CHMP4B;TRAF2;RASA1
prerank,negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.3434210266418659,0.7385167864086348,0.7399678972712681,0.9602187612109291,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.3434210266418659,0.7385167864086348,0.7399678972712681,0.9602187612109291,1.0,2/11,12.45%,FKBP1A;CALM3
prerank,sensory perception of taste (GO:0050909),0.35599071110274283,0.737944785879056,0.7932773109243697,0.9605784669459815,1.0,10/10,64.42%,ASIC2;PKD1L3;PKD2L1;TAS1R3;GNAT3;TAS1R2;TAS1R1;ASIC3;ASIC1;CD36
prerank,cellular response to gamma radiation (GO:0071480),0.32347609737279215,0.7372846736911361,0.7783094098883573,0.961073168202036,1.0,6/17,25.80%,TMEM109;ATM;MAP3K20;WRN;YAP1;RPL26
prerank,cellular response to ionizing radiation (GO:0071479),0.27128938160859395,0.7371959986069223,0.8232044198895028,0.960774326849449,1.0,15/47,24.12%,RHOB;TMEM109;SPIDR;RAD1;ATM;MAP3K20;RAD9B;KDM4D;MAPK14;EEF1D;HUS1;BLM;ECT2;WRN;YAP1
prerank,positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.2955138511477299,-0.7369405982833341,0.8277634961439588,0.9835641245293812,1.0,1/12,1.76%,BMP7
prerank,aminoglycan metabolic process (GO:0006022),-0.31112348439454957,-0.7364438257414508,0.8020050125313283,0.983171311281473,1.0,4/10,23.67%,XYLT1;B3GAT3;B3GAT1;CLN6
prerank,detection of light stimulus involved in sensory perception (GO:0050962),-0.3123705516851817,-0.736227136264758,0.7964376590330788,0.9814085432259199,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,detection of light stimulus involved in visual perception (GO:0050908),-0.3123705516851817,-0.736227136264758,0.7964376590330788,0.9814085432259199,1.0,10/10,68.79%,TULP1;GNAT1;REEP6;GNAT2;CACNA1F;CNGB1;GRM6;RPE65;CEP250;CACNA2D4
prerank,positive regulation of neuroinflammatory response (GO:0150078),-0.2907525082813577,-0.7358912727127083,0.8042452830188679,0.9808478726914943,1.0,1/12,1.83%,NUPR1
prerank,magnesium ion transport (GO:0015693),-0.30800771836000995,-0.7355558068794842,0.8243243243243243,0.9802521245769028,1.0,5/12,18.09%,SLC41A1;TUSC3;NIPA1;MAGT1;NIPAL4
prerank,positive regulation of epithelial cell differentiation (GO:0030858),0.3257758350201686,0.7341641083941126,0.7872670807453416,0.9646106403161976,1.0,2/17,3.51%,BTG1;TMEM100
prerank,neuron differentiation (GO:0030182),0.23097444222576086,0.7335997593641868,0.9193020719738277,0.9649340923550299,1.0,23/165,16.63%,NR4A2;NEUROG2;ATP2B2;OLIG2;TGFB2;PPT1;MEF2C;MYEF2;ALK;NGRN;TENM3;TENM4;SPOCK1;PHOX2A;PIN1;POU3F2;MYT1L;CTNNB1;FZD3;TENM2;TENM1;SNPH;OPHN1
prerank,quinone biosynthetic process (GO:1901663),0.334130896214314,0.7333978099574417,0.7931596091205212,0.9648004264690148,1.0,5/14,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,aggrephagy (GO:0035973),0.29558337121827755,0.7333262070353963,0.8087818696883853,0.9644722058182716,1.0,8/27,21.60%,VIM;UBA52;RPS27A;DYNLL1;DYNC1LI2;DYNLL2;DYNC1I2;UBB
prerank,negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2649121248106336,-0.7331344358367996,0.8457142857142858,0.9822181527863622,1.0,5/19,15.35%,GNL3L;SRC;TENT4B;TEN1;HNRNPU
prerank,postreplication repair (GO:0006301),0.269748722918594,0.7330794775291332,0.83203125,0.9643935620106495,1.0,9/45,15.87%,USP43;POLK;UBA52;RPS27A;TRIM25;BRCA1;RAD18;RFC2;SPRTN
prerank,production of miRNAs involved in gene silencing by miRNA (GO:0035196),0.2910060497988856,0.7327578334368346,0.797752808988764,0.9644050676608464,1.0,7/29,17.51%,PUM2;SMAD2;ZC3H7A;ADAR;AGO4;DROSHA;TUT7
prerank,protein monoubiquitination (GO:0006513),0.2799136666616282,0.7326924224897854,0.8129205921938089,0.9640684976135893,1.0,9/36,14.78%,CUL3;RBX1;TRIM25;OBI1;DTX3L;UBE2T;UBE2E1;RAD18;UBE2D3
prerank,glutathione derivative biosynthetic process (GO:1901687),-0.26154412776148694,-0.7321802753453033,0.8487394957983193,0.9813045215550477,1.0,8/20,22.28%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,glutathione derivative metabolic process (GO:1901685),-0.26154412776148694,-0.7321802753453033,0.8487394957983193,0.9813045215550477,1.0,8/20,22.28%,GSTT1;GSTZ1;GSTA3;GSTM1;GSTM2;AKR1A1;GSTM5;GSTO1
prerank,RNA metabolic process (GO:0016070),0.23512216927475219,0.7321144427922934,0.8909090909090909,0.9644432724085549,1.0,31/127,19.86%,ADARB1;RBPMS;LSM1;SETX;HNRNPA0;ZC3H12A;POLR2G;ADAR;ELAVL4;DHX9;DKC1;DUSP11;POLR2D;HNRNPK;AGO4;RNASE1;RNASEH2B;XRN2;PCBP1;METTL14;RNASE6;HNRNPH2;ATXN1;PRPF4;POLR2I;DROSHA;TENT2;DDX39B;HNRNPUL1;RNASE4;SYNCRIP
prerank,response to UV-B (GO:0010224),-0.2957243808386056,-0.7315350595731109,0.8209366391184573,0.9811118024732608,1.0,4/12,16.09%,HYAL1;CRIP1;MFAP4;CDKN1A
prerank,oligodendrocyte development (GO:0014003),0.332693469908378,0.7309793866068698,0.7898894154818326,0.9655611221291809,1.0,4/15,17.24%,EIF2B2;B4GALT6;SOX10;NSUN5
prerank,long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.3205875004450431,0.730932750236982,0.7942942942942943,0.9652003296423738,1.0,7/18,22.41%,ACSL5;ACSBG1;ELOVL7;ELOVL5;TECR;HACD2;ACSL4
prerank,mRNA destabilization (GO:0061157),-0.22167659790820154,-0.7306375030660617,0.9033457249070632,0.981279038583608,1.0,11/38,19.02%,ROCK2;YTHDF1;FTO;PUM1;TARDBP;YTHDF2;CPEB3;GIGYF2;RC3H1;TUT4;ZFP36
prerank,negative regulation of tumor necrosis factor production (GO:0032720),0.2772451556833624,0.7305770447878489,0.8160442600276625,0.9652499106943906,1.0,8/41,16.90%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR;HAVCR2;RARA
prerank,ion homeostasis (GO:0050801),0.2845069087621406,0.7303686380665146,0.8238557558945908,0.96511440111277,1.0,5/30,10.96%,RHCG;KLHL3;CAMK2D;SLC4A9;NEDD4L
prerank,regulation of immunoglobulin production (GO:0002637),0.3055316625497606,0.7301325501500964,0.8056801195814649,0.9650111788636402,1.0,2/23,5.16%,FCGR2B;GPI
prerank,positive regulation of amyloid-beta formation (GO:1902004),0.31197996233398795,0.7297910651375038,0.7978560490045942,0.9650683695662885,1.0,6/18,21.58%,IFNGR1;EFNA1;CLU;GSK3A;RELA;EPHA4
prerank,chloride transport (GO:0006821),0.24862740178737372,0.7296856229116495,0.8683574879227053,0.9647987577207062,1.0,16/74,18.08%,CLIC4;SLC12A8;ANO6;GABRQ;BEST1;TTYH3;CLCN3;CLCN1;GABRA4;SLC1A1;GABRA2;GABRE;GLRA2;GABRG3;CLIC5;GABRB1
prerank,establishment or maintenance of apical/basal cell polarity (GO:0035088),0.3138500014231689,0.7295091257997887,0.8124006359300477,0.9646262056346837,1.0,7/19,21.37%,CLIC4;MARK2;LRRC7;ERBIN;FOXJ1;MTCL1;CRB1
prerank,mitotic nuclear membrane organization (GO:0101024),0.2620070935865087,0.7291098680954213,0.847457627118644,0.9643118707281444,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,mitotic nuclear membrane reassembly (GO:0007084),0.2620070935865087,0.7291098680954213,0.847457627118644,0.9643118707281444,1.0,12/51,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,protein autoprocessing (GO:0016540),0.32196337771926564,0.7290991687460877,0.7869634340222575,0.9639027021095248,1.0,3/17,15.87%,OMA1;CASP1;SPRTN
prerank,entrainment of circadian clock by photoperiod (GO:0043153),-0.23286304028281254,-0.7288726827067131,0.8832807570977917,0.9823804108842132,1.0,12/27,36.84%,CRY2;SIK1;PER3;FBXL3;PML;USP2;FBXL8;FBXL12;FBXL22;PER2;PPP1CB;TP53
prerank,protein localization to condensed chromosome (GO:1903083),0.34714404935279275,0.7285521429046418,0.7719594594594594,0.9641918381831767,1.0,2/12,8.02%,IK;MTBP
prerank,peroxisome organization (GO:0007031),-0.2426669196032518,-0.7285341011473455,0.874251497005988,0.9817793889869256,1.0,8/25,24.75%,ABCD3;PEX2;SEC16B;DNM1L;PEX7;PEX11B;PEX3;PEX16
prerank,ribosomal large subunit assembly (GO:0000027),0.29767051579807335,0.7282907888522221,0.7939042089985486,0.9641463701955233,1.0,14/24,32.17%,BOP1;DDX28;RPL23A;RSL24D1;NOP53;RPF2;RPL3;MDN1;RPL11;FASTKD2;NOP2;RPL10;NLE1;RPL6
prerank,protein import into mitochondrial matrix (GO:0030150),0.3153461567277308,0.7281578372607751,0.8104265402843602,0.9639109223934246,1.0,3/18,15.95%,TOMM20L;DNLZ;PAM16
prerank,positive regulation of vacuole organization (GO:0044090),-0.3186886476137673,-0.7281041094315959,0.8065326633165829,0.9813253804247507,1.0,2/10,7.77%,ANXA2;PIP4K2A
prerank,sensory perception of pain (GO:0019233),0.3048780694954469,0.7274680363439536,0.794682422451994,0.9644452125835645,1.0,4/21,13.50%,NIPSNAP1;P2RX7;ALOXE3;SCN9A
prerank,T cell activation involved in immune response (GO:0002286),0.3409408683581649,0.7272429353857276,0.7824620573355818,0.964317438458915,1.0,1/12,2.44%,F2RL1
prerank,cellular response to glucose stimulus (GO:0071333),0.2836752545227763,0.7270872206473991,0.8277858176555717,0.9640968913751465,1.0,3/30,8.29%,UNC13B;PCK2;PRKAA1
prerank,protein targeting to membrane (GO:0006612),-0.18879559966597212,-0.7270771542333144,0.9735449735449735,0.9815585351012234,1.0,17/83,15.22%,ABCD3;PARD3;SIL1;ATG3;RAB3IP;SSR1;PRKCI;ATAD1;TRAM1;PEX2;PXMP4;SDCBP;ARL6;SSR2;PXMP2;RABGEF1;GDAP1
prerank,negative regulation of type I interferon-mediated signaling pathway (GO:0060339),0.32823647564269326,0.7270453895233687,0.7909238249594813,0.9637361605727246,1.0,3/15,17.42%,NLRC5;CACTIN;PTPN2
prerank,protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),0.34932498822053637,0.7262433439084977,0.785831960461285,0.9644059103878807,1.0,2/10,8.72%,PLPP1;DGKH
prerank,regulation of biosynthetic process (GO:0009889),0.34486838196637437,0.725916350156179,0.7944732297063903,0.96444437417196,1.0,1/11,6.64%,SLC25A33
prerank,positive regulation of cell division (GO:0051781),-0.22781053098844853,-0.7250836105992826,0.9206349206349206,0.9830207656744128,1.0,7/38,15.69%,FGFR2;FGF1;SVIL;SPAST;DRD2;SIRT2;CDC14B
prerank,regulation of mitotic spindle assembly (GO:1901673),0.30996381239795534,0.725058100327873,0.800599700149925,0.9651855424261119,1.0,10/19,29.79%,HSPA1B;CHMP1B;CHMP3;CHMP2B;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A
prerank,negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),-0.2544450878757866,-0.725054527945339,0.8513513513513513,0.9820572494352777,1.0,1/20,0.19%,NR2F2
prerank,activin receptor signaling pathway (GO:0032924),0.32699512127566427,0.7248587343141717,0.7879282218597063,0.9650395982093838,1.0,4/15,15.16%,ACVR1;SMAD2;ACVR2A;ACVR2B
prerank,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.3073210347834454,0.7229995349233004,0.8090062111801242,0.9671304707736093,1.0,6/20,18.51%,NOTCH1;NFE2L2;CHD6;HIF1A;SMAD4;RELA
prerank,negative regulation of protein transport (GO:0051224),-0.24101565375915135,-0.7229428059361221,0.901840490797546,0.9836273329254138,1.0,8/25,21.98%,APOE;PKDCC;SNX12;DRD2;SERGEF;RHBDF1;CYP51A1;ERP29
prerank,regulation of translational initiation (GO:0006446),0.256719627878828,0.7227011584174102,0.8549222797927462,0.9670883676757327,1.0,15/63,16.50%,UHMK1;HSPB1;POLR2G;EIF3B;EIF2B2;POLR2D;EIF1;NPM1;RPS6KB1;HABP4;PPP1R15B;MTIF2;EIF3H;KLHL25;NCK1
prerank,positive regulation of lymphocyte proliferation (GO:0050671),0.2527078065685625,0.7224838007453437,0.8575063613231552,0.9669444406800277,1.0,4/63,7.82%,VCAM1;TIRAP;MEF2C;SLC7A1
prerank,positive regulation of cell killing (GO:0031343),-0.28661715612232647,-0.722040562438756,0.8222222222222222,0.9836883035561463,1.0,5/13,27.35%,WNT5A;FZD7;MAPK8;SYK;NOXO1
prerank,rRNA transcription (GO:0009303),0.3142019066402839,0.7217337791962437,0.8,0.9675430123193707,1.0,6/17,21.04%,CAVIN1;TAF1B;TCOF1;SPIN1;ANG;BRF1
prerank,"nucleotide-excision repair, DNA gap filling (GO:0006297)",0.2941264867290188,0.721730128698602,0.7979502196193266,0.9671233437899956,1.0,6/24,15.37%,POLK;UBA52;RPS27A;POLB;LIG1;RFC2
prerank,negative regulation of lymphocyte proliferation (GO:0050672),0.28048494439279026,0.7216158795781783,0.8238557558945908,0.9668433637169643,1.0,4/31,13.96%,FCGR2B;ARG1;TYROBP;ATM
prerank,cellular response to corticosteroid stimulus (GO:0071384),0.3232221335486989,0.7215247118382012,0.7936507936507936,0.9665406386491485,1.0,2/15,9.31%,FAM107A;ZFP36L2
prerank,mitochondrial respiratory chain complex assembly (GO:0033108),0.2457781502730612,0.7215048076829,0.8916967509025271,0.96614184172643,1.0,22/87,23.04%,OMA1;TMEM126B;SCO1;UQCC3;SLC25A33;IMMP2L;NDUFS4;NDUFA12;NDUFB5;NDUFB7;UQCRFS1;TIMMDC1;ACAD9;NUBPL;SAMM50;PET100;NDUFB4;UQCC2;NDUFA9;NDUFV1;BCS1L;NDUFC1
prerank,ubiquinone biosynthetic process (GO:0006744),0.3226004600268937,0.7214016533089511,0.8025889967637541,0.9658613301660443,1.0,6/15,22.40%,COQ3;PDSS2;PDSS1;COQ5;COQ7;NDUFA9
prerank,positive regulation of peptidase activity (GO:0010952),0.3109146280926418,0.7211308500452384,0.8118195956454122,0.9658049147714642,1.0,8/20,27.71%,APH1A;VSIR;CTSH;APH1B;NCSTN;GRN;TANK;DDRGK1
prerank,negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),0.2720357983178503,0.7201066740155773,0.8422496570644719,0.9666929949247591,1.0,6/43,10.88%,LGALS9;CD34;NFKBIL1;ZC3H12A;CACTIN;VSIR
prerank,erythrocyte differentiation (GO:0030218),0.2704558411836022,0.7198254246644823,0.842741935483871,0.9666433249305656,1.0,6/44,8.61%,TAL1;ALAS1;MFHAS1;JAK2;RPS14;KMT2E
prerank,regulation of chromosome organization (GO:0033044),-0.2476843207418089,-0.7197845154753622,0.8630952380952381,0.9852872372036359,1.0,11/22,37.72%,YLPM1;XRCC5;HDAC8;SETMAR;RMI2;LIG4;HNRNPD;SMG6;UPF1;MYC;PIF1
prerank,positive regulation of DNA recombination (GO:0045911),-0.23416596195089623,-0.7196608201539422,0.8945686900958466,0.9844294323413965,1.0,8/27,22.29%,KMT5C;FUS;KMT5B;ACTR2;ERCC2;FANCB;TIMELESS;PARP1
prerank,synaptic vesicle cycle (GO:0099504),0.2879359392805831,0.7193135213064366,0.8149717514124294,0.9668869273520417,1.0,8/30,26.91%,SYT7;PIP5K1C;SLC32A1;CPLX1;NLGN1;RIMS1;PLD2;SNCA
prerank,negative regulation of histone acetylation (GO:0035067),-0.3039248495641702,-0.718535625149155,0.8444444444444444,0.9847231031898462,1.0,3/11,18.94%,SET;TAF7;NOC2L
prerank,UV-damage excision repair (GO:0070914),-0.29312985008002446,-0.718443294578663,0.8266666666666667,0.9838112383543587,1.0,2/12,7.98%,DDB2;CUL4B
prerank,negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.2805732402611949,0.7184346168702237,0.8289085545722714,0.9676288112374158,1.0,6/30,17.42%,CAV1;HYAL2;INPP5F;NF2;SH3BP5L;PTPN2
prerank,eosinophil migration (GO:0072677),0.3198568648377173,0.7184038720430324,0.8129139072847682,0.9668308419485901,1.0,14/14,68.04%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,eosinophil chemotaxis (GO:0048245),0.3198568648377173,0.7184038720430324,0.8129139072847682,0.9668308419485901,1.0,14/14,68.04%,CCL4;LGALS3;SCG2;CCL24;CCL26;CCL13;CCL3;CCL1;CCL8;CCL7;CCL11;CCL5;CX3CL1;CCL2
prerank,negative regulation of interleukin-1 beta production (GO:0032691),0.3065694183155466,0.718003998859567,0.8056426332288401,0.9669625742242297,1.0,5/19,18.48%,APOA1;ZC3H12A;CX3CR1;PYDC1;GIT1
prerank,serine family amino acid biosynthetic process (GO:0009070),0.3304658939644568,0.7177024922448522,0.7864406779661017,0.966952075618159,1.0,2/12,11.61%,SERINC3;SERINC5
prerank,positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.25975070627631985,0.7176029562873998,0.8622908622908623,0.9666750683064647,1.0,15/52,22.72%,CASP8;PPP1R13B;BBC3;NMT1;FBXW7;UBE2J2;YWHAH;UBE2D3;GSK3A;BID;TOMM7;PPP3CC;SREBF2;LEPROT;PPP3R1
prerank,triglyceride homeostasis (GO:0070328),0.290962334659288,0.7174084732806905,0.8241430700447094,0.9665275458946742,1.0,2/26,3.48%,HNF4A;APOA1
prerank,chaperone cofactor-dependent protein refolding (GO:0051085),0.29528290122729556,0.7171980592591561,0.8183118741058655,0.9663810302082112,1.0,5/25,18.60%,HSPA1B;HSPE1;PTGES3;DNAJC7;DNAJB5
prerank,positive regulation of T cell cytokine production (GO:0002726),-0.2580355246346747,-0.7163832244882264,0.8579387186629527,0.9851436067227509,1.0,4/20,13.07%,IL1R1;CD55;PRKCZ;CD81
prerank,positive regulation of myelination (GO:0031643),-0.3073124656453289,-0.7161192860325326,0.8443271767810027,0.9844424708049475,1.0,2/11,4.46%,DICER1;PARD3
prerank,cytoskeleton-dependent cytokinesis (GO:0061640),-0.2000331625832521,-0.7160928421717828,0.9720930232558139,0.983481406138873,1.0,23/56,28.68%,ROCK2;SON;IST1;JTB;EFHC1;ANLN;SPAST;RTKN;SNX18;STMN1;USP8;DCTN3;ARL3;INCENP;PDCD6IP;RACGAP1;TTC19;NUSAP1;CKAP2;RHOA;SNX33;CIT;ALKBH4
prerank,protein transport (GO:0015031),0.21817298796277887,0.7160711264272478,0.9776195320447609,0.9673902469669667,1.0,79/332,22.03%,RABGAP1;ARHGEF2;MACF1;RAB6B;ARL6IP5;HERC2;PPT1;STX7;TBC1D30;SCG5;EHD1;SGSM1;RAB34;TBC1D8;TMED10;MYH9;ARRDC1;RAB23;RAB3GAP2;LMTK2;HSP90B1;MCOLN1;TBC1D12;TLK1;TBC1D5;STX12;TBC1D1;CHMP1B;ARF3;LAPTM5;NPM1;VPS35;CLU;TMED9;RAB19;STX19;CHMP3;YWHAH;USP6NL;TBC1D10A;WDR11;TBC1D4;STXBP3;TBC1D9;NSF;VLDLR;TMED4;RUNDC1;TANGO6;CHMP2B;ARL5B;ANK3;ARFIP2;SEL1L;RUFY1;ATP6V1G1;SPTBN1;GOLPH3L;ARL4C;ATP6V1C1;TBC1D8B;GOLPH3;LAMP2;RAB5C;TVP23A;TMED7;ATP6V0A1;REP15;RAB31;LRP1B;ARRDC4;ATP6V1D;SCAMP1;RAB12;AP3D1;MYO6;ARHGAP1;CHMP1A;TBC1D14
prerank,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),-0.2538752286825967,-0.7159572589975319,0.9048991354466859,0.9826218069398496,1.0,5/21,14.80%,PRKN;TXNDC12;CREB3L1;CREB3;BOK
prerank,negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),-0.3166451064206022,-0.7159533921655825,0.8127962085308057,0.9816291130258166,1.0,2/10,6.40%,DCN;XDH
prerank,regulation of mitochondrial membrane permeability (GO:0046902),-0.266093076568157,-0.7156128649590656,0.8670212765957447,0.9810366501637621,1.0,3/18,12.53%,BCL2;SLC25A4;THEM4
prerank,nucleotide-excision repair (GO:0006289),0.236009978697749,0.7154787918181765,0.9078179696616102,0.9677417909786953,1.0,27/101,23.64%,COPS4;PPIE;POLK;UBA52;POLR2G;RPS27A;RBX1;POLR2D;BRIP1;POLA1;POLB;GTF2H3;COPS8;LIG1;ERCC4;XPC;RFC2;POLR2I;MMS19;COPS5;HUS1;MNAT1;UBB;POLR2C;POLR2B;CETN2;POLR2J
prerank,positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.2828801836653486,0.714718804685049,0.8297567954220315,0.9683308853884416,1.0,3/29,5.33%,CAV1;TNFSF10;HYAL2
prerank,positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),0.3408957502081494,0.7145073623912112,0.7849462365591398,0.9681869135661185,1.0,2/10,9.67%,ADAM17;FBXW7
prerank,histone H4 acetylation (GO:0043967),0.2648480480432115,0.7141250126625773,0.817824377457405,0.9682732613596166,1.0,9/47,15.52%,ING3;LEF1;BRD8;JADE2;CHD5;DMAP1;KANSL1;KAT7;TRRAP
prerank,programmed necrotic cell death (GO:0097300),0.31176396428687814,0.7135267185145063,0.7887323943661971,0.9686225008334287,1.0,2/18,9.55%,TLR3;MLKL
prerank,telomere maintenance via telomere lengthening (GO:0010833),0.2743149618698994,0.712874362117829,0.8464566929133859,0.9690752652753276,1.0,13/33,26.87%,ZBTB48;STN1;DKC1;PTGES3;NHP2;CTC1;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1
prerank,telomere maintenance in response to DNA damage (GO:0043247),0.3483833273221707,0.7128595049115742,0.791095890410959,0.9686794289763692,1.0,4/10,23.11%,APEX1;TERF2IP;RIF1;TERF2
prerank,negative regulation of neuroinflammatory response (GO:0150079),0.3215972008219572,0.7128403836608679,0.8096,0.9682865607620911,1.0,3/14,8.68%,TNFRSF1B;CD200;NR1D1
prerank,positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.3202672251240216,0.71250419518706,0.8087248322147651,0.968308801204192,1.0,4/15,16.98%,EHD1;TYROBP;ADGRB1;MAPK14
prerank,glucose 6-phosphate metabolic process (GO:0051156),0.2962520545915818,0.7124008493945159,0.8161094224924013,0.9680279514773451,1.0,3/21,12.42%,PGM2L1;GPI;TALDO1
prerank,positive regulation of triglyceride metabolic process (GO:0090208),-0.2723797939729489,-0.7122286614517798,0.8681948424068768,0.9839146987573049,1.0,5/16,15.80%,GPLD1;SLC27A1;SREBF1;MFSD2A;NR1H3
prerank,lipid phosphorylation (GO:0046834),0.3450748596176118,0.7115169992795447,0.8040540540540541,0.968733102050755,1.0,4/10,25.02%,DGKH;DGKI;DGKA;DGKB
prerank,visual system development (GO:0150063),0.2708364347277246,0.7114466908094285,0.8367346938775511,0.9683985661008115,1.0,4/37,7.12%,TGFB2;SIPA1L3;ADAMTS18;ITGAM
prerank,regulation of programmed necrotic cell death (GO:0062098),0.30693606870370327,0.7100488064569981,0.8553459119496856,0.9697231579255466,1.0,2/20,2.47%,CASP8;SPATA2
prerank,organelle fission (GO:0048285),-0.2440867223518995,-0.710045466842628,0.856338028169014,0.9852571379930962,1.0,10/24,29.49%,PRKN;SEC16B;TMCC1;GDAP1;MTFR1L;DNM1L;PEX11B;MTFR2;OPA1;MTFP1
prerank,response to gamma radiation (GO:0010332),0.2888832627447449,0.709802320057497,0.8189910979228486,0.9696163777113473,1.0,8/24,25.80%,TMEM109;PRKAA1;ATM;MAP3K20;MEN1;WRN;YAP1;RPL26
prerank,"positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.34031463300415016,0.7096100234453806,0.8021201413427562,0.9694403033323216,1.0,1/10,2.67%,LGALS9
prerank,positive regulation of transporter activity (GO:0032411),0.32618125973315193,0.7096029369949457,0.8146964856230032,0.9690331930085264,1.0,2/13,9.30%,STK39;SGK1
prerank,regulation of stem cell proliferation (GO:0072091),0.309699216670582,0.7093911991588664,0.8206349206349206,0.9688862979242094,1.0,1/17,1.04%,ACE
prerank,purine nucleotide metabolic process (GO:0006163),0.2933517171682425,0.7083749130686656,0.8296622613803231,0.9698042562425945,1.0,2/24,3.76%,GDA;GART
prerank,regulation of megakaryocyte differentiation (GO:0045652),0.2607221195637113,0.7083616786282392,0.8649732620320856,0.9693983856474493,1.0,12/49,18.70%,TNRC6C;MEF2C;THPO;KMT2E;KMT2B;AGO4;CBFB;HMGB2;EIF6;RBM15;SIN3A;H3-3A
prerank,positive regulation of neuron apoptotic process (GO:0043525),0.293926464142399,0.7082938222330549,0.8076923076923077,0.9690573108249507,1.0,6/24,14.24%,TGFB2;ITGAM;FBXW7;PRNP;TYROBP;CTNNB1
prerank,canonical glycolysis (GO:0061621),0.2846640161102845,0.7082587546157286,0.8237082066869301,0.9682646591301751,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,glucose catabolic process to pyruvate (GO:0061718),0.2846640161102845,0.7082587546157286,0.8237082066869301,0.9682646591301751,1.0,3/24,8.83%,GPI;PGK1;GAPDH
prerank,organonitrogen compound catabolic process (GO:1901565),0.25426713053746053,0.7077180643717228,0.8685567010309279,0.968522052428404,1.0,4/57,6.50%,ACE;TST;PPT1;TRIM24
prerank,glycine transport (GO:0015816),-0.30124948587021194,-0.707364073062666,0.8442211055276382,0.987125221176358,1.0,2/10,10.92%,SLC6A9;SLC38A5
prerank,positive regulation of protein localization to membrane (GO:1905477),0.23641245322496757,0.7071428255435018,0.9016587677725119,0.9688131320744815,1.0,22/98,18.53%,FYN;ATP2B4;CASP8;PPP1R13B;DPP10;AKAP5;STAC;BBC3;ITGAM;NMT1;MYO1C;PRNP;NKD2;YWHAH;ITGB1BP1;ITGA3;CNPY4;ZDHHC5;ANK3;SPTBN1;NECAB2;BID
prerank,"maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",0.2807932307703613,0.7070792132037833,0.8371757925072046,0.9684895508513492,1.0,10/29,25.51%,RPS21;DHX37;RPS14;WDR46;DCAF13;PWP2;RPS19;RPS8;UTP20;RPS16
prerank,establishment of spindle orientation (GO:0051294),-0.22779046579212006,-0.7066938444387321,0.9082278481012658,0.986896824000867,1.0,5/28,9.85%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,release of cytochrome c from mitochondria (GO:0001836),0.309366669921699,0.7066742765019708,0.8286604361370716,0.9685653997312565,1.0,6/17,21.53%,BBC3;BCL2L1;CLU;FZD9;BID;GGCT
prerank,negative regulation of response to biotic stimulus (GO:0002832),0.2894947441033937,0.7065017071268184,0.8362573099415205,0.9683581192393869,1.0,4/26,9.05%,NFKBIL1;NMI;ACOD1;CACTIN
prerank,internal peptidyl-lysine acetylation (GO:0018393),0.2867558392099793,0.7064993385381898,0.8595679012345679,0.9679448842593018,1.0,6/27,15.52%,BRD8;MRGBP;BAG6;SGF29;KAT7;TRRAP
prerank,mitochondrial genome maintenance (GO:0000002),0.3340390064843133,0.7057710147340313,0.8125,0.9684160390596075,1.0,2/11,6.91%,SLC25A33;AKT3
prerank,bile acid biosynthetic process (GO:0006699),0.2848741572762354,0.7056057610457652,0.8267254038179148,0.9682051861061745,1.0,4/24,14.78%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,positive regulation of blood coagulation (GO:0030194),0.3067609147443935,0.7052822806561595,0.8134796238244514,0.9681752435018877,1.0,2/17,4.92%,ANO6;ENPP4
prerank,response to glucose (GO:0009749),0.2589387223716491,0.7050590791060686,0.8709677419354839,0.9680422200834362,1.0,5/46,9.40%,UNC13B;HNF4A;PCK2;PRKAA1;EIF2B2
prerank,intracellular pH reduction (GO:0051452),-0.21562927798691126,-0.7048072019644276,0.9046052631578947,0.9880218523449142,1.0,16/33,34.15%,ATP6V0A4;ATP6V1B2;ATP6V0B;TCIRG1;ATP6V1A;ATP6V1F;ATP6V1H;ATP6V0D2;ATP6V0C;GPR89B;GPR89A;DMXL1;ATP6V0E2;SLC11A1;TMEM9;RAB20
prerank,protein localization to kinetochore (GO:0034501),0.32550670811030963,0.7047771303988581,0.819078947368421,0.9679837923550547,1.0,2/14,8.02%,IK;MTBP
prerank,histone deubiquitination (GO:0016578),-0.25756827397396753,-0.7042743527482904,0.8624338624338624,0.9875760518682326,1.0,3/18,13.64%,USP3;USP22;ATXN7L3
prerank,regulation of histone H3-K9 methylation (GO:0051570),-0.30041054768075137,-0.704244324255538,0.8530805687203792,0.9866098007853583,1.0,3/10,20.27%,JARID2;DNMT3B;ATRX
prerank,sensory perception (GO:0007600),0.25643655333618254,0.7041807491239277,0.8731836195508587,0.9682968000250661,1.0,7/45,13.50%,GNAL;NIPSNAP1;P2RX7;PCDH15;TMEM150C;ALOXE3;SCN9A
prerank,ciliary basal body-plasma membrane docking (GO:0097711),0.23641991365840292,0.7037624466130555,0.9161747343565525,0.9683919097659713,1.0,16/94,14.33%,RAB11A;TUBB;CSNK1D;TTBK2;TUBB4B;CLASP1;TMEM216;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;KIF24;TUBA1A;CEP83
prerank,protein targeting to mitochondrion (GO:0006626),0.2529960737979747,0.7035887741896788,0.8965952080706179,0.9681924188553513,1.0,8/52,15.95%,FBXO7;TOMM20L;IMMP2L;DNLZ;TSPO;AGK;SAMM50;PAM16
prerank,organic cyclic compound biosynthetic process (GO:1901362),0.2787789825999971,0.7034639386367123,0.8432732316227461,0.967937764136357,1.0,2/31,3.81%,GCH1;GPHN
prerank,positive regulation of synapse assembly (GO:0051965),0.28136929409419553,0.7030620423225209,0.8375350140056023,0.9680169171433678,1.0,9/27,22.79%,AGRN;IL1RAP;SLITRK2;LRRC4B;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1
prerank,sarcomere organization (GO:0045214),0.27912720091844956,0.7029703048191853,0.8468468468468469,0.9677331830949767,1.0,3/27,7.79%,CSRP2;WDR1;CASQ1
prerank,inorganic ion transmembrane transport (GO:0098660),-0.2871580914155528,-0.7029305386332706,0.851010101010101,0.9869836438418095,1.0,3/12,20.02%,ABCC9;CACNA1H;KCNJ8
prerank,tRNA export from nucleus (GO:0006409),0.2785391979074455,0.7029105404206697,0.8361344537815126,0.9669778478625928,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),0.2785391979074455,0.7029105404206697,0.8361344537815126,0.9669778478625928,1.0,8/32,15.93%,NUP54;NUP35;RANBP2;NUP153;NUP160;RAN;NUP42;NUP205
prerank,fatty acid beta-oxidation (GO:0006635),0.25166821845040255,0.7027010182036045,0.8642131979695431,0.9668359783671163,1.0,18/51,22.69%,ETFDH;ETFB;ETFA;ACOX1;ACAD10;SLC27A2;HADHB;ACOX3;CROT;ECI1;ACAT1;DECR2;HADHA;HADH;ACAA2;ABCD2;ABCD4;HSD17B4
prerank,macromolecule catabolic process (GO:0009057),0.2795917284106572,0.702221732542278,0.8495575221238938,0.9669969271987389,1.0,9/26,25.93%,PPT1;TRIM24;SMURF1;KIF16B;MVB12A;SNX25;UVRAG;TGFB1;CLN8
prerank,regulation of early endosome to late endosome transport (GO:2000641),-0.25201740546285506,-0.7022110081255983,0.8664772727272727,0.986737051070853,1.0,6/18,18.62%,DAB2;SRC;MAP2K2;SNX12;PTPN23;EZR
prerank,maturation of SSU-rRNA (GO:0030490),0.2719172214591146,0.7021529400366187,0.8565459610027855,0.9666659568883516,1.0,10/34,21.86%,DHX37;RPS14;WDR46;RPS28;RIOK3;NOB1;DCAF13;PWP2;RPS19;RPS8
prerank,response to light stimulus (GO:0009416),-0.19724578988365143,-0.7012846440557909,0.9441860465116279,0.9866875739130619,1.0,12/55,15.10%,DDB2;BRSK1;USP1;ERCC5;MAP2K7;CLOCK;REV1;UVSSA;MSH6;DRD2;CRY2;ERCC2
prerank,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),0.311546717560004,0.7000164234763672,0.8204724409448819,0.9688090748766149,1.0,2/15,5.76%,ING2;TAF9B
prerank,regulation of B cell proliferation (GO:0030888),0.2587331066562579,0.6999875613830331,0.8696808510638298,0.9684349822224882,1.0,6/44,13.96%,TIRAP;FCGR2B;MEF2C;TYROBP;CD38;ATM
prerank,negative regulation of fibroblast proliferation (GO:0048147),0.29880482505124256,0.6998399448678664,0.8422764227642277,0.968211438098642,1.0,1/18,2.21%,DAB2IP
prerank,positive regulation of endothelial cell chemotaxis (GO:2001028),0.3082556270550253,0.6991952902101991,0.8167202572347267,0.9685831583822492,1.0,4/15,16.19%,PRKD1;HSPB1;PRKD2;TMSB4X
prerank,intracellular sterol transport (GO:0032366),-0.2759356869404412,-0.6990912814454586,0.8730964467005076,0.9879868993871267,1.0,1/13,2.95%,ABCA1
prerank,negative regulation of proteolysis (GO:0045861),0.26605916799046747,0.6986894238856652,0.8423988842398884,0.9687894065496303,1.0,6/34,11.00%,TIMP3;EFNA1;LRRK2;ROCK1;PRNP;BAG6
prerank,regulation of mitochondrion organization (GO:0010821),0.2553238323515657,0.6985950447643346,0.8744939271255061,0.9684954907660962,1.0,17/47,24.90%,OMA1;IAPP;LRRK2;FBXW7;VPS35;INF2;RHOT2;VDAC1;GSK3A;GOLPH3;PISD;PLSCR3;GSK3B;SREBF2;PARL;ATP13A2;CSNK2A2
prerank,establishment of protein localization to mitochondrion (GO:0072655),0.25441058000273986,0.6980806797480757,0.8769230769230769,0.96871277423991,1.0,4/46,8.90%,FBXO7;TOMM20L;DNLZ;TSPO
prerank,protein insertion into ER membrane (GO:0045048),0.26468868728654055,0.6970107926509301,0.8715469613259669,0.9695458466063924,1.0,12/37,23.43%,APP;PRNP;GET1;BAG6;UBE2J2;VAPA;CCDC47;EMC3;CYB5A;EMC10;EMD;SGTA
prerank,snRNA transcription (GO:0009301),0.24157638850911664,0.6969953617497546,0.9069478908188585,0.9691515120418138,1.0,23/70,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;USPL1;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,sterol biosynthetic process (GO:0016126),-0.21769697489995493,-0.6961794036092407,0.9401408450704225,0.9899927502427105,1.0,1/33,0.11%,PRKAG2
prerank,long-chain fatty acid biosynthetic process (GO:0042759),0.28556092389371057,0.6958800021843837,0.8216374269005848,0.9700605174006152,1.0,3/23,12.22%,ASAH2;ACSBG1;ALOXE3
prerank,regulation of dendrite morphogenesis (GO:0048814),0.2682507799559741,0.6951665014048812,0.8549511854951185,0.9705255927857923,1.0,5/32,14.86%,RAPGEF2;LZTS1;NEDD4L;YWHAH;SARM1
prerank,establishment of mitotic spindle localization (GO:0040001),-0.2250564390532931,-0.6948724892663258,0.9047619047619048,0.9902681683560329,1.0,5/28,9.85%,GJA1;GPSM2;NDE1;UBXN2B;NDEL1
prerank,RNA stabilization (GO:0043489),-0.21414532433973404,-0.6941848690937045,0.935251798561151,0.9899516591601256,1.0,11/33,23.54%,PHAX;TENT5A;NOCT;FUS;AXIN2;HNRNPU;LARP1;PABPC1;TENT5D;E2F1;NAF1
prerank,protein N-linked glycosylation via asparagine (GO:0018279),0.270117037046548,0.6940756273475798,0.8884057971014493,0.9713779298116096,1.0,12/30,24.19%,MGAT5;MCFD2;OSTC;DPM1;MGAT1;UGGT1;DDOST;DAD1;MGAT2;FUT8;NUDT14;DPM3
prerank,iron-sulfur cluster assembly (GO:0016226),0.28182325385225443,0.6934871190224783,0.8298507462686567,0.9716311636289445,1.0,8/24,19.32%,BOLA2;ISCA2;GLRX5;GLRX3;HSCB;NUBPL;MMS19;IBA57
prerank,immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.30046446562563867,-0.6933603609416121,0.865,0.989787837365682,1.0,1/10,2.70%,KIT
prerank,nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.24194249784638,0.6924302523643675,0.8962148962148963,0.9724703160258544,1.0,16/72,15.37%,EXD2;ZC3H12A;POLK;UBA52;DCP1B;MEI4;RPS27A;FEN1;RBX1;RNASE1;XRN2;GTF2H3;ERCC4;RNASE6;EDC3;RFC2
prerank,axonemal dynein complex assembly (GO:0070286),-0.23138638068611386,-0.6921940089355173,0.9180327868852459,0.989926212785247,1.0,20/27,43.45%,DNAI4;DNAAF5;ODAD1;DNAH5;DNAL1;ODAD2;DRC1;CCDC39;ODAD3;CCDC65;DNAAF2;ODAD4;CFAP100;DNAH17;CCDC40;DNAAF4;CCDC63;DNAH8;DNAH1;SPAG1
prerank,regulation of synapse organization (GO:0050807),0.2752980983669641,0.6919669229248198,0.859375,0.9725931059751342,1.0,7/26,22.79%,PDLIM5;MEF2C;CTNNA2;SLITRK2;ABHD17B;EPHA4;IL1RAPL1
prerank,"mRNA cis splicing, via spliceosome (GO:0045292)",0.3062505981910325,0.6918129451568341,0.827140549273021,0.9723711736021853,1.0,3/16,13.96%,DCPS;CACTIN;SART1
prerank,mitotic cell cycle checkpoint signaling (GO:0007093),0.28978904791603166,0.6908004371711333,0.8490853658536586,0.9731533217567438,1.0,3/23,13.49%,PLK3;VPS4A;BUB1
prerank,positive regulation of macrophage differentiation (GO:0045651),0.3319134410542154,0.6905554377181888,0.8169717138103162,0.9730271532427689,1.0,1/11,2.41%,CASP8
prerank,rRNA pseudouridine synthesis (GO:0031118),0.334459915090251,0.6904779016093019,0.8400673400673401,0.9727065531795092,1.0,3/10,17.96%,DKC1;NHP2;RPUSD2
prerank,"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",0.27770537436442844,0.6901658164936286,0.8571428571428571,0.9726588891583723,1.0,7/27,20.39%,MSX1;SNAI2;ATM;EEF1E1;DYRK1A;YJU2;SMYD2
prerank,chromosome condensation (GO:0030261),-0.20918792213136578,-0.6892220734988599,0.9630996309963099,0.9917306720024054,1.0,15/36,29.10%,SET;NCAPG2;AKAP8L;GPER1;NCAPH2;INCENP;NCAPD2;PHF8;H1-0;NUSAP1;TOP2A;KMT5A;ACIN1;NCAPH;TTN
prerank,negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.2534875196980669,0.6890388412486386,0.8875661375661376,0.973555367673465,1.0,6/48,9.11%,F2RL1;APOA1;ARG1;NLRC5;CACTIN;STAP1
prerank,3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),0.2911104865948893,0.6887097176401096,0.8558139534883721,0.9735137914966213,1.0,4/19,13.08%,SULT6B1;SLC35B3;BPNT1;PAPSS1
prerank,protein kinase B signaling (GO:0043491),0.28306189755960176,0.6884683812675181,0.8454680534918276,0.9733723707315732,1.0,2/23,6.67%,PLK3;SETX
prerank,protein K11-linked ubiquitination (GO:0070979),-0.2282401523291635,-0.6878211056790317,0.9158878504672897,0.9920638173747046,1.0,4/27,12.45%,UBE2E2;PRKN;RNF4;UBE2L3
prerank,nucleocytoplasmic transport (GO:0006913),0.25319869449892163,0.6873902298242398,0.8824362606232294,0.9742132316985498,1.0,11/40,23.16%,BACH2;XPO1;SNRPE;NPM1;RSRC1;ATXN1;NUP205;MALT1;GEMIN8;LSG1;NXT2
prerank,protein targeting (GO:0006605),0.22076151842346578,0.687321470459958,0.9383720930232559,0.9738848388511526,1.0,21/118,21.52%,AQP11;ZDHHC22;NACAD;FBXO7;SRP14;RASSF9;MYO1C;TSPO;TAOK2;SRPRA;ZDHHC14;LONP2;ZDHHC23;HAP1;LAMP2;TOMM7;ZFAND2A;GIPC1;PEX1;SORL1;NLGN1
prerank,telomere organization (GO:0032200),0.2529150483232073,0.6872361109214924,0.8844621513944223,0.9735656744419472,1.0,16/43,26.09%,APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;H3-3A;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,mRNA catabolic process (GO:0006402),0.25690233585322636,0.687133557869032,0.8744993324432577,0.9732770327447313,1.0,18/44,25.70%,HSPA1B;ZFP36L2;AGO4;XRN2;XRN1;EXOSC9;TUT7;DXO;NBDY;LSM2;ERN1;EXOSC10;DIS3L2;NUDT16;MRTO4;RNH1;NUDT16L1;LSM5
prerank,regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),0.33300592101248605,0.687096880664517,0.8188034188034188,0.972911538611589,1.0,3/11,22.20%,IPPK;PWP1;NOP53
prerank,aromatic amino acid family catabolic process (GO:0009074),0.3071179412539667,0.6868325123459702,0.8348484848484848,0.9727962727783722,1.0,4/15,22.19%,HGD;KYAT1;KYNU;QDPR
prerank,retrograde axonal transport (GO:0008090),0.30657341323039156,0.6863873465295961,0.8344051446945338,0.972879424728463,1.0,5/16,24.69%,DST;KIF1A;HAP1;SOD1;KIF5A
prerank,steroid hormone biosynthetic process (GO:0120178),-0.2189801300019637,-0.6861845667165518,0.9113475177304965,0.9926538581756925,1.0,9/29,28.28%,FDX1;AKR1B1;HSD17B8;STAR;SRD5A1;HSD17B11;HSD17B2;TSPOAP1;SRD5A3
prerank,mRNA cleavage involved in mRNA processing (GO:0098787),-0.26257084167680306,-0.6860815464926469,0.8597883597883598,0.9917750388300866,1.0,4/14,15.74%,NUDT21;NCBP1;TUT1;CSTF2T
prerank,mitotic DNA replication (GO:1902969),0.3306539075106394,0.6848673432501545,0.8482293423271501,0.9741749053268237,1.0,2/10,13.13%,POLA1;LIG1
prerank,negative regulation of signal transduction by p53 class mediator (GO:1901797),-0.25636591052600977,-0.6840888980638172,0.8928571428571429,0.9926568614109298,1.0,5/17,17.89%,PRKN;MDM2;SNAI1;TWIST1;CD74
prerank,nuclear membrane reassembly (GO:0031468),0.2430361823145695,0.6836297936698568,0.9101412066752247,0.9750942510867355,1.0,12/54,15.93%,RANGAP1;KPNB1;NUP35;VRK1;REEP3;VPS4A;CHMP3;NUP160;RAN;CHMP2B;CHMP7;NUP205
prerank,body fluid secretion (GO:0007589),-0.26445370372545557,-0.6835380974134253,0.8952618453865336,0.9921664147922962,1.0,4/15,19.56%,SLC22A4;VEGFA;SLC22A2;ZBTB7B
prerank,positive regulation of bone resorption (GO:0045780),0.3197542804241852,0.6828971784916078,0.8500851788756388,0.9755108463116335,1.0,2/11,7.52%,MC4R;PLEKHM1
prerank,pentose-phosphate shunt (GO:0006098),-0.28906873521954235,-0.6827643526383725,0.8687350835322196,0.9919450080401785,1.0,5/11,27.74%,RPIA;H6PD;PGD;PGLS;SHPK
prerank,negative regulation of striated muscle cell differentiation (GO:0051154),0.2896073107178111,0.6827319941626353,0.8217054263565892,0.9752982875693228,1.0,1/18,1.60%,NOTCH1
prerank,selective autophagy (GO:0061912),0.24433217717452593,0.6825539388666472,0.905422446406053,0.9750850575438017,1.0,14/56,21.84%,VIM;KLHL3;UFM1;UBA52;RPS27A;NBR1;DYNLL1;DYNC1LI2;ATM;ATG14;DYNLL2;DYNC1I2;UBB;USP30
prerank,RNA catabolic process (GO:0006401),0.24917342263335054,0.6820986287781328,0.8836601307189542,0.9751967579743303,1.0,17/46,25.70%,HSPA1B;FEN1;ZFP36L2;AGO4;RNASEH2B;XRN2;RNASE6;DXO;LSM2;ERN1;DIS3L2;NUDT16;RNASEH2A;RNASEH1;RNH1;NUDT16L1;LSM5
prerank,positive regulation of nervous system development (GO:0051962),0.2548594156398376,0.6820965650191113,0.9062918340026773,0.9747898280654925,1.0,14/42,22.89%,RASSF10;IL1RAP;NUMB;SLITRK2;CX3CR1;LRRC4B;SPEN;SOX11;GRID2;BDNF;NRXN1;NLGN1;IL1RAPL1;MME
prerank,negative regulation of hippo signaling (GO:0035331),0.31667405622741795,0.6819266175271724,0.8380165289256198,0.9745567189008117,1.0,4/12,19.90%,WWC2;MARK3;MAPK14;SHANK2
prerank,cellular response to leucine starvation (GO:1990253),-0.2979658101003096,-0.6817367408613014,0.8711217183770883,0.9919131326723876,1.0,3/10,15.27%,SESN1;SESN2;EIF2AK4
prerank,positive regulation of phosphatase activity (GO:0010922),0.2868415763928056,0.6803513386165773,0.852760736196319,0.9758971930671203,1.0,4/21,14.73%,ITGA1;MEF2C;CALM3;PPP1R15B
prerank,double-strand break repair (GO:0006302),0.21377861088173128,0.6802403886281176,0.9646799116997793,0.9756176214069073,1.0,26/158,14.54%,RAD54B;HERC2;RBBP8;RAD21;SETX;EXD2;TENT4A;FEN1;HMGB1;BABAM2;SPIDR;MAD2L2;SFR1;BRIP1;POLA1;POLB;PSMD14;BRCA1;SMARCAD1;DTX3L;AP5Z1;EYA3;ERCC4;RAD51D;ATM;HMGB2
prerank,transcription by RNA polymerase III (GO:0006383),-0.22740718418751127,-0.6792968691671811,0.9411764705882353,0.9931173556122552,1.0,11/27,31.27%,GTF3C3;ELL;CRCP;GTF3C2;GTF3A;TBP;GTF3C1;POLR3K;GTF3C4;POLR2L;SNAPC2
prerank,modulation of excitatory postsynaptic potential (GO:0098815),0.2756980668331873,0.6789264306270165,0.849925705794948,0.9766582997230845,1.0,3/26,7.14%,APP;SHANK3;LRRK2
prerank,osteoclast differentiation (GO:0030316),0.2828602149754286,0.6787253893299366,0.8552437223042836,0.97646290991422,1.0,7/22,22.01%,SNX10;OSCAR;FOXP1;TYROBP;MAPK14;TNFRSF11A;EPHA2
prerank,chromatin remodeling at centromere (GO:0031055),-0.21330618480088587,-0.67818491340928,0.9485530546623794,0.9930968372113107,1.0,15/31,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;HELLS;CENPH;MIS18A;CENPN;CENPA
prerank,mitochondrial transport (GO:0006839),0.24625946100965165,0.6779711371356805,0.9194805194805195,0.9768661891776694,1.0,22/53,30.65%,SLC25A16;FBXO7;BCL2L1;TSPO;TMEM14A;BNIP3;TOMM7;PPIF;BCS1L;TIMM17A;MAIP1;PITRM1;HSP90AA1;FIS1;TIMM22;FLVCR1;TOMM70;SLC25A5;MFF;TOMM34;TIMM8B;STARD3
prerank,negative regulation of cyclin-dependent protein kinase activity (GO:1904030),-0.2364007011418169,-0.6776526715657785,0.90625,0.9926112500344343,1.0,1/22,0.19%,NR2F2
prerank,monocarboxylic acid catabolic process (GO:0072329),-0.23670888844510143,-0.6775100648683278,0.9162011173184358,0.9917661830501836,1.0,8/21,29.59%,CYP26B1;PLA2G15;AGXT;NUDT19;FAAH;PPARD;LPIN3;LPIN1
prerank,regulation of protein-containing complex assembly (GO:0043254),0.22334940240294673,0.6773334052219834,0.9491916859122402,0.9771650504816406,1.0,9/110,6.97%,FBLIM1;TAL1;MMP1;DAB2IP;TIRAP;HRK;IAPP;WARS1;IRGM
prerank,peptidyl-lysine modification (GO:0018205),0.2264438261056091,0.677207080170214,0.9399538106235565,0.9768884934846154,1.0,16/99,14.41%,IFIH1;HDAC9;ATP7A;SUMO2;SUMO3;LIPT2;SIRT4;RANGAP1;SENP5;NUP54;NUP35;RANBP2;LIPT1;NUP153;NUP160;NUP42
prerank,phosphatidic acid biosynthetic process (GO:0006654),0.24830164882481237,0.6771661991824681,0.8935611038107752,0.9765259277812774,1.0,5/46,8.72%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,positive regulation of protein acetylation (GO:1901985),0.31625610172615504,0.6768581520127379,0.8336079077429983,0.9764628408986763,1.0,4/12,18.35%,FAM161A;PRKAA1;DIP2B;TERF2IP
prerank,protein heterooligomerization (GO:0051291),0.29753321325663185,0.676557970717128,0.8387096774193549,0.9763850229493625,1.0,5/17,20.81%,FARSB;GRIN2B;KCNC2;MAT2A;TMEM120B
prerank,regulation of cholesterol esterification (GO:0010872),0.3240592869710074,0.6765472189972129,0.8181818181818182,0.9759914539239197,1.0,1/10,3.48%,APOA1
prerank,histone H4 deacetylation (GO:0070933),0.3244487079061591,0.6764716124071313,0.8557213930348259,0.9756610962601904,1.0,2/10,11.79%,HDAC9;SMARCAD1
prerank,regulation of TOR signaling (GO:0032006),0.23575077316506732,0.6759856905726312,0.9155107187894073,0.9757714378557508,1.0,27/67,26.70%,SMCR8;SH3BP4;WDR59;PRKAA1;RRAGD;RHEB;EPM2A;RICTOR;MIOS;GSK3A;GOLPH3;RRAGA;MAPKAPK5;HTR6;RRAGC;NPRL3;LAMTOR3;AKT1S1;WDR24;PIK3CA;ITFG2;SEH1L;MLST8;RPTOR;TBC1D7;LAMTOR4;PDCD6
prerank,dicarboxylic acid catabolic process (GO:0043649),-0.2733424456402819,-0.6747942630252699,0.884318766066838,0.9932829028446876,1.0,6/13,30.30%,DDO;GOT1;QPRT;ASPA;GOT2;ACSF3
prerank,histone H2A monoubiquitination (GO:0035518),-0.2526890137828638,-0.6745575523822943,0.8950437317784257,0.9924999072234844,1.0,3/17,7.98%,DDB2;PCGF3;CUL4B
prerank,positive regulation of neuroblast proliferation (GO:0002052),0.3256004600002025,0.6744144245976184,0.8393162393162393,0.9770202422223171,1.0,3/10,14.82%,CX3CR1;CTNNB1;FZD3
prerank,negative regulation of JUN kinase activity (GO:0043508),0.3226047660176522,0.6740809968730525,0.836555360281195,0.9769701740506166,1.0,2/10,10.36%,PDCD4;AIDA
prerank,purine-containing compound catabolic process (GO:0072523),0.31225585590700716,0.6739656221654021,0.8241935483870968,0.9767010525973188,1.0,1/13,1.85%,GDA
prerank,mucosal immune response (GO:0002385),0.306576676707743,0.6730543108758243,0.8533333333333334,0.9772559462661339,1.0,1/15,4.04%,DEFA6
prerank,proteolysis involved in cellular protein catabolic process (GO:0051603),0.23280262960305817,0.6729758279601735,0.9286592865928659,0.9769326224137408,1.0,15/71,18.77%,CASP8;OMA1;RHBDD1;SOCS6;UBA52;RPS27A;NR1D1;BAG6;RSPRY1;VPS4A;PSMA8;CTSK;CTSO;NGLY1;MALT1
prerank,positive regulation of behavior (GO:0048520),0.3238941826505738,0.6721881855757902,0.8461538461538461,0.9773708152576722,1.0,1/10,5.32%,MEF2C
prerank,hyaluronan catabolic process (GO:0030214),0.2890600529334775,0.6718271616279383,0.8894080996884736,0.9773543564586313,1.0,2/18,5.33%,CEMIP2;HYAL2
prerank,histone H3 deacetylation (GO:0070932),0.2968212622821875,0.6716721276733575,0.8436018957345972,0.9771066568997916,1.0,2/15,11.79%,HDAC9;SMARCAD1
prerank,positive regulation of B cell proliferation (GO:0030890),-0.22046983404229817,-0.6716404360799806,0.9609120521172638,0.9939833685133873,1.0,11/29,27.28%,BCL2;IRS2;NCKAP1L;CD81;EPHB2;CD74;CD40;GPR183;PTPRC;CD320;NFATC2
prerank,mitotic sister chromatid cohesion (GO:0007064),-0.25093065139976245,-0.6715786140570971,0.888,0.9930593297619419,1.0,2/16,5.01%,MAU2;NIPBL
prerank,camera-type eye morphogenesis (GO:0048593),-0.2968841534114508,-0.6715623731080951,0.8840579710144928,0.9921000028047484,1.0,3/10,11.27%,SHROOM2;VEGFA;TBX2
prerank,DNA dealkylation involved in DNA repair (GO:0006307),0.3307661521430748,0.6715374074398361,0.8590831918505942,0.9764518102337222,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,DNA dealkylation (GO:0035510),0.3307661521430748,0.6715374074398361,0.8590831918505942,0.9764518102337222,1.0,2/10,11.36%,ASCC1;ASCC3
prerank,regulation of leukocyte migration (GO:0002685),0.2981623369590029,0.6712807523568135,0.8637770897832817,0.9763051580528893,1.0,3/16,13.75%,TNFRSF18;RAC1;RHOH
prerank,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.28249150391004096,0.6712737277262016,0.8604294478527608,0.9755024131200213,1.0,3/22,18.21%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.28249150391004096,0.6712737277262016,0.8604294478527608,0.9755024131200213,1.0,3/22,18.21%,ZDHHC22;ZDHHC14;ZDHHC23
prerank,glycolytic process (GO:0006096),0.263168950263213,0.6710649524873958,0.888235294117647,0.9753118773714499,1.0,3/28,8.83%,GPI;PGK1;GAPDH
prerank,snRNA transcription by RNA polymerase II (GO:0042795),0.23281661123455075,0.6699869239393196,0.929192546583851,0.9760207804940301,1.0,22/69,23.64%,INTS11;POLR2G;POLR2D;ELL2;RPRD1B;INTS12;GTF2A1;INTS5;ICE1;TAF11;SNAPC4;POLR2I;TAF8;RPRD2;ZC3H8;SNAPC1;POU2F2;RPRD1A;POLR2C;POLR2B;INTS6;POLR2J
prerank,melanosome organization (GO:0032438),-0.22300486490767057,-0.6698004871222364,0.9363057324840764,0.9925929315074226,1.0,9/26,22.25%,SHROOM2;AP1M1;KIF13A;DTNBP1;HPS4;RAB29;BLOC1S2;RAB32;TRAPPC6A
prerank,telomere maintenance via telomere trimming (GO:0090737),-0.2844012624981773,-0.6686957349344527,0.8776978417266187,0.9905757314104864,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,formation of extrachromosomal circular DNA (GO:0001325),-0.2844012624981773,-0.6686957349344527,0.8776978417266187,0.9905757314104864,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,t-circle formation (GO:0090656),-0.2844012624981773,-0.6686957349344527,0.8776978417266187,0.9905757314104864,1.0,6/10,38.41%,SMARCAL1;XRCC3;SLX4;EXO1;DNA2;ERCC1
prerank,"positive regulation of gene expression, epigenetic (GO:0045815)",0.24409516049713423,0.668625321760459,0.9020134228187919,0.9770174190644083,1.0,10/48,15.35%,SERTAD2;SERTAD1;TAF1A;MYO1C;POLR1F;ASF1A;ACTB;DDX21;TAF1B;ELOF1
prerank,"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",0.20297980492705212,0.668088408578609,0.9812108559498957,0.9771620314726244,1.0,62/241,23.92%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),0.2909888636976627,0.6678240028324415,0.8642745709828393,0.9770146725067935,1.0,4/18,13.65%,HSPB1;NFE2L2;HIF1A;NOL3
prerank,mitotic G2 DNA damage checkpoint signaling (GO:0007095),-0.20660373956964348,-0.6678179766536124,0.9597523219814241,0.9903382980709282,1.0,10/32,21.59%,BRSK1;TRIM39;HMGA2;CDC14B;CDKN1A;DONSON;TAOK1;FZR1;TAOK3;RINT1
prerank,establishment of skin barrier (GO:0061436),0.29616286110825407,0.6675469578654095,0.8521341463414634,0.9764931390204873,1.0,2/15,12.22%,LSR;ALOXE3
prerank,regulation of water loss via skin (GO:0033561),0.29616286110825407,0.6675469578654095,0.8521341463414634,0.9764931390204873,1.0,2/15,12.22%,LSR;ALOXE3
prerank,peptidyl-lysine monomethylation (GO:0018026),-0.2949677306263361,-0.6672302710483416,0.8741258741258742,0.9898365044532577,1.0,4/10,18.12%,EHMT1;SETD7;SETD4;EEF1AKMT2
prerank,ribosomal small subunit biogenesis (GO:0042274),0.252980830120001,0.667197278056083,0.9002732240437158,0.9764290434826929,1.0,10/39,21.23%,RPS14;RPS28;NPM1;RPS25;RPS5;RIOK3;RPS15;NOB1;PWP2;RPS19
prerank,actin nucleation (GO:0045010),0.27949064324125517,0.666459522835593,0.8832335329341318,0.9767684047328524,1.0,8/21,27.87%,WHAMM;ARPC5;ARPC3;ARPC2;SPIRE1;ARPC1B;WASHC1;ARPC1A
prerank,regulation of DNA recombination (GO:0000018),-0.20955870398716012,-0.6663200936915932,0.9614035087719298,0.9895983658406515,1.0,12/32,29.64%,RAD50;KPNA1;THOC1;MSH6;RTEL1;ZRANB3;H1-0;RPA2;RAD51;CHEK1;ZCWPW1;SIRT6
prerank,cellular lipid catabolic process (GO:0044242),0.2699612074998133,0.6660972139892809,0.871301775147929,0.9767234702614339,1.0,2/27,8.17%,AOAH;ACOX1
prerank,glutathione biosynthetic process (GO:0006750),0.32142374915164446,0.6654665018845548,0.8584070796460177,0.9769463125376434,1.0,6/11,29.63%,GSS;CHAC2;GGCT;GCLM;OPLAH;CNDP2
prerank,intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.24550938633873792,0.6652201629088571,0.9182058047493403,0.9767752511776558,1.0,10/48,16.66%,TMEM109;CASP2;TNFRSF1B;CIDEB;BCL2L1;BAG6;BRCA1;ATM;PHLDA3;PYCARD
prerank,protein heterotetramerization (GO:0051290),0.3066094728612908,0.6648064400060845,0.8521594684385382,0.9768067438401922,1.0,2/13,8.37%,FARSB;GRIN2B
prerank,growth hormone receptor signaling pathway (GO:0060396),0.3016321172654765,0.6644906991004718,0.8545454545454545,0.9767093035073855,1.0,3/14,10.63%,JAK2;PTK2;PTPN1
prerank,rhodopsin mediated signaling pathway (GO:0016056),-0.2824954496956003,-0.6644269021395598,0.8824884792626728,0.9901555027155056,1.0,10/10,71.77%,PDE6A;PDE6G;PDE6B;RHO;GNAT1;CNGB1;GRK1;CNGA1;GNB1;SAG
prerank,cellular amide metabolic process (GO:0043603),0.22170350140525802,0.6644108678769438,0.9525462962962963,0.9763934335603397,1.0,7/102,5.93%,ACSM3;SLC25A32;CPD;PLPP1;GLYAT;DNPEP;ASAH2
prerank,negative regulation of synaptic transmission (GO:0050805),0.2747604717519679,0.6627776639115806,0.880354505169867,0.9776421936077889,1.0,6/23,23.24%,LRRK2;SLC30A1;ACHE;SLC24A2;SHANK2;MTMR2
prerank,response to ionizing radiation (GO:0010212),0.22845201200910897,0.6626851091814261,0.9403726708074535,0.9773253665622172,1.0,25/70,26.41%,RHOB;BRAT1;PRKAA1;BABAM2;SPIDR;BRCA1;EYA3;RAD1;ATM;RAD9B;KDM4D;MAPK14;MEN1;EEF1D;HUS1;BLM;ECT2;XRCC4;PAXIP1;NHEJ1;XRRA1;BABAM1;COP1;MTA1;RNF8
prerank,negative regulation of double-strand break repair (GO:2000780),-0.2103897543653942,-0.6624900972065783,0.9551282051282052,0.9907662507715222,1.0,10/30,25.10%,TRIP12;FBH1;HELB;HMGA2;TWIST1;KLHL15;FANCB;CGAS;POLQ;RMI2
prerank,pyrimidine nucleoside biosynthetic process (GO:0046134),0.3103673735412668,0.6619161584986808,0.849025974025974,0.977692675482333,1.0,4/12,21.71%,CAD;UMPS;UPP2;TK1
prerank,mRNA polyadenylation (GO:0006378),0.2674542327897896,0.6616061120491706,0.8988095238095238,0.9772020827439203,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,RNA polyadenylation (GO:0043631),0.2674542327897896,0.6616061120491706,0.8988095238095238,0.9772020827439203,1.0,4/26,10.93%,APP;CPSF1;MTPAP;FIP1L1
prerank,G protein-coupled glutamate receptor signaling pathway (GO:0007216),0.29582170256062434,0.6613536417833911,0.8774834437086093,0.9770398677060935,1.0,3/15,18.06%,HOMER2;GRM5;GRM7
prerank,error-prone translesion synthesis (GO:0042276),0.2779418657379092,0.6601036203242447,0.8686131386861314,0.9778644935980619,1.0,5/21,15.37%,POLK;UBA52;RPS27A;MAD2L2;RFC2
prerank,regulation of type I interferon-mediated signaling pathway (GO:0060338),0.26406957979942086,0.6593832344181625,0.9132947976878613,0.9781364791995223,1.0,4/29,10.63%,TRIM6;NLRC5;CACTIN;PTPN1
prerank,synaptic vesicle localization (GO:0097479),-0.26736684426805124,-0.6592672121787976,0.9137466307277629,0.992329235938616,1.0,5/13,23.84%,SPG11;KIF5C;CDK5;KIF5B;TOR1A
prerank,negative regulation of macroautophagy (GO:0016242),0.2636634283402061,0.658820593650496,0.896600566572238,0.97828858786482,1.0,11/26,27.63%,SMCR8;LRRK2;LZTS1;RUBCN;UBQLN4;FEZ1;PIK3CA;CHMP4A;CHMP4B;SCFD1;CLEC16A
prerank,DNA duplex unwinding (GO:0032508),0.23882596262022154,0.6586734553755595,0.9196891191709845,0.9780302603777721,1.0,8/50,11.55%,SSBP1;PURA;UBA52;RPS27A;DHX9;RBX1;ASCC3;GTF2H3
prerank,histone lysine demethylation (GO:0070076),-0.21989035588582354,-0.6578814303918928,0.9588607594936709,0.992382315101854,1.0,7/25,20.14%,KDM7A;JMJD1C;KDM4A;KDM6B;RIOX2;KDM8;PHF8
prerank,positive regulation of double-strand break repair (GO:2000781),-0.19802354166641667,-0.6577188649257341,0.9593220338983051,0.9915316719907147,1.0,11/39,22.29%,KMT5C;SLF1;FMN2;FUS;KMT5B;ACTR2;FANCB;TIMELESS;PARP3;SLF2;PARP1
prerank,negative regulation of ATPase activity (GO:0032780),0.28959680613795025,0.657490463861563,0.8803680981595092,0.9787659537146656,1.0,3/16,19.44%,PXK;PAM16;PPIF
prerank,negative regulation by host of viral process (GO:0044793),0.3229108198777769,0.6572461385211712,0.8593481989708405,0.9785777697179905,1.0,3/10,14.85%,ZC3H12A;PSMC3;VAPA
prerank,apoptotic mitochondrial changes (GO:0008637),-0.2062534361951305,-0.657127029823058,0.9593220338983051,0.9910001889518276,1.0,7/32,14.80%,BCL2;IFIT2;ATG3;AIFM2;HK2;THEM4;BOK
prerank,"negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",-0.2643431586904757,-0.657035401054263,0.9002624671916011,0.9901093641029282,1.0,4/13,17.89%,MDM2;SNAI1;TWIST1;CD74
prerank,PERK-mediated unfolded protein response (GO:0036499),0.31021397699335007,0.6568935516160203,0.8569078947368421,0.9785199822997197,1.0,4/10,26.29%,NFE2L2;EIF2S1;DDIT3;HERPUD1
prerank,regulation of telomere capping (GO:1904353),0.27278382410164304,0.6566893331235586,0.869983948635634,0.9783055174372689,1.0,4/23,13.96%,MAPK1;NEK7;TNKS;ATM
prerank,apoptotic nuclear changes (GO:0030262),0.2672806518092419,0.656544139828073,0.8859649122807017,0.9780381788288105,1.0,6/24,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.3167982048558573,0.6555223683781013,0.8619528619528619,0.9785867696815425,1.0,3/10,16.50%,JUN;HIF1AN;NCK1
prerank,DNA alkylation (GO:0006305),0.28642772227763746,0.6555137045611743,0.8853695324283559,0.9777946340996512,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,DNA methylation or demethylation (GO:0044728),0.28642772227763746,0.6555137045611743,0.8853695324283559,0.9777946340996512,1.0,4/19,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,peptide catabolic process (GO:0043171),0.2721164359306823,0.6553264036501896,0.8857142857142857,0.9775726275912578,1.0,1/23,1.04%,ACE
prerank,lipoprotein catabolic process (GO:0042159),0.3084380677169293,0.6548451859378188,0.8652246256239601,0.9776374275062645,1.0,4/11,23.73%,PPT1;ABHD17B;LYPLA1;LYPLAL1
prerank,placenta development (GO:0001890),0.30741987271968196,0.65474247573729,0.8619469026548673,0.9773325663623241,1.0,4/12,22.31%,PTK2;E2F7;ANG;SOD1
prerank,icosanoid biosynthetic process (GO:0046456),-0.277865227679869,-0.6547335471323756,0.8841607565011821,0.9909125593947831,1.0,5/10,36.57%,PLA2G4A;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,microtubule bundle formation (GO:0001578),0.24380650050633737,0.6542367745930185,0.9201101928374655,0.9774048500506547,1.0,9/42,21.11%,CFAP206;CLIP1;CLASP1;NUMA1;NAV1;FOXJ1;DCX;MTCL1;MARK4
prerank,negative regulation of cellular component organization (GO:0051129),0.2255647095501434,0.6536545522952727,0.9526184538653366,0.9775419307509806,1.0,19/74,23.24%,MCTP1;PRKD1;APOA1;IAPP;HSPA1B;AIDA;CLU;RIOK3;RUBCN;ABCA7;DNAJB6;DNAJB8;GSK3B;SORL1;LCMT1;CARMIL1;NOP53;TERF2;MTMR2
prerank,inhibitory synapse assembly (GO:1904862),0.31117388364287707,0.6530280957758718,0.8702791461412152,0.9777239087960075,1.0,3/11,13.77%,CBLN4;GABRA2;LGI2
prerank,positive regulation of cation channel activity (GO:2001259),0.25012635978404135,0.6529684688625377,0.9151846785225718,0.9773831861948075,1.0,9/40,18.42%,ADRB2;STAC;SHANK3;GAL;CASQ1;CALM3;TMSB4X;ANK3;HAP1
prerank,cellular response to interleukin-2 (GO:0071352),-0.27844364153377354,-0.6527500653647983,0.8785529715762274,0.9905164716387048,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,interleukin-2-mediated signaling pathway (GO:0038110),-0.27844364153377354,-0.6527500653647983,0.8785529715762274,0.9905164716387048,1.0,7/11,43.16%,SHC1;SYK;JAK3;IL2RA;PTK2B;STAT5B;IL2RB
prerank,regulation of cardiac muscle cell differentiation (GO:2000725),-0.27481151525593295,-0.6527284195623352,0.891358024691358,0.989576267020655,1.0,2/11,7.95%,EFNB2;FZD7
prerank,regulation of phospholipid metabolic process (GO:1903725),-0.28567109562706683,-0.6517886720862148,0.8737623762376238,0.98934580477937,1.0,3/10,19.48%,MFSD2A;PHB2;MTMR4
prerank,regulation of mRNA metabolic process (GO:1903311),0.3029923072870021,0.6516057702055554,0.8513986013986014,0.978244617536996,1.0,5/11,21.39%,DHX9;PTCD2;SRPK1;SAFB2;IWS1
prerank,phosphatidic acid metabolic process (GO:0046473),0.23751583387508451,0.6510660814878066,0.92578125,0.978355975722775,1.0,5/48,8.72%,ACP6;LPCAT4;LCLAT1;PLD1;DGKH
prerank,ncRNA export from nucleus (GO:0097064),0.2524132401121698,0.6509406411652972,0.8980716253443526,0.9780731274755315,1.0,9/36,15.93%,NUP54;NUP35;RANBP2;NPM1;NUP153;NUP160;RAN;NUP42;NUP205
prerank,Golgi to plasma membrane protein transport (GO:0043001),0.25871529684591765,0.650193806512817,0.9130434782608695,0.9783707283882666,1.0,8/30,20.45%,MACF1;RAB34;NSF;ANK3;SPTBN1;GOLPH3L;GOLPH3;RAB31
prerank,protein insertion into mitochondrial inner membrane (GO:0045039),-0.2718222170737952,-0.6501281198061208,0.8979591836734694,0.9896420231781966,1.0,6/11,37.33%,NDUFA13;ROMO1;TIMM29;TIMM10;TIMM9;TIMM13
prerank,positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.24370845288176377,-0.6497706020264407,0.9154929577464789,0.9889440041921538,1.0,11/16,47.41%,ST3GAL4;MDK;RHOA;ITGB2;NFAT5;SELP;ALOX5;FUT4;TNF;SELE;IL6
prerank,autophagosome organization (GO:1905037),0.2384327337263792,0.6494561803838745,0.9124668435013262,0.9786491391248575,1.0,10/50,16.99%,ATG101;GABARAPL1;RAB23;IRGM;STX12;PIK3C3;RAB19;MAP1LC3A;UBQLN2;ATG14
prerank,regulation of axon guidance (GO:1902667),-0.27761581183645573,-0.6492061076847059,0.9187192118226601,0.9884084336764261,1.0,2/10,8.98%,YTHDF1;VEGFA
prerank,transcription by RNA polymerase I (GO:0006360),-0.2020650099686166,-0.6491404128057813,0.9563758389261745,0.98750081987509,1.0,13/34,26.28%,RRN3;TAF1D;TAF1;TTF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP
prerank,carnitine metabolic process (GO:0009437),-0.26176388153223673,-0.6490158174721681,0.9082125603864735,0.9866451390750836,1.0,5/12,21.86%,CPT1C;ACADM;TMLHE;CPT2;BBOX1
prerank,C21-steroid hormone biosynthetic process (GO:0006700),-0.2661521420568037,-0.6489927828659952,0.9042821158690176,0.9857195991369628,1.0,5/12,28.18%,FDX1;AKR1B1;CACNA1H;STAR;TSPOAP1
prerank,negative regulation of interleukin-6 production (GO:0032715),0.2602571574045695,0.6485924924545023,0.8941176470588236,0.9790508495180705,1.0,3/27,8.02%,ZC3H12A;ARRB1;CD200
prerank,skeletal muscle contraction (GO:0003009),-0.23641037408803356,-0.6485787411366466,0.9234972677595629,0.9850982563607993,1.0,8/19,35.65%,RCSD1;STAC3;TNNT3;TNNI1;STAC2;TNNC1;TNNI3;CCDC78
prerank,regulation of Golgi organization (GO:1903358),0.2865996445626661,0.6483376388648558,0.8670886075949367,0.9788895962440315,1.0,7/17,24.46%,CAMSAP2;MAPK1;USP6NL;PDCD10;MAP2K1;PDE4DIP;MYO5A
prerank,purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.29690209294100456,0.6474742031296976,0.8541329011345219,0.9792748376628955,1.0,3/13,18.45%,SULT6B1;BPNT1;SULT1A1
prerank,positive regulation of T-helper cell differentiation (GO:0045624),-0.2500976668441788,-0.6472656417336665,0.9137055837563451,0.9850990544330193,1.0,3/14,13.16%,ANXA1;PRKCZ;CD80
prerank,bile acid metabolic process (GO:0008206),0.256224340838949,0.6470432352126242,0.909221902017291,0.9792719562310611,1.0,4/27,14.78%,CYP39A1;OSBPL1A;OSBPL9;SLC27A2
prerank,glycolytic process through glucose-6-phosphate (GO:0061620),0.25799301523653023,0.6467290793064112,0.875945537065053,0.979133830218705,1.0,3/25,8.83%,GPI;PGK1;GAPDH
prerank,cellular iron ion homeostasis (GO:0006879),0.2320536126143382,0.6459058829612419,0.9368556701030928,0.9794675503040969,1.0,19/55,24.89%,FBXL5;TMPRSS6;HMOX2;BOLA2;CYB561A3;GLRX3;CP;CYBRD1;HEPH;FRRS1;ATP6V1G1;SMAD4;CCDC115;SOD1;TMEM199;FTH1;IREB2;FTL;ATP13A2
prerank,DNA replication-independent nucleosome assembly (GO:0006336),-0.1931842567450776,-0.6456624568907569,0.962457337883959,0.9852998470014023,1.0,18/38,31.93%,RSF1;CENPC;HAT1;SMARCA5;RBBP7;CABIN1;CENPK;ATRX;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;HIRA;CENPA
prerank,positive regulation of viral genome replication (GO:0045070),0.2525915316238647,0.6454978513081476,0.9056316590563166,0.9794296803937776,1.0,7/29,18.64%,ADARB1;PPIE;ADAR;PPIH;PKN2;SRPK1;PPID
prerank,primary miRNA processing (GO:0031053),-0.27896686314506947,-0.6447950650191149,0.9041769041769042,0.984988718200843,1.0,2/10,6.30%,HNRNPA2B1;SMAD3
prerank,Golgi localization (GO:0051645),-0.2736731119760599,-0.6447538239744992,0.8894472361809045,0.984086733230675,1.0,3/11,15.52%,COPG1;ARCN1;ARHGAP21
prerank,regulation of oxidative phosphorylation (GO:0002082),0.2820230205012495,0.6440714651820262,0.8798701298701299,0.9803181217317032,1.0,2/16,6.64%,ATP7A;SLC25A33
prerank,"DNA catabolic process, endonucleolytic (GO:0000737)",0.2680980812250113,0.6427478619083883,0.8904899135446686,0.9810855908785447,1.0,6/23,15.09%,KPNB1;DFFB;HMGB1;EXOG;HMGB2;DFFA
prerank,cytoplasmic translational initiation (GO:0002183),-0.23612594720093386,-0.6425207087747694,0.9166666666666666,0.9847560091793268,1.0,4/17,13.70%,DENR;EIF2S2;EIF2D;EIF3D
prerank,RNA interference (GO:0016246),-0.24630971060521428,-0.6423854713374489,0.9291784702549575,0.9839232976611532,1.0,6/17,25.18%,DICER1;TERT;AGO3;TSNAX;CELF1;MRPL44
prerank,heme biosynthetic process (GO:0006783),0.26675451335480516,0.6418982690434282,0.9071207430340558,0.9814315192287552,1.0,5/22,17.29%,ALAS1;TSPO;COX15;NFE2L1;CPOX
prerank,production of small RNA involved in gene silencing by RNA (GO:0070918),0.2714893481335322,0.6416886613829317,0.8842592592592593,0.9812141181453584,1.0,4/20,16.55%,PUM2;ZC3H7A;AGO4;DROSHA
prerank,positive regulation of heterochromatin assembly (GO:0031453),-0.2615390136313828,-0.6397468168343539,0.910761154855643,0.9848522407581437,1.0,4/11,17.97%,RESF1;MPHOSPH8;SETDB2;ATF7IP
prerank,"mRNA splicing, via spliceosome (GO:0000398)",0.19299674079415877,0.638689198631141,0.9927685950413223,0.9833613186571355,1.0,67/264,23.92%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;DCPS;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;CELF4;PRPF38A;POLR2D;HNRNPK;SNRPE;FIP1L1;PCBP1;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;CLNS1A;HNRNPH2;SART1;PPIH;ELAVL2;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;SRPK1;ZMAT5;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;GEMIN8;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;CWC25;PQBP1;PRCC;SF3B3;POLR2C;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1
prerank,"tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",0.29495720868627845,0.63821865334272,0.8933333333333333,0.9833764642035001,1.0,2/14,6.82%,TRPT1;CPSF1
prerank,negative regulation of cAMP-mediated signaling (GO:0043951),0.30874676917868377,0.6378285222341971,0.8775510204081632,0.9833121370507583,1.0,2/10,15.62%,PDE3B;PDE4D
prerank,mitotic DNA damage checkpoint signaling (GO:0044773),-0.1803349047532201,-0.6373630166365352,0.990990990990991,0.9855280867231254,1.0,30/57,38.31%,TIPIN;BRSK1;TRIM39;ATF2;HMGA2;CDC14B;CDKN1A;WAC;DONSON;RFWD3;TAOK1;FZR1;TAOK3;RINT1;FANCD2;RPA2;EME2;RAD9A;CHEK1;FBXO31;FOXN3;DTL;UIMC1;CDK5RAP3;HUS1B;PLK1;TP53;PRKDC;CDK1;TICRR
prerank,protein export from nucleus (GO:0006611),0.2562125703746796,0.6370204642437937,0.9203007518796993,0.9836228947714382,1.0,6/27,14.41%,DUSP16;XPO6;XPO1;SMURF1;RAN;NUP42
prerank,regulation of autophagy of mitochondrion (GO:1903146),0.2731362386121512,0.6366097743503162,0.906060606060606,0.9835810293315284,1.0,8/19,26.91%,FBXO7;FBXW7;VDAC1;GSK3A;SREBF2;ATP13A2;CSNK2A2;HAX1
prerank,positive regulation of isotype switching (GO:0045830),0.2817513217071789,0.6365368088777529,0.8896,0.9832434226254908,1.0,8/15,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;CLCF1;TGFB1;SHLD1
prerank,CENP-A containing chromatin organization (GO:0061641),-0.20319690741394686,-0.6354628659128329,0.9631901840490797,0.9849619048158522,1.0,14/29,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,CENP-A containing nucleosome assembly (GO:0034080),-0.20319690741394686,-0.6354628659128329,0.9631901840490797,0.9849619048158522,1.0,14/29,31.93%,RSF1;CENPC;SMARCA5;RBBP7;CENPK;CENPQ;MIS18BP1;KNL1;CENPX;NASP;CENPH;MIS18A;CENPN;CENPA
prerank,regulation of B cell differentiation (GO:0045577),-0.23417964108802589,-0.6353395778227102,0.9209039548022598,0.9841008143289782,1.0,4/17,21.63%,MMP14;NCKAP1L;INHBA;SYK
prerank,pre-miRNA processing (GO:0031054),0.2899052757482462,0.6351481068691305,0.8869426751592356,0.9839517200166044,1.0,4/14,17.51%,ADAR;AGO4;DROSHA;TUT7
prerank,growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.30863376658659164,0.6348557661847204,0.8794567062818336,0.9837981799988095,1.0,3/10,20.02%,JAK2;PTPN1;STAT5A
prerank,transcription initiation from RNA polymerase I promoter (GO:0006361),-0.20290526552201835,-0.6339367693341672,0.9601328903654485,0.9840897086830769,1.0,14/32,30.05%,RRN3;TAF1D;TAF1;ERCC2;GTF2H5;UBTF;GTF2H1;GTF2H4;POLR1A;POLR1H;POLR2H;TBP;POLR1E;POLR2L
prerank,telomere maintenance (GO:0000723),0.22670054826259559,0.6329177086024609,0.9394329896907216,0.9849882387693396,1.0,16/50,26.09%,ZBTB48;APEX1;STN1;PTGES3;ERCC4;RAD51D;ATM;CTC1;TERF2IP;HUS1;BLM;RIF1;TERF2;WRN;TINF2;PCNA
prerank,lipid biosynthetic process (GO:0008610),0.21728842169974838,0.6323342304897317,0.953714981729598,0.9850676211492407,1.0,18/77,25.93%,ACSM3;ACSL5;PRKAA1;ELOVL4;ACSS2;PDSS2;PDSS1;MVD;DOLPP1;AGPAT5;OXSM;GGPS1;AGPS;ACLY;MVK;HMGCR;FDFT1;CLN8
prerank,ubiquinone metabolic process (GO:0006743),0.2835981178144284,0.6323135699502058,0.8956661316211878,0.9846827362121505,1.0,5/15,18.47%,COQ3;PDSS2;PDSS1;COQ5;COQ7
prerank,"RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",0.2850841210007148,0.6320993000409066,0.8915857605177994,0.9844658927239728,1.0,4/15,19.18%,TRPT1;CPSF1;CSTF2;ERN1
prerank,histone mRNA metabolic process (GO:0008334),0.25245962227703017,0.6318461671541223,0.9057142857142857,0.9842749240880899,1.0,9/27,21.35%,LSM1;MTPAP;SNRPE;XRN1;ATM;TENT2;TUT7;CPSF3;EXOSC10
prerank,purine nucleoside monophosphate biosynthetic process (GO:0009127),0.29552685342470775,0.6317738929622619,0.8617886178861789,0.9839344546876072,1.0,1/12,3.76%,GART
prerank,negative regulation of voltage-gated calcium channel activity (GO:1901386),0.30622987420751047,0.6315588220831408,0.8780068728522337,0.9837100213751101,1.0,4/10,25.95%,CALM3;GNB5;CRHR1;CALM1
prerank,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),-0.2660824188362161,-0.6309714726085367,0.9176755447941889,0.9849976446306419,1.0,2/11,9.67%,CEBPB;CREB3L1
prerank,negative regulation of mitotic cell cycle (GO:0045930),0.2319788497053018,0.6302728961104167,0.9353099730458221,0.9843630080254749,1.0,9/45,15.41%,BTG2;BTG1;TOM1L1;ZFP36L2;ANGEL2;BUB1;CTNNB1;FZD3;BTG3
prerank,regulation of high voltage-gated calcium channel activity (GO:1901841),0.30305957745920487,0.6299092286082171,0.8933333333333333,0.9842709508763781,1.0,2/10,12.45%,NOS1AP;CALM3
prerank,estrogen metabolic process (GO:0008210),-0.2396226750968794,-0.6295267345737762,0.9184782608695652,0.9849857123127087,1.0,9/15,45.96%,HSD17B8;HSD17B10;HSD17B11;HSD17B2;HSD17B14;HSD17B1;CYP1B1;HSD17B7;CYP1A1
prerank,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.2715524703927823,0.6294885933355139,0.9148606811145511,0.9841968810628058,1.0,4/19,16.66%,TMEM109;BAG6;PHLDA3;PYCARD
prerank,"protein localization to chromosome, centromeric region (GO:0071459)",0.27726431089473474,0.6293819744045628,0.8828125,0.9838937527152539,1.0,3/17,15.47%,IK;MTBP;BOD1
prerank,regulation of synaptic vesicle exocytosis (GO:2000300),0.2784554416546461,0.6292328957531564,0.9100946372239748,0.9836189365624021,1.0,6/18,24.45%,LRRK2;RIMS3;GSK3B;NLGN1;RAP1B;RIMS1
prerank,regulation of rRNA processing (GO:2000232),-0.23989959053990223,-0.629103057773887,0.9502617801047121,0.9843327090662723,1.0,6/16,29.34%,KAT2B;BUD23;YTHDF2;RIOK2;TRMT112;DIMT1
prerank,lysosome organization (GO:0007040),0.23866281522831206,0.6289395990691581,0.9314128943758574,0.9834447791500004,1.0,9/36,21.02%,LRRK2;HOOK1;GNPTAB;TPCN2;NAGPA;CLVS1;TMEM106B;HOOK2;MYO7A
prerank,regulation of double-strand break repair via homologous recombination (GO:0010569),-0.18282332756561176,-0.6288607061481906,0.9855072463768116,0.9835466271556597,1.0,14/42,25.13%,FBH1;FUS;HELB;ACTR2;RTEL1;KLHL15;FANCB;TIMELESS;CGAS;PARP1;POLQ;RPA2;RMI2;RAD51
prerank,DNA metabolic process (GO:0006259),0.1930159598660934,0.6287347773121249,0.9968814968814969,0.9832101974240622,1.0,68/270,24.66%,BTG2;RBBP8;APEX1;RAD21;ORC3;EXD2;ENDOV;PURA;POLK;UBA52;RPS27A;DFFB;FEN1;STN1;HMGB1;NSMCE3;ASF1A;PTGES3;POLA1;POLB;NPM1;WDHD1;GTF2H3;BRCA1;SMARCAD1;ORC5;HINFP;UBE2T;LIG1;DDX21;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAN;RAD18;HMGB2;XPC;RFC2;TRRAP;RAD9B;FBXO6;MEN1;MMS19;ATRIP;CTC1;TERF2IP;BARD1;HUS1;UHRF2;BLM;MNAT1;RIF1;UBB;GEN1;NOP53;MUTYH;TOP3B;TERF2;ORC4;CNBP;RNASEH2A;PRIM2;WRN;PRIMPOL;RNASEH1;UVRAG
prerank,endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.19786752373911662,0.6283996611349522,0.9859913793103449,0.9830887570063203,1.0,37/173,20.03%,TRAPPC8;ATL2;VTI1B;GOPC;COG5;TMED10;MCFD2;CUL3;PGAP1;WHAMM;GRIA1;ERGIC1;PROC;VAMP7;DYNLL1;TRAPPC2;TRAPPC6B;TMED9;TEX261;DYNC1LI2;SEC24B;SPTAN1;NSF;TMED4;VAPA;ANK1;TRAPPC5;COG6;ANK3;GOSR1;VTI1A;SPTBN1;DYNLL2;SEC24A;ACTR1A;TMED7;CAPZA2
prerank,epithelial cell development (GO:0002064),0.2713209448696602,0.6282280955427055,0.8850931677018633,0.9828167344979349,1.0,1/20,3.32%,SIPA1L3
prerank,protein modification by small protein conjugation or removal (GO:0070647),0.28562887950412164,0.6270847914196275,0.8832236842105263,0.9833439010260249,1.0,1/13,3.44%,UBA7
prerank,negative regulation of phosphate metabolic process (GO:0045936),0.2659600582607063,0.6260724572482232,0.9125,0.9837351020185847,1.0,4/22,10.37%,INPP5K;ROCK1;STAP1;DYNLL1
prerank,hyaluronan metabolic process (GO:0030212),0.2582580827730844,0.625632042121203,0.9207317073170732,0.9836704378283652,1.0,2/23,5.33%,CEMIP2;HYAL2
prerank,DNA integrity checkpoint signaling (GO:0031570),0.24129062570908677,0.6255257218057697,0.9471428571428572,0.9833755047198827,1.0,10/36,19.44%,BRIP1;HINFP;RAD1;ATM;MAP3K20;RAD9B;FBXO6;TIPRL;ATRIP;HUS1
prerank,cellular response to oxygen levels (GO:0071453),-0.26197275868245207,-0.6252224136467857,0.8832116788321168,0.9848532916706528,1.0,4/10,27.31%,ATP6AP1;ATP6V1A;PICK1;NDUFS2
prerank,negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.2585833060009011,0.6239700939466425,0.9114906832298136,0.9842108729921363,1.0,6/22,20.25%,FKBP1A;MGAT5;ROCK1;BOD1;TIPRL;GSK3B
prerank,negative regulation of interleukin-12 production (GO:0032695),-0.2432183930413262,-0.623916348591021,0.9184210526315789,0.9847302813612816,1.0,1/14,3.41%,THBS1
prerank,positive regulation of lipid storage (GO:0010884),0.2639988580019753,0.62391225621401,0.9286775631500743,0.9838697702642071,1.0,5/21,21.40%,EHD1;ZC3H12A;VSTM2A;SCARB1;SREBF2
prerank,translesion synthesis (GO:0019985),0.23261090786944122,0.6238132063733755,0.9456233421750663,0.9835589106901815,1.0,8/42,15.87%,USP43;POLK;UBA52;RPS27A;MAD2L2;TRIM25;RFC2;SPRTN
prerank,C21-steroid hormone metabolic process (GO:0008207),-0.21999983676842094,-0.6237468764688792,0.94,0.9838959334247036,1.0,6/20,29.74%,FDX1;AKR1B1;STAR;HSD17B10;TSPOAP1;CYP46A1
prerank,global genome nucleotide-excision repair (GO:0070911),0.25735858710894366,0.6226367110677915,0.9206349206349206,0.9840806634965579,1.0,6/26,15.10%,UBA52;RPS27A;RBX1;GTF2H3;ERCC4;XPC
prerank,carbohydrate derivative transport (GO:1901264),0.27263663557421614,0.6226301625471423,0.8957703927492447,0.9836942918800153,1.0,6/18,22.67%,PLTP;SLC15A4;VLDLR;SCARB1;SLC25A19;SLC10A7
prerank,protein ADP-ribosylation (GO:0006471),-0.20631147828952606,-0.622620843809048,0.952054794520548,0.9836138512261812,1.0,10/28,29.64%,PARP8;SIRT3;ART3;SIRT2;PARP3;PARP1;PARP6;PARP2;HPF1;SIRT6
prerank,mismatch repair (GO:0006298),-0.2036412379342692,-0.6224962277981397,0.9464882943143813,0.9827566555401774,1.0,17/27,38.87%,MLH3;MLH1;MSH6;PMS1;RPA3;ABL1;RPA1;POLD2;RPA2;EXO1;POLD3;PMS2;TDG;MSH4;ERCC1;POLD1;MCM9
prerank,mRNA processing (GO:0006397),0.18821293897288327,0.6223391077765124,1.0,0.9835355706847615,1.0,76/287,24.60%,NOVA2;DDX39A;DDX41;PPIE;IK;BUD13;CPSF1;HNRNPA0;ELAVL1;U2SURP;POLR2G;CWF19L2;CACTIN;DHX9;SNRNP48;PRPF38A;POLR2D;HNRNPK;SNRPE;RPRD1B;FIP1L1;PCBP1;GTF2H3;CHTOP;SMNDC1;RBM17;SRSF9;RSRC1;METTL14;HNRNPH2;SART1;PPIH;ELAVL2;THOC3;SYF2;SF3B4;PRPF4;CRNKL1;YBX1;POLR2I;DHX38;SF3A1;SPEN;RBM15;POLDIP3;ZMAT5;RPRD2;SMU1;DDX39B;CSTF2;HNRNPUL1;SF3B6;LSM2;ERN1;SYNCRIP;YTHDC1;CPSF3;SF3B2;SF3A3;MNAT1;CWC25;RPRD1A;PQBP1;PRCC;SF3B3;POLR2C;TBRG4;KIN;ZCRB1;POLR2B;POLR2J;PRPF40B;FRG1;PRPF6;ALYREF;CCNH
prerank,nuclear envelope organization (GO:0006998),0.26542150207039367,0.6222051712312325,0.9034690799396682,0.9832572849930292,1.0,9/20,24.78%,TMEM43;SUN3;REEP3;VPS4A;SUN1;NEMP1;LEMD3;EMD;CTDNEP1
prerank,monovalent inorganic cation homeostasis (GO:0055067),0.25927679117291236,0.6221321126776775,0.9228441754916793,0.9829185911208126,1.0,3/23,9.59%,SLC12A8;CLCN3;SLC9A7
prerank,regulation of regulatory T cell differentiation (GO:0045589),0.2571320117255883,0.6218594942167824,0.9299552906110283,0.9827328941850649,1.0,4/22,17.07%,TNFRSF18;VSIR;CBFB;SOX12
prerank,mRNA stabilization (GO:0048255),0.23103544176072813,0.6216272918200888,0.9295392953929539,0.9825037263275979,1.0,8/40,16.98%,TIRAP;HNRNPA0;ELAVL1;ELAVL4;DHX9;ANGEL2;YBX1;MAPK14
prerank,lipoxygenase pathway (GO:0019372),0.28536154470158015,0.6210853284062062,0.9059561128526645,0.9825234311311922,1.0,3/14,16.28%,ALOXE3;PON2;PON3
prerank,neuromuscular process (GO:0050905),0.2734692391795541,0.6209312674338338,0.89375,0.9822481200589983,1.0,2/16,12.72%,GCH1;KCNA1
prerank,positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),-0.19448556767797914,-0.6189195744402365,0.9747292418772563,0.9839107494826492,1.0,16/32,38.88%,CEMIP;CALM2;GSTM2;JPH2;GPER1;P2RY6;GSTO1;APLNR;NPSR1;THY1;F2R;PKD2;CAPN3;TRDN;HTT;CX3CL1
prerank,DNA biosynthetic process (GO:0071897),0.2732757802592818,0.6174693467079878,0.9029275808936826,0.9844115595757761,1.0,3/16,15.59%,WRNIP1;POLA1;CDKN2D
prerank,C-terminal protein amino acid modification (GO:0018410),0.290023338241545,0.6172210203031071,0.9031719532554258,0.9842038633610031,1.0,4/11,22.33%,TTL;LCMT1;AGBL4;FOLH1
prerank,mitotic chromosome condensation (GO:0007076),-0.20360613992814564,-0.6168378348556225,0.9587301587301588,0.9841704264093925,1.0,14/26,37.53%,SET;NCAPG2;AKAP8L;NCAPH2;NCAPD2;PHF8;NUSAP1;KMT5A;NCAPH;TTN;PHF13;SMC2;PLK1;CDK1
prerank,negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),0.2894648455241575,0.6162497420412801,0.8784893267651889,0.9845251675617918,1.0,5/12,26.41%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,long-chain fatty acid metabolic process (GO:0001676),0.21548210325845607,0.6146564140516517,0.9545454545454546,0.9852898262561414,1.0,9/64,14.78%,ACSL5;ASAH2;ACSBG1;ACOX1;ALOXE3;ACAD9;CPT1A;ELOVL5;SLC27A2
prerank,snRNA processing (GO:0016180),0.27662739377204476,0.6141751241142751,0.9043062200956937,0.9852475611145463,1.0,4/16,16.28%,INTS11;INTS12;INTS5;INTS6L
prerank,protein kinase A signaling (GO:0010737),0.2881970346782222,0.6141373828519031,0.8959044368600683,0.9848860713796975,1.0,6/12,29.65%,GAL;LCP1;RDX;PRKACB;MYOM1;RAB13
prerank,regulation of chromatin organization (GO:1902275),-0.2353050100990403,-0.6139414372046376,0.9191374663072777,0.9848014191983019,1.0,6/14,29.51%,SETD1A;IGF2;HNRNPU;PARG;ALKBH4;HPF1
prerank,negative regulation of RNA splicing (GO:0033119),-0.22156075400640945,-0.613764410152703,0.9688385269121813,0.9839734996511466,1.0,5/19,17.82%,RBMX;SRSF6;PCBP4;RPS26;U2AF2
prerank,receptor metabolic process (GO:0043112),0.22243729767630538,0.6137601658602541,0.9680426098535286,0.984754659377786,1.0,13/53,20.45%,CAV1;DNM3;LMTK2;AP2M1;SMURF1;LDLRAP1;CD9;KIF16B;PHETA1;NSG1;MVB12A;REP15;RAB31
prerank,7-methylguanosine mRNA capping (GO:0006370),-0.19750743573623847,-0.6136298552896687,0.9822695035460993,0.9822047404953068,1.0,13/31,30.05%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,7-methylguanosine RNA capping (GO:0009452),-0.19750743573623847,-0.6136298552896687,0.9822695035460993,0.9822047404953068,1.0,13/31,30.05%,NCBP1;ERCC2;CMTR1;GTF2F1;RAMAC;GTF2H5;GTF2H1;RNGTT;GTF2H4;NCBP2;POLR2H;CMTR2;POLR2L
prerank,mitochondrial fission (GO:0000266),0.26518410626066924,0.6110459648955273,0.9145299145299145,0.9863052671851035,1.0,1/16,3.29%,DNM3
prerank,non-motile cilium assembly (GO:1905515),0.24113149520076765,0.6109066740629727,0.9636098981077147,0.986015766888385,1.0,3/30,9.16%,CSNK1D;TMEM216;PCM1
prerank,organic cation transport (GO:0015695),0.25415427809809377,0.6104653091395167,0.9150943396226415,0.9859447587579203,1.0,6/19,22.38%,SLC44A1;SLC22A5;SEC14L1;SLC29A4;SLC25A19;SLC25A42
prerank,negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),0.25431063662973197,0.6099085687349531,0.9273255813953488,0.98592242442133,1.0,11/25,29.81%,EFNA1;PRKCG;OPHN1;PSME3IP1;EPHA4;SGTA;CSNK2A2;RPL11;F8A1;HSP90AB1;RPS7
prerank,regulation of double-strand break repair via nonhomologous end joining (GO:2001032),0.24314652237251397,0.6096643877627086,0.9289940828402367,0.985696878765547,1.0,12/28,27.33%,MAD2L2;DTX3L;KDM4D;RIF1;CYREN;SHLD3;SHLD2;NUDT16L1;WRAP53;SHLD1;PARP9;SMCHD1
prerank,regulation of autophagosome assembly (GO:2000785),0.231181991664506,0.6087337575282994,0.9409340659340659,0.9859496736160352,1.0,15/33,29.83%,SMCR8;RAB3GAP2;LRRK2;TBC1D12;UBQLN2;NPRL3;RALB;TBC1D14;FEZ1;CHMP4A;CHMP4B;SCFD1;PIP4K2B;PIKFYVE;SH3GLB1
prerank,DNA repair (GO:0006281),0.1866817043627611,0.607155397250688,0.9979296066252588,0.9866096084873832,1.0,45/284,15.87%,HERC2;BTG2;RBBP8;WRNIP1;APEX1;RAD21;SETX;EXD2;ENDOV;TENT4A;POLK;UBA52;RPS27A;FEN1;NSMCE3;BABAM2;MAD2L2;ASF1A;BRIP1;POLA1;POLB;ASCC1;NPM1;ASCC3;WDHD1;GTF2H3;BRCA1;DTX3L;HINFP;EYA3;UBE2T;LIG1;RAD1;ERCC4;RAD51D;ATM;NSMCE4A;RAD18;XPC;RFC2;TRRAP;RAD9B;CDKN2D;TRAIP;SPRTN
prerank,striated muscle cell development (GO:0055002),0.26719549860775876,0.6069275699887807,0.9048361934477379,0.9863744307804784,1.0,4/14,23.90%,FLII;TMOD3;TMOD1;KLHL41
prerank,mitotic nuclear membrane disassembly (GO:0007077),-0.24718039351707016,-0.6054553209552811,0.9404145077720207,0.9855817029210417,1.0,3/12,15.84%,PRKCB;PRKCA;NEK6
prerank,protein palmitoylation (GO:0018345),0.2394405341553516,0.6041264899755792,0.9418604651162791,0.9879006437338482,1.0,6/30,21.34%,ZDHHC22;ZDHHC14;ZDHHC5;ZDHHC23;SELENOK;ZDHHC13
prerank,mitotic nuclear division (GO:0140014),0.20808327732925858,0.6039336784742964,0.9850187265917603,0.9876382849506985,1.0,12/71,16.20%,RAB11A;KIF2A;CLASP1;KPNB1;DSN1;STAG1;CLASP2;ARHGEF10;RAN;CHMP7;NDC80;SGO1
prerank,regulation of lipid storage (GO:0010883),0.25121040166082775,0.6036974583707871,0.9372197309417041,0.9873889555136679,1.0,4/22,11.80%,ZC3H12A;FBXW7;NFKBIA;VSTM2A
prerank,"endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",0.2799679080885301,0.6023067727849133,0.9183333333333333,0.9879004249329937,1.0,1/13,3.66%,RPS21
prerank,porphyrin-containing compound biosynthetic process (GO:0006779),0.2456399499515402,0.6017922634224361,0.9375951293759512,0.9878457684233469,1.0,6/24,21.42%,ALAS1;TSPO;COX15;NFE2L1;CPOX;RSAD1
prerank,"negative regulation of DNA-templated transcription, elongation (GO:0032785)",0.27857104214735656,0.6005528824409477,0.912396694214876,0.988257401247869,1.0,5/13,26.41%,EAPP;NELFB;NELFA;HEXIM1;RNF8
prerank,histone acetylation (GO:0016573),0.20978564191698604,0.6000928584594306,0.9735849056603774,0.98816104145106,1.0,11/69,15.52%,ING3;LEF1;BRD8;MRGBP;JADE2;CHD5;BRD1;DMAP1;SGF29;KAT7;TRRAP
prerank,positive regulation of telomere maintenance (GO:0032206),-0.1896327598963083,-0.5994180490923278,0.9758620689655172,0.9876562246614355,1.0,13/31,31.43%,HNRNPA2B1;RAD50;PPP1R10;MAP2K7;RTEL1;PML;GNL3;ATRX;NAF1;HNRNPD;NABP2;SIRT6;SLX4
prerank,NAD biosynthetic process (GO:0009435),-0.21365965827528569,-0.5979781764701289,0.9633802816901409,0.9874472127326318,1.0,1/20,1.34%,NMNAT2
prerank,regulation of spindle assembly (GO:0090169),0.24563362978993575,0.5974032467262166,0.9361069836552749,0.989448796223191,1.0,13/25,30.80%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;SENP6;CHMP1A;TPR;VPS4B;CHMP4B;EML3;HSPA1A;DYNC1H1
prerank,macrophage chemotaxis (GO:0048246),0.28707082425883934,0.5973693847576028,0.9034941763727121,0.9890822195606275,1.0,1/10,7.50%,TAFA4
prerank,positive regulation of transcription by RNA polymerase I (GO:0045943),-0.2127383851827869,-0.5965039041033151,0.9666666666666667,0.9872503017472473,1.0,6/22,20.14%,SMARCB1;ERBB2;PIH1D1;UBTF;NCL;PHF8
prerank,negative regulation of telomere maintenance (GO:0032205),0.26883695180162237,0.5951417385649501,0.9161184210526315,0.9900645154381449,1.0,5/15,23.11%,TNKS;ERCC4;ATM;TERF2IP;TERF2
prerank,regulation of macrophage differentiation (GO:0045649),0.268780947211176,0.5947630331211963,0.9279141104294478,0.9899092797461323,1.0,1/15,2.41%,CASP8
prerank,C4-dicarboxylate transport (GO:0015740),0.27164790432908104,0.5944321678674538,0.9146537842190016,0.9897334045260368,1.0,5/14,19.24%,SLC25A30;SLC1A1;SLC1A2;SLC25A10;SLC1A6
prerank,chromatin assembly (GO:0031497),0.2241255172147538,0.5942805843356519,0.9493844049247606,0.9894407290386729,1.0,11/38,21.46%,ASF1A;CDAN1;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;PRDM9;NAP1L3
prerank,cholesterol metabolic process (GO:0008203),0.20656063378225553,0.5933013181557142,0.9726708074534162,0.9896601384318007,1.0,21/68,26.49%,APOA1;LCAT;OSBPL1A;PLPP6;HMGCS1;TSKU;LDLRAP1;MVD;SOAT1;ACAA2;DHCR7;GGPS1;ACLY;OSBPL5;IDI1;MVK;INSIG1;HMGCR;FDFT1;CLN8;LBR
prerank,intracellular cholesterol transport (GO:0032367),-0.2251862177292241,-0.5931412245749149,0.9707446808510638,0.9878908425549302,1.0,1/15,2.95%,ABCA1
prerank,regulation of protein acetylation (GO:1901983),0.27795699598695894,0.5928168019281933,0.9381107491856677,0.9895703095714596,1.0,3/12,20.25%,FAM161A;TERF2IP;GSK3B
prerank,regulation of cell cycle G2/M phase transition (GO:1902749),0.20322811852076467,0.5908131034808696,0.9902200488997555,0.9903802762774062,1.0,11/82,11.25%,TUBB;CSNK1D;TUBB4B;CLASP1;NEDD1;CEP135;HAUS3;PCM1;DYNLL1;CEP76;NPM1
prerank,negative regulation of cholesterol transport (GO:0032375),-0.2493026626695014,-0.5903945417067163,0.9423558897243107,0.9881902749131289,1.0,4/10,41.65%,NFKB1;APOC1;SHH;ABCA2
prerank,anterograde axonal transport (GO:0008089),0.2276081057730183,0.5902820007002434,0.9492242595204513,0.9903053772360556,1.0,14/37,28.93%,BLOC1S6;HSPB1;AP3S1;KIF1A;AP3M1;RAB27B;HAP1;AP3D1;SOD1;KIF5A;AP3B1;BLOC1S5;AP3M2;RAB21
prerank,"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",0.24793186712559093,0.5901402956759814,0.9322533136966127,0.9900054838449232,1.0,5/22,15.10%,UBA52;RPS27A;RBX1;GTF2H3;XPC
prerank,dosage compensation by inactivation of X chromosome (GO:0009048),0.27191848134004254,0.5899730618345553,0.9059967585089141,0.9897229472498184,1.0,6/12,27.60%,BRCA1;RBM15;YTHDC1;LRIF1;SMCHD1;CDYL
prerank,positive regulation of stem cell proliferation (GO:2000648),0.2589563047769151,0.5897919272722798,0.9342723004694836,0.9894569509839587,1.0,4/17,18.99%,CCNE1;THPO;KAT7;SOX11
prerank,regulation of microtubule-based movement (GO:0060632),0.27646331700910654,0.5896644688348246,0.8980263157894737,0.989137055188289,1.0,4/11,22.00%,NEFH;MAP2;HAP1;IGBP1
prerank,base-excision repair (GO:0006284),-0.168601020253154,-0.5893288148008827,0.9957446808510638,0.9877245943483938,1.0,24/48,38.64%,RFC1;XRCC1;ERCC5;LIG3;HMGA2;RPA3;PARG;RPA1;PARP1;POLQ;NEIL1;POLD2;RPA2;POLE;RFC4;APEX2;POLL;POLD3;RFC5;TDG;DNA2;NEIL2;XPA;POLD1
prerank,aerobic electron transport chain (GO:0019646),0.20453917623359003,0.5893065156605632,0.9852216748768473,0.9889562074095252,1.0,19/68,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,chromatin assembly or disassembly (GO:0006333),0.28311683803424365,0.5877332099158461,0.9142394822006472,0.9895264606462854,1.0,4/11,23.77%,CDAN1;SUV39H2;RBBP4;HIRIP3
prerank,nucleosome assembly (GO:0006334),0.23074175453766904,0.586741070066422,0.9570200573065902,0.9896941107536433,1.0,10/31,21.46%,ASF1A;NPM1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;RBBP4;IPO4;NAP1L3
prerank,"protein localization to chromosome, telomeric region (GO:0070198)",-0.23097899426268223,-0.5864233927201774,0.9417721518987342,0.988087354631163,1.0,6/14,30.10%,ATR;TERT;XRCC5;ATRX;NABP2;PINX1
prerank,intracellular protein transmembrane transport (GO:0065002),-0.175877677755188,-0.5859878524099383,0.9889705882352942,0.9873616749906294,1.0,15/42,29.67%,C2CD5;PEX2;TIMM17B;CHCHD4;TIMM21;PEX7;GRPEL2;SEC61A2;ROMO1;DNAJC15;ZFAND2B;PEX16;SEC61G;TIMM50;PEX12
prerank,regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24034196307854797,0.5853639477492334,0.9507959479015919,0.9901134743604374,1.0,10/25,27.64%,EAF1;EAF2;EAPP;NELFB;NELFA;HEXIM1;WDR43;ZMYND11;RNF8;CDC73
prerank,organelle fusion (GO:0048284),0.24199945422884728,0.5851731095971305,0.952755905511811,0.989835243829936,1.0,4/22,13.01%,CHCHD3;MIGA1;MFN1;CYP26C1
prerank,regulation of protein localization to cell surface (GO:2000008),0.221882801071652,0.584824210480623,0.9564032697547684,0.9896505075224786,1.0,9/33,21.66%,GOPC;TAX1BP3;TYROBP;NEDD4L;CTNNB1;ABCA7;BDNF;KCNAB2;LEPROT
prerank,platelet aggregation (GO:0070527),0.23053298727538196,0.5834170359725916,0.9519774011299436,0.990064634608477,1.0,8/33,19.17%,MYH9;HSPB1;ACTG1;ACTB;PIK3CB;STXBP3;FERMT3;VCL
prerank,mRNA export from nucleus (GO:0006406),0.19483096133949396,0.5832014439170652,0.9905992949471211,0.9897986480486137,1.0,23/102,21.39%,HHEX;DDX39A;CPSF1;NUP54;POLR2D;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3;NUP50;IWS1
prerank,late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),0.2585834548113639,0.582235296624769,0.9095163806552262,0.989965401862151,1.0,6/16,27.34%,VPS36;VPS28;CHMP7;LEPROT;CHMP4A;CHMP4B
prerank,protein insertion into membrane (GO:0051205),0.22804663130162367,0.5821682995775851,0.9411764705882353,0.9896207983712486,1.0,10/32,23.43%,APP;PRNP;GET1;REEP1;UBE2J2;VAPA;CCDC47;CYB5A;EMD;SGTA
prerank,nonribosomal peptide biosynthetic process (GO:0019184),-0.23352122648167034,-0.5796664661294589,0.9501187648456056,0.9891817763345104,1.0,2/12,9.63%,GCLC;BDH2
prerank,RNA export from nucleus (GO:0006405),0.19225532973706008,0.5774134472663945,0.9849884526558892,0.9918209040404793,1.0,21/100,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;RAN;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.1991523862111672,0.5757261780239562,0.9914529914529915,0.9923335600277317,1.0,19/69,24.05%,UQCC3;NDUFS4;NDUFA12;UQCRB;NDUFB5;COX5A;NDUFB7;UQCRFS1;UQCRC1;COX15;SDHC;COX6A1;NDUFB4;UQCRC2;COX7C;NDUFA9;NDUFV1;NDUFC1;NDUFA11
prerank,purine ribonucleoside monophosphate metabolic process (GO:0009167),-0.20441239677051287,-0.5755780484599529,0.968299711815562,0.9899261823822171,1.0,4/20,17.73%,AMPD3;LHPP;ATIC;IMPDH2
prerank,error-free translesion synthesis (GO:0070987),-0.19732091924446116,-0.5747916273270339,0.9810725552050473,0.9893224363611504,1.0,8/22,27.35%,RCHY1;RFC1;POLDIP2;REV1;RPA3;RPA1;RPA2;RFC4
prerank,protein localization to chromosome (GO:0034502),0.22026325721579335,0.5735575728625312,0.9710144927536232,0.9931031088704537,1.0,12/34,28.20%,RAD21;TNKS;CHMP7;BOD1;ESR1;TERF2IP;XRCC4;TERF2;CTCF;TINF2;WAPL;TNKS2
prerank,protein import into peroxisome matrix (GO:0016558),-0.23571384259752304,-0.5733975148748737,0.9557739557739557,0.9889556749299586,1.0,5/12,29.67%,PEX2;PEX7;PEX13;PEX16;PEX12
prerank,endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.23934620917863242,0.5730860214623947,0.9283536585365854,0.9929643642824899,1.0,5/20,19.76%,CAMK2D;RAP1GDS1;CCDC47;SELENOK;PACS2
prerank,cellular response to pH (GO:0071467),0.25405922637468464,0.572588574493367,0.9506369426751592,0.9928391758739245,1.0,2/17,10.66%,MCOLN1;GPR68
prerank,maturation of 5.8S rRNA (GO:0000460),0.24753917402406272,0.5708853633888953,0.9440993788819876,0.9933300755706272,1.0,7/17,22.64%,RRP15;EIF6;LAS1L;FTSJ3;C1D;EXOSC10;URB1
prerank,DNA catabolic process (GO:0006308),0.27019037165053644,0.57018389425378,0.9207920792079208,0.9932941615608298,1.0,2/11,10.88%,DFFB;XRN2
prerank,negative regulation of receptor-mediated endocytosis (GO:0048261),0.23810973090941062,0.5696652615159568,0.9597701149425287,0.9931768922765898,1.0,4/25,15.56%,APP;ANKRD13A;RAC1;UBQLN2
prerank,regulation of telomere maintenance via telomere lengthening (GO:1904356),0.2508202606057633,0.568886729164358,0.9293563579277865,0.9931718689411567,1.0,8/16,28.52%,TNKS;ERCC4;ATM;TERF2;DHX36;TINF2;TNKS2;SMG5
prerank,positive regulation of fatty acid biosynthetic process (GO:0045723),0.28301411182151065,0.5679258310978212,0.9271523178807947,0.9932458008617162,1.0,2/10,14.25%,APOA1;ELOVL5
prerank,positive regulation of immunoglobulin mediated immune response (GO:0002891),0.25467392219996215,0.5678905659220206,0.9364820846905537,0.9928777198014036,1.0,6/14,25.96%,MAD2L2;RIF1;SHLD3;PAXIP1;SHLD2;SHLD1
prerank,purine nucleotide biosynthetic process (GO:0006164),0.263464608295453,0.5663696692008146,0.9146757679180887,0.9932057341299823,1.0,1/12,3.76%,GART
prerank,phospholipid metabolic process (GO:0006644),0.19687688491338767,0.5662397553653782,0.9878493317132442,0.9928789617803758,1.0,4/71,5.21%,PLPP1;ACP6;LPCAT4;LCAT
prerank,folic acid-containing compound metabolic process (GO:0006760),0.23705590470539809,0.5643787295594545,0.9547581903276131,0.993406550954574,1.0,1/19,2.70%,SLC25A32
prerank,phagosome maturation (GO:0090382),0.2144215739011254,0.5621570425688628,0.9728958630527818,0.9940605946850516,1.0,8/35,20.77%,RAB39A;RAB34;MCOLN1;ATP6V1G1;ATP6V1C1;ATP6V0A1;RAB31;ATP6V1D
prerank,hydrogen peroxide metabolic process (GO:0042743),0.24039727613118733,0.5604071196519648,0.9544072948328267,0.9944927940876436,1.0,5/19,23.72%,ACOX1;CYBA;MAOB;SOD1;NOX1
prerank,negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.2487821487896263,0.5596481224790884,0.95,0.9944416080319993,1.0,8/16,27.33%,PARPBP;MAD2L2;UBQLN4;RIF1;SHLD3;SHLD2;SHLD1;SMCHD1
prerank,sulfur amino acid metabolic process (GO:0000096),0.22826110746730413,0.5589564719987693,0.9576642335766423,0.9943554374788948,1.0,3/24,14.70%,TST;SMS;MSRA
prerank,axonal transport of mitochondrion (GO:0019896),0.2644596426935518,0.5579632910498775,0.9416809605488851,0.9944117366591643,1.0,3/11,18.42%,HIF1A;SYBU;HAP1
prerank,mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.1877972936646241,0.5575133321347069,0.9952830188679245,0.9942269449516098,1.0,20/96,20.19%,HHEX;DDX39A;CPSF1;NUP54;NUP35;RANBP2;FIP1L1;CHTOP;SRSF9;NUP153;NUP160;THOC3;NUP42;DHX38;NUP205;POLDIP3;DDX39B;SMG7;YTHDC1;CPSF3
prerank,negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),-0.20051427168474245,-0.5575021635885865,0.978021978021978,0.9937150482881028,1.0,11/20,39.62%,GRK3;MET;STMN1;PLEK;RPGRIP1L;GRK2;ADA;RGS2;YWHAB;CCL5;MGRN1
prerank,long-term memory (GO:0007616),-0.20460097405657351,-0.5572560577110948,0.9862637362637363,0.9928829630049066,1.0,3/19,15.27%,APOE;CPEB3;EIF2AK4
prerank,DNA packaging (GO:0006323),-0.21082643936159345,-0.5569754119032608,0.9581005586592178,0.9920559726320942,1.0,5/16,25.78%,HAT1;NOC2L;H1-0;NAA10;CHAF1A
prerank,positive regulation of protein targeting to mitochondrion (GO:1903955),-0.17746053723723848,-0.5565104460237014,0.9863481228668942,0.9912928139951388,1.0,8/30,19.47%,RNF31;UBL5;UBE2L3;ARIH2;HPS4;MICALL2;HTRA2;ABLIM3
prerank,poly(A)+ mRNA export from nucleus (GO:0016973),0.23587003258807182,0.5564672803588667,0.9526717557251908,0.9943158753533662,1.0,1/18,3.31%,HHEX
prerank,nucleosome organization (GO:0034728),0.1994981228847948,0.554709174984575,0.9833333333333333,0.9946758520590653,1.0,15/55,21.46%,SRCAP;ASF1A;NPM1;DMAP1;ACTR6;VPS72;SMARCC1;ANP32B;HMGB2;DAXX;H3-3A;NAP1L4;PRDM9;SETD2;NAP1L3
prerank,epithelial cilium movement involved in extracellular fluid movement (GO:0003351),-0.19815783573868195,-0.5525021531169256,0.9802816901408451,0.9916880978268117,1.0,10/18,35.13%,NPHP3;OFD1;RFX3;CABYR;CFAP53;ROPN1L;SPAG17;CCDC39;DNAAF2;ODAD4
prerank,acylglycerol catabolic process (GO:0046464),0.21550146470279397,0.5518406411847481,0.9728183118741058,0.9954903756342895,1.0,5/30,22.83%,ABHD6;ABHD2;FABP3;PNPLA2;MGLL
prerank,positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.238854710480757,0.5516033794622,0.940809968847352,0.995195912506171,1.0,4/16,17.93%,MRAP2;CHGA;NECAB2;GSK3A
prerank,"regulation of synaptic transmission, GABAergic (GO:0032228)",0.2486940446920619,0.5505609856541943,0.9518459069020867,0.9952317398443802,1.0,1/15,2.87%,SYN3
prerank,insulin secretion (GO:0030073),0.2307523279801016,0.5497597120395382,0.9587301587301588,0.99519300009557,1.0,6/19,29.09%,GAL;SNX19;RAB11FIP2;PTPRN2;SELENOT;MAFA
prerank,regulation of mitochondrial translation (GO:0070129),0.23260836495320192,0.5489408759953522,0.9557251908396946,0.9951574276046036,1.0,2/21,7.26%,MTG2;NGRN
prerank,vacuolar acidification (GO:0007035),-0.1900833607401923,-0.5482685137766142,0.9702380952380952,0.9921181976241231,1.0,11/21,33.67%,ATP6V0A4;TCIRG1;CLN5;CLN3;ATP6V1H;ATP6V0D2;CLN6;DMXL1;ATP6V0E2;SLC11A1;TMEM9
prerank,DNA replication-independent nucleosome organization (GO:0034724),0.2635757488310473,0.5461272574976712,0.9493243243243243,0.9959274611040106,1.0,4/11,20.99%,ASF1A;H3-3A;RBBP4;IPO4
prerank,regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.2658274250679163,0.5451277747297135,0.9262435677530018,0.9959347365302721,1.0,4/10,27.70%,APC;ECT2;KNSTRN;RCC2
prerank,termination of RNA polymerase I transcription (GO:0006363),0.21806571527978272,0.5449863500039929,0.9647058823529412,0.9956082727807567,1.0,5/30,14.18%,TAF1A;POLR1F;CAVIN1;GTF2H3;TAF1B
prerank,histone H2B ubiquitination (GO:0033523),0.26778034041684573,0.5428141433195262,0.9537480063795853,0.9960620382906649,1.0,6/10,27.64%,DTX3L;UBE2E1;RNF20;RNF40;RNF8;CDC73
prerank,DNA replication (GO:0006260),0.17586598319321786,0.5417797596980778,0.9976076555023924,0.9960719931544976,1.0,26/105,24.06%,RBBP8;WRNIP1;ORC3;FEN1;BRIP1;POLA1;POLG2;POLB;WDHD1;BRCA1;ORC5;RAD1;ATM;KAT7;RFC2;RAD9B;MCMBP;ATRIP;BARD1;HUS1;BLM;RMI1;ORC4;KIN;RNASEH2A;WRN
prerank,negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.22125275901377076,0.5417006546973255,0.9746646795827124,0.9957196405098196,1.0,11/24,28.73%,STN1;TNKS;XRN1;ERCC4;CTC1;EXOSC10;TERF2;TINF2;TNKS2;HNRNPC;HNRNPA1
prerank,folic acid metabolic process (GO:0046655),0.23222122745897023,0.5412707756075212,0.9663461538461539,0.9954934944457532,1.0,1/18,2.70%,SLC25A32
prerank,branched-chain amino acid catabolic process (GO:0009083),0.22592363490758355,0.5410777943486887,0.9680365296803652,0.9947994293874584,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,branched-chain amino acid metabolic process (GO:0009081),0.22592363490758355,0.5410777943486887,0.9680365296803652,0.9947994293874584,1.0,5/20,21.20%,BCAT2;DLD;BCKDHB;ACAT1;BCAT1
prerank,neuron projection fasciculation (GO:0106030),0.26767682297676154,0.5384905268592955,0.9323181049069373,0.995351291725687,1.0,4/10,21.58%,NRCAM;RTN4;CNTN4;EPHA4
prerank,tryptophan catabolic process (GO:0006569),0.26073311574190294,0.5362588115936212,0.9469453376205788,0.9957812837293462,1.0,11/11,73.94%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;AFMID;KMO
prerank,water-soluble vitamin metabolic process (GO:0006767),0.18281030233934295,0.53535236631512,0.995079950799508,0.9957245702613154,1.0,6/68,10.72%,SLC2A1;SLC25A32;THTPA;RFK;MMAA;PDZD11
prerank,isotype switching (GO:0045190),0.26133594674066685,0.5347468173641619,0.939799331103679,0.9955594253177028,1.0,1/10,7.65%,EXOSC3
prerank,DNA recombination (GO:0006310),0.20364359005103877,0.5345968636368746,0.9834938101788171,0.9952290270237116,1.0,3/37,9.50%,RAD54B;RAD21;HMGB1
prerank,glycoprotein catabolic process (GO:0006516),0.23648325007341925,0.5337330127403834,0.9655172413793104,0.995159724760966,1.0,6/17,19.34%,MANBA;FBXO2;OGA;FBXO6;NGLY1;NEU4
prerank,positive regulation of cytokinesis (GO:0032467),0.21303101769078014,0.5330545946206589,0.9789029535864979,0.994987971991812,1.0,7/32,21.88%,CUL3;CDC14A;PKN2;MAP10;GIPC1;ECT2;KIF23
prerank,negative regulation of secretion (GO:0051048),0.25680576281945056,0.5261492495280253,0.9433333333333334,0.9969731684422598,1.0,1/10,7.40%,VAMP8
prerank,immune response-activating cell surface receptor signaling pathway (GO:0002429),0.2309614981430858,0.5251391622474135,0.9625585023400937,0.9969091177331728,1.0,2/18,11.00%,CMKLR1;BAG6
prerank,fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),0.23444698953689527,0.5248890070736079,0.953198127925117,0.9966010255868425,1.0,5/14,22.69%,ACOX1;ACOX3;CROT;DECR2;HSD17B4
prerank,indolalkylamine catabolic process (GO:0046218),0.2607167513964729,0.5235574430669934,0.9504950495049505,0.9966309520141811,1.0,10/10,73.94%,KYAT1;KYNU;ACMSD;IDO1;TDO2;IDO2;AADAT;HAAO;IL4I1;KMO
prerank,DNA strand elongation involved in DNA replication (GO:0006271),-0.1866394044872056,-0.5222903166562123,0.9917127071823204,0.9981862874027972,1.0,10/18,37.65%,LIG3;POLD2;GINS1;POLE;RFC4;MCM7;POLE3;POLD3;GINS3;GINS2
prerank,DNA methylation (GO:0006306),0.21777921692726143,0.5205770448321676,0.9724238026124818,0.9971579980889606,1.0,4/23,13.04%,GATAD2A;KMT2E;DMAP1;PPM1D
prerank,cellular response to arsenic-containing substance (GO:0071243),0.2369420565587133,0.5184882339060625,0.9636963696369637,0.9973723922647064,1.0,6/15,28.73%,ZC3H12A;DAXX;PPIF;DHX36;ZFAND1;HNRNPA1
prerank,nucleobase-containing small molecule interconversion (GO:0015949),0.2057037730931084,0.5183983718078227,0.9836065573770492,0.9970136750324228,1.0,2/27,7.42%,CTPS1;CMPK1
prerank,regulation of adaptive immune response (GO:0002819),0.22641905536124918,0.5183673181042291,0.9665144596651446,0.9966400792104783,1.0,1/18,4.30%,FCGR2B
prerank,regulation of mitotic sister chromatid separation (GO:0010965),0.22901518952631525,0.5178786990085378,0.9741518578352181,0.9964019343693352,1.0,3/15,15.98%,PTTG1;CDC27;ANAPC7
prerank,"mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",-0.1900121279870069,-0.5169040160490482,0.9844559585492227,0.9984189643713116,1.0,3/17,12.93%,AFG1L;COX10;COX7A2L
prerank,telomere maintenance via telomerase (GO:0007004),0.20397701493558473,0.5126601320272354,0.9821917808219178,0.9975547033420707,1.0,12/28,29.42%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,"DNA damage response, signal transduction resulting in transcription (GO:0042772)",0.23650454486375214,0.5103074616949279,0.9666666666666667,0.9978189891360534,1.0,1/11,9.89%,MAD2L2
prerank,cilium-dependent cell motility (GO:0060285),-0.17542887238355076,-0.5087668371729018,0.991304347826087,0.9992147705002958,1.0,11/22,36.51%,CFAP44;EFHC1;RFX3;GAS8;RSPH9;DRC1;CCDC39;CCDC65;DNAAF2;TEKT2;DNAH17
prerank,hepatocyte growth factor receptor signaling pathway (GO:0048012),-0.20904292587681433,-0.5062627738647445,0.9847328244274809,0.9988228429782062,1.0,7/11,42.16%,SIRT2;STMN1;MST1R;HPN;PAK1;HGF;NRP1
prerank,DNA modification (GO:0006304),0.2110420199736197,0.505450425312117,0.9823529411764705,0.9987460935204665,1.0,22/22,78.92%,EXOSC3;TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1;SMUG1;NEIL3;MPG;MBD4;UNG;NEIL2;TDG;EXOSC4;EXOSC5;PARP2;NEIL1;PARP1;PARP3
prerank,regulation of phosphate metabolic process (GO:0019220),-0.18967790544358637,-0.5037589899016974,0.9863760217983651,0.998405097079301,1.0,16/16,81.06%,SIRT2;SRPX2;TIGAR;PSEN1;SMG6;MCM7;GNB3;IL4;RAD17;IKBKB;SMG5;PGAM1;IGBP1;SMG7;BARD1;CD24
prerank,cellular response to UV (GO:0034644),0.17403934750965358,0.5035234426628286,1.0,0.9988646804060297,1.0,21/76,26.25%,MMP1;HYAL2;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;XPC;BMF;PPID;TIMP1;COPS9;USP47;MME;TMEM161A;DHX36;CARD16;RPL26;PCNA;RUVBL2
prerank,3'-UTR-mediated mRNA destabilization (GO:0061158),0.2264814729549987,0.5017801225151306,0.968798751950078,0.9989246396827735,1.0,2/16,9.31%,ZC3H12A;ZFP36L2
prerank,NADH dehydrogenase complex assembly (GO:0010257),0.1829608613252452,0.5011510963433355,0.9973890339425587,0.9983088138716354,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,mitochondrial respiratory chain complex I assembly (GO:0032981),0.1829608613252452,0.5011510963433355,0.9973890339425587,0.9983088138716354,1.0,14/56,24.05%,TMEM126B;NDUFS4;NDUFA12;NDUFB5;NDUFB7;TIMMDC1;ACAD9;NUBPL;NDUFB4;NDUFA9;NDUFV1;BCS1L;NDUFC1;NDUFA11
prerank,macrophage migration (GO:1905517),-0.19678093956796944,-0.49967228611918646,0.9813333333333333,0.9982726543300162,1.0,7/13,39.28%,P2RX4;EDNRB;CKLF;CCR2;CCL2;CXCL17;CCL5
prerank,cellular response to light stimulus (GO:0071482),0.17257253728309563,0.49884085821883034,0.9975247524752475,0.9984881797361596,1.0,18/66,28.24%,RRH;RHBDD1;POLK;NSMCE3;NPM1;ERCC4;EIF2S1;BMF;COPS9;USP47;TMEM161A;DHX36;RPL26;PCNA;RUVBL2;SMPD1;ZBTB1;SAG
prerank,protein localization to mitochondrion (GO:0070585),-0.20857629624177587,-0.4962429936000111,0.9877450980392157,0.9979515206462538,1.0,2/11,11.10%,COX18;HK2
prerank,tRNA 5'-end processing (GO:0099116),-0.18705896245742457,-0.49451442724102096,0.9919786096256684,0.9973346005486555,1.0,8/15,41.18%,SSB;RPP14;POP4;HSD17B10;RPP25L;POP7;RPP40;POP5
prerank,Golgi to lysosome transport (GO:0090160),0.23831662468338352,0.49213888785607246,0.9734982332155477,0.9996385662266954,1.0,3/11,19.92%,LAPTM5;SORT1;CCDC91
prerank,negative regulation of protein exit from endoplasmic reticulum (GO:0070862),-0.20693938059111983,-0.48999039802453076,0.9836448598130841,0.997239624855097,1.0,4/10,30.36%,UBE2G2;ERLEC1;SVIP;DERL2
prerank,lysine metabolic process (GO:0006553),0.22461997315653093,0.48891901532515014,0.9713804713804713,0.9995650061692523,1.0,4/12,22.88%,DLD;AASS;PHYKPL;PIPOX
prerank,lysine catabolic process (GO:0006554),0.22461997315653093,0.48891901532515014,0.9713804713804713,0.9995650061692523,1.0,4/12,22.88%,DLD;AASS;PHYKPL;PIPOX
prerank,regulation of MHC class II biosynthetic process (GO:0045346),0.236224097935463,0.48881379181609913,0.9599332220367279,0.9992120075679336,1.0,1/11,8.22%,JAK2
prerank,DNA replication initiation (GO:0006270),0.1851137242604577,0.48674536526879747,0.9929577464788732,0.9992546464662809,1.0,4/37,12.09%,ORC3;PURA;POLA1;ORC5
prerank,"base-excision repair, gap-filling (GO:0006287)",0.18374650259417946,0.48509400379685264,0.9945130315500685,0.999202215185444,1.0,5/35,15.37%,APEX1;FEN1;POLB;LIG1;RFC2
prerank,detection of calcium ion (GO:0005513),0.2248225847780256,0.485035252670632,0.9777070063694268,0.9988323798985544,1.0,5/13,25.95%,CALM3;SYT1;KCNIP2;RYR2;CALM1
prerank,regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.19043455042064128,-0.48147020257201883,0.9868766404199475,0.9976695723501822,1.0,4/13,29.93%,MDK;RHOA;ITGB2;NFAT5
prerank,steroid catabolic process (GO:0006706),-0.21071336804189966,-0.48128369176006647,0.9810874704491725,0.9967915727169554,1.0,3/10,26.88%,SPP1;HSD11B1;HSD17B11
prerank,nucleoside salvage (GO:0043174),0.23033954685244473,0.47816750855723417,0.971900826446281,0.9997938846059327,1.0,10/10,76.98%,UPP2;TK1;UCK2;HPRT1;UCKL1;UPP1;TK2;DCK;UCK1;CDA
prerank,glycerolipid metabolic process (GO:0046486),-0.19978659302033644,-0.47624491321034357,0.9874371859296482,0.9966217667320739,1.0,11/11,80.04%,PLA2G15;GAL3ST1;PDXP;PNPLA3;DGKZ;PGP;DGKQ;PIP5K1A;DGKG;DGKB;DGKA
prerank,leukotriene metabolic process (GO:0006691),-0.1689688598582736,-0.47311155399496513,0.9917355371900827,0.9961686555364294,1.0,9/19,36.57%,PLA2G4A;GGT5;ALOX12;PTGR1;GGT1;PLA2G5;ALOX5AP;MGST2;ALOX5
prerank,regulation of lymphocyte proliferation (GO:0050670),0.21142454978913772,0.47018629585508076,0.9868204283360791,1.0,1.0,1/16,5.71%,TNFRSF1B
prerank,mitotic DNA integrity checkpoint signaling (GO:0044774),0.21769763190534944,0.46487585764687733,0.9915682967959528,1.0,1.0,5/12,30.05%,STK33;HUS1;CHEK2;NAE1;TOPBP1
prerank,serine family amino acid metabolic process (GO:0009069),0.20454570305842418,0.45855042105536986,0.9837133550488599,1.0,1.0,3/16,19.71%,GLYAT;SEPSECS;CDO1
prerank,positive regulation of keratinocyte differentiation (GO:0045618),0.22640274809422006,0.4578881929867855,0.984182776801406,1.0,1.0,3/10,26.67%,NUMA1;PRKCH;NCOA3
prerank,pyrimidine-containing compound metabolic process (GO:0072527),0.2177855874914584,0.45709962374535884,0.9848993288590604,1.0,1.0,3/11,22.32%,THTPA;NT5C3A;SLC25A19
prerank,tRNA 5'-leader removal (GO:0001682),-0.17932361871342167,-0.4564867817577974,0.9948979591836735,0.9972059591576171,1.0,9/13,47.19%,SSB;RPP14;POP4;RPP25L;POP7;RPP40;POP5;PRORP;RPP25
prerank,negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.21343520881602396,0.4532628476285057,0.9884488448844885,1.0,1.0,4/12,25.90%,ZC3H12A;ESR1;NCOR2;TGFB1
prerank,protein exit from endoplasmic reticulum (GO:0032527),0.18753977800587276,0.4518457561009352,0.9906976744186047,1.0,1.0,7/23,26.29%,HSP90B1;TMED9;SEL1L;TECPR2;TMEM129;SELENOS;HERPUD1
prerank,interleukin-7-mediated signaling pathway (GO:0038111),0.201018718282722,0.4471045317459365,0.9839743589743589,1.0,1.0,1/17,3.95%,CISH
prerank,cellular response to interleukin-7 (GO:0098761),0.201018718282722,0.4471045317459365,0.9839743589743589,1.0,1.0,1/17,3.95%,CISH
prerank,"base-excision repair, AP site formation (GO:0006285)",0.19559575293355294,0.4455118243174145,0.9832572298325722,1.0,1.0,8/17,32.43%,TERF2IP;MUTYH;TERF2;TINF2;OGG1;NTHL1;ACD;TERF1
prerank,oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),0.20616555101714792,0.44537885953367157,0.9902912621359223,1.0,1.0,4/13,20.37%,ALG14;ALG11;DPAGT1;ALG1
prerank,icosanoid metabolic process (GO:0006690),0.16596681200716393,0.44465514275817886,0.9946595460614153,1.0,1.0,12/40,27.52%,ALOXE3;ABCC1;ABCC10;PON2;PTGIS;PON3;MAPKAPK2;MGLL;TBXAS1;LTA4H;EPHX1;DPEP2
prerank,mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.20331956919373426,0.4439626443755212,0.9882352941176471,1.0,1.0,4/15,20.01%,NEK11;RAD9B;HUS1;MDC1
prerank,histone H2A ubiquitination (GO:0033522),0.19500176642977962,0.44365611448162007,0.9891640866873065,0.999721899670096,1.0,3/17,16.94%,RYBP;DTX3L;KDM2B
prerank,protein transmembrane import into intracellular organelle (GO:0044743),0.17505436746878994,0.44321392574853374,0.9942196531791907,0.9993928765531112,1.0,9/31,28.31%,TOMM20L;DNLZ;PAM16;PEX1;TIMM17A;PEX26;PEX6;PEX10;TOMM70
prerank,triglyceride catabolic process (GO:0019433),0.18789248932429042,0.44121327910480546,0.9970104633781763,0.9992383022822138,1.0,19/19,81.23%,FABP3;PNPLA2;PNPLA5;PNLIPRP2;PNPLA1;LIPI;FABP2;FABP6;APOC3;FABP5;CPS1;LIPG;PNPLA3;FABP12;FABP4;LIPC;LIPH;FABP7;LPL
prerank,sensory perception of smell (GO:0007608),0.21542331444712426,0.44074563012740736,0.9885245901639345,0.9989112453342172,1.0,3/11,29.47%,SLC24A4;MKKS;ADCY3
prerank,RNA-dependent DNA biosynthetic process (GO:0006278),0.17445928348863957,0.4399661709052645,0.9972489683631361,0.9986216265229431,1.0,12/29,29.42%,DKC1;PTGES3;NHP2;TERF2IP;SHQ1;TERF2;ANKRD28;WRAP53;TINF2;HSP90AA1;NOP10;HSP90AB1
prerank,protein neddylation (GO:0045116),0.2009797920364969,0.43493967703724035,0.9935691318327974,0.9987768138106424,1.0,5/13,32.12%,RBX1;DCUN1D2;RNF7;NAE1;UBE2M
prerank,positive regulation of leukocyte cell-cell adhesion (GO:1903039),0.17278069456733855,0.4298109713753221,0.9985815602836879,0.998924987640617,1.0,4/27,18.51%,CD47;PYCARD;ETS1;RELA
prerank,cobalamin metabolic process (GO:0009235),0.1852671938508001,0.42901396160956556,0.9921135646687698,0.9986203728731599,1.0,2/17,12.95%,MMAA;ABCC1
prerank,regulation of rhodopsin mediated signaling pathway (GO:0022400),0.17710366349799442,0.42550022331348425,0.9954268292682927,0.9985782270929547,1.0,2/23,12.51%,NMT1;METAP2
prerank,fibrinolysis (GO:0042730),-0.17313245448838668,-0.42150920580524076,0.9949874686716792,0.9990547493866028,1.0,13/13,82.71%,SERPINE1;PLAU;HRG;PLG;SERPINB2;CPB2;GP1BA;F2;KRT1;SERPINF2;FGG;PLAT;PLAUR
prerank,telomere capping (GO:0016233),0.18450858528446626,0.4154491973319562,0.9938080495356038,0.9990362837544259,1.0,5/16,25.77%,STN1;CTC1;TERF2IP;TERF2;TINF2
prerank,pyrimidine deoxyribonucleotide catabolic process (GO:0009223),-0.16151914626490899,-0.41368677784549546,0.9945652173913043,0.998582278214984,1.0,13/13,83.87%,NT5M;NEIL1;TDG;NEIL2;DCTPP1;UNG;DUT;MBD4;SMUG1;NTHL1;OGG1;NT5C;UPP2
prerank,regulation of homotypic cell-cell adhesion (GO:0034110),0.1899394566928335,0.4118376289522023,0.9968203497615262,0.9989129140145674,1.0,4/11,27.40%,ANK3;PLAUR;RDX;JAK1
prerank,regulation of mitotic spindle organization (GO:0060236),0.1572262753227045,0.4074352739605684,0.9985632183908046,0.9988538800959395,1.0,14/35,29.79%,HSPA1B;CHMP1B;NUMA1;CHMP3;CHMP2B;CHMP1A;RAE1;TPR;VPS4B;CHMP4B;EML3;DCTN1;CLTC;HSPA1A
prerank,regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),0.19396954865014743,0.40419368527065497,1.0,0.9986779212452749,1.0,2/10,17.53%,NPTX2;NPTX1
prerank,tetrapyrrole metabolic process (GO:0033013),0.17190550528862356,0.40133436446977516,0.9937402190923318,0.9984581525052546,1.0,2/18,12.95%,MMAA;ABCC1
prerank,central nervous system neuron axonogenesis (GO:0021955),0.19027862433747045,0.40074958605381794,0.9951377633711507,0.9981243418272753,1.0,6/12,31.49%,B4GALT6;HSP90AA1;MYCBP2;HSP90AB1;SPTBN4;B4GALT5
prerank,serine family amino acid catabolic process (GO:0009071),0.1818238875290278,0.3748481786631757,0.9947916666666666,0.998961446369205,1.0,10/10,81.83%,DLD;CBS;THNSL2;SDS;AMT;DAO;SHMT1;GLDC;SHMT2;GCSH
